Research
LSP Bibliography
2576724
IXMHRBF6
LSP Paper
2024
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KBFKNBQW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ahdritz%20et%20al.%22%2C%22parsedDate%22%3A%222024-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAhdritz%20G%2C%20Bouatta%20N%2C%20Floristean%20C%2C%20Kadyan%20S%2C%20Xia%20Q%2C%20Gerecke%20W%2C%20O%26%23x2019%3BDonnell%20TJ%2C%20Berenberg%20D%2C%20Fisk%20I%2C%20Zanichelli%20N%2C%20Zhang%20B%2C%20Nowaczynski%20A%2C%20Wang%20B%2C%20Stepniewska-Dziubinska%20MM%2C%20Zhang%20S%2C%20Ojewole%20A%2C%20Guney%20ME%2C%20Biderman%20S%2C%20Watkins%20AM%2C%20Ra%20S%2C%20Lorenzo%20PR%2C%20Nivon%20L%2C%20Weitzner%20B%2C%20Ban%20YEA%2C%20Chen%20S%2C%20Zhang%20M%2C%20Li%20C%2C%20Song%20SL%2C%20He%20Y%2C%20Sorger%20PK%2C%20Mostaque%20E%2C%20Zhang%20Z%2C%20Bonneau%20R%2C%20AlQuraishi%20M.%20OpenFold%3A%20retraining%20AlphaFold2%20yields%20new%20insights%20into%20its%20learning%20mechanisms%20and%20capacity%20for%20generalization.%20Nat%20Methods.%202024%20Aug%3B21%288%29%3A1514%26%23x2013%3B1524.%20PMID%3A%2038744917%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22OpenFold%3A%20retraining%20AlphaFold2%20yields%20new%20insights%20into%20its%20learning%20mechanisms%20and%20capacity%20for%20generalization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustaf%22%2C%22lastName%22%3A%22Ahdritz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazim%22%2C%22lastName%22%3A%22Bouatta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%22%2C%22lastName%22%3A%22Floristean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sachin%22%2C%22lastName%22%3A%22Kadyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qinghui%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Gerecke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22O%27Donnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Berenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Fisk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niccol%5Cu00f2%22%2C%22lastName%22%3A%22Zanichelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arkadiusz%22%2C%22lastName%22%3A%22Nowaczynski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%20M.%22%2C%22lastName%22%3A%22Stepniewska-Dziubinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shang%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adegoke%22%2C%22lastName%22%3A%22Ojewole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%20Efe%22%2C%22lastName%22%3A%22Guney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stella%22%2C%22lastName%22%3A%22Biderman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20M.%22%2C%22lastName%22%3A%22Watkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Ra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20Ribalta%22%2C%22lastName%22%3A%22Lorenzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucas%22%2C%22lastName%22%3A%22Nivon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Weitzner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yih-En%20Andrew%22%2C%22lastName%22%3A%22Ban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shiyang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minjia%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Conglong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuaiwen%20Leon%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuxiong%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emad%22%2C%22lastName%22%3A%22Mostaque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Bonneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22AlphaFold2%20revolutionized%20structural%20biology%20with%20the%20ability%20to%20predict%20protein%20structures%20with%20exceptionally%20high%20accuracy.%20Its%20implementation%2C%20however%2C%20lacks%20the%20code%20and%20data%20required%20to%20train%20new%20models.%20These%20are%20necessary%20to%20%281%29%20tackle%20new%20tasks%2C%20like%20protein-ligand%20complex%20structure%20prediction%2C%20%282%29%20investigate%20the%20process%20by%20which%20the%20model%20learns%20and%20%283%29%20assess%20the%20model%27s%20capacity%20to%20generalize%20to%20unseen%20regions%20of%20fold%20space.%20Here%20we%20report%20OpenFold%2C%20a%20fast%2C%20memory%20efficient%20and%20trainable%20implementation%20of%20AlphaFold2.%20We%20train%20OpenFold%20from%20scratch%2C%20matching%20the%20accuracy%20of%20AlphaFold2.%20Having%20established%20parity%2C%20we%20find%20that%20OpenFold%20is%20remarkably%20robust%20at%20generalizing%20even%20when%20the%20size%20and%20diversity%20of%20its%20training%20set%20is%20deliberately%20limited%2C%20including%20near-complete%20elisions%20of%20classes%20of%20secondary%20structure%20elements.%20By%20analyzing%20intermediate%20structures%20produced%20during%20training%2C%20we%20also%20gain%20insights%20into%20the%20hierarchical%20manner%20in%20which%20OpenFold%20learns%20to%20fold.%20In%20sum%2C%20our%20studies%20demonstrate%20the%20power%20and%20utility%20of%20OpenFold%2C%20which%20we%20believe%20will%20prove%20to%20be%20a%20crucial%20resource%20for%20the%20protein%20modeling%20community.%22%2C%22date%22%3A%222024-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-024-02272-z%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A25%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22G6LA8ARZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bhola%20and%20Letai%22%2C%22parsedDate%22%3A%222024-02-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBhola%20PD%2C%20Letai%20A.%20The%20Siren%20Song%20of%20Synergy.%20Blood%20Cancer%20Discov.%202024%20Feb%208%3BOF1%26%23x2013%3BOF2.%20PMID%3A%2038331415%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Siren%20Song%20of%20Synergy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20D.%22%2C%22lastName%22%3A%22Bhola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%5D%2C%22abstractNote%22%3A%22In%20ancient%20Greek%20mythology%2C%20sirens%20were%20creatures%20of%20stunning%20beauty%20whose%20mystical%20songs%20led%20sailors%20to%20sail%20their%20boats%20onto%20hidden%20rocks%20and%20into%20total%20destruction.%20In%20this%20issue%2C%20Mason-Osann%20and%20colleagues%20present%20data%20in%20the%20context%20of%20acute%20myelogenous%20leukemia%20to%20suggest%20that%20while%20synergy%20may%20show%20initial%20attractions%20in%20drug%20combinations%2C%20it%20may%20carry%20with%20it%20hazards%20previously%20unforeseen.%20See%20related%20article%20by%20Mason-Osann%20et%20al.%20%281%29.%22%2C%22date%22%3A%222024-02-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2643-3230.BCD-24-0004%22%2C%22ISSN%22%3A%222643-3249%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A59%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22KMXCNL8W%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Callahan%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECallahan%20TJ%2C%20Tripodi%20IJ%2C%20Stefanski%20AL%2C%20Cappelletti%20L%2C%20Taneja%20SB%2C%20Wyrwa%20JM%2C%20Casiraghi%20E%2C%20Matentzoglu%20NA%2C%20Reese%20J%2C%20Silverstein%20JC%2C%20Hoyt%20CT%2C%20Boyce%20RD%2C%20Malec%20SA%2C%20Unni%20DR%2C%20Joachimiak%20MP%2C%20Robinson%20PN%2C%20Mungall%20CJ%2C%20Cavalleri%20E%2C%20Fontana%20T%2C%20Valentini%20G%2C%20Mesiti%20M%2C%20Gillenwater%20LA%2C%20Santangelo%20B%2C%20Vasilevsky%20NA%2C%20Hoehndorf%20R%2C%20Bennett%20TD%2C%20Ryan%20PB%2C%20Hripcsak%20G%2C%20Kahn%20MG%2C%20Bada%20M%2C%20Baumgartner%20WA%2C%20Hunter%20LE.%20An%20open%20source%20knowledge%20graph%20ecosystem%20for%20the%20life%20sciences.%20Sci%20Data.%202024%20Apr%2011%3B11%281%29%3A363.%20PMCID%3A%20PMC11009265%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20open%20source%20knowledge%20graph%20ecosystem%20for%20the%20life%20sciences%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiffany%20J.%22%2C%22lastName%22%3A%22Callahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ignacio%20J.%22%2C%22lastName%22%3A%22Tripodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrianne%20L.%22%2C%22lastName%22%3A%22Stefanski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Cappelletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanya%20B.%22%2C%22lastName%22%3A%22Taneja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20M.%22%2C%22lastName%22%3A%22Wyrwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Casiraghi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%20A.%22%2C%22lastName%22%3A%22Matentzoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Reese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20C.%22%2C%22lastName%22%3A%22Silverstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Boyce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20A.%22%2C%22lastName%22%3A%22Malec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%20R.%22%2C%22lastName%22%3A%22Unni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcin%20P.%22%2C%22lastName%22%3A%22Joachimiak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20N.%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Mungall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22Cavalleri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tommaso%22%2C%22lastName%22%3A%22Fontana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Valentini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Mesiti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucas%20A.%22%2C%22lastName%22%3A%22Gillenwater%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brook%22%2C%22lastName%22%3A%22Santangelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20A.%22%2C%22lastName%22%3A%22Vasilevsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Hoehndorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tellen%20D.%22%2C%22lastName%22%3A%22Bennett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20B.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Hripcsak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20G.%22%2C%22lastName%22%3A%22Kahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Bada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20A.%22%2C%22lastName%22%3A%22Baumgartner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%20E.%22%2C%22lastName%22%3A%22Hunter%22%7D%5D%2C%22abstractNote%22%3A%22Translational%20research%20requires%20data%20at%20multiple%20scales%20of%20biological%20organization.%20Advancements%20in%20sequencing%20and%20multi-omics%20technologies%20have%20increased%20the%20availability%20of%20these%20data%2C%20but%20researchers%20face%20significant%20integration%20challenges.%20Knowledge%20graphs%20%28KGs%29%20are%20used%20to%20model%20complex%20phenomena%2C%20and%20methods%20exist%20to%20construct%20them%20automatically.%20However%2C%20tackling%20complex%20biomedical%20integration%20problems%20requires%20flexibility%20in%20the%20way%20knowledge%20is%20modeled.%20Moreover%2C%20existing%20KG%20construction%20methods%20provide%20robust%20tooling%20at%20the%20cost%20of%20fixed%20or%20limited%20choices%20among%20knowledge%20representation%20models.%20PheKnowLator%20%28Phenotype%20Knowledge%20Translator%29%20is%20a%20semantic%20ecosystem%20for%20automating%20the%20FAIR%20%28Findable%2C%20Accessible%2C%20Interoperable%2C%20and%20Reusable%29%20construction%20of%20ontologically%20grounded%20KGs%20with%20fully%20customizable%20knowledge%20representation.%20The%20ecosystem%20includes%20KG%20construction%20resources%20%28e.g.%2C%20data%20preparation%20APIs%29%2C%20analysis%20tools%20%28e.g.%2C%20SPARQL%20endpoint%20resources%20and%20abstraction%20algorithms%29%2C%20and%20benchmarks%20%28e.g.%2C%20prebuilt%20KGs%29.%20We%20evaluated%20the%20ecosystem%20by%20systematically%20comparing%20it%20to%20existing%20open-source%20KG%20construction%20methods%20and%20by%20analyzing%20its%20computational%20performance%20when%20used%20to%20construct%2012%20different%20large-scale%20KGs.%20With%20flexible%20knowledge%20representation%2C%20PheKnowLator%20enables%20fully%20customizable%20KGs%20without%20compromising%20performance%20or%20usability.%22%2C%22date%22%3A%222024-04-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-024-03171-w%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A46%3A07Z%22%7D%7D%2C%7B%22key%22%3A%229SANNNPM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Chidley%20et%20al.%22%2C%22parsedDate%22%3A%222024-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChidley%20C%2C%20Darnell%20AM%2C%20Gaudio%20BL%2C%20Lien%20EC%2C%20Barbeau%20AM%2C%20Vander%20Heiden%20MG%2C%20Sorger%20PK.%20A%20CRISPRi%5C%2Fa%20screening%20platform%20to%20study%20cellular%20nutrient%20transport%20in%20diverse%20microenvironments.%20Nat%20Cell%20Biol.%202024%20May%3B26%285%29%3A825%26%23x2013%3B838.%20PMCID%3A%20PMC11098743%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20CRISPRi%5C%2Fa%20screening%20platform%20to%20study%20cellular%20nutrient%20transport%20in%20diverse%20microenvironments%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20M.%22%2C%22lastName%22%3A%22Darnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20L.%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20C.%22%2C%22lastName%22%3A%22Lien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Barbeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Blocking%20the%20import%20of%20nutrients%20essential%20for%20cancer%20cell%20proliferation%20represents%20a%20therapeutic%20opportunity%2C%20but%20it%20is%20unclear%20which%20transporters%20to%20target.%20Here%20we%20report%20a%20CRISPR%20interference%5C%2Factivation%20screening%20platform%20to%20systematically%20interrogate%20the%20contribution%20of%20nutrient%20transporters%20to%20support%20cancer%20cell%20proliferation%20in%20environments%20ranging%20from%20standard%20culture%20media%20to%20tumours.%20We%20applied%20this%20platform%20to%20identify%20the%20transporters%20of%20amino%20acids%20in%20leukaemia%20cells%20and%20found%20that%20amino%20acid%20transport%20involves%20high%20bidirectional%20flux%20dependent%20on%20the%20microenvironment%20composition.%20While%20investigating%20the%20role%20of%20transporters%20in%20cystine%20starved%20cells%2C%20we%20uncovered%20a%20role%20for%20serotonin%20uptake%20in%20preventing%20ferroptosis.%20Finally%2C%20we%20identified%20transporters%20essential%20for%20cell%20proliferation%20in%20subcutaneous%20tumours%20and%20found%20that%20levels%20of%20glucose%20and%20amino%20acids%20can%20restrain%20proliferation%20in%20that%20environment.%20This%20study%20establishes%20a%20framework%20for%20systematically%20identifying%20critical%20cellular%20nutrient%20transporters%2C%20characterizing%20their%20function%20and%20exploring%20how%20the%20tumour%20microenvironment%20impacts%20cancer%20metabolism.%22%2C%22date%22%3A%222024-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41556-024-01402-1%22%2C%22ISSN%22%3A%221476-4679%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A59%3A38Z%22%7D%7D%2C%7B%22key%22%3A%224HVX38RM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Conger%20et%20al.%22%2C%22parsedDate%22%3A%222024-07-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EConger%20KO%2C%20Chidley%20C%2C%20Ozgurses%20ME%2C%20Zhao%20H%2C%20Kim%20Y%2C%20Semina%20SE%2C%20Burns%20P%2C%20Rawat%20V%2C%20Lietuvninkas%20L%2C%20Sheldon%20R%2C%20Ben-Sahra%20I%2C%20Frasor%20J%2C%20Sorger%20PK%2C%20DeNicola%20GM%2C%20Coloff%20JL.%20ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells.%20Cell%20Rep.%202024%20Jul%2026%3B43%288%29%3A114552.%20PMID%3A%2039068660%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%20O.%22%2C%22lastName%22%3A%22Conger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mete%20Emir%22%2C%22lastName%22%3A%22Ozgurses%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huiping%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yumi%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%20E.%22%2C%22lastName%22%3A%22Semina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippa%22%2C%22lastName%22%3A%22Burns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vipin%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lina%22%2C%22lastName%22%3A%22Lietuvninkas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Sheldon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Issam%22%2C%22lastName%22%3A%22Ben-Sahra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonna%22%2C%22lastName%22%3A%22Frasor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gina%20M.%22%2C%22lastName%22%3A%22DeNicola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20L.%22%2C%22lastName%22%3A%22Coloff%22%7D%5D%2C%22abstractNote%22%3A%22The%20non-essential%20amino%20acid%20serine%20is%20a%20critical%20nutrient%20for%20cancer%20cells%20due%20to%20its%20diverse%20biosynthetic%20functions.%20While%20some%20tumors%20can%20synthesize%20serine%20de%20novo%2C%20others%20are%20auxotrophic%20and%20therefore%20reliant%20on%20serine%20uptake.%20Importantly%2C%20despite%20several%20transporters%20being%20known%20to%20be%20capable%20of%20transporting%20serine%2C%20the%20transporters%20that%20mediate%20serine%20uptake%20in%20cancer%20cells%20are%20not%20known.%20Here%2C%20we%20characterize%20the%20amino%20acid%20transporter%20ASCT2%20%28SLC1A5%29%20as%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells.%20ASCT2%20is%20well%20known%20as%20a%20glutamine%20transporter%20in%20cancer%2C%20and%20our%20work%20demonstrates%20that%20serine%20and%20glutamine%20compete%20for%20uptake%20through%20ASCT2.%20We%20further%20show%20that%20ASCT2-mediated%20serine%20uptake%20is%20essential%20for%20purine%20nucleotide%20biosynthesis%20and%20that%20estrogen%20receptor%20%5Cu03b1%20%28ER%5Cu03b1%29%20promotes%20serine%20uptake%20by%20directly%20activating%20SLC1A5%20transcription.%20Collectively%2C%20our%20work%20defines%20an%20additional%20important%20role%20for%20ASCT2%20as%20a%20serine%20transporter%20in%20cancer%20and%20evaluates%20ASCT2%20as%20a%20potential%20therapeutic%20target.%22%2C%22date%22%3A%222024-07-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2024.114552%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A54%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22JMQL8SSC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Couce%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECouce%20A%2C%20Limdi%20A%2C%20Magnan%20M%2C%20Owen%20SV%2C%20Herren%20CM%2C%20Lenski%20RE%2C%20Tenaillon%20O%2C%20Baym%20M.%20Changing%20fitness%20effects%20of%20mutations%20through%20long-term%20bacterial%20evolution.%20Science.%202024%20Jan%2026%3B383%286681%29%3Aeadd1417.%20PMID%3A%2038271521%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Changing%20fitness%20effects%20of%20mutations%20through%20long-term%20bacterial%20evolution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%22%2C%22lastName%22%3A%22Couce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anurag%22%2C%22lastName%22%3A%22Limdi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Magnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20M.%22%2C%22lastName%22%3A%22Herren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20E.%22%2C%22lastName%22%3A%22Lenski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Tenaillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22The%20distribution%20of%20fitness%20effects%20of%20new%20mutations%20shapes%20evolution%2C%20but%20it%20is%20challenging%20to%20observe%20how%20it%20changes%20as%20organisms%20adapt.%20Using%20Escherichia%20coli%20lineages%20spanning%2050%2C000%20generations%20of%20evolution%2C%20we%20quantify%20the%20fitness%20effects%20of%20insertion%20mutations%20in%20every%20gene.%20Macroscopically%2C%20the%20fraction%20of%20deleterious%20mutations%20changed%20little%20over%20time%20whereas%20the%20beneficial%20tail%20declined%20sharply%2C%20approaching%20an%20exponential%20distribution.%20Microscopically%2C%20changes%20in%20individual%20gene%20essentiality%20and%20deleterious%20effects%20often%20occurred%20in%20parallel%3B%20altered%20essentiality%20is%20only%20partly%20explained%20by%20structural%20variation.%20The%20identity%20and%20effect%20sizes%20of%20beneficial%20mutations%20changed%20rapidly%20over%20time%2C%20but%20many%20targets%20of%20selection%20remained%20predictable%20because%20of%20the%20importance%20of%20loss-of-function%20mutations.%20Taken%20together%2C%20these%20results%20reveal%20the%20dynamic-but%20statistically%20predictable-nature%20of%20mutational%20fitness%20effects.%22%2C%22date%22%3A%222024-01-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.add1417%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A44%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22BYLLLUC2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Coy%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoy%20S%2C%20Lee%20JS%2C%20Chan%20SJ%2C%20Woo%20T%2C%20Jones%20J%2C%20Alexandrescu%20S%2C%20Wen%20PY%2C%20Sorger%20PK%2C%20Ligon%20KL%2C%20Santagata%20S.%20Systematic%20characterization%20of%20antibody-drug%20conjugate%20targets%20in%20central%20nervous%20system%20tumors.%20Neuro%20Oncol.%202024%20Mar%204%3B26%283%29%3A458%26%23x2013%3B472.%20PMCID%3A%20PMC10912007%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systematic%20characterization%20of%20antibody-drug%20conjugate%20targets%20in%20central%20nervous%20system%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Suk%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%20J.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terri%22%2C%22lastName%22%3A%22Woo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacquelyn%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanda%22%2C%22lastName%22%3A%22Alexandrescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Antibody-drug%20conjugates%20%28ADCs%29%20enhance%20the%20specificity%20of%20cytotoxic%20drugs%20by%20directing%20them%20to%20cells%20expressing%20target%20antigens.%20Multiple%20ADCs%20are%20FDA-approved%20for%20solid%20and%20hematologic%20malignancies%2C%20including%20those%20expressing%20HER2%2C%20TROP2%2C%20and%20NECTIN4.%20Recently%2C%20an%20ADC%20targeting%20HER2%20%28Trastuzumab-Deruxtecan%29%20increased%20survival%20and%20reduced%20growth%20of%20brain%20metastases%20in%20treatment-refractory%20metastatic%20breast%20cancer%2C%20even%20in%20tumors%20with%20low%20HER2%20expression.%20Thus%2C%20low-level%20expression%20of%20ADC%20targets%20may%20be%20sufficient%20for%20treatment%20responsiveness.%20However%2C%20ADC%20target%20expression%20is%20poorly%20characterized%20in%20many%20central%20nervous%20system%20%28CNS%29%20tumors.%5CnMETHODS%3A%20We%20analyzed%20publicly%20available%20RNA-sequencing%20and%20proteomic%20data%20from%20the%20children%27s%20brain%20tumor%20network%20%28N%5Cu2005%3D%5Cu2005188%20tumors%29%20and%20gene-expression-omnibus%20RNA-expression%20datasets%20%28N%5Cu2005%3D%5Cu2005356%29%20to%20evaluate%20expression%20of%2014%20potential%20ADC%20targets%20that%20are%20FDA-approved%20or%20under%20investigation%20in%20solid%20cancers.%20We%20also%20used%20immunohistochemistry%20to%20measure%20the%20levels%20of%20HER2%2C%20HER3%2C%20NECTIN4%2C%20TROP2%2C%20CLDN6%2C%20CLDN18.2%2C%20and%20CD276%5C%2FB7-H3%20protein%20in%20glioblastoma%2C%20oligodendroglioma%2C%20meningioma%2C%20ependymoma%2C%20pilocytic%20astrocytoma%2C%20medulloblastoma%2C%20atypical%20teratoid%5C%2Frhabdoid%20tumor%20%28AT%5C%2FRT%29%2C%20adamantinomatous%20craniopharyngioma%20%28ACP%29%2C%20papillary%20craniopharyngioma%20%28PCP%29%2C%20and%20primary%20CNS%20lymphoma%20%28N%5Cu2005%3D%5Cu2005575%29.%5CnRESULTS%3A%20Pan-CNS%20analysis%20showed%20subtype-specific%20expression%20of%20ADC%20target%20proteins.%20Most%20tumors%20expressed%20HER3%2C%20B7-H3%2C%20and%20NECTIN4.%20Ependymomas%20strongly%20expressed%20HER2%2C%20while%20meningiomas%20showed%20weak-moderate%20HER2%20expression.%20ACP%20and%20PCP%20strongly%20expressed%20B7-H3%2C%20with%20TROP2%20expression%20in%20whorled%20ACP%20epithelium.%20AT%5C%2FRT%20strongly%20expressed%20CLDN6.%20Glioblastoma%20showed%20little%20subtype-specific%20marker%20expression%2C%20suggesting%20a%20need%20for%20further%20target%20development.%5CnCONCLUSIONS%3A%20CNS%20tumors%20exhibit%20subtype-specific%20expression%20of%20ADC%20targets%20including%20several%20FDA-approved%20for%20other%20indications.%20Clinical%20trials%20of%20ADCs%20in%20CNS%20tumors%20may%20therefore%20be%20warranted.%22%2C%22date%22%3A%222024-03-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoad205%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A12%3A14Z%22%7D%7D%2C%7B%22key%22%3A%2237QS2S8P%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22De%20Bruijn%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDe%20Bruijn%20I%2C%20Nikolov%20M%2C%20Lau%20C%2C%20Clayton%20A%2C%20Gibbs%20DL%2C%20Mitraka%20E%2C%20Pozhidayeva%20D%2C%20Lash%20A%2C%20Sumer%20SO%2C%20Altreuter%20J%2C%20Anton%20K%2C%20DeFelice%20M%2C%20Li%20X%2C%20Lisman%20A%2C%20R%20Longabaugh%20WJ%2C%20Muhlich%20J%2C%20Santagata%20S%2C%20Nandakumar%20S%2C%20Sorger%20PK%2C%20Suver%20C%2C%20Schultz%20N%2C%20Taylor%20AJ%2C%20Thorsson%20V%2C%20Cerami%20E%2C%20Eddy%20JA.%20Sharing%20Data%20from%20the%20Human%20Tumor%20Atlas%20Network%20through%20Standards%2C%20Infrastructure%2C%20and%20Community%20Engagement.%20bioRxiv%3B%202024.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Sharing%20Data%20from%20the%20Human%20Tumor%20Atlas%20Network%20through%20Standards%2C%20Infrastructure%2C%20and%20Community%20Engagement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22De%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milen%22%2C%22lastName%22%3A%22Nikolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarisse%22%2C%22lastName%22%3A%22Lau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%22%2C%22lastName%22%3A%22Clayton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20L%22%2C%22lastName%22%3A%22Gibbs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvira%22%2C%22lastName%22%3A%22Mitraka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dar%5Cu2019ya%22%2C%22lastName%22%3A%22Pozhidayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Lash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selcuk%20Onur%22%2C%22lastName%22%3A%22Sumer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Altreuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Anton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mialy%22%2C%22lastName%22%3A%22DeFelice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Lisman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J%22%2C%22lastName%22%3A%22R%20Longabaugh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhiksha%22%2C%22lastName%22%3A%22Nandakumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Suver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9steinn%22%2C%22lastName%22%3A%22Thorsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Cerami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A%22%2C%22lastName%22%3A%22Eddy%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20The%20Data%20Coordinating%20Center%20%28DCC%29%20of%20the%20Human%20Tumor%20Atlas%20Network%20%28HTAN%29%20has%20played%20a%20crucial%20role%20in%20enabling%20the%20broad%20sharing%20and%20effective%20utilization%20of%20HTAN%20data%20within%20the%20scienti%5Cufb01c%20community.%20Data%20from%20the%20%5Cufb01rst%20phase%20of%20HTAN%20are%20now%20available%20publicly.%20We%20describe%20the%20diverse%20datasets%20and%20modalities%20shared%2C%20multiple%20access%20routes%20to%20HTAN%20assay%20data%20and%20metadata%2C%20data%20standards%2C%20technical%20infrastructure%20and%20governance%20approaches%2C%20as%20well%20as%20our%20approach%20to%20sustained%20community%20engagement.%20HTAN%20data%20can%20be%20accessed%20via%20the%20HTAN%20Portal%2C%20explored%20in%20visualization%20tools%5Cu2014including%20CellxGene%2C%20Minerva%2C%20and%20cBioPortal%5Cu2014and%20analyzed%20in%20the%20cloud%20through%20the%20NCI%20Cancer%20Research%20Data%20Commons%20nodes.%20We%20have%20developed%20a%20streamlined%20infrastructure%20to%20ingest%20and%20disseminate%20data%20by%20leveraging%20the%20Synapse%20platform.%20Taken%20together%2C%20the%20HTAN%20DCC%5Cu2019s%20approach%20demonstrates%20a%20successful%20model%20for%20coordinating%2C%20standardizing%2C%20and%20disseminating%20complex%20cancer%20research%20data%20via%20multiple%20resources%20in%20the%20cancer%20data%20ecosystem%2C%20offering%20valuable%20insights%20for%20similar%20consortia%2C%20and%20researchers%20looking%20to%20leverage%20HTAN%20data.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-06-30%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.06.25.598921%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A40%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22IX78GQQK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22De%20Los%20Angeles%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDe%20Los%20Angeles%20A%2C%20Hug%20CB%2C%20Gladyshev%20VN%2C%20Church%20GM%2C%20Velychko%20S.%20Sendai%20virus%20persistence%20questions%20the%20transient%20naive%20reprogramming%20method%20for%20iPSC%20generation%20%5BInternet%5D.%20bioRxiv%3B%202024.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.07.583804%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.07.583804%3C%5C%2Fa%3E%20PMCID%3A%20PMC10979911%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Sendai%20virus%20persistence%20questions%20the%20transient%20naive%20reprogramming%20method%20for%20iPSC%20generation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%22%2C%22lastName%22%3A%22De%20Los%20Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%20B.%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vadim%20N.%22%2C%22lastName%22%3A%22Gladyshev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20M.%22%2C%22lastName%22%3A%22Church%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergiy%22%2C%22lastName%22%3A%22Velychko%22%7D%5D%2C%22abstractNote%22%3A%22Since%20the%20revolutionary%20discovery%20of%20induced%20pluripotent%20stem%20cells%20%28iPSCs%29%20by%20Shinya%20Yamanaka%2C%20the%20comparison%20between%20iPSCs%20and%20embryonic%20stem%20cells%20%28ESCs%29%20has%20revealed%20significant%20differences%20in%20their%20epigenetic%20states%20and%20developmental%20potential.%20A%20recent%20compelling%20study%20published%20in%20Nature%20by%20Buckberry%20et%20al.1%20demonstrated%20that%20a%20transient-naive-treatment%20%28TNT%29%20could%20facilitate%20epigenetic%20reprogramming%20and%20improve%20the%20developmental%20potential%20of%20human%20iPSCs%20%28hiPSCs%29.%20However%2C%20the%20study%20characterized%20bulk%20hiPSCs%20instead%20of%20isolating%20clonal%20lines%20and%20overlooked%20the%20persistent%20expression%20of%20Sendai%20virus%20carrying%20exogenous%20Yamanaka%20factors.%20Our%20analyses%20revealed%20that%20Sendai%20genes%20were%20expressed%20in%20most%20control%20PSC%20samples%2C%20including%20hESCs%2C%20which%20were%20not%20intentionally%20infected.%20The%20highest%20levels%20of%20Sendai%20expression%20were%20detected%20in%20samples%20continuously%20treated%20with%20naive%20media%2C%20where%20it%20led%20to%20overexpression%20of%20exogenous%20MYC%2C%20SOX2%2C%20and%20KLF4%2C%20altering%20both%20the%20expression%20levels%20and%20ratios%20of%20reprogramming%20factors.%20Our%20findings%20call%20for%20further%20research%20to%20verify%20the%20effectiveness%20of%20the%20TNT%20method%20in%20the%20context%20of%20delivery%20methods%20that%20ensure%20prompt%20elimination%20of%20exogenous%20factors%2C%20leading%20to%20the%20generation%20of%20bona%20fide%20transgene-independent%20iPSCs.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-03-12%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.03.07.583804%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.07.583804%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A11%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22KUFQ3CJ7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Deng%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDeng%20X%2C%20Seguinot%20BO%2C%20Bradshaw%20G%2C%20Lee%20JS%2C%20Coy%20S%2C%20Kalocsay%20M%2C%20Santagata%20S%2C%20Mitchison%20T.%20STMND1%20is%20a%20phylogenetically%20ancient%20stathmin%20which%20localizes%20to%20motile%20cilia%20and%20exhibits%20nuclear%20translocation%20that%20is%20inhibited%20when%20soluble%20tubulin%20concentration%20increases.%20Mol%20Biol%20Cell.%202024%20Jun%201%3B35%286%29%3Aar82.%20PMCID%3A%20PMC11238091%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22STMND1%20is%20a%20phylogenetically%20ancient%20stathmin%20which%20localizes%20to%20motile%20cilia%20and%20exhibits%20nuclear%20translocation%20that%20is%20inhibited%20when%20soluble%20tubulin%20concentration%20increases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20O.%22%2C%22lastName%22%3A%22Seguinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Suk%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Stathmins%20are%20small%2C%20unstructured%20proteins%20that%20bind%20tubulin%20dimers%20and%20are%20implicated%20in%20several%20human%20diseases%2C%20but%20whose%20function%20remains%20unknown.%20We%20characterized%20a%20new%20stathmin%2C%20STMND1%20%28Stathmin%20Domain%20Containing%201%29%20as%20the%20human%20representative%20of%20an%20ancient%20subfamily.%20STMND1%20features%20a%20N-terminal%20myristoylated%20and%20palmitoylated%20motif%20which%20directs%20it%20to%20membranes%20and%20a%20tubulin-binding%20stathmin-like%20domain%20%28SLD%29%20that%20contains%20an%20internal%20nuclear%20localization%20signal.%20Biochemistry%20and%20proximity%20labeling%20showed%20that%20STMND1%20binds%20tubulin%2C%20and%20live%20imaging%20showed%20that%20tubulin%20binding%20inhibits%20translocation%20from%20cellular%20membranes%20to%20the%20nucleus.%20STMND1%20is%20highly%20expressed%20in%20multiciliated%20epithelial%20cells%2C%20where%20it%20localizes%20to%20motile%20cilia.%20Overexpression%20in%20a%20model%20system%20increased%20the%20length%20of%20primary%20cilia.%20Our%20study%20suggests%20that%20the%20most%20ancient%20stathmins%20have%20cilium-related%20functions%20that%20involve%20sensing%20soluble%20tubulin.%22%2C%22date%22%3A%222024-06-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1091%5C%2Fmbc.E23-12-0514%22%2C%22ISSN%22%3A%221939-4586%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-08-13T03%3A59%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22GERXJZ4D%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Do%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDo%20BT%2C%20Hsu%20PP%2C%20Vermeulen%20SY%2C%20Wang%20Z%2C%20Hirz%20T%2C%20Abbott%20KL%2C%20Aziz%20N%2C%20Replogle%20JM%2C%20Bjelosevic%20S%2C%20Paolino%20J%2C%20Nelson%20SA%2C%20Block%20S%2C%20Darnell%20AM%2C%20Ferreira%20R%2C%20Zhang%20H%2C%20Milosevic%20J%2C%20Schmidt%20DR%2C%20Chidley%20C%2C%20Harris%20IS%2C%20Weissman%20JS%2C%20Pikman%20Y%2C%20Stegmaier%20K%2C%20Cheloufi%20S%2C%20Su%20XA%2C%20Sykes%20DB%2C%20Vander%20Heiden%20MG.%20Nucleotide%20depletion%20promotes%20cell%20fate%20transitions%20by%20inducing%20DNA%20replication%20stress.%20Dev%20Cell.%202024%20Aug%2019%3B59%2816%29%3A2203-2221.e15.%20PMID%3A%2038823395%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nucleotide%20depletion%20promotes%20cell%20fate%20transitions%20by%20inducing%20DNA%20replication%20stress%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20T.%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peggy%20P.%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sidney%20Y.%22%2C%22lastName%22%3A%22Vermeulen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhishan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taghreed%22%2C%22lastName%22%3A%22Hirz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keene%20L.%22%2C%22lastName%22%3A%22Abbott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najihah%22%2C%22lastName%22%3A%22Aziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Replogle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Bjelosevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Paolino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20A.%22%2C%22lastName%22%3A%22Nelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Block%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20M.%22%2C%22lastName%22%3A%22Darnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanyu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jelena%22%2C%22lastName%22%3A%22Milosevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20S.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20S.%22%2C%22lastName%22%3A%22Weissman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yana%22%2C%22lastName%22%3A%22Pikman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Stegmaier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sihem%22%2C%22lastName%22%3A%22Cheloufi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaofeng%20A.%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20B.%22%2C%22lastName%22%3A%22Sykes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%5D%2C%22abstractNote%22%3A%22Control%20of%20cellular%20identity%20requires%20coordination%20of%20developmental%20programs%20with%20environmental%20factors%20such%20as%20nutrient%20availability%2C%20suggesting%20that%20perturbing%20metabolism%20can%20alter%20cell%20state.%20Here%2C%20we%20find%20that%20nucleotide%20depletion%20and%20DNA%20replication%20stress%20drive%20differentiation%20in%20human%20and%20murine%20normal%20and%20transformed%20hematopoietic%20systems%2C%20including%20patient-derived%20acute%20myeloid%20leukemia%20%28AML%29%20xenografts.%20These%20cell%20state%20transitions%20begin%20during%20S%20phase%20and%20are%20independent%20of%20ATR%5C%2FATM%20checkpoint%20signaling%2C%20double-stranded%20DNA%20break%20formation%2C%20and%20changes%20in%20cell%20cycle%20length.%20In%20systems%20where%20differentiation%20is%20blocked%20by%20oncogenic%20transcription%20factor%20expression%2C%20replication%20stress%20activates%20primed%20regulatory%20loci%20and%20induces%20lineage-appropriate%20maturation%20genes%20despite%20the%20persistence%20of%20progenitor%20programs.%20Altering%20the%20baseline%20cell%20state%20by%20manipulating%20transcription%20factor%20expression%20causes%20replication%20stress%20to%20induce%20genes%20specific%20for%20alternative%20lineages.%20The%20ability%20of%20replication%20stress%20to%20selectively%20activate%20primed%20maturation%20programs%20across%20different%20contexts%20suggests%20a%20general%20mechanism%20by%20which%20changes%20in%20metabolism%20can%20promote%20lineage-appropriate%20cell%20state%20transitions.%22%2C%22date%22%3A%222024-08-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.devcel.2024.05.010%22%2C%22ISSN%22%3A%221878-1551%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A21%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22R4LG2E6E%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Eschbacher%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EEschbacher%20KL%2C%20Tran%20QT%2C%20Moskalev%20EA%2C%20Jenkins%20S%2C%20Fritchie%20K%2C%20Stoehr%20R%2C%20Caron%20A%2C%20Link%20MJ%2C%20Brown%20PD%2C%20Guajardo%20A%2C%20Brat%20DJ%2C%20Wu%20A%2C%20Santagata%20S%2C%20Louis%20DN%2C%20Brastianos%20PK%2C%20Kaplan%20AB%2C%20Alexander%20B%2C%20Rossi%20S%2C%20Ferrarese%20F%2C%20Raleigh%20DR%2C%20Nguyen%20MP%2C%20Gross%20J%2C%20Velazquez%20Vega%20J%2C%20Rodriguez%20F%2C%20Perry%20A%2C%20Martinez-Lage%20M%2C%20Orr%20BA%2C%20Haller%20F%2C%20Giannini%20C.%20NAB2%3A%3ASTAT6%20fusions%20and%20genome-wide%20DNA%20methylation%20profiling%3A%20Predictors%20of%20patient%20outcomes%20in%20meningeal%20solitary%20fibrous%20tumors.%20Brain%20Pathol.%202024%20Mar%2024%3Be13256.%20PMID%3A%2038523251%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22NAB2%3A%3ASTAT6%20fusions%20and%20genome-wide%20DNA%20methylation%20profiling%3A%20Predictors%20of%20patient%20outcomes%20in%20meningeal%20solitary%20fibrous%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20L.%22%2C%22lastName%22%3A%22Eschbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quynh%20T.%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evgeny%20A.%22%2C%22lastName%22%3A%22Moskalev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Fritchie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Stoehr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alissa%22%2C%22lastName%22%3A%22Caron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Link%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20D.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Guajardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Brat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20N.%22%2C%22lastName%22%3A%22Louis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20B.%22%2C%22lastName%22%3A%22Kaplan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Rossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Ferrarese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Raleigh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20P.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Gross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Velazquez%20Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fausto%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arie%22%2C%22lastName%22%3A%22Perry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Martinez-Lage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brent%20A.%22%2C%22lastName%22%3A%22Orr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Haller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caterina%22%2C%22lastName%22%3A%22Giannini%22%7D%5D%2C%22abstractNote%22%3A%22Meningeal%20solitary%20fibrous%20tumors%20%28SFT%29%20are%20rare%20and%20have%20a%20high%20frequency%20of%20local%20recurrence%20and%20distant%20metastasis.%20In%20a%20cohort%20of%20126%20patients%20%2857%20female%2C%2069%20male%3B%20mean%20age%20at%20surgery%2053.0%5Cu2009years%29%20with%20pathologically%20confirmed%20meningeal%20SFTs%20with%20extended%20clinical%20follow-up%20%28median%209.9%5Cu2009years%3B%20range%2015%5Cu2009days-43%5Cu2009years%29%2C%20we%20performed%20extensive%20molecular%20characterization%20including%20genome-wide%20DNA%20methylation%20profiling%20%28n%5Cu2009%3D%5Cu200980%29%20and%20targeted%20TERT%20promoter%20mutation%20testing%20%28n%5Cu2009%3D%5Cu200998%29.%20Associations%20were%20examined%20with%20NAB2%3A%3ASTAT6%20fusion%20status%20%28n%5Cu2009%3D%5Cu2009101%20cases%3B%2051%5Cu2009%3D%5Cu2009ex5-7%3A%3Aex16-17%2C%2026%5Cu2009%3D%5Cu2009ex4%3A%3Aex2-3%3B%2012%5Cu2009%3D%5Cu2009ex2-3%3A%3AexANY%5C%2Fother%20and%2012%5Cu2009%3D%5Cu2009no%20fusion%29%20and%20placed%20in%20the%20context%20of%202021%20Central%20Nervous%20System%20%28CNS%29%20WHO%20grade.%20NAB2%3A%3ASTAT6%20fusion%20breakpoints%20%28fusion%20type%29%20were%20significantly%20associated%20with%20metastasis-free%20survival%20%28MFS%29%20%28p%5Cu2009%3D%5Cu20090.03%29%20and%2C%20on%20multivariate%20analysis%2C%20disease-specific%20survival%20%28DSS%29%20when%20adjusting%20for%20CNS%20WHO%20grade%20%28p%5Cu2009%3D%5Cu20090.03%29.%20DNA%20methylation%20profiling%20revealed%20three%20distinct%20clusters%3A%20Cluster%201%20%28n%5Cu2009%3D%5Cu200938%29%2C%20Cluster%202%20%28n%5Cu2009%3D%5Cu200922%29%2C%20and%20Cluster%203%20%28n%5Cu2009%3D%5Cu200920%29.%20Methylation%20clusters%20were%20significantly%20associated%20with%20fusion%20type%20%28p%5Cu2009%3C%5Cu20090.001%29%2C%20with%20Cluster%202%20harboring%20ex4%3A%3Aex2-3%20fusion%20in%2016%20%28of%2020%3B%2080.0%25%29%2C%20nearly%20all%20TERT%20promoter%20mutations%20%287%20of%208%3B%2087.5%25%29%2C%20and%20predominantly%20an%20%5C%22SFT%5C%22%20histologic%20phenotype%20%2815%20of%2022%3B%2068.2%25%29.%20Clusters%201%20and%203%20were%20less%20distinct%2C%20both%20dominated%20by%20tumors%20having%20ex5-7%3A%3Aex16-17%20fusion%20%28respectively%2C%2025%20of%2033%3B%2075.8%25%2C%20and%2012%20of%2018%3B%2066.7%25%29%20and%20with%20variable%20histological%20phenotypes.%20Methylation%20clusters%20were%20significantly%20associated%20with%20MFS%20%28p%5Cu2009%3D%5Cu20090.027%29%2C%20but%20not%20overall%20survival%20%28OS%29.%20In%20summary%2C%20NAB2%3A%3ASTAT6%20fusion%20type%20was%20significantly%20associated%20with%20MFS%20and%20DSS%2C%20suggesting%20that%20tumors%20with%20an%20ex5%3A%3Aex16-17%20fusion%20may%20have%20inferior%20patient%20outcomes.%20Methylation%20clusters%20were%20significantly%20associated%20with%20fusion%20type%2C%20TERT%20promoter%20mutation%20status%2C%20histologic%20phenotype%2C%20and%20MFS.%22%2C%22date%22%3A%222024-03-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fbpa.13256%22%2C%22ISSN%22%3A%221750-3639%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A08%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22LAEIHNXK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Fang%20et%20al.%22%2C%22parsedDate%22%3A%222024-07-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFang%20R%2C%20Vallius%20T%2C%20Zhang%20A%2C%20Van%20Cura%20D%2C%20Alicandri%20F%2C%20Fischer%20G%2C%20Draper%20E%2C%20Xu%20S%2C%20Pelletier%20R%2C%20Katsyv%20I%2C%20Sorger%20PK%2C%20Murphy%20GF%2C%20Lian%20CG.%20PRAME%20expression%20in%20melanoma%20is%20negatively%20regulated%20by%20TET2-mediated%20DNA%20hydroxymethylation%20%5BInternet%5D.%20bioRxiv%3B%202024.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.07.26.605293%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.07.26.605293%3C%5C%2Fa%3E%20PMCID%3A%20PMC11291125%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22PRAME%20expression%20in%20melanoma%20is%20negatively%20regulated%20by%20TET2-mediated%20DNA%20hydroxymethylation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rui%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devon%22%2C%22lastName%22%3A%22Van%20Cura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Alicandri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grant%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Draper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuyun%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%22%2C%22lastName%22%3A%22Katsyv%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%5D%2C%22abstractNote%22%3A%22Preferentially%20Expressed%20Antigen%20in%20Melanoma%20%28PRAME%29%20and%20Ten-Eleven%20Translocation%20%28TET%29%20dioxygenase-mediated%205-hydroxymethylcytosine%20%285hmC%29%20are%20emerging%20melanoma%20biomarkers.%20We%20observed%20an%20inverse%20correlation%20between%20PRAME%20expression%20and%205hmC%20levels%20in%20benign%20nevi%2C%20melanoma%20in%20situ%2C%20primary%20invasive%20melanoma%2C%20and%20metastatic%20melanomas%20via%20immunohistochemistry%20and%20multiplex%20immunofluorescence%3A%20nevi%20exhibited%20high%205hmC%20and%20low%20PRAME%2C%20whereas%20melanomas%20showed%20the%20opposite%20pattern.%20Single-cell%20multiplex%20imaging%20of%20melanoma%20precursors%20revealed%20that%20diminished%205hmC%20coincides%20with%20PRAME%20upregulation%20in%20premalignant%20cells.%20Analysis%20of%20TCGA%20and%20GTEx%20databases%20confirmed%20a%20negative%20relationship%20between%20TET2%20and%20PRAME%20mRNA%20expression%20in%20melanoma.%20Additionally%2C%205hmC%20levels%20were%20reduced%20at%20the%20PRAME%205%27%20promoter%20in%20melanoma%20compared%20to%20nevi%2C%20suggesting%20a%20role%20for%205hmC%20in%20PRAME%20transcription.%20Restoring%205hmC%20levels%20via%20TET2%20overexpression%20notably%20reduced%20PRAME%20expression%20in%20melanoma%20cell%20lines.%20These%20findings%20establish%20a%20function%20of%20TET2-mediated%20DNA%20hydroxymethylation%20in%20regulating%20PRAME%20expression%20and%20demonstrate%20epigenetic%20reprogramming%20as%20pivotal%20in%20melanoma%20tumorigenesis.%5CnTEASER%3A%20Melanoma%20biomarker%20PRAME%20expression%20is%20negatively%20regulated%20epigenetically%20by%20TET2-mediated%20DNA%20hydroxymethylation.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-07-26%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.07.26.605293%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.07.26.605293%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A27%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22FZR727DJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gallo%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGallo%20PN%2C%20Mihelc%20E%2C%20Eisert%20R%2C%20Bradshaw%20GA%2C%20Dimek%20F%2C%20Leffler%20A%2C%20Kalocsay%20M%2C%20Moiseenkova-Bell%20V.%20The%20dynamic%20TRPV2%20ion%20channel%20proximity%20proteome%20reveals%20functional%20links%20of%20calcium%20flux%20with%20cellular%20adhesion%20factors%20NCAM%20and%20L1CAM%20in%20neurite%20outgrowth.%20Cell%20Calcium.%202024%20May%204%3B121%3A102894.%20PMID%3A%2038728789%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20dynamic%20TRPV2%20ion%20channel%20proximity%20proteome%20reveals%20functional%20links%20of%20calcium%20flux%20with%20cellular%20adhesion%20factors%20NCAM%20and%20L1CAM%20in%20neurite%20outgrowth%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20N.%22%2C%22lastName%22%3A%22Gallo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%22%2C%22lastName%22%3A%22Mihelc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Dimek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Leffler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vera%22%2C%22lastName%22%3A%22Moiseenkova-Bell%22%7D%5D%2C%22abstractNote%22%3A%22TRPV2%20voltage-insensitive%2C%20calcium-permeable%20ion%20channels%20play%20important%20roles%20in%20cancer%20progression%2C%20immune%20response%2C%20and%20neuronal%20development.%20Despite%20TRPV2%27s%20physiological%20impact%2C%20underlying%20endogenous%20proteins%20mediating%20TRPV2%20responses%20and%20affected%20signaling%20pathways%20remain%20elusive.%20Using%20quantitative%20peroxidase-catalyzed%20%28APEX2%29%20proximity%20proteomics%20we%20uncover%20dynamic%20changes%20in%20the%20TRPV2-proximal%20proteome%20and%20identify%20calcium%20signaling%20and%20cell%20adhesion%20factors%20recruited%20to%20the%20molecular%20channel%20neighborhood%20in%20response%20to%20activation.%20Quantitative%20TRPV2%20proximity%20proteomics%20further%20revealed%20activation-induced%20enrichment%20of%20protein%20clusters%20with%20biological%20functions%20in%20neural%20and%20cellular%20projection.%20We%20demonstrate%20a%20functional%20connection%20between%20TRPV2%20and%20the%20neural%20immunoglobulin%20cell%20adhesion%20molecules%20NCAM%20and%20L1CAM.%20NCAM%20and%20L1CAM%20stimulation%20robustly%20induces%20TRPV2%20%5BCa2%2B%5DI%20flux%20in%20neuronal%20PC12%20cells%20and%20this%20TRPV2-specific%20%5BCa2%2B%5DI%20flux%20requires%20activation%20of%20the%20protein%20kinase%20PKC%5Cu03b1.%20TRPV2%20expression%20directly%20impacts%20neurite%20lengths%20that%20are%20modulated%20by%20NCAM%20or%20L1CAM%20stimulation.%20Hence%2C%20TRPV2%27s%20calcium%20signaling%20plays%20a%20previously%20undescribed%2C%20yet%20vital%20role%20in%20cell%20adhesion%2C%20and%20TRPV2%20calcium%20flux%20and%20neurite%20development%20are%20intricately%20linked%20via%20NCAM%20and%20L1CAM%20cell%20adhesion%20proteins.%22%2C%22date%22%3A%222024-05-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ceca.2024.102894%22%2C%22ISSN%22%3A%221532-1991%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A41%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22Z8DVFU7U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ghosh%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGhosh%20HS%2C%20Patel%20RV%2C%20Woodward%20E%2C%20Greenwald%20NF%2C%20Bhave%20VM%2C%20Maury%20EA%2C%20Cello%20G%2C%20Hoffman%20SE%2C%20Li%20Y%2C%20Gupta%20H%2C%20Youssef%20G%2C%20Spurr%20LF%2C%20Vogelzang%20J%2C%20Touat%20M%2C%20Dubois%20F%2C%20Cherniack%20AD%2C%20Guo%20X%2C%20Tavakol%20S%2C%20Cioffi%20G%2C%20Lindeman%20NI%2C%20Ligon%20AH%2C%20Chiocca%20EA%2C%20Reardon%20DA%2C%20Wen%20PY%2C%20Meredith%20D%2C%20Santagata%20S%2C%20Barnholtz-Sloan%20JS%2C%20Ligon%20KL%2C%20Beroukhim%20R%2C%20Bi%20WL.%20Contemporary%20Prognostic%20Signatures%20and%20Refined%20Risk%20Stratification%20of%20Gliomas%3A%20An%20Analysis%20of%204%2C400%20Tumors.%20Neuro%20Oncol.%202024%20Aug%2021%3Bnoae164.%20PMID%3A%2039164213%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Contemporary%20Prognostic%20Signatures%20and%20Refined%20Risk%20Stratification%20of%20Gliomas%3A%20An%20Analysis%20of%204%2C400%20Tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hia%20S.%22%2C%22lastName%22%3A%22Ghosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruchit%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%22%2C%22lastName%22%3A%22Woodward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%20F.%22%2C%22lastName%22%3A%22Greenwald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%20M.%22%2C%22lastName%22%3A%22Bhave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20A.%22%2C%22lastName%22%3A%22Maury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Cello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20E.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hersh%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilbert%22%2C%22lastName%22%3A%22Youssef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%20F.%22%2C%22lastName%22%3A%22Spurr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%22%2C%22lastName%22%3A%22Vogelzang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Cherniack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaopeng%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherwin%22%2C%22lastName%22%3A%22Tavakol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gino%22%2C%22lastName%22%3A%22Cioffi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20I.%22%2C%22lastName%22%3A%22Lindeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azra%20H.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%20S.%22%2C%22lastName%22%3A%22Barnholtz-Sloan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20With%20the%20significant%20shift%20in%20the%20classification%2C%20risk%20stratification%2C%20and%20standards%20of%20care%20for%20gliomas%2C%20we%20sought%20to%20understand%20how%20the%20overall%20survival%20of%20patients%20with%20these%20tumors%20is%20impacted%20by%20molecular%20features%2C%20clinical%20metrics%2C%20and%20treatment%20received.%5CnMETHODS%3A%20We%20assembled%20a%20cohort%20of%20patients%20with%20a%20histopathologically%20diagnosed%20glioma%20from%20The%20Cancer%20Genome%20Atlas%2C%20Project%20Genomics%20Evidence%20Neoplasia%20Information%20Exchange%2C%20and%20Dana-Farber%20Cancer%20Institute%5C%2FBrigham%20and%20Women%27s%20Hospital.%20This%20incorporated%20retrospective%20clinical%2C%20histological%2C%20and%20molecular%20data%20alongside%20prospective%20assessment%20of%20patient%20survival.%5CnRESULTS%3A%204%2C400%20gliomas%20were%20identified%3A%202%2C195%20glioblastoma%2C%201%2C198%20IDH1%5C%2F2-mutant%20astrocytoma%2C%20531%20oligodendroglioma%2C%20271%20other%20IDH1%5C%2F2-wildtype%20glioma%2C%20and%20205%20pediatric-type%20glioma.%20Molecular%20classification%20updated%2027.2%25%20of%20gliomas%20from%20their%20original%20histopathologic%20diagnosis.%20Examining%20the%20distribution%20of%20molecular%20alterations%20across%20glioma%20subtypes%20revealed%20mutually%20exclusive%20alterations%20within%20tumorigenic%20pathways.%20Non-TCGA%20patients%20had%20significantly%20improved%20overall%20survival%20compared%20to%20TCGA%20patients%2C%20with%2026.7%25%2C%2055.6%25%2C%20and%20127.8%25%20longer%20survival%20for%20glioblastoma%2C%20IDH1%5C%2F2-mutant%20astrocytoma%2C%20and%20oligodendroglioma%20respectively%20%28all%20p%3C0.01%29.%20Several%20prognostic%20features%20were%20characterized%2C%20including%20NF1%20alteration%20and%2021q%20loss%20in%20glioblastoma%2C%20and%20EGFR%20amplification%20and%2022q%20loss%20in%20IDH1%5C%2F2-mutant%20astrocytoma.%20Leveraging%20the%20size%20of%20this%20cohort%2C%20nomograms%20were%20generated%20to%20assess%20the%20probability%20of%20overall%20survival%20based%20on%20patient%20age%2C%20the%20molecular%20features%20of%20a%20tumor%2C%20and%20the%20treatment%20received.%5CnCONCLUSIONS%3A%20By%20applying%20modern%20molecular%20criteria%2C%20we%20characterize%20the%20genomic%20diversity%20across%20glioma%20subtypes%2C%20identify%20clinically%20applicable%20prognostic%20features%2C%20and%20provide%20a%20contemporary%20update%20on%20patient%20survival%20to%20serve%20as%20a%20reference%20for%20ongoing%20investigations.%22%2C%22date%22%3A%222024-08-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoae164%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A20%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22EW8VTS3V%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gomez%20et%20al.%22%2C%22parsedDate%22%3A%222024-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGomez%20SM%2C%20Axtman%20AD%2C%20Willson%20TM%2C%20Major%20MB%2C%20Townsend%20RR%2C%20Sorger%20PK%2C%20Johnson%20GL.%20Illuminating%20function%20of%20the%20understudied%20druggable%20kinome.%20Drug%20Discov%20Today.%202024%20Mar%3B29%283%29%3A103881.%20PMCID%3A%20PMC11262466%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Illuminating%20function%20of%20the%20understudied%20druggable%20kinome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20M.%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20D.%22%2C%22lastName%22%3A%22Axtman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20M.%22%2C%22lastName%22%3A%22Willson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20B.%22%2C%22lastName%22%3A%22Major%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reid%20R.%22%2C%22lastName%22%3A%22Townsend%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20L.%22%2C%22lastName%22%3A%22Johnson%22%7D%5D%2C%22abstractNote%22%3A%22The%20human%20kinome%2C%20with%20more%20than%20500%20proteins%2C%20is%20crucial%20for%20cell%20signaling%20and%20disease.%20Yet%2C%20about%20one-third%20of%20kinases%20lack%20in-depth%20study.%20The%20Data%20and%20Resource%20Generating%20Center%20for%20Understudied%20Kinases%20has%20developed%20multiple%20resources%20to%20address%20this%20challenge%20including%20creation%20of%20a%20heavy%20amino%20acid%20peptide%20library%20for%20parallel%20reaction%20monitoring%20and%20quantitation%20of%20protein%20kinase%20expression%2C%20use%20of%20understudied%20kinases%20tagged%20with%20a%20miniTurbo-biotin%20ligase%20to%20determine%20interaction%20networks%20by%20proximity-dependent%20protein%20biotinylation%2C%20NanoBRET%20probe%20development%20for%20screening%20chemical%20tool%20target%20specificity%20in%20live%20cells%2C%20characterization%20of%20small%20molecule%20chemical%20tools%20inhibiting%20understudied%20kinases%2C%20and%20computational%20tools%20for%20defining%20kinome%20architecture.%20These%20resources%20are%20available%20through%20the%20Dark%20Kinase%20Knowledgebase%2C%20supporting%20further%20research%20into%20these%20understudied%20protein%20kinases.%22%2C%22date%22%3A%222024-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drudis.2024.103881%22%2C%22ISSN%22%3A%221878-5832%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A12%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22UWZNLHQ2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Grinshpun%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGrinshpun%20A%2C%20Russo%20D%2C%20Ma%20W%2C%20Verma%20A%2C%20Hermida-Prado%20F%2C%20Sherman%20S%2C%20Gaglia%20G%2C%20Kabraji%20S%2C%20Kirkner%20G%2C%20Hughes%20ME%2C%20Lin%20NU%2C%20Sandusky%20Z%2C%20Nardone%20A%2C%20Guarducci%20C%2C%20Nguyen%20QD%2C%20Santagata%20S%2C%20Nagy%20Z%2C%20Jeselsohn%20R.%20Pure%20estrogen%20receptor%20antagonists%20potentiate%20capecitabine%20activity%20in%20ESR1-mutant%20breast%20cancer.%20NPJ%20Breast%20Cancer.%202024%20Jun%208%3B10%281%29%3A42.%20PMCID%3A%20PMC11162492%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pure%20estrogen%20receptor%20antagonists%20potentiate%20capecitabine%20activity%20in%20ESR1-mutant%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Grinshpun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Russo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Verma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Hermida-Prado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shira%22%2C%22lastName%22%3A%22Sherman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheheryar%22%2C%22lastName%22%3A%22Kabraji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Kirkner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20E.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20U.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Sandusky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agostina%22%2C%22lastName%22%3A%22Nardone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Guarducci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quang-De%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zsuzsanna%22%2C%22lastName%22%3A%22Nagy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rinath%22%2C%22lastName%22%3A%22Jeselsohn%22%7D%5D%2C%22abstractNote%22%3A%22The%20ESR1%20ligand%20binding%20domain%20activating%20mutations%20are%20the%20most%20prevalent%20genetic%20mechanism%20of%20acquired%20endocrine%20resistance%20in%20metastatic%20hormone%20receptor-positive%20breast%20cancer.%20These%20mutations%20confer%20endocrine%20resistance%20that%20remains%20estrogen%20receptor%20%28ER%29%20dependent.%20We%20hypothesized%20that%20in%20the%20presence%20of%20the%20ER%20mutations%2C%20continued%20ER%20blockade%20with%20endocrine%20therapies%20that%20target%20mutant%20ER%20is%20essential%20for%20tumor%20suppression%20even%20with%20chemotherapy%20treatment.%20Here%2C%20we%20conducted%20comprehensive%20pre-clinical%20in%20vitro%20and%20in%20vivo%20experiments%20testing%20the%20efficacy%20of%20adding%20fulvestrant%20to%20fluorouracil%20%285FU%29%20and%20the%205FU%20pro-drug%2C%20capecitabine%2C%20in%20models%20of%20wild-type%20%28WT%29%20and%20mutant%20ER.%20Our%20findings%20revealed%20that%20while%20this%20combination%20had%20an%20additive%20effect%20in%20the%20presence%20of%20WT-ER%2C%20in%20the%20presence%20of%20the%20Y537S%20ER%20mutation%20there%20was%20synergy.%20Notably%2C%20these%20effects%20were%20not%20seen%20with%20the%20combination%20of%205FU%20and%20selective%20estrogen%20receptor%20modulators%2C%20such%20as%20tamoxifen%2C%20or%20in%20the%20absence%20of%20intact%20P53.%20Likewise%2C%20in%20a%20patient-derived%20xenograft%20%28PDX%29%20harboring%20a%20Y537S%20ER%20mutation%20the%20addition%20of%20fulvestrant%20to%20capecitabine%20potentiated%20tumor%20suppression.%20Moreover%2C%20multiplex%20immunofluorescence%20revealed%20that%20this%20effect%20was%20due%20to%20decreased%20cell%20proliferation%20in%20all%20cells%20expressing%20ER%20and%20was%20not%20dependent%20on%20the%20degree%20of%20ER%20expression.%20Taken%20together%2C%20these%20results%20support%20the%20clinical%20investigation%20of%20the%20combination%20of%20ER%20antagonists%20with%20capecitabine%20in%20patients%20with%20metastatic%20hormone%20receptor-positive%20breast%20cancer%20who%20have%20experienced%20progression%20on%20endocrine%20therapy%20and%20targeted%20therapies%2C%20particularly%20in%20the%20presence%20of%20an%20ESR1%20activating%20mutation.%22%2C%22date%22%3A%222024-06-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41523-024-00647-1%22%2C%22ISSN%22%3A%222374-4677%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-06-10T15%3A36%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22AVDHB6Q5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gritsch%20et%20al.%22%2C%22parsedDate%22%3A%222024-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGritsch%20D%2C%20Santagata%20S%2C%20Brastianos%20PK.%20Integrating%20Systemic%20Therapies%20into%20the%20Multimodality%20Therapy%20of%20Patients%20with%20Craniopharyngioma.%20Curr%20Treat%20Options%20Oncol.%202024%20Feb%3B25%282%29%3A261%26%23x2013%3B273.%20PMID%3A%2038300480%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrating%20Systemic%20Therapies%20into%20the%20Multimodality%20Therapy%20of%20Patients%20with%20Craniopharyngioma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Gritsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%5D%2C%22abstractNote%22%3A%22The%20integration%20of%20targeted%20therapy%20into%20the%20multimodal%20management%20of%20craniopharyngiomas%20represents%20a%20significant%20advancement%20in%20the%20field%20of%20neuro-oncology.%20Historically%2C%20the%20management%20of%20these%20tumors%20has%20been%20challenging%20due%20to%20their%20proximity%20to%20vital%20brain%20structures%2C%20necessitating%20a%20delicate%20balance%20between%20tumor%20control%20and%20the%20preservation%20of%20neurological%20function.%20Traditional%20treatment%20modalities%2C%20such%20as%20surgical%20resection%20and%20radiation%2C%20while%20effective%2C%20carry%20their%20own%20set%20of%20risks%2C%20including%20potential%20damage%20to%20surrounding%20healthy%20tissues%20and%20the%20potential%20for%20long-term%20side%20effects.%20Recent%20insights%20into%20the%20molecular%20biology%20of%20craniopharyngiomas%2C%20particularly%20the%20discovery%20of%20the%20BRAF%20V600E%20mutation%20in%20nearly%20all%20papillary%20craniopharyngiomas%2C%20have%20paved%20the%20way%20for%20a%20targeted%20systemic%20treatment%20approach.%20However%2C%20advances%20have%20been%20limited%20for%20adamantinomatous%20craniopharyngiomas.%20The%20success%20of%20BRAF%5C%2FMEK%20inhibitors%20in%20clinical%20trials%20underscores%20the%20potential%20of%20these%20targeted%20therapies%20not%20only%20to%20control%20tumor%20growth%20but%20also%20to%20reduce%20the%20need%20for%20more%20invasive%20treatments%2C%20potentially%20minimizing%20treatment-related%20complications.%20However%2C%20the%20introduction%20of%20these%20novel%20therapies%20also%20brings%20forth%20new%20challenges%2C%20such%20as%20determining%20the%20optimal%20timing%2C%20sequencing%2C%20and%20duration%20of%20targeted%20treatments.%20Furthermore%2C%20there%20are%20open%20questions%20regarding%20which%20specific%20BRAF%5C%2FMEK%20inhibitors%20to%20use%2C%20the%20potential%20need%20for%20combination%20therapy%2C%20and%20the%20strategies%20for%20managing%20intolerable%20adverse%20events.%20Finally%2C%20ensuring%20equitable%20access%20to%20these%20therapies%2C%20especially%20in%20healthcare%20systems%20with%20limited%20resources%2C%20is%20crucial%20to%20prevent%20widening%20healthcare%20disparities.%20In%20conclusion%2C%20targeted%20therapy%20with%20BRAF%5C%2FMEK%20inhibitors%20holds%20great%20promise%20for%20improving%20outcomes%20and%20quality%20of%20life%20for%20patients%20with%20BRAF-mutated%20craniopharyngiomas.%20However%2C%20additional%20research%20is%20needed%20to%20address%20the%20questions%20that%20remain%20about%20its%20optimal%20use%20and%20integration%20into%20comprehensive%20treatment%20plans.%22%2C%22date%22%3A%222024-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11864-023-01156-2%22%2C%22ISSN%22%3A%221534-6277%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A38%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22VXAQ4LHR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Guerriero%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGuerriero%20JL%2C%20Lin%20JR%2C%20Pastorello%20RG%2C%20Du%20Z%2C%20Chen%20YA%2C%20Townsend%20MG%2C%20Shimada%20K%2C%20Hughes%20ME%2C%20Ren%20S%2C%20Tayob%20N%2C%20Zheng%20K%2C%20Mei%20S%2C%20Patterson%20A%2C%20Taneja%20KL%2C%20Metzger%20O%2C%20Tolaney%20SM%2C%20Lin%20NU%2C%20Dillon%20DA%2C%20Schnitt%20SJ%2C%20Sorger%20PK%2C%20Mittendorf%20EA%2C%20Santagata%20S.%20Qualification%20of%20a%20multiplexed%20tissue%20imaging%20assay%20and%20detection%20of%20novel%20patterns%20of%20HER2%20heterogeneity%20in%20breast%20cancer.%20NPJ%20Breast%20Cancer.%202024%20Jan%202%3B10%281%29%3A2.%20PMCID%3A%20PMC10761880%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Qualification%20of%20a%20multiplexed%20tissue%20imaging%20assay%20and%20detection%20of%20novel%20patterns%20of%20HER2%20heterogeneity%20in%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%20G.%22%2C%22lastName%22%3A%22Pastorello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeline%20G.%22%2C%22lastName%22%3A%22Townsend%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Shimada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20E.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siyang%22%2C%22lastName%22%3A%22Ren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabihah%22%2C%22lastName%22%3A%22Tayob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%22%2C%22lastName%22%3A%22Patterson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krishan%20L.%22%2C%22lastName%22%3A%22Taneja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%22%2C%22lastName%22%3A%22Metzger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20U.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20J.%22%2C%22lastName%22%3A%22Schnitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Emerging%20data%20suggests%20that%20HER2%20intratumoral%20heterogeneity%20%28ITH%29%20is%20associated%20with%20therapy%20resistance%2C%20highlighting%20the%20need%20for%20new%20strategies%20to%20assess%20HER2%20ITH.%20A%20promising%20approach%20is%20leveraging%20multiplexed%20tissue%20analysis%20techniques%20such%20as%20cyclic%20immunofluorescence%20%28CyCIF%29%2C%20which%20enable%20visualization%20and%20quantification%20of%2010-60%20antigens%20at%20single-cell%20resolution%20from%20individual%20tissue%20sections.%20In%20this%20study%2C%20we%20qualified%20a%20breast%20cancer-specific%20antibody%20panel%2C%20including%20HER2%2C%20ER%2C%20and%20PR%2C%20for%20multiplexed%20tissue%20imaging.%20We%20then%20compared%20the%20performance%20of%20these%20antibodies%20against%20established%20clinical%20standards%20using%20pixel-%2C%20cell-%20and%20tissue-level%20analyses%2C%20utilizing%20866%20tissue%20cores%20%28representing%20294%20patients%29.%20To%20ensure%20reliability%2C%20the%20CyCIF%20antibodies%20were%20qualified%20against%20HER2%20immunohistochemistry%20%28IHC%29%20and%20fluorescence%20in%20situ%20hybridization%20%28FISH%29%20data%20from%20the%20same%20samples.%20Our%20findings%20demonstrate%20the%20successful%20qualification%20of%20a%20breast%20cancer%20antibody%20panel%20for%20CyCIF%2C%20showing%20high%20concordance%20with%20established%20clinical%20antibodies.%20Subsequently%2C%20we%20employed%20the%20qualified%20antibodies%2C%20along%20with%20antibodies%20for%20CD45%2C%20CD68%2C%20PD-L1%2C%20p53%2C%20Ki67%2C%20pRB%2C%20and%20AR%2C%20to%20characterize%20567%20HER2%2B%20invasive%20breast%20cancer%20samples%20from%20189%20patients.%20Through%20single-cell%20analysis%2C%20we%20identified%20four%20distinct%20cell%20clusters%20within%20HER2%2B%20breast%20cancer%20exhibiting%20heterogeneous%20HER2%20expression.%20Furthermore%2C%20these%20clusters%20displayed%20variations%20in%20ER%2C%20PR%2C%20p53%2C%20AR%2C%20and%20PD-L1%20expression.%20To%20quantify%20the%20extent%20of%20heterogeneity%2C%20we%20calculated%20heterogeneity%20scores%20based%20on%20the%20diversity%20among%20these%20clusters.%20Our%20analysis%20revealed%20expression%20patterns%20that%20are%20relevant%20to%20breast%20cancer%20biology%2C%20with%20correlations%20to%20HER2%20ITH%20and%20potential%20relevance%20to%20clinical%20outcomes.%22%2C%22date%22%3A%222024-01-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41523-023-00605-3%22%2C%22ISSN%22%3A%222374-4677%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A50%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22ZFIAGCQ3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Herzberger%20et%20al.%22%2C%22parsedDate%22%3A%222024-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHerzberger%20L%2C%20Hadwiger%20M%2C%20Kruger%20R%2C%20Sorger%20P%2C%20Pfister%20H%2C%20Groller%20E%2C%20Beyer%20J.%20Residency%20Octree%3A%20A%20Hybrid%20Approach%20for%20Scalable%20Web-Based%20Multi-Volume%20Rendering.%20IEEE%20Trans%20Vis%20Comput%20Graph.%202024%20Jan%3B30%281%29%3A1380%26%23x2013%3B1390.%20PMCID%3A%20PMC10840607%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Residency%20Octree%3A%20A%20Hybrid%20Approach%20for%20Scalable%20Web-Based%20Multi-Volume%20Rendering%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Herzberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Hadwiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Kruger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduard%22%2C%22lastName%22%3A%22Groller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Beyer%22%7D%5D%2C%22abstractNote%22%3A%22We%20present%20a%20hybrid%20multi-volume%20rendering%20approach%20based%20on%20a%20novel%20Residency%20Octree%20that%20combines%20the%20advantages%20of%20out-of-core%20volume%20rendering%20using%20page%20tables%20with%20those%20of%20standard%20octrees.%20Octree%20approaches%20work%20by%20performing%20hierarchical%20tree%20traversal.%20However%2C%20in%20octree%20volume%20rendering%2C%20tree%20traversal%20and%20the%20selection%20of%20data%20resolution%20are%20intrinsically%20coupled.%20This%20makes%20fine-grained%20empty-space%20skipping%20costly.%20Page%20tables%2C%20on%20the%20other%20hand%2C%20allow%20access%20to%20any%20cached%20brick%20from%20any%20resolution.%20However%2C%20they%20do%20not%20offer%20a%20clear%20and%20efficient%20strategy%20for%20substituting%20missing%20high-resolution%20data%20with%20lower-resolution%20data.%20We%20enable%20flexible%20mixed-resolution%20out-of-core%20multi-volume%20rendering%20by%20decoupling%20the%20cache%20residency%20of%20multi-resolution%20data%20from%20a%20resolution-independent%20spatial%20subdivision%20determined%20by%20the%20tree.%20Instead%20of%20one-to-one%20node-to-brick%20correspondences%2C%20each%20residency%20octree%20node%20is%20mapped%20to%20a%20set%20of%20bricks%20from%20different%20resolution%20levels.%20This%20makes%20it%20possible%20to%20efficiently%20and%20adaptively%20choose%20and%20mix%20resolutions%2C%20adapt%20sampling%20rates%2C%20and%20compensate%20for%20cache%20misses.%20At%20the%20same%20time%2C%20residency%20octrees%20support%20fine-grained%20empty-space%20skipping%2C%20independent%20of%20the%20data%20subdivision%20used%20for%20caching.%20Finally%2C%20to%20facilitate%20collaboration%20and%20outreach%2C%20and%20to%20eliminate%20local%20data%20storage%2C%20our%20implementation%20is%20a%20web-based%2C%20pure%20client-side%20renderer%20using%20WebGPU%20and%20WebAssembly.%20Our%20method%20is%20faster%20than%20prior%20approaches%20and%20efficient%20for%20many%20data%20channels%20with%20a%20flexible%20and%20adaptive%20choice%20of%20data%20resolution.%22%2C%22date%22%3A%222024-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1109%5C%2FTVCG.2023.3327193%22%2C%22ISSN%22%3A%221941-0506%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A54%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22T3HXE4FL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jain%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJain%20A%2C%20Gyori%20BM%2C%20Hakim%20S%2C%20Jain%20A%2C%20Sun%20L%2C%20Petrova%20V%2C%20Bhuiyan%20SA%2C%20Zhen%20S%2C%20Wang%20Q%2C%20Kawaguchi%20R%2C%20Bunga%20S%2C%20Taub%20DG%2C%20Ruiz-Cantero%20MC%2C%20Tong-Li%20C%2C%20Andrews%20N%2C%20Kotoda%20M%2C%20Renthal%20W%2C%20Sorger%20PK%2C%20Woolf%20CJ.%20Nociceptor-immune%20interactomes%20reveal%20insult-specific%20immune%20signatures%20of%20pain.%20Nat%20Immunol.%202024%20May%2028%3B%20PMID%3A%2038806708%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nociceptor-immune%20interactomes%20reveal%20insult-specific%20immune%20signatures%20of%20pain%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aakanksha%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Hakim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashish%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veselina%22%2C%22lastName%22%3A%22Petrova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamsuddin%20A.%22%2C%22lastName%22%3A%22Bhuiyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Zhen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qing%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riki%22%2C%22lastName%22%3A%22Kawaguchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Bunga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20G.%22%2C%22lastName%22%3A%22Taub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Carmen%22%2C%22lastName%22%3A%22Ruiz-Cantero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Candace%22%2C%22lastName%22%3A%22Tong-Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Andrews%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masakazu%22%2C%22lastName%22%3A%22Kotoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Renthal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%5D%2C%22abstractNote%22%3A%22Inflammatory%20pain%20results%20from%20the%20heightened%20sensitivity%20and%20reduced%20threshold%20of%20nociceptor%20sensory%20neurons%20due%20to%20exposure%20to%20inflammatory%20mediators.%20However%2C%20the%20cellular%20and%20transcriptional%20diversity%20of%20immune%20cell%20and%20sensory%20neuron%20types%20makes%20it%20challenging%20to%20decipher%20the%20immune%20mechanisms%20underlying%20pain.%20Here%20we%20used%20single-cell%20transcriptomics%20to%20determine%20the%20immune%20gene%20signatures%20associated%20with%20pain%20development%20in%20three%20skin%20inflammatory%20pain%20models%20in%20mice%3A%20zymosan%20injection%2C%20skin%20incision%20and%20ultraviolet%20burn.%20We%20found%20that%20macrophage%20and%20neutrophil%20recruitment%20closely%20mirrored%20the%20kinetics%20of%20pain%20development%20and%20identified%20cell-type-specific%20transcriptional%20programs%20associated%20with%20pain%20and%20its%20resolution.%20Using%20a%20comprehensive%20list%20of%20potential%20interactions%20mediated%20by%20receptors%2C%20ligands%2C%20ion%20channels%20and%20metabolites%20to%20generate%20injury-specific%20neuroimmune%20interactomes%2C%20we%20also%20uncovered%20that%20thrombospondin-1%20upregulated%20by%20immune%20cells%20upon%20injury%20inhibited%20nociceptor%20sensitization.%20This%20study%20lays%20the%20groundwork%20for%20identifying%20the%20neuroimmune%20axes%20that%20modulate%20pain%20in%20diverse%20disease%20contexts.%22%2C%22date%22%3A%222024-05-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41590-024-01857-2%22%2C%22ISSN%22%3A%221529-2916%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A53%3A48Z%22%7D%7D%2C%7B%22key%22%3A%223K4AQJ79%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ji%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJi%20W%2C%20Du%20G%2C%20Jiang%20J%2C%20Lu%20W%2C%20Mills%20CE%2C%20Yuan%20L%2C%20Jiang%20F%2C%20He%20Z%2C%20Bradshaw%20GA%2C%20Chung%20M%2C%20Jiang%20Z%2C%20Byun%20WS%2C%20Hinshaw%20SM%2C%20Zhang%20T%2C%20Gray%20NS.%20Discovery%20of%20bivalent%20small%20molecule%20degraders%20of%20cyclin-dependent%20kinase%207%20%28CDK7%29.%20Eur%20J%20Med%20Chem.%202024%20Oct%205%3B276%3A116613.%20PMCID%3A%20PMC11316633%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20bivalent%20small%20molecule%20degraders%20of%20cyclin-dependent%20kinase%207%20%28CDK7%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenzhi%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenchao%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linjie%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fen%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhixiang%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zixuan%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Woong%20Sub%22%2C%22lastName%22%3A%22Byun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20M.%22%2C%22lastName%22%3A%22Hinshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%207%2C%20along%20with%20cyclin%20H%20and%20MAT1%2C%20forms%20the%20CDK-activating%20complex%20%28CAK%29%2C%20which%20directs%20cell%20cycle%20progression%20via%20T-loop%20phosphorylation%20of%20cell%20cycle%20CDKs.%20Pharmacological%20inhibition%20of%20CDK7%20leads%20to%20selective%20anti-cancer%20effects%20in%20cellular%20and%20in%20vivo%20models%2C%20motivating%20several%20ongoing%20clinical%20investigations%20of%20this%20target.%20Current%20CDK7%20inhibitors%20are%20either%20reversible%20or%20covalent%20inhibitors%20of%20its%20catalytic%20activity.%20We%20hypothesized%20that%20small%20molecule%20targeted%20protein%20degradation%20%28TPD%29%20might%20result%20in%20differentiated%20pharmacology%20due%20to%20the%20loss%20of%20scaffolding%20functions.%20Here%2C%20we%20report%20the%20design%20and%20characterization%20of%20a%20potent%20CDK7%20degrader%20that%20is%20comprised%20of%20an%20ATP-competitive%20CDK7%20binder%20linked%20to%20a%20CRL2VHL%20recruiter.%20JWZ-5-13%20effectively%20degrades%20CDK7%20in%20multiple%20cancer%20cells%20and%20leads%20to%20a%20potent%20inhibition%20of%20cell%20proliferation.%20Additionally%2C%20compound%20JWZ-5-13%20displayed%20bioavailability%20in%20a%20pharmacokinetic%20study%20conducted%20in%20mice.%20Therefore%2C%20JWZ-5-13%20is%20a%20useful%20chemical%20probe%20to%20investigate%20the%20pharmacological%20consequences%20of%20CDK7%20degradation.%22%2C%22date%22%3A%222024-10-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ejmech.2024.116613%22%2C%22ISSN%22%3A%221768-3254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A54%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22NANXXSQZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Johnson%20and%20Sarosiek%22%2C%22parsedDate%22%3A%222024-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJohnson%20L%2C%20Sarosiek%20KA.%20Role%20of%20intrinsic%20apoptosis%20in%20environmental%20exposure%20health%20outcomes.%20Trends%20Mol%20Med.%202024%20Jan%3B30%281%29%3A56%26%23x2013%3B73.%20PMID%3A%2038057226%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Role%20of%20intrinsic%20apoptosis%20in%20environmental%20exposure%20health%20outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lissah%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%5D%2C%22abstractNote%22%3A%22Environmental%20exposures%20are%20linked%20to%20diseases%20of%20high%20public%20health%20concern%2C%20including%20cancer%2C%20neurodegenerative%20disorders%2C%20and%20autoimmunity.%20These%20diseases%20are%20caused%20by%20excessive%20or%20insufficient%20cell%20death%2C%20prompting%20investigation%20of%20mechanistic%20links%20between%20environmental%20toxicants%20and%20dysregulation%20of%20cell%20death%20pathways%2C%20including%20apoptosis.%20This%20review%20describes%20how%20legacy%20and%20emerging%20environmental%20exposures%20target%20the%20intrinsic%20apoptosis%20pathway%20to%20potentially%20drive%20pathogenesis.%20Recent%20discoveries%20reveal%20that%20dynamic%20regulation%20of%20apoptosis%20may%20heighten%20the%20vulnerability%20of%20healthy%20tissues%20to%20exposures%20in%20children%2C%20and%20that%20apoptotic%20signaling%20can%20guide%20immune%20responses%2C%20tissue%20repair%2C%20and%20tumorigenesis.%20Understanding%20how%20environmental%20toxicants%20dysregulate%20apoptosis%20will%20uncover%20opportunities%20to%20deploy%20apoptosis-modulating%20agents%20for%20the%20treatment%20or%20prevention%20of%20exposure-linked%20diseases.%22%2C%22date%22%3A%222024-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.molmed.2023.11.003%22%2C%22ISSN%22%3A%221471-499X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A53%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22MPX26ER7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kader%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKader%20T%2C%20Lin%20JR%2C%20Hug%20C%2C%20Coy%20S%2C%20Chen%20YA%2C%20de%20Bruijn%20I%2C%20Shih%20N%2C%20Jung%20E%2C%20Pelletier%20RJ%2C%20Leon%20ML%2C%20Mingo%20G%2C%20Omran%20DK%2C%20Lee%20JS%2C%20Yapp%20C%2C%20Satravada%20BA%2C%20Kundra%20R%2C%20Xu%20Y%2C%20Chan%20S%2C%20Tefft%20JB%2C%20Muhlich%20J%2C%20Kim%20S%2C%20Gysler%20SM%2C%20Agudo%20J%2C%20Heath%20JR%2C%20Schultz%20N%2C%20Drescher%20C%2C%20Sorger%20PK%2C%20Drapkin%20R%2C%20Santagata%20S.%20Multimodal%20Spatial%20Profiling%20Reveals%20Immune%20Suppression%20and%20Microenvironment%20Remodeling%20in%20Fallopian%20Tube%20Precursors%20to%20High-Grade%20Serous%20Ovarian%20Carcinoma.%20bioRxiv%3B%202024.%20PMCID%3A%20PMC11463462%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Multimodal%20Spatial%20Profiling%20Reveals%20Immune%20Suppression%20and%20Microenvironment%20Remodeling%20in%20Fallopian%20Tube%20Precursors%20to%20High-Grade%20Serous%20Ovarian%20Carcinoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanjina%22%2C%22lastName%22%3A%22Kader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22de%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Euihye%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%20J.%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%20Lopez%22%2C%22lastName%22%3A%22Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Mingo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalia%20Khaled%22%2C%22lastName%22%3A%22Omran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Suk%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baby%20Anusha%22%2C%22lastName%22%3A%22Satravada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ritika%22%2C%22lastName%22%3A%22Kundra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliann%20B.%22%2C%22lastName%22%3A%22Tefft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%20M.%22%2C%22lastName%22%3A%22Gysler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Drescher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronny%22%2C%22lastName%22%3A%22Drapkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22High-Grade%20Serous%20Ovarian%20Cancer%20%28HGSOC%29%20originates%20from%20fallopian%20tube%20%28FT%29%20precursors.%20However%2C%20the%20molecular%20changes%20that%20occur%20as%20precancerous%20lesions%20progress%20to%20HGSOC%20are%20not%20well%20understood.%20To%20address%20this%2C%20we%20integrated%20high-plex%20imaging%20and%20spatial%20transcriptomics%20to%20analyze%20human%20tissue%20samples%20at%20different%20stages%20of%20HGSOC%20development%2C%20including%20p53%20signatures%2C%20serous%20tubal%20intraepithelial%20carcinomas%20%28STIC%29%2C%20and%20invasive%20HGSOC.%20Our%20findings%20reveal%20immune%20modulating%20mechanisms%20within%20precursor%20epithelium%2C%20characterized%20by%20chromosomal%20instability%2C%20persistent%20interferon%20%28IFN%29%20signaling%2C%20and%20dysregulated%20innate%20and%20adaptive%20immunity.%20FT%20precursors%20display%20elevated%20expression%20of%20MHC-class%20I%2C%20including%20HLA-E%2C%20and%20IFN-stimulated%20genes%2C%20typically%20linked%20to%20later-stage%20tumorigenesis.%20These%20molecular%20alterations%20coincide%20with%20progressive%20shifts%20in%20the%20tumor%20microenvironment%2C%20transitioning%20from%20immune%20surveillance%20in%20early%20STICs%20to%20immune%20suppression%20in%20advanced%20STICs%20and%20cancer.%20These%20insights%20identify%20potential%20biomarkers%20and%20therapeutic%20targets%20for%20HGSOC%20interception%20and%20clarify%20the%20molecular%20transitions%20from%20precancer%20to%20cancer.%5CnSTATEMENT%20OF%20SIGNIFICANCE%3A%20This%20study%20maps%20the%20immune%20response%20in%20fallopian%20tube%20precursors%20of%20high-grade%20serous%20ovarian%20cancer%2C%20highlighting%20localized%20interferon%20signaling%2C%20CIN%2C%20and%20competing%20immune%20surveillance%20and%20suppression%20along%20the%20progression%20axis.%20It%20provides%20an%20explorable%20public%20spatial%20profiling%20atlas%20for%20investigating%20precancer%20mechanisms%2C%20biomarkers%2C%20and%20early%20detection%20and%20interception%20strategies.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-09-27%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.09.25.615007%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A28%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22FMFI55NX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ke%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKe%20S%2C%20Dang%20F%2C%20Wang%20L%2C%20Chen%20JY%2C%20Naik%20MT%2C%20Li%20W%2C%20Thavamani%20A%2C%20Kim%20N%2C%20Naik%20NM%2C%20Sui%20H%2C%20Tang%20W%2C%20Qiu%20C%2C%20Koikawa%20K%2C%20Batalini%20F%2C%20Stern%20Gatof%20E%2C%20Isaza%20DA%2C%20Patel%20JM%2C%20Wang%20X%2C%20Clohessy%20JG%2C%20Heng%20YJ%2C%20Lahav%20G%2C%20Liu%20Y%2C%20Gray%20NS%2C%20Zhou%20XZ%2C%20Wei%20W%2C%20Wulf%20GM%2C%20Lu%20KP.%20Reciprocal%20antagonism%20of%20PIN1-APC%5C%2FCCDH1%20governs%20mitotic%20protein%20stability%20and%20cell%20cycle%20entry.%20Nat%20Commun.%202024%20Apr%2015%3B15%281%29%3A3220.%20PMCID%3A%20PMC11018817%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reciprocal%20antagonism%20of%20PIN1-APC%5C%2FCCDH1%20governs%20mitotic%20protein%20stability%20and%20cell%20cycle%20entry%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shizhong%22%2C%22lastName%22%3A%22Ke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabin%22%2C%22lastName%22%3A%22Dang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lin%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandar%20T.%22%2C%22lastName%22%3A%22Naik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenxue%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Thavamani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nami%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nandita%20M.%22%2C%22lastName%22%3A%22Naik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huaxiu%22%2C%22lastName%22%3A%22Sui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenxi%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuhiro%22%2C%22lastName%22%3A%22Koikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%22%2C%22lastName%22%3A%22Batalini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Stern%20Gatof%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Arango%22%2C%22lastName%22%3A%22Isaza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaymin%20M.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaodong%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20G.%22%2C%22lastName%22%3A%22Clohessy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yujing%20J.%22%2C%22lastName%22%3A%22Heng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yansheng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%20Zhen%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenyi%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerburg%20M.%22%2C%22lastName%22%3A%22Wulf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun%20Ping%22%2C%22lastName%22%3A%22Lu%22%7D%5D%2C%22abstractNote%22%3A%22Induced%20oncoproteins%20degradation%20provides%20an%20attractive%20anti-cancer%20modality.%20Activation%20of%20anaphase-promoting%20complex%20%28APC%5C%2FCCDH1%29%20prevents%20cell-cycle%20entry%20by%20targeting%20crucial%20mitotic%20proteins%20for%20degradation.%20Phosphorylation%20of%20its%20co-activator%20CDH1%20modulates%20the%20E3%20ligase%20activity%2C%20but%20little%20is%20known%20about%20its%20regulation%20after%20phosphorylation%20and%20how%20to%20effectively%20harness%20APC%5C%2FCCDH1%20activity%20to%20treat%20cancer.%20Peptidyl-prolyl%20cis-trans%20isomerase%20NIMA-interacting%201%20%28PIN1%29-catalyzed%20phosphorylation-dependent%20cis-trans%20prolyl%20isomerization%20drives%20tumor%20malignancy.%20However%2C%20the%20mechanisms%20controlling%20its%20protein%20turnover%20remain%20elusive.%20Through%20proteomic%20screens%20and%20structural%20characterizations%2C%20we%20identify%20a%20reciprocal%20antagonism%20of%20PIN1-APC%5C%2FCCDH1%20mediated%20by%20domain-oriented%20phosphorylation-dependent%20dual%20interactions%20as%20a%20fundamental%20mechanism%20governing%20mitotic%20protein%20stability%20and%20cell-cycle%20entry.%20Remarkably%2C%20combined%20PIN1%20and%20cyclin-dependent%20protein%20kinases%20%28CDKs%29%20inhibition%20creates%20a%20positive%20feedback%20loop%20of%20PIN1%20inhibition%20and%20APC%5C%2FCCDH1%20activation%20to%20irreversibly%20degrade%20PIN1%20and%20other%20crucial%20mitotic%20proteins%2C%20which%20force%20permanent%20cell-cycle%20exit%20and%20trigger%20anti-tumor%20immunity%2C%20translating%20into%20synergistic%20efficacy%20against%20triple-negative%20breast%20cancer.%22%2C%22date%22%3A%222024-04-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-024-47427-w%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A44%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22NRX7CISD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22K%5Cu00f6nig%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EK%26%23xF6%3Bnig%20LE%2C%20Rodriguez%20S%2C%20Hug%20C%2C%20Daneshvari%20S%2C%20Chung%20A%2C%20Bradshaw%20GA%2C%20Sahin%20A%2C%20Zhou%20G%2C%20Eisert%20RJ%2C%20Piccioni%20F%2C%20Das%20S%2C%20Kalocsay%20M%2C%20Sokolov%20A%2C%20Sorger%20P%2C%20Root%20DE%2C%20Albers%20MW.%20TYK2%20as%20a%20novel%20therapeutic%20target%20in%20Alzheimer%26%23x2019%3Bs%20Disease%20with%20TDP-43%20inclusions.%20bioRxiv%3B%202024.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22TYK2%20as%20a%20novel%20therapeutic%20target%20in%20Alzheimer%5Cu2019s%20Disease%20with%20TDP-43%20inclusions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22K%5Cu00f6nig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shayda%22%2C%22lastName%22%3A%22Daneshvari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asli%22%2C%22lastName%22%3A%22Sahin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Piccioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudeshna%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Root%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22SUMMARY%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Neuroinflammation%20is%20a%20pathological%20feature%20of%20many%20neurodegenerative%20diseases%2C%20including%20Alzheimer%5Cu2019s%20disease%20%28AD%29%5Cn%20%20%20%20%20%20%20%20%20%20%20%201%2C2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20and%20amyotrophic%20lateral%20sclerosis%20%28ALS%29%5Cn%20%20%20%20%20%20%20%20%20%20%20%203%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%2C%20raising%20the%20possibility%20of%20common%20therapeutic%20targets.%20We%20previously%20established%20that%20cytoplasmic%20double-stranded%20RNA%20%28cdsRNA%29%20is%20spatially%20coincident%20with%20cytoplasmic%20pTDP-43%20inclusions%20in%20neurons%20of%20patients%20with%20C9ORF72-mediated%20ALS%5Cn%20%20%20%20%20%20%20%20%20%20%20%204%5Cn%20%20%20%20%20%20%20%20%20%20%20%20.%20CdsRNA%20triggers%20a%20type-I%20interferon%20%28IFN-I%29-based%20innate%20immune%20response%20in%20human%20neural%20cells%2C%20resulting%20in%20their%20death%5Cn%20%20%20%20%20%20%20%20%20%20%20%204%5Cn%20%20%20%20%20%20%20%20%20%20%20%20.%20Here%2C%20we%20report%20that%20cdsRNA%20is%20also%20spatially%20coincident%20with%20pTDP-43%20cytoplasmic%20inclusions%20in%20brain%20cells%20of%20patients%20with%20AD%20pathology%20and%20that%20type-I%20interferon%20response%20genes%20are%20significantly%20upregulated%20in%20brain%20regions%20affected%20by%20AD.%20We%20updated%20our%20machine-learning%20pipeline%20DRIAD-SP%20%28Drug%20Repurposing%20In%20Alzheimer%5Cu2019s%20Disease%20with%20Systems%20Pharmacology%29%20to%20incorporate%20cryptic%20exon%20%28CE%29%20detection%20as%20a%20proxy%20of%20pTDP-43%20inclusions%20and%20demonstrated%20that%20the%20FDA-approved%20JAK%20inhibitors%20baricitinib%20and%20ruxolitinib%20that%20block%20interferon%20signaling%20show%20a%20protective%20signal%20only%20in%20cortical%20brain%20regions%20expressing%20multiple%20CEs.%20Furthermore%2C%20the%20JAK%20family%20member%20TYK2%20was%20a%20top%20hit%20in%20a%20CRISPR%20screen%20of%20cdsRNA-mediated%20death%20in%20differentiated%20human%20neural%20cells.%20The%20selective%20TYK2%20inhibitor%20deucravacitinib%2C%20an%20FDA-approved%20drug%20for%20psoriasis%2C%20rescued%20toxicity%20elicited%20by%20cdsRNA.%20Finally%2C%20we%20identified%20CCL2%2C%20CXCL10%2C%20and%20IL-6%20as%20candidate%20predictive%20biomarkers%20for%20cdsRNA-related%20neurodegenerative%20diseases.%20Together%2C%20we%20find%20parallel%20neuroinflammatory%20mechanisms%20between%20TDP-43%20associated-AD%20and%20ALS%20and%20nominate%20TYK2%20as%20a%20possible%20disease-modifying%20target%20of%20these%20incurable%20neurodegenerative%20diseases.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-06-06%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.06.04.595773%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A37%3A14Z%22%7D%7D%2C%7B%22key%22%3A%224MEBDI7G%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Launonen%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-20%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELaunonen%20IM%2C%20Erkan%20EP%2C%20Niemiec%20I%2C%20Junquera%20A%2C%20Hincapi%26%23xE9%3B-Otero%20M%2C%20Afenteva%20D%2C%20Liang%20Z%2C%20Salko%20M%2C%20Szabo%20A%2C%20Perez-Villatoro%20F%2C%20Falco%20MM%2C%20Li%20Y%2C%20Micoli%20G%2C%20Nagaraj%20A%2C%20Haltia%20UM%2C%20Kahelin%20E%2C%20Oikkonen%20J%2C%20Hynninen%20J%2C%20Virtanen%20A%2C%20Nirmal%20AJ%2C%20Vallius%20T%2C%20Hautaniemi%20S%2C%20Sorger%20P%2C%20V%26%23xE4%3Bh%26%23xE4%3Brautio%20A%2C%20F%26%23xE4%3Brkkil%26%23xE4%3B%20A.%20Chemotherapy%20induces%20myeloid-driven%20spatial%20T-cell%20exhaustion%20in%20ovarian%20cancer%20%5BInternet%5D.%202024%20%5Bcited%202024%20Oct%2011%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.19.585657%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.19.585657%3C%5C%2Fa%3E%20PMCID%3A%20PMC10983974%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Chemotherapy%20induces%20myeloid-driven%20spatial%20T-cell%20exhaustion%20in%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga-Maria%22%2C%22lastName%22%3A%22Launonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erdogan%20Pekcan%22%2C%22lastName%22%3A%22Erkan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iga%22%2C%22lastName%22%3A%22Niemiec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ada%22%2C%22lastName%22%3A%22Junquera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%22%2C%22lastName%22%3A%22Hincapi%5Cu00e9-Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daria%22%2C%22lastName%22%3A%22Afenteva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhihan%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Salko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Szabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Perez-Villatoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matias%20M.%22%2C%22lastName%22%3A%22Falco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Micoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Nagaraj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulla-Maija%22%2C%22lastName%22%3A%22Haltia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Essi%22%2C%22lastName%22%3A%22Kahelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaana%22%2C%22lastName%22%3A%22Oikkonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Hynninen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anni%22%2C%22lastName%22%3A%22Virtanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sampsa%22%2C%22lastName%22%3A%22Hautaniemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22V%5Cu00e4h%5Cu00e4rautio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%5D%2C%22abstractNote%22%3A%22To%20uncover%20the%20intricate%2C%20chemotherapy-induced%20spatiotemporal%20remodeling%20of%20the%20tumor%20microenvironment%2C%20we%20conducted%20integrative%20spatial%20and%20molecular%20characterization%20of%2097%20high-grade%20serous%20ovarian%20cancer%20%28HGSC%29%20samples%20collected%20before%20and%20after%20chemotherapy.%20Using%20single-cell%20and%20spatial%20analyses%2C%20we%20identify%20increasingly%20versatile%20immune%20cell%20states%2C%20which%20form%20spatiotemporally%20dynamic%20microcommunities%20at%20the%20tumor-stroma%20interface.%20We%20demonstrate%20that%20chemotherapy%20triggers%20spatial%20redistribution%20and%20exhaustion%20of%20CD8%2B%20T%20cells%20due%20to%20prolonged%20antigen%20presentation%20by%20macrophages%2C%20both%20within%20interconnected%20myeloid%20networks%20termed%20%5C%22Myelonets%5C%22%20and%20at%20the%20tumor%20stroma%20interface.%20Single-cell%20and%20spatial%20transcriptomics%20identifies%20prominent%20TIGIT-NECTIN2%20ligand-receptor%20interactions%20induced%20by%20chemotherapy.%20Using%20a%20functional%20patient-derived%20immuno-oncology%20platform%2C%20we%20show%20that%20CD8%2BT-cell%20activity%20can%20be%20boosted%20by%20combining%20immune%20checkpoint%20blockade%20with%20chemotherapy.%20Our%20discovery%20of%20chemotherapy-induced%20myeloid-driven%20spatial%20T-cell%20exhaustion%20paves%20the%20way%20for%20novel%20immunotherapeutic%20strategies%20to%20unleash%20CD8%2B%20T-cell-mediated%20anti-tumor%20immunity%20in%20HGSC.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-03-20%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.03.19.585657%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.03.19.585657%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A09%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22NTZJEQQC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Loi%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELoi%20P%2C%20Schade%20AE%2C%20Rodriguez%20CL%2C%20Krishnan%20A%2C%20Perurena%20N%2C%20Nguyen%20VTM%2C%20Xu%20Y%2C%20Watanabe%20M%2C%20Davis%20RA%2C%20Gardner%20A%2C%20Pilla%20NF%2C%20Mattioli%20K%2C%20Popow%20O%2C%20Gunduz%20N%2C%20Lannagan%20TRM%2C%20Fitzgerald%20S%2C%20Sicinska%20ET%2C%20Lin%20JR%2C%20Tan%20W%2C%20Brais%20LK%2C%20Haigis%20KM%2C%20Giannakis%20M%2C%20Ng%20K%2C%20Santagata%20S%2C%20Helin%20K%2C%20Sansom%20OJ%2C%20Cichowski%20K.%20Epigenetic%20and%20oncogenic%20inhibitors%20cooperatively%20drive%20differentiation%20and%20kill%20KRAS-mutant%20colorectal%20cancers.%20Cancer%20Discov.%202024%20Aug%2012%3B%20PMID%3A%2039121480%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epigenetic%20and%20oncogenic%20inhibitors%20cooperatively%20drive%20differentiation%20and%20kill%20KRAS-mutant%20colorectal%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Schade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20L.%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjana%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naiara%22%2C%22lastName%22%3A%22Perurena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20T.%20M.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alycia%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20F.%22%2C%22lastName%22%3A%22Pilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaia%22%2C%22lastName%22%3A%22Mattioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olesja%22%2C%22lastName%22%3A%22Popow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nuray%22%2C%22lastName%22%3A%22Gunduz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamsin%20R.%20M.%22%2C%22lastName%22%3A%22Lannagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%20T.%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20K.%22%2C%22lastName%22%3A%22Brais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marios%22%2C%22lastName%22%3A%22Giannakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimmie%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Helin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20J.%22%2C%22lastName%22%3A%22Sansom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Cichowski%22%7D%5D%2C%22abstractNote%22%3A%22Current%20treatments%20for%20KRAS-mutant%20colorectal%20cancers%20%28CRCs%29%20are%20often%20limited%20by%20cellular%20plasticity%20and%20rewiring%20responses.%20Here%20we%20describe%20a%20promising%20therapeutic%20strategy%20that%20simultaneously%20targets%20epigenetic%20and%20oncogenic%20signals.%20Specifically%2C%20we%20show%20that%20inhibitors%20of%20the%20histone%20methyltransferase%2C%20EZH2%2C%20synergize%20with%20various%20RAS%20pathway%20inhibitors%20and%20promote%20dramatic%20tumor%20regression%20in%20vivo.%20Together%20these%20agents%20cooperatively%20suppress%20WNT-driven%20transcription%20and%20drive%20CRCs%20into%20a%20more%20differentiated%20cell%20state%20by%20inducing%20the%20Groucho%5C%2FTLE%20corepressor%2C%20TLE4%2C%20along%20with%20a%20network%20of%20WNT%20pathway%20inhibitors%20and%20intestinal%20differentiation%20proteins.%20However%2C%20these%20agents%20also%20induce%20the%20pro-apoptotic%20protein%20BMF%2C%20which%20subsequently%20kills%20these%20more%20differentiated%20cells.%20Accordingly%2C%20cell%20death%20can%20be%20prevented%20by%20activating%20%5Cu03b2-catenin%2C%20blocking%20differentiation%2C%20or%20by%20ablating%20BMF%20expression.%20Collectively%2C%20these%20studies%20reveal%20a%20new%20therapeutic%20approach%20for%20treating%20KRAS-mutant%20CRCs%20and%20illustrate%20a%20critical%20convergence%20of%20EZH2%20and%20RAS%20on%20oncogenic%20WNT%20signals%2C%20intestinal%20differentiation%2C%20and%20apoptosis.%22%2C%22date%22%3A%222024-08-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-23-0866%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A24%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22I6B3VFS9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lu%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELu%20D%2C%20Faizi%20M%2C%20Drown%20B%2C%20Simerzin%20A%2C%20Fran%26%23xE7%3Bois%20J%2C%20Bradshaw%20G%2C%20Kelleher%20N%2C%20Jambhekar%20A%2C%20Gunawardena%20J%2C%20Lahav%20G.%20Temporal%20regulation%20of%20gene%20expression%20through%20integration%20of%20p53%20dynamics%20and%20modifications.%20Sci%20Adv.%202024%20Oct%2025%3B10%2843%29%3Aeadp2229.%20PMCID%3A%20PMC11506164%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20regulation%20of%20gene%20expression%20through%20integration%20of%20p53%20dynamics%20and%20modifications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjan%22%2C%22lastName%22%3A%22Faizi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryon%22%2C%22lastName%22%3A%22Drown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alina%22%2C%22lastName%22%3A%22Simerzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Fran%5Cu00e7ois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Kelleher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Gunawardena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22The%20master%20regulator%20of%20the%20DNA%20damage%20response%2C%20the%20transcription%20factor%20p53%2C%20orchestrates%20multiple%20downstream%20responses%20and%20coordinates%20repair%20processes.%20In%20response%20to%20double-strand%20DNA%20breaks%2C%20p53%20exhibits%20pulses%20of%20expression%2C%20but%20how%20it%20achieves%20temporal%20coordination%20of%20downstream%20responses%20remains%20unclear.%20Here%2C%20we%20show%20that%20p53%27s%20posttranslational%20modification%20state%20is%20altered%20between%20its%20first%20and%20second%20pulses%20of%20expression.%20We%20show%20that%20acetylations%20at%20two%20sites%2C%20K373%20and%20K382%2C%20were%20reduced%20in%20the%20second%20pulse%2C%20and%20these%20acetylations%20differentially%20affected%20p53%20target%20genes%2C%20resulting%20in%20changes%20in%20gene%20expression%20programs%20over%20time.%20This%20interplay%20between%20dynamics%20and%20modification%20may%20offer%20a%20strategy%20for%20cellular%20hubs%20like%20p53%20to%20temporally%20organize%20multiple%20processes%20in%20individual%20cells.%22%2C%22date%22%3A%222024-10-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.adp2229%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-28T15%3A22%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22F27H89UW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Maliga%20et%20al.%22%2C%22parsedDate%22%3A%222024-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMaliga%20Z%2C%20Kim%20DY%2C%20Bui%20ATN%2C%20Lin%20JR%2C%20Dewan%20AK%2C%20Jadeja%20S%2C%20Murphy%20GF%2C%20Nirmal%20AJ%2C%20Lian%20CG%2C%20Sorger%20PK%2C%20LeBoeuf%20NR.%20Immune%20Profiling%20of%20Dermatologic%20Adverse%20Events%20from%20Checkpoint%20Blockade%20Using%20Tissue%20Cyclic%20Immunofluorescence%3A%20A%20Pilot%20Study.%20J%20Invest%20Dermatol.%202024%20Aug%3B144%288%29%3A1887-1890.e5.%20PMID%3A%2038360200%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immune%20Profiling%20of%20Dermatologic%20Adverse%20Events%20from%20Checkpoint%20Blockade%20Using%20Tissue%20Cyclic%20Immunofluorescence%3A%20A%20Pilot%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20Y.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ai-Tram%20N.%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Dewan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saagar%22%2C%22lastName%22%3A%22Jadeja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jid.2024.01.024%22%2C%22ISSN%22%3A%221523-1747%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A27%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22Z2PUCUTY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Marques%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMarques%20C%2C%20Held%20A%2C%20Dorfman%20K%2C%20Sung%20J%2C%20Song%20C%2C%20Kavuturu%20AS%2C%20Aguilar%20C%2C%20Russo%20T%2C%20Oakley%20DH%2C%20Albers%20MW%2C%20Hyman%20BT%2C%20Petrucelli%20L%2C%20Lagier-Tourenne%20C%2C%20Wainger%20BJ.%20Neuronal%20STING%20activation%20in%20amyotrophic%20lateral%20sclerosis%20and%20frontotemporal%20dementia.%20Acta%20Neuropathol.%202024%20Mar%2013%3B147%281%29%3A56.%20PMCID%3A%20PMC10937762%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Neuronal%20STING%20activation%20in%20amyotrophic%20lateral%20sclerosis%20and%20frontotemporal%20dementia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Marques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Held%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Dorfman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joon%22%2C%22lastName%22%3A%22Sung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amey%20S.%22%2C%22lastName%22%3A%22Kavuturu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corey%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tommaso%22%2C%22lastName%22%3A%22Russo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%20H.%22%2C%22lastName%22%3A%22Oakley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bradley%20T.%22%2C%22lastName%22%3A%22Hyman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonard%22%2C%22lastName%22%3A%22Petrucelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clotilde%22%2C%22lastName%22%3A%22Lagier-Tourenne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20J.%22%2C%22lastName%22%3A%22Wainger%22%7D%5D%2C%22abstractNote%22%3A%22The%20stimulator%20of%20interferon%20genes%20%28STING%29%20pathway%20has%20been%20implicated%20in%20neurodegenerative%20diseases%2C%20including%20Parkinson%27s%20disease%20and%20amyotrophic%20lateral%20sclerosis%20%28ALS%29.%20While%20prior%20studies%20have%20focused%20on%20STING%20within%20immune%20cells%2C%20little%20is%20known%20about%20STING%20within%20neurons.%20Here%2C%20we%20document%20neuronal%20activation%20of%20the%20STING%20pathway%20in%20human%20postmortem%20cortical%20and%20spinal%20motor%20neurons%20from%20individuals%20affected%20by%20familial%20or%20sporadic%20ALS.%20This%20process%20takes%20place%20selectively%20in%20the%20most%5Cu00a0vulnerable%20cortical%20and%20spinal%20motor%20neurons%20but%20not%20in%20neurons%20that%20are%20less%20affected%20by%20the%20disease.%20Concordant%20STING%20activation%20in%20layer%20V%20cortical%20motor%20neurons%20occurs%20in%20a%20mouse%20model%20of%20C9orf72%20repeat-associated%20ALS%20and%20frontotemporal%20dementia%20%28FTD%29.%20To%20establish%20that%20STING%20activation%20occurs%20in%20a%20neuron-autonomous%20manner%2C%20we%20demonstrate%20the%20integrity%20of%20the%20STING%20signaling%20pathway%2C%20including%20both%20upstream%20activators%20and%20downstream%20innate%20immune%20response%20effectors%2C%20in%20dissociated%20mouse%5Cu00a0cortical%20neurons%20and%20neurons%20derived%20from%20control%20human%5Cu00a0induced%20pluripotent%20stem%20cells%20%28iPSCs%29.%20Human%20iPSC-derived%20neurons%20harboring%20different%20familial%20ALS-causing%20mutations%20exhibit%20increased%20STING%20signaling%20with%20DNA%20damage%20as%20a%20main%20driver.%20The%20elevated%20downstream%20inflammatory%20markers%20present%20in%20ALS%20iPSC-derived%20neurons%20can%20be%20suppressed%20with%20a%20STING%20inhibitor.%20Our%20results%20reveal%20an%20immunophenotype%20that%20consists%20of%20innate%20immune%20signaling%20driven%20by%20the%20STING%20pathway%20and%20occurs%20specifically%20within%20vulnerable%20neurons%20in%20ALS%5C%2FFTD.%22%2C%22date%22%3A%222024-03-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00401-024-02688-z%22%2C%22ISSN%22%3A%221432-0533%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A10%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22BKCZQFCY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Minichetti%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMinichetti%20DG%2C%20Boyd%20A%2C%20Lemire%20E%2C%20Hacker%20J%2C%20Haber%20AL%2C%20Roditi%20RE%2C%20Albers%20MW%2C%20Lee%20S%2C%20Buchheit%20KM%2C%20Laidlaw%20TM%2C%20Bankova%20LG.%20Determinants%20of%20Persistence%20and%20Recovery%20of%20Chronic%20COVID19%20Chemosensory%20Dysfunction.%20J%20Allergy%20Clin%20Immunol.%202024%20Sep%2011%3BS0091-6749%2824%2900913%26%23x2013%3B8.%20PMID%3A%2039270802%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%20of%20Persistence%20and%20Recovery%20of%20Chronic%20COVID19%20Chemosensory%20Dysfunction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%20G.%22%2C%22lastName%22%3A%22Minichetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amelia%22%2C%22lastName%22%3A%22Boyd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%22%2C%22lastName%22%3A%22Lemire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Hacker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Haber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20E.%22%2C%22lastName%22%3A%22Roditi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stella%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20M.%22%2C%22lastName%22%3A%22Buchheit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanya%20M.%22%2C%22lastName%22%3A%22Laidlaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lora%20G.%22%2C%22lastName%22%3A%22Bankova%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%202-4%25%20of%20patients%2C%20COVID19%20chemosensory%20dysfunction%20%28CSD%29%20persists%20beyond%20six%20months%2C%20accounting%20for%20up%20to%204%20million%20people%20in%20the%20US.%20The%20predictors%20of%20persistence%20and%20recovery%20require%20further%20exploration.%5CnOBJECTIVE%3A%20To%20define%20the%20predictors%20of%20recovery%20and%20assess%20the%20quality%20of%20CSD%20in%20registry%20subjects%20with%20self-reported%20persistent%20smell%20and%20taste%20dysfunction%20after%20COVID19.%5CnMETHODS%3A%20COVID19%20CSD%20participants%20%28n%3D408%29%20from%20the%20four%20major%20waves%20of%20the%20pandemic%20completed%20questionnaires%20at%20four%20time%20points%20between%202021%20and%202023%2C%20assessing%20demographics%2C%20sinonasal%20symptoms%20and%20self-assessed%20recovery.%20Objective%20measurements%20of%20smell%20%28UPSIT%29%20and%20taste%20%28BWETT%29%20were%20performed%20on%20a%20sub-cohort%20%28n%3D108%29.%5CnRESULTS%3A%20In%20this%20chronic%20CSD%20cohort%2C%20the%20average%20symptom%20duration%20was%2024%5Cu00b15%20months%20but%2070%25%20those%20who%20contracted%20COVID19%20in%202020%20have%20ongoing%20dysfunction.%20Phantosmia%20and%20dysgeusia%20were%20most%20prevalent%20in%20the%20early%20waves%20of%20COVID19%2C%20while%20most%20participants%20reported%20disrupted%20ability%20to%20distinguish%20scents%20and%20flavors%20and%20undulating%20chemosensory%20function.%20Subjects%20reported%20low%20incidence%20of%20subjective%20sinonasal%20symptoms%20but%20high%20prevalence%20of%20sleep%20and%20mood%20disturbance.%20Cigarette%20phantom%20smells%20were%20predictive%20of%20persistence%20of%20CSD.%20Conversely%2C%20self-reported%20environmental%20allergies%20were%20predictive%20of%20recovery%20and%20dust%20mite%20allergies%2C%20specifically%2C%20were%20negative%20predictors%20of%20cigarette%20phantom%20smells.%20Finally%2C%20no%20treatment%20resolved%20CSD%2C%20but%20nasal%20steroids%20were%20reported%20effective%20by%20recovered%20CSD%20subjects.%20Objective%20measures%20of%20both%20smell%20and%20taste%20were%20significantly%20reduced%20in%20chronic%20CSD%20compared%20to%20controls.%5CnCONCLUSIONS%3A%20Chronic%20COVID19%20CSD%20is%20a%20syndrome%20resistant%20to%20standard%20anti-inflammatory%20therapy.%20Pre-existing%20environmental%20allergies%20and%20hypertension%20predict%20recovery%2C%20while%20cigarette%20smoke%20phantosmia%20predicts%20persistence.%22%2C%22date%22%3A%222024-09-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaci.2024.08.027%22%2C%22ISSN%22%3A%221097-6825%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A28%3A25Z%22%7D%7D%2C%7B%22key%22%3A%2243SXTHFZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mollaoglu%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMollaoglu%20G%2C%20Tepper%20A%2C%20Falcomat%26%23xE0%3B%20C%2C%20Potak%20HT%2C%20Pia%20L%2C%20Amabile%20A%2C%20Mateus-Tique%20J%2C%20Rabinovich%20N%2C%20Park%20MD%2C%20LaMarche%20NM%2C%20Brody%20R%2C%20Browning%20L%2C%20Lin%20JR%2C%20Zamarin%20D%2C%20Sorger%20PK%2C%20Santagata%20S%2C%20Merad%20M%2C%20Baccarini%20A%2C%20Brown%20BD.%20Ovarian%20cancer-derived%20IL-4%20promotes%20immunotherapy%20resistance.%20Cell.%202024%20Oct%2025%3BS0092-8674%2824%2901154%26%23x2013%3B1.%20PMID%3A%2039481380%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ovarian%20cancer-derived%20IL-4%20promotes%20immunotherapy%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gurkan%22%2C%22lastName%22%3A%22Mollaoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Tepper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Falcomat%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hunter%20T.%22%2C%22lastName%22%3A%22Potak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisanna%22%2C%22lastName%22%3A%22Pia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%22%2C%22lastName%22%3A%22Amabile%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%22%2C%22lastName%22%3A%22Mateus-Tique%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noam%22%2C%22lastName%22%3A%22Rabinovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20D.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nelson%20M.%22%2C%22lastName%22%3A%22LaMarche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Brody%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Browning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dmitriy%22%2C%22lastName%22%3A%22Zamarin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Merad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessia%22%2C%22lastName%22%3A%22Baccarini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20D.%22%2C%22lastName%22%3A%22Brown%22%7D%5D%2C%22abstractNote%22%3A%22Ovarian%20cancer%20is%20resistant%20to%20immunotherapy%2C%20and%20this%20is%20influenced%20by%20the%20immunosuppressed%20tumor%20microenvironment%20%28TME%29%20dominated%20by%20macrophages.%20Resistance%20is%20also%20affected%20by%20intratumoral%20heterogeneity%2C%20whose%20development%20is%20poorly%20understood.%20To%20identify%20regulators%20of%20ovarian%20cancer%20immunity%2C%20we%20employed%20a%20spatial%20functional%20genomics%20screen%20%28Perturb-map%29%2C%20focused%20on%20receptor%5C%2Fligands%20hypothesized%20to%20be%20involved%20in%20tumor-macrophage%20communication.%20Perturb-map%20recapitulated%20tumor%20heterogeneity%20and%20revealed%20that%20interleukin-4%20%28IL-4%29%20promotes%20resistance%20to%20anti-PD-1.%20We%20find%20ovarian%20cancer%20cells%20are%20the%20key%20source%20of%20IL-4%2C%20which%20directs%20the%20formation%20of%20an%20immunosuppressive%20TME%20via%20macrophage%20control.%20IL-4%20loss%20was%20not%20compensated%20by%20nearby%20IL-4-expressing%20clones%2C%20revealing%20short-range%20regulation%20of%20TME%20composition%20dictating%20tumor%20evolution.%20Our%20studies%20show%20heterogeneous%20TMEs%20can%20emerge%20from%20localized%20altered%20expression%20of%20cancer-derived%20cytokines%5C%2Fchemokines%20that%20establish%20immune-rich%20and%20immune-excluded%20neighborhoods%2C%20which%20drive%20clone%20selection%20and%20immunotherapy%20resistance.%20They%20also%20demonstrate%20the%20potential%20of%20targeting%20IL-4%20signaling%20to%20enhance%20ovarian%20cancer%20response%20to%20immunotherapy.%22%2C%22date%22%3A%222024-10-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2024.10.006%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A21%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22ZMGSUPC8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Nirmal%20and%20Sorger%22%2C%22parsedDate%22%3A%222024-05-29%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENirmal%20AJ%2C%20Sorger%20PK.%20SCIMAP%3A%20A%20Python%20Toolkit%20for%20Integrated%20Spatial%20Analysis%20of%20Multiplexed%20Imaging%20Data.%20J%20Open%20Source%20Softw.%202024%20May%2029%3B9%2897%29%3A6604.%20PMCID%3A%20PMC11173324%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SCIMAP%3A%20A%20Python%20Toolkit%20for%20Integrated%20Spatial%20Analysis%20of%20Multiplexed%20Imaging%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Multiplexed%20imaging%20data%20are%20revolutionizing%20our%20understanding%20of%20the%20composition%20and%20organization%20of%20tissues%20and%20tumors%20%28%5C%22Catching%20up%20with%20Multiplexed%20Tissue%20Imaging%2C%5C%22%202022%29.%20A%20critical%20aspect%20of%20such%20%5C%22tissue%20profiling%5C%22%20is%20quantifying%20the%20spatial%20relationships%20among%20cells%20at%20different%20scales%20from%20the%20interaction%20of%20neighboring%20cells%20to%20recurrent%20communities%20of%20cells%20of%20multiple%20types.%20This%20often%20involves%20statistical%20analysis%20of%20107%20or%20more%20cells%20in%20which%20up%20to%20100%20biomolecules%20%28commonly%20proteins%29%20have%20been%20measured.%20While%20software%20tools%20currently%20cater%20to%20the%20analysis%20of%20spatial%20transcriptomics%20data%20%28Liu%20et%20al.%2C%202022%29%2C%20there%20remains%20a%20need%20for%20toolkits%20explicitly%20tailored%20to%20the%20complexities%20of%20multiplexed%20imaging%20data%20including%20the%20need%20to%20seamlessly%20integrate%20image%20visualization%20with%20data%20analysis%20and%20exploration.%20We%20introduce%20SCIMAP%2C%20a%20Python%20package%20specifically%20crafted%20to%20address%20these%20challenges.%20With%20SCIMAP%2C%20users%20can%20efficiently%20preprocess%2C%20analyze%2C%20and%20visualize%20large%20datasets%2C%20facilitating%20the%20exploration%20of%20spatial%20relationships%20and%20their%20statistical%20significance.%20SCIMAP%27s%20modular%20design%20enables%20the%20integration%20of%20new%20algorithms%2C%20enhancing%20its%20capabilities%20for%20spatial%20analysis.%22%2C%22date%22%3A%222024-05-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21105%5C%2Fjoss.06604%22%2C%22ISSN%22%3A%222475-9066%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A38%3A02Z%22%7D%7D%2C%7B%22key%22%3A%228ISXL44N%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Olesinski%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOlesinski%20EA%2C%20Bhatia%20KS%2C%20Wang%20C%2C%20Pioso%20MS%2C%20Lin%20XX%2C%20Mamdouh%20AM%2C%20Ng%20SX%2C%20Sandhu%20V%2C%20Jasdanwala%20SS%2C%20Yilma%20B%2C%20Bohl%20S%2C%20Ryan%20JA%2C%20Malani%20D%2C%20Luskin%20MR%2C%20Kallioniemi%20O%2C%20Porkka%20K%2C%20Adamia%20S%2C%20Chng%20WJ%2C%20Osato%20M%2C%20Weinstock%20DM%2C%20Garcia%20JS%2C%20Letai%20A%2C%20Bhatt%20S.%20Acquired%20Multidrug%20Resistance%20in%20AML%20Is%20Caused%20by%20Low%20Apoptotic%20Priming%20in%20Relapsed%20Myeloblasts.%20Blood%20Cancer%20Discov.%202024%20May%201%3B5%283%29%3A180%26%23x2013%3B201.%20PMCID%3A%20PMC11061585%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acquired%20Multidrug%20Resistance%20in%20AML%20Is%20Caused%20by%20Low%20Apoptotic%20Priming%20in%20Relapsed%20Myeloblasts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elyse%20A.%22%2C%22lastName%22%3A%22Olesinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karanpreet%20Singh%22%2C%22lastName%22%3A%22Bhatia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chuqi%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%20S.%22%2C%22lastName%22%3A%22Pioso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%20Xian%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%20M.%22%2C%22lastName%22%3A%22Mamdouh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%20Xuan%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vedant%22%2C%22lastName%22%3A%22Sandhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaista%20Shabbir%22%2C%22lastName%22%3A%22Jasdanwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binyam%22%2C%22lastName%22%3A%22Yilma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Bohl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20A.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Disha%22%2C%22lastName%22%3A%22Malani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marlise%20R.%22%2C%22lastName%22%3A%22Luskin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olli%22%2C%22lastName%22%3A%22Kallioniemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimmo%22%2C%22lastName%22%3A%22Porkka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Adamia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wee%20Joo%22%2C%22lastName%22%3A%22Chng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Motomi%22%2C%22lastName%22%3A%22Osato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Weinstock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20S.%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shruti%22%2C%22lastName%22%3A%22Bhatt%22%7D%5D%2C%22abstractNote%22%3A%22In%20many%20cancers%2C%20mortality%20is%20associated%20with%20the%20emergence%20of%20relapse%20with%20multidrug%20resistance%20%28MDR%29.%20Thus%20far%2C%20the%20investigation%20of%20cancer%20relapse%20mechanisms%20has%20largely%20focused%20on%20acquired%20genetic%20mutations.%20Using%20acute%20myeloid%20leukemia%20%28AML%29%20patient-derived%20xenografts%20%28PDX%29%2C%20we%20systematically%20elucidated%20a%20basis%20of%20MDR%20and%20identified%20drug%20sensitivity%20in%20relapsed%20AML.%20We%20derived%20pharmacologic%20sensitivity%20for%2022%20AML%20PDX%20models%20using%20dynamic%20BH3%20profiling%20%28DBP%29%2C%20together%20with%20genomics%20and%20transcriptomics.%20Using%20in%20vivo%20acquired%20resistant%20PDXs%2C%20we%20found%20that%20resistance%20to%20unrelated%2C%20narrowly%20targeted%20agents%20in%20distinct%20PDXs%20was%20accompanied%20by%20broad%20resistance%20to%20drugs%20with%20disparate%20mechanisms.%20Moreover%2C%20baseline%20mitochondrial%20apoptotic%20priming%20was%20consistently%20reduced%20regardless%20of%20the%20class%20of%20drug-inducing%20selection.%20By%20applying%20DBP%2C%20we%20identified%20drugs%20showing%20effective%20in%20vivo%20activity%20in%20resistant%20models.%20This%20study%20implies%20evasion%20of%20apoptosis%20drives%20drug%20resistance%20and%20demonstrates%20the%20feasibility%20of%20the%20DBP%20approach%20to%20identify%20active%20drugs%20for%20patients%20with%20relapsed%20AML.%5CnSIGNIFICANCE%3A%20Acquired%20resistance%20to%20targeted%20therapy%20remains%20challenging%20in%20AML.%20We%20found%20that%20reduction%20in%20mitochondrial%20priming%20and%20common%20transcriptomic%20signatures%20was%20a%20conserved%20mechanism%20of%20acquired%20resistance%20across%20different%20drug%20classes%20in%20vivo.%20Drugs%20active%20in%20vivo%20can%20be%20identified%20even%20in%20the%20multidrug%20resistant%20state%20by%20DBP.%22%2C%22date%22%3A%222024-05-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2643-3230.BCD-24-0001%22%2C%22ISSN%22%3A%222643-3249%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A56%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22ZESBJX8E%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pan%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPan%20RA%2C%20Wang%20Y%2C%20Qiu%20S%2C%20Villalobos-Ortiz%20M%2C%20Ryan%20J%2C%20Morris%20E%2C%20Halilovic%20E%2C%20Letai%20A.%20BH3%20profiling%20as%20pharmacodynamic%20biomarker%20for%20the%20activity%20of%20BH3%20mimetics.%20Haematologica.%202024%20Apr%201%3B109%284%29%3A1253%26%23x2013%3B1258.%20PMCID%3A%20PMC10985422%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22BH3%20profiling%20as%20pharmacodynamic%20biomarker%20for%20the%20activity%20of%20BH3%20mimetics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rongqing%20Aaron%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Youzhen%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shumei%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Villalobos-Ortiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erick%22%2C%22lastName%22%3A%22Morris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ensar%22%2C%22lastName%22%3A%22Halilovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3324%5C%2Fhaematol.2023.283060%22%2C%22ISSN%22%3A%221592-8721%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A04%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22EYG57CJU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Quinones-Olvera%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-12%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EQuinones-Olvera%20N%2C%20Owen%20SV%2C%20McCully%20LM%2C%20Marin%20MG%2C%20Rand%20EA%2C%20Fan%20AC%2C%20Martins%20Dosumu%20OJ%2C%20Paul%20K%2C%20Sanchez%20Casta%26%23xF1%3Bo%20CE%2C%20Petherbridge%20R%2C%20Paull%20JS%2C%20Baym%20M.%20Diverse%20and%20abundant%20phages%20exploit%20conjugative%20plasmids.%20Nat%20Commun.%202024%20Apr%2012%3B15%281%29%3A3197.%20PMCID%3A%20PMC11015023%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diverse%20and%20abundant%20phages%20exploit%20conjugative%20plasmids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Quinones-Olvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%20M.%22%2C%22lastName%22%3A%22McCully%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximillian%20G.%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%20A.%22%2C%22lastName%22%3A%22Rand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20C.%22%2C%22lastName%22%3A%22Fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oluremi%20J.%22%2C%22lastName%22%3A%22Martins%20Dosumu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kay%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleotilde%20E.%22%2C%22lastName%22%3A%22Sanchez%20Casta%5Cu00f1o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Petherbridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jillian%20S.%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Phages%20exert%20profound%20evolutionary%20pressure%20on%20bacteria%20by%20interacting%20with%20receptors%20on%20the%20cell%20surface%20to%20initiate%20infection.%20While%20the%20majority%20of%20phages%20use%20chromosomally%20encoded%20cell%20surface%20structures%20as%20receptors%2C%20plasmid-dependent%20phages%20exploit%20plasmid-encoded%20conjugation%20proteins%2C%20making%20their%20host%20range%20dependent%20on%20horizontal%20transfer%20of%20the%20plasmid.%20Despite%20their%20unique%20biology%20and%20biotechnological%20significance%2C%20only%20a%20small%20number%20of%20plasmid-dependent%20phages%20have%20been%20characterized.%20Here%20we%20systematically%20search%20for%20new%20plasmid-dependent%20phages%20targeting%20IncP%20and%20IncF%20plasmids%20using%20a%20targeted%20discovery%20platform%2C%20and%20find%20that%20they%20are%20common%20and%20abundant%20in%20wastewater%2C%20and%20largely%20unexplored%20in%20terms%20of%20their%20genetic%20diversity.%20Plasmid-dependent%20phages%20are%20enriched%20in%20non-canonical%20types%20of%20phages%2C%20and%20all%20but%20one%20of%20the%2065%20phages%20we%20isolated%20were%20non-tailed%2C%20and%20members%20of%20the%20lipid-containing%20tectiviruses%2C%20ssDNA%20filamentous%20phages%20or%20ssRNA%20phages.%20We%20show%20that%20plasmid-dependent%20tectiviruses%20exhibit%20profound%20differences%20in%20their%20host%20range%20which%20is%20associated%20with%20variation%20in%20the%20phage%20holin%20protein.%20Despite%20their%20relatively%20high%20abundance%20in%20wastewater%2C%20plasmid-dependent%20tectiviruses%20are%20missed%20by%20metaviromic%20analyses%2C%20underscoring%20the%20continued%20importance%20of%20culture-based%20phage%20discovery.%20Finally%2C%20we%20identify%20a%20tailed%20phage%20dependent%20on%20the%20IncF%20plasmid%2C%20and%20find%20related%20structural%20genes%20in%20phages%20that%20use%20the%20orthogonal%20type%204%20pilus%20as%20a%20receptor%2C%20highlighting%20the%20evolutionarily%5Cu00a0promiscuous%20use%20of%20these%20distinct%20contractile%20structures%20by%20multiple%20groups%20of%20phages.%20Taken%20together%2C%20these%20results%20indicate%20plasmid-dependent%20phages%20play%20an%20under-appreciated%20evolutionary%20role%20in%20constraining%20horizontal%20gene%20transfer%20via%20conjugative%20plasmids.%22%2C%22date%22%3A%222024-04-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-024-47416-z%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A45%3A28Z%22%7D%7D%2C%7B%22key%22%3A%223MMFBXRT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ricciuti%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERicciuti%20B%2C%20Lamberti%20G%2C%20Puchala%20SR%2C%20Mahadevan%20NR%2C%20Lin%20JR%2C%20Alessi%20JV%2C%20Chowdhury%20A%2C%20Li%20YY%2C%20Wang%20X%2C%20Spurr%20L%2C%20Pecci%20F%2C%20Di%20Federico%20A%2C%20Venkatraman%20D%2C%20Barrichello%20AP%2C%20Gandhi%20M%2C%20Vaz%20VR%2C%20Pangilinan%20AJ%2C%20Haradon%20D%2C%20Lee%20E%2C%20Gupta%20H%2C%20Pfaff%20KL%2C%20Welsh%20EL%2C%20Nishino%20M%2C%20Cherniack%20AD%2C%20Johnson%20BE%2C%20Weirather%20JL%2C%20Dryg%20ID%2C%20Rodig%20SJ%2C%20Sholl%20LM%2C%20Sorger%20P%2C%20Santagata%20S%2C%20Umeton%20R%2C%20Awad%20MM.%20Genomic%20and%20Immunophenotypic%20Landscape%20of%20Acquired%20Resistance%20to%20PD-%28L%291%20Blockade%20in%20Non-Small-Cell%20Lung%20Cancer.%20J%20Clin%20Oncol.%202024%20Apr%2010%3B42%2811%29%3A1311%26%23x2013%3B1321.%20PMID%3A%2038207230%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genomic%20and%20Immunophenotypic%20Landscape%20of%20Acquired%20Resistance%20to%20PD-%28L%291%20Blockade%20in%20Non-Small-Cell%20Lung%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biagio%22%2C%22lastName%22%3A%22Ricciuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Lamberti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreekar%20R.%22%2C%22lastName%22%3A%22Puchala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20R.%22%2C%22lastName%22%3A%22Mahadevan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joao%20V.%22%2C%22lastName%22%3A%22Alessi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%20Y.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%22%2C%22lastName%22%3A%22Spurr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Pecci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandro%22%2C%22lastName%22%3A%22Di%20Federico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepti%22%2C%22lastName%22%3A%22Venkatraman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20P.%22%2C%22lastName%22%3A%22Barrichello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malini%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%20R.%22%2C%22lastName%22%3A%22Vaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andy%20J.%22%2C%22lastName%22%3A%22Pangilinan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%22%2C%22lastName%22%3A%22Haradon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elinton%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hersh%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20L.%22%2C%22lastName%22%3A%22Pfaff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%20L.%22%2C%22lastName%22%3A%22Welsh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mizuki%22%2C%22lastName%22%3A%22Nishino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Cherniack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20L.%22%2C%22lastName%22%3A%22Weirather%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20D.%22%2C%22lastName%22%3A%22Dryg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynette%20M.%22%2C%22lastName%22%3A%22Sholl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renato%22%2C%22lastName%22%3A%22Umeton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Awad%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Although%20immune%20checkpoint%20inhibitors%20%28ICI%29%20have%20extended%20survival%20in%20patients%20with%20non-small-cell%20lung%20cancer%20%28NSCLC%29%2C%20acquired%20resistance%20%28AR%29%20to%20ICI%20frequently%20develops%20after%20an%20initial%20benefit.%20However%2C%20the%20mechanisms%20of%20AR%20to%20ICI%20in%20NSCLC%20are%20largely%20unknown.%5CnMETHODS%3A%20Comprehensive%20tumor%20genomic%20profiling%2C%20machine%20learning-based%20assessment%20of%20tumor-infiltrating%20lymphocytes%2C%20multiplexed%20immunofluorescence%2C%20and%5C%2For%20HLA-I%20immunohistochemistry%20%28IHC%29%20were%20performed%20on%20matched%20pre-%20and%20post-ICI%20tumor%20biopsies%20from%20patients%20with%20NSCLC%20treated%20with%20ICI%20at%20the%20Dana-Farber%20Cancer%20Institute%20who%20developed%20AR%20to%20ICI.%20Two%20additional%20cohorts%20of%20patients%20with%20intervening%20chemotherapy%20or%20targeted%20therapies%20between%20biopsies%20were%20included%20as%20controls.%5CnRESULTS%3A%20We%20performed%20comprehensive%20genomic%20profiling%20and%20immunophenotypic%20characterization%20on%20samples%20from%2082%20patients%20with%20NSCLC%20and%20matched%20pre-%20and%20post-ICI%20biopsies%20and%20compared%20findings%20with%20a%20control%20cohort%20of%20patients%20with%20non-ICI%20intervening%20therapies%20between%20biopsies%20%28chemotherapy%2C%20N%20%3D%2032%3B%20targeted%20therapies%2C%20N%20%3D%2089%3B%20both%2C%20N%20%3D%2017%29.%20Putative%20resistance%20mutations%20were%20identified%20in%2027.8%25%20of%20immunotherapy-treated%20cases%20and%20included%20acquired%20loss-of-function%20mutations%20in%20STK11%2C%20B2M%2C%20APC%2C%20MTOR%2C%20KEAP1%2C%20and%20JAK1%5C%2F2%3B%20these%20acquired%20alterations%20were%20not%20observed%20in%20the%20control%20groups.%20Immunophenotyping%20of%20matched%20pre-%20and%20post-ICI%20samples%20demonstrated%20significant%20decreases%20in%20intratumoral%20lymphocytes%2C%20CD3e%2B%20and%20CD8a%2B%20T%20cells%2C%20and%20PD-L1-PD1%20engagement%2C%20as%20well%20as%20increased%20distance%20between%20tumor%20cells%20and%20CD8%2BPD-1%2B%20T%20cells.%20There%20was%20a%20significant%20decrease%20in%20HLA%20class%20I%20expression%20in%20the%20immunotherapy%20cohort%20at%20the%20time%20of%20AR%20compared%20with%20the%20chemotherapy%20%28P%20%3D%20.005%29%20and%20the%20targeted%20therapy%20%28P%20%3D%20.01%29%20cohorts.%5CnCONCLUSION%3A%20These%20findings%20highlight%20the%20genomic%20and%20immunophenotypic%20heterogeneity%20of%20ICI%20resistance%20in%20NSCLC%2C%20which%20will%20need%20to%20be%20considered%20when%20developing%20novel%20therapeutic%20strategies%20aimed%20at%20overcoming%20resistance.%22%2C%22date%22%3A%222024-04-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.23.00580%22%2C%22ISSN%22%3A%221527-7755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A19%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22B3WD6BW5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rogava%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-29%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERogava%20M%2C%20Aprati%20TJ%2C%20Chi%20WY%2C%20Melms%20JC%2C%20Hug%20C%2C%20Davis%20SH%2C%20Earlie%20EM%2C%20Chung%20C%2C%20Deshmukh%20SK%2C%20Wu%20S%2C%20Sledge%20G%2C%20Tang%20S%2C%20Ho%20P%2C%20Amin%20AD%2C%20Caprio%20L%2C%20Gurjao%20C%2C%20Tagore%20S%2C%20Ngo%20B%2C%20Lee%20MJ%2C%20Zanetti%20G%2C%20Wang%20Y%2C%20Chen%20S%2C%20Ge%20W%2C%20Melo%20LMN%2C%20Allies%20G%2C%20R%26%23xF6%3Bsler%20J%2C%20Gibney%20GT%2C%20Schmitz%20OJ%2C%20Sykes%20M%2C%20Creusot%20RJ%2C%20T%26%23xFC%3Bting%20T%2C%20Schadendorf%20D%2C%20R%26%23xF6%3Bcken%20M%2C%20Eigentler%20TK%2C%20Molotkov%20A%2C%20Mintz%20A%2C%20Bakhoum%20SF%2C%20Beyaz%20S%2C%20Cantley%20LC%2C%20Sorger%20PK%2C%20Meckelmann%20SW%2C%20Tasdogan%20A%2C%20Liu%20D%2C%20Laughney%20AM%2C%20Izar%20B.%20Loss%20of%20Pip4k2c%20confers%20liver-metastatic%20organotropism%20through%20insulin-dependent%20PI3K-AKT%20pathway%20activation.%20Nat%20Cancer.%202024%20Jan%2029%3B%20PMID%3A%2038286827%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Loss%20of%20Pip4k2c%20confers%20liver-metastatic%20organotropism%20through%20insulin-dependent%20PI3K-AKT%20pathway%20activation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meri%22%2C%22lastName%22%3A%22Rogava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%20J.%22%2C%22lastName%22%3A%22Aprati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Yu%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20H.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20M.%22%2C%22lastName%22%3A%22Earlie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlie%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sachin%20K.%22%2C%22lastName%22%3A%22Deshmukh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Sledge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amit%20Dipak%22%2C%22lastName%22%3A%22Amin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Caprio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carino%22%2C%22lastName%22%3A%22Gurjao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somnath%22%2C%22lastName%22%3A%22Tagore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%22%2C%22lastName%22%3A%22Ngo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgia%22%2C%22lastName%22%3A%22Zanetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yiping%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Ge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luiza%20Martins%20Nascentes%22%2C%22lastName%22%3A%22Melo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriele%22%2C%22lastName%22%3A%22Allies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonas%22%2C%22lastName%22%3A%22R%5Cu00f6sler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Goeffrey%20T.%22%2C%22lastName%22%3A%22Gibney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%20J.%22%2C%22lastName%22%3A%22Schmitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Sykes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9mi%20J.%22%2C%22lastName%22%3A%22Creusot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22T%5Cu00fcting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Schadendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22R%5Cu00f6cken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20K.%22%2C%22lastName%22%3A%22Eigentler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrei%22%2C%22lastName%22%3A%22Molotkov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akiva%22%2C%22lastName%22%3A%22Mintz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20F.%22%2C%22lastName%22%3A%22Bakhoum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Semir%22%2C%22lastName%22%3A%22Beyaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%20C.%22%2C%22lastName%22%3A%22Cantley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sven%20W.%22%2C%22lastName%22%3A%22Meckelmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alpaslan%22%2C%22lastName%22%3A%22Tasdogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%20M.%22%2C%22lastName%22%3A%22Laughney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%5D%2C%22abstractNote%22%3A%22Liver%20metastasis%20%28LM%29%20confers%20poor%20survival%20and%20therapy%20resistance%20across%20cancer%20types%2C%20but%20the%20mechanisms%20of%20liver-metastatic%20organotropism%20remain%20unknown.%20Here%2C%20through%20in%20vivo%20CRISPR-Cas9%20screens%2C%20we%20found%20that%20Pip4k2c%20loss%20conferred%20LM%20but%20had%20no%20impact%20on%20lung%20metastasis%20or%20primary%20tumor%20growth.%20Pip4k2c-deficient%20cells%20were%20hypersensitized%20to%20insulin-mediated%20PI3K%5C%2FAKT%20signaling%20and%20exploited%20the%20insulin-rich%20liver%20milieu%20for%20organ-specific%20metastasis.%20We%20observed%20concordant%20changes%20in%20PIP4K2C%20expression%20and%20distinct%20metabolic%20changes%20in%203%2C511%20patient%20melanomas%2C%20including%20primary%20tumors%2C%20LMs%20and%20lung%20metastases.%20We%20found%20that%20systemic%20PI3K%20inhibition%20exacerbated%20LM%20burden%20in%20mice%20injected%20with%20Pip4k2c-deficient%20cancer%20cells%20through%20host-mediated%20increase%20in%20hepatic%20insulin%20levels%3B%20however%2C%20this%20circuit%20could%20be%20broken%20by%20concurrent%20administration%20of%20an%20SGLT2%20inhibitor%20or%20feeding%20of%20a%20ketogenic%20diet.%20Thus%2C%20this%20work%20demonstrates%20a%20rare%20example%20of%20metastatic%20organotropism%20through%20co-optation%20of%20physiological%20metabolic%20cues%20and%20proposes%20therapeutic%20avenues%20to%20counteract%20these%20mechanisms.%22%2C%22date%22%3A%222024-01-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs43018-023-00704-x%22%2C%22ISSN%22%3A%222662-1347%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A44%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22X9XWDXLP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Sarfraz%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESarfraz%20I%2C%20Wang%20Y%2C%20Shastry%20A%2C%20Teh%20WK%2C%20Sokolov%20A%2C%20Herb%20BR%2C%20Creasy%20HH%2C%20Virshup%20I%2C%20Dries%20R%2C%20Degatano%20K%2C%20Mahurkar%20A%2C%20Schnell%20DJ%2C%20Madrigal%20P%2C%20Hilton%20J%2C%20Gehlenborg%20N%2C%20Tickle%20T%2C%20Campbell%20JD.%20MAMS%3A%20matrix%20and%20analysis%20metadata%20standards%20to%20facilitate%20harmonization%20and%20reproducibility%20of%20single-cell%20data.%20Genome%20Biol.%202024%20Aug%201%3B25%281%29%3A205.%20PMCID%3A%20PMC11292877%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MAMS%3A%20matrix%20and%20analysis%20metadata%20standards%20to%20facilitate%20harmonization%20and%20reproducibility%20of%20single-cell%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irzam%22%2C%22lastName%22%3A%22Sarfraz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yichen%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amulya%22%2C%22lastName%22%3A%22Shastry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%20Kheng%22%2C%22lastName%22%3A%22Teh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20R.%22%2C%22lastName%22%3A%22Herb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20H.%22%2C%22lastName%22%3A%22Creasy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Virshup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruben%22%2C%22lastName%22%3A%22Dries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kylee%22%2C%22lastName%22%3A%22Degatano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anup%22%2C%22lastName%22%3A%22Mahurkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Schnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Madrigal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Hilton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nils%22%2C%22lastName%22%3A%22Gehlenborg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Tickle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Campbell%22%7D%5D%2C%22abstractNote%22%3A%22Many%20datasets%20are%20being%20produced%20by%20consortia%20that%20seek%20to%20characterize%20healthy%20and%20disease%20tissues%20at%20single-cell%20resolution.%20While%20biospecimen%20and%20experimental%20information%20is%20often%20captured%2C%20detailed%20metadata%20standards%20related%20to%20data%20matrices%20and%20analysis%20workflows%20are%20currently%20lacking.%20To%20address%20this%2C%20we%20develop%20the%20matrix%20and%20analysis%20metadata%20standards%20%28MAMS%29%20to%20serve%20as%20a%20resource%20for%20data%20centers%2C%20repositories%2C%20and%20tool%20developers.%20We%20define%20metadata%20fields%20for%20matrices%20and%20parameters%20commonly%20utilized%20in%20analytical%20workflows%20and%20developed%20the%20rmams%20package%20to%20extract%20MAMS%20from%20single-cell%20objects.%20Overall%2C%20MAMS%20promotes%20the%20harmonization%2C%20integration%2C%20and%20reproducibility%20of%20single-cell%20data%20across%20platforms.%22%2C%22date%22%3A%222024-08-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13059-024-03349-w%22%2C%22ISSN%22%3A%221474-760X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A24%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22IX46MV3I%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schade%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchade%20AE%2C%20Perurena%20N%2C%20Yang%20Y%2C%20Rodriguez%20CL%2C%20Krishnan%20A%2C%20Gardner%20A%2C%20Loi%20P%2C%20Xu%20Y%2C%20Nguyen%20VTM%2C%20Mastellone%20GM%2C%20Pilla%20NF%2C%20Watanabe%20M%2C%20Ota%20K%2C%20Davis%20RA%2C%20Mattioli%20K%2C%20Xiang%20D%2C%20Zoeller%20JJ%2C%20Lin%20JR%2C%20Morganti%20S%2C%20Garrido-Castro%20AC%2C%20Tolaney%20SM%2C%20Li%20Z%2C%20Barbie%20DA%2C%20Sorger%20PK%2C%20Helin%20K%2C%20Santagata%20S%2C%20Knott%20SRV%2C%20Cichowski%20K.%20AKT%20and%20EZH2%20inhibitors%20kill%20TNBCs%20by%20hijacking%20mechanisms%20of%20involution.%20Nature.%202024%20Oct%209%3B%20PMID%3A%2039385030%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22AKT%20and%20EZH2%20inhibitors%20kill%20TNBCs%20by%20hijacking%20mechanisms%20of%20involution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Schade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naiara%22%2C%22lastName%22%3A%22Perurena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoona%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20L.%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjana%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alycia%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20T.%20M.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20M.%22%2C%22lastName%22%3A%22Mastellone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20F.%22%2C%22lastName%22%3A%22Pilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keiichi%22%2C%22lastName%22%3A%22Ota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaia%22%2C%22lastName%22%3A%22Mattioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dongxi%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20J.%22%2C%22lastName%22%3A%22Zoeller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Morganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20C.%22%2C%22lastName%22%3A%22Garrido-Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Helin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20R.%20V.%22%2C%22lastName%22%3A%22Knott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Cichowski%22%7D%5D%2C%22abstractNote%22%3A%22Triple-negative%20breast%20cancer%20%28TNBC%29%20is%20the%20most%20aggressive%20breast%20cancer%20subtype%20and%20has%20the%20highest%20rate%20of%20recurrence1.%20The%20predominant%20standard%20of%20care%20for%20advanced%20TNBC%20is%20systemic%20chemotherapy%20with%20or%20without%20immunotherapy%3B%20however%2C%20responses%20are%20typically%20short%20lived1%2C2.%20Thus%2C%20there%20is%20an%20urgent%20need%20to%20develop%20more%20effective%20treatments.%20Components%20of%20the%20PI3K%20pathway%20represent%20plausible%20therapeutic%20targets%3B%20more%20than%2070%25%20of%20TNBCs%20have%20alterations%20in%20PIK3CA%2C%20AKT1%20or%20PTEN3-6.%20However%2C%20in%20contrast%20to%20hormone-receptor-positive%20tumours%2C%20it%20is%20still%20unclear%20whether%20or%20how%20triple-negative%20disease%20will%20respond%20to%20PI3K%20pathway%20inhibitors7.%20Here%20we%20describe%20a%20promising%20AKT-inhibitor-based%20therapeutic%20combination%20for%20TNBC.%20Specifically%2C%20we%20show%20that%20AKT%20inhibitors%20synergize%20with%20agents%20that%20suppress%20the%20histone%20methyltransferase%20EZH2%20and%20promote%20robust%20tumour%20regression%20in%20multiple%20TNBC%20models%20in%20vivo.%20AKT%20and%20EZH2%20inhibitors%20exert%20these%20effects%20by%20first%20cooperatively%20driving%20basal-like%20TNBC%20cells%20into%20a%20more%20differentiated%2C%20luminal-like%20state%2C%20which%20cannot%20be%20effectively%20induced%20by%20either%20agent%20alone.%20Once%5Cu00a0TNBCs%20are%20differentiated%2C%20these%20agents%20kill%20them%20by%20hijacking%20signals%20that%20normally%20drive%20mammary%20gland%20involution.%20Using%20a%20machine%20learning%20approach%2C%20we%20developed%20a%20classifier%20that%20can%20be%20used%20to%20predict%20sensitivity.%20Together%2C%20these%20findings%20identify%20a%20promising%20therapeutic%20strategy%20for%20this%20highly%20aggressive%20tumour%20type%20and%20illustrate%20how%20deregulated%20epigenetic%20enzymes%20can%20insulate%20tumours%20from%20oncogenic%20vulnerabilities.%20These%20studies%20also%20reveal%20how%20developmental%20tissue-specific%20cell%20death%20pathways%20may%20be%20co-opted%20for%20therapeutic%20benefit.%22%2C%22date%22%3A%222024-10-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-024-08031-6%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A19%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22L6ZFMNMI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Souque%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESouque%20C%2C%20Gonz%26%23xE1%3Blez%20Ojeda%20I%2C%20Baym%20M.%20From%20Petri%20Dishes%20to%20Patients%20to%20Populations%3A%20Scales%20and%20Evolutionary%20Mechanisms%20Driving%20Antibiotic%20Resistance.%20Annu%20Rev%20Microbiol%20%5BInternet%5D.%202024%20Aug%2014%3B%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.annualreviews.org%5C%2Fcontent%5C%2Fjournals%5C%2F10.1146%5C%2Fannurev-micro-041522-102707%27%3Ehttps%3A%5C%2F%5C%2Fwww.annualreviews.org%5C%2Fcontent%5C%2Fjournals%5C%2F10.1146%5C%2Fannurev-micro-041522-102707%3C%5C%2Fa%3E%20PMID%3A%2039141706%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20Petri%20Dishes%20to%20Patients%20to%20Populations%3A%20Scales%20and%20Evolutionary%20Mechanisms%20Driving%20Antibiotic%20Resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9lia%22%2C%22lastName%22%3A%22Souque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Indra%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez%20Ojeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Tackling%20the%20challenge%20created%20by%20antibiotic%20resistance%20requires%20understanding%20the%20mechanisms%20behind%20its%20evolution.%20Like%20any%20evolutionary%20process%2C%20the%20evolution%20of%20antimicrobial%20resistance%20%28AMR%29%20is%20driven%20by%20the%20underlying%20variation%20in%20a%20bacterial%20population%20and%20the%20selective%20pressures%20acting%20upon%20it.%20Importantly%2C%20both%20selection%20and%20variation%20will%20depend%20on%20the%20scale%20at%20which%20resistance%20evolution%20is%20considered%20%28from%20evolution%20within%20a%20single%20patient%20to%20the%20host%20population%20level%29.%20While%20laboratory%20experiments%20have%20generated%20fundamental%20insights%20into%20the%20mechanisms%20underlying%20antibiotic%20resistance%20evolution%2C%20the%20technological%20advances%20in%20whole%20genome%20sequencing%20now%20allow%20us%20to%20probe%20antibiotic%20resistance%20evolution%20beyond%20the%20lab%20and%20directly%20record%20it%20in%20individual%20patients%20and%20host%20populations.%20Here%20we%20review%20the%20evolutionary%20forces%20driving%20antibiotic%20resistance%20at%20each%20of%20these%20scales%2C%20highlight%20gaps%20in%20our%20current%20understanding%20of%20AMR%20evolution%2C%20and%20discuss%20future%20steps%20toward%20evolution-guided%20interventions.%22%2C%22date%22%3A%222024-08-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1146%5C%2Fannurev-micro-041522-102707%22%2C%22ISSN%22%3A%221545-3251%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.annualreviews.org%5C%2Fcontent%5C%2Fjournals%5C%2F10.1146%5C%2Fannurev-micro-041522-102707%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A14%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22A9U4X8F6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stojanovic%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-21%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EStojanovic%20L%2C%20Abbotts%20R%2C%20Tripathi%20K%2C%20Coon%20CM%2C%20Rajendran%20S%2C%20Farid%20EA%2C%20Hostetter%20G%2C%20Guarnieri%20JW%2C%20Wallace%20DC%2C%20Liu%20S%2C%20Wan%20J%2C%20Calendo%20G%2C%20Marker%20R%2C%20Gohari%20Z%2C%20Inayatullah%20MMA%2C%20Tiwari%20VK%2C%20Kader%20T%2C%20Santagata%20S%2C%20Drapkin%20R%2C%20Kommoss%20S%2C%20Pfisterer%20J%2C%20Konecny%20GE%2C%20Coopergard%20R%2C%20Issa%20JP%2C%20Winterhoff%20BJN%2C%20Topper%20MJ%2C%20Sandusky%20GE%2C%20Miller%20KD%2C%20Baylin%20SB%2C%20Nephew%20KP%2C%20Rassool%20FV.%20ZNFX1%20is%20a%20Novel%20Master%20Regulator%20in%20Epigenetically-induced%20Pathogen%20Mimicry%20and%20Inflammasome%20Signaling%20in%20Cancer.%20bioRxiv.%202024%20Oct%2021%3B2024.10.18.618659.%20PMCID%3A%20PMC11526927%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ZNFX1%20is%20a%20Novel%20Master%20Regulator%20in%20Epigenetically-induced%20Pathogen%20Mimicry%20and%20Inflammasome%20Signaling%20in%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lora%22%2C%22lastName%22%3A%22Stojanovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Abbotts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaushlendra%22%2C%22lastName%22%3A%22Tripathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Collin%20M.%22%2C%22lastName%22%3A%22Coon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saranya%22%2C%22lastName%22%3A%22Rajendran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elnaz%20Abbasi%22%2C%22lastName%22%3A%22Farid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galen%22%2C%22lastName%22%3A%22Hostetter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20W.%22%2C%22lastName%22%3A%22Guarnieri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20C.%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gennaro%22%2C%22lastName%22%3A%22Calendo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Marker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahra%22%2C%22lastName%22%3A%22Gohari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%20M.%20A.%22%2C%22lastName%22%3A%22Inayatullah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20K.%22%2C%22lastName%22%3A%22Tiwari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanjina%22%2C%22lastName%22%3A%22Kader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronny%22%2C%22lastName%22%3A%22Drapkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Kommoss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacobus%22%2C%22lastName%22%3A%22Pfisterer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gottfried%20E.%22%2C%22lastName%22%3A%22Konecny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Coopergard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Issa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boris%20J.%20N.%22%2C%22lastName%22%3A%22Winterhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Topper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20E.%22%2C%22lastName%22%3A%22Sandusky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%20D.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20B.%22%2C%22lastName%22%3A%22Baylin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20P.%22%2C%22lastName%22%3A%22Nephew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feyruz%20V.%22%2C%22lastName%22%3A%22Rassool%22%7D%5D%2C%22abstractNote%22%3A%22DNA%20methyltransferase%20and%20poly%28ADP-ribose%29%20polymerase%20inhibitors%20%28DNMTis%2C%20PARPis%29%20induce%20a%20stimulator%20of%20interferon%20%28IFN%29%20genes%20%28STING%29-dependent%20pathogen%20mimicry%20response%20%28PMR%29%20in%20ovarian%20%28OC%29%20and%20other%20cancers.%20We%20now%20show%20that%20combining%20DNMTis%20and%20PARPis%20upregulates%20expression%20of%20a%20little-studied%20nucleic-acid%20sensor%2C%20NFX1-type%20zinc%20finger-containing%201%20protein%20%28ZNFX1%29.%20We%20demonstrate%20that%20ZNFX1%20is%20a%20novel%20master%20regulator%20for%20PMR%20induction%20in%20mitochondria%2C%20serving%20as%20a%20gateway%20for%20STING-dependent%20PMR.%20In%20patient%20OC%20databases%2C%20high%20ZNFX1%20expression%20levels%20correlate%20with%20advanced%20stage%20disease.%20ZNFX1%20expression%20alone%20significantly%20correlates%20with%20an%20increase%20in%20overall%20survival%20in%20a%20phase%203%20trial%20for%20therapy-resistant%20OC%20patients%20receiving%20bevacizumab%20in%20combination%20with%20chemotherapy.%20In%20correlative%20RNA-seq%20data%2C%20inflammasome%20signaling%20through%20ZNFX1%20correlates%20with%20abnormal%20vasculogenesis.%20ZNFX1%20controls%20PMR%20signaling%20through%20the%20mitochondria%20and%20may%20serve%20as%20a%20biomarker%20to%20facilitate%20offering%20personalized%20therapy%20in%20OC%20patients%2C%20highlighting%20the%20strong%20translational%20significance%20of%20our%20findings.%5CnSIGNIFICANCE%20STATEMENT%3A%20DNA%20methyltransferase%20and%20poly%28ADP-ribose%29%20polymerase%20inhibitors%20upregulate%20expression%20of%20a%20novel%20nucleic-acid%20sensor%2C%20ZNFX1%20that%20serves%20as%20a%20mitochondrial%20gateway%20to%20STING-dependent%20interferon%5C%2Finflammasome%20signaling%20with%20tumor%20suppressor%20properties%20in%20ovarian%20cancer.%22%2C%22date%22%3A%222024-10-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.10.18.618659%22%2C%22ISSN%22%3A%222692-8205%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A39%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22G5442MYJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Susa%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESusa%20KJ%2C%20Bradshaw%20GA%2C%20Eisert%20RJ%2C%20Schilling%20CM%2C%20Kalocsay%20M%2C%20Blacklow%20SC%2C%20Kruse%20AC.%20A%20spatiotemporal%20map%20of%20co-receptor%20signaling%20networks%20underlying%20B%20cell%20activation.%20Cell%20Rep.%202024%20Jun%207%3B43%286%29%3A114332.%20PMID%3A%2038850533%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20spatiotemporal%20map%20of%20co-receptor%20signaling%20networks%20underlying%20B%20cell%20activation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20J.%22%2C%22lastName%22%3A%22Susa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%20M.%22%2C%22lastName%22%3A%22Schilling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20C.%22%2C%22lastName%22%3A%22Blacklow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20C.%22%2C%22lastName%22%3A%22Kruse%22%7D%5D%2C%22abstractNote%22%3A%22The%20B%20cell%20receptor%20%28BCR%29%20signals%20together%20with%20a%20multi-component%20co-receptor%20complex%20to%20initiate%20B%20cell%20activation%20in%20response%20to%20antigen%20binding.%20Here%2C%20we%20take%20advantage%20of%20peroxidase-catalyzed%20proximity%20labeling%20combined%20with%20quantitative%20mass%20spectrometry%20to%20track%20co-receptor%20signaling%20dynamics%20in%20Raji%20cells%20from%2010%5Cu00a0s%20to%202%5Cu00a0h%20after%20BCR%20stimulation.%20This%20approach%20enables%20tracking%20of%202%2C814%20proximity-labeled%20proteins%20and%201%2C394%20phosphosites%20and%20provides%20an%20unbiased%20and%20quantitative%20molecular%20map%20of%20proteins%20recruited%20to%20the%20vicinity%20of%20CD19%2C%20the%20signaling%20subunit%20of%20the%20co-receptor%20complex.%20We%20detail%20the%20recruitment%20kinetics%20of%20signaling%20effectors%20to%20CD19%20and%20identify%20previously%20uncharacterized%20mediators%20of%20B%20cell%20activation.%20We%20show%20that%20the%20glutamate%20transporter%20SLC1A1%20is%20responsible%20for%20mediating%20rapid%20metabolic%20reprogramming%20and%20for%20maintaining%20redox%20homeostasis%20during%20B%20cell%20activation.%20This%20study%20provides%20a%20comprehensive%20map%20of%20BCR%20signaling%20and%20a%20rich%20resource%20for%20uncovering%20the%20complex%20signaling%20networks%20that%20regulate%20activation.%22%2C%22date%22%3A%222024-06-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2024.114332%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-06-10T15%3A55%3A45Z%22%7D%7D%2C%7B%22key%22%3A%2244CV6EMP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sutcliffe%20et%20al.%22%2C%22parsedDate%22%3A%222024-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESutcliffe%20SG%2C%20Kraemer%20SA%2C%20Ellmen%20I%2C%20Knapp%20JJ%2C%20Overton%20AK%2C%20Nash%20D%2C%20Nissimov%20JI%2C%20Charles%20TC%2C%20Dreifuss%20D%2C%20Topolsky%20I%2C%20Baykal%20PI%2C%20Fuhrmann%20L%2C%20Jablonski%20KP%2C%20Beerenwinkel%20N%2C%20Levy%20JI%2C%20Olabode%20AS%2C%20Becker%20DG%2C%20Gugan%20G%2C%20Brintnell%20E%2C%20Poon%20AFY%2C%20Valieris%20R%2C%20Drummond%20RD%2C%20Defelicibus%20A%2C%20Dias-Neto%20E%2C%20Rosales%20RA%2C%20Tojal%20da%20Silva%20I%2C%20Orfanou%20A%2C%20Psomopoulos%20F%2C%20Pechlivanis%20N%2C%20Pipes%20L%2C%20Chen%20Z%2C%20Baaijens%20JA%2C%20Baym%20M%2C%20Shapiro%20BJ.%20Tracking%20SARS-CoV-2%20variants%20of%20concern%20in%20wastewater%3A%20an%20assessment%20of%20nine%20computational%20tools%20using%20simulated%20genomic%20data.%20Microb%20Genom.%202024%20May%3B10%285%29.%20PMID%3A%2038785221%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tracking%20SARS-CoV-2%20variants%20of%20concern%20in%20wastewater%3A%20an%20assessment%20of%20nine%20computational%20tools%20using%20simulated%20genomic%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20G.%22%2C%22lastName%22%3A%22Sutcliffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%20A.%22%2C%22lastName%22%3A%22Kraemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Ellmen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20J.%22%2C%22lastName%22%3A%22Knapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%20K.%22%2C%22lastName%22%3A%22Overton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delaney%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jozef%20I.%22%2C%22lastName%22%3A%22Nissimov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trevor%20C.%22%2C%22lastName%22%3A%22Charles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Dreifuss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Topolsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pelin%20I.%22%2C%22lastName%22%3A%22Baykal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%22%2C%22lastName%22%3A%22Fuhrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%20P.%22%2C%22lastName%22%3A%22Jablonski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niko%22%2C%22lastName%22%3A%22Beerenwinkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20I.%22%2C%22lastName%22%3A%22Levy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abayomi%20S.%22%2C%22lastName%22%3A%22Olabode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devan%20G.%22%2C%22lastName%22%3A%22Becker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gopi%22%2C%22lastName%22%3A%22Gugan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22Brintnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Art%20F.%20Y.%22%2C%22lastName%22%3A%22Poon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renan%22%2C%22lastName%22%3A%22Valieris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20D.%22%2C%22lastName%22%3A%22Drummond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Defelicibus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Dias-Neto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%20A.%22%2C%22lastName%22%3A%22Rosales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Israel%22%2C%22lastName%22%3A%22Tojal%20da%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aspasia%22%2C%22lastName%22%3A%22Orfanou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fotis%22%2C%22lastName%22%3A%22Psomopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaos%22%2C%22lastName%22%3A%22Pechlivanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lenore%22%2C%22lastName%22%3A%22Pipes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zihao%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jasmijn%20A.%22%2C%22lastName%22%3A%22Baaijens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20Jesse%22%2C%22lastName%22%3A%22Shapiro%22%7D%5D%2C%22abstractNote%22%3A%22Wastewater-based%20surveillance%20%28WBS%29%20is%20an%20important%20epidemiological%20and%20public%20health%20tool%20for%20tracking%20pathogens%20across%20the%20scale%20of%20a%20building%2C%20neighbourhood%2C%20city%2C%20or%20region.%20WBS%20gained%20widespread%20adoption%20globally%20during%20the%20SARS-CoV-2%20pandemic%20for%20estimating%20community%20infection%20levels%20by%20qPCR.%20Sequencing%20pathogen%20genes%20or%20genomes%20from%20wastewater%20adds%20information%20about%20pathogen%20genetic%20diversity%2C%20which%20can%20be%20used%20to%20identify%20viral%20lineages%20%28including%20variants%20of%20concern%29%20that%20are%20circulating%20in%20a%20local%20population.%20Capturing%20the%20genetic%20diversity%20by%20WBS%20sequencing%20is%20not%20trivial%2C%20as%20wastewater%20samples%20often%20contain%20a%20diverse%20mixture%20of%20viral%20lineages%20with%20real%20mutations%20and%20sequencing%20errors%2C%20which%20must%20be%20deconvoluted%20computationally%20from%20short%20sequencing%20reads.%20In%20this%20study%20we%20assess%20nine%20different%20computational%20tools%20that%20have%20recently%20been%20developed%20to%20address%20this%20challenge.%20We%20simulated%20100%20wastewater%20sequence%20samples%20consisting%20of%20SARS-CoV-2%20BA.1%2C%20BA.2%2C%20and%20Delta%20lineages%2C%20in%20various%20mixtures%2C%20as%20well%20as%20a%20Delta-Omicron%20recombinant%20and%20a%20synthetic%20%27novel%27%20lineage.%20Most%20tools%20performed%20well%20in%20identifying%20the%20true%20lineages%20present%20and%20estimating%20their%20relative%20abundances%20and%20were%20generally%20robust%20to%20variation%20in%20sequencing%20depth%20and%20read%20length.%20While%20many%20tools%20identified%20lineages%20present%20down%20to%201%5Cu200a%25%20frequency%2C%20results%20were%20more%20reliable%20above%20a%205%5Cu200a%25%20threshold.%20The%20presence%20of%20an%20unknown%20synthetic%20lineage%2C%20which%20represents%20an%20unclassified%20SARS-CoV-2%20lineage%2C%20increases%20the%20error%20in%20relative%20abundance%20estimates%20of%20other%20lineages%2C%20but%20the%20magnitude%20of%20this%20effect%20was%20small%20for%20most%20tools.%20The%20tools%20also%20varied%20in%20how%20they%20labelled%20novel%20synthetic%20lineages%20and%20recombinants.%20While%20our%20simulated%20dataset%20represents%20just%20one%20of%20many%20possible%20use%20cases%20for%20these%20methods%2C%20we%20hope%20it%20helps%20users%20understand%20potential%20sources%20of%20error%20or%20bias%20in%20wastewater%20sequencing%20analysis%20and%20to%20appreciate%20the%20commonalities%20and%20differences%20across%20methods.%22%2C%22date%22%3A%222024-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1099%5C%2Fmgen.0.001249%22%2C%22ISSN%22%3A%222057-5858%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A41%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22CQWMWEM5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tobochnik%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-12%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETobochnik%20S%2C%20Regan%20MS%2C%20Dorotan%20MKC%2C%20Reich%20D%2C%20Lapinskas%20E%2C%20Hossain%20MA%2C%20Stopka%20S%2C%20Santagata%20S%2C%20Murphy%20MM%2C%20Arnaout%20O%2C%20Bi%20WL%2C%20Chiocca%20EA%2C%20Golby%20AJ%2C%20Mooney%20MA%2C%20Smith%20TR%2C%20Ligon%20KL%2C%20Wen%20PY%2C%20Agar%20NYR%2C%20Lee%20JW.%20Pilot%20trial%20of%20perampanel%20on%20peritumoral%20hyperexcitability%20and%20clinical%20outcomes%20in%20newly%20diagnosed%20high-grade%20glioma%20%5BInternet%5D.%20medRxiv%3B%202024%20%5Bcited%202024%20Oct%2011%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.04.11.24305666%27%3Ehttp%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.04.11.24305666%3C%5C%2Fa%3E%20PMCID%3A%20PMC11030478%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Pilot%20trial%20of%20perampanel%20on%20peritumoral%20hyperexcitability%20and%20clinical%20outcomes%20in%20newly%20diagnosed%20high-grade%20glioma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Tobochnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20K.%20C.%22%2C%22lastName%22%3A%22Dorotan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dustine%22%2C%22lastName%22%3A%22Reich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Lapinskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Amin%22%2C%22lastName%22%3A%22Hossain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20M.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Arnaout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20J.%22%2C%22lastName%22%3A%22Golby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Mooney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Woo%22%2C%22lastName%22%3A%22Lee%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Glutamatergic%20neuron-glioma%20synaptogenesis%20and%20peritumoral%20hyperexcitability%20promote%20glioma%20growth%20in%20a%20positive%20feedback%20loop.%20The%20objective%20of%20this%20study%20was%20to%20evaluate%20the%20feasibility%20and%20estimated%20effect%20sizes%20of%20the%20AMPA-R%20antagonist%2C%20perampanel%2C%20on%20intraoperative%20electrophysiologic%20hyperexcitability%20and%20clinical%20outcomes.%5CnMETHODS%3A%20An%20open-label%20trial%20was%20performed%20comparing%20perampanel%20to%20standard%20of%20care%20%28SOC%29%20in%20patients%20undergoing%20resection%20of%20newly-diagnosed%20radiologic%20high-grade%20glioma.%20Perampanel%20was%20administered%20as%20a%20pre-operative%20loading%20dose%20followed%20by%20maintenance%20therapy%20until%20progressive%20disease%20or%20up%20to%2012-months.%20SOC%20treatment%20involved%20levetiracetam%20for%207-days%20or%20as%20clinically%20indicated.%20The%20primary%20outcome%20of%20hyperexcitability%20was%20defined%20by%20intra-operative%20electrocorticography%20high%20frequency%20oscillation%20%28HFO%29%20rates.%20Seizure-freedom%20and%20overall%20survival%20%28OS%29%20were%20estimated%20by%20the%20Kaplan-Meier%20method.%20Tissue%20concentrations%20of%20perampanel%2C%20levetiracetam%2C%20and%20metabolites%20were%20measured%20by%20mass%20spectrometry.%5CnRESULTS%3A%20HFO%20rates%20were%20similar%20between%20perampanel-treated%20and%20SOC%20cohorts.%20The%20trial%20was%20terminated%20early%20after%20interim%20analysis%20for%20futility%2C%20and%20outcomes%20assessed%20in%2011%20patients%20%287%20perampanel-treated%2C%204%20SOC%29.%20Over%20a%20median%20281%20days%20of%20post-enrollment%20follow-up%2C%2027%25%20of%20patients%20had%20seizures%2C%20including%2014%25%20treated%20with%20perampanel%20and%2050%25%20treated%20with%20SOC.%20OS%20in%20perampanel-treated%20patients%20was%20similar%20to%20a%20glioblastoma%20reference%20cohort%20%28p%3D0.81%29.%20Glutamate%20concentrations%20in%20surface%20biopsies%20were%20positively%20correlated%20with%20HFO%20rates%20in%20adjacent%20electrode%20contacts%20and%20were%20not%20significantly%20associated%20with%20treatment%20assignment%20or%20drug%20concentrations.%5CnCONCLUSIONS%3A%20A%20peri-operative%20loading%20regimen%20of%20perampanel%20was%20safe%20and%20well-tolerated%2C%20with%20similar%20peritumoral%20hyperexcitability%20as%20in%20levetiracetam-treated%20patients.%20Maintenance%20anti-glutamatergic%20therapy%20was%20not%20observed%20to%20impact%20survival%20outcomes.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-04-12%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.04.11.24305666%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2024.04.11.24305666%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A44%3A25Z%22%7D%7D%2C%7B%22key%22%3A%229LABQV53%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wala%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWala%20J%2C%20de%20Bruijn%20I%2C%20Coy%20S%2C%20Gagn%26%23xE9%3B%20A%2C%20Chan%20S%2C%20Chen%20YA%2C%20Hoffer%20J%2C%20Muhlich%20J%2C%20Schultz%20N%2C%20Santagata%20S%2C%20Sorger%20PK.%20Integrating%20spatial%20profiles%20and%20cancer%20genomics%20to%20identify%20immune-infiltrated%20mismatch%20repair%20proficient%20colorectal%20cancers.%20bioRxiv%3B%202024.%20PMCID%3A%20PMC11463659%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Integrating%20spatial%20profiles%20and%20cancer%20genomics%20to%20identify%20immune-infiltrated%20mismatch%20repair%20proficient%20colorectal%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremiah%22%2C%22lastName%22%3A%22Wala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22de%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22Gagn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Predicting%20the%20progression%20of%20solid%20cancers%20based%20solely%20on%20genetics%20is%20challenging%20due%20to%20the%20influence%20of%20the%20tumor%20microenvironment%20%28TME%29.%20For%20colorectal%20cancer%20%28CRC%29%2C%20tumors%20deficient%20in%20mismatch%20repair%20%28dMMR%29%20are%20more%20immune%20infiltrated%20than%20mismatch%20repair%20proficient%20%28pMMR%29%20tumors%20and%20have%20better%20prognosis%20following%20resection.%20Here%20we%20quantify%20features%20of%20the%20CRC%20TME%20by%20combining%20spatial%20profiling%20with%20genetic%20analysis%20and%20release%20our%20findings%20via%20a%20spatially%20enhanced%20version%20of%20cBioPortal%20that%20facilitates%20multi-modal%20data%20exploration%20and%20analysis.%20We%20find%20that%20%5Cu223c20%25%20of%20pMMR%20tumors%20exhibit%20similar%20levels%20of%20T%20cell%20infiltration%20as%20dMMR%20tumors%20and%20that%20this%20is%20associated%20with%20better%20survival%20but%20not%20any%20specific%20somatic%20mutation.%20These%20T%20cell-infiltrated%20pMMR%20%28tipMMR%29%20tumors%20contain%20abundant%20cells%20expressing%20PD1%20and%20PDL1%20as%20well%20as%20T%20regulatory%20cells%2C%20consistent%20with%20a%20suppressed%20immune%20response.%20Thus%2C%20like%20dMMR%20CRC%2C%20tipMMR%20CRC%20may%20benefit%20from%20immune%20checkpoint%20inhibitor%20therapy.%5CnSIGNIFICANCE%3A%20pMMR%20tumors%20with%20high%20T%20cell%20infiltration%20and%20active%20immunosuppression%20are%20identifiable%20with%20a%20mid-plex%20imaging%20assay%20whose%20clinical%20deployment%20might%20double%20the%20number%20of%20treatment-na%5Cu00efve%20CRCs%20eligible%20for%20ICIs.%20Moreover%2C%20the%20low%20tumor%20mutational%20burden%20in%20tipMMR%20CRC%20shows%20that%20MMR%20status%20is%20not%20the%20only%20factor%20promoting%20immune%20infiltration.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-09-26%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.09.24.614701%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T15%3A26%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22SU8CJIYB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Wan%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWan%20G%2C%20Maliga%20Z%2C%20Yan%20B%2C%20Vallius%20T%2C%20Shi%20Y%2C%20Khattab%20S%2C%20Chang%20C%2C%20Nirmal%20AJ%2C%20Yu%20KH%2C%20Liu%20D%2C%20Lian%20CG%2C%20DeSimone%20MS%2C%20Sorger%20PK%2C%20Semenov%20YR.%20SpatialCells%3A%20automated%20profiling%20of%20tumor%20microenvironments%20with%20spatially%20resolved%20multiplexed%20single-cell%20data.%20Brief%20Bioinform.%202024%20Mar%2027%3B25%283%29%3Abbae189.%20PMCID%3A%20PMC11066940%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SpatialCells%3A%20automated%20profiling%20of%20tumor%20microenvironments%20with%20spatially%20resolved%20multiplexed%20single-cell%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guihong%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boshen%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Khattab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crystal%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun-Hsing%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mia%20S.%22%2C%22lastName%22%3A%22DeSimone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R.%22%2C%22lastName%22%3A%22Semenov%22%7D%5D%2C%22abstractNote%22%3A%22Cancer%20is%20a%20complex%20cellular%20ecosystem%20where%20malignant%20cells%20coexist%20and%20interact%20with%20immune%2C%20stromal%20and%20other%20cells%20within%20the%20tumor%20microenvironment%20%28TME%29.%20Recent%20technological%20advancements%20in%20spatially%20resolved%20multiplexed%20imaging%20at%20single-cell%20resolution%20have%20led%20to%20the%20generation%20of%20large-scale%20and%20high-dimensional%20datasets%20from%20biological%20specimens.%20This%20underscores%20the%20necessity%20for%20automated%20methodologies%20that%20can%20effectively%20characterize%20molecular%2C%20cellular%20and%20spatial%20properties%20of%20TMEs%20for%20various%20malignancies.%20This%20study%20introduces%20SpatialCells%2C%20an%20open-source%20software%20package%20designed%20for%20region-based%20exploratory%20analysis%20and%20comprehensive%20characterization%20of%20TMEs%20using%20multiplexed%20single-cell%20data.%20The%20source%20code%20and%20tutorials%20are%20available%20at%20https%3A%5C%2F%5C%2Fsemenovlab.github.io%5C%2FSpatialCells.%20SpatialCells%20efficiently%20streamlines%20the%20automated%20extraction%20of%20features%20from%20multiplexed%20single-cell%20data%20and%20can%20process%20samples%20containing%20millions%20of%20cells.%20Thus%2C%20SpatialCells%20facilitates%20subsequent%20association%20analyses%20and%20machine%20learning%20predictions%2C%20making%20it%20an%20essential%20tool%20in%20advancing%20our%20understanding%20of%20tumor%20growth%2C%20invasion%20and%20metastasis.%22%2C%22date%22%3A%222024-03-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbib%5C%2Fbbae189%22%2C%22ISSN%22%3A%221477-4054%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A05%3A55Z%22%7D%7D%2C%7B%22key%22%3A%227ME9CFQE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Warchol%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWarchol%20S%2C%20Troidl%20J%2C%20Muhlich%20J%2C%20Krueger%20R%2C%20Hoffer%20J%2C%20Lin%20T%2C%20Beyer%20J%2C%20Glassman%20E%2C%20Sorger%20P%2C%20Pfister%20H.%20psudo%3A%20Exploring%20Multi%26%23x2010%3BChannel%20Biomedical%20Image%20Data%20with%20Spatially%20and%20Perceptually%20Optimized%20Pseudocoloring.%20Computer%20Graphics%20Forum.%202024%20Jun%2010%3Be15103.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22psudo%3A%20Exploring%20Multi%5Cu2010Channel%20Biomedical%20Image%20Data%20with%20Spatially%20and%20Perceptually%20Optimized%20Pseudocoloring%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Warchol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Troidl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Beyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Glassman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Over%20the%20past%20century%2C%20multichannel%20fluorescence%20imaging%20has%20been%20pivotal%20in%20myriad%20scientific%20breakthroughs%20by%20enabling%20the%20spatial%20visualization%20of%20proteins%20within%20a%20biological%20sample.%20With%20the%20shift%20to%20digital%20methods%20and%20visualization%20software%2C%20experts%20can%20now%20flexibly%20pseudocolor%20and%20combine%20image%20channels%2C%20each%20corresponding%20to%20a%20different%20protein%2C%20to%20explore%20their%20spatial%20relationships.%20We%20thus%20propose%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20psudo%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20an%20interactive%20system%20that%20allows%20users%20to%20create%20optimal%20color%20palettes%20for%20multichannel%20spatial%20data.%20In%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20psudo%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20a%20novel%20optimization%20method%20generates%20palettes%20that%20maximize%20the%20perceptual%20differences%20between%20channels%20while%20mitigating%20confusing%20color%20blending%20in%20overlapping%20channels.%20We%20integrate%20this%20method%20into%20a%20system%20that%20allows%20users%20to%20explore%20multi%5Cu2010channel%20image%20data%20and%20compare%20and%20evaluate%20color%20palettes%20for%20their%20data.%20An%20interactive%20lensing%20approach%20provides%20on%5Cu2010demand%20feedback%20on%20channel%20overlap%20and%20a%20color%20confusion%20metric%20while%20giving%20context%20to%20the%20underlying%20channel%20values.%20Color%20palettes%20can%20be%20applied%20globally%20or%2C%20using%20the%20lens%2C%20to%20local%20regions%20of%20interest.%20We%20evaluate%20our%20palette%20optimization%20approach%20using%20three%20graphical%20perception%20tasks%20in%20a%20crowdsourced%20user%20study%20with%20150%20participants%2C%20showing%20that%20users%20are%20more%20accurate%20at%20discerning%20and%20comparing%20the%20underlying%20data%20using%20our%20approach.%20Additionally%2C%20we%20showcase%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20psudo%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20a%20case%20study%20exploring%20the%20complex%20immune%20responses%20in%20cancer%20tissue%20data%20with%20a%20biologist.%22%2C%22date%22%3A%222024-06-10%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1111%5C%2Fcgf.15103%22%2C%22ISSN%22%3A%220167-7055%2C%201467-8659%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T12%3A41%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22B9LJZ4QE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhang%20X%2C%20Pant%20SM%2C%20Ritch%20CC%2C%20Tang%20HY%2C%20Shao%20H%2C%20Dweep%20H%2C%20Gong%20YY%2C%20Brooks%20R%2C%20Brafford%20P%2C%20Wolpaw%20AJ%2C%20Lee%20Y%2C%20Weeraratna%20A%2C%20Sehgal%20A%2C%20Herlyn%20M%2C%20Kossenkov%20A%2C%20Speicher%20D%2C%20Sorger%20PK%2C%20Santagata%20S%2C%20Dang%20CV.%20Cell%20state%20dependent%20effects%20of%20Bmal1%20on%20melanoma%20immunity%20and%20tumorigenicity.%20Nat%20Commun.%202024%20Jan%2020%3B15%281%29%3A633.%20PMCID%3A%20PMC10799901%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cell%20state%20dependent%20effects%20of%20Bmal1%20on%20melanoma%20immunity%20and%20tumorigenicity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xue%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%20M.%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecily%20C.%22%2C%22lastName%22%3A%22Ritch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hsin-Yao%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongguang%22%2C%22lastName%22%3A%22Shao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harsh%22%2C%22lastName%22%3A%22Dweep%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yao-Yu%22%2C%22lastName%22%3A%22Gong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebekah%22%2C%22lastName%22%3A%22Brooks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Brafford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Wolpaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yool%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashani%22%2C%22lastName%22%3A%22Weeraratna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amita%22%2C%22lastName%22%3A%22Sehgal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meenhard%22%2C%22lastName%22%3A%22Herlyn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Kossenkov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Speicher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20V.%22%2C%22lastName%22%3A%22Dang%22%7D%5D%2C%22abstractNote%22%3A%22The%20circadian%20clock%20regulator%20Bmal1%20modulates%20tumorigenesis%2C%20but%20its%20reported%20effects%20are%20inconsistent.%20Here%2C%20we%20show%20that%20Bmal1%20has%20a%20context-dependent%20role%20in%20mouse%20melanoma%20tumor%20growth.%20Loss%20of%20Bmal1%20in%20YUMM2.1%20or%20B16-F10%20melanoma%20cells%20eliminates%20clock%20function%20and%20diminishes%20hypoxic%20gene%20expression%20and%20tumorigenesis%2C%20which%20could%20be%20rescued%20by%20ectopic%20expression%20of%20HIF1%5Cu03b1%20in%20YUMM2.1%20cells.%20By%20contrast%2C%20over-expressed%20wild-type%20or%20a%20transcriptionally%20inactive%20mutant%20Bmal1%20non-canonically%20sequester%20myosin%20heavy%20chain%209%20%28Myh9%29%20to%20increase%20MRTF-SRF%20activity%20and%20AP-1%20transcriptional%20signature%2C%20and%20shift%20YUMM2.1%20cells%20from%20a%20Sox10high%20to%20a%20Sox9high%20immune%20resistant%2C%20mesenchymal%20cell%20state%20that%20is%20found%20in%20human%20melanomas.%20Our%20work%20describes%20a%20link%20between%20Bmal1%2C%20Myh9%2C%20mouse%20melanoma%20cell%20plasticity%2C%20and%20tumor%20immunity.%20This%20connection%20may%20underlie%20cancer%20therapeutic%20resistance%20and%20underpin%20the%20link%20between%20the%20circadian%20clock%2C%20MRTF-SRF%20and%20the%20cytoskeleton.%22%2C%22date%22%3A%222024-01-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-024-44778-2%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A45%3A26Z%22%7D%7D%5D%7D
1.
Ahdritz G, Bouatta N, Floristean C, Kadyan S, Xia Q, Gerecke W, O’Donnell TJ, Berenberg D, Fisk I, Zanichelli N, Zhang B, Nowaczynski A, Wang B, Stepniewska-Dziubinska MM, Zhang S, Ojewole A, Guney ME, Biderman S, Watkins AM, Ra S, Lorenzo PR, Nivon L, Weitzner B, Ban YEA, Chen S, Zhang M, Li C, Song SL, He Y, Sorger PK, Mostaque E, Zhang Z, Bonneau R, AlQuraishi M. OpenFold: retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalization. Nat Methods. 2024 Aug;21(8):1514–1524. PMID: 38744917
1.
Bhola PD, Letai A. The Siren Song of Synergy. Blood Cancer Discov. 2024 Feb 8;OF1–OF2. PMID: 38331415
1.
Callahan TJ, Tripodi IJ, Stefanski AL, Cappelletti L, Taneja SB, Wyrwa JM, Casiraghi E, Matentzoglu NA, Reese J, Silverstein JC, Hoyt CT, Boyce RD, Malec SA, Unni DR, Joachimiak MP, Robinson PN, Mungall CJ, Cavalleri E, Fontana T, Valentini G, Mesiti M, Gillenwater LA, Santangelo B, Vasilevsky NA, Hoehndorf R, Bennett TD, Ryan PB, Hripcsak G, Kahn MG, Bada M, Baumgartner WA, Hunter LE. An open source knowledge graph ecosystem for the life sciences. Sci Data. 2024 Apr 11;11(1):363. PMCID: PMC11009265
1.
Chidley C, Darnell AM, Gaudio BL, Lien EC, Barbeau AM, Vander Heiden MG, Sorger PK. A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments. Nat Cell Biol. 2024 May;26(5):825–838. PMCID: PMC11098743
1.
Conger KO, Chidley C, Ozgurses ME, Zhao H, Kim Y, Semina SE, Burns P, Rawat V, Lietuvninkas L, Sheldon R, Ben-Sahra I, Frasor J, Sorger PK, DeNicola GM, Coloff JL. ASCT2 is a major contributor to serine uptake in cancer cells. Cell Rep. 2024 Jul 26;43(8):114552. PMID: 39068660
1.
Couce A, Limdi A, Magnan M, Owen SV, Herren CM, Lenski RE, Tenaillon O, Baym M. Changing fitness effects of mutations through long-term bacterial evolution. Science. 2024 Jan 26;383(6681):eadd1417. PMID: 38271521
1.
Coy S, Lee JS, Chan SJ, Woo T, Jones J, Alexandrescu S, Wen PY, Sorger PK, Ligon KL, Santagata S. Systematic characterization of antibody-drug conjugate targets in central nervous system tumors. Neuro Oncol. 2024 Mar 4;26(3):458–472. PMCID: PMC10912007
1.
De Bruijn I, Nikolov M, Lau C, Clayton A, Gibbs DL, Mitraka E, Pozhidayeva D, Lash A, Sumer SO, Altreuter J, Anton K, DeFelice M, Li X, Lisman A, R Longabaugh WJ, Muhlich J, Santagata S, Nandakumar S, Sorger PK, Suver C, Schultz N, Taylor AJ, Thorsson V, Cerami E, Eddy JA. Sharing Data from the Human Tumor Atlas Network through Standards, Infrastructure, and Community Engagement. bioRxiv; 2024.
1.
De Los Angeles A, Hug CB, Gladyshev VN, Church GM, Velychko S. Sendai virus persistence questions the transient naive reprogramming method for iPSC generation [Internet]. bioRxiv; 2024. Available from: http://biorxiv.org/lookup/doi/10.1101/2024.03.07.583804 PMCID: PMC10979911
1.
Deng X, Seguinot BO, Bradshaw G, Lee JS, Coy S, Kalocsay M, Santagata S, Mitchison T. STMND1 is a phylogenetically ancient stathmin which localizes to motile cilia and exhibits nuclear translocation that is inhibited when soluble tubulin concentration increases. Mol Biol Cell. 2024 Jun 1;35(6):ar82. PMCID: PMC11238091
1.
Do BT, Hsu PP, Vermeulen SY, Wang Z, Hirz T, Abbott KL, Aziz N, Replogle JM, Bjelosevic S, Paolino J, Nelson SA, Block S, Darnell AM, Ferreira R, Zhang H, Milosevic J, Schmidt DR, Chidley C, Harris IS, Weissman JS, Pikman Y, Stegmaier K, Cheloufi S, Su XA, Sykes DB, Vander Heiden MG. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. Dev Cell. 2024 Aug 19;59(16):2203-2221.e15. PMID: 38823395
1.
Eschbacher KL, Tran QT, Moskalev EA, Jenkins S, Fritchie K, Stoehr R, Caron A, Link MJ, Brown PD, Guajardo A, Brat DJ, Wu A, Santagata S, Louis DN, Brastianos PK, Kaplan AB, Alexander B, Rossi S, Ferrarese F, Raleigh DR, Nguyen MP, Gross J, Velazquez Vega J, Rodriguez F, Perry A, Martinez-Lage M, Orr BA, Haller F, Giannini C. NAB2::STAT6 fusions and genome-wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors. Brain Pathol. 2024 Mar 24;e13256. PMID: 38523251
1.
Fang R, Vallius T, Zhang A, Van Cura D, Alicandri F, Fischer G, Draper E, Xu S, Pelletier R, Katsyv I, Sorger PK, Murphy GF, Lian CG. PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation [Internet]. bioRxiv; 2024. Available from: http://biorxiv.org/lookup/doi/10.1101/2024.07.26.605293 PMCID: PMC11291125
1.
Gallo PN, Mihelc E, Eisert R, Bradshaw GA, Dimek F, Leffler A, Kalocsay M, Moiseenkova-Bell V. The dynamic TRPV2 ion channel proximity proteome reveals functional links of calcium flux with cellular adhesion factors NCAM and L1CAM in neurite outgrowth. Cell Calcium. 2024 May 4;121:102894. PMID: 38728789
1.
Ghosh HS, Patel RV, Woodward E, Greenwald NF, Bhave VM, Maury EA, Cello G, Hoffman SE, Li Y, Gupta H, Youssef G, Spurr LF, Vogelzang J, Touat M, Dubois F, Cherniack AD, Guo X, Tavakol S, Cioffi G, Lindeman NI, Ligon AH, Chiocca EA, Reardon DA, Wen PY, Meredith D, Santagata S, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Bi WL. Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors. Neuro Oncol. 2024 Aug 21;noae164. PMID: 39164213
1.
Gomez SM, Axtman AD, Willson TM, Major MB, Townsend RR, Sorger PK, Johnson GL. Illuminating function of the understudied druggable kinome. Drug Discov Today. 2024 Mar;29(3):103881. PMCID: PMC11262466
1.
Grinshpun A, Russo D, Ma W, Verma A, Hermida-Prado F, Sherman S, Gaglia G, Kabraji S, Kirkner G, Hughes ME, Lin NU, Sandusky Z, Nardone A, Guarducci C, Nguyen QD, Santagata S, Nagy Z, Jeselsohn R. Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. NPJ Breast Cancer. 2024 Jun 8;10(1):42. PMCID: PMC11162492
1.
Gritsch D, Santagata S, Brastianos PK. Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma. Curr Treat Options Oncol. 2024 Feb;25(2):261–273. PMID: 38300480
1.
Guerriero JL, Lin JR, Pastorello RG, Du Z, Chen YA, Townsend MG, Shimada K, Hughes ME, Ren S, Tayob N, Zheng K, Mei S, Patterson A, Taneja KL, Metzger O, Tolaney SM, Lin NU, Dillon DA, Schnitt SJ, Sorger PK, Mittendorf EA, Santagata S. Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer. NPJ Breast Cancer. 2024 Jan 2;10(1):2. PMCID: PMC10761880
1.
Herzberger L, Hadwiger M, Kruger R, Sorger P, Pfister H, Groller E, Beyer J. Residency Octree: A Hybrid Approach for Scalable Web-Based Multi-Volume Rendering. IEEE Trans Vis Comput Graph. 2024 Jan;30(1):1380–1390. PMCID: PMC10840607
1.
Jain A, Gyori BM, Hakim S, Jain A, Sun L, Petrova V, Bhuiyan SA, Zhen S, Wang Q, Kawaguchi R, Bunga S, Taub DG, Ruiz-Cantero MC, Tong-Li C, Andrews N, Kotoda M, Renthal W, Sorger PK, Woolf CJ. Nociceptor-immune interactomes reveal insult-specific immune signatures of pain. Nat Immunol. 2024 May 28; PMID: 38806708
1.
Ji W, Du G, Jiang J, Lu W, Mills CE, Yuan L, Jiang F, He Z, Bradshaw GA, Chung M, Jiang Z, Byun WS, Hinshaw SM, Zhang T, Gray NS. Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). Eur J Med Chem. 2024 Oct 5;276:116613. PMCID: PMC11316633
1.
Johnson L, Sarosiek KA. Role of intrinsic apoptosis in environmental exposure health outcomes. Trends Mol Med. 2024 Jan;30(1):56–73. PMID: 38057226
1.
Kader T, Lin JR, Hug C, Coy S, Chen YA, de Bruijn I, Shih N, Jung E, Pelletier RJ, Leon ML, Mingo G, Omran DK, Lee JS, Yapp C, Satravada BA, Kundra R, Xu Y, Chan S, Tefft JB, Muhlich J, Kim S, Gysler SM, Agudo J, Heath JR, Schultz N, Drescher C, Sorger PK, Drapkin R, Santagata S. Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma. bioRxiv; 2024. PMCID: PMC11463462
1.
Ke S, Dang F, Wang L, Chen JY, Naik MT, Li W, Thavamani A, Kim N, Naik NM, Sui H, Tang W, Qiu C, Koikawa K, Batalini F, Stern Gatof E, Isaza DA, Patel JM, Wang X, Clohessy JG, Heng YJ, Lahav G, Liu Y, Gray NS, Zhou XZ, Wei W, Wulf GM, Lu KP. Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry. Nat Commun. 2024 Apr 15;15(1):3220. PMCID: PMC11018817
1.
König LE, Rodriguez S, Hug C, Daneshvari S, Chung A, Bradshaw GA, Sahin A, Zhou G, Eisert RJ, Piccioni F, Das S, Kalocsay M, Sokolov A, Sorger P, Root DE, Albers MW. TYK2 as a novel therapeutic target in Alzheimer’s Disease with TDP-43 inclusions. bioRxiv; 2024.
1.
Launonen IM, Erkan EP, Niemiec I, Junquera A, Hincapié-Otero M, Afenteva D, Liang Z, Salko M, Szabo A, Perez-Villatoro F, Falco MM, Li Y, Micoli G, Nagaraj A, Haltia UM, Kahelin E, Oikkonen J, Hynninen J, Virtanen A, Nirmal AJ, Vallius T, Hautaniemi S, Sorger P, Vähärautio A, Färkkilä A. Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer [Internet]. 2024 [cited 2024 Oct 11]. Available from: http://biorxiv.org/lookup/doi/10.1101/2024.03.19.585657 PMCID: PMC10983974
1.
Loi P, Schade AE, Rodriguez CL, Krishnan A, Perurena N, Nguyen VTM, Xu Y, Watanabe M, Davis RA, Gardner A, Pilla NF, Mattioli K, Popow O, Gunduz N, Lannagan TRM, Fitzgerald S, Sicinska ET, Lin JR, Tan W, Brais LK, Haigis KM, Giannakis M, Ng K, Santagata S, Helin K, Sansom OJ, Cichowski K. Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers. Cancer Discov. 2024 Aug 12; PMID: 39121480
1.
Lu D, Faizi M, Drown B, Simerzin A, François J, Bradshaw G, Kelleher N, Jambhekar A, Gunawardena J, Lahav G. Temporal regulation of gene expression through integration of p53 dynamics and modifications. Sci Adv. 2024 Oct 25;10(43):eadp2229. PMCID: PMC11506164
1.
Maliga Z, Kim DY, Bui ATN, Lin JR, Dewan AK, Jadeja S, Murphy GF, Nirmal AJ, Lian CG, Sorger PK, LeBoeuf NR. Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study. J Invest Dermatol. 2024 Aug;144(8):1887-1890.e5. PMID: 38360200
1.
Marques C, Held A, Dorfman K, Sung J, Song C, Kavuturu AS, Aguilar C, Russo T, Oakley DH, Albers MW, Hyman BT, Petrucelli L, Lagier-Tourenne C, Wainger BJ. Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. 2024 Mar 13;147(1):56. PMCID: PMC10937762
1.
Minichetti DG, Boyd A, Lemire E, Hacker J, Haber AL, Roditi RE, Albers MW, Lee S, Buchheit KM, Laidlaw TM, Bankova LG. Determinants of Persistence and Recovery of Chronic COVID19 Chemosensory Dysfunction. J Allergy Clin Immunol. 2024 Sep 11;S0091-6749(24)00913–8. PMID: 39270802
1.
Mollaoglu G, Tepper A, Falcomatà C, Potak HT, Pia L, Amabile A, Mateus-Tique J, Rabinovich N, Park MD, LaMarche NM, Brody R, Browning L, Lin JR, Zamarin D, Sorger PK, Santagata S, Merad M, Baccarini A, Brown BD. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 2024 Oct 25;S0092-8674(24)01154–1. PMID: 39481380
1.
Nirmal AJ, Sorger PK. SCIMAP: A Python Toolkit for Integrated Spatial Analysis of Multiplexed Imaging Data. J Open Source Softw. 2024 May 29;9(97):6604. PMCID: PMC11173324
1.
Olesinski EA, Bhatia KS, Wang C, Pioso MS, Lin XX, Mamdouh AM, Ng SX, Sandhu V, Jasdanwala SS, Yilma B, Bohl S, Ryan JA, Malani D, Luskin MR, Kallioniemi O, Porkka K, Adamia S, Chng WJ, Osato M, Weinstock DM, Garcia JS, Letai A, Bhatt S. Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood Cancer Discov. 2024 May 1;5(3):180–201. PMCID: PMC11061585
1.
Pan RA, Wang Y, Qiu S, Villalobos-Ortiz M, Ryan J, Morris E, Halilovic E, Letai A. BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. Haematologica. 2024 Apr 1;109(4):1253–1258. PMCID: PMC10985422
1.
Quinones-Olvera N, Owen SV, McCully LM, Marin MG, Rand EA, Fan AC, Martins Dosumu OJ, Paul K, Sanchez Castaño CE, Petherbridge R, Paull JS, Baym M. Diverse and abundant phages exploit conjugative plasmids. Nat Commun. 2024 Apr 12;15(1):3197. PMCID: PMC11015023
1.
Ricciuti B, Lamberti G, Puchala SR, Mahadevan NR, Lin JR, Alessi JV, Chowdhury A, Li YY, Wang X, Spurr L, Pecci F, Di Federico A, Venkatraman D, Barrichello AP, Gandhi M, Vaz VR, Pangilinan AJ, Haradon D, Lee E, Gupta H, Pfaff KL, Welsh EL, Nishino M, Cherniack AD, Johnson BE, Weirather JL, Dryg ID, Rodig SJ, Sholl LM, Sorger P, Santagata S, Umeton R, Awad MM. Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. J Clin Oncol. 2024 Apr 10;42(11):1311–1321. PMID: 38207230
1.
Rogava M, Aprati TJ, Chi WY, Melms JC, Hug C, Davis SH, Earlie EM, Chung C, Deshmukh SK, Wu S, Sledge G, Tang S, Ho P, Amin AD, Caprio L, Gurjao C, Tagore S, Ngo B, Lee MJ, Zanetti G, Wang Y, Chen S, Ge W, Melo LMN, Allies G, Rösler J, Gibney GT, Schmitz OJ, Sykes M, Creusot RJ, Tüting T, Schadendorf D, Röcken M, Eigentler TK, Molotkov A, Mintz A, Bakhoum SF, Beyaz S, Cantley LC, Sorger PK, Meckelmann SW, Tasdogan A, Liu D, Laughney AM, Izar B. Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nat Cancer. 2024 Jan 29; PMID: 38286827
1.
Sarfraz I, Wang Y, Shastry A, Teh WK, Sokolov A, Herb BR, Creasy HH, Virshup I, Dries R, Degatano K, Mahurkar A, Schnell DJ, Madrigal P, Hilton J, Gehlenborg N, Tickle T, Campbell JD. MAMS: matrix and analysis metadata standards to facilitate harmonization and reproducibility of single-cell data. Genome Biol. 2024 Aug 1;25(1):205. PMCID: PMC11292877
1.
Schade AE, Perurena N, Yang Y, Rodriguez CL, Krishnan A, Gardner A, Loi P, Xu Y, Nguyen VTM, Mastellone GM, Pilla NF, Watanabe M, Ota K, Davis RA, Mattioli K, Xiang D, Zoeller JJ, Lin JR, Morganti S, Garrido-Castro AC, Tolaney SM, Li Z, Barbie DA, Sorger PK, Helin K, Santagata S, Knott SRV, Cichowski K. AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution. Nature. 2024 Oct 9; PMID: 39385030
1.
Souque C, González Ojeda I, Baym M. From Petri Dishes to Patients to Populations: Scales and Evolutionary Mechanisms Driving Antibiotic Resistance. Annu Rev Microbiol [Internet]. 2024 Aug 14; Available from: https://www.annualreviews.org/content/journals/10.1146/annurev-micro-041522-102707 PMID: 39141706
1.
Stojanovic L, Abbotts R, Tripathi K, Coon CM, Rajendran S, Farid EA, Hostetter G, Guarnieri JW, Wallace DC, Liu S, Wan J, Calendo G, Marker R, Gohari Z, Inayatullah MMA, Tiwari VK, Kader T, Santagata S, Drapkin R, Kommoss S, Pfisterer J, Konecny GE, Coopergard R, Issa JP, Winterhoff BJN, Topper MJ, Sandusky GE, Miller KD, Baylin SB, Nephew KP, Rassool FV. ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer. bioRxiv. 2024 Oct 21;2024.10.18.618659. PMCID: PMC11526927
1.
Susa KJ, Bradshaw GA, Eisert RJ, Schilling CM, Kalocsay M, Blacklow SC, Kruse AC. A spatiotemporal map of co-receptor signaling networks underlying B cell activation. Cell Rep. 2024 Jun 7;43(6):114332. PMID: 38850533
1.
Sutcliffe SG, Kraemer SA, Ellmen I, Knapp JJ, Overton AK, Nash D, Nissimov JI, Charles TC, Dreifuss D, Topolsky I, Baykal PI, Fuhrmann L, Jablonski KP, Beerenwinkel N, Levy JI, Olabode AS, Becker DG, Gugan G, Brintnell E, Poon AFY, Valieris R, Drummond RD, Defelicibus A, Dias-Neto E, Rosales RA, Tojal da Silva I, Orfanou A, Psomopoulos F, Pechlivanis N, Pipes L, Chen Z, Baaijens JA, Baym M, Shapiro BJ. Tracking SARS-CoV-2 variants of concern in wastewater: an assessment of nine computational tools using simulated genomic data. Microb Genom. 2024 May;10(5). PMID: 38785221
1.
Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain MA, Stopka S, Santagata S, Murphy MM, Arnaout O, Bi WL, Chiocca EA, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen PY, Agar NYR, Lee JW. Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma [Internet]. medRxiv; 2024 [cited 2024 Oct 11]. Available from: http://medrxiv.org/lookup/doi/10.1101/2024.04.11.24305666 PMCID: PMC11030478
1.
Wala J, de Bruijn I, Coy S, Gagné A, Chan S, Chen YA, Hoffer J, Muhlich J, Schultz N, Santagata S, Sorger PK. Integrating spatial profiles and cancer genomics to identify immune-infiltrated mismatch repair proficient colorectal cancers. bioRxiv; 2024. PMCID: PMC11463659
1.
Wan G, Maliga Z, Yan B, Vallius T, Shi Y, Khattab S, Chang C, Nirmal AJ, Yu KH, Liu D, Lian CG, DeSimone MS, Sorger PK, Semenov YR. SpatialCells: automated profiling of tumor microenvironments with spatially resolved multiplexed single-cell data. Brief Bioinform. 2024 Mar 27;25(3):bbae189. PMCID: PMC11066940
1.
Warchol S, Troidl J, Muhlich J, Krueger R, Hoffer J, Lin T, Beyer J, Glassman E, Sorger P, Pfister H. psudo: Exploring Multi‐Channel Biomedical Image Data with Spatially and Perceptually Optimized Pseudocoloring. Computer Graphics Forum. 2024 Jun 10;e15103.
1.
Zhang X, Pant SM, Ritch CC, Tang HY, Shao H, Dweep H, Gong YY, Brooks R, Brafford P, Wolpaw AJ, Lee Y, Weeraratna A, Sehgal A, Herlyn M, Kossenkov A, Speicher D, Sorger PK, Santagata S, Dang CV. Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity. Nat Commun. 2024 Jan 20;15(1):633. PMCID: PMC10799901
2576724
IXMHRBF6
LSP Paper
2023
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22R7G48UXK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aguilar%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAguilar%20F%2C%20Yu%20S%2C%20Grant%20RA%2C%20Swanson%20S%2C%20Ghose%20D%2C%20Su%20BG%2C%20Sarosiek%20KA%2C%20Keating%20AE.%20Peptides%20from%20human%20BNIP5%20and%20PXT1%20and%20non-native%20binders%20of%20pro-apoptotic%20BAK%20can%20directly%20activate%20or%20inhibit%20BAK-mediated%20membrane%20permeabilization.%20Structure.%202023%20Mar%202%3B31%283%29%3A265-281.e7.%20PMCID%3A%20PMC9992319%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peptides%20from%20human%20BNIP5%20and%20PXT1%20and%20non-native%20binders%20of%20pro-apoptotic%20BAK%20can%20directly%20activate%20or%20inhibit%20BAK-mediated%20membrane%20permeabilization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacey%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Grant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Swanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dia%22%2C%22lastName%22%3A%22Ghose%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%20G.%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Keating%22%7D%5D%2C%22abstractNote%22%3A%22Apoptosis%20is%20important%20for%20development%20and%20tissue%20homeostasis%2C%20and%20its%20dysregulation%20can%20lead%20to%20diseases%2C%20including%20cancer.%20As%20an%20apoptotic%20effector%2C%20BAK%20undergoes%20conformational%20changes%20that%20promote%20mitochondrial%20outer%20membrane%20disruption%2C%20leading%20to%20cell%20death.%20This%20is%20termed%20%5C%22activation%5C%22%20and%20can%20be%20induced%20by%20peptides%20from%20the%20human%20proteins%20BID%2C%20BIM%2C%20and%20PUMA.%20To%20identify%20additional%20peptides%20that%20can%20regulate%20BAK%2C%20we%20used%20computational%20protein%20design%2C%20yeast%20surface%20display%20screening%2C%20and%20structure-based%20energy%20scoring%20to%20identify%2010%20diverse%20new%20binders.%20We%20discovered%20peptides%20from%20the%20human%20proteins%20BNIP5%20and%20PXT1%20and%20three%20non-native%20peptides%20that%20activate%20BAK%20in%20liposome%20assays%20and%20induce%20cytochrome%20c%20release%20from%20mitochondria.%20Crystal%20structures%20and%20binding%20studies%20reveal%20a%20high%20degree%20of%20similarity%20among%20peptide%20activators%20and%20inhibitors%2C%20ruling%20out%20a%20simple%20function-determining%20property.%20Our%20results%20shed%20light%20on%20the%20vast%20peptide%20sequence%20space%20that%20can%20regulate%20BAK%20function%20and%20will%20guide%20the%20design%20of%20BAK-modulating%20tools%20and%20therapeutics.%22%2C%22date%22%3A%222023-03-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.str.2023.01.001%22%2C%22ISSN%22%3A%221878-4186%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A40%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22QE9E9W7H%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ahdritz%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAhdritz%20G%2C%20Bouatta%20N%2C%20Kadyan%20S%2C%20Jarosch%20L%2C%20Berenberg%20D%2C%20Fisk%20I%2C%20Watkins%20AM%2C%20Ra%20S%2C%20Bonneau%20R%2C%20AlQuraishi%20M.%20OpenProteinSet%3A%20training%20data%20for%20structural%20biology%20at%20scale%20%5BInternet%5D.%20arXiv%3B%202023%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Farxiv.org%5C%2Fabs%5C%2F2308.05326%27%3Ehttps%3A%5C%2F%5C%2Farxiv.org%5C%2Fabs%5C%2F2308.05326%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22OpenProteinSet%3A%20training%20data%20for%20structural%20biology%20at%20scale%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustaf%22%2C%22lastName%22%3A%22Ahdritz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazim%22%2C%22lastName%22%3A%22Bouatta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sachin%22%2C%22lastName%22%3A%22Kadyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Jarosch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Berenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Fisk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20M.%22%2C%22lastName%22%3A%22Watkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Ra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Bonneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22Multiple%20sequence%20alignments%20%28MSAs%29%20of%20proteins%20encode%20rich%20biological%20information%20and%20have%20been%20workhorses%20in%20bioinformatic%20methods%20for%20tasks%20like%20protein%20design%20and%20protein%20structure%20prediction%20for%20decades.%20Recent%20breakthroughs%20like%20AlphaFold2%20that%20use%20transformers%20to%20attend%20directly%20over%20large%20quantities%20of%20raw%20MSAs%20have%20reaffirmed%20their%20importance.%20Generation%20of%20MSAs%20is%20highly%20computationally%20intensive%2C%20however%2C%20and%20no%20datasets%20comparable%20to%20those%20used%20to%20train%20AlphaFold2%20have%20been%20made%20available%20to%20the%20research%20community%2C%20hindering%20progress%20in%20machine%20learning%20for%20proteins.%20To%20remedy%20this%20problem%2C%20we%20introduce%20OpenProteinSet%2C%20an%20open-source%20corpus%20of%20more%20than%2016%20million%20MSAs%2C%20associated%20structural%20homologs%20from%20the%20Protein%20Data%20Bank%2C%20and%20AlphaFold2%20protein%20structure%20predictions.%20We%20have%20previously%20demonstrated%20the%20utility%20of%20OpenProteinSet%20by%20successfully%20retraining%20AlphaFold2%20on%20it.%20We%20expect%20OpenProteinSet%20to%20be%20broadly%20useful%20as%20training%20and%20validation%20data%20for%201%29%20diverse%20tasks%20focused%20on%20protein%20structure%2C%20function%2C%20and%20design%20and%202%29%20large-scale%20multimodal%20machine%20learning%20research.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22arXiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-08-10%22%2C%22DOI%22%3A%2210.48550%5C%2FARXIV.2308.05326%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Farxiv.org%5C%2Fabs%5C%2F2308.05326%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A46%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22KKVA7CLP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bachman%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBachman%20JA%2C%20Gyori%20BM%2C%20Sorger%20PK.%20Automated%20assembly%20of%20molecular%20mechanisms%20at%20scale%20from%20text%20mining%20and%20curated%20databases.%20Mol%20Syst%20Biol.%202023%20May%209%3B19%285%29%3Ae11325.%20PMCID%3A%20PMC10167483%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Automated%20assembly%20of%20molecular%20mechanisms%20at%20scale%20from%20text%20mining%20and%20curated%20databases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20analysis%20of%20omic%20data%20depends%20on%20machine-readable%20information%20about%20protein%20interactions%2C%20modifications%2C%20and%20activities%20as%20found%20in%20protein%20interaction%20networks%2C%20databases%20of%20post-translational%20modifications%2C%20and%20curated%20models%20of%20gene%20and%20protein%20function.%20These%20resources%20typically%20depend%20heavily%20on%20human%20curation.%20Natural%20language%20processing%20systems%20that%20read%20the%20primary%20literature%20have%20the%20potential%20to%20substantially%20extend%20knowledge%20resources%20while%20reducing%20the%20burden%20on%20human%20curators.%20However%2C%20machine-reading%20systems%20are%20limited%20by%20high%20error%20rates%20and%20commonly%20generate%20fragmentary%20and%20redundant%20information.%20Here%2C%20we%20describe%20an%20approach%20to%20precisely%20assemble%20molecular%20mechanisms%20at%20scale%20using%20multiple%20natural%20language%20processing%20systems%20and%20the%20Integrated%20Network%20and%20Dynamical%20Reasoning%20Assembler%20%28INDRA%29.%20INDRA%20identifies%20full%20and%20partial%20overlaps%20in%20information%20extracted%20from%20published%20papers%20and%20pathway%20databases%2C%20uses%20predictive%20models%20to%20improve%20the%20reliability%20of%20machine%20reading%2C%20and%20thereby%20assembles%20individual%20pieces%20of%20information%20into%20non-redundant%20and%20broadly%20usable%20mechanistic%20knowledge.%20Using%20INDRA%20to%20create%20high-quality%20corpora%20of%20causal%20knowledge%20we%20show%20it%20is%20possible%20to%20extend%20protein-protein%20interaction%20databases%20and%20explain%20co-dependencies%20in%20the%20Cancer%20Dependency%20Map.%22%2C%22date%22%3A%222023-05-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.202211325%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A06%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22S8TVYCXW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Baker%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBaker%20GJ%2C%20Novikov%20E%2C%20Zhao%20Z%2C%20Vallius%20T%2C%20Davis%20JA%2C%20Lin%20JR%2C%20Muhlich%20JL%2C%20Mittendorf%20EA%2C%20Santagata%20S%2C%20Guerriero%20JL%2C%20Sorger%20PK.%20Quality%20Control%20for%20Single%20Cell%20Analysis%20of%20High-plex%20Tissue%20Profiles%20using%20CyLinter.%20bioRxiv%3B%202023.%20PMCID%3A%20PMC10634977%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Quality%20Control%20for%20Single%20Cell%20Analysis%20of%20High-plex%20Tissue%20Profiles%20using%20CyLinter%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Novikov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziyuan%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janae%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Tumors%20are%20complex%20assemblies%20of%20cellular%20and%20acellular%20structures%20patterned%20on%20spatial%20scales%20from%20microns%20to%20centimeters.%20Study%20of%20these%20assemblies%20has%20advanced%20dramatically%20with%20the%20introduction%20of%20high-plex%20spatial%20profiling.%20Image-based%20profiling%20methods%20reveal%20the%20intensities%20and%20spatial%20distributions%20of%2020-100%20proteins%20at%20subcellular%20resolution%20in%2010%5Cn%20%20%20%20%20%20%20%20%20%20%20%203%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-10%5Cn%20%20%20%20%20%20%20%20%20%20%20%207%5Cn%20%20%20%20%20%20%20%20%20%20%20%20cells%20per%20specimen.%20Despite%20extensive%20work%20on%20methods%20for%20extracting%20single-cell%20data%20from%20these%20images%2C%20all%20tissue%20images%20contain%20artefacts%20such%20as%20folds%2C%20debris%2C%20antibody%20aggregates%2C%20optical%20aberrations%20and%20image%20processing%20errors%20that%20arise%20from%20imperfections%20in%20specimen%20preparation%2C%20data%20acquisition%2C%20image%20assembly%2C%20and%20feature%20extraction.%20We%20show%20that%20these%20artefacts%20dramatically%20impact%20single-cell%20data%20analysis%2C%20obscuring%20meaningful%20biological%20interpretation.%20We%20describe%20an%20interactive%20quality%20control%20software%20tool%2C%20CyLinter%2C%20that%20identifies%20and%20removes%20data%20associated%20with%20imaging%20artefacts.%20CyLinter%20greatly%20improves%20single-cell%20analysis%2C%20especially%20for%20archival%20specimens%20sectioned%20many%20years%20prior%20to%20data%20collection%2C%20such%20as%20those%20from%20clinical%20trials.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-11-01%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.11.01.565120%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T16%3A00%3A53Z%22%7D%7D%2C%7B%22key%22%3A%224AQRLA6R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bergholz%20et%20al.%22%2C%22parsedDate%22%3A%222023-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBergholz%20JS%2C%20Wang%20Q%2C%20Wang%20Q%2C%20Ramseier%20M%2C%20Prakadan%20S%2C%20Wang%20W%2C%20Fang%20R%2C%20Kabraji%20S%2C%20Zhou%20Q%2C%20Gray%20GK%2C%20Abell-Hart%20K%2C%20Xie%20S%2C%20Guo%20X%2C%20Gu%20H%2C%20Von%20T%2C%20Jiang%20T%2C%20Tang%20S%2C%20Freeman%20GJ%2C%20Kim%20HJ%2C%20Shalek%20AK%2C%20Roberts%20TM%2C%20Zhao%20JJ.%20PI3K%26%23x3B2%3B%20controls%20immune%20evasion%20in%20PTEN-deficient%20breast%20tumours.%20Nature.%202023%20May%3B617%287959%29%3A139%26%23x2013%3B146.%20PMCID%3A%20PMC10494520%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PI3K%5Cu03b2%20controls%20immune%20evasion%20in%20PTEN-deficient%20breast%20tumours%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johann%20S.%22%2C%22lastName%22%3A%22Bergholz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiwei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%22%2C%22lastName%22%3A%22Ramseier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Prakadan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weihua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rong%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheheryar%22%2C%22lastName%22%3A%22Kabraji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Kenneth%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kayley%22%2C%22lastName%22%3A%22Abell-Hart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaozhen%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaocan%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanh%22%2C%22lastName%22%3A%22Von%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuang%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20J.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hye-Jung%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20K.%22%2C%22lastName%22%3A%22Shalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20M.%22%2C%22lastName%22%3A%22Roberts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Loss%20of%20the%20PTEN%20tumour%20suppressor%20is%20one%20of%20the%20most%20common%20oncogenic%20drivers%20across%20all%20cancer%20types1.%20PTEN%20is%20the%20major%20negative%20regulator%20of%20PI3K%20signalling.%20The%20PI3K%5Cu03b2%20isoform%20has%20been%20shown%20to%20play%20an%20important%20role%20in%20PTEN-deficient%20tumours%2C%20but%20the%20mechanisms%20underlying%20the%20importance%20of%20PI3K%5Cu03b2%20activity%20remain%20elusive.%20Here%2C%20using%20a%20syngeneic%20genetically%20engineered%20mouse%20model%20of%20invasive%20breast%20cancer%20driven%20by%20ablation%20of%20both%20Pten%20and%20Trp53%20%28which%20encodes%20p53%29%2C%20we%20show%20that%20genetic%20inactivation%20of%20PI3K%5Cu03b2%20led%20to%20a%20robust%20anti-tumour%20immune%20response%20that%20abrogated%20tumour%20growth%20in%20syngeneic%20immunocompetent%20mice%2C%20but%20not%20in%20immunodeficient%20mice.%20Mechanistically%2C%20PI3K%5Cu03b2%20inactivation%20in%20the%20PTEN-null%20setting%20led%20to%20reduced%20STAT3%20signalling%20and%20increased%20the%20expression%20of%20immune%20stimulatory%20molecules%2C%20thereby%20promoting%20anti-tumour%20immune%20responses.%20Pharmacological%20PI3K%5Cu03b2%20inhibition%20also%20elicited%20anti-tumour%20immunity%20and%20synergized%20with%20immunotherapy%20to%20inhibit%20tumour%20growth.%20Mice%20with%20complete%20responses%20to%20the%20combined%20treatment%20displayed%20immune%20memory%20and%20rejected%20tumours%20upon%20re-challenge.%20Our%20findings%20demonstrate%20a%20molecular%20mechanism%20linking%20PTEN%20loss%20and%20STAT3%20activation%20in%20cancer%20and%20suggest%20that%20PI3K%5Cu03b2%20controls%20immune%20escape%20in%20PTEN-null%20tumours%2C%20providing%20a%20rationale%20for%20combining%20PI3K%5Cu03b2%20inhibitors%20with%20immunotherapy%20for%20the%20treatment%20of%20PTEN-deficient%20breast%20cancer.%22%2C%22date%22%3A%222023-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-023-05940-w%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-27T20%3A40%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22G28JCYT2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bouatta%20and%20AlQuraishi%22%2C%22parsedDate%22%3A%222023-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBouatta%20N%2C%20AlQuraishi%20M.%20Structural%20biology%20at%20the%20scale%20of%20proteomes.%20Nat%20Struct%20Mol%20Biol.%202023%20Feb%3B30%282%29%3A129%26%23x2013%3B130.%20PMCID%3A%20PMC10389299%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20biology%20at%20the%20scale%20of%20proteomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazim%22%2C%22lastName%22%3A%22Bouatta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22AlphaFold2%20has%20already%20changed%20structural%20biology%20but%20its%20true%20power%20may%20lie%20in%20how%20it%20changes%20the%20way%20we%20think%20about%20cells%20and%20organisms.%20Two%20studies%20broadly%20analyze%20and%20assess%20the%20performance%20of%20AlphaFold2%20to%20outline%20the%20extent%20of%20its%20utility%20and%20limitations%20in%20providing%20structural%20models%20that%20shed%20light%20on%20biological%20questions%2C%20including%20mutations%2C%20post-translational%20modifications%2C%20and%20protein-protein%20complex%20interactions.%22%2C%22date%22%3A%222023-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41594-023-00924-w%22%2C%22ISSN%22%3A%221545-9985%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A46%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22ZH6ZLU4N%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Brastianos%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrastianos%20PK%2C%20Twohy%20EL%2C%20Gerstner%20ER%2C%20Kaufmann%20TJ%2C%20Iafrate%20AJ%2C%20Lennerz%20J%2C%20Jeyapalan%20S%2C%20Piccioni%20DE%2C%20Monga%20V%2C%20Fadul%20CE%2C%20Schiff%20D%2C%20Taylor%20JW%2C%20Chowdhary%20SA%2C%20Bettegowda%20C%2C%20Ansstas%20G%2C%20De%20La%20Fuente%20M%2C%20Anderson%20MD%2C%20Shonka%20N%2C%20Damek%20D%2C%20Carrillo%20J%2C%20Kunschner-Ronan%20LJ%2C%20Chaudhary%20R%2C%20Jaeckle%20KA%2C%20Senecal%20FM%2C%20Kaley%20T%2C%20Morrison%20T%2C%20Thomas%20AA%2C%20Welch%20MR%2C%20Iwamoto%20F%2C%20Cachia%20D%2C%20Cohen%20AL%2C%20Vora%20S%2C%20Knopp%20M%2C%20Dunn%20IF%2C%20Kumthekar%20P%2C%20Sarkaria%20J%2C%20Geyer%20S%2C%20Carrero%20XW%2C%20Martinez-Lage%20M%2C%20Cahill%20DP%2C%20Brown%20PD%2C%20Giannini%20C%2C%20Santagata%20S%2C%20Barker%20FG%2C%20Galanis%20E.%20Alliance%20A071401%3A%20phase%20II%20trial%20of%20focal%20adhesion%20kinase%20inhibition%20in%20meningiomas%20with%20somatic%20NF2%20mutations.%20J%20Clin%20Oncol.%202023%20Jan%2020%3B41%283%29%3A618%26%23x2013%3B628.%20PMCID%3A%20PMC9870228%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Alliance%20A071401%3A%20phase%20II%20trial%20of%20focal%20adhesion%20kinase%20inhibition%20in%20meningiomas%20with%20somatic%20NF2%20mutations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20L.%22%2C%22lastName%22%3A%22Twohy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20R.%22%2C%22lastName%22%3A%22Gerstner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Kaufmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20John%22%2C%22lastName%22%3A%22Iafrate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jochen%22%2C%22lastName%22%3A%22Lennerz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suriya%22%2C%22lastName%22%3A%22Jeyapalan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Piccioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%22%2C%22lastName%22%3A%22Monga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camilo%20E.%22%2C%22lastName%22%3A%22Fadul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schiff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennie%20W.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sajeel%20A.%22%2C%22lastName%22%3A%22Chowdhary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chetan%22%2C%22lastName%22%3A%22Bettegowda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Ansstas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarena%22%2C%22lastName%22%3A%22De%20La%20Fuente%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20D.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Shonka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Damek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Carrillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20J.%22%2C%22lastName%22%3A%22Kunschner-Ronan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rekha%22%2C%22lastName%22%3A%22Chaudhary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%20A.%22%2C%22lastName%22%3A%22Jaeckle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%20M.%22%2C%22lastName%22%3A%22Senecal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Kaley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tara%22%2C%22lastName%22%3A%22Morrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alissa%20A.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20R.%22%2C%22lastName%22%3A%22Welch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Iwamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Cachia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shivangi%22%2C%22lastName%22%3A%22Vora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Knopp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20F.%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Kumthekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jann%22%2C%22lastName%22%3A%22Sarkaria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Geyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiomara%20W.%22%2C%22lastName%22%3A%22Carrero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Martinez-Lage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20D.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caterina%22%2C%22lastName%22%3A%22Giannini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20G.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Patients%20with%20progressive%20or%20recurrent%20meningiomas%20have%20limited%20systemic%20therapy%20options.%20Focal%20adhesion%20kinase%20%28FAK%29%20inhibition%20has%20a%20synthetic%20lethal%20relationship%20with%20NF2%20loss.%20Given%20the%20predominance%20of%20NF2%20mutations%20in%20meningiomas%2C%20we%20evaluated%20the%20efficacy%20of%20GSK2256098%2C%20a%20FAK%20inhibitor%2C%20as%20part%20of%20the%20first%20genomically%20driven%20phase%20II%20study%20in%20recurrent%20or%20progressive%20grade%201-3%20meningiomas.%5CnPATIENTS%20AND%20METHODS%3A%20Eligible%20patients%20whose%20tumors%20screened%20positively%20for%20NF2%20mutations%20were%20treated%20with%20GSK2256098%2C%20750%20mg%20orally%20twice%20daily%2C%20until%20progressive%20disease.%20Efficacy%20was%20evaluated%20using%20two%20coprimary%20end%20points%3A%20progression-free%20survival%20at%206%20months%20%28PFS6%29%20and%20response%20rate%20by%20Macdonald%20criteria%2C%20where%20PFS6%20was%20evaluated%20separately%20within%20grade-based%20subgroups%3A%20grade%201%20versus%202%5C%2F3%20meningiomas.%20Per%20study%20design%2C%20the%20FAK%20inhibitor%20would%20be%20considered%20promising%20in%20this%20patient%20population%20if%20either%20end%20point%20met%20the%20corresponding%20decision%20criteria%20for%20efficacy.%5CnRESULTS%3A%20Of%20322%20patients%20screened%20for%20all%20mutation%20cohorts%20of%20the%20study%2C%2036%20eligible%20and%20evaluable%20patients%20with%20NF2%20mutations%20were%20enrolled%20and%20treated%3A%2012%20grade%201%20and%2024%20grade%202%5C%2F3%20patients.%20Across%20all%20grades%2C%20one%20patient%20had%20a%20partial%20response%20and%2024%20had%20stable%20disease%20as%20their%20best%20response%20to%20treatment.%20In%20grade%201%20patients%2C%20the%20observed%20PFS6%20rate%20was%2083%25%20%2810%5C%2F12%20patients%3B%2095%25%20CI%2C%2052%20to%2098%29.%20In%20grade%202%5C%2F3%20patients%2C%20the%20observed%20PFS6%20rate%20was%2033%25%20%288%5C%2F24%20patients%3B%2095%25%20CI%2C%2016%20to%2055%29.%20The%20study%20met%20the%20PFS6%20efficacy%20end%20point%20both%20for%20the%20grade%201%20and%20the%20grade%202%5C%2F3%20cohorts.%20Treatment%20was%20well%20tolerated%3B%20seven%20patients%20had%20a%20maximum%20grade%203%20adverse%20event%20that%20was%20at%20least%20possibly%20related%20to%20treatment%20with%20no%20grade%204%20or%205%20events.%5CnCONCLUSION%3A%20GSK2256098%20was%20well%20tolerated%20and%20resulted%20in%20an%20improved%20PFS6%20rate%20in%20patients%20with%20recurrent%20or%20progressive%20NF2-mutated%20meningiomas%2C%20compared%20with%20historical%20controls.%20The%20criteria%20for%20promising%20activity%20were%20met%2C%20and%20FAK%20inhibition%20warrants%20further%20evaluation%20for%20this%20patient%20population.%22%2C%22date%22%3A%222023-01-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.21.02371%22%2C%22ISSN%22%3A%221527-7755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A25%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22Q4JRKPIG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brastianos%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrastianos%20PK%2C%20Twohy%20E%2C%20Geyer%20S%2C%20Gerstner%20ER%2C%20Kaufmann%20TJ%2C%20Tabrizi%20S%2C%20Kabat%20B%2C%20Thierauf%20J%2C%20Ruff%20MW%2C%20Bota%20DA%2C%20Reardon%20DA%2C%20Cohen%20AL%2C%20De%20La%20Fuente%20MI%2C%20Lesser%20GJ%2C%20Campian%20J%2C%20Agarwalla%20PK%2C%20Kumthekar%20P%2C%20Mann%20B%2C%20Vora%20S%2C%20Knopp%20M%2C%20Iafrate%20AJ%2C%20Curry%20WT%2C%20Cahill%20DP%2C%20Shih%20HA%2C%20Brown%20PD%2C%20Santagata%20S%2C%20Barker%20FG%2C%20Galanis%20E.%20BRAF-MEK%20inhibition%20in%20newly%20diagnosed%20papillary%20craniopharyngiomas.%20N%20Engl%20J%20Med.%202023%20Jul%2013%3B389%282%29%3A118%26%23x2013%3B126.%20PMCID%3A%20PMC10464854%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22BRAF-MEK%20inhibition%20in%20newly%20diagnosed%20papillary%20craniopharyngiomas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22Twohy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Geyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20R.%22%2C%22lastName%22%3A%22Gerstner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Kaufmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shervin%22%2C%22lastName%22%3A%22Tabrizi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Kabat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Thierauf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20W.%22%2C%22lastName%22%3A%22Ruff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20A.%22%2C%22lastName%22%3A%22Bota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarena%20I.%22%2C%22lastName%22%3A%22De%20La%20Fuente%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20J.%22%2C%22lastName%22%3A%22Lesser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jian%22%2C%22lastName%22%3A%22Campian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pankaj%20K.%22%2C%22lastName%22%3A%22Agarwalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Kumthekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhupinder%22%2C%22lastName%22%3A%22Mann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shivangi%22%2C%22lastName%22%3A%22Vora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Knopp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20John%22%2C%22lastName%22%3A%22Iafrate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20T.%22%2C%22lastName%22%3A%22Curry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%20A.%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20D.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%20G.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Craniopharyngiomas%2C%20primary%20brain%20tumors%20of%20the%20pituitary-hypothalamic%20axis%2C%20can%20cause%20clinically%20significant%20sequelae.%20Treatment%20with%20the%20use%20of%20surgery%2C%20radiation%2C%20or%20both%20is%20often%20associated%20with%20substantial%20morbidity%20related%20to%20vision%20loss%2C%20neuroendocrine%20dysfunction%2C%20and%20memory%20loss.%20Genotyping%20has%20shown%20that%20more%20than%2090%25%20of%20papillary%20craniopharyngiomas%20carry%20BRAF%20V600E%20mutations%2C%20but%20data%20are%20lacking%20with%20regard%20to%20the%20safety%20and%20efficacy%20of%20BRAF-MEK%20inhibition%20in%20patients%20with%20papillary%20craniopharyngiomas%20who%20have%20not%20undergone%20previous%20radiation%20therapy.%5CnMETHODS%3A%20Eligible%20patients%20who%20had%20papillary%20craniopharyngiomas%20that%20tested%20positive%20for%20BRAF%20mutations%2C%20had%20not%20undergone%20radiation%20therapy%20previously%2C%20and%20had%20measurable%20disease%20received%20the%20BRAF-MEK%20inhibitor%20combination%20vemurafenib-cobimetinib%20in%2028-day%20cycles.%20The%20primary%20end%20point%20of%20this%20single-group%2C%20phase%202%20study%20was%20objective%20response%20at%204%20months%20as%20determined%20with%20the%20use%20of%20centrally%20determined%20volumetric%20data.%5CnRESULTS%3A%20Of%20the%2016%20patients%20in%20the%20study%2C%2015%20%2894%25%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%2070%20to%20100%29%20had%20a%20durable%20objective%20partial%20response%20or%20better%20to%20therapy.%20The%20median%20reduction%20in%20the%20volume%20of%20the%20tumor%20was%2091%25%20%28range%2C%2068%20to%2099%29.%20The%20median%20follow-up%20was%2022%20months%20%2895%25%20CI%2C%2019%20to%2030%29%20and%20the%20median%20number%20of%20treatment%20cycles%20was%208.%20Progression-free%20survival%20was%2087%25%20%2895%25%20CI%2C%2057%20to%2098%29%20at%2012%20months%20and%2058%25%20%2895%25%20CI%2C%2010%20to%2089%29%20at%2024%20months.%20Three%20patients%20had%20disease%20progression%20during%20follow-up%20after%20therapy%20had%20been%20discontinued%3B%20none%20have%20died.%20The%20sole%20patient%20who%20did%20not%20have%20a%20response%20stopped%20treatment%20after%208%20days%20owing%20to%20toxic%20effects.%20Grade%203%20adverse%20events%20that%20were%20at%20least%20possibly%20related%20to%20treatment%20occurred%20in%2012%20patients%2C%20including%20rash%20in%206%20patients.%20In%202%20patients%2C%20grade%204%20adverse%20events%20%28hyperglycemia%20in%201%20patient%20and%20increased%20creatine%20kinase%20levels%20in%201%20patient%29%20were%20reported%3B%203%20patients%20discontinued%20treatment%20owing%20to%20adverse%20events.%5CnCONCLUSIONS%3A%20In%20this%20small%2C%20single-group%20study%20involving%20patients%20with%20papillary%20craniopharyngiomas%2C%2015%20of%2016%20patients%20had%20a%20partial%20response%20or%20better%20to%20the%20BRAF-MEK%20inhibitor%20combination%20vemurafenib-cobimetinib.%20%28Funded%20by%20the%20National%20Cancer%20Institute%20and%20others%3B%20ClinicalTrials.gov%20number%2C%20NCT03224767.%29.%22%2C%22date%22%3A%222023-07-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa2213329%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A35%3A41Z%22%7D%7D%2C%7B%22key%22%3A%227436PN8G%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Burlingame%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBurlingame%20E%2C%20Ternes%20L%2C%20Lin%20JR%2C%20Chen%20YA%2C%20Kim%20EN%2C%20Gray%20JW%2C%20Chang%20YH.%203D%20multiplexed%20tissue%20imaging%20reconstruction%20and%20optimized%20region%20of%20interest%20%28ROI%29%20selection%20through%20deep%20learning%20model%20of%20channels%20embedding.%20Front%20Bioinform.%202023%3B3%3A1275402.%20PMCID%3A%20PMC10620917%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%223D%20multiplexed%20tissue%20imaging%20reconstruction%20and%20optimized%20region%20of%20interest%20%28ROI%29%20selection%20through%20deep%20learning%20model%20of%20channels%20embedding%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%22%2C%22lastName%22%3A%22Burlingame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Ternes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eun%20Na%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20Hwan%22%2C%22lastName%22%3A%22Chang%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Tissue-based%20sampling%20and%20diagnosis%20are%20defined%20as%20the%20extraction%20of%20information%20from%20certain%20limited%20spaces%20and%20its%20diagnostic%20significance%20of%20a%20certain%20object.%20Pathologists%20deal%20with%20issues%20related%20to%20tumor%20heterogeneity%20since%20analyzing%20a%20single%20sample%20does%20not%20necessarily%20capture%20a%20representative%20depiction%20of%20cancer%2C%20and%20a%20tissue%20biopsy%20usually%20only%20presents%20a%20small%20fraction%20of%20the%20tumor.%20Many%20multiplex%20tissue%20imaging%20platforms%20%28MTIs%29%20make%20the%20assumption%20that%20tissue%20microarrays%20%28TMAs%29%20containing%20small%20core%20samples%20of%202-dimensional%20%282D%29%20tissue%20sections%20are%20a%20good%20approximation%20of%20bulk%20tumors%20although%20tumors%20are%20not%202D.%20However%2C%20emerging%20whole%20slide%20imaging%20%28WSI%29%20or%203D%20tumor%20atlases%20that%20use%20MTIs%20like%20cyclic%20immunofluorescence%20%28CyCIF%29%20strongly%20challenge%20this%20assumption.%20In%20spite%20of%20the%20additional%20insight%20gathered%20by%20measuring%20the%20tumor%20microenvironment%20in%20WSI%20or%203D%2C%20it%20can%20be%20prohibitively%20expensive%20and%20time-consuming%20to%20process%20tens%20or%20hundreds%20of%20tissue%20sections%20with%20CyCIF.%20Even%20when%20resources%20are%20not%20limited%2C%20the%20criteria%20for%20region%20of%20interest%20%28ROI%29%20selection%20in%20tissues%20for%20downstream%20analysis%20remain%20largely%20qualitative%20and%20subjective%20as%20stratified%20sampling%20requires%20the%20knowledge%20of%20objects%20and%20evaluates%20their%20features.%20Despite%20the%20fact%20TMAs%20fail%20to%20adequately%20approximate%20whole%20tissue%20features%2C%20a%20theoretical%20subsampling%20of%20tissue%20exists%20that%20can%20best%20represent%20the%20tumor%20in%20the%20whole%20slide%20image.%20Methods%3A%20To%20address%20these%20challenges%2C%20we%20propose%20deep%20learning%20approaches%20to%20learn%20multi-modal%20image%20translation%20tasks%20from%20two%20aspects%3A%201%29%20generative%20modeling%20approach%20to%20reconstruct%203D%20CyCIF%20representation%20and%202%29%20co-embedding%20CyCIF%20image%20and%20Hematoxylin%20and%20Eosin%20%28H%26E%29%20section%20to%20learn%20multi-modal%20mappings%20by%20a%20cross-domain%20translation%20for%20minimum%20representative%20ROI%20selection.%20Results%20and%20discussion%3A%20We%20demonstrate%20that%20generative%20modeling%20enables%20a%203D%20virtual%20CyCIF%20reconstruction%20of%20a%20colorectal%20cancer%20specimen%20given%20a%20small%20subset%20of%20the%20imaging%20data%20at%20training%20time.%20By%20co-embedding%20histology%20and%20MTI%20features%2C%20we%20propose%20a%20simple%20convex%20optimization%20for%20objective%20ROI%20selection.%20We%20demonstrate%20the%20potential%20application%20of%20ROI%20selection%20and%20the%20efficiency%20of%20its%20performance%20with%20respect%20to%20cellular%20heterogeneity.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffbinf.2023.1275402%22%2C%22ISSN%22%3A%222673-7647%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-11-06T20%3A28%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22Q2MND573%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cello%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECello%20G%2C%20Patel%20RV%2C%20McMahon%20JT%2C%20Santagata%20S%2C%20Bi%20WL.%20Impact%20of%20H3K27%20trimethylation%20loss%20in%20meningiomas%3A%20a%20meta-analysis.%20Acta%20Neuropathol%20Commun.%202023%20Jul%2025%3B11%281%29%3A122.%20PMCID%3A%20PMC10369842%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20H3K27%20trimethylation%20loss%20in%20meningiomas%3A%20a%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Cello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruchit%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20Tanner%22%2C%22lastName%22%3A%22McMahon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%5D%2C%22abstractNote%22%3A%22Trimethylation%20of%20lysine%2027%20on%20histone%203%20%28H3K27me3%29%20loss%20has%20been%20implicated%20in%20worse%20prognoses%20for%20patients%20with%20meningiomas.%20However%2C%20there%20have%20been%20challenges%20in%20measuring%20H3K27me3%20loss%2C%20quantifying%20its%20impact%2C%20and%20interpreting%20its%20clinical%20utility.%20We%20conducted%20a%20systematic%20review%20across%20Pubmed%2C%20Embase%2C%20and%20Web%20of%20Science%20to%20identify%20studies%20examining%20H3K27me3%20loss%20in%20meningioma.%20Clinical%2C%20histopathological%2C%20and%20immunohistochemistry%20%28IHC%29%20characteristics%20were%20aggregated.%20A%20meta-analysis%20was%20performed%20using%20a%20random-effects%20model%20to%20assess%20prevalence%20of%20H3K27me3%20loss%20and%20meningioma%20recurrence%20risk.%20Study%20bias%20was%20characterized%20using%20the%20NIH%20Quality%20Assessment%20Tool%20and%20funnel%20plots.%20Nine%20publications%20met%20inclusion%20criteria%20with%20a%20total%20of%202376%20meningioma%20cases.%20The%20prevalence%20of%20H3K27me3%20loss%20was%2016%25%20%2895%25%20CI%200.09-0.27%29%2C%20with%20higher%20grade%20tumors%20associated%20with%20a%20significantly%20greater%20proportion%20of%20loss.%20H3K27me3%20loss%20was%20more%20common%20in%20patients%20who%20were%20male%2C%20had%20recurrent%20meningiomas%2C%20or%20required%20adjuvant%20radiation%20therapy.%20Patients%20were%201.70%20times%20more%20likely%20to%20have%20tumor%20recurrence%20with%20H3K27me3%20loss%20%2895%25%20CI%201.35-2.15%29.%20The%20prevalence%20of%20H3K27me3%20loss%20in%20WHO%20grade%202%20and%203%20meningiomas%20was%20found%20to%20be%20significantly%20greater%20in%20tissue%20samples%20less%20than%20five%20years%20old%20versus%20tissue%20of%20all%20ages%20and%20when%20a%20broader%20definition%20of%20IHC%20staining%20loss%20was%20applied.%20This%20analysis%20demonstrates%20that%20H3K27me3%20loss%20significantly%20associates%20with%20more%20aggressive%20meningiomas.%20While%20differences%20in%20IHC%20and%20tumor%20tissue%20age%20have%20led%20to%20heterogeneity%20in%20studying%20H3K27me3%20loss%2C%20a%20robust%20prognostic%20signal%20is%20present.%20Our%20findings%20suggest%20an%20opportunity%20to%20improve%20study%20design%20and%20standardize%20tissue%20processing%20to%20optimize%20clinical%20viability%20of%20this%20epigenetic%20marker.%22%2C%22date%22%3A%222023-07-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs40478-023-01615-9%22%2C%22ISSN%22%3A%222051-5960%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-07-31T14%3A26%3A00Z%22%7D%7D%2C%7B%22key%22%3A%229A3VZ3WB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChen%20JY%2C%20Hug%20C%2C%20Reyes%20J%2C%20Tian%20C%2C%20Gerosa%20L%2C%20Fr%26%23xF6%3Bhlich%20F%2C%20Ponsioen%20B%2C%20Snippert%20HJG%2C%20Spencer%20SL%2C%20Jambhekar%20A%2C%20Sorger%20PK%2C%20Lahav%20G.%20Multi-range%20ERK%20responses%20shape%20the%20proliferative%20trajectory%20of%20single%20cells%20following%20oncogene%20induction.%20Cell%20Rep.%202023%20Mar%2028%3B42%283%29%3A112252.%20PMCID%3A%20PMC10153468%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multi-range%20ERK%20responses%20shape%20the%20proliferative%20trajectory%20of%20single%20cells%20following%20oncogene%20induction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chengzhe%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bas%22%2C%22lastName%22%3A%22Ponsioen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%20J.%20G.%22%2C%22lastName%22%3A%22Snippert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%20L.%22%2C%22lastName%22%3A%22Spencer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22Oncogene-induced%20senescence%20is%20a%20phenomenon%20in%20which%20aberrant%20oncogene%20expression%20causes%20non-transformed%20cells%20to%20enter%20a%20non-proliferative%20state.%20Cells%20undergoing%20oncogenic%20induction%20display%20phenotypic%20heterogeneity%2C%20with%20some%20cells%20senescing%20and%20others%20remaining%20proliferative.%20The%20causes%20of%20heterogeneity%20remain%20unclear.%20We%20studied%20the%20sources%20of%20heterogeneity%20in%20the%20responses%20of%20human%20epithelial%20cells%20to%20oncogenic%20BRAFV600E%20expression.%20We%20found%20that%20a%20narrow%20expression%20range%20of%20BRAFV600E%20generated%20a%20wide%20range%20of%20activities%20of%20its%20downstream%20effector%20ERK.%20In%20population-level%20and%20single-cell%20assays%2C%20ERK%20activity%20displayed%20a%20non-monotonic%20relationship%20to%20proliferation%2C%20with%20intermediate%20ERK%20activities%20leading%20to%20maximal%20proliferation.%20We%20profiled%20gene%20expression%20across%20a%20range%20of%20ERK%20activities%20over%20time%20and%20characterized%20four%20distinct%20ERK%20response%20classes%2C%20which%20we%20propose%20act%20in%20concert%20to%20generate%20the%20ERK-proliferation%20response.%20Altogether%2C%20our%20studies%20map%20the%20input-output%20relationships%20between%20ERK%20activity%20and%20proliferation%2C%20elucidating%20how%20heterogeneity%20can%20be%20generated%20during%20oncogene%20induction.%22%2C%22date%22%3A%222023-03-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2023.112252%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-05-17T18%3A05%3A28Z%22%7D%7D%2C%7B%22key%22%3A%228GS7F94K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222023-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChen%20WC%2C%20Choudhury%20A%2C%20Youngblood%20MW%2C%20Polley%20MYC%2C%20Lucas%20CHG%2C%20Mirchia%20K%2C%20Maas%20SLN%2C%20Suwala%20AK%2C%20Won%20M%2C%20Bayley%20JC%2C%20Harmanci%20AS%2C%20Harmanci%20AO%2C%20Klisch%20TJ%2C%20Nguyen%20MP%2C%20Vasudevan%20HN%2C%20McCortney%20K%2C%20Yu%20TJ%2C%20Bhave%20V%2C%20Lam%20TC%2C%20Pu%20JKS%2C%20Li%20LF%2C%20Leung%20GKK%2C%20Chan%20JW%2C%20Perlow%20HK%2C%20Palmer%20JD%2C%20Haberler%20C%2C%20Berghoff%20AS%2C%20Preusser%20M%2C%20Nicolaides%20TP%2C%20Mawrin%20C%2C%20Agnihotri%20S%2C%20Resnick%20A%2C%20Rood%20BR%2C%20Chew%20J%2C%20Young%20JS%2C%20Boreta%20L%2C%20Braunstein%20SE%2C%20Schulte%20J%2C%20Butowski%20N%2C%20Santagata%20S%2C%20Spetzler%20D%2C%20Bush%20NAO%2C%20Villanueva-Meyer%20JE%2C%20Chandler%20JP%2C%20Solomon%20DA%2C%20Rogers%20CL%2C%20Pugh%20SL%2C%20Mehta%20MP%2C%20Sneed%20PK%2C%20Berger%20MS%2C%20Horbinski%20CM%2C%20McDermott%20MW%2C%20Perry%20A%2C%20Bi%20WL%2C%20Patel%20AJ%2C%20Sahm%20F%2C%20Magill%20ST%2C%20Raleigh%20DR.%20Targeted%20gene%20expression%20profiling%20predicts%20meningioma%20outcomes%20and%20radiotherapy%20responses.%20Nat%20Med.%202023%20Dec%3B29%2812%29%3A3067%26%23x2013%3B3076.%20PMID%3A%2037944590%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeted%20gene%20expression%20profiling%20predicts%20meningioma%20outcomes%20and%20radiotherapy%20responses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abrar%22%2C%22lastName%22%3A%22Choudhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Youngblood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Yin%20C.%22%2C%22lastName%22%3A%22Polley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Calixto-Hope%20G.%22%2C%22lastName%22%3A%22Lucas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanish%22%2C%22lastName%22%3A%22Mirchia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sybren%20L.%20N.%22%2C%22lastName%22%3A%22Maas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abigail%20K.%22%2C%22lastName%22%3A%22Suwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minhee%22%2C%22lastName%22%3A%22Won%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%22%2C%22lastName%22%3A%22Bayley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akdes%20S.%22%2C%22lastName%22%3A%22Harmanci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arif%20O.%22%2C%22lastName%22%3A%22Harmanci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiemo%20J.%22%2C%22lastName%22%3A%22Klisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20P.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harish%20N.%22%2C%22lastName%22%3A%22Vasudevan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22McCortney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theresa%20J.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%22%2C%22lastName%22%3A%22Bhave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tai-Chung%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenny%20Kan-Suen%22%2C%22lastName%22%3A%22Pu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lai-Fung%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilberto%20Ka-Kit%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20W.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haley%20K.%22%2C%22lastName%22%3A%22Perlow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Haberler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20S.%22%2C%22lastName%22%3A%22Berghoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Preusser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%20P.%22%2C%22lastName%22%3A%22Nicolaides%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Mawrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sameer%22%2C%22lastName%22%3A%22Agnihotri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Resnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20R.%22%2C%22lastName%22%3A%22Rood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Chew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20S.%22%2C%22lastName%22%3A%22Young%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Boreta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%20E.%22%2C%22lastName%22%3A%22Braunstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Schulte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Butowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Spetzler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20Ann%20Oberheim%22%2C%22lastName%22%3A%22Bush%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javier%20E.%22%2C%22lastName%22%3A%22Villanueva-Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Chandler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Solomon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20Leland%22%2C%22lastName%22%3A%22Rogers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20L.%22%2C%22lastName%22%3A%22Pugh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minesh%20P.%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Penny%20K.%22%2C%22lastName%22%3A%22Sneed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mitchel%20S.%22%2C%22lastName%22%3A%22Berger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20M.%22%2C%22lastName%22%3A%22Horbinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20W.%22%2C%22lastName%22%3A%22McDermott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arie%22%2C%22lastName%22%3A%22Perry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akash%20J.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Sahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20T.%22%2C%22lastName%22%3A%22Magill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Raleigh%22%7D%5D%2C%22abstractNote%22%3A%22Surgery%20is%20the%20mainstay%20of%20treatment%20for%20meningioma%2C%20the%20most%20common%20primary%20intracranial%20tumor%2C%20but%20improvements%20in%20meningioma%20risk%20stratification%20are%20needed%20and%20indications%20for%20postoperative%20radiotherapy%20are%20controversial.%20Here%20we%20develop%20a%20targeted%20gene%20expression%20biomarker%20that%20predicts%20meningioma%20outcomes%20and%20radiotherapy%20responses.%20Using%20a%20discovery%20cohort%20of%20173%20meningiomas%2C%20we%20developed%20a%2034-gene%20expression%20risk%20score%20and%20performed%20clinical%20and%20analytical%20validation%20of%20this%20biomarker%20on%20independent%20meningiomas%20from%2012%20institutions%20across%203%20continents%20%28N%5Cu2009%3D%5Cu20091%2C856%29%2C%20including%20103%20meningiomas%20from%20a%20prospective%20clinical%20trial.%20The%20gene%20expression%20biomarker%20improved%20discrimination%20of%20outcomes%20compared%20with%20all%20other%20systems%20tested%20%28N%5Cu2009%3D%5Cu20099%29%20in%20the%20clinical%20validation%20cohort%20for%20local%20recurrence%20%285-year%20area%20under%20the%20curve%20%28AUC%29%200.81%29%20and%20overall%20survival%20%285-year%20AUC%200.80%29.%20The%20increase%20in%20AUC%20compared%20with%20the%20standard%20of%20care%2C%20World%20Health%20Organization%202021%20grade%2C%20was%200.11%20for%20local%20recurrence%20%2895%25%20confidence%20interval%200.07%20to%200.17%2C%20P%5Cu2009%3C%5Cu20090.001%29.%20The%20gene%20expression%20biomarker%20identified%20meningiomas%20benefiting%20from%20postoperative%20radiotherapy%20%28hazard%20ratio%200.54%2C%2095%25%20confidence%20interval%200.37%20to%200.78%2C%20P%5Cu2009%3D%5Cu20090.0001%29%20and%20suggested%20postoperative%20management%20could%20be%20refined%20for%2029.8%25%20of%20patients.%20In%20sum%2C%20our%20results%20identify%20a%20targeted%20gene%20expression%20biomarker%20that%20improves%20discrimination%20of%20meningioma%20outcomes%2C%20including%20prediction%20of%20postoperative%20radiotherapy%20responses.%22%2C%22date%22%3A%222023-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-023-02586-z%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A57%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22VKCKQJQI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Choudhury%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChoudhury%20A%2C%20Chen%20WC%2C%20Lucas%20CHG%2C%20Bayley%20JC%2C%20Harmanci%20AS%2C%20Maas%20SLN%2C%20Santagata%20S%2C%20Klisch%20T%2C%20Perry%20A%2C%20Bi%20WL%2C%20Sahm%20F%2C%20Patel%20AJ%2C%20Magill%20ST%2C%20Raleigh%20DR.%20Hypermitotic%20meningiomas%20harbor%20DNA%20methylation%20subgroups%20with%20distinct%20biological%20and%20clinical%20features.%20Neuro%20Oncol.%202023%20Mar%2014%3B25%283%29%3A520%26%23x2013%3B530.%20PMCID%3A%20PMC10013643%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hypermitotic%20meningiomas%20harbor%20DNA%20methylation%20subgroups%20with%20distinct%20biological%20and%20clinical%20features%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abrar%22%2C%22lastName%22%3A%22Choudhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Calixto-Hope%20G.%22%2C%22lastName%22%3A%22Lucas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%22%2C%22lastName%22%3A%22Bayley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akdes%20S.%22%2C%22lastName%22%3A%22Harmanci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sybren%20L.%20N.%22%2C%22lastName%22%3A%22Maas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiemo%22%2C%22lastName%22%3A%22Klisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arie%22%2C%22lastName%22%3A%22Perry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Sahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akash%20J.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20T.%22%2C%22lastName%22%3A%22Magill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Raleigh%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Meningiomas%2C%20the%20most%20common%20primary%20intracranial%20tumors%2C%20can%20be%20separated%20into%203%20DNA%20methylation%20groups%20with%20distinct%20biological%20drivers%2C%20clinical%20outcomes%2C%20and%20therapeutic%20vulnerabilities.%20Alternative%20meningioma%20grouping%20schemes%20using%20copy%20number%20variants%2C%20gene%20expression%20profiles%2C%20somatic%20short%20variants%2C%20or%20integrated%20molecular%20models%20have%20been%20proposed.%20These%20data%20suggest%20meningioma%20DNA%20methylation%20groups%20may%20harbor%20subgroups%20unifying%20contrasting%20theories%20of%20meningioma%20biology.%5CnMETHODS%3A%20A%20total%20of%20565%20meningioma%20DNA%20methylation%20profiles%20from%20patients%20with%20comprehensive%20clinical%20follow-up%20at%20independent%20discovery%20%28n%20%3D%20200%29%20or%20validation%20%28n%20%3D%20365%29%20institutions%20were%20reanalyzed%20and%20classified%20into%20Merlin-intact%2C%20Immune-enriched%2C%20or%20Hypermitotic%20DNA%20methylation%20groups.%20RNA%20sequencing%20from%20the%20discovery%20%28n%20%3D%20200%29%20or%20validation%20%28n%20%3D%20302%29%20cohort%20were%20analyzed%20in%20the%20context%20of%20DNA%20methylation%20groups%20to%20identify%20subgroups.%20Biological%20features%20and%20clinical%20outcomes%20were%20analyzed%20across%20meningioma%20grouping%20schemes.%5CnRESULTS%3A%20RNA%20sequencing%20revealed%20differential%20enrichment%20of%20FOXM1%20target%20genes%20across%20two%20subgroups%20of%20Hypermitotic%20meningiomas.%20Differential%20expression%20and%20ontology%20analyses%20showed%20the%20subgroup%20of%20Hypermitotic%20meningiomas%20without%20FOXM1%20target%20gene%20enrichment%20was%20distinguished%20by%20gene%20expression%20programs%20driving%20macromolecular%20metabolism.%20Analysis%20of%20genetic%2C%20epigenetic%2C%20gene%20expression%2C%20or%20cellular%20features%20revealed%20Hypermitotic%20meningioma%20subgroups%20were%20concordant%20with%20Proliferative%20or%20Hypermetabolic%20meningiomas%2C%20which%20were%20previously%20reported%20alongside%20Merlin-intact%20and%20Immune-enriched%20tumors%20using%20an%20integrated%20molecular%20model.%20The%20addition%20of%20DNA%20methylation%20subgroups%20to%20clinical%20models%20refined%20the%20prediction%20of%20postoperative%20outcomes%20compared%20to%20the%20addition%20of%20DNA%20methylation%20groups.%5CnCONCLUSIONS%3A%20Meningiomas%20can%20be%20separated%20into%20three%20DNA%20methylation%20groups%20and%20Hypermitotic%20meningiomas%20can%20be%20subdivided%20into%20Proliferative%20and%20Hypermetabolic%20subgroups%2C%20each%20with%20distinct%20biological%20and%20clinical%20features.%22%2C%22date%22%3A%222023-03-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoac224%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-07-31T14%3A40%3A10Z%22%7D%7D%2C%7B%22key%22%3A%226WWL7BIF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Coy%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoy%20S%2C%20Cheng%20B%2C%20Lee%20JS%2C%20Rashid%20R%2C%20Browning%20L%2C%20Xu%20Y%2C%20Chakrabarty%20SS%2C%20Yapp%20C%2C%20Chan%20S%2C%20Tefft%20JB%2C%20Scott%20E%2C%20Spektor%20A%2C%20Ligon%20KL%2C%20Baker%20GJ%2C%20Pellman%20D%2C%20Sorger%20PK%2C%20Santagata%20S.%202D%20and%203D%20multiplexed%20subcellular%20profiling%20of%20nuclear%20instability%20in%20human%20cancer.%20bioRxiv%3B%202023.%20PMCID%3A%20PMC10659270%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%222D%20and%203D%20multiplexed%20subcellular%20profiling%20of%20nuclear%20instability%20in%20human%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Suk%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Browning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sankha%20S.%22%2C%22lastName%22%3A%22Chakrabarty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliann%20B.%22%2C%22lastName%22%3A%22Tefft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Scott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Spektor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Pellman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Nuclear%20atypia%2C%20including%20altered%20nuclear%20size%2C%20contour%2C%20and%20chromatin%20organization%2C%20is%20ubiquitous%20in%20cancer%20cells.%20Atypical%20primary%20nuclei%20and%20micronuclei%20can%20rupture%20during%20interphase%3B%20however%2C%20the%20frequency%2C%20causes%2C%20and%20consequences%20of%20nuclear%20rupture%20are%20unknown%20in%20most%20cancers.%20We%20demonstrate%20that%20nuclear%20envelope%20rupture%20is%20surprisingly%20common%20in%20many%20human%20cancers%2C%20particularly%20glioblastoma.%20Using%20highly-multiplexed%202D%20and%20super-resolution%203D-imaging%20of%20glioblastoma%20tissues%20and%20patient-derived%20xenografts%20and%20cells%2C%20we%20link%20primary%20nuclear%20rupture%20with%20reduced%20lamin%20A%5C%2FC%20and%20micronuclear%20rupture%20with%20reduced%20lamin%20B1.%20Moreover%2C%20ruptured%20glioblastoma%20cells%20activate%20cGAS-STING-signaling%20involved%20in%20innate%20immunity.%20We%20observe%20that%20local%20patterning%20of%20cell%20states%20influences%20tumor%20spatial%20organization%20and%20is%20linked%20to%20both%20lamin%20expression%20and%20rupture%20frequency%2C%20with%20neural-progenitor-cell-like%20states%20exhibiting%20the%20lowest%20lamin%20A%5C%2FC%20levels%20and%20greatest%20susceptibility%20to%20primary%20nuclear%20rupture.%20Our%20study%20reveals%20that%20nuclear%20instability%20is%20a%20core%20feature%20of%20cancer%2C%20and%20links%20nuclear%20integrity%2C%20cell%20state%2C%20and%20immune%20signaling.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-11-11%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.11.07.566063%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A09%3A09Z%22%7D%7D%2C%7B%22key%22%3A%228VVVJGUT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Creason%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-29%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECreason%20AL%2C%20Egger%20J%2C%20Watson%20C%2C%20Sivagnanam%20S%2C%20Chin%20K%2C%20MacPherson%20K%2C%20Lin%20JR%2C%20Chen%20YA%2C%20Johnson%20BE%2C%20Feiler%20HS%2C%20Galipeau%20D%2C%20Navin%20NE%2C%20Demir%20E%2C%20Chang%20YH%2C%20Corless%20CL%2C%20Mitri%20ZI%2C%20Sorger%20PK%2C%20Thomas%20GV%2C%20Coussens%20LM%2C%20Adey%20AC%2C%20Gray%20JW%2C%20Mills%20GB%2C%20Goecks%20J.%20Longitudinal%20and%20multimodal%20auditing%20of%20tumor%20adaptation%20to%20CDK4%5C%2F6%20inhibitors%20in%20HR%2B%20metastatic%20breast%20cancers%20%5BInternet%5D.%20bioRxiv%3B%202023%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.27.557464%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.27.557464%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Longitudinal%20and%20multimodal%20auditing%20of%20tumor%20adaptation%20to%20CDK4%5C%2F6%20inhibitors%20in%20HR%2B%20metastatic%20breast%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20L.%22%2C%22lastName%22%3A%22Creason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%22%2C%22lastName%22%3A%22Watson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamilene%22%2C%22lastName%22%3A%22Sivagnanam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koei%22%2C%22lastName%22%3A%22Chin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22MacPherson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brett%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20S.%22%2C%22lastName%22%3A%22Feiler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%22%2C%22lastName%22%3A%22Galipeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20E.%22%2C%22lastName%22%3A%22Navin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emek%22%2C%22lastName%22%3A%22Demir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20Hwan%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20L.%22%2C%22lastName%22%3A%22Corless%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahi%20I.%22%2C%22lastName%22%3A%22Mitri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20M.%22%2C%22lastName%22%3A%22Coussens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20C.%22%2C%22lastName%22%3A%22Adey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20B.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Goecks%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20CDK4%5C%2F6%20inhibitors%20%28CDK4%5C%2F6i%29%20have%20transformed%20the%20treatment%20of%20hormone%20receptor-positive%20%28HR%2B%29%2C%20HER2-negative%20%28HR%2B%29%20breast%20cancers%20as%20they%20are%20effective%20across%20all%20clinicopathological%2C%20age%2C%20and%20ethnicity%20subgroups%20for%20metastatic%20HR%2B%20breast%20cancer.%20In%20metastatic%20ER%2B%20breast%20cancer%2C%20CDK4%5C%2F6i%20lead%20to%20strong%20and%20consistent%20improvement%20in%20survival%20across%20different%20lines%20of%20therapy.%20To%20understand%20how%20metastatic%20HR%2B%20breast%20cancers%20become%20refractory%20to%20CDK4%5C%2F6i%2C%20we%20have%20created%20a%20multimodal%20and%20longitudinal%20tumor%20atlas%20to%20investigate%20therapeutic%20adaptations%20in%20malignant%20cells%20and%20in%20the%20tumor%20immune%20microenvironment.%20This%20atlas%20is%20part%20of%20the%20NCI%20Cancer%20Moonshot%20Human%20Tumor%20Atlas%20Network%20and%20includes%20seven%20pairs%20of%20pre-%20and%20on-progression%20biopsies%20from%20five%20metastatic%20HR%2B%20breast%20cancer%20patients%20treated%20with%20CDK4%5C%2F6i.%20Biopsies%20were%20profiled%20with%20bulk%20genomics%2C%20transcriptomics%2C%20and%20proteomics%20as%20well%20as%20single-cell%20ATAC-seq%20and%20multiplex%20tissue%20imaging%20for%20spatial%2C%20single-cell%20resolution.%20These%20molecular%20datasets%20were%20then%20linked%20with%20detailed%20clinical%20metadata%20to%20create%20an%20atlas%20for%20understanding%20tumor%20adaptations%20during%20therapy.%20Analysis%20of%20our%20atlas%20datasets%20revealed%20a%20diverse%20but%20tractable%20set%20of%20tumor%20adaptations%20to%20CDK4%5C%2F6i%20therapy.%20Malignant%20cells%20adapted%20to%20therapy%20via%20mTORC1%20activation%2C%20cell%20cycle%20bypass%2C%20and%20increased%20replication%20stress.%20The%20tumor%20immune%20microenvironment%20displayed%20evidence%20of%20both%20immune%20activation%20and%20immune%20suppression%2C%20including%20increased%20PD-1%20expression%2C%20features%20of%20T%20cell%20dysfunction%2C%20and%20CD163%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20macrophage%20infiltration.%20Together%2C%20our%20metastatic%20ER%2B%20breast%20cancer%20atlas%20represents%20a%20rich%20multimodal%20resource%20to%20understand%20tumor%20therapeutic%20adaptations%20to%20CDK4%5C%2F6i%20therapy.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-09-29%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.09.27.557464%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.27.557464%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-11-01T14%3A10%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22MT2GVVLC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22D%5Cu00edez%20Men%5Cu00e9ndez%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-06%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ED%26%23xED%3Bez%20Men%26%23xE9%3Bndez%20C%2C%20Poczai%20P%2C%20Williams%20B%2C%20Myllys%20L%2C%20Amiryousefi%20A.%20IRplus%3A%20an%20augmented%20tool%20to%20detect%20inverted%20repeats%20in%20plastid%20genomes.%20Genome%20Biol%20Evol.%202023%20Oct%206%3B15%2810%29%3Aevad177.%20PMCID%3A%20PMC10581538%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22IRplus%3A%20an%20augmented%20tool%20to%20detect%20inverted%20repeats%20in%20plastid%20genomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22D%5Cu00edez%20Men%5Cu00e9ndez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Poczai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernardo%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leena%22%2C%22lastName%22%3A%22Myllys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Amiryousefi%22%7D%5D%2C%22abstractNote%22%3A%22High-throughput%20sequencing%20methods%20have%20increased%20the%20accessibility%20of%20plastid%20genomes%2C%20which%20are%20crucial%20for%20clarifying%20phylogenetic%20relationships.%20Current%20large%20sequencing%20efforts%20require%20software%20tools%20for%20routine%20display%20of%20their%20distinctive%20quadripartite%20structure%2C%20which%20is%20denoted%20by%20four%20junction%20sites.%20By%20concentrating%20on%20these%20junctions%20and%20their%20close%20vicinity%2C%20IRscope%20has%20emerged%20as%20the%20standard%20tool%20for%20detection%20of%20this%20structure%20and%20creating%20simplified%20comparative%20graphical%20maps%20of%20plastid%20genomes.%20Here%2C%20we%20provide%20an%20augmented%20version%20%28IRplus%29%20that%20encompasses%20a%20novel%20set%20of%20functions%20such%20as%20integrated%20error%20detection%2C%20flexible%20color%20schemes%2C%20and%20an%20upgraded%20method%20to%20detect%20inverted%20repeats%20in%20genomic%20sequences.%20Spanning%20across%20the%20plant%20tree%20of%20life%2C%20IRplus%20allows%20the%20quick%20visualization%20of%20various%20sets%20of%20plastid%20genomes%20and%20features%2C%20next%20to%20smooth%20interoperability%20with%20other%20widely%20used%20annotation%20file%20formats%20and%20platforms.%20The%20IRplus%20can%20be%20accessed%20at%20https%3A%5C%2F%5C%2Firscope.shinyapps.io%5C%2FIRplus%5C%2F%2C%20and%20source%20codes%20are%20freely%20available%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2FAmiryousefiLab%5C%2FIRplus.%22%2C%22date%22%3A%222023-10-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fgbe%5C%2Fevad177%22%2C%22ISSN%22%3A%221759-6653%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T15%3A05%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22EPKZNSZI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Driver%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDriver%20J%2C%20Santagata%20S%2C%20Bi%20WL%2C%20Chi%20JH.%20Genomic%20analysis%20of%20spinal%20meningiomas%3A%20correlation%20with%20histopathological%20grade.%20J%20Neurosurg%20Spine.%202023%20Aug%2025%3B1%26%23x2013%3B5.%20PMID%3A%2037728381%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genomic%20analysis%20of%20spinal%20meningiomas%3A%20correlation%20with%20histopathological%20grade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Driver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20H.%22%2C%22lastName%22%3A%22Chi%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Spinal%20meningiomas%20are%20one%20of%20the%20most%20common%20primary%20intradural%20tumors%20of%20the%20adult%20spine.%20Spinal%20meningiomas%20typically%20have%20a%20benign%20course%20with%20low%20rates%20of%20recurrence.%20Recent%20advances%20in%20genomic%20profiling%20have%20provided%20valuable%20information%20on%20meningioma%20biology%20and%20natural%20history%2C%20but%20these%20studies%20have%20focused%20primarily%20on%20cranial%20meningiomas.%20Chromosomal%20copy%20number%20analysis%20of%20meningiomas%20has%20been%20shown%20to%20be%20a%20valuable%20molecular%20profiling%20technique%20for%20distinguishing%20benign%20from%20aggressive%20tumors.%20The%20Integrated%20Grade%20for%20Meningioma%20is%20a%20novel%20grading%20scheme%20that%20uses%20mitotic%20index%20and%20copy-number%20profile%20to%20identify%20aggressive%20tumors%20at%20high%20risk%20for%20recurrence.%20The%20integrated%20grade%20has%20been%20shown%20to%20be%20a%20better%20predictor%20of%20tumor%20behavior%20than%20WHO%20grade%20alone.%20The%20objective%20of%20this%20study%20was%20to%20evaluate%20the%20chromosomal%20copy-number%20profile%20of%20spinal%20meningiomas%2C%20and%20to%20correlate%20these%20findings%20with%20the%20assigned%20WHO%20grades.%5CnMETHODS%3A%20The%20authors%20evaluated%2094%20spinal%20meningiomas%20treated%20surgically%20at%20their%20institution%20between%202002%20and%202022.%20The%20histopathological%20results%20including%20WHO%20grade%2C%20mitotic%20index%2C%20presence%20of%20atypical%20features%2C%20and%20MIB-1%20index%20were%20recorded.%20Chromosomal%20copy%20number%20as%20determined%20by%20institutional%20whole-genome%20DNA%20copy-number%20profiling%20was%20available%20for%2057%20tumors.%5CnRESULTS%3A%20The%20WHO%20grades%20of%20the%20cohort%20consisted%20of%2081%20%2886%25%29%20WHO%20grade%201%20tumors%20and%2013%20%2814%25%29%20WHO%20grade%202%20tumors.%20In%20tumors%20for%20which%20copy-number%20profiling%20was%20available%2C%2044%20%2877%25%29%20of%2057%20demonstrated%20loss%20of%2022q%5C%2FNF2.%20Notably%20absent%20were%20frequent%20high-risk%20copy%20number%20alterations%20including%20loss%20of%201p%2C%203p%2C%204p%5C%2Fq%2C%206p%5C%2Fq%2C%2010p%5C%2Fq%2C%2014q%2C%2018p%5C%2Fq%2C%2019p%5C%2Fq%2C%20and%20focal%20loss%20of%20CDKN2A%20on%209p.%20Of%20the%209%20WHO%20grade%202%20tumors%20for%20which%20copy-number%20profiling%20was%20available%2C%206%20tumors%20were%20reclassified%20to%20a%20lower%20risk%20profile%20%28integrated%20grade%201%29.%5CnCONCLUSIONS%3A%20This%20analysis%20suggests%20that%20spinal%20meningiomas%20exhibit%20overwhelmingly%20indolent%20biology%2C%20as%20supported%20by%20their%20benign%20integrated%20grade.%20These%20findings%20have%20implications%20in%20the%20surgical%20management%20of%20these%20patients%20in%20relation%20to%20the%20need%20for%20complete%20Simpson%20grade%20I%20resection%2C%20as%20well%20as%20the%20potential%20avoidance%20of%20adjuvant%20therapy%20following%20surgery%20in%20the%20setting%20of%20otherwise%20frequently%20benign%20pathology.%22%2C%22date%22%3A%222023-08-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3171%5C%2F2023.6.SPINE23425%22%2C%22ISSN%22%3A%221547-5646%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-06T16%3A33%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22GKVHPGL7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dulberger%20et%20al.%22%2C%22parsedDate%22%3A%222023-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDulberger%20CL%2C%20Guerrero-Bustamante%20CA%2C%20Owen%20SV%2C%20Wilson%20S%2C%20Wuo%20MG%2C%20Garlena%20RA%2C%20Serpa%20LA%2C%20Russell%20DA%2C%20Zhu%20J%2C%20Braunecker%20BJ%2C%20Squyres%20GR%2C%20Baym%20M%2C%20Kiessling%20LL%2C%20Garner%20EC%2C%20Rubin%20EJ%2C%20Hatfull%20GF.%20Mycobacterial%20nucleoid-associated%20protein%20Lsr2%20is%20required%20for%20productive%20mycobacteriophage%20infection.%20Nat%20Microbiol.%202023%20Apr%3B8%284%29%3A695%26%23x2013%3B710.%20PMCID%3A%20PMC10066036%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterial%20nucleoid-associated%20protein%20Lsr2%20is%20required%20for%20productive%20mycobacteriophage%20infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L.%22%2C%22lastName%22%3A%22Dulberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20A.%22%2C%22lastName%22%3A%22Guerrero-Bustamante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20G.%22%2C%22lastName%22%3A%22Wuo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20A.%22%2C%22lastName%22%3A%22Garlena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lexi%20A.%22%2C%22lastName%22%3A%22Serpa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Russell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junhao%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%20J.%22%2C%22lastName%22%3A%22Braunecker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgia%20R.%22%2C%22lastName%22%3A%22Squyres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20L.%22%2C%22lastName%22%3A%22Kiessling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20C.%22%2C%22lastName%22%3A%22Garner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Rubin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%20F.%22%2C%22lastName%22%3A%22Hatfull%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacteriophages%20are%20a%20diverse%20group%20of%20viruses%20infecting%20Mycobacterium%20with%20substantial%20therapeutic%20potential.%20However%2C%20as%20this%20potential%20becomes%20realized%2C%20the%20molecular%20details%20of%20phage%20infection%20and%20mechanisms%20of%20resistance%20remain%20ill-defined.%20Here%20we%20use%20live-cell%20fluorescence%20microscopy%20to%20visualize%20the%20spatiotemporal%20dynamics%20of%20mycobacteriophage%20infection%20in%20single%20cells%20and%20populations%2C%20showing%20that%20infection%20is%20dependent%20on%20the%20host%20nucleoid-associated%20Lsr2%20protein.%20Mycobacteriophages%20preferentially%20adsorb%20at%20Mycobacterium%20smegmatis%20sites%20of%20new%20cell%20wall%20synthesis%20and%20following%20DNA%20injection%2C%20Lsr2%20reorganizes%20away%20from%20host%20replication%20foci%20to%20establish%20zones%20of%20phage%20DNA%20replication%20%28ZOPR%29.%20Cells%20lacking%20Lsr2%20proceed%20through%20to%20cell%20lysis%20when%20infected%20but%20fail%20to%20generate%20consecutive%20phage%20bursts%20that%20trigger%20epidemic%20spread%20of%20phage%20particles%20to%20neighbouring%20cells.%20Many%20mycobacteriophages%20code%20for%20their%20own%20Lsr2-related%20proteins%2C%20and%20although%20their%20roles%20are%20unknown%2C%20they%20do%20not%20rescue%20the%20loss%20of%20host%20Lsr2.%22%2C%22date%22%3A%222023-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41564-023-01333-x%22%2C%22ISSN%22%3A%222058-5276%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A47%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22NU4N67K7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Fr%5Cu00f6hlich%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFr%26%23xF6%3Bhlich%20F%2C%20Gerosa%20L%2C%20Muhlich%20J%2C%20Sorger%20PK.%20Mechanistic%20model%20of%20MAPK%20signaling%20reveals%20how%20allostery%20and%20rewiring%20contribute%20to%20drug%20resistance.%20Mol%20Syst%20Biol.%202023%20Feb%2010%3B19%282%29%3Ae10988.%20PMCID%3A%20PMC9912026%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mechanistic%20model%20of%20MAPK%20signaling%20reveals%20how%20allostery%20and%20rewiring%20contribute%20to%20drug%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22BRAF%20is%20prototypical%20of%20oncogenes%20that%20can%20be%20targeted%20therapeutically%20and%20the%20treatment%20of%20BRAFV600E%20melanomas%20with%20RAF%20and%20MEK%20inhibitors%20results%20in%20rapid%20tumor%20regression.%20However%2C%20drug-induced%20rewiring%20generates%20a%20drug%20adapted%20state%20thought%20to%20be%20involved%20in%20acquired%20resistance%20and%20disease%20recurrence.%20In%20this%20article%2C%20we%20study%20mechanisms%20of%20adaptive%20rewiring%20in%20BRAFV600E%20melanoma%20cells%20using%20an%20energy-based%20implementation%20of%20ordinary%20differential%20equation%5Cu00a0%28ODE%29%20modeling%20in%20combination%20with%20proteomic%2C%20transcriptomic%20and%20imaging%20data.%20We%20develop%20a%20method%20for%20causal%20tracing%20of%20ODE%20models%20and%20identify%20two%20parallel%20MAPK%20reaction%20channels%20that%20are%20differentially%20sensitive%20to%20RAF%20and%20MEK%20inhibitors%20due%20to%20differences%20in%20protein%20oligomerization%20and%20drug%20binding.%20We%20describe%20how%20these%20channels%2C%20and%20timescale%20separation%20between%20immediate-early%20signaling%20and%20transcriptional%20feedback%2C%20create%20a%20state%20in%20which%20the%20RAS-regulated%20MAPK%20channel%20can%20be%20activated%20by%20growth%20factors%20under%20conditions%20in%20which%20the%20BRAFV600E%20-driven%20channel%20is%20fully%20inhibited.%20Further%20development%20of%20the%20approaches%20in%20this%20article%20is%20expected%20to%20yield%20a%20unified%20model%20of%20adaptive%20drug%20resistance%20in%20melanoma.%22%2C%22date%22%3A%222023-02-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.202210988%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A19%3A19Z%22%7D%7D%2C%7B%22key%22%3A%2227BSLQLS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gaglia%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGaglia%20G%2C%20Burger%20ML%2C%20Ritch%20CC%2C%20Rammos%20D%2C%20Dai%20Y%2C%20Crossland%20GE%2C%20Tavana%20SZ%2C%20Warchol%20S%2C%20Jaeger%20AM%2C%20Naranjo%20S%2C%20Coy%20S%2C%20Nirmal%20AJ%2C%20Krueger%20R%2C%20Lin%20JR%2C%20Pfister%20H%2C%20Sorger%20PK%2C%20Jacks%20T%2C%20Santagata%20S.%20Lymphocyte%20networks%20are%20dynamic%20cellular%20communities%20in%20the%20immunoregulatory%20landscape%20of%20lung%20adenocarcinoma.%20Cancer%20Cell.%202023%20May%208%3B41%285%29%3A871-886.e10.%20PMCID%3A%20PMC10193529%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lymphocyte%20networks%20are%20dynamic%20cellular%20communities%20in%20the%20immunoregulatory%20landscape%20of%20lung%20adenocarcinoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20L.%22%2C%22lastName%22%3A%22Burger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecily%20C.%22%2C%22lastName%22%3A%22Ritch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danae%22%2C%22lastName%22%3A%22Rammos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grace%20E.%22%2C%22lastName%22%3A%22Crossland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20Z.%22%2C%22lastName%22%3A%22Tavana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Warchol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20M.%22%2C%22lastName%22%3A%22Jaeger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Santiago%22%2C%22lastName%22%3A%22Naranjo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%22%2C%22lastName%22%3A%22Jacks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Lymphocytes%20are%20key%20for%20immune%20surveillance%20of%20tumors%2C%20but%20our%20understanding%20of%20the%20spatial%20organization%20and%20physical%20interactions%20that%20facilitate%20lymphocyte%20anti-cancer%20functions%20is%20limited.%20We%20used%20multiplexed%20imaging%2C%20quantitative%20spatial%20analysis%2C%20and%20machine%20learning%20to%20create%20high-definition%20maps%20of%20lung%20tumors%20from%20a%20Kras%5C%2FTrp53-mutant%20mouse%20model%20and%20human%20resections.%20Networks%20of%20interacting%20lymphocytes%20%28%5C%22lymphonets%5C%22%29%20emerged%20as%20a%20distinctive%20feature%20of%20the%20anti-cancer%20immune%20response.%20Lymphonets%20nucleated%20from%20small%20T%5Cu00a0cell%20clusters%20and%20incorporated%20B%20cells%20with%20increasing%20size.%20CXCR3-mediated%20trafficking%20modulated%20lymphonet%20size%20and%20number%2C%20but%20T%5Cu00a0cell%20antigen%20expression%20directed%20intratumoral%20localization.%20Lymphonets%20preferentially%20harbored%20TCF1%2B%20PD-1%2B%20progenitor%20CD8%2B%20T%5Cu00a0cells%20involved%20in%20responses%20to%20immune%20checkpoint%20blockade%20%28ICB%29%20therapy.%20Upon%20treatment%20of%20mice%20with%20ICB%20or%20an%20antigen-targeted%20vaccine%2C%20lymphonets%20retained%20progenitor%20and%20gained%20cytotoxic%20CD8%2B%20T%5Cu00a0cell%20populations%2C%20likely%20via%20progenitor%20differentiation.%20These%20data%20show%20that%20lymphonets%20create%20a%20spatial%20environment%20supportive%20of%20CD8%2B%20T%5Cu00a0cell%20anti-tumor%20responses.%22%2C%22date%22%3A%222023-05-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2023.03.015%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A59%3A14Z%22%7D%7D%2C%7B%22key%22%3A%223SLFR6E4%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ghosh%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGhosh%20HS%2C%20Patel%20RV%2C%20Woodward%20E%2C%20Greenwald%20NF%2C%20Bhave%20VM%2C%20Maury%20EA%2C%20Cello%20G%2C%20Hoffman%20SE%2C%20Li%20Y%2C%20Gupta%20H%2C%20Spurr%20LF%2C%20Vogelzang%20J%2C%20Touat%20M%2C%20Dubois%20F%2C%20Cherniack%20AD%2C%20Guo%20X%2C%20Tavakol%20S%2C%20Cioffi%20G%2C%20Lindeman%20NI%2C%20Ligon%20AH%2C%20Chiocca%20EA%2C%20Reardon%20DA%2C%20Wen%20PY%2C%20Meredith%20D%2C%20Santagata%20S%2C%20Barnholtz-Sloan%20JS%2C%20Ligon%20KL%2C%20Beroukhim%20R%2C%20Bi%20WL.%20Molecular%20landscape%20and%20contemporary%20prognostic%20signatures%20of%20gliomas%20%5BInternet%5D.%20medRxiv%3B%202023%20%5Bcited%202023%20Oct%203%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.09.23295096%27%3Ehttp%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.09.23295096%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Molecular%20landscape%20and%20contemporary%20prognostic%20signatures%20of%20gliomas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hia%20S.%22%2C%22lastName%22%3A%22Ghosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruchit%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%22%2C%22lastName%22%3A%22Woodward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%20F.%22%2C%22lastName%22%3A%22Greenwald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%20M.%22%2C%22lastName%22%3A%22Bhave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20A.%22%2C%22lastName%22%3A%22Maury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Cello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20E.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hersh%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%20F.%22%2C%22lastName%22%3A%22Spurr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%22%2C%22lastName%22%3A%22Vogelzang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Cherniack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaopeng%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherwin%22%2C%22lastName%22%3A%22Tavakol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gino%22%2C%22lastName%22%3A%22Cioffi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20I.%22%2C%22lastName%22%3A%22Lindeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azra%20H.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%20S.%22%2C%22lastName%22%3A%22Barnholtz-Sloan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Molecularly-driven%20treatments%20are%20expanding%20options%20for%20patients%20with%20gliomas%2C%20driving%20a%20need%20for%20molecularly-informed%20prognostic%20information.%20To%20characterize%20the%20genomic%20landscape%20and%20contemporary%20outcomes%20of%20gliomas%2C%20we%20analyzed%204%2C400%20gliomas%20from%20multi-institutional%20datasets%20and%20The%20Cancer%20Genome%20Atlas%20%28TCGA%29%3A%202%2C195%20glioblastoma%2C%201%2C198%5Cn%20%20%20%20%20%20%20%20%20%20%20%20IDH1%5C%2F2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-mutant%20astrocytoma%2C%20531%20oligodendroglioma%2C%20271%20other%5Cn%20%20%20%20%20%20%20%20%20%20%20%20IDH1%5C%2F2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-wildtype%20glioma%2C%20and%20205%20pediatric-type%20glioma.%20Molecular%20classification%20updated%2027.4%25%20of%20gliomas%20from%20their%20original%20histopathologic%20diagnosis.%20Canonical%20alterations%20helped%20categorize%20glioma%20subtypes%2C%20revealing%20mutually%20exclusive%20alterations%20within%20tumorigenic%20pathways.%20Across%20each%20glioma%20subtype%2C%20non-TCGA%20patients%20had%20longer%20survival%20compared%20to%20TCGA%20patients.%20Several%20novel%20prognostic%20alterations%20emerged%2C%20including%5Cn%20%20%20%20%20%20%20%20%20%20%20%20NF1%5Cn%20%20%20%20%20%20%20%20%20%20%20%20alteration%20and%2021q%20loss%20in%20glioblastoma%2C%20and%5Cn%20%20%20%20%20%20%20%20%20%20%20%20EGFR%5Cn%20%20%20%20%20%20%20%20%20%20%20%20amplification%20and%2022q%20loss%20in%5Cn%20%20%20%20%20%20%20%20%20%20%20%20IDH1%5C%2F2-%5Cn%20%20%20%20%20%20%20%20%20%20%20%20mutant%20astrocytoma.%20Certain%20prognostic%20features%20varied%20across%20age%2C%20with%20decreasing%20prevalence%20of%5Cn%20%20%20%20%20%20%20%20%20%20%20%20IDH1%5C%2F2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-mutation%20over%20time%20while%5Cn%20%20%20%20%20%20%20%20%20%20%20%20MGMT%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-methylation%20remained%20steady.%20Our%20findings%20provide%20a%20framework%20for%20further%20exploration%20and%20validation%20of%20glioma%20prognostic%20indicators%20in%20clinically%20representative%20cohorts%20and%20trials.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-09-11%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.09.09.23295096%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.09.23295096%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A37%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22BNAYKJ33%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gray%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-31%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGray%20GK%2C%20Girnius%20N%2C%20Kuiken%20HJ%2C%20Henstridge%20AZ%2C%20Brugge%20JS.%20Single-cell%20and%20spatial%20analyses%20reveal%20a%20tradeoff%20between%20murine%20mammary%20proliferation%20and%20lineage%20programs%20associated%20with%20endocrine%20cues.%20Cell%20Rep.%202023%20Oct%2031%3B42%2810%29%3A113293.%20PMCID%3A%20PMC10840493%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-cell%20and%20spatial%20analyses%20reveal%20a%20tradeoff%20between%20murine%20mammary%20proliferation%20and%20lineage%20programs%20associated%20with%20endocrine%20cues%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Kenneth%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nomeda%22%2C%22lastName%22%3A%22Girnius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hendrik%20J.%22%2C%22lastName%22%3A%22Kuiken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aylin%20Z.%22%2C%22lastName%22%3A%22Henstridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan%20S.%22%2C%22lastName%22%3A%22Brugge%22%7D%5D%2C%22abstractNote%22%3A%22Although%20distinct%20epithelial%20cell%20types%20have%20been%20distinguished%20in%20glandular%20tissues%20such%20as%20the%20mammary%20gland%2C%20the%20extent%20of%20heterogeneity%20within%20each%20cell%20type%20and%20the%20degree%20of%20endocrine%20control%20of%20this%20diversity%20across%20development%20are%20incompletely%20understood.%20By%20combining%20mass%20cytometry%20and%20cyclic%20immunofluorescence%2C%20we%20define%20a%20rich%20array%20of%20murine%20mammary%20epithelial%20cell%20subtypes%20associated%20with%20puberty%2C%20the%20estrous%20cycle%2C%20and%20sex.%20These%20subtypes%20are%20differentially%20proliferative%20and%20spatially%20segregate%20distinctly%20in%20adult%20versus%20pubescent%20glands.%20Further%2C%20we%20identify%20systematic%20suppression%20of%20lineage%20programs%20at%20the%20protein%20and%20RNA%20levels%20as%20a%20common%20feature%20of%20mammary%20epithelial%20expansion%20during%20puberty%2C%20the%20estrous%20cycle%2C%20and%20gestation%20and%20uncover%20a%20pervasive%20enrichment%20of%20ribosomal%20protein%20genes%20in%20luminal%20cells%20elicited%20specifically%20during%20progesterone-dominant%20expansionary%20periods.%20Collectively%2C%20these%20data%20expand%20our%20knowledge%20of%20murine%20mammary%20epithelial%20heterogeneity%20and%20connect%20endocrine-driven%20epithelial%20expansion%20with%20lineage%20suppression.%22%2C%22date%22%3A%222023-10-31%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2023.113293%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T15%3A05%3A25Z%22%7D%7D%2C%7B%22key%22%3A%2239WJ84GV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hermida-Prado%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-02%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHermida-Prado%20F%2C%20Xie%20Y%2C%20Sherman%20S%2C%20Nagy%20Z%2C%20Russo%20D%2C%20Akhshi%20T%2C%20Chu%20Z%2C%20Feit%20A%2C%20Campisi%20M%2C%20Chen%20M%2C%20Nardone%20A%2C%20Guarducci%20C%2C%20Lim%20K%2C%20Font-Tello%20A%2C%20Lee%20I%2C%20Garc%26%23xED%3Ba-Pedrero%20J%2C%20Ca%26%23xF1%3Badas%20I%2C%20Agudo%20J%2C%20Huang%20Y%2C%20Sella%20T%2C%20Jin%20Q%2C%20Tayob%20N%2C%20Mittendorf%20EA%2C%20Tolaney%20SM%2C%20Qiu%20X%2C%20Long%20H%2C%20Symmans%20WF%2C%20Lin%20JR%2C%20Santagata%20S%2C%20Bedrosian%20I%2C%20Yardley%20DA%2C%20Mayer%20IA%2C%20Richardson%20ET%2C%20Oliveira%20G%2C%20Wu%20CJ%2C%20Schuster%20EF%2C%20Dowsett%20M%2C%20Welm%20AL%2C%20Barbie%20D%2C%20Metzger%20O%2C%20Jeselsohn%20R.%20Endocrine%20therapy%20synergizes%20with%20SMAC%20mimetics%20to%20potentiate%20antigen%20presentation%20and%20tumor%20regression%20in%20hormone%20receptor-positive%20breast%20cancer.%20Cancer%20Res.%202023%20Oct%202%3B83%2819%29%3A3284%26%23x2013%3B3304.%20PMCID%3A%20PMC10543960%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Endocrine%20therapy%20synergizes%20with%20SMAC%20mimetics%20to%20potentiate%20antigen%20presentation%20and%20tumor%20regression%20in%20hormone%20receptor-positive%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Hermida-Prado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingtian%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shira%22%2C%22lastName%22%3A%22Sherman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zsuzsanna%22%2C%22lastName%22%3A%22Nagy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Russo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tara%22%2C%22lastName%22%3A%22Akhshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhengtao%22%2C%22lastName%22%3A%22Chu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avery%22%2C%22lastName%22%3A%22Feit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Campisi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minyue%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agostina%22%2C%22lastName%22%3A%22Nardone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Guarducci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klothilda%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alba%22%2C%22lastName%22%3A%22Font-Tello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juana%22%2C%22lastName%22%3A%22Garc%5Cu00eda-Pedrero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Israel%22%2C%22lastName%22%3A%22Ca%5Cu00f1adas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tal%22%2C%22lastName%22%3A%22Sella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qingchun%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabihah%22%2C%22lastName%22%3A%22Tayob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xintao%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henry%22%2C%22lastName%22%3A%22Long%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20F.%22%2C%22lastName%22%3A%22Symmans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bedrosian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%20A.%22%2C%22lastName%22%3A%22Yardley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingrid%20A.%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20T.%22%2C%22lastName%22%3A%22Richardson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giacomo%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20J.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20F.%22%2C%22lastName%22%3A%22Schuster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mitch%22%2C%22lastName%22%3A%22Dowsett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alana%20L.%22%2C%22lastName%22%3A%22Welm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%22%2C%22lastName%22%3A%22Metzger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rinath%22%2C%22lastName%22%3A%22Jeselsohn%22%7D%5D%2C%22abstractNote%22%3A%22Immunotherapies%20have%20yet%20to%20demonstrate%20significant%20efficacy%20in%20the%20treatment%20of%20hormone%20receptor-positive%20%28HR%2B%29%20breast%20cancer.%20Given%20that%20endocrine%20therapy%20%28ET%29%20is%20the%20primary%20approach%20for%20treating%20HR%2B%20breast%20cancer%2C%20we%20investigated%20the%20effects%20of%20ET%20on%20the%20tumor%20immune%20microenvironment%20%28TME%29%20in%20HR%2B%20breast%20cancer.%20Spatial%20proteomics%20of%20primary%20HR%2B%20breast%20cancer%20samples%20obtained%20at%20baseline%20and%20after%20ET%20from%20patients%20enrolled%20in%20a%20neoadjuvant%20clinical%20trial%20%28NCT02764541%29%20indicated%20that%20ET%20upregulated%20%5Cu03b22-microglobulin%20and%20influenced%20the%20TME%20in%20a%20manner%20that%20promotes%20enhanced%20immunogenicity.%20To%20gain%20a%20deeper%20understanding%20of%20the%20underlying%20mechanisms%2C%20the%20intrinsic%20effects%20of%20ET%20on%20cancer%20cells%20were%20explored%2C%20which%20revealed%20that%20ET%20plays%20a%20crucial%20role%20in%20facilitating%20the%20chromatin%20binding%20of%20RelA%2C%20a%20key%20component%20of%20the%20NF-%5Cu03baB%20complex.%20Consequently%2C%20heightened%20NF-%5Cu03baB%20signaling%20enhanced%20the%20response%20to%20interferon-gamma%2C%20leading%20to%20the%20upregulation%20of%20%5Cu03b22-microglobulin%20and%20other%20antigen%20presentation-related%20genes.%20Further%2C%20modulation%20of%20NF-%5Cu03baB%20signaling%20using%20a%20SMAC%20mimetic%20in%20conjunction%20with%20ET%20augmented%20T-cell%20migration%20and%20enhanced%20MHC-I-specific%20T-cell-mediated%20cytotoxicity.%20Remarkably%2C%20the%20combination%20of%20ET%20and%20SMAC%20mimetics%2C%20which%20also%20blocks%20prosurvival%20effects%20of%20NF-%5Cu03baB%20signaling%20through%20the%20degradation%20of%20inhibitors%20of%20apoptosis%20proteins%2C%20elicited%20tumor%20regression%20through%20cell%20autonomous%20mechanisms%2C%20providing%20additional%20support%20for%20their%20combined%20use%20in%20HR%2B%20breast%20cancer.%5CnSIGNIFICANCE%3A%20Adding%20SMAC%20mimetics%20to%20endocrine%20therapy%20enhances%20tumor%20regression%20in%20a%20cell%20autonomous%20manner%20while%20increasing%20tumor%20immunogenicity%2C%20indicating%20that%20this%20combination%20could%20be%20an%20effective%20treatment%20for%20HR%2B%20patients%20with%20breast%20cancer.%22%2C%22date%22%3A%222023-10-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-23-1711%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A42%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22GLZIZ5Q5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoyt%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoyt%20CT%2C%20Zdrazil%20B%2C%20Guha%20R%2C%20Jeliazkova%20N%2C%20Martinez-Mayorga%20K%2C%20Nittinger%20E.%20Improving%20reproducibility%20and%20reusability%20in%20the%20Journal%20of%20Cheminformatics.%20J%20Cheminform.%202023%20Jun%2030%3B15%281%29%3A62.%20PMCID%3A%20PMC10314397%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20reproducibility%20and%20reusability%20in%20the%20Journal%20of%20Cheminformatics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Zdrazil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajarshi%22%2C%22lastName%22%3A%22Guha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nina%22%2C%22lastName%22%3A%22Jeliazkova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karina%22%2C%22lastName%22%3A%22Martinez-Mayorga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Nittinger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-06-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13321-023-00730-y%22%2C%22ISSN%22%3A%221758-2946%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-07-05T14%3A21%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22PS3P9KQG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hoyt%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoyt%20CT%2C%20Hoyt%20AL%2C%20Gyori%20BM.%20Prediction%20and%20curation%20of%20missing%20biomedical%20identifier%20mappings%20with%20Biomappings.%20Bioinformatics.%202023%20Apr%203%3B39%284%29%3Abtad130.%20PMCID%3A%20PMC10076045%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prediction%20and%20curation%20of%20missing%20biomedical%20identifier%20mappings%20with%20Biomappings%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amelia%20L.%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%5D%2C%22abstractNote%22%3A%22MOTIVATION%3A%20Biomedical%20identifier%20resources%20%28such%20as%20ontologies%2C%20taxonomies%2C%20and%20controlled%20vocabularies%29%20commonly%20overlap%20in%20scope%20and%20contain%20equivalent%20entries%20under%20different%20identifiers.%20Maintaining%20mappings%20between%20these%20entries%20is%20crucial%20for%20interoperability%20and%20the%20integration%20of%20data%20and%20knowledge.%20However%2C%20there%20are%20substantial%20gaps%20in%20available%20mappings%20motivating%20their%20semi-automated%20curation.%5CnRESULTS%3A%20Biomappings%20implements%20a%20curation%20workflow%20for%20missing%20mappings%20which%20combines%20automated%20prediction%20with%20human-in-the-loop%20curation.%20It%20supports%20multiple%20prediction%20approaches%20and%20provides%20a%20web-based%20user%20interface%20for%20reviewing%20predicted%20mappings%20for%20correctness%2C%20combined%20with%20automated%20consistency%20checking.%20Predicted%20and%20curated%20mappings%20are%20made%20available%20in%20public%2C%20version-controlled%20resource%20files%20on%20GitHub.%20Biomappings%20currently%20makes%20available%209274%20curated%20mappings%20and%2040%5Cu00a0691%20predicted%20ones%2C%20providing%20previously%20missing%20mappings%20between%20widely%20used%20identifier%20resources%20covering%20small%20molecules%2C%20cell%20lines%2C%20diseases%2C%20and%20other%20concepts.%20We%20demonstrate%20the%20value%20of%20Biomappings%20on%20case%20studies%20involving%20predicting%20and%20curating%20missing%20mappings%20among%20cancer%20cell%20lines%20as%20well%20as%20small%20molecules%20tested%20in%20clinical%20trials.%20We%20also%20present%20how%20previously%20missing%20mappings%20curated%20using%20Biomappings%20were%20contributed%20back%20to%20multiple%20widely%20used%20community%20ontologies.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20The%20data%20and%20code%20are%20available%20under%20the%20CC0%20and%20MIT%20licenses%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fbiopragmatics%5C%2Fbiomappings.%22%2C%22date%22%3A%222023-04-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtad130%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A06%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22UQZUPEVA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Iorgulescu%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIorgulescu%20JB%2C%20Ruthen%20N%2C%20Ahn%20R%2C%20Panagioti%20E%2C%20Gokhale%20PC%2C%20Neagu%20M%2C%20Speranza%20MC%2C%20Eschle%20BK%2C%20Soroko%20KM%2C%20Piranlioglu%20R%2C%20Datta%20M%2C%20Krishnan%20S%2C%20Yates%20KB%2C%20Baker%20GJ%2C%20Jain%20RK%2C%20Suv%26%23xE0%3B%20ML%2C%20Neuberg%20D%2C%20White%20FM%2C%20Chiocca%20EA%2C%20Freeman%20GJ%2C%20Sharpe%20AH%2C%20Wu%20CJ%2C%20Reardon%20DA.%20Antigen%20presentation%20deficiency%2C%20mesenchymal%20differentiation%2C%20and%20resistance%20to%20immunotherapy%20in%20the%20murine%20syngeneic%20CT2A%20tumor%20model.%20Front%20Immunol.%202023%3B14%3A1297932.%20PMCID%3A%20PMC10782385%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antigen%20presentation%20deficiency%2C%20mesenchymal%20differentiation%2C%20and%20resistance%20to%20immunotherapy%20in%20the%20murine%20syngeneic%20CT2A%20tumor%20model%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Bryan%22%2C%22lastName%22%3A%22Iorgulescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Ruthen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryuhjin%22%2C%22lastName%22%3A%22Ahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleni%22%2C%22lastName%22%3A%22Panagioti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prafulla%20C.%22%2C%22lastName%22%3A%22Gokhale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Neagu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20C.%22%2C%22lastName%22%3A%22Speranza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20K.%22%2C%22lastName%22%3A%22Eschle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20M.%22%2C%22lastName%22%3A%22Soroko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raziye%22%2C%22lastName%22%3A%22Piranlioglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meenal%22%2C%22lastName%22%3A%22Datta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shanmugarajan%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20B.%22%2C%22lastName%22%3A%22Yates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rakesh%20K.%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20L.%22%2C%22lastName%22%3A%22Suv%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donna%22%2C%22lastName%22%3A%22Neuberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Forest%20M.%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20J.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20J.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20GL261%20and%20CT2A%20syngeneic%20tumor%20lines%20are%20frequently%20used%20as%20immunocompetent%20orthotopic%20mouse%20models%20of%20human%20glioblastoma%20%28huGBM%29%20but%20demonstrate%20distinct%20differences%20in%20their%20responses%20to%20immunotherapy.%5CnMETHODS%3A%20To%20decipher%20the%20cell-intrinsic%20mechanisms%20that%20drive%20immunotherapy%20resistance%20in%20CT2A-luc%20and%20to%20define%20the%20aspects%20of%20human%20cancer%20biology%20that%20these%20lines%20can%20best%20model%2C%20we%20systematically%20compared%20their%20characteristics%20using%20whole%20exome%20and%20transcriptome%20sequencing%2C%20and%20protein%20analysis%20through%20immunohistochemistry%2C%20Western%20blot%2C%20flow%20cytometry%2C%20immunopeptidomics%2C%20and%20phosphopeptidomics.%5CnRESULTS%3A%20The%20transcriptional%20profiles%20of%20GL261-luc2%20and%20CT2A-luc%20tumors%20resembled%20those%20of%20some%20huGBMs%2C%20despite%20neither%20line%20sharing%20the%20essential%20genetic%20or%20histologic%20features%20of%20huGBM.%20Both%20models%20exhibited%20striking%20hypermutation%2C%20with%20clonal%20hotspot%20mutations%20in%20RAS%20genes%20%28Kras%20p.G12C%20in%20GL261-luc2%20and%20Nras%20p.Q61L%20in%20CT2A-luc%29.%20CT2A-luc%20distinctly%20displayed%20mesenchymal%20differentiation%2C%20upregulated%20angiogenesis%2C%20and%20multiple%20defects%20in%20antigen%20presentation%20machinery%20%28e.g.%20Tap1%20p.Y488C%20and%20Psmb8%20p.A275P%20mutations%29%20and%20interferon%20response%20pathways%20%28e.g.%20copy%20number%20losses%20of%20loci%20including%20IFN%20genes%20and%20reduced%20phosphorylation%20of%20JAK%5C%2FSTAT%20pathway%20members%29.%20The%20defect%20in%20MHC%20class%20I%20expression%20could%20be%20overcome%20in%20CT2A-luc%20by%20interferon-%5Cu03b3%20treatment%2C%20which%20may%20underlie%20the%20modest%20efficacy%20of%20some%20immunotherapy%20combinations.%20Additionally%2C%20CT2A-luc%20demonstrated%20substantial%20baseline%20secretion%20of%20the%20CCL-2%2C%20CCL-5%2C%20and%20CCL-22%20chemokines%2C%20which%20play%20important%20roles%20as%20myeloid%20chemoattractants.%5CnCONCLUSION%3A%20Although%20the%20clinical%20contexts%20that%20can%20be%20modeled%20by%20GL261%20and%20CT2A%20for%20huGBM%20are%20limited%2C%20CT2A%20may%20be%20an%20informative%20model%20of%20immunotherapy%20resistance%20due%20to%20its%20deficits%20in%20antigen%20presentation%20machinery%20and%20interferon%20response%20pathways.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2023.1297932%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-16T16%3A40%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22C5D2IEC6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Kalocsay%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKalocsay%20M%2C%20Berberich%20MJ%2C%20Everley%20RA%2C%20Nariya%20MK%2C%20Chung%20M%2C%20Gaudio%20B%2C%20Victor%20C%2C%20Bradshaw%20GA%2C%20Eisert%20RJ%2C%20Hafner%20M%2C%20Sorger%20PK%2C%20Mills%20CE%2C%20Subramanian%20K.%20Proteomic%20profiling%20across%20breast%20cancer%20cell%20lines%20and%20models.%20Sci%20Data.%202023%20Aug%204%3B10%281%29%3A514.%20PMCID%3A%20PMC10403526%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Proteomic%20profiling%20across%20breast%20cancer%20cell%20lines%20and%20models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Victor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%5D%2C%22abstractNote%22%3A%22We%20performed%20quantitative%20proteomics%20on%2060%20human-derived%20breast%20cancer%20cell%20line%20models%20to%20a%20depth%20of%20~13%2C000%20proteins.%20The%20resulting%20high-throughput%20datasets%20were%20assessed%20for%20quality%20and%20reproducibility.%20We%20used%20the%20datasets%20to%20identify%20and%20characterize%20the%20subtypes%20of%20breast%20cancer%20and%20showed%20that%20they%20conform%20to%20known%20transcriptional%20subtypes%2C%20revealing%20that%20molecular%20subtypes%20are%20preserved%20even%20in%20under-sampled%20protein%20feature%20sets.%20All%20datasets%20are%20freely%20available%20as%20public%20resources%20on%20the%20LINCS%20portal.%20We%20anticipate%20that%20these%20datasets%2C%20either%20in%20isolation%20or%20in%20combination%20with%20complimentary%20measurements%20such%20as%20genomics%2C%20transcriptomics%20and%20phosphoproteomics%2C%20can%20be%20mined%20for%20the%20purpose%20of%20predicting%20drug%20response%2C%20informing%20cell%20line%20specific%20context%20in%20models%20of%20signalling%20pathways%2C%20and%20identifying%20markers%20of%20sensitivity%20or%20resistance%20to%20therapeutics.%22%2C%22date%22%3A%222023-08-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-023-02355-0%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A00%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22LATY833N%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kurmi%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKurmi%20K%2C%20Liang%20D%2C%20van%20de%20Ven%20R%2C%20Georgiev%20P%2C%20Gassaway%20BM%2C%20Han%20S%2C%20Notarangelo%20G%2C%20Harris%20IS%2C%20Yao%20CH%2C%20Park%20JS%2C%20Hu%20SH%2C%20Peng%20J%2C%20Drijvers%20JM%2C%20Boswell%20S%2C%20Sokolov%20A%2C%20Dougan%20SK%2C%20Sorger%20PK%2C%20Gygi%20SP%2C%20Sharpe%20AH%2C%20Haigis%20MC.%20Metabolic%20modulation%20of%20mitochondrial%20mass%20during%20CD4%2B%20T%26%23xA0%3Bcell%20activation.%20Cell%20Chem%20Biol.%202023%20Sep%2021%3B30%289%29%3A1064-1075.e8.%20PMCID%3A%20PMC10604707%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metabolic%20modulation%20of%20mitochondrial%20mass%20during%20CD4%2B%20T%5Cu00a0cell%20activation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiran%22%2C%22lastName%22%3A%22Kurmi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22van%20de%20Ven%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Georgiev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brandon%20Mark%22%2C%22lastName%22%3A%22Gassaway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SeongJun%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Notarangelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20S.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cong-Hui%22%2C%22lastName%22%3A%22Yao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joon%20Seok%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Song-Hua%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingyu%22%2C%22lastName%22%3A%22Peng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jefte%20M.%22%2C%22lastName%22%3A%22Drijvers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20K.%22%2C%22lastName%22%3A%22Dougan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Mitochondrial%20biogenesis%20initiates%20within%20hours%20of%20T%5Cu00a0cell%20receptor%20%28TCR%29%20engagement%20and%20is%20critical%20for%20T%5Cu00a0cell%20activation%2C%20function%2C%20and%20survival%3B%20yet%2C%20how%20metabolic%20programs%20support%20mitochondrial%20biogenesis%20during%20TCR%20signaling%20is%20not%20fully%20understood.%20Here%2C%20we%20performed%20a%20multiplexed%20metabolic%20chemical%20screen%20in%20CD4%2B%20T%20lymphocytes%20to%20identify%20modulators%20of%20metabolism%20that%20impact%20mitochondrial%20mass%20during%20early%20T%5Cu00a0cell%20activation.%20Treatment%20of%20T%5Cu00a0cells%20with%20pyrvinium%20pamoate%20early%20during%20their%20activation%20blocks%20an%20increase%20in%20mitochondrial%20mass%20and%20results%20in%20reduced%20proliferation%2C%20skewed%20CD4%2B%20T%5Cu00a0cell%20differentiation%2C%20and%20reduced%20cytokine%20production.%20Furthermore%2C%20administration%20of%20pyrvinium%20pamoate%20at%20the%20time%20of%20induction%20of%20experimental%20autoimmune%20encephalomyelitis%2C%20an%20experimental%20model%20of%20multiple%20sclerosis%20in%20mice%2C%20prevented%20the%20onset%20of%20clinical%20disease.%20Thus%2C%20modulation%20of%20mitochondrial%20biogenesis%20may%20provide%20a%20therapeutic%20strategy%20for%20modulating%20T%5Cu00a0cell%20immune%20responses.%22%2C%22date%22%3A%222023-09-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2023.08.008%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A22%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22GHJXKUAZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lecky%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELecky%20E%2C%20Mukherji%20A%2C%20German%20R%2C%20Antonellis%20G%2C%20Lin%20JR%2C%20Yorsz%20M%2C%20McQueeney%20KE%2C%20Ryan%20J%2C%20Ng%20K%2C%20Sicinska%20E%2C%20Sorger%20PK%2C%20Letai%20A%2C%20Bhola%20PD.%20Sequential%20apoptotic%20and%20multiplexed%20proteomic%20evaluation%20of%20single%20cancer%20cells.%20Sci%20Adv.%202023%20Jun%2023%3B9%2825%29%3Aeadg4128.%20PMCID%3A%20PMC10289660%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sequential%20apoptotic%20and%20multiplexed%20proteomic%20evaluation%20of%20single%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmalyn%22%2C%22lastName%22%3A%22Lecky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atreyi%22%2C%22lastName%22%3A%22Mukherji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22German%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Antonellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Yorsz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelley%20E.%22%2C%22lastName%22%3A%22McQueeney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimmie%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20D.%22%2C%22lastName%22%3A%22Bhola%22%7D%5D%2C%22abstractNote%22%3A%22A%20potential%20cause%20of%20cancer%20relapse%20is%20pretreatment%20chemoresistant%20subpopulations.%20Identifying%20targetable%20features%20of%20subpopulations%20that%20are%20poorly%20primed%20for%20therapy-induced%20cell%20death%20may%20improve%20cancer%20therapy.%20Here%2C%20we%20develop%20and%20validate%20real-time%20BH3%20profiling%2C%20a%20live%20and%20functional%20single-cell%20measurement%20of%20pretreatment%20apoptotic%20sensitivity%20that%20occurs%20upstream%20of%20apoptotic%20protease%20activation.%20On%20the%20same%20single%20cells%2C%20we%20perform%20cyclic%20immunofluorescence%2C%20which%20enables%20multiplexed%20immunofluorescence%20of%20more%20than%2030%20proteins%20on%20the%20same%20cell.%20Using%20cultured%20cells%20and%20rapid%20ex%20vivo%20cultures%20of%20colon%20cancer%20patient-derived%20xenograft%20%28PDX%29%20models%2C%20we%20identify%20Bak%20as%20a%20univariate%20correlate%20of%20apoptotic%20priming%2C%20find%20that%20poorly%20primed%20subpopulations%20can%20correspond%20to%20specific%20stages%20of%20the%20cell%20cycle%2C%20and%2C%20in%20some%20PDX%20models%2C%20identify%20increased%20expression%20of%20Bcl-XL%2C%20Mcl-1%2C%20or%20Her2%20in%20subpopulations%20that%20are%20poorly%20primed%20for%20apoptosis.%20Last%2C%20we%20generate%20and%20validate%20mathematical%20models%20of%20single-cell%20priming%20that%20describe%20how%20targetable%20proteins%20contribute%20to%20apoptotic%20priming.%22%2C%22date%22%3A%222023-06-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.adg4128%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A58%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22554BMIXM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Limdi%20and%20Baym%22%2C%22parsedDate%22%3A%222023-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELimdi%20A%2C%20Baym%20M.%20Resolving%20deleterious%20and%20near-neutral%20effects%20requires%20different%20pooled%20fitness%20assay%20designs.%20J%20Mol%20Evol.%202023%20Jun%3B91%283%29%3A325%26%23x2013%3B333.%20PMID%3A%2037160452%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Resolving%20deleterious%20and%20near-neutral%20effects%20requires%20different%20pooled%20fitness%20assay%20designs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anurag%22%2C%22lastName%22%3A%22Limdi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Pooled%20sequencing-based%20fitness%20assays%20are%20a%20powerful%20and%20widely%20used%20approach%20to%20quantifying%20fitness%20of%20thousands%20of%20genetic%20variants%20in%20parallel.%20Despite%20the%20throughput%20of%20such%20assays%2C%20they%20are%20prone%20to%20biases%20in%20fitness%20estimates%2C%20and%20errors%20in%20measurements%20are%20typically%20larger%20for%20deleterious%20fitness%20effects%2C%20relative%20to%20neutral%20effects.%20In%20practice%2C%20designing%20pooled%20fitness%20assays%20involves%20tradeoffs%20between%20the%20number%20of%20timepoints%2C%20the%20sequencing%20depth%2C%20and%20other%20parameters%20to%20gain%20as%20much%20information%20as%20possible%20within%20a%20feasible%20experiment.%20Here%2C%20we%20combined%20simulations%20and%20reanalysis%20of%20an%20existing%20experimental%20dataset%20to%20explore%20how%20assay%20parameters%20impact%20measurements%20of%20near-neutral%20and%20deleterious%20fitness%20effects%20using%20a%20standard%20fitness%20estimator.%20We%20found%20that%20sequencing%20multiple%20timepoints%20at%20relatively%20modest%20depth%20improved%20estimates%20of%20near-neutral%20fitness%20effects%2C%20but%20systematically%20biased%20measurements%20of%20deleterious%20effects.%20We%20showed%20that%20a%20fixed%20total%20number%20of%20reads%2C%20deeper%20sequencing%20at%20fewer%20timepoints%20improved%20resolution%20of%20deleterious%20fitness%20effects.%20Our%20results%20highlight%20a%20tradeoff%20between%20measurement%20of%20deleterious%20and%20near-neutral%20effect%20sizes%20for%20a%20fixed%20amount%20of%20data%20and%20suggest%20that%20fitness%20assay%20design%20should%20be%20tuned%20for%20fitness%20effects%20that%20are%20relevant%20to%20the%20specific%20biological%20question.%22%2C%22date%22%3A%222023-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00239-023-10110-7%22%2C%22ISSN%22%3A%221432-1432%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A35%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22YJ95V4GV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR%2C%20Wang%20S%2C%20Coy%20S%2C%20Chen%20YA%2C%20Yapp%20C%2C%20Tyler%20M%2C%20Nariya%20MK%2C%20Heiser%20CN%2C%20Lau%20KS%2C%20Santagata%20S%2C%20Sorger%20PK.%20Multiplexed%203D%20atlas%20of%20state%20transitions%20and%20immune%20interaction%20in%20colorectal%20cancer.%20Cell.%202023%20Jan%2019%3B186%282%29%3A363-381.e19.%20PMCID%3A%20PMC10019067%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiplexed%203D%20atlas%20of%20state%20transitions%20and%20immune%20interaction%20in%20colorectal%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madison%22%2C%22lastName%22%3A%22Tyler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cody%20N.%22%2C%22lastName%22%3A%22Heiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%20S.%22%2C%22lastName%22%3A%22Lau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Advanced%20solid%20cancers%20are%20complex%20assemblies%20of%20tumor%2C%20immune%2C%20and%20stromal%20cells%20characterized%20by%20high%20intratumoral%20variation.%20We%20use%20highly%20multiplexed%20tissue%20imaging%2C%203D%20reconstruction%2C%20spatial%20statistics%2C%20and%20machine%20learning%20to%20identify%20cell%20types%20and%20states%20underlying%20morphological%20features%20of%20known%20diagnostic%20and%20prognostic%20significance%20in%20colorectal%20cancer.%20Quantitation%20of%20these%20features%20in%20high-plex%20marker%20space%20reveals%20recurrent%20transitions%20from%20one%20tumor%20morphology%20to%20the%20next%2C%20some%20of%20which%20are%20coincident%20with%20long-range%20gradients%20in%20the%20expression%20of%20oncogenes%20and%20epigenetic%20regulators.%20At%20the%20tumor%20invasive%20margin%2C%20where%20tumor%2C%20normal%2C%20and%20immune%20cells%20compete%2C%20T%5Cu00a0cell%20suppression%20involves%20multiple%20cell%20types%20and%203D%20imaging%20shows%20that%20seemingly%20localized%202D%20features%20such%20as%20tertiary%20lymphoid%20structures%20are%20commonly%20interconnected%20and%20have%20graded%20molecular%20properties.%20Thus%2C%20while%20cancer%20genetics%20emphasizes%20the%20importance%20of%20discrete%20changes%20in%20tumor%20state%2C%20whole-specimen%20imaging%20reveals%20large-scale%20morphological%20and%20molecular%20gradients%20analogous%20to%20those%20in%20developing%20tissues.%22%2C%22date%22%3A%222023-01-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2022.12.028%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A41%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22P742XUPD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222023-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR%2C%20Chen%20YA%2C%20Campton%20D%2C%20Cooper%20J%2C%20Coy%20S%2C%20Yapp%20C%2C%20Tefft%20JB%2C%20McCarty%20E%2C%20Ligon%20KL%2C%20Rodig%20SJ%2C%20Reese%20S%2C%20George%20T%2C%20Santagata%20S%2C%20Sorger%20PK.%20High-plex%20immunofluorescence%20imaging%20and%20traditional%20histology%20of%20the%20same%20tissue%20section%20for%20discovering%20image-based%20biomarkers.%20Nat%20Cancer.%202023%20Jul%3B4%287%29%3A1036%26%23x2013%3B1052.%20PMCID%3A%20PMC10368530%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High-plex%20immunofluorescence%20imaging%20and%20traditional%20histology%20of%20the%20same%20tissue%20section%20for%20discovering%20image-based%20biomarkers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Campton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliann%20B.%22%2C%22lastName%22%3A%22Tefft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22McCarty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Reese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tad%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Precision%20medicine%20is%20critically%20dependent%20on%20better%20methods%20for%20diagnosing%20and%20staging%20disease%20and%20predicting%20drug%20response.%20Histopathology%20using%20hematoxylin%20and%20eosin%20%28H%26E%29-stained%20tissue%20%28not%20genomics%29%20remains%20the%20primary%20diagnostic%20method%20in%20cancer.%20Recently%20developed%20highly%20multiplexed%20tissue%20imaging%20methods%20promise%20to%20enhance%20research%20studies%20and%20clinical%20practice%20with%20precise%2C%20spatially%20resolved%20single-cell%20data.%20Here%2C%20we%20describe%20the%20%27Orion%27%20platform%20for%20collecting%20H%26E%20and%20high-plex%20immunofluorescence%20images%20from%20the%20same%20cells%20in%20a%20whole-slide%20format%20suitable%20for%20diagnosis.%20Using%20a%20retrospective%20cohort%20of%2074%20colorectal%20cancer%20resections%2C%20we%20show%20that%20immunofluorescence%20and%20H%26E%20images%20provide%20human%20experts%20and%20machine%20learning%20algorithms%20with%20complementary%20information%20that%20can%20be%20used%20to%20generate%20interpretable%2C%20multiplexed%20image-based%20models%20predictive%20of%20progression-free%20survival.%20Combining%20models%20of%20immune%20infiltration%20and%20tumor-intrinsic%20features%20achieves%20a%2010-%20to%2020-fold%20discrimination%20between%20rapid%20and%20slow%20%28or%20no%29%20progression%2C%20demonstrating%20the%20ability%20of%20multimodal%20tissue%20imaging%20to%20generate%20high-performance%20biomarkers.%22%2C%22date%22%3A%222023-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs43018-023-00576-1%22%2C%22ISSN%22%3A%222662-1347%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A44%3A54Z%22%7D%7D%2C%7B%22key%22%3A%222NHKW5MH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELiu%20C%2C%20Kutchukian%20P%2C%20Nguyen%20ND%2C%20AlQuraishi%20M%2C%20Sorger%20PK.%20A%20hybrid%20structure-based%20machine%20learning%20approach%20for%20predicting%20kinase%20inhibition%20by%20small%20molecules.%20J%20Chem%20Inf%20Model.%202023%20Sep%2011%3B63%2817%29%3A5457%26%23x2013%3B5472.%20PMCID%3A%20PMC10498990%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20hybrid%20structure-based%20machine%20learning%20approach%20for%20predicting%20kinase%20inhibition%20by%20small%20molecules%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changchang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Kutchukian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhan%20D.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Kinases%20have%20been%20the%20focus%20of%20drug%20discovery%20programs%20for%20three%20decades%20leading%20to%20over%2070%20therapeutic%20kinase%20inhibitors%20and%20biophysical%20affinity%20measurements%20for%20over%20130%2C000%20kinase-compound%20pairs.%20Nonetheless%2C%20the%20precise%20target%20spectrum%20for%20many%20kinases%20remains%20only%20partly%20understood.%20In%20this%20study%2C%20we%20describe%20a%20computational%20approach%20to%20unlocking%20qualitative%20and%20quantitative%20kinome-wide%20binding%20measurements%20for%20structure-based%20machine%20learning.%20Our%20study%20has%20three%20components%3A%20%28i%29%20a%20Kinase%20Inhibitor%20Complex%20%28KinCo%29%20data%20set%20comprising%20in%20silico%20predicted%20kinase%20structures%20paired%20with%20experimental%20binding%20constants%2C%20%28ii%29%20a%20machine%20learning%20loss%20function%20that%20integrates%20qualitative%20and%20quantitative%20data%20for%20model%20training%2C%20and%20%28iii%29%20a%20structure-based%20machine%20learning%20model%20trained%20on%20KinCo.%20We%20show%20that%20our%20approach%20outperforms%20methods%20trained%20on%20crystal%20structures%20alone%20in%20predicting%20binary%20and%20quantitative%20kinase-compound%20interaction%20affinities%3B%20relative%20to%20structure-free%20methods%2C%20our%20approach%20also%20captures%20known%20kinase%20biochemistry%20and%20more%20successfully%20generalizes%20to%20distant%20kinase%20sequences%20and%20compound%20scaffolds.%22%2C%22date%22%3A%222023-09-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.jcim.3c00347%22%2C%22ISSN%22%3A%221549-960X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A47%3A47Z%22%7D%7D%2C%7B%22key%22%3A%229ANJZ324%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lobentanzer%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELobentanzer%20S%2C%20Aloy%20P%2C%20Baumbach%20J%2C%20Bohar%20B%2C%20Carey%20VJ%2C%20Charoentong%20P%2C%20Danhauser%20K%2C%20Do%26%23x11F%3Ban%20T%2C%20Dreo%20J%2C%20Dunham%20I%2C%20Farr%20E%2C%20Fernandez-Torras%20A%2C%20Gyori%20BM%2C%20Hartung%20M%2C%20Hoyt%20CT%2C%20Klein%20C%2C%20Korcsmaros%20T%2C%20Maier%20A%2C%20Mann%20M%2C%20Ochoa%20D%2C%20Pareja-Lorente%20E%2C%20Popp%20F%2C%20Preusse%20M%2C%20Probul%20N%2C%20Schwikowski%20B%2C%20Sen%20B%2C%20Strauss%20MT%2C%20Turei%20D%2C%20Ulusoy%20E%2C%20Waltemath%20D%2C%20Wodke%20JAH%2C%20Saez-Rodriguez%20J.%20Democratizing%20knowledge%20representation%20with%20BioCypher.%20Nat%20Biotechnol.%202023%20Jun%2019%3B%20PMID%3A%2037337100%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Democratizing%20knowledge%20representation%20with%20BioCypher%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Lobentanzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Aloy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Baumbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Balazs%22%2C%22lastName%22%3A%22Bohar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20J.%22%2C%22lastName%22%3A%22Carey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pornpimol%22%2C%22lastName%22%3A%22Charoentong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Danhauser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tunca%22%2C%22lastName%22%3A%22Do%5Cu011fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johann%22%2C%22lastName%22%3A%22Dreo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Dunham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elias%22%2C%22lastName%22%3A%22Farr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adri%5Cu00e0%22%2C%22lastName%22%3A%22Fernandez-Torras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Hartung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Klein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamas%22%2C%22lastName%22%3A%22Korcsmaros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Maier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Mann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Ochoa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Pareja-Lorente%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ferdinand%22%2C%22lastName%22%3A%22Popp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Preusse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niklas%22%2C%22lastName%22%3A%22Probul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benno%22%2C%22lastName%22%3A%22Schwikowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00fcnyamin%22%2C%22lastName%22%3A%22Sen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximilian%20T.%22%2C%22lastName%22%3A%22Strauss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denes%22%2C%22lastName%22%3A%22Turei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erva%22%2C%22lastName%22%3A%22Ulusoy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dagmar%22%2C%22lastName%22%3A%22Waltemath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%20A.%20H.%22%2C%22lastName%22%3A%22Wodke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julio%22%2C%22lastName%22%3A%22Saez-Rodriguez%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-06-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41587-023-01848-y%22%2C%22ISSN%22%3A%221546-1696%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-06-26T14%3A06%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22N8Z8GEIF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martin%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMartin%20AP%2C%20Bradshaw%20GA%2C%20Eisert%20RJ%2C%20Egan%20ED%2C%20Tveriakhina%20L%2C%20Rogers%20JM%2C%20Dates%20AN%2C%20Scanavachi%20G%2C%20Aster%20JC%2C%20Kirchhausen%20T%2C%20Kalocsay%20M%2C%20Blacklow%20SC.%20A%20spatiotemporal%20Notch%20interaction%20map%20from%20plasma%20membrane%20to%20nucleus.%20Sci%20Signal.%202023%20Aug%3B16%28796%29%3Aeadg6474.%20PMCID%3A%20PMC10560377%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20spatiotemporal%20Notch%20interaction%20map%20from%20plasma%20membrane%20to%20nucleus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%20P.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20D.%22%2C%22lastName%22%3A%22Egan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lena%22%2C%22lastName%22%3A%22Tveriakhina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%20M.%22%2C%22lastName%22%3A%22Rogers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20N.%22%2C%22lastName%22%3A%22Dates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Scanavachi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%20C.%22%2C%22lastName%22%3A%22Aster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%22%2C%22lastName%22%3A%22Kirchhausen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20C.%22%2C%22lastName%22%3A%22Blacklow%22%7D%5D%2C%22abstractNote%22%3A%22Notch%20signaling%20relies%20on%20ligand-induced%20proteolysis%20of%20the%20transmembrane%20receptor%20Notch%20to%20liberate%20a%20nuclear%20effector%20that%20drives%20cell%20fate%20decisions.%20Upon%20ligand%20binding%2C%20sequential%20cleavage%20of%20Notch%20by%20the%20transmembrane%20protease%20ADAM10%20and%20the%20intracellular%20protease%20%5Cu03b3-secretase%20releases%20the%20Notch%20intracellular%20domain%20%28NICD%29%2C%20which%20translocates%20to%20the%20nucleus%20and%20forms%20a%20complex%20that%20induces%20target%20gene%20transcription.%20To%20map%20the%20location%20and%20timing%20of%20the%20individual%20steps%20required%20for%20the%20proteolysis%20and%20movement%20of%20Notch%20from%20the%20plasma%20membrane%20to%20the%20nucleus%2C%20we%20used%20proximity%20labeling%20with%20quantitative%2C%20multiplexed%20mass%20spectrometry%20to%20monitor%20the%20interaction%20partners%20of%20endogenous%20NOTCH2%20after%20ligand%20stimulation%20in%20the%20presence%20of%20a%20%5Cu03b3-secretase%20inhibitor%20and%20as%20a%20function%20of%20time%20after%20inhibitor%20removal.%20Our%20studies%20showed%20that%20%5Cu03b3-secretase-mediated%20cleavage%20of%20NOTCH2%20occurred%20in%20an%20intracellular%20compartment%20and%20that%20formation%20of%20nuclear%20complexes%20and%20recruitment%20of%20chromatin-modifying%20enzymes%20occurred%20within%2045%20min%20of%20inhibitor%20washout.%20These%20findings%20provide%20a%20detailed%20spatiotemporal%20map%20tracking%20the%20path%20of%20Notch%20from%20the%20plasma%20membrane%20to%20the%20nucleus%20and%20identify%20signaling%20events%20that%20are%20potential%20targets%20for%20modulating%20Notch%20activity.%22%2C%22date%22%3A%222023-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscisignal.adg6474%22%2C%22ISSN%22%3A%221937-9145%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22K5XPAPM3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mohammad-Taheri%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMohammad-Taheri%20S%2C%20Tewari%20V%2C%20Kapre%20R%2C%20Rahiminasab%20E%2C%20Sachs%20K%2C%20Taply%20Hoyt%20C%2C%20Zucker%20J%2C%20Vitek%20O.%20Optimal%20adjustment%20sets%20for%20causal%20query%20estimation%20in%20partially%20observed%20biomolecular%20networks.%20Bioinformatics.%202023%20Jun%2030%3B39%2839%20Suppl%201%29%3Ai494%26%23x2013%3Bi503.%20PMCID%3A%20PMC10311316%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimal%20adjustment%20sets%20for%20causal%20query%20estimation%20in%20partially%20observed%20biomolecular%20networks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Mohammad-Taheri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vartika%22%2C%22lastName%22%3A%22Tewari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%22%2C%22lastName%22%3A%22Kapre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ehsan%22%2C%22lastName%22%3A%22Rahiminasab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Sachs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Taply%20Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Zucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Vitek%22%7D%5D%2C%22abstractNote%22%3A%22Causal%20query%20estimation%20in%20biomolecular%20networks%20commonly%20selects%20a%20%27valid%20adjustment%20set%27%2C%20i.e.%20a%20subset%20of%20network%20variables%20that%20eliminates%20the%20bias%20of%20the%20estimator.%20A%20same%20query%20may%20have%20multiple%20valid%20adjustment%20sets%2C%20each%20with%20a%20different%20variance.%20When%20networks%20are%20partially%20observed%2C%20current%20methods%20use%20graph-based%20criteria%20to%20find%20an%20adjustment%20set%20that%20minimizes%20asymptotic%20variance.%20Unfortunately%2C%20many%20models%20that%20share%20the%20same%20graph%20topology%2C%20and%20therefore%20same%20functional%20dependencies%2C%20may%20differ%20in%20the%20processes%20that%20generate%20the%20observational%20data.%20In%20these%20cases%2C%20the%20topology-based%20criteria%20fail%20to%20distinguish%20the%20variances%20of%20the%20adjustment%20sets.%20This%20deficiency%20can%20lead%20to%20sub-optimal%20adjustment%20sets%2C%20and%20to%20miss-characterization%20of%20the%20effect%20of%20the%20intervention.%20We%20propose%20an%20approach%20for%20deriving%20%27optimal%20adjustment%20sets%27%20that%20takes%20into%20account%20the%20nature%20of%20the%20data%2C%20bias%20and%20finite-sample%20variance%20of%20the%20estimator%2C%20and%20cost.%20It%20empirically%20learns%20the%20data%20generating%20processes%20from%20historical%20experimental%20data%2C%20and%20characterizes%20the%20properties%20of%20the%20estimators%20by%20simulation.%20We%20demonstrate%20the%20utility%20of%20the%20proposed%20approach%20in%20four%20biomolecular%20Case%20studies%20with%20different%20topologies%20and%20different%20data%20generation%20processes.%20The%20implementation%20and%20reproducible%20Case%20studies%20are%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fsrtaheri%5C%2FOptimalAdjustmentSet.%22%2C%22date%22%3A%222023-06-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtad270%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-07-06T14%3A59%3A28Z%22%7D%7D%2C%7B%22key%22%3A%228WN6NI3R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Nariya%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENariya%20MK%2C%20Mills%20CE%2C%20Sorger%20PK%2C%20Sokolov%20A.%20Paired%20evaluation%20of%20machine-learning%20models%20characterizes%20effects%20of%20confounders%20and%20outliers.%20Patterns%20%28N%20Y%29.%202023%20Aug%2011%3B4%288%29%3A100791.%20PMCID%3A%20PMC10435952%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Paired%20evaluation%20of%20machine-learning%20models%20characterizes%20effects%20of%20confounders%20and%20outliers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%5D%2C%22abstractNote%22%3A%22The%20true%20accuracy%20of%20a%20machine-learning%20model%20is%20a%20population-level%20statistic%20that%20cannot%20be%20observed%20directly.%20In%20practice%2C%20predictor%20performance%20is%20estimated%20against%20one%20or%20more%20test%20datasets%2C%20and%20the%20accuracy%20of%20this%20estimate%20strongly%20depends%20on%20how%20well%20the%20test%20sets%20represent%20all%20possible%20unseen%20datasets.%20Here%20we%20describe%20paired%20evaluation%20as%20a%20simple%2C%20robust%20approach%20for%20evaluating%20performance%20of%20machine-learning%20models%20in%20small-sample%20biological%20and%20clinical%20studies.%20We%20use%20the%20method%20to%20evaluate%20predictors%20of%20drug%20response%20in%20breast%20cancer%20cell%20lines%20and%20of%20disease%20severity%20in%20patients%20with%20Alzheimer%27s%20disease%2C%20demonstrating%20that%20the%20choice%20of%20test%20data%20can%20cause%20estimates%20of%20performance%20to%20vary%20by%20as%20much%20as%2020%25.%20We%20show%20that%20paired%20evaluation%20makes%20it%20possible%20to%20identify%20outliers%2C%20improve%20the%20accuracy%20of%20performance%20estimates%20in%20the%20presence%20of%20known%20confounders%2C%20and%20assign%20statistical%20significance%20when%20comparing%20machine-learning%20models.%22%2C%22date%22%3A%222023-08-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.patter.2023.100791%22%2C%22ISSN%22%3A%222666-3899%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A02%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22I38VNADC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Netterfield%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENetterfield%20TS%2C%20Ostheimer%20GJ%2C%20Tentner%20AR%2C%20Joughin%20BA%2C%20Dakoyannis%20AM%2C%20Sharma%20CD%2C%20Sorger%20PK%2C%20Janes%20KA%2C%20Lauffenburger%20DA%2C%20Yaffe%20MB.%20Biphasic%20JNK-Erk%20signaling%20separates%20the%20induction%20and%20maintenance%20of%20cell%20senescence%20after%20DNA%20damage%20induced%20by%20topoisomerase%20II%20inhibition.%20Cell%20Syst.%202023%20Jul%2019%3B14%287%29%3A582-604.e10.%20PMID%3A%2037473730%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biphasic%20JNK-Erk%20signaling%20separates%20the%20induction%20and%20maintenance%20of%20cell%20senescence%20after%20DNA%20damage%20induced%20by%20topoisomerase%20II%20inhibition%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatiana%20S.%22%2C%22lastName%22%3A%22Netterfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%20J.%22%2C%22lastName%22%3A%22Ostheimer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20R.%22%2C%22lastName%22%3A%22Tentner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20A.%22%2C%22lastName%22%3A%22Joughin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20M.%22%2C%22lastName%22%3A%22Dakoyannis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charvi%20D.%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20A.%22%2C%22lastName%22%3A%22Janes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20A.%22%2C%22lastName%22%3A%22Lauffenburger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20B.%22%2C%22lastName%22%3A%22Yaffe%22%7D%5D%2C%22abstractNote%22%3A%22Genotoxic%20stress%20in%20mammalian%20cells%2C%20including%20those%20caused%20by%20anti-cancer%20chemotherapy%2C%20can%20induce%20temporary%20cell-cycle%20arrest%2C%20DNA%20damage-induced%20senescence%20%28DDIS%29%2C%20or%20apoptotic%20cell%20death.%20Despite%20obvious%20clinical%20importance%2C%20it%20is%20unclear%20how%20the%20signals%20emerging%20from%20DNA%20damage%20are%20integrated%20together%20with%20other%20cellular%20signaling%20pathways%20monitoring%20the%20cell%27s%20environment%20and%5C%2For%20internal%20state%20to%20control%20different%20cell%20fates.%20Using%20single-cell-based%20signaling%20measurements%20combined%20with%20tensor%20partial%20least%20square%20regression%20%28t-PLSR%29%5C%2Fprincipal%20component%20analysis%20%28PCA%29%20analysis%2C%20we%20show%20that%20JNK%20and%20Erk%20MAPK%20signaling%20regulates%20the%20initiation%20of%20cell%20senescence%20through%20the%20transcription%20factor%20AP-1%20at%20early%20times%20after%20doxorubicin-induced%20DNA%20damage%20and%20the%20senescence-associated%20secretory%20phenotype%20%28SASP%29%20at%20late%20times%20after%20damage.%20These%20results%20identify%20temporally%20distinct%20roles%20for%20signaling%20pathways%20beyond%20the%20classic%20DNA%20damage%20response%20%28DDR%29%20that%20control%20the%20cell%20senescence%20decision%20and%20modulate%20the%20tumor%20microenvironment%20and%20reveal%20fundamental%20similarities%20between%20signaling%20pathways%20responsible%20for%20oncogene-induced%20senescence%20%28OIS%29%20and%20senescence%20caused%20by%20topoisomerase%20II%20inhibition.%20A%20record%20of%20this%20paper%27s%20transparent%20peer%20review%20process%20is%20included%20in%20the%20supplemental%20information.%22%2C%22date%22%3A%222023-07-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2023.06.005%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-07-27T19%3A39%3A42Z%22%7D%7D%2C%7B%22key%22%3A%2272A6GWES%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Nirmal%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENirmal%20AJ%2C%20Yapp%20C%2C%20Santagata%20S%2C%20Sorger%20PK.%20Cell%20Spotter%20%28CSPOT%29%3A%20a%20machine-learning%20approach%20to%20automated%20cell%20spotting%20and%20quantification%20of%20highly%20multiplexed%20tissue%20images%20%5BInternet%5D.%20bioRxiv%3B%202023%20%5Bcited%202023%20Dec%2015%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.11.15.567196%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.11.15.567196%3C%5C%2Fa%3E%20PMCID%3A%20PMC10680730%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Cell%20Spotter%20%28CSPOT%29%3A%20a%20machine-learning%20approach%20to%20automated%20cell%20spotting%20and%20quantification%20of%20highly%20multiplexed%20tissue%20images%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Highly%20multiplexed%20tissue%20imaging%20and%20in%20situ%20spatial%20profiling%20aim%20to%20extract%20single-cell%20data%20from%20specimens%20containing%20closely%20packed%20cells%20of%20diverse%20morphology.%20This%20is%20challenging%20due%20to%20the%20difficulty%20of%20accurately%20assigning%20boundaries%20between%20cells%20%28segmentation%29%20and%20then%20generating%20per-cell%20staining%20intensities.%20Existing%20methods%20use%20gating%20to%20convert%20per-cell%20intensity%20data%20to%20positive%20and%20negative%20scores%3B%20this%20is%20a%20common%20approach%20in%20flow%20cytometry%2C%20but%20one%20that%20is%20problematic%20in%20imaging.%20In%20contrast%2C%20human%20experts%20identify%20cells%20in%20crowded%20environments%20using%20morphological%2C%20neighborhood%2C%20and%20intensity%20information.%20Here%20we%20describe%20a%20computational%20approach%20%28Cell%20Spotter%20or%20CSPOT%29%20that%20uses%20supervised%20machine%20learning%20in%20combination%20with%20classical%20segmentation%20to%20perform%20automated%20cell%20type%20calling.%20CSPOT%20is%20robust%20to%20artifacts%20that%20commonly%20afflict%20tissue%20imaging%20and%20can%20replace%20conventional%20gating.%20The%20end-to-end%20Python%20implementation%20of%20CSPOT%20can%20be%20integrated%20into%20cloud-based%20image%20processing%20pipelines%20to%20substantially%20improve%20the%20speed%2C%20accuracy%2C%20and%20reproducibility%20of%20single-cell%20spatial%20data.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-11-17%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.11.15.567196%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.11.15.567196%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T15%3A01%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22CL8WAX3T%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nyerges%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENyerges%20A%2C%20Vinke%20S%2C%20Flynn%20R%2C%20Owen%20SV%2C%20Rand%20EA%2C%20Budnik%20B%2C%20Keen%20E%2C%20Narasimhan%20K%2C%20Marchand%20JA%2C%20Baas-Thomas%20M%2C%20Liu%20M%2C%20Chen%20K%2C%20Chiappino-Pepe%20A%2C%20Hu%20F%2C%20Baym%20M%2C%20Church%20GM.%20A%20swapped%20genetic%20code%20prevents%20viral%20infections%20and%20gene%20transfer.%20Nature.%202023%20Mar%3B615%287953%29%3A720%26%23x2013%3B727.%20PMCID%3A%20PMC10151025%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20swapped%20genetic%20code%20prevents%20viral%20infections%20and%20gene%20transfer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akos%22%2C%22lastName%22%3A%22Nyerges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svenja%22%2C%22lastName%22%3A%22Vinke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regan%22%2C%22lastName%22%3A%22Flynn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%20A.%22%2C%22lastName%22%3A%22Rand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bogdan%22%2C%22lastName%22%3A%22Budnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Keen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamesh%22%2C%22lastName%22%3A%22Narasimhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20A.%22%2C%22lastName%22%3A%22Marchand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximilien%22%2C%22lastName%22%3A%22Baas-Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kangming%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anush%22%2C%22lastName%22%3A%22Chiappino-Pepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fangxiang%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20M.%22%2C%22lastName%22%3A%22Church%22%7D%5D%2C%22abstractNote%22%3A%22Engineering%20the%20genetic%20code%20of%20an%20organism%20has%20been%20proposed%20to%20provide%20a%20firewall%20from%20natural%20ecosystems%20by%20preventing%20viral%20infections%20and%20gene%20transfer1-6.%20However%2C%20numerous%20viruses%20and%20mobile%20genetic%20elements%20encode%20parts%20of%20the%20translational%20apparatus7-9%2C%20potentially%20rendering%20a%20genetic-code-based%20firewall%20ineffective.%20Here%20we%20show%20that%20such%20mobile%20transfer%20RNAs%20%28tRNAs%29%20enable%20gene%20transfer%20and%20allow%20viral%20replication%20in%20Escherichia%20coli%20despite%20the%20genome-wide%20removal%20of%203%20of%20the%2064%20codons%20and%20the%20previously%20essential%20cognate%20tRNA%20and%20release%20factor%20genes.%20We%20then%20establish%20a%20genetic%20firewall%20by%20discovering%20viral%20tRNAs%20that%20provide%20exceptionally%20efficient%20codon%20reassignment%20allowing%20us%20to%20develop%20cells%20bearing%20an%20amino%20acid-swapped%20genetic%20code%20that%20reassigns%20two%20of%20the%20six%20serine%20codons%20to%20leucine%20during%20translation.%20This%20amino%20acid-swapped%20genetic%20code%20renders%20cells%20resistant%20to%20viral%20infections%20by%20mistranslating%20viral%20proteomes%20and%20prevents%20the%20escape%20of%20synthetic%20genetic%20information%20by%20engineered%20reliance%20on%20serine%20codons%20to%20produce%20leucine-requiring%20proteins.%20As%20these%20cells%20may%20have%20a%20selective%20advantage%20over%20wild%20organisms%20due%20to%20virus%20resistance%2C%20we%20also%20repurpose%20a%20third%20codon%20to%20biocontain%20this%20virus-resistant%20host%20through%20dependence%20on%20an%20amino%20acid%20not%20found%20in%20nature10.%20Our%20results%20may%20provide%20the%20basis%20for%20a%20general%20strategy%20to%20make%20any%20organism%20safely%20resistant%20to%20all%20natural%20viruses%20and%20prevent%20genetic%20information%20flow%20into%20and%20out%20of%20genetically%20modified%20organisms.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-023-05824-z%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A35Z%22%7D%7D%2C%7B%22key%22%3A%225S68L9ZZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Perurena%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-18%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPerurena%20N%2C%20Lock%20R%2C%20Davis%20RA%2C%20Raghavan%20S%2C%20Pilla%20NF%2C%20Ng%20R%2C%20Loi%20P%2C%20Guild%20CJ%2C%20Miller%20AL%2C%20Sicinska%20E%2C%20Cleary%20JM%2C%20Rubinson%20DA%2C%20Wolpin%20BM%2C%20Gray%20NS%2C%20Santagata%20S%2C%20Hahn%20WC%2C%20Morton%20JP%2C%20Sansom%20OJ%2C%20Aguirre%20AJ%2C%20Cichowski%20K.%20USP9X%20mediates%20an%20acute%20adaptive%20response%20to%20MAPK%20suppression%20in%20pancreatic%20cancer%20but%20creates%20multiple%20actionable%20therapeutic%20vulnerabilities.%20Cell%20Rep%20Med.%202023%20Apr%2018%3B4%284%29%3A101007.%20PMCID%3A%20PMC10140597%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22USP9X%20mediates%20an%20acute%20adaptive%20response%20to%20MAPK%20suppression%20in%20pancreatic%20cancer%20but%20creates%20multiple%20actionable%20therapeutic%20vulnerabilities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naiara%22%2C%22lastName%22%3A%22Perurena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Lock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srivatsan%22%2C%22lastName%22%3A%22Raghavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20F.%22%2C%22lastName%22%3A%22Pilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20J.%22%2C%22lastName%22%3A%22Guild%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abigail%20L.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Cleary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20A.%22%2C%22lastName%22%3A%22Rubinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Wolpin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20P.%22%2C%22lastName%22%3A%22Morton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20J.%22%2C%22lastName%22%3A%22Sansom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20J.%22%2C%22lastName%22%3A%22Aguirre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Cichowski%22%7D%5D%2C%22abstractNote%22%3A%22Pancreatic%20ductal%20adenocarcinomas%20%28PDACs%29%20frequently%20harbor%20KRAS%20mutations.%20Although%20MEK%20inhibitors%20represent%20a%20plausible%20therapeutic%20option%2C%20most%20PDACs%20are%20innately%20resistant%20to%20these%20agents.%20Here%2C%20we%20identify%20a%20critical%20adaptive%20response%20that%20mediates%20resistance.%20Specifically%2C%20we%20show%20that%20MEK%20inhibitors%20upregulate%20the%20anti-apoptotic%20protein%20Mcl-1%20by%20triggering%20an%20association%20with%20its%20deubiquitinase%2C%20USP9X%2C%20resulting%20in%20acute%20Mcl-1%20stabilization%20and%20protection%20from%20apoptosis.%20Notably%2C%20these%20findings%20contrast%20the%20canonical%20positive%20regulation%20of%20Mcl-1%20by%20RAS%5C%2FERK.%20We%20further%20show%20that%20Mcl-1%20inhibitors%20and%20cyclin-dependent%20kinase%20%28CDK%29%20inhibitors%2C%20which%20suppress%20Mcl-1%20transcription%2C%20prevent%20this%20protective%20response%20and%20induce%20tumor%20regression%20when%20combined%20with%20MEK%20inhibitors.%20Finally%2C%20we%20identify%20USP9X%20as%20an%20additional%20potential%20therapeutic%20target.%20Together%2C%20these%20studies%20%281%29%20demonstrate%20that%20USP9X%20regulates%20a%20critical%20mechanism%20of%20resistance%20in%20PDAC%2C%20%282%29%20reveal%20an%20unexpected%20mechanism%20of%20Mcl-1%20regulation%20in%20response%20to%20RAS%20pathway%20suppression%2C%20and%20%283%29%20provide%20multiple%20distinct%20promising%20therapeutic%20strategies%20for%20this%20deadly%20malignancy.%22%2C%22date%22%3A%222023-04-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xcrm.2023.101007%22%2C%22ISSN%22%3A%222666-3791%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-08-05T19%3A56%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22RE4E4WUL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pillich%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPillich%20RT%2C%20Chen%20J%2C%20Churas%20C%2C%20Fong%20D%2C%20Gyori%20BM%2C%20Ideker%20T%2C%20Karis%20K%2C%20Liu%20SN%2C%20Ono%20K%2C%20Pico%20A%2C%20Pratt%20D.%20NDEx%20IQuery%3A%20a%20multi-method%20network%20gene%20set%20analysis%20leveraging%20the%20Network%20Data%20Exchange.%20Bioinformatics.%202023%20Mar%201%3B39%283%29%3Abtad118.%20PMCID%3A%20PMC10023220%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22NDEx%20IQuery%3A%20a%20multi-method%20network%20gene%20set%20analysis%20leveraging%20the%20Network%20Data%20Exchange%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rudolf%20T.%22%2C%22lastName%22%3A%22Pillich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Churas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dylan%22%2C%22lastName%22%3A%22Fong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trey%22%2C%22lastName%22%3A%22Ideker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klas%22%2C%22lastName%22%3A%22Karis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%20N.%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keiichiro%22%2C%22lastName%22%3A%22Ono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Pico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dexter%22%2C%22lastName%22%3A%22Pratt%22%7D%5D%2C%22abstractNote%22%3A%22MOTIVATION%3A%20The%20investigation%20of%20sets%20of%20genes%20using%20biological%20pathways%20is%20a%20common%20task%20for%20researchers%20and%20is%20supported%20by%20a%20wide%20variety%20of%20software%20tools.%20This%20type%20of%20analysis%20generates%20hypotheses%20about%20the%20biological%20processes%20that%20are%20active%20or%20modulated%20in%20a%20specific%20experimental%20context.%5CnRESULTS%3A%20The%20Network%20Data%20Exchange%20Integrated%20Query%20%28NDEx%20IQuery%29%20is%20a%20new%20tool%20for%20network%20and%20pathway-based%20gene%20set%20interpretation%20that%20complements%20or%20extends%20existing%20resources.%20It%20combines%20novel%20sources%20of%20pathways%2C%20integration%20with%20Cytoscape%2C%20and%20the%20ability%20to%20store%20and%20share%20analysis%20results.%20The%20NDEx%20IQuery%20web%20application%20performs%20multiple%20gene%20set%20analyses%20based%20on%20diverse%20pathways%20and%20networks%20stored%20in%20NDEx.%20These%20include%20curated%20pathways%20from%20WikiPathways%20and%20SIGNOR%2C%20published%20pathway%20figures%20from%20the%20last%2027%5Cu2009years%2C%20machine-assembled%20networks%20using%20the%20INDRA%20system%2C%20and%20the%20new%20NCI-PID%20v2.0%2C%20an%20updated%20version%20of%20the%20popular%20NCI%20Pathway%20Interaction%20Database.%20NDEx%20IQuery%27s%20integration%20with%20MSigDB%20and%20cBioPortal%20now%20provides%20pathway%20analysis%20in%20the%20context%20of%20these%20two%20resources.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20NDEx%20IQuery%20is%20available%20at%20https%3A%5C%2F%5C%2Fwww.ndexbio.org%5C%2Fiquery%20and%20is%20implemented%20in%20Javascript%20and%20Java.%22%2C%22date%22%3A%222023-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtad118%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-03-27T20%3A57%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22WKRG4EMG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prabhakaran%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPrabhakaran%20S%2C%20Yapp%20C%2C%20Baker%20GJ%2C%20Beyer%20J%2C%20Chang%20YH%2C%20Creason%20AL%2C%20Krueger%20R%2C%20Muhlich%20J%2C%20Patterson%20NH%2C%20Sidak%20K%2C%20Sudar%20D%2C%20Taylor%20AJ%2C%20Ternes%20L%2C%20Troidl%20J%2C%20Xie%20Y%2C%20Sokolov%20A%2C%20Tyson%20DR%2C%20the%20Cell%20Imaging%20Hackathon%202022%20Participants%20%28Alphabetical%20authorship%2C%20apart%20from%20primary%20contributors%29.%20Addressing%20persistent%20challenges%20in%20digital%20image%20analysis%20of%20cancerous%20tissues%20%5BInternet%5D.%20bioRxiv%3B%202023%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.07.21.548450%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.07.21.548450%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Addressing%20persistent%20challenges%20in%20digital%20image%20analysis%20of%20cancerous%20tissues%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandhya%22%2C%22lastName%22%3A%22Prabhakaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Beyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20Hwan%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20L.%22%2C%22lastName%22%3A%22Creason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20Heath%22%2C%22lastName%22%3A%22Patterson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Sidak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damir%22%2C%22lastName%22%3A%22Sudar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Ternes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakob%22%2C%22lastName%22%3A%22Troidl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yubin%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20R.%22%2C%22lastName%22%3A%22Tyson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22the%20Cell%20Imaging%20Hackathon%202022%20Participants%20%28Alphabetical%20authorship%2C%20apart%20from%20primary%20contributors%29%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20The%20National%20Cancer%20Institute%20%28NCI%29%20supports%20many%20research%20programs%20and%20consortia%2C%20many%20of%20which%20use%20imaging%20as%20a%20major%20modality%20for%20characterizing%20cancerous%20tissue.%20A%20trans-consortia%20Image%20Analysis%20Working%20Group%20%28IAWG%29%20was%20established%20in%202019%20with%20a%20mission%20to%20disseminate%20imaging-related%20work%20and%20foster%20collaborations.%20In%202022%2C%20the%20IAWG%20held%20a%20virtual%20hackathon%20focused%20on%20addressing%20challenges%20of%20analyzing%20high%20dimensional%20datasets%20from%20fixed%20cancerous%20tissues.%20Standard%20image%20processing%20techniques%20have%20automated%20feature%20extraction%2C%20but%20the%20next%20generation%20of%20imaging%20data%20requires%20more%20advanced%20methods%20to%20fully%20utilize%20the%20available%20information.%20In%20this%20perspective%2C%20we%20discuss%20current%20limitations%20of%20the%20automated%20analysis%20of%20multiplexed%20tissue%20images%2C%20the%20first%20steps%20toward%20deeper%20understanding%20of%20these%20limitations%2C%20what%20possible%20solutions%20have%20been%20developed%2C%20any%20new%20or%20refined%20approaches%20that%20were%20developed%20during%20the%20Image%20Analysis%20Hackathon%202022%2C%20and%20where%20further%20effort%20is%20required.%20The%20outstanding%20problems%20addressed%20in%20the%20hackathon%20fell%20into%20three%20main%20themes%3A%201%29%20challenges%20to%20cell%20type%20classification%20and%20assessment%2C%202%29%20translation%20and%20visual%20representation%20of%20spatial%20aspects%20of%20high%20dimensional%20data%2C%20and%203%29%20scaling%20digital%20image%20analyses%20to%20large%20%28multi-TB%29%20datasets.%20We%20describe%20the%20rationale%20for%20each%20specific%20challenge%20and%20the%20progress%20made%20toward%20addressing%20it%20during%20the%20hackathon.%20We%20also%20suggest%20areas%20that%20would%20benefit%20from%20more%20focus%20and%20offer%20insight%20into%20broader%20challenges%20that%20the%20community%20will%20need%20to%20address%20as%20new%20technologies%20are%20developed%20and%20integrated%20into%20the%20broad%20range%20of%20image-based%20modalities%20and%20analytical%20resources%20already%20in%20use%20within%20the%20cancer%20research%20community.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-07-24%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.07.21.548450%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.07.21.548450%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-11-01T16%3A45%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22FQ7CCTWU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rahman%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERahman%20R%2C%20Trippa%20L%2C%20Lee%20EQ%2C%20Arrillaga-Romany%20I%2C%20Fell%20G%2C%20Touat%20M%2C%20McCluskey%20C%2C%20Wiley%20J%2C%20Gaffey%20S%2C%20Drappatz%20J%2C%20Welch%20MR%2C%20Galanis%20E%2C%20Ahluwalia%20MS%2C%20Colman%20H%2C%20Nabors%20LB%2C%20Hepel%20J%2C%20Elinzano%20H%2C%20Schiff%20D%2C%20Chukwueke%20UN%2C%20Beroukhim%20R%2C%20Nayak%20L%2C%20McFaline-Figueroa%20JR%2C%20Batchelor%20TT%2C%20Rinne%20ML%2C%20Kaley%20TJ%2C%20Lu-Emerson%20C%2C%20Mellinghoff%20IK%2C%20Bi%20WL%2C%20Arnaout%20O%2C%20Peruzzi%20PP%2C%20Haas-Kogan%20D%2C%20Tanguturi%20S%2C%20Cagney%20D%2C%20Aizer%20A%2C%20Doherty%20L%2C%20Lavallee%20M%2C%20Fisher-Longden%20B%2C%20Dowling%20S%2C%20Geduldig%20J%2C%20Watkinson%20F%2C%20Pisano%20W%2C%20Malinowski%20S%2C%20Ramkissoon%20S%2C%20Santagata%20S%2C%20Meredith%20DM%2C%20Chiocca%20EA%2C%20Reardon%20DA%2C%20Alexander%20BM%2C%20Ligon%20KL%2C%20Wen%20PY.%20Inaugural%20results%20of%20the%20Individualized%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%3A%20a%20phase%20II%20platform%20trial%20for%20newly%20diagnosed%20glioblastoma%20using%20Bayesian%20adaptive%20randomization.%20J%20Clin%20Oncol.%202023%20Dec%2020%3B41%2836%29%3A5524%26%23x2013%3B5535.%20PMID%3A%2037722087%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inaugural%20results%20of%20the%20Individualized%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%3A%20a%20phase%20II%20platform%20trial%20for%20newly%20diagnosed%20glioblastoma%20using%20Bayesian%20adaptive%20randomization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rifaquat%22%2C%22lastName%22%3A%22Rahman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Trippa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Q.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Arrillaga-Romany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22McCluskey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Wiley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Gaffey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Drappatz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20R.%22%2C%22lastName%22%3A%22Welch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manmeet%20S.%22%2C%22lastName%22%3A%22Ahluwalia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Howard%22%2C%22lastName%22%3A%22Colman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Burt%22%2C%22lastName%22%3A%22Nabors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaroslaw%22%2C%22lastName%22%3A%22Hepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Elinzano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schiff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugonma%20N.%22%2C%22lastName%22%3A%22Chukwueke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakshmi%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Ricardo%22%2C%22lastName%22%3A%22McFaline-Figueroa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracy%20T.%22%2C%22lastName%22%3A%22Batchelor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikael%20L.%22%2C%22lastName%22%3A%22Rinne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Kaley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Lu-Emerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingo%20K.%22%2C%22lastName%22%3A%22Mellinghoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Arnaout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pier%20Paolo%22%2C%22lastName%22%3A%22Peruzzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daphne%22%2C%22lastName%22%3A%22Haas-Kogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%22%2C%22lastName%22%3A%22Tanguturi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Cagney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayal%22%2C%22lastName%22%3A%22Aizer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Lavallee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brittany%22%2C%22lastName%22%3A%22Fisher-Longden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shanna%22%2C%22lastName%22%3A%22Dowling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jack%22%2C%22lastName%22%3A%22Geduldig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22Watkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Pisano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seth%22%2C%22lastName%22%3A%22Malinowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shakti%22%2C%22lastName%22%3A%22Ramkissoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20Individualized%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%20%28INSIGhT%29%20is%20a%20phase%20II%20platform%20trial%20that%20uses%20response%20adaptive%20randomization%20and%20genomic%20profiling%20to%20efficiently%20identify%20novel%20therapies%20for%20phase%20III%20testing.%20Three%20initial%20experimental%20arms%20%28abemaciclib%20%5Ba%20cyclin-dependent%20kinase%20%5BCDK%5D4%5C%2F6%20inhibitor%5D%2C%20neratinib%20%5Ban%20epidermal%20growth%20factor%20receptor%20%5BEGFR%5D%5C%2Fhuman%20epidermal%20growth%20factor%20receptor%202%20inhibitor%5D%2C%20and%20CC-115%20%5Ba%20deoxyribonucleic%20acid-dependent%20protein%20kinase%5C%2Fmammalian%20target%20of%20rapamycin%20inhibitor%5D%29%20were%20simultaneously%20evaluated%20against%20a%20common%20control%20arm.%20We%20report%20the%20results%20for%20each%20arm%20and%20examine%20the%20feasibility%20and%20conduct%20of%20the%20adaptive%20platform%20design.%5CnPATIENTS%20AND%20METHODS%3A%20Patients%20with%20newly%20diagnosed%20O6-methylguanine-DNA%20methyltransferase-unmethylated%20glioblastoma%20were%20eligible%20if%20they%20had%20tumor%20genotyping%20to%20identify%20prespecified%20biomarker%20subpopulations%20of%20dominant%20glioblastoma%20signaling%20pathways%20%28EGFR%2C%20phosphatidylinositol%203-kinase%2C%20and%20CDK%29.%20Initial%20random%20assignment%20was%201%3A1%3A1%3A1%20between%20control%20%28radiation%20therapy%20and%20temozolomide%29%20and%20the%20experimental%20arms.%20Subsequent%20Bayesian%20adaptive%20randomization%20was%20incorporated%20on%20the%20basis%20of%20biomarker-specific%20progression-free%20survival%20%28PFS%29%20data.%20The%20primary%20end%20point%20was%20overall%20survival%20%28OS%29%2C%20and%20one-sided%20P%20values%20are%20reported.%20The%20trial%20is%20registered%20with%20ClinicalTrials.gov%20%28identifier%3A%20NCT02977780%29.%5CnRESULTS%3A%20Two%20hundred%20thirty-seven%20patients%20were%20treated%20%2871%20control%3B%2073%20abemaciclib%3B%2081%20neratinib%3B%2012%20CC-115%29%20in%20years%202017-2021.%20Abemaciclib%20and%20neratinib%20were%20well%20tolerated%2C%20but%20CC-115%20was%20associated%20with%20%5Cu2265%20grade%203%20treatment-related%20toxicity%20in%2058%25%20of%20patients.%20PFS%20was%20significantly%20longer%20with%20abemaciclib%20%28hazard%20ratio%20%5BHR%5D%2C%200.72%3B%2095%25%20CI%2C%200.49%20to%201.06%3B%20one-sided%20P%20%3D%20.046%29%20and%20neratinib%20%28HR%2C%200.72%3B%2095%25%20CI%2C%200.50%20to%201.02%3B%20one-sided%20P%20%3D%20.033%29%20relative%20to%20the%20control%20arm%20but%20there%20was%20no%20PFS%20benefit%20with%20CC-115%20%28one-sided%20P%20%3D%20.523%29.%20None%20of%20the%20experimental%20therapies%20demonstrated%20a%20significant%20OS%20benefit%20%28P%20%3E%20.05%29.%5CnCONCLUSION%3A%20The%20INSIGhT%20design%20enabled%20efficient%20simultaneous%20testing%20of%20three%20experimental%20agents%20using%20a%20shared%20control%20arm%20and%20adaptive%20randomization.%20Two%20investigational%20arms%20had%20superior%20PFS%20compared%20with%20the%20control%20arm%2C%20but%20none%20demonstrated%20an%20OS%20benefit.%20The%20INSIGhT%20design%20may%20promote%20improved%20and%20more%20efficient%20therapeutic%20discovery%20in%20glioblastoma.%20New%20arms%20have%20been%20added%20to%20the%20trial.%22%2C%22date%22%3A%222023-12-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.23.00493%22%2C%22ISSN%22%3A%221527-7755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T14%3A57%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22BRVXINVX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Smith%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-02%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESmith%20NP%2C%20Yan%20Y%2C%20Pan%20Y%2C%20Williams%20JB%2C%20Manakongtreecheep%20K%2C%20Pant%20S%2C%20Zhao%20J%2C%20Tian%20T%2C%20Pan%20T%2C%20Stingley%20C%2C%20Wu%20K%2C%20Zhang%20J%2C%20Kley%20AL%2C%20Sorger%20PK%2C%20Villani%20AC%2C%20Kupper%20TS.%20Resident%20memory%20T%20cell%20development%20is%20associated%20with%20AP-1%20transcription%20factor%20upregulation%20across%20anatomical%20niches%20%5BInternet%5D.%20bioRxiv%3B%202023%20%5Bcited%202023%20Nov%2013%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.29.560006%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.29.560006%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Resident%20memory%20T%20cell%20development%20is%20associated%20with%20AP-1%20transcription%20factor%20upregulation%20across%20anatomical%20niches%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20P.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Youdong%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20B.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kasidet%22%2C%22lastName%22%3A%22Manakongtreecheep%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingxia%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tian%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Stingley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiang%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20L.%22%2C%22lastName%22%3A%22Kley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra-Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Villani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20S.%22%2C%22lastName%22%3A%22Kupper%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Tissue-resident%20memory%20T%20%28T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%29%20cells%20play%20a%20central%20role%20in%20immune%20responses%20to%20pathogens%20across%20all%20barrier%20tissues%20after%20infection.%20However%2C%20the%20underlying%20mechanisms%20that%20drive%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20differentiation%20and%20priming%20for%20their%20recall%20effector%20function%20remains%20unclear.%20In%20this%20study%2C%20we%20leveraged%20both%20newly%20generated%20and%20publicly%20available%20single-cell%20RNA-sequencing%20%28scRNAseq%29%20data%20generated%20across%2010%20developmental%20time%20points%20to%20define%20features%20of%20CD8%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20across%20both%20skin%20and%20small-intestine%20intraepithelial%20lymphocytes%20%28siIEL%29.%20We%20employed%20linear%20modeling%20to%20capture%20temporally-associated%20gene%20programs%20that%20increase%20their%20expression%20levels%20in%20T%20cell%20subsets%20transitioning%20from%20an%20effector%20to%20a%20memory%20T%20cell%20state.%20In%20addition%20to%20capturing%20tissue-specific%20gene%20programs%2C%20we%20defined%20a%20consensus%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20signature%20of%2060%20genes%20across%20skin%20and%20siIEL%20that%20can%20effectively%20distinguish%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20from%20circulating%20T%20cell%20populations%2C%20providing%20a%20more%20specific%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20signature%20than%20what%20was%20previously%20generated%20by%20comparing%20bulk%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20to%20na%5Cu00efve%20or%20non-tissue%20resident%20memory%20populations.%20This%20updated%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20signature%20included%20the%20AP-1%20transcription%20factor%20family%20members%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Fos%2C%20Fosb%5Cn%20%20%20%20%20%20%20%20%20%20%20%20and%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Fosl2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20.%20Moreover%2C%20ATACseq%20analysis%20detected%20an%20enrichment%20of%20AP-1-specific%20motifs%20at%20open%20chromatin%20sites%20in%20mature%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20CyCIF%5Cn%20%20%20%20%20%20%20%20%20%20%20%20tissue%20imaging%20detected%20nuclear%20co-localization%20of%20AP-1%20members%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Fosb%5Cn%20%20%20%20%20%20%20%20%20%20%20%20and%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Junb%5Cn%20%20%20%20%20%20%20%20%20%20%20%20in%20resting%20CD8%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%3E100%20days%20post-infection.%20Taken%20together%2C%20these%20results%20reveal%20a%20critical%20role%20of%20AP-1%20transcription%20factor%20members%20in%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20biology%20and%20suggests%20a%20novel%20mechanism%20for%20rapid%20reactivation%20of%20resting%20T%5Cn%20%20%20%20%20%20%20%20%20%20%20%20RM%5Cn%20%20%20%20%20%20%20%20%20%20%20%20in%20tissue%20upon%20antigen%20encounter.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222023-10-02%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2023.09.29.560006%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A14%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22LP8Z3FI9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stopka%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EStopka%20SA%2C%20Ruiz%20D%2C%20Baquer%20G%2C%20Bodineau%20C%2C%20Hossain%20MA%2C%20Pellens%20VT%2C%20Regan%20MS%2C%20Pourqui%26%23xE9%3B%20O%2C%20Haigis%20MC%2C%20Bi%20WL%2C%20Coy%20SM%2C%20Santagata%20S%2C%20Agar%20NYR%2C%20Basu%20SS.%20Chemical%20QuantArray%3A%20a%20quantitative%20tool%20for%20mass%20spectrometry%20imaging.%20Anal%20Chem.%202023%20Aug%201%3B95%2830%29%3A11243%26%23x2013%3B11253.%20PMCID%3A%20PMC10445330%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemical%20QuantArray%3A%20a%20quantitative%20tool%20for%20mass%20spectrometry%20imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Baquer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9ment%22%2C%22lastName%22%3A%22Bodineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Amin%22%2C%22lastName%22%3A%22Hossain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentina%20T.%22%2C%22lastName%22%3A%22Pellens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Pourqui%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20L.%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%20M.%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sankha%20S.%22%2C%22lastName%22%3A%22Basu%22%7D%5D%2C%22abstractNote%22%3A%22Matrix-assisted%20laser%20desorption%20ionization%20mass%20spectrometry%20imaging%20%28MALDI-MSI%29%20is%20a%20powerful%20analytical%20technique%20that%20provides%20spatially%20preserved%20detection%20and%20quantification%20of%20analytes%20in%20tissue%20specimens.%20However%2C%20clinical%20translation%20still%20requires%20improved%20throughput%2C%20precision%2C%20and%20accuracy.%20To%20accomplish%20this%2C%20we%20created%20%5C%22Chemical%20QuantArray%5C%22%2C%20a%20gelatin%20tissue%20microarray%20%28TMA%29%20mold%20filled%20with%20serial%20dilutions%20of%20isotopically%20labeled%20endogenous%20metabolite%20standards.%20The%20mold%20is%20then%20cryo-sectioned%20onto%20a%20tissue%20homogenate%20to%20produce%20calibration%20curves.%20To%20improve%20precision%20and%20accuracy%2C%20we%20automatically%20remove%20pixels%20outside%20of%20each%20TMA%20well%20and%20investigated%20several%20intensity%20normalizations%2C%20including%20the%20utilization%20of%20a%20second%20stable%20isotope%20internal%20standard%20%28IS%29.%20Chemical%20QuantArray%20enables%20the%20quantification%20of%20several%20endogenous%20metabolites%20over%20a%20wide%20dynamic%20range%20and%20significantly%20improve%20over%20current%20approaches.%20The%20technique%20reduces%20the%20space%20needed%20on%20the%20MALDI%20slides%20for%20calibration%20standards%20by%20approximately%2080%25.%20Furthermore%2C%20removal%20of%20empty%20pixels%20and%20normalization%20to%20an%20internal%20standard%20or%20matrix%20peak%20provided%20precision%20%28%3C20%25%20RSD%29%20and%20accuracy%20%28%3C20%25%20DEV%29.%20Finally%2C%20we%20demonstrate%20the%20applicability%20of%20Chemical%20QuantArray%20by%20quantifying%20multiple%20purine%20metabolites%20in%2014%20clinical%20tumor%20specimens%20using%20a%20single%20MALDI%20slide.%20Chemical%20QuantArray%20improves%20the%20analytical%20characteristics%20and%20practical%20feasibility%20of%20MALDI-MSI%20metabolite%20quantification%20in%20clinical%20and%20translational%20applications.%22%2C%22date%22%3A%222023-08-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.analchem.3c00803%22%2C%22ISSN%22%3A%221520-6882%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A36%3A40Z%22%7D%7D%2C%7B%22key%22%3A%229ZVZ79MS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Sun%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESun%20Y%2C%20Revach%20OY%2C%20Anderson%20S%2C%20Kessler%20EA%2C%20Wolfe%20CH%2C%20Jenney%20A%2C%20Mills%20CE%2C%20Robitschek%20EJ%2C%20Davis%20TGR%2C%20Kim%20S%2C%20Fu%20A%2C%20Ma%20X%2C%20Gwee%20J%2C%20Tiwari%20P%2C%20Du%20PP%2C%20Sindurakar%20P%2C%20Tian%20J%2C%20Mehta%20A%2C%20Schneider%20AM%2C%20Yizhak%20K%2C%20Sade-Feldman%20M%2C%20LaSalle%20T%2C%20Sharova%20T%2C%20Xie%20H%2C%20Liu%20S%2C%20Michaud%20WA%2C%20Saad-Beretta%20R%2C%20Yates%20KB%2C%20Iracheta-Vellve%20A%2C%20Spetz%20JKE%2C%20Qin%20X%2C%20Sarosiek%20KA%2C%20Zhang%20G%2C%20Kim%20JW%2C%20Su%20MY%2C%20Cicerchia%20AM%2C%20Rasmussen%20MQ%2C%20Klempner%20SJ%2C%20Juric%20D%2C%20Pai%20SI%2C%20Miller%20DM%2C%20Giobbie-Hurder%20A%2C%20Chen%20JH%2C%20Pelka%20K%2C%20Frederick%20DT%2C%20Stinson%20S%2C%20Ivanova%20E%2C%20Aref%20AR%2C%20Paweletz%20CP%2C%20Barbie%20DA%2C%20Sen%20DR%2C%20Fisher%20DE%2C%20Corcoran%20RB%2C%20Hacohen%20N%2C%20Sorger%20PK%2C%20Flaherty%20KT%2C%20Boland%20GM%2C%20Manguso%20RT%2C%20Jenkins%20RW.%20Targeting%20TBK1%20to%20overcome%20resistance%20to%20cancer%20immunotherapy.%20Nature.%202023%20Mar%3B615%287950%29%3A158%26%23x2013%3B167.%20PMCID%3A%20PMC10171827%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20TBK1%20to%20overcome%20resistance%20to%20cancer%20immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Or-Yam%22%2C%22lastName%22%3A%22Revach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seth%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20A.%22%2C%22lastName%22%3A%22Kessler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%20H.%22%2C%22lastName%22%3A%22Wolfe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Jenney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20J.%22%2C%22lastName%22%3A%22Robitschek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20G.%20R.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amina%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia%22%2C%22lastName%22%3A%22Gwee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payal%22%2C%22lastName%22%3A%22Tiwari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20P.%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Princy%22%2C%22lastName%22%3A%22Sindurakar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnav%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20M.%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keren%22%2C%22lastName%22%3A%22Yizhak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moshe%22%2C%22lastName%22%3A%22Sade-Feldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22LaSalle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatyana%22%2C%22lastName%22%3A%22Sharova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongyan%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuming%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20A.%22%2C%22lastName%22%3A%22Michaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Saad-Beretta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20B.%22%2C%22lastName%22%3A%22Yates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arvin%22%2C%22lastName%22%3A%22Iracheta-Vellve%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%20K.%20E.%22%2C%22lastName%22%3A%22Spetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Wook%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mack%20Y.%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelina%20M.%22%2C%22lastName%22%3A%22Cicerchia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20Q.%22%2C%22lastName%22%3A%22Rasmussen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20J.%22%2C%22lastName%22%3A%22Klempner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dejan%22%2C%22lastName%22%3A%22Juric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20I.%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Giobbie-Hurder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20H.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karin%22%2C%22lastName%22%3A%22Pelka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennie%20T.%22%2C%22lastName%22%3A%22Frederick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanna%22%2C%22lastName%22%3A%22Stinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Ivanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amir%20R.%22%2C%22lastName%22%3A%22Aref%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cloud%20P.%22%2C%22lastName%22%3A%22Paweletz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debattama%20R.%22%2C%22lastName%22%3A%22Sen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20B.%22%2C%22lastName%22%3A%22Corcoran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nir%22%2C%22lastName%22%3A%22Hacohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M.%22%2C%22lastName%22%3A%22Boland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20T.%22%2C%22lastName%22%3A%22Manguso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20W.%22%2C%22lastName%22%3A%22Jenkins%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20the%5Cu00a0success%20of%20PD-1%20blockade%20in%20melanoma%20and%20other%20cancers%2C%20effective%20treatment%20strategies%20to%20overcome%20resistance%20to%20cancer%20immunotherapy%20are%20lacking1%2C2.%20Here%20we%20identify%20the%20innate%20immune%20kinase%20TANK-binding%20kinase%201%20%28TBK1%293%20as%20a%20candidate%20immune-evasion%20gene%20in%20a%20pooled%20genetic%20screen4.%20Using%20a%20suite%20of%20genetic%20and%20pharmacological%20tools%20across%20multiple%20experimental%20model%20systems%2C%20we%20confirm%20a%20role%20for%20TBK1%20as%20an%20immune-evasion%20gene.%20Targeting%20TBK1%20enhances%20responses%20to%20PD-1%20blockade%20by%20decreasing%20the%20cytotoxicity%20threshold%20to%20effector%20cytokines%20%28TNF%20and%20IFN%5Cu03b3%29.%20TBK1%20inhibition%20in%20combination%20with%20PD-1%20blockade%20also%20demonstrated%20efficacy%20using%20patient-derived%20tumour%20models%2C%20with%20concordant%20findings%20in%20matched%20patient-derived%20organotypic%20tumour%20spheroids%20and%20matched%20patient-derived%20organoids.%20Tumour%20cells%20lacking%20TBK1%20are%20primed%20to%20undergo%20RIPK-%20and%20caspase-dependent%20cell%20death%20in%20response%20to%20TNF%20and%20IFN%5Cu03b3%20in%20a%20JAK-STAT-dependent%20manner.%20Taken%20together%2C%20our%20results%20demonstrate%20that%20targeting%20TBK1%20is%20an%20effective%20strategy%20to%20overcome%20resistance%20to%20cancer%20immunotherapy.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-023-05704-6%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A55%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22BA24MG7V%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Vakulenko-Lagun%20et%20al.%22%2C%22parsedDate%22%3A%222023-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVakulenko-Lagun%20B%2C%20Magdamo%20C%2C%20Charpignon%20ML%2C%20Zheng%20B%2C%20Albers%20MW%2C%20Das%20S.%20causalCmprsk%3A%20an%20R%20package%20for%20nonparametric%20and%20Cox-based%20estimation%20of%20average%20treatment%20effects%20in%20competing%20risks%20data.%20Comput%20Methods%20Programs%20Biomed.%202023%20Dec%3B242%3A107819.%20PMID%3A%2037774426%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22causalCmprsk%3A%20an%20R%20package%20for%20nonparametric%20and%20Cox-based%20estimation%20of%20average%20treatment%20effects%20in%20competing%20risks%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bella%22%2C%22lastName%22%3A%22Vakulenko-Lagun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Magdamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Charpignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bang%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudeshna%22%2C%22lastName%22%3A%22Das%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20AND%20OBJECTIVE%3A%20Competing%20risks%20data%20arise%20in%20both%20observational%20and%20experimental%20clinical%20studies%20with%20time-to-event%20outcomes%2C%20when%20each%20patient%20might%20follow%20one%20of%20the%20multiple%20mutually%20exclusive%20competing%20paths.%20Ignoring%20competing%20risks%20in%20the%20analysis%20can%20result%20in%20biased%20conclusions.%20In%20addition%2C%20possible%20confounding%20bias%20of%20the%20treatment-outcome%20relationship%20has%20to%20be%20addressed%2C%20when%20estimating%20treatment%20effects%20from%20observational%20data.%20In%20order%20to%20provide%20tools%20for%20estimation%20of%20average%20treatment%20effects%20on%20time-to-event%20outcomes%20in%20the%20presence%20of%20competing%20risks%2C%20we%20developed%20the%20R%20package%20causalCmprsk.%20We%20illustrate%20the%20package%20functionality%20in%20the%20estimation%20of%20effects%20of%20a%20right%20heart%20catheterization%20procedure%20on%20discharge%20and%20in-hospital%20death%20from%20observational%20data.%5CnMETHODS%3A%20The%20causalCmprsk%20package%20implements%20an%20inverse%20probability%20weighting%20estimation%20approach%2C%20aiming%20to%20emulate%20baseline%20randomization%20and%20alleviate%20possible%20treatment%20selection%20bias.%20The%20package%20allows%20for%20different%20types%20of%20weights%2C%20representing%20different%20target%20populations.%20causalCmprsk%20builds%20on%20existing%20methods%20from%20survival%20analysis%20and%20adapts%20them%20to%20the%20causal%20analysis%20in%20non-parametric%20and%20semi-parametric%20frameworks.%5CnRESULTS%3A%20The%20causalCmprsk%20package%20has%20two%20main%20functions%3A%20fit.cox%20assumes%20a%20semiparametric%20structural%20Cox%20proportional%20hazards%20model%20for%20the%20counterfactual%20cause-specific%20hazards%2C%20while%20fit.nonpar%20does%20not%20impose%20any%20structural%20assumptions.%20In%20both%20frameworks%2C%20causalCmprsk%20implements%20estimators%20of%20%28i%29%20absolute%20risks%20for%20each%20treatment%20arm%2C%20e.g.%2C%20cumulative%20hazards%20or%20cumulative%20incidence%20functions%2C%20and%20%28ii%29%20relative%20treatment%20effects%2C%20e.g.%2C%20hazard%20ratios%2C%20or%20restricted%20mean%20time%20differences.%20The%20latter%20treatment%20effect%20measure%20translates%20the%20treatment%20effect%20from%20probability%20into%20more%20intuitive%20time%20domain%20and%20allows%20the%20user%20to%20quantify%2C%20for%20example%2C%20by%20how%20many%20days%20or%20months%20the%20treatment%20accelerates%20the%20recovery%20or%20postpones%20illness%20or%20death.%5CnCONCLUSIONS%3A%20The%20causalCmprsk%20package%20provides%20a%20convenient%20and%20useful%20tool%20for%20causal%20analysis%20of%20competing%20risks%20data.%20It%20allows%20the%20user%20to%20distinguish%20between%20different%20causes%20of%20the%20end%20of%20follow-up%20and%20provides%20several%20time-varying%20measures%20of%20treatment%20effects.%20The%20package%20is%20accompanied%20by%20a%20vignette%20that%20contains%20more%20details%2C%20examples%20and%20code%2C%20making%20the%20package%20accessible%20even%20for%20non-expert%20users.%22%2C%22date%22%3A%222023-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmpb.2023.107819%22%2C%22ISSN%22%3A%221872-7565%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A50%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22F7CTV3FA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wan%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWan%20G%2C%20Leung%20B%2C%20Nguyen%20N%2C%20DeSimone%20MS%2C%20Liu%20F%2C%20Choi%20MS%2C%20Ho%20D%2C%20Laucks%20V%2C%20Duey%20S%2C%20Sullivan%20RJ%2C%20Boland%20GM%2C%20LeBoeuf%20NR%2C%20Liu%20D%2C%20Gusev%20A%2C%20Kwatra%20SG%2C%20Sorger%20PK%2C%20Yu%20KH%2C%20Semenov%20YR.%20The%20impact%20of%20stage-related%20features%20in%20melanoma%20recurrence%20prediction%3A%20A%20machine%20learning%20approach.%20JAAD%20Int.%202023%20Mar%3B10%3A28%26%23x2013%3B30.%20PMCID%3A%20PMC9678753%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20impact%20of%20stage-related%20features%20in%20melanoma%20recurrence%20prediction%3A%20A%20machine%20learning%20approach%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guihong%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nga%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mia%20S.%22%2C%22lastName%22%3A%22DeSimone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%20Seok%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diane%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Laucks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacey%22%2C%22lastName%22%3A%22Duey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M.%22%2C%22lastName%22%3A%22Boland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Gusev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20G.%22%2C%22lastName%22%3A%22Kwatra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun-Hsing%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R.%22%2C%22lastName%22%3A%22Semenov%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jdin.2022.08.014%22%2C%22ISSN%22%3A%222666-3287%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-03-22T20%3A35%3A14Z%22%7D%7D%2C%7B%22key%22%3A%225CPN6IGT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wan%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWan%20G%2C%20Leung%20BW%2C%20DeSimone%20MS%2C%20Nguyen%20N%2C%20Rajeh%20A%2C%20Collier%20MR%2C%20Rashdan%20H%2C%20Roster%20K%2C%20Zhou%20X%2C%20Moseley%20CB%2C%20Nirmal%20AJ%2C%20Pelletier%20RJ%2C%20Maliga%20Z%2C%20Marko-Varga%20G%2C%20N%26%23xE9%3Bmeth%20IB%2C%20Tsao%20H%2C%20Asgari%20MM%2C%20Gusev%20A%2C%20Stagner%20AM%2C%20Lian%20CG%2C%20Hurlbert%20MS%2C%20Liu%20F%2C%20Yu%20KH%2C%20Sorger%20PK%2C%20Semenov%20YR.%20Development%20and%20validation%20of%20time-to-event%20models%20to%20predict%20metastatic%20recurrence%20of%20localized%20cutaneous%20melanoma.%20J%20Am%20Acad%20Dermatol.%202023%20Oct%203%3BS0190-9622%2823%2902881%26%23x2013%3B5.%20PMID%3A%2037797836%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20and%20validation%20of%20time-to-event%20models%20to%20predict%20metastatic%20recurrence%20of%20localized%20cutaneous%20melanoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guihong%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%20W.%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mia%20S.%22%2C%22lastName%22%3A%22DeSimone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nga%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%22%2C%22lastName%22%3A%22Rajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22Collier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%22%2C%22lastName%22%3A%22Rashdan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katie%22%2C%22lastName%22%3A%22Roster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xu%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20B.%22%2C%22lastName%22%3A%22Moseley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%20J.%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gyorgy%22%2C%22lastName%22%3A%22Marko-Varga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Istv%5Cu00e1n%20Bal%5Cu00e1zs%22%2C%22lastName%22%3A%22N%5Cu00e9meth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hensin%22%2C%22lastName%22%3A%22Tsao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryam%20M.%22%2C%22lastName%22%3A%22Asgari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Gusev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Stagner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20S.%22%2C%22lastName%22%3A%22Hurlbert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun-Hsing%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R.%22%2C%22lastName%22%3A%22Semenov%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20recent%20expansion%20of%20immunotherapy%20for%20stage%20IIB%5C%2FIIC%20melanoma%20highlights%20a%20growing%20clinical%20need%20to%20identify%20patients%20at%20high%20risk%20of%20metastatic%20recurrence%20and%2C%20therefore%2C%20most%20likely%20to%20benefit%20from%20this%20therapeutic%20modality.%5CnOBJECTIVE%3A%20To%20develop%20time-to-event%20risk%20prediction%20models%20for%20melanoma%20metastatic%20recurrence.%5CnMETHODS%3A%20Patients%20diagnosed%20with%20stage%20I%5C%2FII%20primary%20cutaneous%20melanoma%20between%202000%20and%202020%20at%20Mass%20General%20Brigham%20and%20Dana-Farber%20Cancer%20Institute%20were%20included.%20Melanoma%20recurrence%20date%20and%20type%20were%20determined%20by%20chart%20review.%20Thirty%20clinicopathologic%20factors%20were%20extracted%20from%20electronic%20health%20records.%20Three%20types%20of%20time-to-event%20machine-learning%20models%20were%20evaluated%20internally%20and%20externally%20in%20the%20distant%20versus%20locoregional%5C%2Fnon-recurrence%20prediction.%5CnRESULTS%3A%20This%20study%20included%20954%20melanomas%20%28155%20distant%2C%20163%20locoregional%2C%20and%20636%201%3A2%20matched%20non-recurrences%29.%20Distant%20recurrences%20were%20associated%20with%20worse%20survival%20compared%20to%20locoregional%5C%2Fnon-recurrences%20%28HR%3A%206.21%2C%20p%3C0.001%29%20and%20to%20locoregional%20recurrences%20only%20%28HR%3A%205.79%2C%20p%3C0.001%29.%20The%20Gradient%20Boosting%20Survival%20model%20achieved%20the%20best%20performance%20%28concordance%20index%3A%200.816%3B%20time-dependent%20AUC%3A%200.842%3B%20Brier%20score%3A%200.103%29%20in%20the%20external%20validation.%5CnLIMITATIONS%3A%20Retrospective%20nature%20and%20cohort%20from%20one%20geography.%5CnCONCLUSIONS%3A%20These%20results%20suggest%20that%20time-to-event%20machine-learning%20models%20can%20reliably%20predict%20the%20metastatic%20recurrence%20from%20localized%20melanoma%20and%20help%20identify%20high-risk%20patients%20who%20are%20most%20likely%20to%20benefit%20from%20immunotherapy.%22%2C%22date%22%3A%222023-10-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaad.2023.08.105%22%2C%22ISSN%22%3A%221097-6787%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T15%3A06%3A09Z%22%7D%7D%5D%7D
1.
Aguilar F, Yu S, Grant RA, Swanson S, Ghose D, Su BG, Sarosiek KA, Keating AE. Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization. Structure. 2023 Mar 2;31(3):265-281.e7. PMCID: PMC9992319
1.
Ahdritz G, Bouatta N, Kadyan S, Jarosch L, Berenberg D, Fisk I, Watkins AM, Ra S, Bonneau R, AlQuraishi M. OpenProteinSet: training data for structural biology at scale [Internet]. arXiv; 2023 [cited 2023 Oct 31]. Available from: https://arxiv.org/abs/2308.05326
1.
Bachman JA, Gyori BM, Sorger PK. Automated assembly of molecular mechanisms at scale from text mining and curated databases. Mol Syst Biol. 2023 May 9;19(5):e11325. PMCID: PMC10167483
1.
Baker GJ, Novikov E, Zhao Z, Vallius T, Davis JA, Lin JR, Muhlich JL, Mittendorf EA, Santagata S, Guerriero JL, Sorger PK. Quality Control for Single Cell Analysis of High-plex Tissue Profiles using CyLinter. bioRxiv; 2023. PMCID: PMC10634977
1.
Bergholz JS, Wang Q, Wang Q, Ramseier M, Prakadan S, Wang W, Fang R, Kabraji S, Zhou Q, Gray GK, Abell-Hart K, Xie S, Guo X, Gu H, Von T, Jiang T, Tang S, Freeman GJ, Kim HJ, Shalek AK, Roberts TM, Zhao JJ. PI3Kβ controls immune evasion in PTEN-deficient breast tumours. Nature. 2023 May;617(7959):139–146. PMCID: PMC10494520
1.
Bouatta N, AlQuraishi M. Structural biology at the scale of proteomes. Nat Struct Mol Biol. 2023 Feb;30(2):129–130. PMCID: PMC10389299
1.
Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG, Galanis E. Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations. J Clin Oncol. 2023 Jan 20;41(3):618–628. PMCID: PMC9870228
1.
Brastianos PK, Twohy E, Geyer S, Gerstner ER, Kaufmann TJ, Tabrizi S, Kabat B, Thierauf J, Ruff MW, Bota DA, Reardon DA, Cohen AL, De La Fuente MI, Lesser GJ, Campian J, Agarwalla PK, Kumthekar P, Mann B, Vora S, Knopp M, Iafrate AJ, Curry WT, Cahill DP, Shih HA, Brown PD, Santagata S, Barker FG, Galanis E. BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023 Jul 13;389(2):118–126. PMCID: PMC10464854
1.
Burlingame E, Ternes L, Lin JR, Chen YA, Kim EN, Gray JW, Chang YH. 3D multiplexed tissue imaging reconstruction and optimized region of interest (ROI) selection through deep learning model of channels embedding. Front Bioinform. 2023;3:1275402. PMCID: PMC10620917
1.
Cello G, Patel RV, McMahon JT, Santagata S, Bi WL. Impact of H3K27 trimethylation loss in meningiomas: a meta-analysis. Acta Neuropathol Commun. 2023 Jul 25;11(1):122. PMCID: PMC10369842
1.
Chen JY, Hug C, Reyes J, Tian C, Gerosa L, Fröhlich F, Ponsioen B, Snippert HJG, Spencer SL, Jambhekar A, Sorger PK, Lahav G. Multi-range ERK responses shape the proliferative trajectory of single cells following oncogene induction. Cell Rep. 2023 Mar 28;42(3):112252. PMCID: PMC10153468
1.
Chen WC, Choudhury A, Youngblood MW, Polley MYC, Lucas CHG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JKS, Li LF, Leung GKK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023 Dec;29(12):3067–3076. PMID: 37944590
1.
Choudhury A, Chen WC, Lucas CHG, Bayley JC, Harmanci AS, Maas SLN, Santagata S, Klisch T, Perry A, Bi WL, Sahm F, Patel AJ, Magill ST, Raleigh DR. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol. 2023 Mar 14;25(3):520–530. PMCID: PMC10013643
1.
Coy S, Cheng B, Lee JS, Rashid R, Browning L, Xu Y, Chakrabarty SS, Yapp C, Chan S, Tefft JB, Scott E, Spektor A, Ligon KL, Baker GJ, Pellman D, Sorger PK, Santagata S. 2D and 3D multiplexed subcellular profiling of nuclear instability in human cancer. bioRxiv; 2023. PMCID: PMC10659270
1.
Creason AL, Egger J, Watson C, Sivagnanam S, Chin K, MacPherson K, Lin JR, Chen YA, Johnson BE, Feiler HS, Galipeau D, Navin NE, Demir E, Chang YH, Corless CL, Mitri ZI, Sorger PK, Thomas GV, Coussens LM, Adey AC, Gray JW, Mills GB, Goecks J. Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers [Internet]. bioRxiv; 2023 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/2023.09.27.557464
1.
Díez Menéndez C, Poczai P, Williams B, Myllys L, Amiryousefi A. IRplus: an augmented tool to detect inverted repeats in plastid genomes. Genome Biol Evol. 2023 Oct 6;15(10):evad177. PMCID: PMC10581538
1.
Driver J, Santagata S, Bi WL, Chi JH. Genomic analysis of spinal meningiomas: correlation with histopathological grade. J Neurosurg Spine. 2023 Aug 25;1–5. PMID: 37728381
1.
Dulberger CL, Guerrero-Bustamante CA, Owen SV, Wilson S, Wuo MG, Garlena RA, Serpa LA, Russell DA, Zhu J, Braunecker BJ, Squyres GR, Baym M, Kiessling LL, Garner EC, Rubin EJ, Hatfull GF. Mycobacterial nucleoid-associated protein Lsr2 is required for productive mycobacteriophage infection. Nat Microbiol. 2023 Apr;8(4):695–710. PMCID: PMC10066036
1.
Fröhlich F, Gerosa L, Muhlich J, Sorger PK. Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. Mol Syst Biol. 2023 Feb 10;19(2):e10988. PMCID: PMC9912026
1.
Gaglia G, Burger ML, Ritch CC, Rammos D, Dai Y, Crossland GE, Tavana SZ, Warchol S, Jaeger AM, Naranjo S, Coy S, Nirmal AJ, Krueger R, Lin JR, Pfister H, Sorger PK, Jacks T, Santagata S. Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma. Cancer Cell. 2023 May 8;41(5):871-886.e10. PMCID: PMC10193529
1.
Ghosh HS, Patel RV, Woodward E, Greenwald NF, Bhave VM, Maury EA, Cello G, Hoffman SE, Li Y, Gupta H, Spurr LF, Vogelzang J, Touat M, Dubois F, Cherniack AD, Guo X, Tavakol S, Cioffi G, Lindeman NI, Ligon AH, Chiocca EA, Reardon DA, Wen PY, Meredith D, Santagata S, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Bi WL. Molecular landscape and contemporary prognostic signatures of gliomas [Internet]. medRxiv; 2023 [cited 2023 Oct 3]. Available from: http://medrxiv.org/lookup/doi/10.1101/2023.09.09.23295096
1.
Gray GK, Girnius N, Kuiken HJ, Henstridge AZ, Brugge JS. Single-cell and spatial analyses reveal a tradeoff between murine mammary proliferation and lineage programs associated with endocrine cues. Cell Rep. 2023 Oct 31;42(10):113293. PMCID: PMC10840493
1.
Hermida-Prado F, Xie Y, Sherman S, Nagy Z, Russo D, Akhshi T, Chu Z, Feit A, Campisi M, Chen M, Nardone A, Guarducci C, Lim K, Font-Tello A, Lee I, García-Pedrero J, Cañadas I, Agudo J, Huang Y, Sella T, Jin Q, Tayob N, Mittendorf EA, Tolaney SM, Qiu X, Long H, Symmans WF, Lin JR, Santagata S, Bedrosian I, Yardley DA, Mayer IA, Richardson ET, Oliveira G, Wu CJ, Schuster EF, Dowsett M, Welm AL, Barbie D, Metzger O, Jeselsohn R. Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer Res. 2023 Oct 2;83(19):3284–3304. PMCID: PMC10543960
1.
Hoyt CT, Zdrazil B, Guha R, Jeliazkova N, Martinez-Mayorga K, Nittinger E. Improving reproducibility and reusability in the Journal of Cheminformatics. J Cheminform. 2023 Jun 30;15(1):62. PMCID: PMC10314397
1.
Hoyt CT, Hoyt AL, Gyori BM. Prediction and curation of missing biomedical identifier mappings with Biomappings. Bioinformatics. 2023 Apr 3;39(4):btad130. PMCID: PMC10076045
1.
Iorgulescu JB, Ruthen N, Ahn R, Panagioti E, Gokhale PC, Neagu M, Speranza MC, Eschle BK, Soroko KM, Piranlioglu R, Datta M, Krishnan S, Yates KB, Baker GJ, Jain RK, Suvà ML, Neuberg D, White FM, Chiocca EA, Freeman GJ, Sharpe AH, Wu CJ, Reardon DA. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Front Immunol. 2023;14:1297932. PMCID: PMC10782385
1.
Kalocsay M, Berberich MJ, Everley RA, Nariya MK, Chung M, Gaudio B, Victor C, Bradshaw GA, Eisert RJ, Hafner M, Sorger PK, Mills CE, Subramanian K. Proteomic profiling across breast cancer cell lines and models. Sci Data. 2023 Aug 4;10(1):514. PMCID: PMC10403526
1.
Kurmi K, Liang D, van de Ven R, Georgiev P, Gassaway BM, Han S, Notarangelo G, Harris IS, Yao CH, Park JS, Hu SH, Peng J, Drijvers JM, Boswell S, Sokolov A, Dougan SK, Sorger PK, Gygi SP, Sharpe AH, Haigis MC. Metabolic modulation of mitochondrial mass during CD4+ T cell activation. Cell Chem Biol. 2023 Sep 21;30(9):1064-1075.e8. PMCID: PMC10604707
1.
Lecky E, Mukherji A, German R, Antonellis G, Lin JR, Yorsz M, McQueeney KE, Ryan J, Ng K, Sicinska E, Sorger PK, Letai A, Bhola PD. Sequential apoptotic and multiplexed proteomic evaluation of single cancer cells. Sci Adv. 2023 Jun 23;9(25):eadg4128. PMCID: PMC10289660
1.
Limdi A, Baym M. Resolving deleterious and near-neutral effects requires different pooled fitness assay designs. J Mol Evol. 2023 Jun;91(3):325–333. PMID: 37160452
1.
Lin JR, Wang S, Coy S, Chen YA, Yapp C, Tyler M, Nariya MK, Heiser CN, Lau KS, Santagata S, Sorger PK. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer. Cell. 2023 Jan 19;186(2):363-381.e19. PMCID: PMC10019067
1.
Lin JR, Chen YA, Campton D, Cooper J, Coy S, Yapp C, Tefft JB, McCarty E, Ligon KL, Rodig SJ, Reese S, George T, Santagata S, Sorger PK. High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers. Nat Cancer. 2023 Jul;4(7):1036–1052. PMCID: PMC10368530
1.
Liu C, Kutchukian P, Nguyen ND, AlQuraishi M, Sorger PK. A hybrid structure-based machine learning approach for predicting kinase inhibition by small molecules. J Chem Inf Model. 2023 Sep 11;63(17):5457–5472. PMCID: PMC10498990
1.
Lobentanzer S, Aloy P, Baumbach J, Bohar B, Carey VJ, Charoentong P, Danhauser K, Doğan T, Dreo J, Dunham I, Farr E, Fernandez-Torras A, Gyori BM, Hartung M, Hoyt CT, Klein C, Korcsmaros T, Maier A, Mann M, Ochoa D, Pareja-Lorente E, Popp F, Preusse M, Probul N, Schwikowski B, Sen B, Strauss MT, Turei D, Ulusoy E, Waltemath D, Wodke JAH, Saez-Rodriguez J. Democratizing knowledge representation with BioCypher. Nat Biotechnol. 2023 Jun 19; PMID: 37337100
1.
Martin AP, Bradshaw GA, Eisert RJ, Egan ED, Tveriakhina L, Rogers JM, Dates AN, Scanavachi G, Aster JC, Kirchhausen T, Kalocsay M, Blacklow SC. A spatiotemporal Notch interaction map from plasma membrane to nucleus. Sci Signal. 2023 Aug;16(796):eadg6474. PMCID: PMC10560377
1.
Mohammad-Taheri S, Tewari V, Kapre R, Rahiminasab E, Sachs K, Taply Hoyt C, Zucker J, Vitek O. Optimal adjustment sets for causal query estimation in partially observed biomolecular networks. Bioinformatics. 2023 Jun 30;39(39 Suppl 1):i494–i503. PMCID: PMC10311316
1.
Nariya MK, Mills CE, Sorger PK, Sokolov A. Paired evaluation of machine-learning models characterizes effects of confounders and outliers. Patterns (N Y). 2023 Aug 11;4(8):100791. PMCID: PMC10435952
1.
Netterfield TS, Ostheimer GJ, Tentner AR, Joughin BA, Dakoyannis AM, Sharma CD, Sorger PK, Janes KA, Lauffenburger DA, Yaffe MB. Biphasic JNK-Erk signaling separates the induction and maintenance of cell senescence after DNA damage induced by topoisomerase II inhibition. Cell Syst. 2023 Jul 19;14(7):582-604.e10. PMID: 37473730
1.
Nirmal AJ, Yapp C, Santagata S, Sorger PK. Cell Spotter (CSPOT): a machine-learning approach to automated cell spotting and quantification of highly multiplexed tissue images [Internet]. bioRxiv; 2023 [cited 2023 Dec 15]. Available from: http://biorxiv.org/lookup/doi/10.1101/2023.11.15.567196 PMCID: PMC10680730
1.
Nyerges A, Vinke S, Flynn R, Owen SV, Rand EA, Budnik B, Keen E, Narasimhan K, Marchand JA, Baas-Thomas M, Liu M, Chen K, Chiappino-Pepe A, Hu F, Baym M, Church GM. A swapped genetic code prevents viral infections and gene transfer. Nature. 2023 Mar;615(7953):720–727. PMCID: PMC10151025
1.
Perurena N, Lock R, Davis RA, Raghavan S, Pilla NF, Ng R, Loi P, Guild CJ, Miller AL, Sicinska E, Cleary JM, Rubinson DA, Wolpin BM, Gray NS, Santagata S, Hahn WC, Morton JP, Sansom OJ, Aguirre AJ, Cichowski K. USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities. Cell Rep Med. 2023 Apr 18;4(4):101007. PMCID: PMC10140597
1.
Pillich RT, Chen J, Churas C, Fong D, Gyori BM, Ideker T, Karis K, Liu SN, Ono K, Pico A, Pratt D. NDEx IQuery: a multi-method network gene set analysis leveraging the Network Data Exchange. Bioinformatics. 2023 Mar 1;39(3):btad118. PMCID: PMC10023220
1.
Prabhakaran S, Yapp C, Baker GJ, Beyer J, Chang YH, Creason AL, Krueger R, Muhlich J, Patterson NH, Sidak K, Sudar D, Taylor AJ, Ternes L, Troidl J, Xie Y, Sokolov A, Tyson DR, the Cell Imaging Hackathon 2022 Participants (Alphabetical authorship, apart from primary contributors). Addressing persistent challenges in digital image analysis of cancerous tissues [Internet]. bioRxiv; 2023 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/2023.07.21.548450
1.
Rahman R, Trippa L, Lee EQ, Arrillaga-Romany I, Fell G, Touat M, McCluskey C, Wiley J, Gaffey S, Drappatz J, Welch MR, Galanis E, Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D, Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR, Batchelor TT, Rinne ML, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL, Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Cagney D, Aizer A, Doherty L, Lavallee M, Fisher-Longden B, Dowling S, Geduldig J, Watkinson F, Pisano W, Malinowski S, Ramkissoon S, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Alexander BM, Ligon KL, Wen PY. Inaugural results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: a phase II platform trial for newly diagnosed glioblastoma using Bayesian adaptive randomization. J Clin Oncol. 2023 Dec 20;41(36):5524–5535. PMID: 37722087
1.
Smith NP, Yan Y, Pan Y, Williams JB, Manakongtreecheep K, Pant S, Zhao J, Tian T, Pan T, Stingley C, Wu K, Zhang J, Kley AL, Sorger PK, Villani AC, Kupper TS. Resident memory T cell development is associated with AP-1 transcription factor upregulation across anatomical niches [Internet]. bioRxiv; 2023 [cited 2023 Nov 13]. Available from: http://biorxiv.org/lookup/doi/10.1101/2023.09.29.560006
1.
Stopka SA, Ruiz D, Baquer G, Bodineau C, Hossain MA, Pellens VT, Regan MS, Pourquié O, Haigis MC, Bi WL, Coy SM, Santagata S, Agar NYR, Basu SS. Chemical QuantArray: a quantitative tool for mass spectrometry imaging. Anal Chem. 2023 Aug 1;95(30):11243–11253. PMCID: PMC10445330
1.
Sun Y, Revach OY, Anderson S, Kessler EA, Wolfe CH, Jenney A, Mills CE, Robitschek EJ, Davis TGR, Kim S, Fu A, Ma X, Gwee J, Tiwari P, Du PP, Sindurakar P, Tian J, Mehta A, Schneider AM, Yizhak K, Sade-Feldman M, LaSalle T, Sharova T, Xie H, Liu S, Michaud WA, Saad-Beretta R, Yates KB, Iracheta-Vellve A, Spetz JKE, Qin X, Sarosiek KA, Zhang G, Kim JW, Su MY, Cicerchia AM, Rasmussen MQ, Klempner SJ, Juric D, Pai SI, Miller DM, Giobbie-Hurder A, Chen JH, Pelka K, Frederick DT, Stinson S, Ivanova E, Aref AR, Paweletz CP, Barbie DA, Sen DR, Fisher DE, Corcoran RB, Hacohen N, Sorger PK, Flaherty KT, Boland GM, Manguso RT, Jenkins RW. Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature. 2023 Mar;615(7950):158–167. PMCID: PMC10171827
1.
Vakulenko-Lagun B, Magdamo C, Charpignon ML, Zheng B, Albers MW, Das S. causalCmprsk: an R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data. Comput Methods Programs Biomed. 2023 Dec;242:107819. PMID: 37774426
1.
Wan G, Leung B, Nguyen N, DeSimone MS, Liu F, Choi MS, Ho D, Laucks V, Duey S, Sullivan RJ, Boland GM, LeBoeuf NR, Liu D, Gusev A, Kwatra SG, Sorger PK, Yu KH, Semenov YR. The impact of stage-related features in melanoma recurrence prediction: A machine learning approach. JAAD Int. 2023 Mar;10:28–30. PMCID: PMC9678753
1.
Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2023 Oct 3;S0190-9622(23)02881–5. PMID: 37797836
2576724
IXMHRBF6
LSP Paper
2022
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22PY2H7LRJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Anderson%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAnderson%20AC%2C%20Yanai%20I%2C%20Yates%20LR%2C%20Wang%20L%2C%20Swarbrick%20A%2C%20Sorger%20P%2C%20Santagata%20S%2C%20Fridman%20WH%2C%20Gao%20Q%2C%20Jerby%20L%2C%20Izar%20B%2C%20Shang%20L%2C%20Zhou%20X.%20Spatial%20transcriptomics.%20Cancer%20Cell.%202022%20Sep%2012%3B40%289%29%3A895%26%23x2013%3B900.%20PMID%3A%2036099884%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spatial%20transcriptomics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20C.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itai%22%2C%22lastName%22%3A%22Yanai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%20R.%22%2C%22lastName%22%3A%22Yates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linghua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Swarbrick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wolf%20H.%22%2C%22lastName%22%3A%22Fridman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiang%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Livnat%22%2C%22lastName%22%3A%22Jerby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lulu%22%2C%22lastName%22%3A%22Shang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Zhou%22%7D%5D%2C%22abstractNote%22%3A%22Spatial%20transcriptomics%2C%20with%20other%20spatial%20technologies%2C%20has%20enabled%20scientists%20to%20dissect%20the%20organization%20and%20interaction%20of%20different%20cell%20types%20within%20the%20tumor%20microenvironment.%20We%20asked%20experts%20to%20discuss%20some%20aspects%20of%20this%20technology%20from%20revealing%20the%20tumor%20microenvironment%20and%20heterogeneity%2C%20to%20tracking%20tumor%20evolution%2C%20to%20guiding%20tumor%20therapy%2C%20to%20current%20technical%20challenges.%22%2C%22date%22%3A%222022-09-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2022.08.021%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A20%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22LLGINLEN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balabin%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBalabin%20H%2C%20Hoyt%20CT%2C%20Birkenbihl%20C%2C%20Gyori%20BM%2C%20Bachman%20J%2C%20Kodamullil%20AT%2C%20Pl%26%23xF6%3Bger%20PG%2C%20Hofmann-Apitius%20M%2C%20Domingo-Fern%26%23xE1%3Bndez%20D.%20STonKGs%3A%20a%20sophisticated%20transformer%20trained%20on%20biomedical%20text%20and%20knowledge%20graphs.%20Bioinformatics.%202022%20Mar%204%3B38%286%29%3A1648%26%23x2013%3B1656.%20PMCID%3A%20PMC8896635%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22STonKGs%3A%20a%20sophisticated%20transformer%20trained%20on%20biomedical%20text%20and%20knowledge%20graphs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Balabin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Birkenbihl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alpha%20Tom%22%2C%22lastName%22%3A%22Kodamullil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20G.%22%2C%22lastName%22%3A%22Pl%5Cu00f6ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Hofmann-Apitius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Domingo-Fern%5Cu00e1ndez%22%7D%5D%2C%22abstractNote%22%3A%22MOTIVATION%3A%20The%20majority%20of%20biomedical%20knowledge%20is%20stored%20in%20structured%20databases%20or%20as%20unstructured%20text%20in%20scientific%20publications.%20This%20vast%20amount%20of%20information%20has%20led%20to%20numerous%20machine%20learning-based%20biological%20applications%20using%20either%20text%20through%20natural%20language%20processing%20%28NLP%29%20or%20structured%20data%20through%20knowledge%20graph%20embedding%20models.%20However%2C%20representations%20based%20on%20a%20single%20modality%20are%20inherently%20limited.%5CnRESULTS%3A%20To%20generate%20better%20representations%20of%20biological%20knowledge%2C%20we%20propose%20STonKGs%2C%20a%20Sophisticated%20Transformer%20trained%20on%20biomedical%20text%20and%20Knowledge%20Graphs%20%28KGs%29.%20This%20multimodal%20Transformer%20uses%20combined%20input%20sequences%20of%20structured%20information%20from%20KGs%20and%20unstructured%20text%20data%20from%20biomedical%20literature%20to%20learn%20joint%20representations%20in%20a%20shared%20embedding%20space.%20First%2C%20we%20pre-trained%20STonKGs%20on%20a%20knowledge%20base%20assembled%20by%20the%20Integrated%20Network%20and%20Dynamical%20Reasoning%20Assembler%20consisting%20of%20millions%20of%20text-triple%20pairs%20extracted%20from%20biomedical%20literature%20by%20multiple%20NLP%20systems.%20Then%2C%20we%20benchmarked%20STonKGs%20against%20three%20baseline%20models%20trained%20on%20either%20one%20of%20the%20modalities%20%28i.e.%20text%20or%20KG%29%20across%20eight%20different%20classification%20tasks%2C%20each%20corresponding%20to%20a%20different%20biological%20application.%20Our%20results%20demonstrate%20that%20STonKGs%20outperforms%20both%20baselines%2C%20especially%20on%20the%20more%20challenging%20tasks%20with%20respect%20to%20the%20number%20of%20classes%2C%20improving%20upon%20the%20F1-score%20of%20the%20best%20baseline%20by%20up%20to%200.084%20%28i.e.%20from%200.881%20to%200.965%29.%20Finally%2C%20our%20pre-trained%20model%20as%20well%20as%20the%20model%20architecture%20can%20be%20adapted%20to%20various%20other%20transfer%20learning%20applications.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20We%20make%20the%20source%20code%20and%20the%20Python%20package%20of%20STonKGs%20available%20at%20GitHub%20%28https%3A%5C%2F%5C%2Fgithub.com%5C%2Fstonkgs%5C%2Fstonkgs%29%20and%20PyPI%20%28https%3A%5C%2F%5C%2Fpypi.org%5C%2Fproject%5C%2Fstonkgs%5C%2F%29.%20The%20pre-trained%20STonKGs%20models%20and%20the%20task-specific%20classification%20models%20are%20respectively%20available%20at%20https%3A%5C%2F%5C%2Fhuggingface.co%5C%2Fstonkgs%5C%2Fstonkgs-150k%20and%20https%3A%5C%2F%5C%2Fzenodo.org%5C%2Fcommunities%5C%2Fstonkgs.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20online.%22%2C%22date%22%3A%222022-03-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtac001%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-02-07T15%3A34%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22ZWS8UWQ7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bi%20and%20Santagata%22%2C%22parsedDate%22%3A%222022-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBi%20WL%2C%20Santagata%20S.%20Skull%20base%20tumors%3A%20neuropathology%20and%20clinical%20implications.%20Neurosurgery.%202022%20Mar%201%3B90%283%29%3A243%26%23x2013%3B261.%20PMID%3A%2034164689%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Skull%20base%20tumors%3A%20neuropathology%20and%20clinical%20implications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Tumors%20that%20arise%20in%20and%20around%20the%20skull%20base%20comprise%20a%20wide%20range%20of%20common%20and%20rare%20entities.%20Recent%20studies%20have%20advanced%20our%20understanding%20of%20their%20pathogenesis%2C%20which%20in%20some%20cases%2C%20have%20significantly%20influenced%20clinical%20practice.%20The%20genotype%20of%20meningiomas%20is%20strongly%20associated%20with%20their%20phenotype%2C%20including%20histologic%20subtype%20and%20tumor%20location%2C%20and%20clinical%20outcome.%20A%20single%20molecular%20alteration%2C%20NAB2-STAT6%20fusion%2C%20has%20redefined%20the%20category%20of%20solitary%20fibrous%20tumors%20to%20include%20the%20previous%20entity%20hemangiopericytomas.%20Schwannomas%2C%20both%20sporadic%20and%20familial%2C%20are%20characterized%20by%20near%20ubiquitous%20alterations%20in%20NF2%20%2C%20with%20additional%20mutations%20in%20SMARCB1%20or%20LZTR1%20in%20schwannomatosis.%20In%20pituitary%20adenohypophyseal%20tumors%2C%20cell%20lineage%20transcription%20factors%20such%20as%20SF-1%2C%20T-PIT%2C%20and%20PIT-1%20are%20now%20essential%20for%20classification%2C%20providing%20a%20more%20rigorous%20taxonomy%20for%20tumors%20that%20were%20previously%20considered%20null%20cell%20adenomas.%20The%20pituicyte%20lineage%20transcription%20factor%20TTF-1%20defines%20neurohypophyseal%20tumors%2C%20which%20may%20represent%20a%20single%20nosological%20entity%20with%20a%20spectrum%20of%20morphologic%20manifestations%20%28ie%2C%20granular%20cell%20tumor%2C%20pituicytoma%2C%20and%20spindle%20cell%20oncocytoma%29.%20Likewise%2C%20the%20notochord%20cell%20lineage%20transcription%20factor%20brachyury%20defines%20chordoma%2C%20discriminating%20them%20from%20chondrosarcomas.%20The%20identification%20of%20nonoverlapping%20genetic%20drivers%20of%20adamantinomatous%20craniopharyngiomas%20and%20papillary%20craniopharyngiomas%20indicates%20that%20these%20are%20distinct%20tumor%20entities%20and%20has%20led%20to%20successful%20targeted%20treatment%20of%20papillary%20craniopharyngiomas%20using%20BRAF%20and%5C%2For%20mitogen-activated%20protein%20kinase%20inhibitors.%20Similarly%2C%20dramatic%20therapeutic%20responses%20have%20been%20achieved%20in%20patients%20with%20Langerhans%20cell%20histiocytosis%2C%20both%20with%20BRAF%20-mutant%20and%20BRAF%20-wildtype%20tumors.%20Familiarity%20with%20the%20pathology%20of%20skull%20base%20tumors%2C%20their%20natural%20history%2C%20and%20molecular%20features%20is%20essential%20for%20optimizing%20patient%20care.%22%2C%22date%22%3A%222022-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuros%5C%2Fnyab209%22%2C%22ISSN%22%3A%221524-4040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A21%3A11Z%22%7D%7D%2C%7B%22key%22%3A%2254U4RR6F%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bi%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-05%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBi%20WL%2C%20Nayak%20L%2C%20Meredith%20DM%2C%20Driver%20J%2C%20Du%20Z%2C%20Hoffman%20S%2C%20Li%20Y%2C%20Lee%20EQ%2C%20Beroukhim%20R%2C%20Rinne%20M%2C%20McFaline-Figueroa%20R%2C%20Chukwueke%20U%2C%20McCluskey%20C%2C%20Gaffey%20S%2C%20Cherniack%20AD%2C%20Stefanik%20J%2C%20Doherty%20L%2C%20Taubert%20C%2C%20Cifrino%20M%2C%20LaFrankie%20D%2C%20Graillon%20T%2C%20Wen%20PY%2C%20Ligon%20KL%2C%20Al-Mefty%20O%2C%20Huang%20RY%2C%20Muzikansky%20A%2C%20Chiocca%20EA%2C%20Santagata%20S%2C%20Dunn%20IF%2C%20Reardon%20DA.%20Activity%20of%20PD-1%20blockade%20with%20nivolumab%20among%20patients%20with%20recurrent%20atypical%5C%2Fanaplastic%20meningioma%3A%20phase%20II%20trial%20results.%20Neuro%20Oncol.%202022%20Jan%205%3B24%281%29%3A101%26%23x2013%3B113.%20PMCID%3A%20PMC8730772%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Activity%20of%20PD-1%20blockade%20with%20nivolumab%20among%20patients%20with%20recurrent%20atypical%5C%2Fanaplastic%20meningioma%3A%20phase%20II%20trial%20results%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakshmi%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Driver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Quant%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikael%22%2C%22lastName%22%3A%22Rinne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%22%2C%22lastName%22%3A%22McFaline-Figueroa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugonma%22%2C%22lastName%22%3A%22Chukwueke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22McCluskey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Gaffey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Cherniack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Stefanik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%22%2C%22lastName%22%3A%22Taubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meghan%22%2C%22lastName%22%3A%22Cifrino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22LaFrankie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Graillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ossama%22%2C%22lastName%22%3A%22Al-Mefty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20Y.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alona%22%2C%22lastName%22%3A%22Muzikansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20F.%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Programmed%20death%20ligand%201%20%28PD-L1%29%20contributes%20to%20tumor%20immunosuppression%20and%20is%20upregulated%20in%20aggressive%20meningiomas.%20We%20performed%20a%20phase%20II%20study%20of%20nivolumab%2C%20a%20programmed%20death%201%20%28PD-1%29%20blocking%20antibody%20among%20patients%20with%20grade%20%5Cu22652%20meningioma%20that%20recurred%20after%20surgery%20and%20radiation%20therapy.%5CnMETHODS%3A%20Twenty-five%20patients%20received%20nivolumab%20%28240%20mg%20biweekly%29%20until%20progression%2C%20voluntary%20withdrawal%2C%20unacceptable%20toxicity%2C%20or%20death.%20Tumor%20mutational%20burden%20%28TMB%29%20and%20quantification%20of%20tumor-infiltrating%20lymphocytes%20%28TIL%29%20were%20evaluated%20as%20potential%20immunocorrelative%20biomarkers.%20Change%20in%20neurologic%20function%20was%20prospectively%20assessed%20using%20the%20Neurologic%20Assessment%20in%20Neuro-Oncology%20%28NANO%29%20scale.%5CnRESULTS%3A%20Enrolled%20patients%20had%20multiple%20recurrences%20including%20%5Cu22653%20prior%20surgeries%20and%20%5Cu22652%20prior%20courses%20of%20radiation%20in%2060%25%20and%2072%25%2C%20respectively.%20Nivolumab%20was%20well%20tolerated%20with%20no%20unexpected%20adverse%20events.%20Six-month%20progression-free%20survival%20%28PFS-6%29%20rate%20was%2042.4%25%20%2895%25%20CI%3A%2022.8%2C%2060.7%29%20and%20the%20median%20OS%20was%2030.9%20months%20%2895%25%20CI%3A%2017.6%2C%20NA%29.%20One%20patient%20achieved%20radiographic%20response%20%28ongoing%20at%204.5%20years%29.%20TMB%20was%20%3E10%5C%2FMb%20in%202%20of%2015%20profiled%20tumors%20%2813.3%25%29.%20Baseline%20TIL%20density%20was%20low%20but%20increased%20posttreatment%20in%203%20patients%20including%20both%20patients%20with%20elevated%20TMB.%20Most%20patients%20who%20achieved%20PFS-6%20maintained%20neurologic%20function%20prior%20to%20progression%20as%20assessed%20by%20NANO.%5CnCONCLUSION%3A%20Nivolumab%20was%20well%20tolerated%20but%20failed%20to%20improve%20PFS-6%2C%20although%20a%20subset%20of%20patients%20appeared%20to%20derive%20benefit.%20Low%20levels%20of%20TMB%20and%20TIL%20density%20were%20typically%20observed.%20NANO%20assessment%20of%20neurologic%20function%20contributed%20to%20outcome%20assessment.%20Future%20studies%20may%20consider%20rationally%20designed%20combinatorial%20regimens.%22%2C%22date%22%3A%222022-01-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoab118%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-03T23%3A42%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22LSPIEWFL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bonner%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBonner%20S%2C%20Barrett%20IP%2C%20Ye%20C%2C%20Swiers%20R%2C%20Engkvist%20O%2C%20Bender%20A%2C%20Hoyt%20CT%2C%20Hamilton%20WL.%20A%20review%20of%20biomedical%20datasets%20relating%20to%20drug%20discovery%3A%20a%20knowledge%20graph%20perspective.%20Brief%20Bioinform.%202022%20Nov%2019%3B23%286%29%3Abbac404.%20PMID%3A%2036151740%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20review%20of%20biomedical%20datasets%20relating%20to%20drug%20discovery%3A%20a%20knowledge%20graph%20perspective%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Bonner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20P.%22%2C%22lastName%22%3A%22Barrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheng%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rowan%22%2C%22lastName%22%3A%22Swiers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ola%22%2C%22lastName%22%3A%22Engkvist%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Bender%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20L.%22%2C%22lastName%22%3A%22Hamilton%22%7D%5D%2C%22abstractNote%22%3A%22Drug%20discovery%20and%20development%20is%20a%20complex%20and%20costly%20process.%20Machine%20learning%20approaches%20are%20being%20investigated%20to%20help%20improve%20the%20effectiveness%20and%20speed%20of%20multiple%20stages%20of%20the%20drug%20discovery%20pipeline.%20Of%20these%2C%20those%20that%20use%20Knowledge%20Graphs%20%28KG%29%20have%20promise%20in%20many%20tasks%2C%20including%20drug%20repurposing%2C%20drug%20toxicity%20prediction%20and%20target%20gene-disease%20prioritization.%20In%20a%20drug%20discovery%20KG%2C%20crucial%20elements%20including%20genes%2C%20diseases%20and%20drugs%20are%20represented%20as%20entities%2C%20while%20relationships%20between%20them%20indicate%20an%20interaction.%20However%2C%20to%20construct%20high-quality%20KGs%2C%20suitable%20data%20are%20required.%20In%20this%20review%2C%20we%20detail%20publicly%20available%20sources%20suitable%20for%20use%20in%20constructing%20drug%20discovery%20focused%20KGs.%20We%20aim%20to%20help%20guide%20machine%20learning%20and%20KG%20practitioners%20who%20are%20interested%20in%20applying%20new%20techniques%20to%20the%20drug%20discovery%20field%2C%20but%20who%20may%20be%20unfamiliar%20with%20the%20relevant%20data%20sources.%20The%20datasets%20are%20selected%20via%20strict%20criteria%2C%20categorized%20according%20to%20the%20primary%20type%20of%20information%20contained%20within%20and%20are%20considered%20based%20upon%20what%20information%20could%20be%20extracted%20to%20build%20a%20KG.%20We%20then%20present%20a%20comparative%20analysis%20of%20existing%20public%20drug%20discovery%20KGs%20and%20an%20evaluation%20of%20selected%20motivating%20case%20studies%20from%20the%20literature.%20Additionally%2C%20we%20raise%20numerous%20and%20unique%20challenges%20and%20issues%20associated%20with%20the%20domain%20and%20its%20datasets%2C%20while%20also%20highlighting%20key%20future%20research%20directions.%20We%20hope%20this%20review%20will%20motivate%20KGs%20use%20in%20solving%20key%20and%20emerging%20questions%20in%20the%20drug%20discovery%20domain.%22%2C%22date%22%3A%222022-11-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbib%5C%2Fbbac404%22%2C%22ISSN%22%3A%221477-4054%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-27T20%3A43%3A40Z%22%7D%7D%2C%7B%22key%22%3A%227RIC93TE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Brastianos%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrastianos%20PK%2C%20Kim%20AE%2C%20Giobbie-Hurder%20A%2C%20Lee%20EQ%2C%20Wang%20N%2C%20Eichler%20AF%2C%20Chukwueke%20U%2C%20Forst%20DA%2C%20Arrillaga-Romany%20IC%2C%20Dietrich%20J%2C%20Corbin%20Z%2C%20Moliterno%20J%2C%20Baehring%20J%2C%20White%20M%2C%20Lou%20KW%2C%20Larson%20J%2C%20de%20Sauvage%20MA%2C%20Evancic%20K%2C%20Mora%20J%2C%20Nayyar%20N%2C%20Loeffler%20J%2C%20Oh%20K%2C%20Shih%20HA%2C%20Curry%20WT%2C%20Cahill%20DP%2C%20Barker%20FG%2C%20Gerstner%20ER%2C%20Santagata%20S.%20Phase%202%20study%20of%20pembrolizumab%20in%20patients%20with%20recurrent%20and%20residual%20high-grade%20meningiomas.%20Nat%20Commun.%202022%20Mar%2014%3B13%281%29%3A1325.%20PMCID%3A%20PMC8921328%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phase%202%20study%20of%20pembrolizumab%20in%20patients%20with%20recurrent%20and%20residual%20high-grade%20meningiomas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20E.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Giobbie-Hurder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Quant%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20F.%22%2C%22lastName%22%3A%22Eichler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugonma%22%2C%22lastName%22%3A%22Chukwueke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Forst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%20C.%22%2C%22lastName%22%3A%22Arrillaga-Romany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorg%22%2C%22lastName%22%3A%22Dietrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Corbin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Moliterno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joachim%22%2C%22lastName%22%3A%22Baehring%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20W.%22%2C%22lastName%22%3A%22Lou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliana%22%2C%22lastName%22%3A%22Larson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Magali%20A.%22%2C%22lastName%22%3A%22de%20Sauvage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Evancic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joana%22%2C%22lastName%22%3A%22Mora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naema%22%2C%22lastName%22%3A%22Nayyar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Loeffler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%20A.%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20T.%22%2C%22lastName%22%3A%22Curry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%20G.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20R.%22%2C%22lastName%22%3A%22Gerstner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22High-grade%20meningiomas%20are%20associated%20with%20neuro-cognitive%20morbidity%20and%20have%20limited%20treatments.%20High-grade%20meningiomas%20harbor%20an%20immunosuppressive%20tumor%20microenvironment%20%28TME%29%20and%20programmed%20death-ligand%201%20%28PD-L1%29%20expression%20may%20contribute%20to%20their%20aggressive%20phenotype.%20Here%2C%20we%20present%20the%20results%20of%20a%20single-arm%2C%20open-label%20phase%202%20trial%20%28NCT03279692%29%20evaluating%20the%20efficacy%20of%20pembrolizumab%2C%20a%20PD-1%20inhibitor%2C%20in%20a%20cohort%20of%2025%20evaluable%20patients%20with%20recurrent%20and%20progressive%20grade%202%20and%203%20meningiomas.%20The%20primary%20endpoint%20is%20the%20proportion%20of%20patients%20alive%20and%20progression-free%20at%206%20months%20%28PFS-6%29.%20Secondary%20endpoints%20include%20progression-free%20and%20overall%20survival%2C%20best%20intracranial%20response%2C%20and%20toxicity.%20Our%20study%20has%20met%20its%20primary%20endpoint%20and%20achieved%20a%20PFS-6%20rate%20of%200.48%20%2890%25%20exact%20CI%3A%200.31-0.66%29%20and%20a%20median%20PFS%20of%207.6%20months%20%2890%25%20CI%3A%203.4-12.9%20months%29.%20Twenty%20percent%20of%20patients%20have%20experienced%20one%20%28or%20more%29%20grade-3%20or%20higher%20treatment-related%20adverse%20events.%20These%20results%20suggest%20that%20pembrolizumab%20exerts%20promising%20efficacy%20on%20a%20subset%20of%20these%20tumors.%20Further%20studies%20are%20needed%20to%20identify%20the%20biological%20facets%20within%20the%20meningioma%20TME%20that%20may%20drive%20response%20to%20immune-based%20therapies.%22%2C%22date%22%3A%222022-03-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-29052-7%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-04-07T02%3A48%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22L83HD3SJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Charpignon%20et%20al.%22%2C%22parsedDate%22%3A%222022-12-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECharpignon%20ML%2C%20Vakulenko-Lagun%20B%2C%20Zheng%20B%2C%20Magdamo%20C%2C%20Su%20B%2C%20Evans%20K%2C%20Rodriguez%20S%2C%20Sokolov%20A%2C%20Boswell%20S%2C%20Sheu%20YH%2C%20Somai%20M%2C%20Middleton%20L%2C%20Hyman%20BT%2C%20Betensky%20RA%2C%20Finkelstein%20SN%2C%20Welsch%20RE%2C%20Tzoulaki%20I%2C%20Blacker%20D%2C%20Das%20S%2C%20Albers%20MW.%20Causal%20inference%20in%20medical%20records%20and%20complementary%20systems%20pharmacology%20for%20metformin%20drug%20repurposing%20towards%20dementia.%20Nat%20Commun.%202022%20Dec%2010%3B13%281%29%3A7652.%20PMCID%3A%20PMC9741618%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Causal%20inference%20in%20medical%20records%20and%20complementary%20systems%20pharmacology%20for%20metformin%20drug%20repurposing%20towards%20dementia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Charpignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bella%22%2C%22lastName%22%3A%22Vakulenko-Lagun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bang%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Magdamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bowen%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Han%22%2C%22lastName%22%3A%22Sheu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melek%22%2C%22lastName%22%3A%22Somai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lefkos%22%2C%22lastName%22%3A%22Middleton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bradley%20T.%22%2C%22lastName%22%3A%22Hyman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20A.%22%2C%22lastName%22%3A%22Betensky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stan%20N.%22%2C%22lastName%22%3A%22Finkelstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%20E.%22%2C%22lastName%22%3A%22Welsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioanna%22%2C%22lastName%22%3A%22Tzoulaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Blacker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudeshna%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22Metformin%2C%20a%20diabetes%20drug%20with%20anti-aging%20cellular%20responses%2C%20has%20complex%20actions%20that%20may%20alter%20dementia%20onset.%20Mixed%20results%20are%20emerging%20from%20prior%20observational%20studies.%20To%20address%20this%20complexity%2C%20we%20deploy%20a%20causal%20inference%20approach%20accounting%20for%20the%20competing%20risk%20of%20death%20in%20emulated%20clinical%20trials%20using%20two%20distinct%20electronic%20health%20record%20systems.%20In%20intention-to-treat%20analyses%2C%20metformin%20use%20associates%20with%20lower%20hazard%20of%20all-cause%20mortality%20and%20lower%20cause-specific%20hazard%20of%20dementia%20onset%2C%20after%20accounting%20for%20prolonged%20survival%2C%20relative%20to%20sulfonylureas.%20In%20parallel%20systems%20pharmacology%20studies%2C%20the%20expression%20of%20two%20AD-related%20proteins%2C%20APOE%20and%20SPP1%2C%20was%20suppressed%20by%20pharmacologic%20concentrations%20of%20metformin%20in%20differentiated%20human%20neural%20cells%2C%20relative%20to%20a%20sulfonylurea.%20Together%2C%20our%20findings%20suggest%20that%20metformin%20might%20reduce%20the%20risk%20of%20dementia%20in%20diabetes%20patients%20through%20mechanisms%20beyond%20glycemic%20control%2C%20and%20that%20SPP1%20is%20a%20candidate%20biomarker%20for%20metformin%27s%20action%20in%20the%20brain.%22%2C%22date%22%3A%222022-12-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-35157-w%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A17%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22SGX4S2X2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Chowdhury%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChowdhury%20R%2C%20Bouatta%20N%2C%20Biswas%20S%2C%20Floristean%20C%2C%20Kharkar%20A%2C%20Roy%20K%2C%20Rochereau%20C%2C%20Ahdritz%20G%2C%20Zhang%20J%2C%20Church%20GM%2C%20Sorger%20PK%2C%20AlQuraishi%20M.%20Single-sequence%20protein%20structure%20prediction%20using%20a%20language%20model%20and%20deep%20learning.%20Nat%20Biotechnol.%202022%20Nov%3B40%2811%29%3A1617%26%23x2013%3B1623.%20PMCID%3A%20PMC10440047%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-sequence%20protein%20structure%20prediction%20using%20a%20language%20model%20and%20deep%20learning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ratul%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazim%22%2C%22lastName%22%3A%22Bouatta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Surojit%22%2C%22lastName%22%3A%22Biswas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%22%2C%22lastName%22%3A%22Floristean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anant%22%2C%22lastName%22%3A%22Kharkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koushik%22%2C%22lastName%22%3A%22Roy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Rochereau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustaf%22%2C%22lastName%22%3A%22Ahdritz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanna%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20M.%22%2C%22lastName%22%3A%22Church%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22AlphaFold2%20and%20related%20computational%20systems%20predict%20protein%20structure%20using%20deep%20learning%20and%20co-evolutionary%20relationships%20encoded%20in%20multiple%20sequence%20alignments%20%28MSAs%29.%20Despite%20high%20prediction%20accuracy%20achieved%20by%20these%20systems%2C%20challenges%20remain%20in%20%281%29%20prediction%20of%20orphan%20and%20rapidly%20evolving%20proteins%20for%20which%20an%20MSA%20cannot%20be%20generated%3B%20%282%29%20rapid%20exploration%20of%20designed%20structures%3B%20and%20%283%29%20understanding%20the%20rules%20governing%20spontaneous%20polypeptide%20folding%20in%20solution.%20Here%20we%20report%20development%20of%20an%20end-to-end%20differentiable%20recurrent%20geometric%20network%20%28RGN%29%20that%20uses%20a%20protein%20language%20model%20%28AminoBERT%29%20to%20learn%20latent%20structural%20information%20from%20unaligned%20proteins.%20A%20linked%20geometric%20module%20compactly%20represents%20C%5Cu03b1%20backbone%20geometry%20in%20a%20translationally%20and%20rotationally%20invariant%20way.%20On%20average%2C%20RGN2%20outperforms%20AlphaFold2%20and%20RoseTTAFold%20on%20orphan%20proteins%20and%20classes%20of%20designed%20proteins%20while%20achieving%20up%20to%20a%20106-fold%20reduction%20in%20compute%20time.%20These%20findings%20demonstrate%20the%20practical%20and%20theoretical%20strengths%20of%20protein%20language%20models%20relative%20to%20MSAs%20in%20structure%20prediction.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41587-022-01432-w%22%2C%22ISSN%22%3A%221546-1696%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A45%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22ULG489J3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Coy%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoy%20S%2C%20Wang%20S%2C%20Stopka%20SA%2C%20Lin%20JR%2C%20Yapp%20C%2C%20Ritch%20CC%2C%20Salhi%20L%2C%20Baker%20GJ%2C%20Rashid%20R%2C%20Baquer%20G%2C%20Regan%20M%2C%20Khadka%20P%2C%20Cole%20KA%2C%20Hwang%20J%2C%20Wen%20PY%2C%20Bandopadhayay%20P%2C%20Santi%20M%2C%20De%20Raedt%20T%2C%20Ligon%20KL%2C%20Agar%20NYR%2C%20Sorger%20PK%2C%20Touat%20M%2C%20Santagata%20S.%20Single%20cell%20spatial%20analysis%20reveals%20the%20topology%20of%20immunomodulatory%20purinergic%20signaling%20in%20glioblastoma.%20Nat%20Commun.%202022%20Aug%2016%3B13%281%29%3A4814.%20PMCID%3A%20PMC9381513%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single%20cell%20spatial%20analysis%20reveals%20the%20topology%20of%20immunomodulatory%20purinergic%20signaling%20in%20glioblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecily%20C.%22%2C%22lastName%22%3A%22Ritch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Salhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Baquer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prasidda%22%2C%22lastName%22%3A%22Khadka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristina%20A.%22%2C%22lastName%22%3A%22Cole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaeho%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pratiti%22%2C%22lastName%22%3A%22Bandopadhayay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariarita%22%2C%22lastName%22%3A%22Santi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22De%20Raedt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22How%20the%20glioma%20immune%20microenvironment%20fosters%20tumorigenesis%20remains%20incompletely%20defined.%20Here%2C%20we%20use%20single-cell%20RNA-sequencing%20and%20multiplexed%20tissue-imaging%20to%20characterize%20the%20composition%2C%20spatial%20organization%2C%20and%20clinical%20significance%20of%20extracellular%20purinergic%20signaling%20in%20glioma.%20We%20show%20that%20microglia%20are%20the%20predominant%20source%20of%20CD39%2C%20while%20tumor%20cells%20principally%20express%20CD73.%20In%20glioblastoma%2C%20CD73%20is%20associated%20with%20EGFR%20amplification%2C%20astrocyte-like%20differentiation%2C%20and%20increased%20adenosine%2C%20and%20is%20linked%20to%20hypoxia.%20Glioblastomas%20enriched%20for%20CD73%20exhibit%20inflammatory%20microenvironments%2C%20suggesting%20that%20purinergic%20signaling%20regulates%20immune%20adaptation.%20Spatially-resolved%20single-cell%20analyses%20demonstrate%20a%20strong%20spatial%20correlation%20between%20tumor-CD73%20and%20microglial-CD39%2C%20with%20proximity%20associated%20with%20poor%20outcomes.%20Similar%20spatial%20organization%20is%20present%20in%20pediatric%20high-grade%20gliomas%20including%20H3K27M-mutant%20diffuse%20midline%20glioma.%20These%20data%20reveal%20that%20purinergic%20signaling%20in%20gliomas%20is%20shaped%20by%20genotype%2C%20lineage%2C%20and%20functional%20state%2C%20and%20that%20core%20enzymes%20expressed%20by%20tumor%20and%20myeloid%20cells%20are%20organized%20to%20promote%20adenosine-rich%20microenvironments%20potentially%20amenable%20to%20therapeutic%20targeting.%22%2C%22date%22%3A%222022-08-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-32430-w%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A16%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22AQBGWR3H%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Creason%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECreason%20AL%2C%20Watson%20C%2C%20Gu%20Q%2C%20Persson%20D%2C%20Sargent%20L%2C%20Chen%20YA%2C%20Lin%20JR%2C%20Sivagnanam%20S%2C%20W%26%23xFC%3Bnnemann%20F%2C%20Nirmal%20AJ%2C%20Chin%20K%2C%20Feiler%20HS%2C%20Coussens%20LM%2C%20Schapiro%20D%2C%20Gr%26%23xFC%3Bning%20B%2C%20Sorger%20PK%2C%20Sokolov%20A%2C%20Goecks%20J.%20A%20web-based%20software%20resource%20for%20interactive%20analysis%20of%20multiplex%20tissue%20imaging%20datasets%20%5BInternet%5D.%20bioRxiv%3B%202022%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2022.08.18.504436%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2022.08.18.504436%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22A%20web-based%20software%20resource%20for%20interactive%20analysis%20of%20multiplex%20tissue%20imaging%20datasets%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20L.%22%2C%22lastName%22%3A%22Creason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%22%2C%22lastName%22%3A%22Watson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiang%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Persson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Sargent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamilene%22%2C%22lastName%22%3A%22Sivagnanam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22W%5Cu00fcnnemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koei%22%2C%22lastName%22%3A%22Chin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20S.%22%2C%22lastName%22%3A%22Feiler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20M.%22%2C%22lastName%22%3A%22Coussens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bj%5Cu00f6rn%22%2C%22lastName%22%3A%22Gr%5Cu00fcning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Goecks%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Highly%20multiplexed%20tissue%20imaging%20%28MTI%29%20are%20powerful%20spatial%20proteomics%20technologies%20that%20enable%5Cn%20%20%20%20%20%20%20%20%20%20%20%20in%20situ%5Cn%20%20%20%20%20%20%20%20%20%20%20%20single-cell%20characterization%20of%20tissues.%20However%2C%20analysis%20and%20visualization%20of%20MTI%20datasets%20remains%20challenging%2C%20and%20we%20developed%20the%20Galaxy-ME%20software%20hub%20to%20address%20this%20challenge.Galaxy-ME%20is%20a%20web-based%2C%20interactive%20software%20hub%20that%20enables%20end-to-end%20analysis%20and%20visualization%20of%20MTI%20datasets%20and%20is%20accessible%20to%20everyone.%20To%20demonstrate%20its%20utility%2C%20Galaxy-ME%20was%20used%20to%20analyze%20datasets%20obtained%20from%20multiple%20MTI%20assays%20and%20evaluate%20assay%20concordance%20in%20both%20normal%20and%20cancerous%20tissues.%20Galaxy-ME%20is%20a%20publicly%20available%20web%20resource.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222022-08-19%22%2C%22DOI%22%3A%2210.1101%5C%2F2022.08.18.504436%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2022.08.18.504436%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T16%3A23%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22XEU4SFYA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22CSBC%5C%2FPS-ON%20Image%20Analysis%20Working%20Group%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECSBC%5C%2FPS-ON%20Image%20Analysis%20Working%20Group%2C%20Vizcarra%20JC%2C%20Burlingame%20EA%2C%20Hug%20CB%2C%20Goltsev%20Y%2C%20White%20BS%2C%20Tyson%20DR%2C%20Sokolov%20A.%20A%20community-based%20approach%20to%20image%20analysis%20of%20cells%2C%20tissues%20and%20tumors.%20Comput%20Med%20Imaging%20Graph.%202022%20Jan%3B95%3A102013.%20PMCID%3A%20PMC8761177%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20community-based%20approach%20to%20image%20analysis%20of%20cells%2C%20tissues%20and%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CSBC%5C%2FPS-ON%20Image%20Analysis%20Working%20Group%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Vizcarra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20A.%22%2C%22lastName%22%3A%22Burlingame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%20B.%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yury%22%2C%22lastName%22%3A%22Goltsev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20S.%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20R.%22%2C%22lastName%22%3A%22Tyson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%5D%2C%22abstractNote%22%3A%22Emerging%20multiplexed%20imaging%20platforms%20provide%20an%20unprecedented%20view%20of%20an%20increasing%20number%20of%20molecular%20markers%20at%20subcellular%20resolution%20and%20the%20dynamic%20evolution%20of%20tumor%20cellular%20composition.%20As%20such%2C%20they%20are%20capable%20of%20elucidating%20cell-to-cell%20interactions%20within%20the%20tumor%20microenvironment%20that%20impact%20clinical%20outcome%20and%20therapeutic%20response.%20However%2C%20the%20rapid%20development%20of%20these%20platforms%20has%20far%20outpaced%20the%20computational%20methods%20for%20processing%20and%20analyzing%20the%20data%20they%20generate.%20While%20being%20technologically%20disparate%2C%20all%20imaging%20assays%20share%20many%20computational%20requirements%20for%20post-collection%20data%20processing.%20As%20such%2C%20our%20Image%20Analysis%20Working%20Group%20%28IAWG%29%2C%20composed%20of%20researchers%20in%20the%20Cancer%20Systems%20Biology%20Consortium%20%28CSBC%29%20and%20the%20Physical%20Sciences%20-%20Oncology%20Network%20%28PS-ON%29%2C%20convened%20a%20workshop%20on%20%5C%22Computational%20Challenges%20Shared%20by%20Diverse%20Imaging%20Platforms%5C%22%20to%20characterize%20these%20common%20issues%20and%20a%20follow-up%20hackathon%20to%20implement%20solutions%20for%20a%20selected%20subset%20of%20them.%20Here%2C%20we%20delineate%20these%20areas%20that%20reflect%20major%20axes%20of%20research%20within%20the%20field%2C%20including%20image%20registration%2C%20segmentation%20of%20cells%20and%20subcellular%20structures%2C%20and%20identification%20of%20cell%20types%20from%20their%20morphology.%20We%20further%20describe%20the%20logistical%20organization%20of%20these%20events%2C%20believing%20our%20lessons%20learned%20can%20aid%20others%20in%20uniting%20the%20imaging%20community%20around%20self-identified%20topics%20of%20mutual%20interest%2C%20in%20designing%20and%20implementing%20operational%20procedures%20to%20address%20those%20topics%20and%20in%20mitigating%20issues%20inherent%20in%20image%20analysis%20%28e.g.%2C%20sharing%20exemplar%20images%20of%20large%20datasets%20and%20disseminating%20baseline%20solutions%20to%20hackathon%20challenges%20through%20open-source%20code%20repositories%29.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.compmedimag.2021.102013%22%2C%22ISSN%22%3A%221879-0771%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-01-11T18%3A29%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22FRK6JI99%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Cr%5Cu00e9cy-Lagard%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3Ede%20Cr%26%23xE9%3Bcy-Lagard%20V%2C%20Amorin%20de%20Hegedus%20R%2C%20Arighi%20C%2C%20Babor%20J%2C%20Bateman%20A%2C%20Blaby%20I%2C%20Blaby-Haas%20C%2C%20Bridge%20AJ%2C%20Burley%20SK%2C%20Cleveland%20S%2C%20Colwell%20LJ%2C%20Conesa%20A%2C%20Dallago%20C%2C%20Danchin%20A%2C%20de%20Waard%20A%2C%20Deutschbauer%20A%2C%20Dias%20R%2C%20Ding%20Y%2C%20Fang%20G%2C%20Friedberg%20I%2C%20Gerlt%20J%2C%20Goldford%20J%2C%20Gorelik%20M%2C%20Gyori%20BM%2C%20Henry%20C%2C%20Hutinet%20G%2C%20Jaroch%20M%2C%20Karp%20PD%2C%20Kondratova%20L%2C%20Lu%20Z%2C%20Marchler-Bauer%20A%2C%20Martin%20MJ%2C%20McWhite%20C%2C%20Moghe%20GD%2C%20Monaghan%20P%2C%20Morgat%20A%2C%20Mungall%20CJ%2C%20Natale%20DA%2C%20Nelson%20WC%2C%20O%26%23x2019%3BDonoghue%20S%2C%20Orengo%20C%2C%20O%26%23x2019%3BToole%20KH%2C%20Radivojac%20P%2C%20Reed%20C%2C%20Roberts%20RJ%2C%20Rodionov%20D%2C%20Rodionova%20IA%2C%20Rudolf%20JD%2C%20Saleh%20L%2C%20Sheynkman%20G%2C%20Thibaud-Nissen%20F%2C%20Thomas%20PD%2C%20Uetz%20P%2C%20Vallenet%20D%2C%20Carter%20EW%2C%20Weigele%20PR%2C%20Wood%20V%2C%20Wood-Charlson%20EM%2C%20Xu%20J.%20A%20roadmap%20for%20the%20functional%20annotation%20of%20protein%20families%3A%20a%20community%20perspective.%20Database%20%28Oxford%29.%202022%20Aug%2012%3B2022%3Abaac062.%20PMCID%3A%20PMC9374478%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20roadmap%20for%20the%20functional%20annotation%20of%20protein%20families%3A%20a%20community%20perspective%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22de%20Cr%5Cu00e9cy-Lagard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rocio%22%2C%22lastName%22%3A%22Amorin%20de%20Hegedus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecilia%22%2C%22lastName%22%3A%22Arighi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%22%2C%22lastName%22%3A%22Babor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Bateman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Blaby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crysten%22%2C%22lastName%22%3A%22Blaby-Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20J.%22%2C%22lastName%22%3A%22Bridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Burley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacey%22%2C%22lastName%22%3A%22Cleveland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%20J.%22%2C%22lastName%22%3A%22Colwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Conesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Dallago%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Danchin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22de%20Waard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Deutschbauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Dias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousong%22%2C%22lastName%22%3A%22Ding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gang%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iddo%22%2C%22lastName%22%3A%22Friedberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Gerlt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Goldford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Gorelik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Hutinet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marshall%22%2C%22lastName%22%3A%22Jaroch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20D.%22%2C%22lastName%22%3A%22Karp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liudmyla%22%2C%22lastName%22%3A%22Kondratova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aron%22%2C%22lastName%22%3A%22Marchler-Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria-Jesus%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22McWhite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaurav%20D.%22%2C%22lastName%22%3A%22Moghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Monaghan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Morgat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Mungall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20A.%22%2C%22lastName%22%3A%22Natale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Nelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Se%5Cu00e1n%22%2C%22lastName%22%3A%22O%27Donoghue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Orengo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20H.%22%2C%22lastName%22%3A%22O%27Toole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Predrag%22%2C%22lastName%22%3A%22Radivojac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colbie%22%2C%22lastName%22%3A%22Reed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Roberts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dmitri%22%2C%22lastName%22%3A%22Rodionov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%20A.%22%2C%22lastName%22%3A%22Rodionova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20D.%22%2C%22lastName%22%3A%22Rudolf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lana%22%2C%22lastName%22%3A%22Saleh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gloria%22%2C%22lastName%22%3A%22Sheynkman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francoise%22%2C%22lastName%22%3A%22Thibaud-Nissen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20D.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Uetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Vallenet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erica%20Watson%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20R.%22%2C%22lastName%22%3A%22Weigele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisha%20M.%22%2C%22lastName%22%3A%22Wood-Charlson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin%22%2C%22lastName%22%3A%22Xu%22%7D%5D%2C%22abstractNote%22%3A%22Over%20the%20last%2025%5Cu2009years%2C%20biology%20has%20entered%20the%20genomic%20era%20and%20is%20becoming%20a%20science%20of%20%27big%20data%27.%20Most%20interpretations%20of%20genomic%20analyses%20rely%20on%20accurate%20functional%20annotations%20of%20the%20proteins%20encoded%20by%20more%20than%20500%5Cu2009000%20genomes%20sequenced%20to%20date.%20By%20different%20estimates%2C%20only%20half%20the%20predicted%20sequenced%20proteins%20carry%20an%20accurate%20functional%20annotation%2C%20and%20this%20percentage%20varies%20drastically%20between%20different%20organismal%20lineages.%20Such%20a%20large%20gap%20in%20knowledge%20hampers%20all%20aspects%20of%20biological%20enterprise%20and%2C%20thereby%2C%20is%20standing%20in%20the%20way%20of%20genomic%20biology%20reaching%20its%20full%20potential.%20A%20brainstorming%20meeting%20to%20address%20this%20issue%20funded%20by%20the%20National%20Science%20Foundation%20was%20held%20during%203-4%20February%202022.%20Bringing%20together%20data%20scientists%2C%20biocurators%2C%20computational%20biologists%20and%20experimentalists%20within%20the%20same%20venue%20allowed%20for%20a%20comprehensive%20assessment%20of%20the%20current%20state%20of%20functional%20annotations%20of%20protein%20families.%20Further%2C%20major%20issues%20that%20were%20obstructing%20the%20field%20were%20identified%20and%20discussed%2C%20which%20ultimately%20allowed%20for%20the%20proposal%20of%20solutions%20on%20how%20to%20move%20forward.%22%2C%22date%22%3A%222022-08-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fdatabase%5C%2Fbaac062%22%2C%22ISSN%22%3A%221758-0463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-09-01T13%3A32%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22CJC5YXJR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Doherty%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-23%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDoherty%20LM%2C%20Mills%20CE%2C%20Boswell%20SA%2C%20Liu%20X%2C%20Hoyt%20CT%2C%20Gyori%20B%2C%20Buhrlage%20SJ%2C%20Sorger%20PK.%20Integrating%20multi-omics%20data%20reveals%20function%20and%20therapeutic%20potential%20of%20deubiquitinating%20enzymes.%20Elife.%202022%20Jun%2023%3B11%3Ae72879.%20PMCID%3A%20PMC9225015%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrating%20multi-omics%20data%20reveals%20function%20and%20therapeutic%20potential%20of%20deubiquitinating%20enzymes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoxi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20J.%22%2C%22lastName%22%3A%22Buhrlage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Deubiquitinating%20enzymes%20%28DUBs%29%2C%20~100%20of%20which%20are%20found%20in%20human%20cells%2C%20are%20proteases%20that%20remove%20ubiquitin%20conjugates%20from%20proteins%2C%20thereby%20regulating%20protein%20turnover.%20They%20are%20involved%20in%20a%20wide%20range%20of%20cellular%20activities%20and%20are%20emerging%20therapeutic%20targets%20for%20cancer%20and%20other%20diseases.%20Drugs%20targeting%20USP1%20and%20USP30%20are%20in%20clinical%20development%20for%20cancer%20and%20kidney%20disease%20respectively.%20However%2C%20the%20majority%20of%20substrates%20and%20pathways%20regulated%20by%20DUBs%20remain%20unknown%2C%20impeding%20efforts%20to%20prioritize%20specific%20enzymes%20for%20research%20and%20drug%20development.%20To%20assemble%20a%20knowledgebase%20of%20DUB%20activities%2C%20co-dependent%20genes%2C%20and%20substrates%2C%20we%20combined%20targeted%20experiments%20using%20CRISPR%20libraries%20and%20inhibitors%20with%20systematic%20mining%20of%20functional%20genomic%20databases.%20Analysis%20of%20the%20Dependency%20Map%2C%20Connectivity%20Map%2C%20Cancer%20Cell%20Line%20Encyclopedia%2C%20and%20multiple%20protein-protein%20interaction%20databases%20yielded%20specific%20hypotheses%20about%20DUB%20function%2C%20a%20subset%20of%20which%20were%20confirmed%20in%20follow-on%20experiments.%20The%20data%20in%20this%20paper%20are%20browsable%20online%20in%20a%20newly%20developed%20DUB%20Portal%20and%20promise%20to%20improve%20understanding%20of%20DUBs%20as%20a%20family%20as%20well%20as%20the%20activities%20of%20incompletely%20characterized%20DUBs%20%28e.g.%20USPL1%20and%20USP32%29%20and%20those%20already%20targeted%20with%20investigational%20cancer%20therapeutics%20%28e.g.%20USP14%2C%20UCHL5%2C%20and%20USP7%29.%22%2C%22date%22%3A%222022-06-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.72879%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A07%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22BG5YA683%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fraser%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFraser%20CS%2C%20Spetz%20JKE%2C%20Qin%20X%2C%20Presser%20A%2C%20Choiniere%20J%2C%20Li%20C%2C%20Yu%20S%2C%20Blevins%20F%2C%20Hata%20AN%2C%20Miller%20JW%2C%20Bradshaw%20GA%2C%20Kalocsay%20M%2C%20Sanchorawala%20V%2C%20Sarosiek%20S%2C%20Sarosiek%20KA.%20Exploiting%20endogenous%20and%20therapy-induced%20apoptotic%20vulnerabilities%20in%20immunoglobulin%20light%20chain%20amyloidosis%20with%20BH3%20mimetics.%20Nat%20Commun.%202022%20Oct%202%3B13%281%29%3A5789.%20PMCID%3A%20PMC9527241%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Exploiting%20endogenous%20and%20therapy-induced%20apoptotic%20vulnerabilities%20in%20immunoglobulin%20light%20chain%20amyloidosis%20with%20BH3%20mimetics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20S.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%20K.%20E.%22%2C%22lastName%22%3A%22Spetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Presser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Choiniere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chendi%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacey%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frances%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20N.%22%2C%22lastName%22%3A%22Hata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20W.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaishali%22%2C%22lastName%22%3A%22Sanchorawala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shayna%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%5D%2C%22abstractNote%22%3A%22Immunoglobulin%20light%20chain%20%28AL%29%20amyloidosis%20is%20an%20incurable%20hematologic%20disorder%20typically%20characterized%20by%20the%20production%20of%20amyloidogenic%20light%20chains%20by%20clonal%20plasma%20cells.%20These%20light%20chains%20misfold%20and%20aggregate%20in%20healthy%20tissues%20as%20amyloid%20fibrils%2C%20leading%20to%20life-threatening%20multi-organ%20dysfunction.%20Here%20we%20show%20that%20the%20clonal%20plasma%20cells%20in%20AL%20amyloidosis%20are%20highly%20primed%20to%20undergo%20apoptosis%20and%20dependent%20on%20pro-survival%20proteins%20MCL-1%20and%20BCL-2.%20Notably%2C%20this%20MCL-1%20dependency%20is%20indirectly%20targeted%20by%20the%20proteasome%20inhibitor%20bortezomib%2C%20currently%20the%20standard%20of%20care%20for%20this%20disease%20and%20the%20related%20plasma%20cell%20disorder%20multiple%20myeloma%2C%20due%20to%20upregulation%20of%20pro-apoptotic%20Noxa%20and%20its%20inhibitory%20binding%20to%20MCL-1.%20BCL-2%20inhibitors%20sensitize%20clonal%20plasma%20cells%20to%20multiple%20front-line%20therapies%20including%20bortezomib%2C%20dexamethasone%20and%20lenalidomide.%20Strikingly%2C%20in%20mice%20bearing%20AL%20amyloidosis%20cell%20line%20xenografts%2C%20single%20agent%20treatment%20with%20the%20BCL-2%20inhibitor%20ABT-199%20%28venetoclax%29%20produces%20deeper%20remissions%20than%20bortezomib%20and%20triples%20median%20survival.%20Mass%20spectrometry-based%20proteomic%20analysis%20reveals%20rewiring%20of%20signaling%20pathways%20regulating%20apoptosis%2C%20proliferation%20and%20mitochondrial%20metabolism%20between%20isogenic%20AL%20amyloidosis%20and%20multiple%20myeloma%20cells%20that%20divergently%20alter%20their%20sensitivity%20to%20therapies.%20These%20findings%20provide%20a%20roadmap%20for%20the%20use%20of%20BH3%20mimetics%20to%20exploit%20endogenous%20and%20induced%20apoptotic%20vulnerabilities%20in%20AL%20amyloidosis.%22%2C%22date%22%3A%222022-10-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-33461-z%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22PXTEKLDS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Fr%5Cu00f6hlich%20and%20Sorger%22%2C%22parsedDate%22%3A%222022-07-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFr%26%23xF6%3Bhlich%20F%2C%20Sorger%20PK.%20Fides%3A%20Reliable%20trust-region%20optimization%20for%20parameter%20estimation%20of%20ordinary%20differential%20equation%20models.%20PLoS%20Comput%20Biol.%202022%20Jul%2013%3B18%287%29%3Ae1010322.%20PMCID%3A%20PMC9312381%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fides%3A%20Reliable%20trust-region%20optimization%20for%20parameter%20estimation%20of%20ordinary%20differential%20equation%20models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Ordinary%20differential%20equation%20%28ODE%29%20models%20are%20widely%20used%20to%20study%20biochemical%20reactions%20in%20cellular%20networks%20since%20they%20effectively%20describe%20the%20temporal%20evolution%20of%20these%20networks%20using%20mass%20action%20kinetics.%20The%20parameters%20of%20these%20models%20are%20rarely%20known%20a%20priori%20and%20must%20instead%20be%20estimated%20by%20calibration%20using%20experimental%20data.%20Optimization-based%20calibration%20of%20ODE%20models%20on%20is%20often%20challenging%2C%20even%20for%20low-dimensional%20problems.%20Multiple%20hypotheses%20have%20been%20advanced%20to%20explain%20why%20biochemical%20model%20calibration%20is%20challenging%2C%20including%20non-identifiability%20of%20model%20parameters%2C%20but%20there%20are%20few%20comprehensive%20studies%20that%20test%20these%20hypotheses%2C%20likely%20because%20tools%20for%20performing%20such%20studies%20are%20also%20lacking.%20Nonetheless%2C%20reliable%20model%20calibration%20is%20essential%20for%20uncertainty%20analysis%2C%20model%20comparison%2C%20and%20biological%20interpretation.%20We%20implemented%20an%20established%20trust-region%20method%20as%20a%20modular%20Python%20framework%20%28fides%29%20to%20enable%20systematic%20comparison%20of%20different%20approaches%20to%20ODE%20model%20calibration%20involving%20a%20variety%20of%20Hessian%20approximation%20schemes.%20We%20evaluated%20fides%20on%20a%20recently%20developed%20corpus%20of%20biologically%20realistic%20benchmark%20problems%20for%20which%20real%20experimental%20data%20are%20available.%20Unexpectedly%2C%20we%20observed%20high%20variability%20in%20optimizer%20performance%20among%20different%20implementations%20of%20the%20same%20mathematical%20instructions%20%28algorithms%29.%20Analysis%20of%20possible%20sources%20of%20poor%20optimizer%20performance%20identified%20limitations%20in%20the%20widely%20used%20Gauss-Newton%2C%20BFGS%20and%20SR1%20Hessian%20approximation%20schemes.%20We%20addressed%20these%20drawbacks%20with%20a%20novel%20hybrid%20Hessian%20approximation%20scheme%20that%20enhances%20optimizer%20performance%20and%20outperforms%20existing%20hybrid%20approaches.%20When%20applied%20to%20the%20corpus%20of%20test%20models%2C%20we%20found%20that%20fides%20was%20on%20average%20more%20reliable%20and%20efficient%20than%20existing%20methods%20using%20a%20variety%20of%20criteria.%20We%20expect%20fides%20to%20be%20broadly%20useful%20for%20ODE%20constrained%20optimization%20problems%20in%20biochemical%20models%20and%20to%20be%20a%20foundation%20for%20future%20methods%20development.%22%2C%22date%22%3A%222022-07-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1010322%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22I6WLHXQY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gaglia%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGaglia%20G%2C%20Kabraji%20S%2C%20Rammos%20D%2C%20Dai%20Y%2C%20Verma%20A%2C%20Wang%20S%2C%20Mills%20CE%2C%20Chung%20M%2C%20Bergholz%20JS%2C%20Coy%20S%2C%20Lin%20JR%2C%20Jeselsohn%20R%2C%20Metzger%20O%2C%20Winer%20EP%2C%20Dillon%20DA%2C%20Zhao%20JJ%2C%20Sorger%20PK%2C%20Santagata%20S.%20Temporal%20and%20spatial%20topography%20of%20cell%20proliferation%20in%20cancer.%20Nat%20Cell%20Biol.%202022%20Mar%3B24%283%29%3A316%26%23x2013%3B326.%20PMCID%3A%20PMC8959396%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20and%20spatial%20topography%20of%20cell%20proliferation%20in%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheheryar%22%2C%22lastName%22%3A%22Kabraji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danae%22%2C%22lastName%22%3A%22Rammos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Verma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johann%20S.%22%2C%22lastName%22%3A%22Bergholz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rinath%22%2C%22lastName%22%3A%22Jeselsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%22%2C%22lastName%22%3A%22Metzger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20P.%22%2C%22lastName%22%3A%22Winer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Proliferation%20is%20a%20fundamental%20trait%20of%20cancer%20cells%2C%20but%20its%20properties%20and%20spatial%20organization%20in%20tumours%20are%20poorly%20characterized.%20Here%20we%20use%20highly%20multiplexed%20tissue%20imaging%20to%20perform%20single-cell%20quantification%20of%20cell%20cycle%20regulators%20and%20then%20develop%20robust%2C%20multivariate%2C%20proliferation%20metrics.%20Across%20diverse%20cancers%2C%20proliferative%20architecture%20is%20organized%20at%20two%20spatial%20scales%3A%20large%20domains%2C%20and%20smaller%20niches%20enriched%20for%20specific%20immune%20lineages.%20Some%20tumour%20cells%20express%20cell%20cycle%20regulators%20in%20the%20%28canonical%29%20patterns%20expected%20of%20freely%20growing%20cells%2C%20a%20phenomenon%20we%20refer%20to%20as%20%27cell%20cycle%20coherence%27.%20By%20contrast%2C%20the%20cell%20cycles%20of%20other%20tumour%20cell%20populations%20are%20skewed%20towards%20specific%20phases%20or%20exhibit%20non-canonical%20%28incoherent%29%20marker%20combinations.%20Coherence%20varies%20across%20space%2C%20with%20changes%20in%20oncogene%20activity%20and%20therapeutic%20intervention%2C%20and%20is%20associated%20with%20aggressive%20tumour%20behaviour.%20Thus%2C%20multivariate%20measures%20from%20high-plex%20tissue%20images%20capture%20clinically%20significant%20features%20of%20cancer%20proliferation%2C%20a%20fundamental%20step%20in%20enabling%20more%20precise%20use%20of%20anti-cancer%20therapies.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41556-022-00860-9%22%2C%22ISSN%22%3A%221476-4679%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T19%3A39%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22CRYRSPBK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gray%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGray%20GK%2C%20Li%20CMC%2C%20Rosenbluth%20JM%2C%20Selfors%20LM%2C%20Girnius%20N%2C%20Lin%20JR%2C%20Schackmann%20RCJ%2C%20Goh%20WL%2C%20Moore%20K%2C%20Shapiro%20HK%2C%20Mei%20S%2C%20D%26%23x2019%3BAndrea%20K%2C%20Nathanson%20KL%2C%20Sorger%20PK%2C%20Santagata%20S%2C%20Regev%20A%2C%20Garber%20JE%2C%20Dillon%20DA%2C%20Brugge%20JS.%20A%20human%20breast%20atlas%20integrating%20single-cell%20proteomics%20and%20transcriptomics.%20Dev%20Cell.%202022%20Jun%206%3B57%2811%29%3A1400-1420.e7.%20PMCID%3A%20PMC9202341%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20human%20breast%20atlas%20integrating%20single-cell%20proteomics%20and%20transcriptomics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Kenneth%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carman%20Man-Chung%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20M.%22%2C%22lastName%22%3A%22Rosenbluth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Selfors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nomeda%22%2C%22lastName%22%3A%22Girnius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%20C.%20J.%22%2C%22lastName%22%3A%22Schackmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%20L.%22%2C%22lastName%22%3A%22Goh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaitlin%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hana%20K.%22%2C%22lastName%22%3A%22Shapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%22%2C%22lastName%22%3A%22D%27Andrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20L.%22%2C%22lastName%22%3A%22Nathanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judy%20E.%22%2C%22lastName%22%3A%22Garber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan%20S.%22%2C%22lastName%22%3A%22Brugge%22%7D%5D%2C%22abstractNote%22%3A%22The%20breast%20is%20a%20dynamic%20organ%20whose%20response%20to%20physiological%20and%20pathophysiological%20conditions%20alters%20its%20disease%20susceptibility%2C%20yet%20the%20specific%20effects%20of%20these%20clinical%20variables%20on%20cell%20state%20remain%20poorly%20annotated.%20We%20present%20a%20unified%2C%20high-resolution%20breast%20atlas%20by%20integrating%20single-cell%20RNA-seq%2C%20mass%20cytometry%2C%20and%20cyclic%20immunofluorescence%2C%20encompassing%20a%20myriad%20of%20states.%20We%20define%20cell%20subtypes%20within%20the%20alveolar%2C%20hormone-sensing%2C%20and%20basal%20epithelial%20lineages%2C%20delineating%20associations%20of%20several%20subtypes%20with%20cancer%20risk%20factors%2C%20including%20age%2C%20parity%2C%20and%20BRCA2%20germline%20mutation.%20Of%20particular%20interest%20is%20a%20subset%20of%20alveolar%20cells%20termed%20basal-luminal%20%28BL%29%20cells%2C%20which%20exhibit%20poor%20transcriptional%20lineage%20fidelity%2C%20accumulate%20with%20age%2C%20and%20carry%20a%20gene%20signature%20associated%20with%20basal-like%20breast%20cancer.%20We%20further%20utilize%20a%20medium-depletion%20approach%20to%20identify%20molecular%20factors%20regulating%20cell-subtype%20proportion%20in%20organoids.%20Together%2C%20these%20data%20are%20a%20rich%20resource%20to%20elucidate%20diverse%20mammary%20cell%20states.%22%2C%22date%22%3A%222022-06-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.devcel.2022.05.003%22%2C%22ISSN%22%3A%221878-1551%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A00%3A42Z%22%7D%7D%2C%7B%22key%22%3A%229MJW9TCU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gross%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGross%20SM%2C%20Dane%20MA%2C%20Smith%20RL%2C%20Devlin%20KL%2C%20McLean%20IC%2C%20Derrick%20DS%2C%20Mills%20CE%2C%20Subramanian%20K%2C%20London%20AB%2C%20Torre%20D%2C%20Evangelista%20JE%2C%20Clarke%20DJB%2C%20Xie%20Z%2C%20Erdem%20C%2C%20Lyons%20N%2C%20Natoli%20T%2C%20Pessa%20S%2C%20Lu%20X%2C%20Mullahoo%20J%2C%20Li%20J%2C%20Adam%20M%2C%20Wassie%20B%2C%20Liu%20M%2C%20Kilburn%20DF%2C%20Liby%20TA%2C%20Bucher%20E%2C%20Sanchez-Aguila%20C%2C%20Daily%20K%2C%20Omberg%20L%2C%20Wang%20Y%2C%20Jacobson%20C%2C%20Yapp%20C%2C%20Chung%20M%2C%20Vidovic%20D%2C%20Lu%20Y%2C%20Schurer%20S%2C%20Lee%20A%2C%20Pillai%20A%2C%20Subramanian%20A%2C%20Papanastasiou%20M%2C%20Fraenkel%20E%2C%20Feiler%20HS%2C%20Mills%20GB%2C%20Jaffe%20JD%2C%20Ma%26%23x2019%3Bayan%20A%2C%20Birtwistle%20MR%2C%20Sorger%20PK%2C%20Korkola%20JE%2C%20Gray%20JW%2C%20Heiser%20LM.%20A%20multi-omic%20analysis%20of%20MCF10A%20cells%20provides%20a%20resource%20for%20integrative%20assessment%20of%20ligand-mediated%20molecular%20and%20phenotypic%20responses.%20Commun%20Biol.%202022%20Oct%207%3B5%281%29%3A1066.%20PMCID%3A%20PMC9546880%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20multi-omic%20analysis%20of%20MCF10A%20cells%20provides%20a%20resource%20for%20integrative%20assessment%20of%20ligand-mediated%20molecular%20and%20phenotypic%20responses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20M.%22%2C%22lastName%22%3A%22Gross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Dane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20L.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaylyn%20L.%22%2C%22lastName%22%3A%22Devlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20C.%22%2C%22lastName%22%3A%22McLean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20S.%22%2C%22lastName%22%3A%22Derrick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22London%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Torre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20Erol%22%2C%22lastName%22%3A%22Evangelista%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%20B.%22%2C%22lastName%22%3A%22Clarke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhuorui%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cemal%22%2C%22lastName%22%3A%22Erdem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Lyons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ted%22%2C%22lastName%22%3A%22Natoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Pessa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaodong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Mullahoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Adam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brook%22%2C%22lastName%22%3A%22Wassie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moqing%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20F.%22%2C%22lastName%22%3A%22Kilburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiera%20A.%22%2C%22lastName%22%3A%22Liby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmar%22%2C%22lastName%22%3A%22Bucher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crystal%22%2C%22lastName%22%3A%22Sanchez-Aguila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Daily%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larsson%22%2C%22lastName%22%3A%22Omberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yunguan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dusica%22%2C%22lastName%22%3A%22Vidovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yiling%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Schurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Pillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aravind%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malvina%22%2C%22lastName%22%3A%22Papanastasiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%22%2C%22lastName%22%3A%22Fraenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20S.%22%2C%22lastName%22%3A%22Feiler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20B.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jake%20D.%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avi%22%2C%22lastName%22%3A%22Ma%27ayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Birtwistle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Korkola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Heiser%22%7D%5D%2C%22abstractNote%22%3A%22The%20phenotype%20of%20a%20cell%20and%20its%20underlying%20molecular%20state%20is%20strongly%20influenced%20by%20extracellular%20signals%2C%20including%20growth%20factors%2C%20hormones%2C%20and%20extracellular%20matrix%20proteins.%20While%20these%20signals%20are%20normally%20tightly%20controlled%2C%20their%20dysregulation%20leads%20to%20phenotypic%20and%20molecular%20states%20associated%20with%20diverse%20diseases.%20To%20develop%20a%20detailed%20understanding%20of%20the%20linkage%20between%20molecular%20and%20phenotypic%20changes%2C%20we%20generated%20a%20comprehensive%20dataset%20that%20catalogs%20the%20transcriptional%2C%20proteomic%2C%20epigenomic%20and%20phenotypic%20responses%20of%20MCF10A%20mammary%20epithelial%20cells%20after%20exposure%20to%20the%20ligands%20EGF%2C%20HGF%2C%20OSM%2C%20IFNG%2C%20TGFB%20and%20BMP2.%20Systematic%20assessment%20of%20the%20molecular%20and%20cellular%20phenotypes%20induced%20by%20these%20ligands%20comprise%20the%20LINCS%20Microenvironment%20%28ME%29%20perturbation%20dataset%2C%20which%20has%20been%20curated%20and%20made%20publicly%20available%20for%20community-wide%20analysis%20and%20development%20of%20novel%20computational%20methods%20%28%20synapse.org%5C%2FLINCS_MCF10A%20%29.%20In%20illustrative%20analyses%2C%20we%20demonstrate%20how%20this%20dataset%20can%20be%20used%20to%20discover%20functionally%20related%20molecular%20features%20linked%20to%20specific%20cellular%20phenotypes.%20Beyond%20these%20analyses%2C%20this%20dataset%20will%20serve%20as%20a%20resource%20for%20the%20broader%20scientific%20community%20to%20mine%20for%20biological%20insights%2C%20to%20compare%20signals%20carried%20across%20distinct%20molecular%20modalities%2C%20and%20to%20develop%20new%20computational%20methods%20for%20integrative%20data%20analysis.%22%2C%22date%22%3A%222022-10-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs42003-022-03975-9%22%2C%22ISSN%22%3A%222399-3642%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-11-07T17%3A04%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22FQCV9DFT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gyori%20and%20Hoyt%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGyori%20BM%2C%20Hoyt%20CT.%20PyBioPAX%3A%20biological%20pathway%20exchange%20in%20Python.%20J%20Open%20Source%20Softw.%202022%3B7%2871%29%3A4136.%20PMCID%3A%20PMC9447860%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PyBioPAX%3A%20biological%20pathway%20exchange%20in%20Python%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21105%5C%2Fjoss.04136%22%2C%22ISSN%22%3A%222475-9066%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A07%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22MJH3UM8S%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gyori%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGyori%20BM%2C%20Hoyt%20CT%2C%20Steppi%20A.%20Gilda%3A%20biomedical%20entity%20text%20normalization%20with%20machine-learned%20disambiguation%20as%20a%20service.%20Bioinform%20Adv.%202022%3B2%281%29%3Avbac034.%20PMCID%3A%20PMC9710686%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gilda%3A%20biomedical%20entity%20text%20normalization%20with%20machine-learned%20disambiguation%20as%20a%20service%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Steppi%22%7D%5D%2C%22abstractNote%22%3A%22SUMMARY%3A%20Gilda%20is%20a%20software%20tool%20and%20web%20service%20that%20implements%20a%20scored%20string%20matching%20algorithm%20for%20names%20and%20synonyms%20across%20entries%20in%20biomedical%20ontologies%20covering%20genes%2C%20proteins%20%28and%20their%20families%20and%20complexes%29%2C%20small%20molecules%2C%20biological%20processes%20and%20diseases.%20Gilda%20integrates%20machine-learned%20disambiguation%20models%20to%20choose%20between%20ambiguous%20strings%20given%20relevant%20surrounding%20text%20as%20context%2C%20and%20supports%20species-prioritization%20in%20case%20of%20ambiguity.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20The%20Gilda%20web%20service%20is%20available%20at%20http%3A%5C%2F%5C%2Fgrounding.indra.bio%20with%20source%20code%2C%20documentation%20and%20tutorials%20available%20via%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Findralab%5C%2Fgilda.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20Advances%20online.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioadv%5C%2Fvbac034%22%2C%22ISSN%22%3A%222635-0041%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A06%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22I83Z39LS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hodis%20et%20al.%22%2C%22parsedDate%22%3A%222022-04-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHodis%20E%2C%20Torlai%20Triglia%20E%2C%20Kwon%20JYH%2C%20Biancalani%20T%2C%20Zakka%20LR%2C%20Parkar%20S%2C%20H%26%23xFC%3Btter%20JC%2C%20Buffoni%20L%2C%20Delorey%20TM%2C%20Phillips%20D%2C%20Dionne%20D%2C%20Nguyen%20LT%2C%20Schapiro%20D%2C%20Maliga%20Z%2C%20Jacobson%20CA%2C%20Hendel%20A%2C%20Rozenblatt-Rosen%20O%2C%20Mihm%20MC%2C%20Garraway%20LA%2C%20Regev%20A.%20Stepwise-edited%2C%20human%20melanoma%20models%20reveal%20mutations%26%23x2019%3B%20effect%20on%20tumor%20and%20microenvironment.%20Science.%202022%20Apr%2029%3B376%286592%29%3Aeabi8175.%20PMCID%3A%20PMC9427199%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Stepwise-edited%2C%20human%20melanoma%20models%20reveal%20mutations%27%20effect%20on%20tumor%20and%20microenvironment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eran%22%2C%22lastName%22%3A%22Hodis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Torlai%20Triglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20Y.%20H.%22%2C%22lastName%22%3A%22Kwon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tommaso%22%2C%22lastName%22%3A%22Biancalani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Labib%20R.%22%2C%22lastName%22%3A%22Zakka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saurabh%22%2C%22lastName%22%3A%22Parkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan-Christian%22%2C%22lastName%22%3A%22H%5Cu00fctter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Buffoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toni%20M.%22%2C%22lastName%22%3A%22Delorey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devan%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%22%2C%22lastName%22%3A%22Dionne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lan%20T.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayal%22%2C%22lastName%22%3A%22Hendel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20C.%22%2C%22lastName%22%3A%22Mihm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%5D%2C%22abstractNote%22%3A%22Establishing%20causal%20relationships%20between%20genetic%20alterations%20of%20human%20cancers%20and%20specific%20phenotypes%20of%20malignancy%20remains%20a%20challenge.%20We%20sequentially%20introduced%20mutations%20into%20healthy%20human%20melanocytes%20in%20up%20to%20five%20genes%20spanning%20six%20commonly%20disrupted%20melanoma%20pathways%2C%20forming%20nine%20genetically%20distinct%20cellular%20models%20of%20melanoma.%20We%20connected%20mutant%20melanocyte%20genotypes%20to%20malignant%20cell%20expression%20programs%20in%20vitro%20and%20in%20vivo%2C%20replicative%20immortality%2C%20malignancy%2C%20rapid%20tumor%20growth%2C%20pigmentation%2C%20metastasis%2C%20and%20histopathology.%20Mutations%20in%20malignant%20cells%20also%20affected%20tumor%20microenvironment%20composition%20and%20cell%20states.%20Our%20melanoma%20models%20shared%20genotype-associated%20expression%20programs%20with%20patient%20melanomas%2C%20and%20a%20deep%20learning%20model%20showed%20that%20these%20models%20partially%20recapitulated%20genotype-associated%20histopathological%20features%20as%20well.%20Thus%2C%20a%20progressive%20series%20of%20genome-edited%20human%20cancer%20models%20can%20causally%20connect%20genotypes%20carrying%20multiple%20mutations%20to%20phenotype.%22%2C%22date%22%3A%222022-04-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.abi8175%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A02Z%22%7D%7D%2C%7B%22key%22%3A%228573XGX7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hoyt%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoyt%20CT%2C%20Balk%20M%2C%20Callahan%20TJ%2C%20Domingo-Fern%26%23xE1%3Bndez%20D%2C%20Haendel%20MA%2C%20Hegde%20HB%2C%20Himmelstein%20DS%2C%20Karis%20K%2C%20Kunze%20J%2C%20Lubiana%20T%2C%20Matentzoglu%20N%2C%20McMurry%20J%2C%20Moxon%20S%2C%20Mungall%20CJ%2C%20Rutz%20A%2C%20Unni%20DR%2C%20Willighagen%20E%2C%20Winston%20D%2C%20Gyori%20BM.%20Unifying%20the%20identification%20of%20biomedical%20entities%20with%20the%20Bioregistry.%20Sci%20Data.%202022%20Nov%2019%3B9%281%29%3A714.%20PMCID%3A%20PMC9675740%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Unifying%20the%20identification%20of%20biomedical%20entities%20with%20the%20Bioregistry%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meghan%22%2C%22lastName%22%3A%22Balk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiffany%20J.%22%2C%22lastName%22%3A%22Callahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Domingo-Fern%5Cu00e1ndez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20A.%22%2C%22lastName%22%3A%22Haendel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harshad%20B.%22%2C%22lastName%22%3A%22Hegde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20S.%22%2C%22lastName%22%3A%22Himmelstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klas%22%2C%22lastName%22%3A%22Karis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Kunze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiago%22%2C%22lastName%22%3A%22Lubiana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Matentzoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22McMurry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sierra%22%2C%22lastName%22%3A%22Moxon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Mungall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriano%22%2C%22lastName%22%3A%22Rutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%20R.%22%2C%22lastName%22%3A%22Unni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Egon%22%2C%22lastName%22%3A%22Willighagen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%22%2C%22lastName%22%3A%22Winston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%5D%2C%22abstractNote%22%3A%22The%20standardized%20identification%20of%20biomedical%20entities%20is%20a%20cornerstone%20of%20interoperability%2C%20reuse%2C%20and%20data%20integration%20in%20the%20life%20sciences.%20Several%20registries%20have%20been%20developed%20to%20catalog%20resources%20maintaining%20identifiers%20for%20biomedical%20entities%20such%20as%20small%20molecules%2C%20proteins%2C%20cell%20lines%2C%20and%20clinical%20trials.%20However%2C%20existing%20registries%20have%20struggled%20to%20provide%20sufficient%20coverage%20and%20metadata%20standards%20that%20meet%20the%20evolving%20needs%20of%20modern%20life%20sciences%20researchers.%20Here%2C%20we%20introduce%20the%20Bioregistry%2C%20an%20integrative%2C%20open%2C%20community-driven%20metaregistry%20that%20synthesizes%20and%20substantially%20expands%20upon%2023%20existing%20registries.%20The%20Bioregistry%20addresses%20the%20need%20for%20a%20sustainable%20registry%20by%20leveraging%20public%20infrastructure%20and%20automation%2C%20and%20employing%20a%20progressive%20governance%20model%20centered%20around%20open%20code%20and%20open%20data%20to%20foster%20community%20contribution.%20The%20Bioregistry%20can%20be%20used%20to%20support%20the%20standardized%20annotation%20of%20data%2C%20models%2C%20ontologies%2C%20and%20scientific%20literature%2C%20thereby%20promoting%20their%20interoperability%20and%20reuse.%20The%20Bioregistry%20can%20be%20accessed%20through%20https%3A%5C%2F%5C%2Fbioregistry.io%20and%20its%20source%20code%20and%20data%20are%20available%20under%20the%20MIT%20and%20CC0%20Licenses%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fbiopragmatics%5C%2Fbioregistry%20.%22%2C%22date%22%3A%222022-11-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-022-01807-3%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A06%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22VTCPTH37%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jessup%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJessup%20J%2C%20Krueger%20R%2C%20Warchol%20S%2C%20Hoffer%20J%2C%20Muhlich%20J%2C%20Ritch%20CC%2C%20Gaglia%20G%2C%20Coy%20S%2C%20Chen%20YA%2C%20Lin%20JR%2C%20Santagata%20S%2C%20Sorger%20PK%2C%20Pfister%20H.%20Scope2Screen%3A%20focus%2Bcontext%20techniques%20for%20pathology%20tumor%20assessment%20in%20multivariate%20image%20data.%20IEEE%20Trans%20Vis%20Comput%20Graph.%202022%20Jan%3B28%281%29%3A259%26%23x2013%3B269.%20PMCID%3A%20PMC8805697%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Scope2Screen%3A%20focus%2Bcontext%20techniques%20for%20pathology%20tumor%20assessment%20in%20multivariate%20image%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jared%22%2C%22lastName%22%3A%22Jessup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Warchol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecily%20C.%22%2C%22lastName%22%3A%22Ritch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22Inspection%20of%20tissues%20using%20a%20light%20microscope%20is%20the%20primary%20method%20of%20diagnosing%20many%20diseases%2C%20notably%20cancer.%20Highly%20multiplexed%20tissue%20imaging%20builds%20on%20this%20foundation%2C%20enabling%20the%20collection%20of%20up%20to%2060%20channels%20of%20molecular%20information%20plus%20cell%20and%20tissue%20morphology%20using%20antibody%20staining.%20This%20provides%20unique%20insight%20into%20disease%20biology%20and%20promises%20to%20help%20with%20the%20design%20of%20patient-specific%20therapies.%20However%2C%20a%20substantial%20gap%20remains%20with%20respect%20to%20visualizing%20the%20resulting%20multivariate%20image%20data%20and%20effectively%20supporting%20pathology%20workflows%20in%20digital%20environments%20on%20screen.%20We%2C%20therefore%2C%20developed%20Scope2Screen%2C%20a%20scalable%20software%20system%20for%20focus%2Bcontext%20exploration%20and%20annotation%20of%20whole-slide%2C%20high-plex%2C%20tissue%20images.%20Our%20approach%20scales%20to%20analyzing%20100GB%20images%20of%20109%20or%20more%20pixels%20per%20channel%2C%20containing%20millions%20of%20individual%20cells.%20A%20multidisciplinary%20team%20of%20visualization%20experts%2C%20microscopists%2C%20and%20pathologists%20identified%20key%20image%20exploration%20and%20annotation%20tasks%20involving%20finding%2C%20magnifying%2C%20quantifying%2C%20and%20organizing%20regions%20of%20interest%20%28ROIs%29%20in%20an%20intuitive%20and%20cohesive%20manner.%20Building%20on%20a%20scope-to-screen%20metaphor%2C%20we%20present%20interactive%20lensing%20techniques%20that%20operate%20at%20single-cell%20and%20tissue%20levels.%20Lenses%20are%20equipped%20with%20task-specific%20functionality%20and%20descriptive%20statistics%2C%20making%20it%20possible%20to%20analyze%20image%20features%2C%20cell%20types%2C%20and%20spatial%20arrangements%20%28neighborhoods%29%20across%20image%20channels%20and%20scales.%20A%20fast%20sliding-window%20search%20guides%20users%20to%20regions%20similar%20to%20those%20under%20the%20lens%3B%20these%20regions%20can%20be%20analyzed%20and%20considered%20either%20separately%20or%20as%20part%20of%20a%20larger%20image%20collection.%20A%20novel%20snapshot%20method%20enables%20linked%20lens%20configurations%20and%20image%20statistics%20to%20be%20saved%2C%20restored%2C%20and%20shared%20with%20these%20regions.%20We%20validate%20our%20designs%20with%20domain%20experts%20and%20apply%20Scope2Screen%20in%20two%20case%20studies%20involving%20lung%20and%20colorectal%20cancers%20to%20discover%20cancer-relevant%20image%20features.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1109%5C%2FTVCG.2021.3114786%22%2C%22ISSN%22%3A%221941-0506%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22DJDXZ7IC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jim%5Cu00e9nez%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJim%26%23xE9%3Bnez%20A%2C%20Lu%20D%2C%20Kalocsay%20M%2C%20Berberich%20MJ%2C%20Balbi%20P%2C%20Jambhekar%20A%2C%20Lahav%20G.%20Time-series%20transcriptomics%20and%20proteomics%20reveal%20alternative%20modes%20to%20decode%20p53%20oscillations.%20Mol%20Syst%20Biol.%202022%20Mar%3B18%283%29%3Ae10588.%20PMCID%3A%20PMC8919251%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Time-series%20transcriptomics%20and%20proteomics%20reveal%20alternative%20modes%20to%20decode%20p53%20oscillations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alba%22%2C%22lastName%22%3A%22Jim%5Cu00e9nez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petra%22%2C%22lastName%22%3A%22Balbi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22The%20cell%20stress-responsive%20transcription%20factor%20p53%20influences%20the%20expression%20of%20its%20target%20genes%20and%20subsequent%20cellular%20responses%20based%20in%20part%20on%20its%20dynamics%20%28changes%20in%20level%20over%20time%29.%20The%20mechanisms%20decoding%20p53%20dynamics%20into%20subsequent%20target%20mRNA%20and%20protein%20dynamics%20remain%20unclear.%20We%20systematically%20quantified%20p53%20target%20mRNA%20and%20protein%20expression%20over%20time%20under%20two%20p53%20dynamical%20regimes%2C%20oscillatory%20and%20rising%2C%20using%20RNA-sequencing%20and%20TMT%20mass%20spectrometry.%20Oscillatory%20dynamics%20allowed%20for%5Cu202fa%20greater%5Cu202fvariety%5Cu202fof%20dynamical%20patterns%20for%20both%20mRNAs%20and%20proteins.%20Mathematical%20modeling%20of%20empirical%20data%20revealed%20three%20distinct%20mechanisms%20that%20decode%20p53%20dynamics.%20Specific%20combinations%20of%20these%20mechanisms%20at%20the%20transcriptional%20and%20post-transcriptional%20levels%20enabled%20exclusive%20induction%20of%20proteins%20under%20particular%20dynamics.%20In%20addition%2C%20rising%20induction%20of%20p53%20led%20to%20higher%20induction%20of%20proteins%20regardless%20of%20their%20functional%20class%2C%20including%20proteins%20promoting%20arrest%20of%20proliferation%2C%20the%20primary%20cellular%20outcome%20under%20rising%20p53.%20Our%20results%20highlight%20the%20diverse%20mechanisms%20cells%20employ%20to%20distinguish%20complex%20transcription%20factor%20dynamics%20to%20regulate%20gene%20expression.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.202110588%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-05-02T16%3A34%3A06Z%22%7D%7D%2C%7B%22key%22%3A%226S55IHTJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Johnson%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJohnson%20S%2C%20Haigis%20MC%2C%20Dougan%20SK.%20Dangerous%20dynamic%20duo%3A%20lactic%20acid%20and%20PD-1%20blockade.%20Cancer%20Cell.%202022%20Feb%2014%3B40%282%29%3A127%26%23x2013%3B130.%20PMID%3A%2035093211%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dangerous%20dynamic%20duo%3A%20lactic%20acid%20and%20PD-1%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheila%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20K.%22%2C%22lastName%22%3A%22Dougan%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20issue%20of%20Cancer%20Cell%2C%20Kumagai%20et%5Cu00a0al.%20reveal%20lactic%20acid%20as%20a%20mediator%20of%20checkpoint%20blockade%20resistance.%20Tumor-derived%20lactic%20acid%20promotes%20T%20regulatory%20cell%20%28Treg%29%20activity%20and%20impairs%20CD8%2B%20T%5Cu00a0cell%20function.%20PD-1%20blockade%20synergizes%20with%20lactic%20acid%20to%20enhance%20Treg%20suppression%20and%20impede%20antitumor%20immunity.%22%2C%22date%22%3A%222022-02-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2022.01.008%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-30T19%3A37%3A50Z%22%7D%7D%2C%7B%22key%22%3A%222J8CUQWB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Larkins-Ford%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELarkins-Ford%20J%2C%20Degefu%20YN%2C%20Van%20N%2C%20Sokolov%20A%2C%20Aldridge%20BB.%20Design%20principles%20to%20assemble%20drug%20combinations%20for%20effective%20tuberculosis%20therapy%20using%20interpretable%20pairwise%20drug%20response%20measurements.%20Cell%20Rep%20Med.%202022%20Sep%2020%3B3%289%29%3A100737.%20PMCID%3A%20PMC9512659%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%20principles%20to%20assemble%20drug%20combinations%20for%20effective%20tuberculosis%20therapy%20using%20interpretable%20pairwise%20drug%20response%20measurements%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonah%22%2C%22lastName%22%3A%22Larkins-Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yonatan%20N.%22%2C%22lastName%22%3A%22Degefu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhi%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22A%20challenge%20in%20tuberculosis%20treatment%20regimen%20design%20is%20the%20necessity%20to%20combine%20three%20or%20more%20antibiotics.%20We%20narrow%20the%20prohibitively%20large%20search%20space%20by%20breaking%20down%20high-order%20drug%20combinations%20into%20drug%20pair%20units.%20Using%20pairwise%20in%5Cu00a0vitro%20measurements%2C%20we%20train%20machine%20learning%20models%20to%20predict%20higher-order%20combination%20treatment%20outcomes%20in%20the%20relapsing%20BALB%5C%2Fc%20mouse%20model.%20Classifiers%20perform%20well%20and%20predict%20many%20of%20the%20%3E500%20possible%20combinations%20among%2012%20antibiotics%20to%20be%20improved%20over%20bedaquiline%5Cu00a0%2B%20pretomanid%5Cu00a0%2B%20linezolid%2C%20a%20treatment-shortening%20regimen%20compared%20with%20the%20standard%20of%20care%20in%20mice.%20We%20reformulate%20classifiers%20as%20simple%20rulesets%20to%20reveal%20guiding%20principles%20of%20constructing%20combination%20therapies%20for%20both%20preclinical%20and%20clinical%20outcomes.%20One%20example%20ruleset%20combines%20a%20drug%20pair%20that%20is%20synergistic%20in%20a%20dormancy%20model%20with%20a%20pair%20that%20is%20potent%20in%20a%20cholesterol-rich%20growth%20environment.%20These%20rulesets%20are%20predictive%2C%20intuitive%2C%20and%20practical%2C%20thus%20enabling%20rational%20construction%20of%20drug%20combinations.%22%2C%22date%22%3A%222022-09-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xcrm.2022.100737%22%2C%22ISSN%22%3A%222666-3791%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A51%3A06Z%22%7D%7D%2C%7B%22key%22%3A%229WFYLLCV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Launonen%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-11%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELaunonen%20IM%2C%20Lyytik%26%23xE4%3Binen%20N%2C%20Casado%20J%2C%20Anttila%20EA%2C%20Szab%26%23xF3%3B%20A%2C%20Haltia%20UM%2C%20Jacobson%20CA%2C%20Lin%20JR%2C%20Maliga%20Z%2C%20Howitt%20BE%2C%20Strickland%20KC%2C%20Santagata%20S%2C%20Elias%20K%2C%20D%26%23x2019%3BAndrea%20AD%2C%20Konstantinopoulos%20PA%2C%20Sorger%20PK%2C%20F%26%23xE4%3Brkkil%26%23xE4%3B%20A.%20Single-cell%20tumor-immune%20microenvironment%20of%20BRCA1%5C%2F2%20mutated%20high-grade%20serous%20ovarian%20cancer.%20Nat%20Commun.%202022%20Feb%2011%3B13%281%29%3A835.%20PMCID%3A%20PMC8837628%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-cell%20tumor-immune%20microenvironment%20of%20BRCA1%5C%2F2%20mutated%20high-grade%20serous%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.-M.%22%2C%22lastName%22%3A%22Launonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lyytik%5Cu00e4inen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Casado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20A.%22%2C%22lastName%22%3A%22Anttila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Szab%5Cu00f3%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.-M.%22%2C%22lastName%22%3A%22Haltia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20R.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20E.%22%2C%22lastName%22%3A%22Howitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20C.%22%2C%22lastName%22%3A%22Strickland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Elias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20D.%22%2C%22lastName%22%3A%22D%27Andrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20A.%22%2C%22lastName%22%3A%22Konstantinopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%5D%2C%22abstractNote%22%3A%22The%20majority%20of%20high-grade%20serous%20ovarian%20cancers%20%28HGSCs%29%20are%20deficient%20in%20homologous%20recombination%20%28HR%29%20DNA%20repair%2C%20most%20commonly%20due%20to%20mutations%20or%20hypermethylation%20of%20the%20BRCA1%5C%2F2%20genes.%20We%20aimed%20to%20discover%20how%20BRCA1%5C%2F2%20mutations%20shape%20the%20cellular%20phenotypes%20and%20spatial%20interactions%20of%20the%20tumor%20microenvironment.%20Using%20a%20highly%20multiplex%20immunofluorescence%20and%20image%20analysis%20we%20generate%20spatial%20proteomic%20data%20for%2021%20markers%20in%20124%2C623%20single%20cells%20from%20112%20tumor%20cores%20originating%20from%2031%20tumors%20with%20BRCA1%5C%2F2%20mutation%20%28BRCA1%5C%2F2mut%29%2C%20and%20from%2013%20tumors%20without%20alterations%20in%20HR%20genes.%20We%20identify%20a%20phenotypically%20distinct%20tumor%20microenvironment%20in%20the%20BRCA1%5C%2F2mut%20tumors%20with%20evidence%20of%20increased%20immunosurveillance.%20Importantly%2C%20we%20report%20a%20prognostic%20role%20of%20a%20proliferative%20tumor-cell%20subpopulation%2C%20which%20associates%20with%20enhanced%20spatial%20tumor-immune%20interactions%20by%20CD8%2B%20and%20CD4%5Cu2009%2B%5Cu2009T-cells%20in%20the%5Cu00a0BRCA1%5C%2F2mut%20tumors.%20The%20single-cell%20spatial%20landscapes%20indicate%20distinct%20patterns%20of%20spatial%20immunosurveillance%20with%20the%20potential%20to%20improve%20immunotherapeutic%20strategies%20and%20patient%20stratification%20in%20HGSC.%22%2C%22date%22%3A%222022-02-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-28389-3%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A10%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22QKEEAYU3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lomakin%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELomakin%20A%2C%20Svedlund%20J%2C%20Strell%20C%2C%20Gataric%20M%2C%20Shmatko%20A%2C%20Rukhovich%20G%2C%20Park%20JS%2C%20Ju%20YS%2C%20Dentro%20S%2C%20Kleshchevnikov%20V%2C%20Vaskivskyi%20V%2C%20Li%20T%2C%20Bayraktar%20OA%2C%20Pinder%20S%2C%20Richardson%20AL%2C%20Santagata%20S%2C%20Campbell%20PJ%2C%20Russnes%20H%2C%20Gerstung%20M%2C%20Nilsson%20M%2C%20Yates%20LR.%20Spatial%20genomics%20maps%20the%20structure%2C%20nature%20and%20evolution%20of%20cancer%20clones.%20Nature.%202022%20Nov%3B611%287936%29%3A594%26%23x2013%3B602.%20PMCID%3A%20PMC9668746%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spatial%20genomics%20maps%20the%20structure%2C%20nature%20and%20evolution%20of%20cancer%20clones%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Lomakin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Svedlund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Strell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milana%22%2C%22lastName%22%3A%22Gataric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Shmatko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gleb%22%2C%22lastName%22%3A%22Rukhovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Sung%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20Seok%22%2C%22lastName%22%3A%22Ju%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Dentro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vitalii%22%2C%22lastName%22%3A%22Kleshchevnikov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vasyl%22%2C%22lastName%22%3A%22Vaskivskyi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omer%20Ali%22%2C%22lastName%22%3A%22Bayraktar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Pinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20L.%22%2C%22lastName%22%3A%22Richardson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20J.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hege%22%2C%22lastName%22%3A%22Russnes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moritz%22%2C%22lastName%22%3A%22Gerstung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mats%22%2C%22lastName%22%3A%22Nilsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%20R.%22%2C%22lastName%22%3A%22Yates%22%7D%5D%2C%22abstractNote%22%3A%22Genome%20sequencing%20of%20cancers%20often%20reveals%20mosaics%20of%20different%20subclones%20present%20in%20the%20same%20tumour%3Csup%3E1-3%3C%5C%2Fsup%3E.%20Although%20these%20are%20believed%20to%20arise%20according%20to%20the%20principles%20of%20somatic%20evolution%2C%20the%20exact%20spatial%20growth%20patterns%20and%20underlying%20mechanisms%20remain%20elusive%3Csup%3E4%2C5%3C%5C%2Fsup%3E.%20Here%2C%20to%20address%20this%20need%2C%20we%20developed%20a%20workflow%20that%20generates%20detailed%20quantitative%20maps%20of%20genetic%20subclone%20composition%20across%20whole-tumour%20sections.%20These%20provide%20the%20basis%20for%20studying%20clonal%20growth%20patterns%2C%20and%20the%20histological%20characteristics%2C%20microanatomy%20and%20microenvironmental%20composition%20of%20each%20clone.%20The%20approach%20rests%20on%20whole-genome%20sequencing%2C%20followed%20by%20highly%20multiplexed%20base-specific%20in%20situ%20sequencing%2C%20single-cell%20resolved%20transcriptomics%20and%20dedicated%20algorithms%20to%20link%20these%20layers.%20Applying%20the%20base-specific%20in%20situ%20sequencing%20workflow%20to%20eight%20tissue%20sections%20from%20two%20multifocal%20primary%20breast%20cancers%20revealed%20intricate%20subclonal%20growth%20patterns%20that%20were%20validated%20by%20microdissection.%20In%20a%20case%20of%20ductal%20carcinoma%20in%20situ%2C%20polyclonal%20neoplastic%20expansions%20occurred%20at%20the%20macroscopic%20scale%20but%20segregated%20within%20microanatomical%20structures.%20Across%20the%20stages%20of%20ductal%20carcinoma%20in%20situ%2C%20invasive%20cancer%20and%20lymph%20node%20metastasis%2C%20subclone%20territories%20are%20shown%20to%20exhibit%20distinct%20transcriptional%20and%20histological%20features%20and%20cellular%20microenvironments.%20These%20results%20provide%20examples%20of%20the%20benefits%20afforded%20by%20spatial%20genomics%20for%20deciphering%20the%20mechanisms%20underlying%20cancer%20evolution%20and%20microenvironmental%20ecology.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-022-05425-2%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-11-28T16%3A53%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22JYUBAL7W%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Matentzoglu%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMatentzoglu%20N%2C%20Goutte-Gattat%20D%2C%20Tan%20SZK%2C%20Balhoff%20JP%2C%20Carbon%20S%2C%20Caron%20AR%2C%20Duncan%20WD%2C%20Flack%20JE%2C%20Haendel%20M%2C%20Harris%20NL%2C%20Hogan%20WR%2C%20Hoyt%20CT%2C%20Jackson%20RC%2C%20Kim%20H%2C%20Kir%20H%2C%20Larralde%20M%2C%20McMurry%20JA%2C%20Overton%20JA%2C%20Peters%20B%2C%20Pilgrim%20C%2C%20Stefancsik%20R%2C%20Robb%20SM%2C%20Toro%20S%2C%20Vasilevsky%20NA%2C%20Walls%20R%2C%20Mungall%20CJ%2C%20Osumi-Sutherland%20D.%20Ontology%20Development%20Kit%3A%20a%20toolkit%20for%20building%2C%20maintaining%20and%20standardizing%20biomedical%20ontologies.%20Database%20%28Oxford%29.%202022%20Oct%208%3B2022%3Abaac087.%20PMCID%3A%20PMC9547537%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ontology%20Development%20Kit%3A%20a%20toolkit%20for%20building%2C%20maintaining%20and%20standardizing%20biomedical%20ontologies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Matentzoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%22%2C%22lastName%22%3A%22Goutte-Gattat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20Zheng%20Kai%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Balhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seth%22%2C%22lastName%22%3A%22Carbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%20R.%22%2C%22lastName%22%3A%22Caron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20D.%22%2C%22lastName%22%3A%22Duncan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20E.%22%2C%22lastName%22%3A%22Flack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Haendel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nomi%20L.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20R.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20C.%22%2C%22lastName%22%3A%22Jackson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22HyeongSik%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huseyin%22%2C%22lastName%22%3A%22Kir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Larralde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20A.%22%2C%22lastName%22%3A%22McMurry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22Overton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bjoern%22%2C%22lastName%22%3A%22Peters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clare%22%2C%22lastName%22%3A%22Pilgrim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ray%22%2C%22lastName%22%3A%22Stefancsik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sofia%20Mc%22%2C%22lastName%22%3A%22Robb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Toro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20A.%22%2C%22lastName%22%3A%22Vasilevsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramona%22%2C%22lastName%22%3A%22Walls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Mungall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Osumi-Sutherland%22%7D%5D%2C%22abstractNote%22%3A%22Similar%20to%20managing%20software%20packages%2C%20managing%20the%20ontology%20life%20cycle%20involves%20multiple%20complex%20workflows%20such%20as%20preparing%20releases%2C%20continuous%20quality%20control%20checking%20and%20dependency%20management.%20To%20manage%20these%20processes%2C%20a%20diverse%20set%20of%20tools%20is%20required%2C%20from%20command-line%20utilities%20to%20powerful%20ontology-engineering%20environmentsr.%20Particularly%20in%20the%20biomedical%20domain%2C%20which%20has%20developed%20a%20set%20of%20highly%20diverse%20yet%20inter-dependent%20ontologies%2C%20standardizing%20release%20practices%20and%20metadata%20and%20establishing%20shared%20quality%20standards%20are%20crucial%20to%20enable%20interoperability.%20The%20Ontology%20Development%20Kit%20%28ODK%29%20provides%20a%20set%20of%20standardized%2C%20customizable%20and%20automatically%20executable%20workflows%2C%20and%20packages%20all%20required%20tooling%20in%20a%20single%20Docker%20image.%20In%20this%20paper%2C%20we%20provide%20an%20overview%20of%20how%20the%20ODK%20works%2C%20show%20how%20it%20is%20used%20in%20practice%20and%20describe%20how%20we%20envision%20it%20driving%20standardization%20efforts%20in%20our%20community.%20Database%20URL%3A%20https%3A%5C%2F%5C%2Fgithub.com%5C%2FINCATools%5C%2Fontology-development-kit.%22%2C%22date%22%3A%222022-10-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fdatabase%5C%2Fbaac087%22%2C%22ISSN%22%3A%221758-0463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-10-24T14%3A27%3A16Z%22%7D%7D%2C%7B%22key%22%3A%2278WG5WJP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Mills%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMills%20CE%2C%20Subramanian%20K%2C%20Hafner%20M%2C%20Niepel%20M%2C%20Gerosa%20L%2C%20Chung%20M%2C%20Victor%20C%2C%20Gaudio%20B%2C%20Yapp%20C%2C%20Nirmal%20AJ%2C%20Clark%20N%2C%20Sorger%20PK.%20Multiplexed%20and%20reproducible%20high%20content%20screening%20of%20live%20and%20fixed%20cells%20using%20Dye%20Drop.%20Nat%20Commun.%202022%20Nov%2014%3B13%281%29%3A6918.%20PMCID%3A%20PMC9663587%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiplexed%20and%20reproducible%20high%20content%20screening%20of%20live%20and%20fixed%20cells%20using%20Dye%20Drop%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Victor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22High-throughput%20measurement%20of%20cells%20perturbed%20using%20libraries%20of%20small%20molecules%2C%20gene%20knockouts%2C%20or%20different%20microenvironmental%20factors%20is%20a%20key%20step%20in%20functional%20genomics%20and%20pre-clinical%20drug%20discovery.%20However%2C%20it%20remains%20difficult%20to%20perform%20accurate%20single-cell%20assays%20in%20384-well%20plates%2C%20limiting%20many%20studies%20to%20well-average%20measurements%20%28e.g.%2C%20CellTiter-Glo%5Cu00ae%29.%20Here%20we%20describe%20a%20public%20domain%20Dye%20Drop%20method%20that%20uses%20sequential%20density%20displacement%20and%20microscopy%20to%20perform%20multi-step%20assays%20on%20living%20cells.%20We%20use%20Dye%20Drop%20cell%20viability%20and%20DNA%20replication%20assays%20followed%20by%20immunofluorescence%20imaging%20to%20collect%20single-cell%20dose-response%20data%20for%2067%20investigational%20and%20clinical-grade%20small%20molecules%20in%2058%20breast%20cancer%20cell%20lines.%20By%20separating%20the%20cytostatic%20and%20cytotoxic%20effects%20of%20drugs%20computationally%2C%20we%20uncover%20unexpected%20relationships%20between%20the%20two.%20Dye%20Drop%20is%20rapid%2C%20reproducible%2C%20customizable%2C%20and%20compatible%20with%20manual%20or%20automated%20laboratory%20equipment.%20Dye%20Drop%20improves%20the%20tradeoff%20between%20data%20content%20and%20cost%2C%20enabling%20the%20collection%20of%20information-rich%20perturbagen-response%20datasets.%22%2C%22date%22%3A%222022-11-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-34536-7%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A00%3A34Z%22%7D%7D%2C%7B%22key%22%3A%225C7E846L%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mohammad-Taheri%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMohammad-Taheri%20S%2C%20Zucker%20J%2C%20Hoyt%20CT%2C%20Sachs%20K%2C%20Tewari%20V%2C%20Ness%20R%2C%20Vitek%20O.%20Do-calculus%20enables%20estimation%20of%20causal%20effects%20in%20partially%20observed%20biomolecular%20pathways.%20Bioinformatics.%202022%20Jun%2024%3B38%28Suppl%201%29%3Ai350%26%23x2013%3Bi358.%20PMCID%3A%20PMC9235495%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Do-calculus%20enables%20estimation%20of%20causal%20effects%20in%20partially%20observed%20biomolecular%20pathways%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Mohammad-Taheri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Zucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Sachs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vartika%22%2C%22lastName%22%3A%22Tewari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Ness%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Vitek%22%7D%5D%2C%22abstractNote%22%3A%22MOTIVATION%3A%20Estimating%20causal%20queries%2C%20such%20as%20changes%20in%20protein%20abundance%20in%20response%20to%20a%20perturbation%2C%20is%20a%20fundamental%20task%20in%20the%20analysis%20of%20biomolecular%20pathways.%20The%20estimation%20requires%20experimental%20measurements%20on%20the%20pathway%20components.%20However%2C%20in%20practice%20many%20pathway%20components%20are%20left%20unobserved%20%28latent%29%20because%20they%20are%20either%20unknown%2C%20or%20difficult%20to%20measure.%20Latent%20variable%20models%20%28LVMs%29%20are%20well-suited%20for%20such%20estimation.%20Unfortunately%2C%20LVM-based%20estimation%20of%20causal%20queries%20can%20be%20inaccurate%20when%20parameters%20of%20the%20latent%20variables%20are%20not%20uniquely%20identified%2C%20or%20when%20the%20number%20of%20latent%20variables%20is%20misspecified.%20This%20has%20limited%20the%20use%20of%20LVMs%20for%20causal%20inference%20in%20biomolecular%20pathways.%5CnRESULTS%3A%20In%20this%20article%2C%20we%20propose%20a%20general%20and%20practical%20approach%20for%20LVM-based%20estimation%20of%20causal%20queries.%20We%20prove%20that%2C%20despite%20the%20challenges%20above%2C%20LVM-based%20estimators%20of%20causal%20queries%20are%20accurate%20if%20the%20queries%20are%20identifiable%20according%20to%20Pearl%27s%20do-calculus%20and%20describe%20an%20algorithm%20for%20its%20estimation.%20We%20illustrate%20the%20breadth%20and%20the%20practical%20utility%20of%20this%20approach%20for%20estimating%20causal%20queries%20in%20four%20synthetic%20and%20two%20experimental%20case%20studies%2C%20where%20structures%20of%20biomolecular%20pathways%20challenge%20the%20existing%20methods%20for%20causal%20query%20estimation.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20The%20code%20and%20the%20data%20documenting%20all%20the%20case%20studies%20are%20available%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fsrtaheri%5C%2FLVMwithDoCalculus.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20online.%22%2C%22date%22%3A%222022-06-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtac251%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A32Z%22%7D%7D%2C%7B%22key%22%3A%222EUSG4K4%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Muhlich%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-16%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMuhlich%20JL%2C%20Chen%20YA%2C%20Yapp%20C%2C%20Russell%20D%2C%20Santagata%20S%2C%20Sorger%20PK.%20Stitching%20and%20registering%20highly%20multiplexed%20whole%20slide%20images%20of%20tissues%20and%20tumors%20using%20ASHLAR.%20Bioinformatics.%202022%20Aug%2016%3Bbtac544.%20PMCID%3A%20PMC9525007%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Stitching%20and%20registering%20highly%20multiplexed%20whole%20slide%20images%20of%20tissues%20and%20tumors%20using%20ASHLAR%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Russell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22MOTIVATION%3A%20Stitching%20microscope%20images%20into%20a%20mosaic%20is%20an%20essential%20step%20in%20the%20analysis%20and%20visualization%20of%20large%20biological%20specimens%2C%20particularly%20human%20and%20animal%20tissues.%20Recent%20approaches%20to%20highly-multiplexed%20imaging%20generate%20high-plex%20data%20from%20sequential%20rounds%20of%20lower-plex%20imaging.%20These%20multiplexed%20imaging%20methods%20promise%20to%20yield%20precise%20molecular%20single-cell%20data%20and%20information%20on%20cellular%20neighborhoods%20and%20tissue%20architecture.%20However%2C%20attaining%20mosaic%20images%20with%20single-cell%20accuracy%20requires%20robust%20image%20stitching%20and%20image%20registration%20capabilities%20that%20are%20not%20met%20by%20existing%20methods.%5CnRESULTS%3A%20We%20describe%20the%20development%20and%20testing%20of%20ASHLAR%2C%20a%20Python%20tool%20for%20coordinated%20stitching%20and%20registration%20of%20103%20or%20more%20individual%20multiplexed%20images%20to%20generate%20accurate%20whole-slide%20mosaics.%20ASHLAR%20reads%20image%20formats%20from%20most%20commercial%20microscopes%20and%20slide%20scanners%2C%20and%20we%20show%20that%20it%20performs%20better%20than%20existing%20open%20source%20and%20commercial%20software.%20ASHLAR%20outputs%20standard%20OME-TIFF%20images%20that%20are%20ready%20for%20analysis%20by%20other%20open-source%20tools%20and%20recently%20developed%20image%20analysis%20pipelines.%5CnAVAILABILITY%3A%20ASHLAR%20is%20written%20in%20Python%20and%20available%20under%20the%20MIT%20license%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Flabsyspharm%5C%2Fashlar.%20An%20informational%20website%20with%20user%20guides%20and%20test%20data%20is%20available%20at%20https%3A%5C%2F%5C%2Flabsyspharm.github.io%5C%2Fashlar%5C%2F.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20online.%22%2C%22date%22%3A%222022-08-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtac544%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A40%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22YJLWM4GN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ng%20et%20al.%22%2C%22parsedDate%22%3A%222022-04-29%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENg%20TSC%2C%20Hu%20H%2C%20Kronister%20S%2C%20Lee%20C%2C%20Li%20R%2C%20Gerosa%20L%2C%20Stopka%20SA%2C%20Burgenske%20DM%2C%20Khurana%20I%2C%20Regan%20MS%2C%20Vallabhaneni%20S%2C%20Putta%20N%2C%20Scott%20E%2C%20Matvey%20D%2C%20Giobbie-Hurder%20A%2C%20Kohler%20RH%2C%20Sarkaria%20JN%2C%20Parangi%20S%2C%20Sorger%20PK%2C%20Agar%20NYR%2C%20Jacene%20HA%2C%20Sullivan%20RJ%2C%20Buchbinder%20E%2C%20Mikula%20H%2C%20Weissleder%20R%2C%20Miller%20MA.%20Overcoming%20differential%20tumor%20penetration%20of%20BRAF%20inhibitors%20using%20computationally%20guided%20combination%20therapy.%20Sci%20Adv.%202022%20Apr%2029%3B8%2817%29%3Aeabl6339.%20PMCID%3A%20PMC9054019%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Overcoming%20differential%20tumor%20penetration%20of%20BRAF%20inhibitors%20using%20computationally%20guided%20combination%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20S.%20C.%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huiyu%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Kronister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chanseo%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%20M.%22%2C%22lastName%22%3A%22Burgenske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ishaan%22%2C%22lastName%22%3A%22Khurana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreeram%22%2C%22lastName%22%3A%22Vallabhaneni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Putta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ella%22%2C%22lastName%22%3A%22Scott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dylan%22%2C%22lastName%22%3A%22Matvey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Giobbie-Hurder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rainer%20H.%22%2C%22lastName%22%3A%22Kohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jann%20N.%22%2C%22lastName%22%3A%22Sarkaria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sareh%22%2C%22lastName%22%3A%22Parangi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20A.%22%2C%22lastName%22%3A%22Jacene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Buchbinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannes%22%2C%22lastName%22%3A%22Mikula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%22%2C%22lastName%22%3A%22Weissleder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miles%20A.%22%2C%22lastName%22%3A%22Miller%22%7D%5D%2C%22abstractNote%22%3A%22BRAF-targeted%20kinase%20inhibitors%20%28KIs%29%20are%20used%20to%20treat%20malignancies%20including%20BRAF-mutant%20non-small%20cell%20lung%20cancer%2C%20colorectal%20cancer%2C%20anaplastic%20thyroid%20cancer%2C%20and%2C%20most%20prominently%2C%20melanoma.%20However%2C%20KI%20selection%20criteria%20in%20patients%20remain%20unclear%2C%20as%20are%20pharmacokinetic%5C%2Fpharmacodynamic%20%28PK%5C%2FPD%29%20mechanisms%20that%20may%20limit%20context-dependent%20efficacy%20and%20differentiate%20related%20drugs.%20To%20address%20this%20issue%2C%20we%20imaged%20mouse%20models%20of%20BRAF-mutant%20cancers%2C%20fluorescent%20KI%20tracers%2C%20and%20unlabeled%20drug%20to%20calibrate%20in%20silico%20spatial%20PK%5C%2FPD%20models.%20Results%20indicated%20that%20drug%20lipophilicity%2C%20plasma%20clearance%2C%20faster%20target%20dissociation%2C%20and%2C%20in%20particular%2C%20high%20albumin%20binding%20could%20limit%20dabrafenib%20action%20in%20visceral%20metastases%20compared%20to%20other%20KIs.%20This%20correlated%20with%20retrospective%20clinical%20observations.%20Computational%20modeling%20identified%20a%20timed%20strategy%20for%20combining%20dabrafenib%20and%20encorafenib%20to%20better%20sustain%20BRAF%20inhibition%2C%20which%20showed%20enhanced%20efficacy%20in%20mice.%20This%20study%20thus%20offers%20principles%20of%20spatial%20drug%20action%20that%20may%20help%20guide%20drug%20development%2C%20KI%20selection%2C%20and%20combination.%22%2C%22date%22%3A%222022-04-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.abl6339%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-10-28T03%3A46%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22RDKDE8NJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Nirmal%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-02%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENirmal%20AJ%2C%20Maliga%20Z%2C%20Vallius%20T%2C%20Quattrochi%20B%2C%20Chen%20AA%2C%20Jacobson%20CA%2C%20Pelletier%20RJ%2C%20Yapp%20C%2C%20Arias-Camison%20R%2C%20Chen%20YA%2C%20Lian%20CG%2C%20Murphy%20GF%2C%20Santagata%20S%2C%20Sorger%20PK.%20The%20spatial%20landscape%20of%20progression%20and%20immunoediting%20in%20primary%20melanoma%20at%20single-cell%20resolution.%20Cancer%20Discov.%202022%20Jun%202%3B12%286%29%3A1518%26%23x2013%3B1541.%20PMCID%3A%20PMC9167783%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20spatial%20landscape%20of%20progression%20and%20immunoediting%20in%20primary%20melanoma%20at%20single-cell%20resolution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Quattrochi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyce%20A.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%20J.%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Arias-Camison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Cutaneous%20melanoma%20is%20a%20highly%20immunogenic%20malignancy%20that%20is%20surgically%20curable%20at%20early%20stages%20but%20life-threatening%20when%20metastatic.%20Here%20we%20integrate%20high-plex%20imaging%2C%203D%20high-resolution%20microscopy%2C%20and%20spatially%20resolved%20microregion%20transcriptomics%20to%20study%20immune%20evasion%20and%20immunoediting%20in%20primary%20melanoma.%20We%20find%20that%20recurrent%20cellular%20neighborhoods%20involving%20tumor%2C%20immune%2C%20and%20stromal%20cells%20change%20significantly%20along%20a%20progression%20axis%20involving%20precursor%20states%2C%20melanoma%20in%20situ%2C%20and%20invasive%20tumor.%20Hallmarks%20of%20immunosuppression%20are%20already%20detectable%20in%20precursor%20regions.%20When%20tumors%20become%20locally%20invasive%2C%20a%20consolidated%20and%20spatially%20restricted%20suppressive%20environment%20forms%20along%20the%20tumor-stromal%20boundary.%20This%20environment%20is%20established%20by%20cytokine%20gradients%20that%20promote%20expression%20of%20MHC-II%20and%20IDO1%2C%20and%20by%20PD1-PDL1-mediated%20cell%20contacts%20involving%20macrophages%2C%20dendritic%20cells%2C%20and%20T%20cells.%20A%20few%20millimeters%20away%2C%20cytotoxic%20T%20cells%20synapse%20with%20melanoma%20cells%20in%20fields%20of%20tumor%20regression.%20Thus%2C%20invasion%20and%20immunoediting%20can%20coexist%20within%20a%20few%20millimeters%20of%20each%20other%20in%20a%20single%20specimen.%5CnSIGNIFICANCE%3A%20The%20reorganization%20of%20the%20tumor%20ecosystem%20in%20primary%20melanoma%20is%20an%20excellent%20setting%20in%20which%20to%20study%20immunoediting%20and%20immune%20evasion.%20Guided%20by%20classic%20histopathology%2C%20spatial%20profiling%20of%20proteins%20and%20mRNA%20reveals%20recurrent%20morphologic%20and%20molecular%20features%20of%20tumor%20evolution%20that%20involve%20localized%20paracrine%20cytokine%20signaling%20and%20direct%20cell-cell%20contact.%20This%20article%20is%20highlighted%20in%20the%20In%20This%20Issue%20feature%2C%20p.%201397.%22%2C%22date%22%3A%222022-06-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-21-1357%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A42%3A34Z%22%7D%7D%2C%7B%22key%22%3A%226HKXMX5L%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Notarangelo%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENotarangelo%20G%2C%20Spinelli%20JB%2C%20Perez%20EM%2C%20Baker%20GJ%2C%20Kurmi%20K%2C%20Elia%20I%2C%20Stopka%20SA%2C%20Baquer%20G%2C%20Lin%20JR%2C%20Golby%20AJ%2C%20Joshi%20S%2C%20Baron%20HF%2C%20Drijvers%20JM%2C%20Georgiev%20P%2C%20Ringel%20AE%2C%20Zaganjor%20E%2C%20McBrayer%20SK%2C%20Sorger%20PK%2C%20Sharpe%20AH%2C%20Wucherpfennig%20KW%2C%20Santagata%20S%2C%20Agar%20NYR%2C%20Suv%26%23xE0%3B%20ML%2C%20Haigis%20MC.%20Oncometabolite%20d-2HG%20alters%20T%20cell%20metabolism%20to%20impair%20CD8%2B%20T%20cell%20function.%20Science.%202022%20Sep%2030%3B377%286614%29%3A1519%26%23x2013%3B1529.%20PMCID%3A%20PMC9629749%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Oncometabolite%20d-2HG%20alters%20T%20cell%20metabolism%20to%20impair%20CD8%2B%20T%20cell%20function%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Notarangelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20B.%22%2C%22lastName%22%3A%22Spinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20M.%22%2C%22lastName%22%3A%22Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiran%22%2C%22lastName%22%3A%22Kurmi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Elia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Baquer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20J.%22%2C%22lastName%22%3A%22Golby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shakchhi%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heide%20F.%22%2C%22lastName%22%3A%22Baron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jefte%20M.%22%2C%22lastName%22%3A%22Drijvers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Georgiev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20E.%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elma%22%2C%22lastName%22%3A%22Zaganjor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20K.%22%2C%22lastName%22%3A%22McBrayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%20W.%22%2C%22lastName%22%3A%22Wucherpfennig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20L.%22%2C%22lastName%22%3A%22Suv%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Gain-of-function%20mutations%20in%20isocitrate%20dehydrogenase%20%28IDH%29%20in%20human%20cancers%20result%20in%20the%20production%20of%20d-2-hydroxyglutarate%20%28d-2HG%29%2C%20an%20oncometabolite%20that%20promotes%20tumorigenesis%20through%20epigenetic%20alterations.%20The%20cancer%20cell-intrinsic%20effects%20of%20d-2HG%20are%20well%20understood%2C%20but%20its%20tumor%20cell-nonautonomous%20roles%20remain%20poorly%20explored.%20We%20compared%20the%20oncometabolite%20d-2HG%20with%20its%20enantiomer%2C%20l-2HG%2C%20and%20found%20that%20tumor-derived%20d-2HG%20was%20taken%20up%20by%20CD8%2B%20T%20cells%20and%20altered%20their%20metabolism%20and%20antitumor%20functions%20in%20an%20acute%20and%20reversible%20fashion.%20We%20identified%20the%20glycolytic%20enzyme%20lactate%20dehydrogenase%20%28LDH%29%20as%20a%20molecular%20target%20of%20d-2HG.%20d-2HG%20and%20inhibition%20of%20LDH%20drive%20a%20metabolic%20program%20and%20immune%20CD8%2B%20T%20cell%20signature%20marked%20by%20decreased%20cytotoxicity%20and%20impaired%20interferon-%5Cu03b3%20signaling%20that%20was%20recapitulated%20in%20clinical%20samples%20from%20human%20patients%20with%20IDH1%20mutant%20gliomas.%22%2C%22date%22%3A%222022-09-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.abj5104%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A29%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22KIALERC8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-15%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Izar%20B%2C%20Hwangbo%20H%2C%20Sorger%20PK.%20Predictable%20clinical%20benefits%20without%20evidence%20of%20synergy%20in%20trials%20of%20combination%20therapies%20with%20immune-checkpoint%20inhibitors.%20Clin%20Cancer%20Res.%202022%20Jan%2015%3B28%282%29%3A368%26%23x2013%3B377.%20PMCID%3A%20PMC9068233%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Predictable%20clinical%20benefits%20without%20evidence%20of%20synergy%20in%20trials%20of%20combination%20therapies%20with%20immune-checkpoint%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haeun%22%2C%22lastName%22%3A%22Hwangbo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Combinations%20of%20immune-checkpoint%20inhibitors%20%28ICI%29%20with%20other%20cancer%20therapies%20have%20been%20approved%20for%20advanced%20cancers%20in%20multiple%20indications%2C%20and%20numerous%20trials%20are%20under%20way%20to%20test%20new%20combinations.%20However%2C%20the%20mechanisms%20that%20account%20for%20the%20superiority%20of%20approved%20ICI%20combinations%20relative%20to%20their%20constituent%20monotherapies%20remain%20unknown.%5CnEXPERIMENTAL%20DESIGN%3A%20We%20analyzed%2013%20phase%20III%20clinical%20trials%20testing%20combinations%20of%20ICIs%20with%20each%20other%20or%20other%20drugs%20in%20patients%20with%20advanced%20melanoma%20and%20lung%2C%20breast%2C%20gastric%2C%20kidney%2C%20and%20head%20and%20neck%20cancers.%20The%20clinical%20activity%20of%20the%20individual%20constituent%20therapies%2C%20measured%20in%20the%20same%20or%20a%20closely%20matched%20trial%20cohort%2C%20was%20used%20to%20compute%20progression-free%20survival%20%28PFS%29%20curves%20expected%20under%20a%20model%20of%20independent%20drug%20action.%20To%20identify%20additive%20or%20synergistic%20efficacy%2C%20PFS%20expected%20under%20this%20null%20model%20was%20compared%20with%20observed%20PFS%20by%20Cox%20regression.%5CnRESULTS%3A%20PFS%20elicited%20by%20approved%20combination%20therapies%20with%20ICIs%20could%20be%20accurately%20predicted%20from%20monotherapy%20data%20using%20the%20independent%20drug%20action%20model%20%28Pearson%20r%20%3D%200.98%2C%20P%20%3C%205%20%5Cu00d7%2010-9%2C%20N%20%3D%204%2C173%20patients%2C%208%20types%20of%20cancer%29.%20We%20found%20no%20evidence%20of%20drug%20additivity%20or%20synergy%20except%20in%20one%20trial%20in%20which%20such%20interactions%20might%20have%20extended%20median%20PFS%20by%209%20days.%5CnCONCLUSIONS%3A%20Combining%20ICIs%20with%20other%20cancer%20therapies%20affords%20predictable%20and%20clinically%20meaningful%20benefit%20by%20providing%20patients%20with%20multiple%20chances%20of%20response%20to%20a%20single%20agent.%20Conversely%2C%20there%20exists%20no%20evidence%20in%20phase%20III%20trials%20that%20other%20therapies%20interact%20with%20and%20enhance%20the%20activity%20of%20ICIs.%20These%20findings%20can%20inform%20the%20design%20and%20testing%20of%20new%20ICI%20combination%20therapies%20while%20emphasizing%20the%20importance%20of%20developing%20better%20predictors%20%28biomarkers%29%20of%20ICI%20response.%22%2C%22date%22%3A%222022-01-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-21-2275%22%2C%22ISSN%22%3A%221557-3265%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-15T20%3A31%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22N8VW5EYI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Papa%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPapa%20A%2C%20Zakharov%20SI%2C%20Katchman%20AN%2C%20Kushner%20JS%2C%20Chen%20BX%2C%20Yang%20L%2C%20Liu%20G%2C%20Jimenez%20AS%2C%20Eisert%20RJ%2C%20Bradshaw%20GA%2C%20Dun%20W%2C%20Ali%20SR%2C%20Rodriques%20A%2C%20Zhou%20K%2C%20Topkara%20V%2C%20Yang%20M%2C%20Morrow%20JP%2C%20Tsai%20EJ%2C%20Karlin%20A%2C%20Wan%20E%2C%20Kalocsay%20M%2C%20Pitt%20GS%2C%20Colecraft%20HM%2C%20Ben-Johny%20M%2C%20Marx%20SO.%20Rad%20regulation%20of%20CaV1.2%20channels%20controls%20cardiac%20fight-or-flight%20response.%20Nat%20Cardiovasc%20Res.%202022%20Nov%3B1%2811%29%3A1022%26%23x2013%3B1038.%20PMCID%3A%20PMC9681059%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rad%20regulation%20of%20CaV1.2%20channels%20controls%20cardiac%20fight-or-flight%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianne%22%2C%22lastName%22%3A%22Papa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%20I.%22%2C%22lastName%22%3A%22Zakharov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20N.%22%2C%22lastName%22%3A%22Katchman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jared%20S.%22%2C%22lastName%22%3A%22Kushner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bi-Xing%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lin%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guoxia%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%20Sanchez%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Dun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shah%20R.%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Rodriques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veli%22%2C%22lastName%22%3A%22Topkara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mu%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20P.%22%2C%22lastName%22%3A%22Morrow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20J.%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Karlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20S.%22%2C%22lastName%22%3A%22Pitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henry%20M.%22%2C%22lastName%22%3A%22Colecraft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manu%22%2C%22lastName%22%3A%22Ben-Johny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20O.%22%2C%22lastName%22%3A%22Marx%22%7D%5D%2C%22abstractNote%22%3A%22Fight-or-flight%20responses%20involve%20%5Cu03b2-adrenergic-induced%20increases%20in%20heart%20rate%20and%20contractile%20force.%20In%20the%20present%20study%2C%20we%20uncover%20the%20primary%20mechanism%20underlying%20the%20heart%27s%20innate%20contractile%20reserve.%20We%20show%20that%20four%20protein%20kinase%20A%20%28PKA%29-phosphorylated%20residues%20in%20Rad%2C%20a%20calcium%20channel%20inhibitor%2C%20are%20crucial%20for%20controlling%20basal%20calcium%20current%20and%20essential%20for%20%5Cu03b2-adrenergic%20augmentation%20of%20calcium%20influx%20in%20cardiomyocytes.%20Even%20with%20intact%20PKA%20signaling%20to%20other%20proteins%20modulating%20calcium%20handling%2C%20preventing%20adrenergic%20activation%20of%20calcium%20channels%20in%20Rad-phosphosite-mutant%20mice%20%284SA-Rad%29%20has%20profound%20physiological%20effects%3A%20reduced%20heart%20rate%20with%20increased%20pauses%2C%20reduced%20basal%20contractility%2C%20near-complete%20attenuation%20of%20%5Cu03b2-adrenergic%20contractile%20response%20and%20diminished%20exercise%20capacity.%20Conversely%2C%20expression%20of%20mutant%20calcium-channel%20%5Cu03b2-subunits%20that%20cannot%20bind%204SA-Rad%20is%20sufficient%20to%20enhance%20basal%20calcium%20influx%20and%20contractility%20to%20adrenergically%20augmented%20levels%20of%20wild-type%20mice%2C%20rescuing%20the%20failing%20heart%20phenotype%20of%204SA-Rad%20mice.%20Hence%2C%20disruption%20of%20interactions%20between%20Rad%20and%20calcium%20channels%20constitutes%20the%20foundation%20toward%20next-generation%20therapeutics%20specifically%20enhancing%20cardiac%20contractility.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs44161-022-00157-y%22%2C%22ISSN%22%3A%222731-0590%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-11-28T16%3A22%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22UTZBBV75%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Pernas%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPernas%20S%2C%20Guerriero%20JL%2C%20Naumenko%20S%2C%20Goel%20S%2C%20Regan%20MM%2C%20Hu%20J%2C%20Harrison%20BT%2C%20Lynce%20F%2C%20Lin%20NU%2C%20Partridge%20A%2C%20Morikawa%20A%2C%20Hutchinson%20J%2C%20Mittendorf%20EA%2C%20Sokolov%20A%2C%20Overmoyer%20B.%20Early%20on-treatment%20transcriptional%20profiling%20as%20a%20tool%20for%20improving%20pathological%20response%20prediction%20in%20HER2-positive%20inflammatory%20breast%20cancer.%20Ther%20Adv%20Med%20Oncol.%202022%20Jul%2030%3B14%3A17588359221113268.%20PMCID%3A%20PMC9340890%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Early%20on-treatment%20transcriptional%20profiling%20as%20a%20tool%20for%20improving%20pathological%20response%20prediction%20in%20HER2-positive%20inflammatory%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Pernas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%22%2C%22lastName%22%3A%22Naumenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shom%22%2C%22lastName%22%3A%22Goel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%20M.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiani%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beth%20T.%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filipa%22%2C%22lastName%22%3A%22Lynce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20U.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%22%2C%22lastName%22%3A%22Partridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aki%22%2C%22lastName%22%3A%22Morikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hutchinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beth%22%2C%22lastName%22%3A%22Overmoyer%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Inflammatory%20breast%20cancer%20%28IBC%29%20is%20a%20rare%20and%20understudied%20disease%2C%20with%2040%25%20of%20cases%20presenting%20with%20human%20epidermal%20growth%20factor%20receptor%202%20%28HER2%29-positive%20subtype.%20The%20goals%20of%20this%20study%20were%20to%20%28i%29%20assess%20the%20pathologic%20complete%20response%20%28pCR%29%20rate%20of%20short-term%20neoadjuvant%20dual-HER2-blockade%20and%20paclitaxel%2C%20%28ii%29%20contrast%20baseline%20and%20on-treatment%20transcriptional%20profiles%20of%20IBC%20tumor%20biopsies%20associated%20with%20pCR%2C%20and%20%28iii%29%20identify%20biological%20pathways%20that%20may%20explain%20the%20effect%20of%20neoadjuvant%20therapy%20on%20tumor%20response.%5CnPatients%20and%20Methods%3A%20A%20single-arm%20phase%20II%20trial%20of%20neoadjuvant%20trastuzumab%20%28H%29%2C%20pertuzumab%20%28P%29%2C%20and%20paclitaxel%20for%2016%5Cu2009weeks%20was%20completed%20among%20patients%20with%20newly%20diagnosed%20HER2-positive%20IBC.%20Fresh-frozen%20tumor%20biopsies%20were%20obtained%20pretreatment%20%28D1%29%20and%208%5Cu2009days%20later%20%28D8%29%2C%20following%20a%20single%20dose%20of%20HP%2C%20prior%20to%20adding%20paclitaxel.%20We%20performed%20RNA-sequencing%20on%20D1%20and%20D8%20tumor%20biopsies%2C%20identified%20genes%20associated%20with%20pCR%20using%20differential%20gene%20expression%20analysis%2C%20identified%20pathways%20associated%20with%20pCR%20using%20gene%20set%20enrichment%20and%20gene%20expression%20deconvolution%20methods%2C%20and%20compared%20the%20pCR%20predictive%20value%20of%20principal%20components%20derived%20from%20gene%20expression%20profiles%20by%20calculating%20and%20area%20under%20the%20curve%20for%20D1%20and%20D8%20subsets.%5CnResults%3A%20Twenty-three%20participants%20were%20enrolled%2C%20of%20whom%2021%20completed%20surgery%20following%20neoadjuvant%20therapy.%20Paired%20longitudinal%20fresh-frozen%20tumor%20samples%20%28D1%20and%20D8%29%20were%20obtained%20from%20all%20patients.%20Among%20the%2021%20patients%20who%20underwent%20surgery%2C%20the%20pCR%20and%20the%204-year%20disease-free%20survival%20were%2048%25%20%2890%25%20CI%200.29-0.67%29%20and%2090%25%20%2895%25%20CI%2066-97%25%29%2C%20respectively.%20The%20transcriptional%20profile%20of%20D8%20biopsies%20was%20found%20to%20be%20more%20predictive%20of%20pCR%20%28AUC%5Cu2009%3D%5Cu20090.91%2C%2095%25%20CI%3A%200.7993-1%29%20than%20the%20D1%20biopsies%20%28AUC%5Cu2009%3D%5Cu20090.79%2C%2095%25%20CI%3A%200.5905-0.9822%29.%5CnConclusions%3A%20In%20patients%20with%20HER2-positive%20IBC%20treated%20with%20neoadjuvant%20HP%20and%20paclitaxel%20for%2016%5Cu2009weeks%2C%20gene%20expression%20patterns%20of%20tumor%20biopsies%20measured%201%5Cu2009week%20after%20treatment%20initiation%20not%20only%20offered%20different%20biological%20information%20but%20importantly%20served%20as%20a%20better%20predictor%20of%20pCR%20than%20baseline%20transcriptional%20analysis.%5CnTrial%20Registration%3A%20ClinicalTrials.gov%20identifier%3A%20NCT01796197%20%28https%3A%5C%2F%5C%2Fclinicaltrials.gov%5C%2Fct2%5C%2Fshow%5C%2FNCT01796197%29%3B%20registered%20on%20February%2021%2C%202013.%22%2C%22date%22%3A%222022%20Jul%2030%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F17588359221113269%22%2C%22ISSN%22%3A%221758-8340%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-10-28T03%3A54%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22QAR3WD9U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Plana%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-15%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPlana%20D%2C%20Fell%20G%2C%20Alexander%20BM%2C%20Palmer%20AC%2C%20Sorger%20PK.%20Cancer%20patient%20survival%20can%20be%20parametrized%20to%20improve%20trial%20precision%20and%20reveal%20time-dependent%20therapeutic%20effects.%20Nat%20Commun.%202022%20Feb%2015%3B13%281%29%3A873.%20PMCID%3A%20PMC8847344%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer%20patient%20survival%20can%20be%20parametrized%20to%20improve%20trial%20precision%20and%20reveal%20time-dependent%20therapeutic%20effects%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Individual%20participant%20data%20%28IPD%29%20from%20oncology%20clinical%20trials%20is%20invaluable%20for%20identifying%20factors%20that%20influence%20trial%20success%20and%20failure%2C%20improving%20trial%20design%20and%20interpretation%2C%20and%20comparing%20pre-clinical%20studies%20to%20clinical%20outcomes.%20However%2C%20the%20IPD%20used%20to%20generate%20published%20survival%20curves%20are%20not%20generally%20publicly%20available.%20We%20impute%20survival%20IPD%20from%20~500%20arms%20of%20Phase%203%20oncology%20trials%20%28representing%20~220%2C000%20events%29%20and%20find%20that%20they%20are%20well%20fit%20by%20a%20two-parameter%20Weibull%20distribution.%20Use%20of%20Weibull%20functions%20with%20overall%20survival%20significantly%20increases%20the%20precision%20of%20small%20arms%20typical%20of%20early%20phase%20trials%3A%20analysis%20of%20a%2050-patient%20trial%20arm%20using%20parametric%20forms%20is%20as%20precise%20as%20traditional%2C%20non-parametric%20analysis%20of%20a%2090-patient%20arm.%20We%20also%20show%20that%20frequent%20deviations%20from%20the%20Cox%20proportional%20hazards%20assumption%2C%20particularly%20in%20trials%20of%20immune%20checkpoint%20inhibitors%2C%20arise%20from%20time-dependent%20therapeutic%20effects.%20Trial%20duration%20therefore%20has%20an%20underappreciated%20impact%20on%20the%20likelihood%20of%20success.%22%2C%22date%22%3A%222022-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-022-28410-9%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A19%3A03Z%22%7D%7D%2C%7B%22key%22%3A%224GQNPQW9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Plana%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-01%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPlana%20D%2C%20Palmer%20AC%2C%20Sorger%20PK.%20Independent%20drug%20action%20in%20combination%20therapy%3A%20implications%20for%20precision%20oncology.%20Cancer%20Discov.%202022%20Mar%201%3B12%283%29%3A606%26%23x2013%3B624.%20PMCID%3A%20PMC8904281%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Independent%20drug%20action%20in%20combination%20therapy%3A%20implications%20for%20precision%20oncology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20therapies%20are%20superior%20to%20monotherapy%20for%20many%20cancers.%20This%20advantage%20was%20historically%20ascribed%20to%20the%20ability%20of%20combinations%20to%20address%20tumor%20heterogeneity%2C%20but%20synergistic%20interaction%20is%20now%20a%20common%20explanation%20as%20well%20as%20a%20design%20criterion%20for%20new%20combinations.%20We%20review%20evidence%20that%20independent%20drug%20action%2C%20described%20in%201961%2C%20explains%20the%20efficacy%20of%20many%20practice-changing%20combination%20therapies%3A%20it%20provides%20populations%20of%20patients%20with%20heterogeneous%20drug%20sensitivities%20multiple%20chances%20of%20benefit%20from%20at%20least%20one%20drug.%20Understanding%20response%20heterogeneity%20could%20reveal%20predictive%20or%20pharmacodynamic%20biomarkers%20for%20more%20precise%20use%20of%20existing%20drugs%20and%20realize%20the%20benefits%20of%20additivity%20or%20synergy.%5CnSIGNIFICANCE%3A%20The%20model%20of%20independent%20drug%20action%20represents%20an%20effective%20means%20to%20predict%20the%20magnitude%20of%20benefit%20likely%20to%20be%20observed%20in%20new%20clinical%20trials%20for%20combination%20therapies.%20The%20%5C%22bet-hedging%5C%22%20strategy%20implicit%20in%20independent%20action%20suggests%20that%20individual%20patients%20often%20benefit%20from%20only%20a%20subset-sometimes%20one-of%20the%20drugs%20in%20a%20combination.%20Personalized%2C%20targeted%20combination%20therapy%2C%20consisting%20of%20agents%20likely%20to%20be%20active%20in%20a%20particular%20patient%2C%20will%20increase%2C%20perhaps%20substantially%2C%20the%20magnitude%20of%20therapeutic%20benefit.%20Precision%20approaches%20of%20this%20type%20will%20require%20a%20better%20understanding%20of%20variability%20in%20drug%20response%20and%20new%20biomarkers%2C%20which%20will%20entail%20preclinical%20research%20on%20diverse%20panels%20of%20cancer%20models%20rather%20than%20studying%20drug%20synergy%20in%20unusually%20sensitive%20models.%22%2C%22date%22%3A%222022-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-21-0212%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A05%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22PE24JIM8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Pomeroy%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPomeroy%20AE%2C%20Schmidt%20EV%2C%20Sorger%20PK%2C%20Palmer%20AC.%20Drug%20independence%20and%20the%20curability%20of%20cancer%20by%20combination%20chemotherapy.%20Trends%20Cancer.%202022%20Nov%3B8%2811%29%3A915%26%23x2013%3B929.%20PMCID%3A%20PMC9588605%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Drug%20independence%20and%20the%20curability%20of%20cancer%20by%20combination%20chemotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Pomeroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmett%20V.%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20chemotherapy%20can%20cure%20certain%20leukemias%20and%20lymphomas%2C%20but%20most%20solid%20cancers%20are%20only%20curable%20at%20early%20stages.%20We%20review%20quantitative%20principles%20that%20explain%20the%20benefits%20of%20combining%20independently%20active%20cancer%20therapies%20in%20both%20settings.%20Understanding%20the%20mechanistic%20principles%20underlying%20curative%20treatments%2C%20including%20those%20developed%20many%20decades%20ago%2C%20is%20valuable%20for%20improving%20future%20combination%20therapies.%20We%20discuss%20contemporary%20evidence%20for%20long-established%20but%20currently%20neglected%20ideas%20of%20how%20combination%20therapy%20overcomes%20tumor%20heterogeneity.%20We%20show%20that%20a%20unified%20model%20of%20interpatient%20and%20intratumor%20heterogeneity%20describes%20historical%20progress%20in%20the%20treatment%20of%20pediatric%20acute%20lymphocytic%20leukemia%20%28ALL%29%2C%20in%20which%20increasingly%20intensive%20combination%20regimens%20ultimately%20achieved%20high%20cure%20rates.%20We%20also%20describe%20three%20distinct%20aspects%20of%20drug%20independence%20that%20apply%20at%20different%20biological%20scales.%20The%20ability%20of%20these%20principles%20to%20quantitatively%20explain%20curative%20regimens%20suggests%20that%20supra-additive%20%28synergistic%29%20drug%20interactions%20are%20not%20required%20for%20successful%20combination%20therapy.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.trecan.2022.06.009%22%2C%22ISSN%22%3A%222405-8025%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A11%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22WFDIRJDS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rashid%20et%20al.%22%2C%22parsedDate%22%3A%222022-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERashid%20R%2C%20Chen%20YA%2C%20Hoffer%20J%2C%20Muhlich%20JL%2C%20Lin%20JR%2C%20Krueger%20R%2C%20Pfister%20H%2C%20Mitchell%20R%2C%20Santagata%20S%2C%20Sorger%20PK.%20Narrative%20online%20guides%20for%20the%20interpretation%20of%20digital-pathology%20images%20and%20tissue-atlas%20data.%20Nat%20Biomed%20Eng.%202022%20May%3B6%285%29%3A515%26%23x2013%3B526.%20PMCID%3A%20PMC9079188%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Narrative%20online%20guides%20for%20the%20interpretation%20of%20digital-pathology%20images%20and%20tissue-atlas%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Mitchell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Multiplexed%20tissue%20imaging%20facilitates%20the%20diagnosis%20and%20understanding%20of%20complex%20disease%20traits.%20However%2C%20the%20analysis%20of%20such%20digital%20images%20heavily%20relies%20on%20the%20experience%20of%20anatomical%20pathologists%20for%20the%20review%2C%20annotation%20and%20description%20of%20tissue%20features.%20In%20addition%2C%20the%20wider%20use%20of%20data%20from%20tissue%20atlases%20in%20basic%20and%20translational%20research%20and%20in%20classrooms%20would%20benefit%20from%20software%20that%20facilitates%20the%20easy%20visualization%20and%20sharing%20of%20the%20images%20and%20the%20results%20of%20their%20analyses.%20In%20this%20Perspective%2C%20we%20describe%20the%20ecosystem%20of%20software%20available%20for%20the%20analysis%20of%20tissue%20images%20and%20discuss%20the%20need%20for%20interactive%20online%20guides%20that%20help%20histopathologists%20make%20complex%20images%20comprehensible%20to%20non-specialists.%20We%20illustrate%20this%20idea%20via%20a%20software%20interface%20%28Minerva%29%2C%20accessible%20via%20web%20browsers%2C%20that%20integrates%20multi-omic%20and%20tissue-atlas%20features.%20We%20argue%20that%20such%20interactive%20narrative%20guides%20can%20effectively%20disseminate%20digital%20histology%20data%20and%20aid%20their%20interpretation.%22%2C%22date%22%3A%222022-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41551-021-00789-8%22%2C%22ISSN%22%3A%222157-846X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A34%3A01Z%22%7D%7D%2C%7B%22key%22%3A%229SKMEJZT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reichart%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EReichart%20D%2C%20Lindberg%20EL%2C%20Maatz%20H%2C%20Miranda%20AMA%2C%20Viveiros%20A%2C%20Shvetsov%20N%2C%20G%26%23xE4%3Brtner%20A%2C%20Nadelmann%20ER%2C%20Lee%20M%2C%20Kanemaru%20K%2C%20Ruiz-Orera%20J%2C%20Strohmenger%20V%2C%20DeLaughter%20DM%2C%20Patone%20G%2C%20Zhang%20H%2C%20Woehler%20A%2C%20Lippert%20C%2C%20Kim%20Y%2C%20Adami%20E%2C%20Gorham%20JM%2C%20Barnett%20SN%2C%20Brown%20K%2C%20Buchan%20RJ%2C%20Chowdhury%20RA%2C%20Constantinou%20C%2C%20Cranley%20J%2C%20Felkin%20LE%2C%20Fox%20H%2C%20Ghauri%20A%2C%20Gummert%20J%2C%20Kanda%20M%2C%20Li%20R%2C%20Mach%20L%2C%20McDonough%20B%2C%20Samari%20S%2C%20Shahriaran%20F%2C%20Yapp%20C%2C%20Stanasiuk%20C%2C%20Theotokis%20PI%2C%20Theis%20FJ%2C%20van%20den%20Bogaerdt%20A%2C%20Wakimoto%20H%2C%20Ware%20JS%2C%20Worth%20CL%2C%20Barton%20PJR%2C%20Lee%20YA%2C%20Teichmann%20SA%2C%20Milting%20H%2C%20Noseda%20M%2C%20Oudit%20GY%2C%20Heinig%20M%2C%20Seidman%20JG%2C%20Hubner%20N%2C%20Seidman%20CE.%20Pathogenic%20variants%20damage%20cell%20composition%20and%20single%20cell%20transcription%20in%20cardiomyopathies.%20Science.%202022%20Aug%205%3B377%286606%29%3Aeabo1984.%20PMCID%3A%20PMC9528698%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pathogenic%20variants%20damage%20cell%20composition%20and%20single%20cell%20transcription%20in%20cardiomyopathies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Reichart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20L.%22%2C%22lastName%22%3A%22Lindberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrike%22%2C%22lastName%22%3A%22Maatz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%20M.%20A.%22%2C%22lastName%22%3A%22Miranda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anissa%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolay%22%2C%22lastName%22%3A%22Shvetsov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22G%5Cu00e4rtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20R.%22%2C%22lastName%22%3A%22Nadelmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazumasa%22%2C%22lastName%22%3A%22Kanemaru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Ruiz-Orera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viktoria%22%2C%22lastName%22%3A%22Strohmenger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20M.%22%2C%22lastName%22%3A%22DeLaughter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giannino%22%2C%22lastName%22%3A%22Patone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Woehler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lippert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleonora%22%2C%22lastName%22%3A%22Adami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Gorham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sam%20N.%22%2C%22lastName%22%3A%22Barnett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kemar%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20J.%22%2C%22lastName%22%3A%22Buchan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rasheda%20A.%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chrystalla%22%2C%22lastName%22%3A%22Constantinou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Cranley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leanne%20E.%22%2C%22lastName%22%3A%22Felkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahla%22%2C%22lastName%22%3A%22Ghauri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Gummert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masatoshi%22%2C%22lastName%22%3A%22Kanda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruoyan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Mach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22McDonough%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Samari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farnoush%22%2C%22lastName%22%3A%22Shahriaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Stanasiuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pantazis%20I.%22%2C%22lastName%22%3A%22Theotokis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%20J.%22%2C%22lastName%22%3A%22Theis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoon%22%2C%22lastName%22%3A%22van%20den%20Bogaerdt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroko%22%2C%22lastName%22%3A%22Wakimoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20S.%22%2C%22lastName%22%3A%22Ware%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20L.%22%2C%22lastName%22%3A%22Worth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%20R.%22%2C%22lastName%22%3A%22Barton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young-Ae%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Teichmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hendrik%22%2C%22lastName%22%3A%22Milting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michela%22%2C%22lastName%22%3A%22Noseda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gavin%20Y.%22%2C%22lastName%22%3A%22Oudit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Heinig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20G.%22%2C%22lastName%22%3A%22Seidman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norbert%22%2C%22lastName%22%3A%22Hubner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20E.%22%2C%22lastName%22%3A%22Seidman%22%7D%5D%2C%22abstractNote%22%3A%22Pathogenic%20variants%20in%20genes%20that%20cause%20dilated%20cardiomyopathy%20%28DCM%29%20and%20arrhythmogenic%20cardiomyopathy%20%28ACM%29%20convey%20high%20risks%20for%20the%20development%20of%20heart%20failure%20through%20unknown%20mechanisms.%20Using%20single-nucleus%20RNA%20sequencing%2C%20we%20characterized%20the%20transcriptome%20of%20880%2C000%20nuclei%20from%2018%20control%20and%2061%20failing%2C%20nonischemic%20human%20hearts%20with%20pathogenic%20variants%20in%20DCM%20and%20ACM%20genes%20or%20idiopathic%20disease.%20We%20performed%20genotype-stratified%20analyses%20of%20the%20ventricular%20cell%20lineages%20and%20transcriptional%20states.%20The%20resultant%20DCM%20and%20ACM%20ventricular%20cell%20atlas%20demonstrated%20distinct%20right%20and%20left%20ventricular%20responses%2C%20highlighting%20genotype-associated%20pathways%2C%20intercellular%20interactions%2C%20and%20differential%20gene%20expression%20at%20single-cell%20resolution.%20Together%2C%20these%20data%20illuminate%20both%20shared%20and%20distinct%20cellular%20and%20molecular%20architectures%20of%20human%20heart%20failure%20and%20suggest%20candidate%20therapeutic%20targets.%22%2C%22date%22%3A%222022-08-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.abo1984%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-03-16T15%3A34%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22EXU7UN2D%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Schapiro%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchapiro%20D%2C%20Sokolov%20A%2C%20Yapp%20C%2C%20Chen%20YA%2C%20Muhlich%20JL%2C%20Hess%20J%2C%20Creason%20AL%2C%20Nirmal%20AJ%2C%20Baker%20GJ%2C%20Nariya%20MK%2C%20Lin%20JR%2C%20Maliga%20Z%2C%20Jacobson%20CA%2C%20Hodgman%20MW%2C%20Ruokonen%20J%2C%20Farhi%20SL%2C%20Abbondanza%20D%2C%20McKinley%20ET%2C%20Persson%20D%2C%20Betts%20C%2C%20Sivagnanam%20S%2C%20Regev%20A%2C%20Goecks%20J%2C%20Coffey%20RJ%2C%20Coussens%20LM%2C%20Santagata%20S%2C%20Sorger%20PK.%20MCMICRO%3A%20a%20scalable%2C%20modular%20image-processing%20pipeline%20for%20multiplexed%20tissue%20imaging.%20Nat%20Methods.%202022%20Mar%3B19%283%29%3A311%26%23x2013%3B315.%20PMCID%3A%20PMC8916956%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MCMICRO%3A%20a%20scalable%2C%20modular%20image-processing%20pipeline%20for%20multiplexed%20tissue%20imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Hess%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20L.%22%2C%22lastName%22%3A%22Creason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20W.%22%2C%22lastName%22%3A%22Hodgman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juha%22%2C%22lastName%22%3A%22Ruokonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samouil%20L.%22%2C%22lastName%22%3A%22Farhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Domenic%22%2C%22lastName%22%3A%22Abbondanza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliot%20T.%22%2C%22lastName%22%3A%22McKinley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Persson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Courtney%22%2C%22lastName%22%3A%22Betts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamilene%22%2C%22lastName%22%3A%22Sivagnanam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Goecks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Coffey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20M.%22%2C%22lastName%22%3A%22Coussens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Highly%20multiplexed%20tissue%20imaging%20makes%20detailed%20molecular%20analysis%20of%20single%20cells%20possible%20in%20a%20preserved%20spatial%20context.%20However%2C%20reproducible%20analysis%20of%20large%20multichannel%20images%20poses%20a%20substantial%20computational%20challenge.%20Here%2C%20we%20describe%20a%20modular%20and%20open-source%20computational%20pipeline%2C%20MCMICRO%2C%20for%20performing%20the%20sequential%20steps%20needed%20to%20transform%20whole-slide%20images%20into%20single-cell%20data.%20We%20demonstrate%20the%20use%20of%20MCMICRO%20on%20tissue%20and%20tumor%20images%20acquired%20using%20multiple%20imaging%20platforms%2C%20thereby%20providing%20a%20solid%20foundation%20for%20the%20continued%20development%20of%20tissue%20imaging%20software.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-021-01308-y%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A19%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22CI2ZMUL3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Schapiro%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchapiro%20D%2C%20Yapp%20C%2C%20Sokolov%20A%2C%20Reynolds%20SM%2C%20Chen%20YA%2C%20Sudar%20D%2C%20Xie%20Y%2C%20Muhlich%20J%2C%20Arias-Camison%20R%2C%20Arena%20S%2C%20Taylor%20AJ%2C%20Nikolov%20M%2C%20Tyler%20M%2C%20Lin%20JR%2C%20Burlingame%20EA%2C%20Human%20Tumor%20Atlas%20Network%2C%20Chang%20YH%2C%20Farhi%20SL%2C%20Thorsson%20V%2C%20Venkatamohan%20N%2C%20Drewes%20JL%2C%20Pe%26%23x2019%3Ber%20D%2C%20Gutman%20DA%2C%20Herrmann%20MD%2C%20Gehlenborg%20N%2C%20Bankhead%20P%2C%20Roland%20JT%2C%20Herndon%20JM%2C%20Snyder%20MP%2C%20Angelo%20M%2C%20Nolan%20G%2C%20Swedlow%20JR%2C%20Schultz%20N%2C%20Merrick%20DT%2C%20Mazzili%20SA%2C%20Cerami%20E%2C%20Rodig%20SJ%2C%20Santagata%20S%2C%20Sorger%20PK.%20MITI%20minimum%20information%20guidelines%20for%20highly%20multiplexed%20tissue%20images.%20Nat%20Methods.%202022%20Mar%3B19%283%29%3A262%26%23x2013%3B267.%20PMCID%3A%20PMC9009186%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MITI%20minimum%20information%20guidelines%20for%20highly%20multiplexed%20tissue%20images%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheila%20M.%22%2C%22lastName%22%3A%22Reynolds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damir%22%2C%22lastName%22%3A%22Sudar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yubin%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Arias-Camison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Arena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milen%22%2C%22lastName%22%3A%22Nikolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madison%22%2C%22lastName%22%3A%22Tyler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20A.%22%2C%22lastName%22%3A%22Burlingame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Human%20Tumor%20Atlas%20Network%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20H.%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samouil%20L.%22%2C%22lastName%22%3A%22Farhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9steinn%22%2C%22lastName%22%3A%22Thorsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nithya%22%2C%22lastName%22%3A%22Venkatamohan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%20L.%22%2C%22lastName%22%3A%22Drewes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Pe%27er%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Gutman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%20D.%22%2C%22lastName%22%3A%22Herrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nils%22%2C%22lastName%22%3A%22Gehlenborg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Bankhead%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20T.%22%2C%22lastName%22%3A%22Roland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Herndon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Snyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Angelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Garry%22%2C%22lastName%22%3A%22Nolan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20R.%22%2C%22lastName%22%3A%22Swedlow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20T.%22%2C%22lastName%22%3A%22Merrick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Mazzili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Cerami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-022-01415-4%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A20%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22WR8BNN57%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schink%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchink%20SJ%2C%20Christodoulou%20D%2C%20Mukherjee%20A%2C%20Athaide%20E%2C%20Brunner%20V%2C%20Fuhrer%20T%2C%20Bradshaw%20GA%2C%20Sauer%20U%2C%20Basan%20M.%20Glycolysis%5C%2Fgluconeogenesis%20specialization%20in%20microbes%20is%20driven%20by%20biochemical%20constraints%20of%20flux%20sensing.%20Mol%20Syst%20Biol.%202022%20Jan%3B18%281%29%3Ae10704.%20PMCID%3A%20PMC8738977%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Glycolysis%5C%2Fgluconeogenesis%20specialization%20in%20microbes%20is%20driven%20by%20biochemical%20constraints%20of%20flux%20sensing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Severin%20Josef%22%2C%22lastName%22%3A%22Schink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimitris%22%2C%22lastName%22%3A%22Christodoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avik%22%2C%22lastName%22%3A%22Mukherjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Athaide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viktoria%22%2C%22lastName%22%3A%22Brunner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tobias%22%2C%22lastName%22%3A%22Fuhrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20Andrew%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uwe%22%2C%22lastName%22%3A%22Sauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Basan%22%7D%5D%2C%22abstractNote%22%3A%22Central%20carbon%20metabolism%20is%20highly%20conserved%20across%20microbial%20species%2C%20but%20can%20catalyze%20very%20different%20pathways%20depending%20on%20the%20organism%20and%20their%20ecological%20niche.%20Here%2C%20we%20study%20the%20dynamic%20reorganization%20of%20central%20metabolism%20after%20switches%20between%20the%20two%20major%20opposing%20pathway%20configurations%20of%20central%20carbon%20metabolism%2C%20glycolysis%2C%20and%20gluconeogenesis%20in%20Escherichia%20coli%2C%20Pseudomonas%20aeruginosa%2C%20and%20Pseudomonas%20putida.%20We%20combined%20growth%20dynamics%20and%20dynamic%20changes%20in%20intracellular%20metabolite%20levels%20with%20a%20coarse-grained%20model%20that%20integrates%20fluxes%2C%20regulation%2C%20protein%20synthesis%2C%20and%20growth%20and%20uncovered%20fundamental%20limitations%20of%20the%20regulatory%20network%3A%20After%20nutrient%20shifts%2C%20metabolite%20concentrations%20collapse%20to%20their%20equilibrium%2C%20rendering%20the%20cell%20unable%20to%20sense%20which%20direction%20the%20flux%20is%20supposed%20to%20flow%20through%20the%20metabolic%20network.%20The%20cell%20can%20partially%20alleviate%20this%20by%20picking%20a%20preferred%20direction%20of%20regulation%20at%20the%20expense%20of%20increasing%20lag%20times%20in%20the%20opposite%20direction.%20Moreover%2C%20decreasing%20both%20lag%20times%20simultaneously%20comes%20at%20the%20cost%20of%20reduced%20growth%20rate%20or%20higher%20futile%20cycling%20between%20metabolic%20enzymes.%20These%20three%20trade-offs%20can%20explain%20why%20microorganisms%20specialize%20for%20either%20glycolytic%20or%20gluconeogenic%20substrates%20and%20can%20help%20elucidate%20the%20complex%20growth%20patterns%20exhibited%20by%20different%20microbial%20species.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.202110704%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22VQSQBQ5R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Scholten%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EScholten%20B%2C%20Sim%26%23xF3%3Bn%20LG%2C%20Krishnan%20S%2C%20Vermeulen%20R%2C%20Pronk%20A%2C%20Gyori%20BM%2C%20Bachman%20JA%2C%20Vlaanderen%20J%2C%20Stierum%20R.%20Automated%20network%20assembly%20of%20mechanistic%20literature%20for%20informed%20evidence%20identification%20to%20support%20cancer%20risk%20assessment.%20Environ%20Health%20Perspect.%202022%20Mar%3B130%283%29%3A37002.%20PMCID%3A%20PMC8893280%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Automated%20network%20assembly%20of%20mechanistic%20literature%20for%20informed%20evidence%20identification%20to%20support%20cancer%20risk%20assessment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernice%22%2C%22lastName%22%3A%22Scholten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20Guerrero%22%2C%22lastName%22%3A%22Sim%5Cu00f3n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaji%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roel%22%2C%22lastName%22%3A%22Vermeulen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjoeka%22%2C%22lastName%22%3A%22Pronk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jelle%22%2C%22lastName%22%3A%22Vlaanderen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rob%22%2C%22lastName%22%3A%22Stierum%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Mechanistic%20data%20is%20increasingly%20used%20in%20hazard%20identification%20of%20chemicals.%20However%2C%20the%20volume%20of%20data%20is%20large%2C%20challenging%20the%20efficient%20identification%20and%20clustering%20of%20relevant%20data.%5CnOBJECTIVES%3A%20We%20investigated%20whether%20evidence%20identification%20for%20hazard%20assessment%20can%20become%20more%20efficient%20and%20informed%20through%20an%20automated%20approach%20that%20combines%20machine%20reading%20of%20publications%20with%20network%20visualization%20tools.%5CnMETHODS%3A%20We%20chose%2013%20chemicals%20that%20were%20evaluated%20by%20the%20International%20Agency%20for%20Research%20on%20Cancer%20%28IARC%29%20Monographs%20program%20incorporating%20the%20key%20characteristics%20of%20carcinogens%20%28KCCs%29%20approach.%20Using%20established%20literature%20search%20terms%20for%20KCCs%2C%20we%20retrieved%20and%20analyzed%20literature%20using%20Integrated%20Network%20and%20Dynamical%20Reasoning%20Assembler%20%28INDRA%29.%20INDRA%20combines%20large-scale%20literature%20processing%20with%20pathway%20databases%20and%20extracts%20relationships%20between%20biomolecules%2C%20bioprocesses%2C%20and%20chemicals%20into%20statements%20%28e.g.%2C%20%5C%22benzene%20activates%20DNA%20damage%5C%22%29.%20These%20statements%20were%20subsequently%20assembled%20into%20networks%20and%20compared%20with%20the%20KCC%20evaluation%20by%20the%20IARC%2C%20to%20evaluate%20the%20informativeness%20of%20our%20approach.%5CnRESULTS%3A%20We%20found%2C%20in%20general%2C%20larger%20networks%20for%20those%20chemicals%20which%20the%20IARC%20has%20evaluated%20the%20evidence%20to%20be%20strong%20for%20KCC%20induction.%20Larger%20networks%20were%20not%20directly%20linked%20to%20publication%20count%2C%20given%20that%20we%20retrieved%20small%20networks%20for%20several%20chemicals%20with%20little%20support%20for%20KCC%20activation%20according%20to%20the%20IARC%2C%20despite%20the%20significant%20volume%20of%20literature%20for%20these%20specific%20chemicals.%20In%20addition%2C%20interpreting%20networks%20for%20genotoxicity%20and%20DNA%20repair%20showed%20concordance%20with%20the%20IARC%20KCC%20evaluation.%5CnDISCUSSION%3A%20Our%20method%20is%20an%20automated%20approach%20to%20condense%20mechanistic%20literature%20into%20searchable%20and%20interpretable%20networks%20based%20on%20an%20a%20priori%20ontology.%20The%20approach%20is%20no%20replacement%20of%20expert%20evaluation%20but%2C%20instead%2C%20provides%20an%20informed%20structure%20for%20experts%20to%20quickly%20identify%20which%20statements%20are%20made%20in%20which%20papers%20and%20how%20these%20could%20connect.%20We%20focused%20on%20the%20KCCs%20because%20these%20are%20supported%20by%20well-described%20search%20terms.%20The%20method%20needs%20to%20be%20tested%20in%20other%20frameworks%20as%20well%20to%20demonstrate%20its%20generalizability.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1289%5C%2FEHP9112.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1289%5C%2FEHP9112%22%2C%22ISSN%22%3A%221552-9924%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A07%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22J7AM9I2I%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sekar%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-21%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESekar%20G%2C%20Singh%20G%2C%20Qin%20X%2C%20Guibao%20CD%2C%20Schwam%20B%2C%20Inde%20Z%2C%20Grace%20CR%2C%20Zhang%20W%2C%20Slavish%20PJ%2C%20Lin%20W%2C%20Chen%20T%2C%20Lee%20RE%2C%20Rankovic%20Z%2C%20Sarosiek%20K%2C%20Moldoveanu%20T.%20Small%20molecule%20SJ572946%20activates%20BAK%20to%20initiate%20apoptosis.%20iScience.%202022%20Oct%2021%3B25%2810%29%3A105064.%20PMCID%3A%20PMC9485059%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Small%20molecule%20SJ572946%20activates%20BAK%20to%20initiate%20apoptosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giridhar%22%2C%22lastName%22%3A%22Sekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geetika%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20D.%22%2C%22lastName%22%3A%22Guibao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brittany%22%2C%22lastName%22%3A%22Schwam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zintis%22%2C%22lastName%22%3A%22Inde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christy%20R.%22%2C%22lastName%22%3A%22Grace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weixing%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20Jake%22%2C%22lastName%22%3A%22Slavish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenwei%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taosheng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20E.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoran%22%2C%22lastName%22%3A%22Rankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tudor%22%2C%22lastName%22%3A%22Moldoveanu%22%7D%5D%2C%22abstractNote%22%3A%22Poration%20of%20the%20outer%20mitochondrial%20membrane%20by%20the%20effector%20BCL-2%20proteins%20BAK%20and%20BAX%20initiates%20apoptosis.%20BH3-only%20initiators%20BID%20and%20BIM%20trigger%20conformational%20changes%20in%20BAK%20and%20BAX%20transforming%20them%20from%20globular%20dormant%20proteins%20to%20oligomers%20of%20the%20apoptotic%20pores.%20Small%20molecules%20that%20can%20directly%20activate%20effectors%20are%20being%20sought%20for%20applications%20in%20cancer%20treatment.%20Here%2C%20we%20describe%20the%20small%20molecule%20SJ572946%2C%20discovered%20in%20a%20fragment-based%20screen%20that%20binds%20to%20the%20activation%20groove%20of%20BAK%20and%20selectively%20triggers%20BAK%20activation%20over%20that%20of%20BAX%20in%20liposome%20and%20mitochondrial%20permeabilization%20assays.%20SJ572946%20independently%20kills%20BAK-expressing%20BCL2allKO%20HCT116%20cells%20revealing%20on%20target%20cellular%20activity.%20In%20combination%20with%20apoptotic%20inducers%20and%20BH3%20mimetics%2C%20SJ572946%20kills%20experimental%20cancer%20cell%20lines.%20SJ572946%20also%20cooperates%20with%20the%20endogenous%20BAK%20activator%20BID%20in%20activating%20a%20misfolded%20BAK%20mutant%20substantially%20impaired%20in%20activation.%20SJ572946%20is%20a%20proof-of-concept%20tool%20for%20probing%20BAK-mediated%20apoptosis%20in%20preclinical%20cancer%20research.%22%2C%22date%22%3A%222022-10-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.isci.2022.105064%22%2C%22ISSN%22%3A%222589-0042%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T18%3A42%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22BSNMTYV9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Spetz%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESpetz%20JKE%2C%20Florido%20MHC%2C%20Fraser%20CS%2C%20Qin%20X%2C%20Choiniere%20J%2C%20Yu%20SJ%2C%20Singh%20R%2C%20Friesen%20M%2C%20Rubin%20LL%2C%20Salem%20JE%2C%20Moslehi%20JJ%2C%20Sarosiek%20KA.%20Heightened%20apoptotic%20priming%20of%20vascular%20cells%20across%20tissues%20and%20life%20span%20predisposes%20them%20to%20cancer%20therapy-induced%20toxicities.%20Sci%20Adv.%202022%20Nov%2011%3B8%2845%29%3Aeabn6579.%20PMCID%3A%20PMC9645721%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Heightened%20apoptotic%20priming%20of%20vascular%20cells%20across%20tissues%20and%20life%20span%20predisposes%20them%20to%20cancer%20therapy-induced%20toxicities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%20K.%20E.%22%2C%22lastName%22%3A%22Spetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20H.%20C.%22%2C%22lastName%22%3A%22Florido%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20S.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Choiniere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacey%20J.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumani%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Friesen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%20L.%22%2C%22lastName%22%3A%22Rubin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe-Elie%22%2C%22lastName%22%3A%22Salem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javid%20J.%22%2C%22lastName%22%3A%22Moslehi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%5D%2C%22abstractNote%22%3A%22Although%20major%20organ%20toxicities%20frequently%20arise%20in%20patients%20treated%20with%20cytotoxic%20or%20targeted%20cancer%20therapies%2C%20the%20mechanisms%20that%20drive%20them%20are%20poorly%20understood.%20Here%2C%20we%20report%20that%20vascular%20endothelial%20cells%20%28ECs%29%20are%20more%20highly%20primed%20for%20apoptosis%20than%20parenchymal%20cells%20across%20many%20adult%20tissues.%20Consequently%2C%20ECs%20readily%20undergo%20apoptosis%20in%20response%20to%20many%20commonly%20used%20anticancer%20agents%20including%20cytotoxic%20and%20targeted%20drugs%20and%20are%20more%20sensitive%20to%20ionizing%20radiation%20and%20BH3%20mimetics%20than%20parenchymal%20cells%20in%20vivo.%20Further%2C%20using%20differentiated%20isogenic%20human%20induced%20pluripotent%20stem%20cell%20models%20of%20ECs%20and%20vascular%20smooth%20muscle%20cells%20%28VSMCs%29%2C%20we%20find%20that%20these%20vascular%20cells%20exhibit%20distinct%20drug%20toxicity%20patterns%2C%20which%20are%20linked%20to%20divergent%20therapy-induced%20vascular%20toxicities%20in%20patients.%20Collectively%2C%20our%20results%20demonstrate%20that%20vascular%20cells%20are%20highly%20sensitive%20to%20apoptosis-inducing%20stress%20across%20life%20span%20and%20may%20represent%20a%20%5C%22weakest%20link%5C%22%20vulnerability%20in%20multiple%20tissues%20for%20development%20of%20toxicities.%22%2C%22date%22%3A%222022-11-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.abn6579%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-11-28T17%3A19%3A04Z%22%7D%7D%5D%7D
1.
Anderson AC, Yanai I, Yates LR, Wang L, Swarbrick A, Sorger P, Santagata S, Fridman WH, Gao Q, Jerby L, Izar B, Shang L, Zhou X. Spatial transcriptomics. Cancer Cell. 2022 Sep 12;40(9):895–900. PMID: 36099884
1.
Balabin H, Hoyt CT, Birkenbihl C, Gyori BM, Bachman J, Kodamullil AT, Plöger PG, Hofmann-Apitius M, Domingo-Fernández D. STonKGs: a sophisticated transformer trained on biomedical text and knowledge graphs. Bioinformatics. 2022 Mar 4;38(6):1648–1656. PMCID: PMC8896635
1.
Bi WL, Santagata S. Skull base tumors: neuropathology and clinical implications. Neurosurgery. 2022 Mar 1;90(3):243–261. PMID: 34164689
1.
Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF, Reardon DA. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 Jan 5;24(1):101–113. PMCID: PMC8730772
1.
Bonner S, Barrett IP, Ye C, Swiers R, Engkvist O, Bender A, Hoyt CT, Hamilton WL. A review of biomedical datasets relating to drug discovery: a knowledge graph perspective. Brief Bioinform. 2022 Nov 19;23(6):bbac404. PMID: 36151740
1.
Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, Wang N, Eichler AF, Chukwueke U, Forst DA, Arrillaga-Romany IC, Dietrich J, Corbin Z, Moliterno J, Baehring J, White M, Lou KW, Larson J, de Sauvage MA, Evancic K, Mora J, Nayyar N, Loeffler J, Oh K, Shih HA, Curry WT, Cahill DP, Barker FG, Gerstner ER, Santagata S. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022 Mar 14;13(1):1325. PMCID: PMC8921328
1.
Charpignon ML, Vakulenko-Lagun B, Zheng B, Magdamo C, Su B, Evans K, Rodriguez S, Sokolov A, Boswell S, Sheu YH, Somai M, Middleton L, Hyman BT, Betensky RA, Finkelstein SN, Welsch RE, Tzoulaki I, Blacker D, Das S, Albers MW. Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia. Nat Commun. 2022 Dec 10;13(1):7652. PMCID: PMC9741618
1.
Chowdhury R, Bouatta N, Biswas S, Floristean C, Kharkar A, Roy K, Rochereau C, Ahdritz G, Zhang J, Church GM, Sorger PK, AlQuraishi M. Single-sequence protein structure prediction using a language model and deep learning. Nat Biotechnol. 2022 Nov;40(11):1617–1623. PMCID: PMC10440047
1.
Coy S, Wang S, Stopka SA, Lin JR, Yapp C, Ritch CC, Salhi L, Baker GJ, Rashid R, Baquer G, Regan M, Khadka P, Cole KA, Hwang J, Wen PY, Bandopadhayay P, Santi M, De Raedt T, Ligon KL, Agar NYR, Sorger PK, Touat M, Santagata S. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022 Aug 16;13(1):4814. PMCID: PMC9381513
1.
Creason AL, Watson C, Gu Q, Persson D, Sargent L, Chen YA, Lin JR, Sivagnanam S, Wünnemann F, Nirmal AJ, Chin K, Feiler HS, Coussens LM, Schapiro D, Grüning B, Sorger PK, Sokolov A, Goecks J. A web-based software resource for interactive analysis of multiplex tissue imaging datasets [Internet]. bioRxiv; 2022 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/2022.08.18.504436
1.
CSBC/PS-ON Image Analysis Working Group, Vizcarra JC, Burlingame EA, Hug CB, Goltsev Y, White BS, Tyson DR, Sokolov A. A community-based approach to image analysis of cells, tissues and tumors. Comput Med Imaging Graph. 2022 Jan;95:102013. PMCID: PMC8761177
1.
de Crécy-Lagard V, Amorin de Hegedus R, Arighi C, Babor J, Bateman A, Blaby I, Blaby-Haas C, Bridge AJ, Burley SK, Cleveland S, Colwell LJ, Conesa A, Dallago C, Danchin A, de Waard A, Deutschbauer A, Dias R, Ding Y, Fang G, Friedberg I, Gerlt J, Goldford J, Gorelik M, Gyori BM, Henry C, Hutinet G, Jaroch M, Karp PD, Kondratova L, Lu Z, Marchler-Bauer A, Martin MJ, McWhite C, Moghe GD, Monaghan P, Morgat A, Mungall CJ, Natale DA, Nelson WC, O’Donoghue S, Orengo C, O’Toole KH, Radivojac P, Reed C, Roberts RJ, Rodionov D, Rodionova IA, Rudolf JD, Saleh L, Sheynkman G, Thibaud-Nissen F, Thomas PD, Uetz P, Vallenet D, Carter EW, Weigele PR, Wood V, Wood-Charlson EM, Xu J. A roadmap for the functional annotation of protein families: a community perspective. Database (Oxford). 2022 Aug 12;2022:baac062. PMCID: PMC9374478
1.
Doherty LM, Mills CE, Boswell SA, Liu X, Hoyt CT, Gyori B, Buhrlage SJ, Sorger PK. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Elife. 2022 Jun 23;11:e72879. PMCID: PMC9225015
1.
Fraser CS, Spetz JKE, Qin X, Presser A, Choiniere J, Li C, Yu S, Blevins F, Hata AN, Miller JW, Bradshaw GA, Kalocsay M, Sanchorawala V, Sarosiek S, Sarosiek KA. Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics. Nat Commun. 2022 Oct 2;13(1):5789. PMCID: PMC9527241
1.
Fröhlich F, Sorger PK. Fides: Reliable trust-region optimization for parameter estimation of ordinary differential equation models. PLoS Comput Biol. 2022 Jul 13;18(7):e1010322. PMCID: PMC9312381
1.
Gaglia G, Kabraji S, Rammos D, Dai Y, Verma A, Wang S, Mills CE, Chung M, Bergholz JS, Coy S, Lin JR, Jeselsohn R, Metzger O, Winer EP, Dillon DA, Zhao JJ, Sorger PK, Santagata S. Temporal and spatial topography of cell proliferation in cancer. Nat Cell Biol. 2022 Mar;24(3):316–326. PMCID: PMC8959396
1.
Gray GK, Li CMC, Rosenbluth JM, Selfors LM, Girnius N, Lin JR, Schackmann RCJ, Goh WL, Moore K, Shapiro HK, Mei S, D’Andrea K, Nathanson KL, Sorger PK, Santagata S, Regev A, Garber JE, Dillon DA, Brugge JS. A human breast atlas integrating single-cell proteomics and transcriptomics. Dev Cell. 2022 Jun 6;57(11):1400-1420.e7. PMCID: PMC9202341
1.
Gross SM, Dane MA, Smith RL, Devlin KL, McLean IC, Derrick DS, Mills CE, Subramanian K, London AB, Torre D, Evangelista JE, Clarke DJB, Xie Z, Erdem C, Lyons N, Natoli T, Pessa S, Lu X, Mullahoo J, Li J, Adam M, Wassie B, Liu M, Kilburn DF, Liby TA, Bucher E, Sanchez-Aguila C, Daily K, Omberg L, Wang Y, Jacobson C, Yapp C, Chung M, Vidovic D, Lu Y, Schurer S, Lee A, Pillai A, Subramanian A, Papanastasiou M, Fraenkel E, Feiler HS, Mills GB, Jaffe JD, Ma’ayan A, Birtwistle MR, Sorger PK, Korkola JE, Gray JW, Heiser LM. A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses. Commun Biol. 2022 Oct 7;5(1):1066. PMCID: PMC9546880
1.
Gyori BM, Hoyt CT. PyBioPAX: biological pathway exchange in Python. J Open Source Softw. 2022;7(71):4136. PMCID: PMC9447860
1.
Gyori BM, Hoyt CT, Steppi A. Gilda: biomedical entity text normalization with machine-learned disambiguation as a service. Bioinform Adv. 2022;2(1):vbac034. PMCID: PMC9710686
1.
Hodis E, Torlai Triglia E, Kwon JYH, Biancalani T, Zakka LR, Parkar S, Hütter JC, Buffoni L, Delorey TM, Phillips D, Dionne D, Nguyen LT, Schapiro D, Maliga Z, Jacobson CA, Hendel A, Rozenblatt-Rosen O, Mihm MC, Garraway LA, Regev A. Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment. Science. 2022 Apr 29;376(6592):eabi8175. PMCID: PMC9427199
1.
Hoyt CT, Balk M, Callahan TJ, Domingo-Fernández D, Haendel MA, Hegde HB, Himmelstein DS, Karis K, Kunze J, Lubiana T, Matentzoglu N, McMurry J, Moxon S, Mungall CJ, Rutz A, Unni DR, Willighagen E, Winston D, Gyori BM. Unifying the identification of biomedical entities with the Bioregistry. Sci Data. 2022 Nov 19;9(1):714. PMCID: PMC9675740
1.
Jessup J, Krueger R, Warchol S, Hoffer J, Muhlich J, Ritch CC, Gaglia G, Coy S, Chen YA, Lin JR, Santagata S, Sorger PK, Pfister H. Scope2Screen: focus+context techniques for pathology tumor assessment in multivariate image data. IEEE Trans Vis Comput Graph. 2022 Jan;28(1):259–269. PMCID: PMC8805697
1.
Jiménez A, Lu D, Kalocsay M, Berberich MJ, Balbi P, Jambhekar A, Lahav G. Time-series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations. Mol Syst Biol. 2022 Mar;18(3):e10588. PMCID: PMC8919251
1.
Johnson S, Haigis MC, Dougan SK. Dangerous dynamic duo: lactic acid and PD-1 blockade. Cancer Cell. 2022 Feb 14;40(2):127–130. PMID: 35093211
1.
Larkins-Ford J, Degefu YN, Van N, Sokolov A, Aldridge BB. Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements. Cell Rep Med. 2022 Sep 20;3(9):100737. PMCID: PMC9512659
1.
Launonen IM, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia UM, Jacobson CA, Lin JR, Maliga Z, Howitt BE, Strickland KC, Santagata S, Elias K, D’Andrea AD, Konstantinopoulos PA, Sorger PK, Färkkilä A. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 Feb 11;13(1):835. PMCID: PMC8837628
1.
Lomakin A, Svedlund J, Strell C, Gataric M, Shmatko A, Rukhovich G, Park JS, Ju YS, Dentro S, Kleshchevnikov V, Vaskivskyi V, Li T, Bayraktar OA, Pinder S, Richardson AL, Santagata S, Campbell PJ, Russnes H, Gerstung M, Nilsson M, Yates LR. Spatial genomics maps the structure, nature and evolution of cancer clones. Nature. 2022 Nov;611(7936):594–602. PMCID: PMC9668746
1.
Matentzoglu N, Goutte-Gattat D, Tan SZK, Balhoff JP, Carbon S, Caron AR, Duncan WD, Flack JE, Haendel M, Harris NL, Hogan WR, Hoyt CT, Jackson RC, Kim H, Kir H, Larralde M, McMurry JA, Overton JA, Peters B, Pilgrim C, Stefancsik R, Robb SM, Toro S, Vasilevsky NA, Walls R, Mungall CJ, Osumi-Sutherland D. Ontology Development Kit: a toolkit for building, maintaining and standardizing biomedical ontologies. Database (Oxford). 2022 Oct 8;2022:baac087. PMCID: PMC9547537
1.
Mills CE, Subramanian K, Hafner M, Niepel M, Gerosa L, Chung M, Victor C, Gaudio B, Yapp C, Nirmal AJ, Clark N, Sorger PK. Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop. Nat Commun. 2022 Nov 14;13(1):6918. PMCID: PMC9663587
1.
Mohammad-Taheri S, Zucker J, Hoyt CT, Sachs K, Tewari V, Ness R, Vitek O. Do-calculus enables estimation of causal effects in partially observed biomolecular pathways. Bioinformatics. 2022 Jun 24;38(Suppl 1):i350–i358. PMCID: PMC9235495
1.
Muhlich JL, Chen YA, Yapp C, Russell D, Santagata S, Sorger PK. Stitching and registering highly multiplexed whole slide images of tissues and tumors using ASHLAR. Bioinformatics. 2022 Aug 16;btac544. PMCID: PMC9525007
1.
Ng TSC, Hu H, Kronister S, Lee C, Li R, Gerosa L, Stopka SA, Burgenske DM, Khurana I, Regan MS, Vallabhaneni S, Putta N, Scott E, Matvey D, Giobbie-Hurder A, Kohler RH, Sarkaria JN, Parangi S, Sorger PK, Agar NYR, Jacene HA, Sullivan RJ, Buchbinder E, Mikula H, Weissleder R, Miller MA. Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy. Sci Adv. 2022 Apr 29;8(17):eabl6339. PMCID: PMC9054019
1.
Nirmal AJ, Maliga Z, Vallius T, Quattrochi B, Chen AA, Jacobson CA, Pelletier RJ, Yapp C, Arias-Camison R, Chen YA, Lian CG, Murphy GF, Santagata S, Sorger PK. The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution. Cancer Discov. 2022 Jun 2;12(6):1518–1541. PMCID: PMC9167783
1.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, Stopka SA, Baquer G, Lin JR, Golby AJ, Joshi S, Baron HF, Drijvers JM, Georgiev P, Ringel AE, Zaganjor E, McBrayer SK, Sorger PK, Sharpe AH, Wucherpfennig KW, Santagata S, Agar NYR, Suvà ML, Haigis MC. Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function. Science. 2022 Sep 30;377(6614):1519–1529. PMCID: PMC9629749
1.
Palmer AC, Izar B, Hwangbo H, Sorger PK. Predictable clinical benefits without evidence of synergy in trials of combination therapies with immune-checkpoint inhibitors. Clin Cancer Res. 2022 Jan 15;28(2):368–377. PMCID: PMC9068233
1.
Papa A, Zakharov SI, Katchman AN, Kushner JS, Chen BX, Yang L, Liu G, Jimenez AS, Eisert RJ, Bradshaw GA, Dun W, Ali SR, Rodriques A, Zhou K, Topkara V, Yang M, Morrow JP, Tsai EJ, Karlin A, Wan E, Kalocsay M, Pitt GS, Colecraft HM, Ben-Johny M, Marx SO. Rad regulation of CaV1.2 channels controls cardiac fight-or-flight response. Nat Cardiovasc Res. 2022 Nov;1(11):1022–1038. PMCID: PMC9681059
1.
Pernas S, Guerriero JL, Naumenko S, Goel S, Regan MM, Hu J, Harrison BT, Lynce F, Lin NU, Partridge A, Morikawa A, Hutchinson J, Mittendorf EA, Sokolov A, Overmoyer B. Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. Ther Adv Med Oncol. 2022 Jul 30;14:17588359221113268. PMCID: PMC9340890
1.
Plana D, Fell G, Alexander BM, Palmer AC, Sorger PK. Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects. Nat Commun. 2022 Feb 15;13(1):873. PMCID: PMC8847344
1.
Plana D, Palmer AC, Sorger PK. Independent drug action in combination therapy: implications for precision oncology. Cancer Discov. 2022 Mar 1;12(3):606–624. PMCID: PMC8904281
1.
Pomeroy AE, Schmidt EV, Sorger PK, Palmer AC. Drug independence and the curability of cancer by combination chemotherapy. Trends Cancer. 2022 Nov;8(11):915–929. PMCID: PMC9588605
1.
Rashid R, Chen YA, Hoffer J, Muhlich JL, Lin JR, Krueger R, Pfister H, Mitchell R, Santagata S, Sorger PK. Narrative online guides for the interpretation of digital-pathology images and tissue-atlas data. Nat Biomed Eng. 2022 May;6(5):515–526. PMCID: PMC9079188
1.
Reichart D, Lindberg EL, Maatz H, Miranda AMA, Viveiros A, Shvetsov N, Gärtner A, Nadelmann ER, Lee M, Kanemaru K, Ruiz-Orera J, Strohmenger V, DeLaughter DM, Patone G, Zhang H, Woehler A, Lippert C, Kim Y, Adami E, Gorham JM, Barnett SN, Brown K, Buchan RJ, Chowdhury RA, Constantinou C, Cranley J, Felkin LE, Fox H, Ghauri A, Gummert J, Kanda M, Li R, Mach L, McDonough B, Samari S, Shahriaran F, Yapp C, Stanasiuk C, Theotokis PI, Theis FJ, van den Bogaerdt A, Wakimoto H, Ware JS, Worth CL, Barton PJR, Lee YA, Teichmann SA, Milting H, Noseda M, Oudit GY, Heinig M, Seidman JG, Hubner N, Seidman CE. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. Science. 2022 Aug 5;377(6606):eabo1984. PMCID: PMC9528698
1.
Schapiro D, Sokolov A, Yapp C, Chen YA, Muhlich JL, Hess J, Creason AL, Nirmal AJ, Baker GJ, Nariya MK, Lin JR, Maliga Z, Jacobson CA, Hodgman MW, Ruokonen J, Farhi SL, Abbondanza D, McKinley ET, Persson D, Betts C, Sivagnanam S, Regev A, Goecks J, Coffey RJ, Coussens LM, Santagata S, Sorger PK. MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging. Nat Methods. 2022 Mar;19(3):311–315. PMCID: PMC8916956
1.
Schapiro D, Yapp C, Sokolov A, Reynolds SM, Chen YA, Sudar D, Xie Y, Muhlich J, Arias-Camison R, Arena S, Taylor AJ, Nikolov M, Tyler M, Lin JR, Burlingame EA, Human Tumor Atlas Network, Chang YH, Farhi SL, Thorsson V, Venkatamohan N, Drewes JL, Pe’er D, Gutman DA, Herrmann MD, Gehlenborg N, Bankhead P, Roland JT, Herndon JM, Snyder MP, Angelo M, Nolan G, Swedlow JR, Schultz N, Merrick DT, Mazzili SA, Cerami E, Rodig SJ, Santagata S, Sorger PK. MITI minimum information guidelines for highly multiplexed tissue images. Nat Methods. 2022 Mar;19(3):262–267. PMCID: PMC9009186
1.
Schink SJ, Christodoulou D, Mukherjee A, Athaide E, Brunner V, Fuhrer T, Bradshaw GA, Sauer U, Basan M. Glycolysis/gluconeogenesis specialization in microbes is driven by biochemical constraints of flux sensing. Mol Syst Biol. 2022 Jan;18(1):e10704. PMCID: PMC8738977
1.
Scholten B, Simón LG, Krishnan S, Vermeulen R, Pronk A, Gyori BM, Bachman JA, Vlaanderen J, Stierum R. Automated network assembly of mechanistic literature for informed evidence identification to support cancer risk assessment. Environ Health Perspect. 2022 Mar;130(3):37002. PMCID: PMC8893280
1.
Sekar G, Singh G, Qin X, Guibao CD, Schwam B, Inde Z, Grace CR, Zhang W, Slavish PJ, Lin W, Chen T, Lee RE, Rankovic Z, Sarosiek K, Moldoveanu T. Small molecule SJ572946 activates BAK to initiate apoptosis. iScience. 2022 Oct 21;25(10):105064. PMCID: PMC9485059
1.
Spetz JKE, Florido MHC, Fraser CS, Qin X, Choiniere J, Yu SJ, Singh R, Friesen M, Rubin LL, Salem JE, Moslehi JJ, Sarosiek KA. Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy-induced toxicities. Sci Adv. 2022 Nov 11;8(45):eabn6579. PMCID: PMC9645721
2576724
IXMHRBF6
LSP Paper
2021
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MJ93D9WW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Abtahi%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAbtahi%20S%2C%20Gliksman%20NR%2C%20Heneghan%20JF%2C%20Nilsen%20SP%2C%20Muhlich%20JL%2C%20Copeland%20J%2C%20Rozbicki%20E%2C%20Allan%20C%2C%20Dudeja%20PK%2C%20Turner%20JR.%20A%20simple%20method%20for%20creating%20a%20high-content%20microscope%20for%20imaging%20multiplexed%20tissue%20microarrays.%20Curr%20Protoc.%202021%20Apr%3B1%284%29%3Ae68.%20PMCID%3A%20PMC8103673%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20simple%20method%20for%20creating%20a%20high-content%20microscope%20for%20imaging%20multiplexed%20tissue%20microarrays%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shabnam%22%2C%22lastName%22%3A%22Abtahi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20R.%22%2C%22lastName%22%3A%22Gliksman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Heneghan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Nilsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Copeland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emil%22%2C%22lastName%22%3A%22Rozbicki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Allan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pradeep%20K.%22%2C%22lastName%22%3A%22Dudeja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerrold%20R.%22%2C%22lastName%22%3A%22Turner%22%7D%5D%2C%22abstractNote%22%3A%22High-throughput%2C%20high-content%20imaging%20technologies%20and%20multiplex%20slide%20scanning%20have%20become%20widely%20used.%20Advantages%20of%20these%20approaches%20include%20the%20ability%20to%20archive%20digital%20copies%20of%20slides%2C%20review%20slides%20as%20teams%20using%20virtual%20microscopy%20software%2C%20and%20standardize%20analytical%20approaches.%20The%20cost%20and%20hardware%20and%20software%20inflexibility%20of%20dedicated%20slide%20scanning%20devices%20can%2C%20however%2C%20complicate%20implementation.%20Here%2C%20we%20describe%20a%20simple%20method%20that%20allows%20any%20microscope%20to%20be%20used%20for%20slide%20scanning.%20The%20only%20requirements%20are%20that%20the%20microscope%20be%20equipped%20with%20a%20motorized%20filter%20turret%20or%20wheels%20%28for%20multi-channel%20fluorescence%29%20and%20a%20motorized%20xyz%20stage.%20This%20example%20uses%20MetaMorph%20software%2C%20but%20the%20same%20principles%20can%20be%20used%20with%20any%20microscope%20control%20software%20that%20includes%20a%20few%20standard%20functions%20and%20allows%20programming%20of%20simple%20command%20routines%2C%20or%20journals.%20The%20series%20of%20journals%20that%20implement%20the%20method%20perform%20key%20functions%2C%20including%20assistance%20in%20defining%20an%20unlimited%20number%20of%20regions%20of%20interest%20%28ROI%29%20and%20imaging%20parameters.%20Fully%20automated%20acquisition%20is%20rapid%2C%20taking%20less%20than%203%20hr%20to%20image%20fifty%202.5-mm%20ROIs%20in%20four%20channels.%20Following%20acquisition%2C%20images%20can%20be%20easily%20stitched%20and%20displayed%20using%20open-source%20or%20commercial%20image-processing%20and%20virtual%20microscope%20applications.%20%5Cu00a9%202021%20Wiley%20Periodicals%20LLC.%20Basic%20Protocol%201%3A%20Hardware%20and%20software%20configuration%20Basic%20Protocol%202%3A%20Create%20a%20preliminary%20scan%20Basic%20Protocol%203%3A%20Select%2C%20save%2C%20and%20position%20ROIs%20Basic%20Protocol%204%3A%20Determine%20and%20set%20autofocus%20parameters%20Basic%20Protocol%205%3A%20Acquire%20tiled%20images%20Basic%20Protocol%206%3A%20Review%20the%20scans%20Basic%20Protocol%207%3A%20Reimage%20ROIs%20as%20needed%20Basic%20Protocol%208%3A%20Stitch%2C%20stack%2C%20and%20assemble%20images%20Basic%20Protocol%209%3A%20Repeat%20scanning%20for%20multiplex%20immunostaining%20or%20background%20subtraction.%22%2C%22date%22%3A%222021-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcpz1.68%22%2C%22ISSN%22%3A%222691-1299%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A47%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22BRBIJXZN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22AlQuraishi%20and%20Sorger%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M%2C%20Sorger%20PK.%20Differentiable%20biology%3A%20using%20deep%20learning%20for%20biophysics-based%20and%20data-driven%20modeling%20of%20molecular%20mechanisms.%20Nat%20Methods.%202021%20Oct%3B18%2810%29%3A1169%26%23x2013%3B1180.%20PMCID%3A%20PMC8793939%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Differentiable%20biology%3A%20using%20deep%20learning%20for%20biophysics-based%20and%20data-driven%20modeling%20of%20molecular%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Deep%20learning%20using%20neural%20networks%20relies%20on%20a%20class%20of%20machine-learnable%20models%20constructed%20using%20%27differentiable%20programs%27.%20These%20programs%20can%20combine%20mathematical%20equations%20specific%20to%20a%20particular%20domain%20of%20natural%20science%20with%20general-purpose%2C%20machine-learnable%20components%20trained%20on%20experimental%20data.%20Such%20programs%20are%20having%20a%20growing%20impact%20on%20molecular%20and%20cellular%20biology.%20In%20this%20Perspective%2C%20we%20describe%20an%20emerging%20%27differentiable%20biology%27%20in%20which%20phenomena%20ranging%20from%20the%20small%20and%20specific%20%28for%20example%2C%20one%20experimental%20assay%29%20to%20the%20broad%20and%20complex%20%28for%20example%2C%20protein%20folding%29%20can%20be%20modeled%20effectively%20and%20efficiently%2C%20often%20by%20exploiting%20knowledge%20about%20basic%20natural%20phenomena%20to%20overcome%20the%20limitations%20of%20sparse%2C%20incomplete%20and%20noisy%20data.%20By%20distilling%20differentiable%20biology%20into%20a%20small%20set%20of%20conceptual%20primitives%20and%20illustrative%20vignettes%2C%20we%20show%20how%20it%20can%20help%20to%20address%20long-standing%20challenges%20in%20integrating%20multimodal%20data%20from%20diverse%20experiments%20across%20biological%20scales.%20This%20promises%20to%20benefit%20fields%20as%20diverse%20as%20biophysics%20and%20functional%20genomics.%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-021-01283-4%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A47%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22TU6XA7GM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Antonini%20et%20al.%22%2C%22parsedDate%22%3A%222021-03%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAntonini%20MJ%2C%20Plana%20D%2C%20Srinivasan%20S%2C%20Atta%20L%2C%20Achanta%20A%2C%20Yang%20H%2C%20Cramer%20AK%2C%20Freake%20J%2C%20Sinha%20MS%2C%20Yu%20SH%2C%20LeBoeuf%20NR%2C%20Linville-Engler%20B%2C%20Sorger%20PK.%20A%20crisis-responsive%20framework%20for%20medical%20device%20development%20applied%20to%20the%20COVID-19%20pandemic.%20Front%20Digit%20Health.%202021%20Mar%3B3%3A617106.%20PMCID%3A%20PMC8064560%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20crisis-responsive%20framework%20for%20medical%20device%20development%20applied%20to%20the%20COVID-19%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc-Joseph%22%2C%22lastName%22%3A%22Antonini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shriya%22%2C%22lastName%22%3A%22Srinivasan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyla%22%2C%22lastName%22%3A%22Atta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aditya%22%2C%22lastName%22%3A%22Achanta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%20K.%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Freake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%22%2C%22lastName%22%3A%22Linville-Engler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20disruption%20of%20conventional%20manufacturing%2C%20supply%2C%20and%20distribution%20channels%20during%20the%20COVID-19%20pandemic%20caused%20widespread%20shortages%20in%20personal%20protective%20equipment%20%28PPE%29%20and%20other%20medical%20supplies.%20These%20shortages%20catalyzed%20local%20efforts%20to%20use%20nontraditional%2C%20rapid%20manufacturing%20to%20meet%20urgent%20healthcare%20needs.%20Here%20we%20present%20a%20crisis-responsive%20design%20framework%20designed%20to%20assist%20with%20product%20development%20under%20pandemic%20conditions.%20The%20framework%20emphasizes%20stakeholder%20engagement%2C%20comprehensive%20but%20efficient%20needs%20assessment%2C%20rapid%20manufacturing%2C%20and%20modified%20product%20testing%20to%20enable%20accelerated%20development%20of%20healthcare%20products.%20We%20contrast%20this%20framework%20with%20traditional%20medical%20device%20manufacturing%20that%20proceeds%20at%20a%20more%20deliberate%20pace%2C%20discuss%20strengths%20and%20weakness%20of%20pandemic-responsive%20fabrication%2C%20and%20consider%20relevant%20regulatory%20policies.%20We%20highlight%20the%20use%20of%20the%20crisis-responsive%20framework%20in%20a%20case%20study%20of%20face%20shield%20design%20and%20production%20for%20a%20large%20US%20academic%20hospital.%20Finally%2C%20we%20make%20recommendations%20aimed%20at%20improving%20future%20resilience%20to%20pandemics%20and%20healthcare%20emergencies.%20These%20include%20continued%20development%20of%20open%20source%20designs%20suitable%20for%20rapid%20manufacturing%2C%20education%20of%20maker%20communities%20and%20hospital%20administrators%20about%20rapidly-manufactured%20medical%20devices%2C%20and%20changes%20in%20regulatory%20policy%20that%20help%20strike%20a%20balance%20between%20quality%20and%20innovation.%22%2C%22date%22%3A%222021-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffdgth.2021.617106%22%2C%22ISSN%22%3A%222673-253X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A03%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22DC9V9PLR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bouatta%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-01%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBouatta%20N%2C%20Sorger%20P%2C%20AlQuraishi%20M.%20Protein%20structure%20prediction%20by%20AlphaFold2%3A%20are%20attention%20and%20symmetries%20all%20you%20need%3F%20Acta%20Crystallogr%20D%20Struct%20Biol.%202021%20Aug%201%3B77%28Pt%208%29%3A982%26%23x2013%3B991.%20PMCID%3A%20PMC8329862%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Protein%20structure%20prediction%20by%20AlphaFold2%3A%20are%20attention%20and%20symmetries%20all%20you%20need%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazim%22%2C%22lastName%22%3A%22Bouatta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22The%20functions%20of%20most%20proteins%20result%20from%20their%203D%20structures%2C%20but%20determining%20their%20structures%20experimentally%20remains%20a%20challenge%2C%20despite%20steady%20advances%20in%20crystallography%2C%20NMR%20and%20single-particle%20cryoEM.%20Computationally%20predicting%20the%20structure%20of%20a%20protein%20from%20its%20primary%20sequence%20has%20long%20been%20a%20grand%20challenge%20in%20bioinformatics%2C%20intimately%20connected%20with%20understanding%20protein%20chemistry%20and%20dynamics.%20Recent%20advances%20in%20deep%20learning%2C%20combined%20with%20the%20availability%20of%20genomic%20data%20for%20inferring%20co-evolutionary%20patterns%2C%20provide%20a%20new%20approach%20to%20protein%20structure%20prediction%20that%20is%20complementary%20to%20longstanding%20physics-based%20approaches.%20The%20outstanding%20performance%20of%20AlphaFold2%20in%20the%20recent%20Critical%20Assessment%20of%20protein%20Structure%20Prediction%20%28CASP14%29%20experiment%20demonstrates%20the%20remarkable%20power%20of%20deep%20learning%20in%20structure%20prediction.%20In%20this%20perspective%2C%20we%20focus%20on%20the%20key%20features%20of%20AlphaFold2%2C%20including%20its%20use%20of%20%28i%29%20attention%20mechanisms%20and%20Transformers%20to%20capture%20long-range%20dependencies%2C%20%28ii%29%20symmetry%20principles%20to%20facilitate%20reasoning%20over%20protein%20structures%20in%20three%20dimensions%20and%20%28iii%29%20end-to-end%20differentiability%20as%20a%20unifying%20framework%20for%20learning%20from%20protein%20data.%20The%20rules%20of%20protein%20folding%20are%20ultimately%20encoded%20in%20the%20physical%20principles%20that%20underpin%20it%3B%20to%20conclude%2C%20the%20implications%20of%20having%20a%20powerful%20computational%20model%20for%20structure%20prediction%20that%20does%20not%20explicitly%20rely%20on%20those%20principles%20are%20discussed.%22%2C%22date%22%3A%222021-08-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1107%5C%2FS2059798321007531%22%2C%22ISSN%22%3A%222059-7983%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A46%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22PS66ZGPR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22B%5Cu0159inda%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EB%26%23x159%3Binda%20K%2C%20Baym%20M%2C%20Kucherov%20G.%20Simplitigs%20as%20an%20efficient%20and%20scalable%20representation%20of%20de%20Bruijn%20graphs.%20Genome%20Biol.%202021%20Apr%206%3B22%281%29%3A96.%20PMCID%3A%20PMC8025321%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Simplitigs%20as%20an%20efficient%20and%20scalable%20representation%20of%20de%20Bruijn%20graphs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karel%22%2C%22lastName%22%3A%22B%5Cu0159inda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Kucherov%22%7D%5D%2C%22abstractNote%22%3A%22de%20Bruijn%20graphs%20play%20an%20essential%20role%20in%20bioinformatics%2C%20yet%20they%20lack%20a%20universal%20scalable%20representation.%20Here%2C%20we%20introduce%20simplitigs%20as%20a%20compact%2C%20efficient%2C%20and%20scalable%20representation%2C%20and%20ProphAsm%2C%20a%20fast%20algorithm%20for%20their%20computation.%20For%20the%20example%20of%20assemblies%20of%20model%20organisms%20and%20two%20bacterial%20pan-genomes%2C%20we%20compare%20simplitigs%20to%20unitigs%2C%20the%20best%20existing%20representation%2C%20and%20demonstrate%20that%20simplitigs%20provide%20a%20substantial%20improvement%20in%20the%20cumulative%20sequence%20length%20and%20their%20number.%20When%20combined%20with%20the%20commonly%20used%20Burrows-Wheeler%20Transform%20index%2C%20simplitigs%20reduce%20memory%2C%20and%20index%20loading%20and%20query%20times%2C%20as%20demonstrated%20with%20large-scale%20examples%20of%20GenBank%20bacterial%20pan-genomes.%22%2C%22date%22%3A%222021-04-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13059-021-02297-z%22%2C%22ISSN%22%3A%221474-760X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-05-10T14%3A10%3A06Z%22%7D%7D%2C%7B%22key%22%3A%227NC2GTSQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Burger%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-16%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBurger%20ML%2C%20Cruz%20AM%2C%20Crossland%20GE%2C%20Gaglia%20G%2C%20Ritch%20CC%2C%20Blatt%20SE%2C%20Bhutkar%20A%2C%20Canner%20D%2C%20Kienka%20T%2C%20Tavana%20SZ%2C%20Barandiaran%20AL%2C%20Garmilla%20A%2C%20Schenkel%20JM%2C%20Hillman%20M%2C%20de%20Los%20Rios%20Kobara%20I%2C%20Li%20A%2C%20Jaeger%20AM%2C%20Hwang%20WL%2C%20Westcott%20PMK%2C%20Manos%20MP%2C%20Holovatska%20MM%2C%20Hodi%20FS%2C%20Regev%20A%2C%20Santagata%20S%2C%20Jacks%20T.%20Antigen%20dominance%20hierarchies%20shape%20TCF1%2B%20progenitor%20CD8%20T%26%23xA0%3Bcell%20phenotypes%20in%20tumors.%20Cell.%202021%20Sep%2016%3B184%2819%29%3A4996-5014.e26.%20PMCID%3A%20PMC8522630%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antigen%20dominance%20hierarchies%20shape%20TCF1%2B%20progenitor%20CD8%20T%5Cu00a0cell%20phenotypes%20in%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20L.%22%2C%22lastName%22%3A%22Burger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20M.%22%2C%22lastName%22%3A%22Cruz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grace%20E.%22%2C%22lastName%22%3A%22Crossland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecily%20C.%22%2C%22lastName%22%3A%22Ritch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20E.%22%2C%22lastName%22%3A%22Blatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arjun%22%2C%22lastName%22%3A%22Bhutkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Canner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamina%22%2C%22lastName%22%3A%22Kienka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20Z.%22%2C%22lastName%22%3A%22Tavana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexia%20L.%22%2C%22lastName%22%3A%22Barandiaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Garmilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20M.%22%2C%22lastName%22%3A%22Schenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%22%2C%22lastName%22%3A%22Hillman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Izumi%22%2C%22lastName%22%3A%22de%20Los%20Rios%20Kobara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20M.%22%2C%22lastName%22%3A%22Jaeger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20L.%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%20K.%22%2C%22lastName%22%3A%22Westcott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Manos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%20M.%22%2C%22lastName%22%3A%22Holovatska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Stephen%22%2C%22lastName%22%3A%22Hodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%22%2C%22lastName%22%3A%22Jacks%22%7D%5D%2C%22abstractNote%22%3A%22CD8%20T%5Cu00a0cell%20responses%20against%20different%20tumor%20neoantigens%20occur%20simultaneously%2C%20yet%20little%20is%20known%20about%20the%20interplay%20between%20responses%20and%20its%20impact%20on%20T%5Cu00a0cell%20function%20and%20tumor%20control.%20In%20mouse%20lung%20adenocarcinoma%2C%20we%20found%20that%20immunodominance%20is%20established%20in%20tumors%2C%20wherein%20CD8%20T%5Cu00a0cell%20expansion%20is%20predominantly%20driven%20by%20the%20antigen%20that%20most%20stably%20binds%20MHC.%20T%5Cu00a0cells%20responding%20to%20subdominant%20antigens%20were%20enriched%20for%20a%20TCF1%2B%20progenitor%20phenotype%20correlated%20with%20response%20to%20immune%20checkpoint%20blockade%20%28ICB%29%20therapy.%20However%2C%20the%20subdominant%20T%5Cu00a0cell%20response%20did%20not%20preferentially%20benefit%20from%20ICB%20due%20to%20a%20dysfunctional%20subset%20of%20TCF1%2B%20cells%20marked%20by%20CCR6%20and%20Tc17%20differentiation.%20Analysis%20of%20human%20samples%20and%20sequencing%20datasets%20revealed%20that%20CCR6%2B%20TCF1%2B%20cells%20exist%20across%20human%20cancers%20and%20are%20not%20correlated%20with%20ICB%20response.%20Vaccination%20eliminated%20CCR6%2B%20TCF1%2B%20cells%20and%20dramatically%20improved%20the%20subdominant%20response%2C%20highlighting%20a%20strategy%20to%20optimally%20engage%20concurrent%20neoantigen%20responses%20against%20tumors.%22%2C%22date%22%3A%222021-09-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2021.08.020%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22APJUHLY3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Cramer%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-21%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECramer%20AK%2C%20Plana%20D%2C%20Yang%20H%2C%20Carmack%20MM%2C%20Tian%20E%2C%20Sinha%20MS%2C%20Krikorian%20D%2C%20Turner%20D%2C%20Mo%20J%2C%20Li%20J%2C%20Gupta%20R%2C%20Manning%20H%2C%20Bourgeois%20FT%2C%20Yu%20SH%2C%20Sorger%20PK%2C%20LeBoeuf%20NR.%20Analysis%20of%20SteraMist%20ionized%20hydrogen%20peroxide%20technology%20in%20the%20sterilization%20of%20N95%20respirators%20and%20other%20PPE.%20Sci%20Rep.%202021%20Jan%2021%3B11%281%29%3A2051.%20PMCID%3A%20PMC7819989%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Analysis%20of%20SteraMist%20ionized%20hydrogen%20peroxide%20technology%20in%20the%20sterilization%20of%20N95%20respirators%20and%20other%20PPE%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%20K.%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20M.%22%2C%22lastName%22%3A%22Carmack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enze%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Krikorian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhan%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajiv%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%22%2C%22lastName%22%3A%22Manning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%20T.%22%2C%22lastName%22%3A%22Bourgeois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20has%20led%20to%20widespread%20shortages%20of%20personal%20protective%20equipment%20%28PPE%29%20for%20healthcare%20workers%2C%20including%20of%20N95%20masks%20%28filtering%20facepiece%20respirators%3B%20FFRs%29.%20These%20masks%20are%20intended%20for%20single%20use%20but%20their%20sterilization%20and%20subsequent%20reuse%20has%20the%20potential%20to%20substantially%20mitigate%20shortages.%20Here%20we%20investigate%20PPE%20sterilization%20using%20ionized%20hydrogen%20peroxide%20%28iHP%29%2C%20generated%20by%20SteraMist%20equipment%20%28TOMI%3B%20Frederick%2C%20MD%29%2C%20in%20a%20sealed%20environment%20chamber.%20The%20efficacy%20of%20sterilization%20by%20iHP%20was%20assessed%20using%20bacterial%20spores%20in%20biological%20indicator%20assemblies.%20After%20one%20or%20more%20iHP%20treatments%2C%20five%20models%20of%20N95%20masks%20from%20three%20manufacturers%20were%20assessed%20for%20retention%20of%20function%20based%20on%20their%20ability%20to%20form%20an%20airtight%20seal%20%28measured%20using%20a%20quantitative%20fit%20test%29%20and%20filter%20aerosolized%20particles.%20Filtration%20testing%20was%20performed%20at%20a%20university%20lab%20and%20at%20a%20National%20Institute%20for%20Occupational%20Safety%20and%20Health%20%28NIOSH%29%20pre-certification%20laboratory.%20The%20data%20demonstrate%20that%20N95%20masks%20sterilized%20using%20SteraMist%20iHP%20technology%20retain%20filtration%20efficiency%20up%20to%20ten%20cycles%2C%20the%20maximum%20number%20tested%20to%20date.%20A%20typical%20iHP%20environment%20chamber%20with%20a%20volume%20of%20~%5Cu200980%5Cu00a0m3%20can%20treat%20~%5Cu20097000%20masks%20and%20other%20items%20%28e.g.%20other%20PPE%2C%20iPADs%29%2C%20making%20this%20an%20effective%20approach%20for%20a%20busy%20medical%20center.%22%2C%22date%22%3A%222021-01-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-81365-7%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A03%3A27Z%22%7D%7D%2C%7B%22key%22%3A%226YAPPZVP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Drijvers%20et%20al.%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDrijvers%20JM%2C%20Gillis%20JE%2C%20Muijlwijk%20T%2C%20Nguyen%20TH%2C%20Gaudiano%20EF%2C%20Harris%20IS%2C%20LaFleur%20MW%2C%20Ringel%20AE%2C%20Yao%20CH%2C%20Kurmi%20K%2C%20Juneja%20VR%2C%20Trombley%20JD%2C%20Haigis%20MC%2C%20Sharpe%20AH.%20Pharmacologic%20screening%20identifies%20metabolic%20vulnerabilities%20of%20CD8%2B%20T%20cells.%20Cancer%20Immunol%20Res.%202021%20Feb%3B9%282%29%3A184%26%23x2013%3B199.%20PMCID%3A%20PMC7864883%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacologic%20screening%20identifies%20metabolic%20vulnerabilities%20of%20CD8%2B%20T%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jefte%20M.%22%2C%22lastName%22%3A%22Drijvers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20E.%22%2C%22lastName%22%3A%22Gillis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tara%22%2C%22lastName%22%3A%22Muijlwijk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thao%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20F.%22%2C%22lastName%22%3A%22Gaudiano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20S.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20W.%22%2C%22lastName%22%3A%22LaFleur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20E.%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cong-Hui%22%2C%22lastName%22%3A%22Yao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiran%22%2C%22lastName%22%3A%22Kurmi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikram%20R.%22%2C%22lastName%22%3A%22Juneja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20D.%22%2C%22lastName%22%3A%22Trombley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%5D%2C%22abstractNote%22%3A%22Metabolic%20constraints%20in%20the%20tumor%20microenvironment%20constitute%20a%20barrier%20to%20effective%20antitumor%20immunity%20and%20similarities%20in%20the%20metabolic%20properties%20of%20T%20cells%20and%20cancer%20cells%20impede%20the%20specific%20therapeutic%20targeting%20of%20metabolism%20in%20either%20population.%20To%20identify%20distinct%20metabolic%20vulnerabilities%20of%20CD8%2B%20T%20cells%20and%20cancer%20cells%2C%20we%20developed%20a%20high-throughput%20in%20vitro%20pharmacologic%20screening%20platform%20and%20used%20it%20to%20measure%20the%20cell%20type-specific%20sensitivities%20of%20activated%20CD8%2B%20T%20cells%20and%20B16%20melanoma%20cells%20to%20a%20wide%20array%20of%20metabolic%20perturbations%20during%20antigen-specific%20killing%20of%20cancer%20cells%20by%20CD8%2B%20T%20cells.%20We%20illustrated%20the%20applicability%20of%20this%20screening%20platform%20by%20showing%20that%20CD8%2B%20T%20cells%20were%20more%20sensitive%20to%20ferroptosis%20induction%20by%20inhibitors%20of%20glutathione%20peroxidase%204%20%28GPX4%29%20than%20B16%20and%20MC38%20cancer%20cells.%20Overexpression%20of%20ferroptosis%20suppressor%20protein%201%20%28FSP1%29%20or%20cytosolic%20GPX4%20yielded%20ferroptosis-resistant%20CD8%2B%20T%20cells%20without%20compromising%20their%20function%2C%20while%20genetic%20deletion%20of%20the%20ferroptosis%20sensitivity-promoting%20enzyme%20acyl-CoA%20synthetase%20long-chain%20family%20member%204%20%28ACSL4%29%20protected%20CD8%2B%20T%20cells%20from%20ferroptosis%20but%20impaired%20antitumor%20CD8%2B%20T-cell%20responses.%20Our%20screen%20also%20revealed%20high%20T%20cell-specific%20vulnerabilities%20for%20compounds%20targeting%20NAD%2B%20metabolism%20or%20autophagy%20and%20endoplasmic%20reticulum%20%28ER%29%20stress%20pathways.%20We%20focused%20the%20current%20screening%20effort%20on%20metabolic%20agents.%20However%2C%20this%20in%20vitro%20screening%20platform%20may%20also%20be%20valuable%20for%20rapid%20testing%20of%20other%20types%20of%20compounds%20to%20identify%20regulators%20of%20antitumor%20CD8%2B%20T-cell%20function%20and%20potential%20therapeutic%20targets.%22%2C%22date%22%3A%222021-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2326-6066.CIR-20-0384%22%2C%22ISSN%22%3A%222326-6074%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A01%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22U69FAWFX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duraiswamy%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-13%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuraiswamy%20J%2C%20Turrini%20R%2C%20Minasyan%20A%2C%20Barras%20D%2C%20Crespo%20I%2C%20Grimm%20AJ%2C%20Casado%20J%2C%20Genolet%20R%2C%20Benedetti%20F%2C%20Wicky%20A%2C%20Ioannidou%20K%2C%20Castro%20W%2C%20Neal%20C%2C%20Moriot%20A%2C%20Renaud-Tissot%20S%2C%20Anstett%20V%2C%20Fahr%20N%2C%20Tanyi%20JL%2C%20Eiva%20MA%2C%20Jacobson%20CA%2C%20Montone%20KT%2C%20Westergaard%20MCW%2C%20Svane%20IM%2C%20Kandalaft%20LE%2C%20Delorenzi%20M%2C%20Sorger%20PK%2C%20F%26%23xE4%3Brkkil%26%23xE4%3B%20A%2C%20Michielin%20O%2C%20Zoete%20V%2C%20Carmona%20SJ%2C%20Foukas%20PG%2C%20Powell%20DJ%2C%20Rusakiewicz%20S%2C%20Doucey%20MA%2C%20Dangaj%20Laniti%20D%2C%20Coukos%20G.%20Myeloid%20antigen-presenting%20cell%20niches%20sustain%20antitumor%20T%26%23xA0%3Bcells%20and%20license%20PD-1%20blockade%20via%20CD28%20costimulation.%20Cancer%20Cell.%202021%20Dec%2013%3B39%2812%29%3A1623-1642.e20.%20PMCID%3A%20PMC8861565%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Myeloid%20antigen-presenting%20cell%20niches%20sustain%20antitumor%20T%5Cu00a0cells%20and%20license%20PD-1%20blockade%20via%20CD28%20costimulation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaikumar%22%2C%22lastName%22%3A%22Duraiswamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riccardo%22%2C%22lastName%22%3A%22Turrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aspram%22%2C%22lastName%22%3A%22Minasyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Barras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Crespo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliz%5Cu00e9e%20J.%22%2C%22lastName%22%3A%22Grimm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Casado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Genolet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrizio%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Wicky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kalliopi%22%2C%22lastName%22%3A%22Ioannidou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilson%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Neal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amandine%22%2C%22lastName%22%3A%22Moriot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Renaud-Tissot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Anstett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22No%5Cu00e9mie%22%2C%22lastName%22%3A%22Fahr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janos%20L.%22%2C%22lastName%22%3A%22Tanyi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%20A.%22%2C%22lastName%22%3A%22Eiva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20T.%22%2C%22lastName%22%3A%22Montone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Christine%20Wulff%22%2C%22lastName%22%3A%22Westergaard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inge%20Marie%22%2C%22lastName%22%3A%22Svane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lana%20E.%22%2C%22lastName%22%3A%22Kandalaft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Delorenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Michielin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Zoete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Santiago%20J.%22%2C%22lastName%22%3A%22Carmona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Periklis%20G.%22%2C%22lastName%22%3A%22Foukas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Powell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Rusakiewicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Doucey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denarda%22%2C%22lastName%22%3A%22Dangaj%20Laniti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Coukos%22%7D%5D%2C%22abstractNote%22%3A%22The%20mechanisms%20regulating%20exhaustion%20of%20tumor-infiltrating%20lymphocytes%20%28TIL%29%20and%20responsiveness%20to%20PD-1%20blockade%20remain%20partly%20unknown.%20In%20human%20ovarian%20cancer%2C%20we%20show%20that%20tumor-specific%20CD8%2B%20TIL%20accumulate%20in%20tumor%20islets%2C%20where%20they%20engage%20antigen%20and%20upregulate%20PD-1%2C%20which%20restrains%20their%20functions.%20Intraepithelial%20PD-1%2BCD8%2B%20TIL%20can%20be%2C%20however%2C%20polyfunctional.%20PD-1%2B%20TIL%20indeed%20exhibit%20a%20continuum%20of%20exhaustion%20states%2C%20with%20variable%20levels%20of%20CD28%20costimulation%2C%20which%20is%20provided%20by%20antigen-presenting%20cells%20%28APC%29%20in%20intraepithelial%20tumor%20myeloid%20niches.%20CD28%20costimulation%20is%20associated%20with%20improved%20effector%20fitness%20of%20exhausted%20CD8%2B%20TIL%20and%20is%20required%20for%20their%20activation%20upon%20PD-1%20blockade%2C%20which%20also%20requires%20tumor%20myeloid%20APC.%20Exhausted%20TIL%20lacking%20proper%20CD28%20costimulation%20in%20situ%20fail%20to%20respond%20to%20PD-1%20blockade%2C%20and%20their%20response%20may%20be%20rescued%20by%20local%20CTLA-4%20blockade%20and%20tumor%20APC%20stimulation%20via%20CD40L.%22%2C%22date%22%3A%222021-12-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2021.10.008%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22SUEPLDQ3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22F%5Cu00e4rkkil%5Cu00e4%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-15%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EF%26%23xE4%3Brkkil%26%23xE4%3B%20A%2C%20Rodr%26%23xED%3Bguez%20A%2C%20Oikkonen%20J%2C%20Gulhan%20DC%2C%20Nguyen%20H%2C%20Dom%26%23xED%3Bnguez%20J%2C%20Ramos%20S%2C%20Mills%20CE%2C%20P%26%23xE9%3Brez-Villatoro%20F%2C%20Lazaro%20JB%2C%20Zhou%20J%2C%20Clairmont%20CS%2C%20Moreau%20LA%2C%20Park%20PJ%2C%20Sorger%20PK%2C%20Hautaniemi%20S%2C%20Frias%20S%2C%20D%26%23x2019%3BAndrea%20AD.%20Heterogeneity%20and%20clonal%20evolution%20of%20acquired%20PARP%20inhibitor%20resistance%20in%20TP53-%20and%20BRCA1-deficient%20cells.%20Cancer%20Res.%202021%20May%2015%3B81%2810%29%3A2774%26%23x2013%3B2787.%20PMCID%3A%20PMC8323804%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Heterogeneity%20and%20clonal%20evolution%20of%20acquired%20PARP%20inhibitor%20resistance%20in%20TP53-%20and%20BRCA1-deficient%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfredo%22%2C%22lastName%22%3A%22Rodr%5Cu00edguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaana%22%2C%22lastName%22%3A%22Oikkonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doga%20C.%22%2C%22lastName%22%3A%22Gulhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huy%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julieta%22%2C%22lastName%22%3A%22Dom%5Cu00ednguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Villatoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Bernard%22%2C%22lastName%22%3A%22Lazaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20S.%22%2C%22lastName%22%3A%22Clairmont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20A.%22%2C%22lastName%22%3A%22Moreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20J.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sampsa%22%2C%22lastName%22%3A%22Hautaniemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Frias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20D.%22%2C%22lastName%22%3A%22D%27Andrea%22%7D%5D%2C%22abstractNote%22%3A%22Homologous%20recombination%20%28HR%29-deficient%20cancers%20are%20sensitive%20to%20inhibitors%20of%20Poly-ADP%20Ribose%20Polymerase%20%28PARPi%29%2C%20which%20have%20shown%20clinical%20efficacy%20in%20the%20treatment%20of%20high-grade%20serous%20cancers%20%28HGSC%29.%20However%2C%20the%20majority%20of%20patients%20will%20relapse%2C%20and%20acquired%20PARPi%20resistance%20is%20emerging%20as%20a%20pressing%20clinical%20problem.%20Here%20we%20generated%20seven%20single-cell%20clones%20with%20acquired%20PARPi%20resistance%20derived%20from%20a%20PARPi-sensitive%2C%20TP53-%5C%2F-%20and%20BRCA1-%5C%2F-%20epithelial%20cell%20line%20generated%20using%20CRISPR%5C%2FCas9.%20These%20clones%20showed%20diverse%20resistance%20mechanisms%2C%20and%20some%20clones%20presented%20with%20multiple%20mechanisms%20of%20resistance%20at%20the%20same%20time.%20Genomic%20analysis%20of%20the%20clones%20revealed%20unique%20transcriptional%20and%20mutational%20profiles%20and%20increased%20genomic%20instability%20in%20comparison%20to%20a%20PARPi-sensitive%20cell%20line.%20Clonal%20evolutionary%20analyses%20suggested%20that%20acquired%20PARPi%20resistance%20arose%20via%20clonal%20selection%20from%20an%20intrinsically%20unstable%20and%20heterogenous%20cell%20population%20in%20the%20sensitive%20cell%20line%2C%20which%20contained%20pre-existing%20drug%20tolerant%20cells.%20Similarly%2C%20clonal%20and%20spatial%20heterogeneity%20in%20tumor%20biopsies%20from%20a%20clinical%20BRCA1-mutant%20HGSC%20patient%20with%20acquired%20PARPi%20resistance%20were%20observed.%20In%20an%20imaging-based%20drug%20screening%2C%20the%20clones%20showed%20heterogenous%20responses%20to%20targeted%20therapeutic%20agents%2C%20indicating%20that%20not%20all%20PARPi-resistant%20clones%20can%20be%20targeted%20with%20just%20one%20therapy.%20Furthermore%2C%20PARPi-resistant%20clones%20showed%20mechanism-dependent%20vulnerabilities%20to%20the%20selected%20agents%2C%20demonstrating%20that%20a%20deeper%20understanding%20on%20the%20mechanisms%20of%20resistance%20could%20lead%20to%20improved%20targeting%20and%20biomarkers%20for%20HGSC%20with%20acquired%20PARPi%20resistance.%22%2C%22date%22%3A%222021-05-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-20-2912%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A48%3A33Z%22%7D%7D%2C%7B%22key%22%3A%226NXWB3MH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fr%5Cu00f6hlich%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-02%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFr%26%23xF6%3Bhlich%20F%2C%20Weindl%20D%2C%20Sch%26%23xE4%3Blte%20Y%2C%20Pathirana%20D%2C%20Paszkowski%20%26%23x141%3B%2C%20Lines%20GT%2C%20Stapor%20P%2C%20Hasenauer%20J.%20AMICI%3A%20high-performance%20sensitivity%20analysis%20for%20large%20ordinary%20differential%20equation%20models.%20Bioinformatics.%202021%20Apr%202%3Bbtab227.%20PMCID%3A%20PMC8545331%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22AMICI%3A%20high-performance%20sensitivity%20analysis%20for%20large%20ordinary%20differential%20equation%20models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Weindl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yannik%22%2C%22lastName%22%3A%22Sch%5Cu00e4lte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dilan%22%2C%22lastName%22%3A%22Pathirana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu0141ukasz%22%2C%22lastName%22%3A%22Paszkowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20Terje%22%2C%22lastName%22%3A%22Lines%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Stapor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Hasenauer%22%7D%5D%2C%22abstractNote%22%3A%22SUMMARY%3A%20Ordinary%20differential%20equation%20models%20facilitate%20the%20understanding%20of%20cellular%20signal%20transduction%20and%20other%20biological%20processes.%20However%2C%20for%20large%20and%20comprehensive%20models%2C%20the%20computational%20cost%20of%20simulating%20or%20calibrating%20can%20be%20limiting.%20AMICI%20is%20a%20modular%20toolbox%20implemented%20in%20C%5Cu2009%2B%2B%5C%2FPython%5C%2FMATLAB%20that%20provides%20efficient%20simulation%20and%20sensitivity%20analysis%20routines%20tailored%20for%20scalable%2C%20gradient-based%20parameter%20estimation%20and%20uncertainty%20quantification.%5CnAVAILABILITY%3A%20AMICI%20is%20published%20under%20the%20permissive%20BSD-3-Clause%20license%20with%20source%20code%20publicly%20available%20on%20https%3A%5C%2F%5C%2Fgithub.com%5C%2FAMICI-dev%5C%2FAMICI.%20Citeable%20releases%20are%20archived%20on%20Zenodo.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20online.%22%2C%22date%22%3A%222021-04-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtab227%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A23Z%22%7D%7D%2C%7B%22key%22%3A%227PYDA2PX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gevertz%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGevertz%20JL%2C%20Greene%20JM%2C%20Sanchez-Tapia%20CH%2C%20Sontag%20ED.%20A%20novel%20COVID-19%20epidemiological%20model%20with%20explicit%20susceptible%20and%20asymptomatic%20isolation%20compartments%20reveals%20unexpected%20consequences%20of%20timing%20social%20distancing.%20J%20Theor%20Biol.%202021%20Feb%207%3B510%3A110539.%20PMCID%3A%20PMC7840295%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20novel%20COVID-19%20epidemiological%20model%20with%20explicit%20susceptible%20and%20asymptomatic%20isolation%20compartments%20reveals%20unexpected%20consequences%20of%20timing%20social%20distancing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jana%20L.%22%2C%22lastName%22%3A%22Gevertz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Greene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20H.%22%2C%22lastName%22%3A%22Sanchez-Tapia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20D.%22%2C%22lastName%22%3A%22Sontag%22%7D%5D%2C%22abstractNote%22%3A%22Motivated%20by%20the%20current%20COVID-19%20epidemic%2C%20this%20work%20introduces%20an%20epidemiological%20model%20in%20which%20separate%20compartments%20are%20used%20for%20susceptible%20and%20asymptomatic%20%5C%22socially%20distant%5C%22%20populations.%20Distancing%20directives%20are%20represented%20by%20rates%20of%20flow%20into%20these%20compartments%2C%20as%20well%20as%20by%20a%20reduction%20in%20contacts%20that%20lessens%20disease%20transmission.%20The%20dynamical%20behavior%20of%20this%20system%20is%20analyzed%2C%20under%20various%20different%20rate%20control%20strategies%2C%20and%20the%20sensitivity%20of%20the%20basic%20reproduction%20number%20to%20various%20parameters%20is%20studied.%20One%20of%20the%20striking%20features%20of%20this%20model%20is%20the%20existence%20of%20a%20critical%20implementation%20delay%20%28CID%29%20in%20issuing%20distancing%20mandates%3A%20while%20a%20delay%20of%20about%20two%20weeks%20does%20not%20have%20an%20appreciable%20effect%20on%20the%20peak%20number%20of%20infections%2C%20issuing%20mandates%20even%20slightly%20after%20this%20critical%20time%20results%20in%20a%20far%20greater%20incidence%20of%20infection.%20Thus%2C%20there%20is%20a%20nontrivial%20but%20tight%20%5C%22window%20of%20opportunity%5C%22%20for%20commencing%20social%20distancing%20in%20order%20to%20meet%20the%20capacity%20of%20healthcare%20resources.%20However%2C%20if%20one%20wants%20to%20also%20delay%20the%20timing%20of%20peak%20infections%20-%20so%20as%20to%20take%20advantage%20of%20potential%20new%20therapies%20and%20vaccines%20-%20action%20must%20be%20taken%20much%20faster%20than%20the%20CID.%20Different%20relaxation%20strategies%20are%20also%20simulated%2C%20with%20surprising%20results.%20Periodic%20relaxation%20policies%20suggest%20a%20schedule%20which%20may%20significantly%20inhibit%20peak%20infective%20load%2C%20but%20that%20this%20schedule%20is%20very%20sensitive%20to%20parameter%20values%20and%20the%20schedule%27s%20frequency.%20Furthermore%2C%20we%20considered%20the%20impact%20of%20steadily%20reducing%20social%20distancing%20measures%20over%20time.%20We%20find%20that%20a%20too-sudden%20reopening%20of%20society%20may%20negate%20the%20progress%20achieved%20under%20initial%20distancing%20guidelines%2C%20but%20the%20negative%20effects%20can%20be%20mitigated%20if%20the%20relaxation%20strategy%20is%20carefully%20designed.%22%2C%22date%22%3A%222021-02-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jtbi.2020.110539%22%2C%22ISSN%22%3A%221095-8541%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A34%3A27Z%22%7D%7D%2C%7B%22key%22%3A%228CN4CYEQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Goldberg%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGoldberg%20J%2C%20Pastorello%20RG%2C%20Vallius%20T%2C%20Davis%20J%2C%20Cui%20YX%2C%20Agudo%20J%2C%20Waks%20AG%2C%20Keenan%20T%2C%20McAllister%20SS%2C%20Tolaney%20SM%2C%20Mittendorf%20EA%2C%20Guerriero%20JL.%20The%20immunology%20of%20hormone%20receptor%20positive%20breast%20cancer.%20Front%20Immunol.%202021%3B12%3A674192.%20PMCID%3A%20PMC8202289%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20immunology%20of%20hormone%20receptor%20positive%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Goldberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%20G.%22%2C%22lastName%22%3A%22Pastorello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janae%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%20Xiaoyong%22%2C%22lastName%22%3A%22Cui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrienne%20G.%22%2C%22lastName%22%3A%22Waks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanya%22%2C%22lastName%22%3A%22Keenan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20S.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%5D%2C%22abstractNote%22%3A%22Immune%20checkpoint%20blockade%20%28ICB%29%20has%20revolutionized%20the%20treatment%20of%20cancer%20patients.%20The%20main%20focus%20of%20ICB%20has%20been%20on%20reinvigorating%20the%20adaptive%20immune%20response%2C%20namely%2C%20activating%20cytotoxic%20T%20cells.%20ICB%20has%20demonstrated%20only%20modest%20benefit%20against%20advanced%20breast%20cancer%2C%20as%20breast%20tumors%20typically%20establish%20an%20immune%20suppressive%20tumor%20microenvironment%20%28TME%29.%20Triple-negative%20breast%20cancer%20%28TNBC%29%20is%20associated%20with%20infiltration%20of%20tumor%20infiltrating%20lymphocytes%20%28TILs%29%20and%20patients%20with%20TNBC%20have%20shown%20clinical%20responses%20to%20ICB.%20In%20contrast%2C%20hormone%20receptor%20positive%20%28HR%2B%29%20breast%20cancer%20is%20characterized%20by%20low%20TIL%20infiltration%20and%20minimal%20response%20to%20ICB.%20Here%20we%20review%20how%20HR%2B%20breast%20tumors%20establish%20a%20TME%20devoid%20of%20TILs%2C%20have%20low%20HLA%20class%20I%20expression%2C%20and%20recruit%20immune%20cells%2C%20other%20than%20T%20cells%2C%20which%20impact%20response%20to%20therapy.%20In%20addition%2C%20we%20review%20emerging%20technologies%20that%20have%20been%20employed%20to%20characterize%20components%20of%20the%20TME%20to%20reveal%20that%20tumor%20associated%20macrophages%20%28TAMs%29%20are%20abundant%20in%20HR%2B%20cancer%2C%20are%20highly%20immune-suppressive%2C%20associated%20with%20tumor%20progression%2C%20chemotherapy%20and%20ICB-resistance%2C%20metastasis%20and%20poor%20survival.%20We%20reveal%20novel%20therapeutic%20targets%20and%20possible%20combinations%20with%20ICB%20to%20enhance%20anti-tumor%20immune%20responses%2C%20which%20may%20have%20great%20potential%20in%20HR%2B%20breast%20cancer.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2021.674192%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A02%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22YJEJ4DPZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gyori%20and%20Bachman%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGyori%20BM%2C%20Bachman%20JA.%20From%20knowledge%20to%20models%3A%20automated%20modeling%20in%20systems%20and%20synthetic%20biology.%20Current%20Opinion%20in%20Systems%20Biology%20%5BInternet%5D.%202021%20%5Bcited%202023%20Oct%2030%5D%3B28%3A100362.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2452310021000561%27%3Ehttps%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2452310021000561%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20knowledge%20to%20models%3A%20automated%20modeling%20in%20systems%20and%20synthetic%20biology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.coisb.2021.100362%22%2C%22ISSN%22%3A%2224523100%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2452310021000561%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A08%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22NFQRYNKP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hemming%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-15%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHemming%20ML%2C%20Coy%20S%2C%20Lin%20JR%2C%20Andersen%20JL%2C%20Przybyl%20J%2C%20Mazzola%20E%2C%20Abdelhamid%20Ahmed%20AH%2C%20van%20de%20Rijn%20M%2C%20Sorger%20PK%2C%20Armstrong%20SA%2C%20Demetri%20GD%2C%20Santagata%20S.%20HAND1%20and%20BARX1%20act%20as%20transcriptional%20and%20anatomic%20determinants%20of%20malignancy%20in%20gastrointestinal%20stromal%20tumor.%20Clin%20Cancer%20Res.%202021%20Mar%2015%3B27%286%29%3A1706%26%23x2013%3B1719.%20PMCID%3A%20PMC7956056%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HAND1%20and%20BARX1%20act%20as%20transcriptional%20and%20anatomic%20determinants%20of%20malignancy%20in%20gastrointestinal%20stromal%20tumor%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Hemming%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanna%22%2C%22lastName%22%3A%22Przybyl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22Mazzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amr%20H.%22%2C%22lastName%22%3A%22Abdelhamid%20Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matt%22%2C%22lastName%22%3A%22van%20de%20Rijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20A.%22%2C%22lastName%22%3A%22Armstrong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20D.%22%2C%22lastName%22%3A%22Demetri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Gastrointestinal%20stromal%20tumor%20%28GIST%29%20arises%20from%20interstitial%20cells%20of%20Cajal%20%28ICC%29%20or%20their%20precursors%2C%20which%20are%20present%20throughout%20the%20gastrointestinal%20tract.%20Although%20gastric%20GIST%20is%20commonly%20indolent%20and%20small%20intestine%20GIST%20more%20aggressive%2C%20a%20molecular%20understanding%20of%20disease%20behavior%20would%20inform%20therapy%20decisions%20in%20GIST.%20Although%20a%20core%20transcription%20factor%20%28TF%29%20network%20is%20conserved%20across%20GIST%2C%20accessory%20TFs%20HAND1%20and%20BARX1%20are%20expressed%20in%20a%20disease%20state-specific%20pattern.%20Here%2C%20we%20characterize%20two%20divergent%20transcriptional%20programs%20maintained%20by%20HAND1%20and%20BARX1%2C%20and%20evaluate%20their%20association%20with%20clinical%20outcomes.%5CnEXPERIMENTAL%20DESIGN%3A%20We%20evaluated%20RNA%20sequencing%20and%20TF%20chromatin%20immunoprecipitation%20with%20sequencing%20in%20GIST%20samples%20and%20cultured%20cells%20for%20transcriptional%20programs%20associated%20with%20HAND1%20and%20BARX1.%20Multiplexed%20tissue-based%20cyclic%20immunofluorescence%20and%20IHC%20evaluated%20tissue-%20and%20cell-level%20expression%20of%20TFs%20and%20their%20association%20with%20clinical%20factors.%5CnRESULTS%3A%20We%20show%20that%20HAND1%20is%20expressed%20in%20aggressive%20GIST%2C%20modulating%20KIT%20and%20core%20TF%20expression%20and%20supporting%20proliferative%20cellular%20programs.%20In%20contrast%2C%20BARX1%20is%20expressed%20in%20indolent%20and%20micro-GISTs.%20HAND1%20and%20BARX1%20expression%20were%20superior%20predictors%20of%20relapse-free%20survival%2C%20as%20compared%20with%20standard%20risk%20stratification%2C%20and%20they%20predict%20progression-free%20survival%20on%20imatinib.%20Reflecting%20the%20developmental%20origins%20of%20accessory%20TF%20programs%2C%20HAND1%20was%20expressed%20solely%20in%20small%20intestine%20ICCs%2C%20whereas%20BARX1%20expression%20was%20restricted%20to%20gastric%20ICCs.%5CnCONCLUSIONS%3A%20Our%20results%20define%20anatomic%20and%20transcriptional%20determinants%20of%20GIST%20and%20molecular%20origins%20of%20clinical%20phenotypes.%20Assessment%20of%20HAND1%20and%20BARX1%20expression%20in%20GIST%20may%20provide%20prognostic%20information%20and%20improve%20clinical%20decisions%20on%20the%20administration%20of%20adjuvant%20therapy.%22%2C%22date%22%3A%222021-03-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-20-3538%22%2C%22ISSN%22%3A%221557-3265%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A39%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22MH8SC32P%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ietswaart%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-02%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIetswaart%20R%2C%20Gyori%20BM%2C%20Bachman%20JA%2C%20Sorger%20PK%2C%20Churchman%20LS.%20GeneWalk%20identifies%20relevant%20gene%20functions%20for%20a%20biological%20context%20using%20network%20representation%20learning.%20Genome%20Biol.%202021%20Feb%202%3B22%281%29%3A55.%20PMCID%3A%20PMC7852222%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22GeneWalk%20identifies%20relevant%20gene%20functions%20for%20a%20biological%20context%20using%20network%20representation%20learning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Ietswaart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Stirling%22%2C%22lastName%22%3A%22Churchman%22%7D%5D%2C%22abstractNote%22%3A%22A%20bottleneck%20in%20high-throughput%20functional%20genomics%20experiments%20is%20identifying%20the%20most%20important%20genes%20and%20their%20relevant%20functions%20from%20a%20list%20of%20gene%20hits.%20Gene%20Ontology%20%28GO%29%20enrichment%20methods%20provide%20insight%20at%20the%20gene%20set%20level.%20Here%2C%20we%20introduce%20GeneWalk%20%28%20github.com%5C%2Fchurchmanlab%5C%2Fgenewalk%20%29%20that%20identifies%20individual%20genes%20and%20their%20relevant%20functions%20critical%20for%20the%20experimental%20setting%20under%20examination.%20After%20the%20automatic%20assembly%20of%20an%20experiment-specific%20gene%20regulatory%20network%2C%20GeneWalk%20uses%20representation%20learning%20to%20quantify%20the%20similarity%20between%20vector%20representations%20of%20each%20gene%20and%20its%20GO%20annotations%2C%20yielding%20annotation%20significance%20scores%20that%20reflect%20the%20experimental%20context.%20By%20performing%20gene-%20and%20condition-specific%20functional%20analysis%2C%20GeneWalk%20converts%20a%20list%20of%20genes%20into%20data-driven%20hypotheses.%22%2C%22date%22%3A%222021-02-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13059-021-02264-8%22%2C%22ISSN%22%3A%221474-760X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A08%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22LUM7J832%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Inde%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-18%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EInde%20Z%2C%20Croker%20BA%2C%20Yapp%20C%2C%20Joshi%20GN%2C%20Spetz%20J%2C%20Fraser%20C%2C%20Qin%20X%2C%20Xu%20L%2C%20Deskin%20B%2C%20Ghelfi%20E%2C%20Webb%20G%2C%20Carlin%20AF%2C%20Zhu%20YP%2C%20Leibel%20SL%2C%20Garretson%20AF%2C%20Clark%20AE%2C%20Duran%20JM%2C%20Pretorius%20V%2C%20Crotty-Alexander%20LE%2C%20Li%20C%2C%20Lee%20JC%2C%20Sodhi%20C%2C%20Hackam%20DJ%2C%20Sun%20X%2C%20Hata%20AN%2C%20Kobzik%20L%2C%20Miller%20J%2C%20Park%20JA%2C%20Brownfield%20D%2C%20Jia%20H%2C%20Sarosiek%20KA.%20Age-dependent%20regulation%20of%20SARS-CoV-2%20cell%20entry%20genes%20and%20cell%20death%20programs%20correlates%20with%20COVID-19%20severity.%20Sci%20Adv.%202021%20Aug%2018%3B7%2834%29%3Aeabf8609.%20PMCID%3A%20PMC8373124%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Age-dependent%20regulation%20of%20SARS-CoV-2%20cell%20entry%20genes%20and%20cell%20death%20programs%20correlates%20with%20COVID-19%20severity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zintis%22%2C%22lastName%22%3A%22Inde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%20A.%22%2C%22lastName%22%3A%22Croker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaurav%20N.%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Spetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Le%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Deskin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ghelfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabrielle%22%2C%22lastName%22%3A%22Webb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20F.%22%2C%22lastName%22%3A%22Carlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanfang%20Peipei%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20L.%22%2C%22lastName%22%3A%22Leibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20F.%22%2C%22lastName%22%3A%22Garretson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20E.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20M.%22%2C%22lastName%22%3A%22Duran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Pretorius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22Crotty-Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chendi%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%20Casey%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chhinder%22%2C%22lastName%22%3A%22Sodhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Hackam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20N.%22%2C%22lastName%22%3A%22Hata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lester%22%2C%22lastName%22%3A%22Kobzik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin-Ah%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Brownfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongpeng%22%2C%22lastName%22%3A%22Jia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%5D%2C%22abstractNote%22%3A%22Novel%20coronavirus%20disease%202019%20%28COVID-19%29%20severity%20is%20highly%20variable%2C%20with%20pediatric%20patients%20typically%20experiencing%20less%20severe%20infection%20than%20adults%20and%20especially%20the%20elderly.%20The%20basis%20for%20this%20difference%20is%20unclear.%20We%20find%20that%20mRNA%20and%20protein%20expression%20of%20angiotensin-converting%20enzyme%202%20%28ACE2%29%2C%20the%20cell%20entry%20receptor%20for%20the%20novel%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20%28SARS-CoV-2%29%20that%20causes%20COVID-19%2C%20increases%20with%20advancing%20age%20in%20distal%20lung%20epithelial%20cells.%20However%2C%20in%20humans%2C%20ACE2%20expression%20exhibits%20high%20levels%20of%20intra-%20and%20interindividual%20heterogeneity.%20Further%2C%20cells%20infected%20with%20SARS-CoV-2%20experience%20endoplasmic%20reticulum%20stress%2C%20triggering%20an%20unfolded%20protein%20response%20and%20caspase-mediated%20apoptosis%2C%20a%20natural%20host%20defense%20system%20that%20halts%20virion%20production.%20Apoptosis%20of%20infected%20cells%20can%20be%20selectively%20induced%20by%20treatment%20with%20apoptosis-modulating%20BH3%20mimetic%20drugs.%20Notably%2C%20epithelial%20cells%20within%20young%20lungs%20and%20airways%20are%20more%20primed%20to%20undergo%20apoptosis%20than%20those%20in%20adults%2C%20which%20may%20naturally%20hinder%20virion%20production%20and%20support%20milder%20COVID-19%20severity.%22%2C%22date%22%3A%222021-08-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.abf8609%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T17%3A50%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22YVFWLS2C%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Jayakar%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJayakar%20S%2C%20Shim%20J%2C%20Jo%20S%2C%20Bean%20BP%2C%20Singe%26%23xE7%3B%20I%2C%20Woolf%20CJ.%20Developing%20nociceptor-selective%20treatments%20for%20acute%20and%20chronic%20pain.%20Sci%20Transl%20Med.%202021%20Nov%2010%3B13%28619%29%3Aeabj9837.%20PMCID%3A%20PMC9964063%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Developing%20nociceptor-selective%20treatments%20for%20acute%20and%20chronic%20pain%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selwyn%22%2C%22lastName%22%3A%22Jayakar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaehoon%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sooyeon%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20P.%22%2C%22lastName%22%3A%22Bean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilyas%22%2C%22lastName%22%3A%22Singe%5Cu00e7%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20substantial%20efforts%20dedicated%20to%20the%20development%20of%20new%2C%20nonaddictive%20analgesics%2C%20success%20in%20treating%20pain%20has%20been%20limited.%20Clinically%20available%20analgesic%20agents%20generally%20lack%20efficacy%20and%20may%20have%20undesirable%20side%20effects.%20Traditional%20target-based%20drug%20discovery%20efforts%20that%20generate%20compounds%20with%20selectivity%20for%20single%20targets%20have%20a%20high%20rate%20of%20attrition%20because%20of%20their%20poor%20clinical%20efficacy.%20Here%2C%20we%20examine%20the%20challenges%20associated%20with%20the%20current%20analgesic%20drug%20discovery%20model%20and%20review%20evidence%20in%20favor%20of%20stem%20cell%5Cu2013derived%20neuronal-based%20screening%20approaches%20for%20the%20identification%20of%20analgesic%20targets%20and%20compounds%20for%20treating%20diverse%20forms%20of%20acute%20and%20chronic%20pain.%22%2C%22date%22%3A%222021-11-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.abj9837%22%2C%22ISSN%22%3A%221946-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A57%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22YQWX3IYP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Jerby-Arnon%20et%20al.%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJerby-Arnon%20L%2C%20Neftel%20C%2C%20Shore%20ME%2C%20Weisman%20HR%2C%20Mathewson%20ND%2C%20McBride%20MJ%2C%20Haas%20B%2C%20Izar%20B%2C%20Volorio%20A%2C%20Boulay%20G%2C%20Cironi%20L%2C%20Richman%20AR%2C%20Broye%20LC%2C%20Gurski%20JM%2C%20Luo%20CC%2C%20Mylvaganam%20R%2C%20Nguyen%20L%2C%20Mei%20S%2C%20Melms%20JC%2C%20Georgescu%20C%2C%20Cohen%20O%2C%20Buendia-Buendia%20JE%2C%20Segerstolpe%20A%2C%20Sud%20M%2C%20Cuoco%20MS%2C%20Labes%20D%2C%20Gritsch%20S%2C%20Zollinger%20DR%2C%20Ortogero%20N%2C%20Beechem%20JM%2C%20Petur%20Nielsen%20G%2C%20Chebib%20I%2C%20Nguyen-Ngoc%20T%2C%20Montemurro%20M%2C%20Cote%20GM%2C%20Choy%20E%2C%20Letovanec%20I%2C%20Cherix%20S%2C%20Wagle%20N%2C%20Sorger%20PK%2C%20Haynes%20AB%2C%20Mullen%20JT%2C%20Stamenkovic%20I%2C%20Rivera%20MN%2C%20Kadoch%20C%2C%20Wucherpfennig%20KW%2C%20Rozenblatt-Rosen%20O%2C%20Suv%26%23xE0%3B%20ML%2C%20Riggi%20N%2C%20Regev%20A.%20Opposing%20immune%20and%20genetic%20mechanisms%20shape%20oncogenic%20programs%20in%20synovial%20sarcoma.%20Nat%20Med.%202021%20Feb%3B27%282%29%3A289%26%23x2013%3B300.%20PMCID%3A%20PMC8817899%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Opposing%20immune%20and%20genetic%20mechanisms%20shape%20oncogenic%20programs%20in%20synovial%20sarcoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Livnat%22%2C%22lastName%22%3A%22Jerby-Arnon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyril%22%2C%22lastName%22%3A%22Neftel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marni%20E.%22%2C%22lastName%22%3A%22Shore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20R.%22%2C%22lastName%22%3A%22Weisman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20D.%22%2C%22lastName%22%3A%22Mathewson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22McBride%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Volorio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaylor%22%2C%22lastName%22%3A%22Boulay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22Cironi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%20R.%22%2C%22lastName%22%3A%22Richman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliane%20C.%22%2C%22lastName%22%3A%22Broye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Gurski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20C.%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravindra%22%2C%22lastName%22%3A%22Mylvaganam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lan%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Georgescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofir%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20E.%22%2C%22lastName%22%3A%22Buendia-Buendia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asa%22%2C%22lastName%22%3A%22Segerstolpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malika%22%2C%22lastName%22%3A%22Sud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Cuoco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danny%22%2C%22lastName%22%3A%22Labes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Gritsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Zollinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ortogero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Beechem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Petur%20Nielsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Chebib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tu%22%2C%22lastName%22%3A%22Nguyen-Ngoc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Montemurro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20M.%22%2C%22lastName%22%3A%22Cote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%22%2C%22lastName%22%3A%22Choy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%22%2C%22lastName%22%3A%22Letovanec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Cherix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikhil%22%2C%22lastName%22%3A%22Wagle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20B.%22%2C%22lastName%22%3A%22Haynes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20T.%22%2C%22lastName%22%3A%22Mullen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Stamenkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%20N.%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cigall%22%2C%22lastName%22%3A%22Kadoch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%20W.%22%2C%22lastName%22%3A%22Wucherpfennig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20L.%22%2C%22lastName%22%3A%22Suv%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicol%5Cu00f2%22%2C%22lastName%22%3A%22Riggi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%5D%2C%22abstractNote%22%3A%22Synovial%20sarcoma%20%28SyS%29%20is%20an%20aggressive%20neoplasm%20driven%20by%20the%20SS18-SSX%20fusion%2C%20and%20is%20characterized%20by%20low%20T%20cell%20infiltration.%20Here%2C%20we%20studied%20the%20cancer-immune%20interplay%20in%20SyS%20using%20an%20integrative%20approach%20that%20combines%20single-cell%20RNA%20sequencing%20%28scRNA-seq%29%2C%20spatial%20profiling%20and%20genetic%20and%20pharmacological%20perturbations.%20scRNA-seq%20of%2016%2C872%20cells%20from%2012%20human%20SyS%20tumors%20uncovered%20a%20malignant%20subpopulation%20that%20marks%20immune-deprived%20niches%20in%20situ%20and%20is%20predictive%20of%20poor%20clinical%20outcomes%20in%20two%20independent%20cohorts.%20Functional%20analyses%20revealed%20that%20this%20malignant%20cell%20state%20is%20controlled%20by%20the%20SS18-SSX%20fusion%2C%20is%20repressed%20by%20cytokines%20secreted%20by%20macrophages%20and%20T%20cells%2C%20and%20can%20be%20synergistically%20targeted%20with%20a%20combination%20of%20HDAC%20and%20CDK4%5C%2FCDK6%20inhibitors.%20This%20drug%20combination%20enhanced%20malignant-cell%20immunogenicity%20in%20SyS%20models%2C%20leading%20to%20induced%20T%20cell%20reactivity%20and%20T%20cell-mediated%20killing.%20Our%20study%20provides%20a%20blueprint%20for%20investigating%20heterogeneity%20in%20fusion-driven%20malignancies%20and%20demonstrates%20an%20interplay%20between%20immune%20evasion%20and%20oncogenic%20processes%20that%20can%20be%20co-targeted%20in%20SyS%20and%20potentially%20in%20other%20malignancies.%22%2C%22date%22%3A%222021-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-020-01212-6%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A23%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22Z8TGD4LW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jiang%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJiang%20B%2C%20Gao%20Y%2C%20Che%20J%2C%20Lu%20W%2C%20Kaltheuner%20IH%2C%20Dries%20R%2C%20Kalocsay%20M%2C%20Berberich%20MJ%2C%20Jiang%20J%2C%20You%20I%2C%20Kwiatkowski%20N%2C%20Riching%20KM%2C%20Daniels%20DL%2C%20Sorger%20PK%2C%20Geyer%20M%2C%20Zhang%20T%2C%20Gray%20NS.%20Discovery%20and%20resistance%20mechanism%20of%20a%20selective%20CDK12%20degrader.%20Nat%20Chem%20Biol.%202021%20Jun%3B17%286%29%3A675%26%23x2013%3B683.%20PMCID%3A%20PMC8590456%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20and%20resistance%20mechanism%20of%20a%20selective%20CDK12%20degrader%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baishan%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianwei%22%2C%22lastName%22%3A%22Che%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenchao%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ines%20H.%22%2C%22lastName%22%3A%22Kaltheuner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruben%22%2C%22lastName%22%3A%22Dries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inchul%22%2C%22lastName%22%3A%22You%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Kwiatkowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%20M.%22%2C%22lastName%22%3A%22Riching%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danette%20L.%22%2C%22lastName%22%3A%22Daniels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Geyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%2012%20%28CDK12%29%20is%20an%20emerging%20therapeutic%20target%20due%20to%20its%20role%20in%20regulating%20transcription%20of%20DNA-damage%20response%20%28DDR%29%20genes.%20However%2C%20development%20of%20selective%20small%20molecules%20targeting%20CDK12%20has%20been%20challenging%20due%20to%20the%20high%20degree%20of%20homology%20between%20kinase%20domains%20of%20CDK12%20and%20other%20transcriptional%20CDKs%2C%20most%20notably%20CDK13.%20In%20the%20present%20study%2C%20we%20report%20the%20rational%20design%20and%20characterization%20of%20a%20CDK12-specific%20degrader%2C%20BSJ-4-116.%20BSJ-4-116%20selectively%20degraded%20CDK12%20as%20assessed%20through%20quantitative%20proteomics.%20Selective%20degradation%20of%20CDK12%20resulted%20in%20premature%20cleavage%20and%20poly%28adenylation%29%20of%20DDR%20genes.%20Moreover%2C%20BSJ-4-116%20exhibited%20potent%20antiproliferative%20effects%2C%20alone%20and%20in%20combination%20with%20the%20poly%28ADP-ribose%29%20polymerase%20inhibitor%20olaparib%2C%20as%20well%20as%20when%20used%20as%20a%20single%20agent%20against%20cell%20lines%20resistant%20to%20covalent%20CDK12%20inhibitors.%20Two%20point%20mutations%20in%20CDK12%20were%20identified%20that%20confer%20resistance%20to%20BSJ-4-116%2C%20demonstrating%20a%20potential%20mechanism%20that%20tumor%20cells%20can%20use%20to%20evade%20bivalent%20degrader%20molecules.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41589-021-00765-y%22%2C%22ISSN%22%3A%221552-4469%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22KXYHT7HK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Kassamali%20et%20al.%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKassamali%20B%2C%20Yu%20Z%2C%20Davis%20C%2C%20Carmack%20M%2C%20Bui%20ATN%2C%20Said%20JT%2C%20Plana%20D%2C%20Yang%20H%2C%20Sorger%20P%2C%20LeBoeuf%20NR%2C%20LaChance%20AH.%20Conversion%20of%20existing%20UVB%20phototherapy%20units%20to%20UVC%20germicidal%20chambers%20for%20N95%20decontamination%3A%20lessons%20learned.%20Photobiomodul%20Photomed%20Laser%20Surg.%202021%20Feb%3B39%282%29%3A83%26%23x2013%3B85.%20PMCID%3A%20PMC8106246%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Conversion%20of%20existing%20UVB%20phototherapy%20units%20to%20UVC%20germicidal%20chambers%20for%20N95%20decontamination%3A%20lessons%20learned%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bina%22%2C%22lastName%22%3A%22Kassamali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zizi%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Carmack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ai-Tram%20N.%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20T.%22%2C%22lastName%22%3A%22Said%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avery%20H.%22%2C%22lastName%22%3A%22LaChance%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fphotob.2020.4968%22%2C%22ISSN%22%3A%222578-5478%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A03%3A18Z%22%7D%7D%2C%7B%22key%22%3A%222RQMDVIH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Keenan%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-15%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKeenan%20TE%2C%20Li%20T%2C%20Vallius%20T%2C%20Guerriero%20JL%2C%20Tayob%20N%2C%20Kochupurakkal%20B%2C%20Davis%20J%2C%20Pastorello%20R%2C%20Tahara%20RK%2C%20Anderson%20L%2C%20Conway%20J%2C%20He%20MX%2C%20Shannon%20E%2C%20Godin%20RE%2C%20Sorger%20PK%2C%20D%26%23x2019%3BAndrea%20A%2C%20Overmoyer%20B%2C%20Winer%20EP%2C%20Mittendorf%20EA%2C%20Van%20Allen%20EM%2C%20Shapiro%20GI%2C%20Tolaney%20SM.%20Clinical%20efficacy%20and%20molecular%20response%20correlates%20of%20the%20WEE1%20inhibitor%20adavosertib%20combined%20with%20cisplatin%20in%20patients%20with%20metastatic%20triple-negative%20breast%20cancer.%20Clin%20Cancer%20Res.%202021%20Feb%2015%3B27%284%29%3A983%26%23x2013%3B991.%20PMCID%3A%20PMC7887044%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20efficacy%20and%20molecular%20response%20correlates%20of%20the%20WEE1%20inhibitor%20adavosertib%20combined%20with%20cisplatin%20in%20patients%20with%20metastatic%20triple-negative%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanya%20E.%22%2C%22lastName%22%3A%22Keenan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tianyu%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabihah%22%2C%22lastName%22%3A%22Tayob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bose%22%2C%22lastName%22%3A%22Kochupurakkal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janae%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%22%2C%22lastName%22%3A%22Pastorello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rie%20K.%22%2C%22lastName%22%3A%22Tahara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leilani%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jake%22%2C%22lastName%22%3A%22Conway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%20X.%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22Shannon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Godin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22D%27Andrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beth%22%2C%22lastName%22%3A%22Overmoyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20P.%22%2C%22lastName%22%3A%22Winer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20I.%22%2C%22lastName%22%3A%22Shapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20We%20report%20results%20from%20a%20phase%20II%20study%20assessing%20the%20efficacy%20of%20the%20WEE1%20inhibitor%20adavosertib%20with%20cisplatin%20in%20metastatic%20triple-negative%20breast%20cancer%20%28mTNBC%29.%5CnPATIENTS%20AND%20METHODS%3A%20Patients%20with%20mTNBC%20treated%20with%200-1%20prior%20lines%20of%20chemotherapy%20received%20cisplatin%2075%20mg%5C%2Fm2%20i.v.%20followed%2021%20days%20later%20by%20cisplatin%20plus%20adavosertib%20200%20mg%20oral%20twice%20daily%20for%20five%20doses%20every%2021%20days.%20The%20study%20had%2090%25%20power%20to%20detect%20the%20difference%20between%20null%20%2820%25%29%20and%20alternative%20%2840%25%29%20objective%20response%20rates%20%28ORR%29%20with%20a%20one-sided%20type%20I%20error%20of%200.1%3A%20an%20ORR%20%3E30%25%20was%20predefined%20as%20making%20the%20regimen%20worthy%20of%20further%20study.%20RNA%20sequencing%20and%20multiplex%20cyclic%20immunofluorescence%20on%20pre-%20and%20post-adavosertib%20tumor%20biopsies%2C%20as%20well%20as%20targeted%20next-generation%20sequencing%20on%20archival%20tissue%2C%20were%20correlated%20with%20clinical%20benefit%2C%20defined%20as%20stable%20disease%20%5Cu22656%20months%20or%20complete%20or%20partial%20response.%5CnRESULTS%3A%20A%20total%20of%2034%20patients%20initiated%20protocol%20therapy%3B%20median%20age%20was%2056%20years%2C%202%20patients%20%286%25%29%20had%20BRCA2%20mutations%2C%20and%2014%20%2841%25%29%20had%20one%20prior%20chemotherapy.%20ORR%20was%2026%25%20%5B95%25%20confidence%20interval%20%28CI%29%2C%2013-44%5D%2C%20and%20median%20progression-free%20survival%20was%204.9%20months%20%2895%25%20CI%2C%202.3-5.7%29.%20Treatment-related%20grade%203-5%20adverse%20events%20occurred%20in%2053%25%20of%20patients%2C%20most%20commonly%20diarrhea%20in%2021%25.%20One%20death%20occurred%20because%20of%20sepsis%2C%20possibly%20related%20to%20study%20therapy.%20Tumors%20from%20patients%20with%20clinical%20benefit%20demonstrated%20enriched%20immune%20gene%20expression%20and%20T-cell%20infiltration.%5CnCONCLUSIONS%3A%20Among%20patients%20with%20mTNBC%20treated%20with%200-1%20prior%20lines%2C%20adavosertib%20combined%20with%20cisplatin%20missed%20the%20prespecified%20ORR%20cutoff%20of%20%3E30%25.%20The%20finding%20of%20immune-infiltrated%20tumors%20in%20patients%20with%20clinical%20benefit%20warrants%20validation.%22%2C%22date%22%3A%222021-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-20-3089%22%2C%22ISSN%22%3A%221557-3265%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A01%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22KSZIWLS9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Koikawa%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKoikawa%20K%2C%20Kibe%20S%2C%20Suizu%20F%2C%20Sekino%20N%2C%20Kim%20N%2C%20Manz%20TD%2C%20Pinch%20BJ%2C%20Akshinthala%20D%2C%20Verma%20A%2C%20Gaglia%20G%2C%20Nezu%20Y%2C%20Ke%20S%2C%20Qiu%20C%2C%20Ohuchida%20K%2C%20Oda%20Y%2C%20Lee%20TH%2C%20Wegiel%20B%2C%20Clohessy%20JG%2C%20London%20N%2C%20Santagata%20S%2C%20Wulf%20GM%2C%20Hidalgo%20M%2C%20Muthuswamy%20SK%2C%20Nakamura%20M%2C%20Gray%20NS%2C%20Zhou%20XZ%2C%20Lu%20KP.%20Targeting%20Pin1%20renders%20pancreatic%20cancer%20eradicable%20by%20synergizing%20with%20immunochemotherapy.%20Cell.%202021%20Sep%202%3B184%2818%29%3A4753-4771.e27.%20PMCID%3A%20PMC8557351%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20Pin1%20renders%20pancreatic%20cancer%20eradicable%20by%20synergizing%20with%20immunochemotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuhiro%22%2C%22lastName%22%3A%22Koikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shin%22%2C%22lastName%22%3A%22Kibe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Futoshi%22%2C%22lastName%22%3A%22Suizu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nobufumi%22%2C%22lastName%22%3A%22Sekino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nami%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theresa%20D.%22%2C%22lastName%22%3A%22Manz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benika%20J.%22%2C%22lastName%22%3A%22Pinch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipikaa%22%2C%22lastName%22%3A%22Akshinthala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Verma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yutaka%22%2C%22lastName%22%3A%22Nezu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shizhong%22%2C%22lastName%22%3A%22Ke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenxi%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenoki%22%2C%22lastName%22%3A%22Ohuchida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshinao%22%2C%22lastName%22%3A%22Oda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tae%20Ho%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Babara%22%2C%22lastName%22%3A%22Wegiel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20G.%22%2C%22lastName%22%3A%22Clohessy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nir%22%2C%22lastName%22%3A%22London%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerburg%20M.%22%2C%22lastName%22%3A%22Wulf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%22%2C%22lastName%22%3A%22Hidalgo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Senthil%20K.%22%2C%22lastName%22%3A%22Muthuswamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masafumi%22%2C%22lastName%22%3A%22Nakamura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%20Zhen%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun%20Ping%22%2C%22lastName%22%3A%22Lu%22%7D%5D%2C%22abstractNote%22%3A%22Pancreatic%20ductal%20adenocarcinoma%20%28PDAC%29%20is%20characterized%20by%20notorious%20resistance%20to%20current%20therapies%20attributed%20to%20inherent%20tumor%20heterogeneity%20and%20highly%20desmoplastic%20and%20immunosuppressive%20tumor%20microenvironment%20%28TME%29.%20Unique%20proline%20isomerase%20Pin1%20regulates%20multiple%20cancer%20pathways%2C%20but%20its%20role%20in%20the%20TME%20and%20cancer%20immunotherapy%20is%20unknown.%20Here%2C%20we%20find%20that%20Pin1%20is%20overexpressed%20both%20in%20cancer%20cells%20and%20cancer-associated%20fibroblasts%20%28CAFs%29%20and%20correlates%20with%20poor%20survival%20in%20PDAC%20patients.%20Targeting%20Pin1%20using%20clinically%20available%20drugs%20induces%20complete%20elimination%20or%20sustained%20remissions%20of%20aggressive%20PDAC%20by%20synergizing%20with%20anti-PD-1%20and%20gemcitabine%20in%20diverse%20model%20systems.%20Mechanistically%2C%20Pin1%20drives%20the%20desmoplastic%20and%20immunosuppressive%20TME%20by%20acting%20on%20CAFs%20and%20induces%20lysosomal%20degradation%20of%20the%20PD-1%20ligand%20PD-L1%20and%20the%20gemcitabine%20transporter%20ENT1%20in%20cancer%20cells%2C%20besides%20activating%20multiple%20cancer%20pathways.%20Thus%2C%20Pin1%20inhibition%20simultaneously%20blocks%20multiple%20cancer%20pathways%2C%20disrupts%20the%20desmoplastic%20and%20immunosuppressive%20TME%2C%20and%20upregulates%20PD-L1%20and%20ENT1%2C%20rendering%20PDAC%20eradicable%20by%20immunochemotherapy.%22%2C%22date%22%3A%222021-09-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2021.07.020%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A26Z%22%7D%7D%2C%7B%22key%22%3A%228E49DPJR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kothakonda%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-06%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKothakonda%20A%2C%20Atta%20L%2C%20Plana%20D%2C%20Ward%20F%2C%20Davis%20C%2C%20Cramer%20A%2C%20Moran%20R%2C%20Freake%20J%2C%20Tian%20E%2C%20Mazor%20O%2C%20Gorelik%20P%2C%20Van%20C%2C%20Hansen%20C%2C%20Yang%20H%2C%20Li%20Y%2C%20Sinha%20MS%2C%20Li%20J%2C%20Yu%20SH%2C%20LeBoeuf%20NR%2C%20Sorger%20PK.%20De%20novo%20powered%20air-purifying%20respirator%20design%20and%20fabrication%20for%20pandemic%20response.%20Front%20Bioeng%20Biotechnol.%202021%20Sep%206%3B9%3A690905.%20PMCID%3A%20PMC8450396%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22De%20novo%20powered%20air-purifying%20respirator%20design%20and%20fabrication%20for%20pandemic%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%22%2C%22lastName%22%3A%22Kothakonda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyla%22%2C%22lastName%22%3A%22Atta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ferrous%22%2C%22lastName%22%3A%22Ward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Moran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Freake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enze%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofer%22%2C%22lastName%22%3A%22Mazor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pavel%22%2C%22lastName%22%3A%22Gorelik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yao%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20rapid%20spread%20of%20COVID-19%20and%20disruption%20of%20normal%20supply%20chains%20has%20resulted%20in%20severe%20shortages%20of%20personal%20protective%20equipment%20%28PPE%29%2C%20particularly%20devices%20with%20few%20suppliers%20such%20as%20powered%20air-purifying%20respirators%20%28PAPRs%29.%20A%20scarcity%20of%20information%20describing%20design%20and%20performance%20criteria%20for%20PAPRs%20represents%20a%20substantial%20barrier%20to%20mitigating%20shortages.%20We%20sought%20to%20apply%20open-source%20product%20development%20%28OSPD%29%20to%20PAPRs%20to%20enable%20alternative%20sources%20of%20supply%20and%20further%20innovation.%20We%20describe%20the%20design%2C%20prototyping%2C%20validation%2C%20and%20user%20testing%20of%20locally%20manufactured%2C%20modular%2C%20PAPR%20components%2C%20including%20filter%20cartridges%20and%20blower%20units%2C%20developed%20by%20the%20Greater%20Boston%20Pandemic%20Fabrication%20Team%20%28PanFab%29.%20Two%20designs%2C%20one%20with%20a%20fully%20custom-made%20filter%20and%20blower%20unit%20housing%2C%20and%20the%20other%20with%20commercially%20available%20variants%20%28the%20%5C%22Custom%5C%22%20and%20%5C%22Commercial%5C%22%20designs%2C%20respectively%29%20were%20developed%3B%20the%20components%20in%20the%20Custom%20design%20are%20interchangeable%20with%20those%20in%20Commercial%20design%2C%20although%20the%20form%20factor%20differs.%20The%20engineering%20performance%20of%20the%20prototypes%20was%20measured%20and%20safety%20validated%20using%20National%20Institutes%20for%20Occupational%20Safety%20and%20Health%20%28NIOSH%29-equivalent%20tests%20on%20apparatus%20available%20under%20pandemic%20conditions%20at%20university%20laboratories.%20Feedback%20was%20obtained%20from%20four%20individuals%3B%20two%20clinicians%20working%20in%20ambulatory%20clinical%20care%20and%20two%20research%20technical%20staff%20for%20whom%20PAPR%20use%20is%20standard%20occupational%20PPE%3B%20these%20individuals%20were%20asked%20to%20compare%20PanFab%20prototypes%20to%20commercial%20PAPRs%20from%20the%20perspective%20of%20usability%20and%20suggest%20areas%20for%20improvement.%20Respondents%20rated%20the%20PanFab%20Custom%20PAPR%20a%204%20to%205%20on%20a%205%20Likert-scale%201%29%20as%20compared%20to%20current%20PPE%20options%2C%202%29%20for%20the%20sense%20of%20security%20with%20use%20in%20a%20clinical%20setting%2C%20and%203%29%20for%20comfort%20compared%20to%20standard%2C%20commercially%20available%20PAPRs.%20The%20three%20other%20versions%20of%20the%20designs%20%28with%20a%20Commercial%20blower%20unit%2C%20filter%2C%20or%20both%29%20performed%20favorably%2C%20with%20survey%20responses%20consisting%20of%20scores%20ranging%20from%203%20to%205.%20Engineering%20testing%20and%20clinical%20feedback%20demonstrate%20that%20the%20PanFab%20designs%20represent%20favorable%20alternatives%20to%20traditional%20PAPRs%20in%20terms%20of%20user%20comfort%2C%20mobility%2C%20and%20sense%20of%20security.%20A%20nonrestrictive%20license%20promotes%20innovation%20in%20respiratory%20protection%20for%20current%20and%20future%20medical%20emergencies.%22%2C%22date%22%3A%222021-09-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffbioe.2021.690905%22%2C%22ISSN%22%3A%222296-4185%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-08-14T13%3A55%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22ZUYD6S6A%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Larkins-Ford%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELarkins-Ford%20J%2C%20Greenstein%20T%2C%20Van%20N%2C%20Degefu%20YN%2C%20Olson%20MC%2C%20Sokolov%20A%2C%20Aldridge%20BB.%20Systematic%20measurement%20of%20combination-drug%20landscapes%20to%20predict%20in%26%23xA0%3Bvivo%20treatment%20outcomes%20for%20tuberculosis.%20Cell%20Syst.%202021%20Nov%2017%3B12%2811%29%3A1046-1063.e7.%20PMCID%3A%20PMC8617591%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systematic%20measurement%20of%20combination-drug%20landscapes%20to%20predict%20in%5Cu00a0vivo%20treatment%20outcomes%20for%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonah%22%2C%22lastName%22%3A%22Larkins-Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Talia%22%2C%22lastName%22%3A%22Greenstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhi%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yonatan%20N.%22%2C%22lastName%22%3A%22Degefu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michaela%20C.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22Lengthy%20multidrug%20chemotherapy%20is%20required%20to%20achieve%20a%20durable%20cure%20in%20tuberculosis.%20However%2C%20we%20lack%20well-validated%2C%20high-throughput%20in%5Cu00a0vitro%20models%20that%20predict%20animal%20outcomes.%20Here%2C%20we%20provide%20an%20extensible%20approach%20to%20rationally%20prioritize%20combination%20therapies%20for%20testing%20in%20in%5Cu00a0vivo%20mouse%20models%20of%20tuberculosis.%20We%20systematically%20measured%20Mycobacterium%20tuberculosis%20response%20to%20all%20two-%20and%20three-drug%20combinations%20among%20ten%20antibiotics%20in%20eight%20conditions%20that%20reproduce%20lesion%20microenvironments%2C%20resulting%20in%20%3E500%2C000%20measurements.%20Using%20these%20in%5Cu00a0vitro%20data%2C%20we%20developed%20classifiers%20predictive%20of%20multidrug%20treatment%20outcome%20in%20a%20mouse%20model%20of%20disease%20relapse%20and%20identified%20ensembles%20of%20in%5Cu00a0vitro%20models%20that%20best%20describe%20in%5Cu00a0vivo%20treatment%20outcomes.%20We%20identified%20signatures%20of%20potencies%20and%20drug%20interactions%20in%20specific%20in%5Cu00a0vitro%20models%5Cu00a0that%20distinguish%20whether%20drug%20combinations%20are%20better%20than%20the%20standard%20of%20care%20in%20two%20important%20preclinical%5Cu00a0mouse%20models.%20Our%20framework%20is%20generalizable%20to%20other%20difficult-to-treat%20diseases%20requiring%20combination%20therapies.%20A%20record%20of%20this%20paper%27s%20transparent%20peer%20review%20process%20is%20included%20in%20the%20supplemental%20information.%22%2C%22date%22%3A%222021-11-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2021.08.004%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A55%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22G2PV6F9P%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELee%20J%2C%20Vernet%20A%2C%20Gruber%20NG%2C%20Kready%20KM%2C%20Burrill%20DR%2C%20Way%20JC%2C%20Silver%20PA.%20Rational%20engineering%20of%20an%20erythropoietin%20fusion%20protein%20to%20treat%20hypoxia.%20Protein%20Eng%20Des%20Sel.%202021%20Feb%2015%3B34%3Agzab025.%20PMID%3A%2034725710%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rational%20engineering%20of%20an%20erythropoietin%20fusion%20protein%20to%20treat%20hypoxia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jungmin%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andyna%22%2C%22lastName%22%3A%22Vernet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20G.%22%2C%22lastName%22%3A%22Gruber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kasia%20M.%22%2C%22lastName%22%3A%22Kready%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devin%20R.%22%2C%22lastName%22%3A%22Burrill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20C.%22%2C%22lastName%22%3A%22Way%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Silver%22%7D%5D%2C%22abstractNote%22%3A%22Erythropoietin%20enhances%20oxygen%20delivery%20and%20reduces%20hypoxia-induced%20cell%20death%2C%20but%20its%20pro-thrombotic%20activity%20is%20problematic%20for%20use%20of%20erythropoietin%20in%20treating%20hypoxia.%20We%20constructed%20a%20fusion%20protein%20that%20stimulates%20red%20blood%20cell%20production%20and%20neuroprotection%20without%20triggering%20platelet%20production%2C%20a%20marker%20for%20thrombosis.%20The%20protein%20consists%20of%20an%20anti-glycophorin%20A%20nanobody%20and%20an%20erythropoietin%20mutant%20%28L108A%29.%20The%20mutation%20reduces%20activation%20of%20erythropoietin%20receptor%20homodimers%20that%20induce%20erythropoiesis%20and%20thrombosis%2C%20but%20maintains%20the%20tissue-protective%20signaling.%20The%20binding%20of%20the%20nanobody%20element%20to%20glycophorin%20A%20rescues%20homodimeric%20erythropoietin%20receptor%20activation%20on%20red%20blood%20cell%20precursors.%20In%20a%20cell%20proliferation%20assay%2C%20the%20fusion%20protein%20is%20active%20at%2010-14%5Cu00a0M%2C%20allowing%20an%20estimate%20of%20the%20number%20of%20receptor-ligand%20complexes%20needed%20for%20signaling.%20This%20fusion%20protein%20stimulates%20erythroid%20cell%20proliferation%20in%20vitro%20and%20in%20mice%2C%20and%20shows%20neuroprotective%20activity%20in%20vitro.%20Our%20erythropoietin%20fusion%20protein%20presents%20a%20novel%20molecule%20for%20treating%20hypoxia.%22%2C%22date%22%3A%222021-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fprotein%5C%2Fgzab025%22%2C%22ISSN%22%3A%221741-0134%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-11-08T16%3A01%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22TEW25C5W%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leipzig%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELeipzig%20J%2C%20N%26%23xFC%3Bst%20D%2C%20Hoyt%20CT%2C%20Ram%20K%2C%20Greenberg%20J.%20The%20role%20of%20metadata%20in%20reproducible%20computational%20research.%20Patterns%20%28N%20Y%29.%202021%20Sep%2010%3B2%289%29%3A100322.%20PMCID%3A%20PMC8441584%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20role%20of%20metadata%20in%20reproducible%20computational%20research%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Leipzig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22N%5Cu00fcst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karthik%22%2C%22lastName%22%3A%22Ram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jane%22%2C%22lastName%22%3A%22Greenberg%22%7D%5D%2C%22abstractNote%22%3A%22Reproducible%20computational%20research%20%28RCR%29%20is%20the%20keystone%20of%20the%20scientific%20method%20for%20in%20silico%20analyses%2C%20packaging%20the%20transformation%20of%20raw%20data%20to%20published%20results.%20In%20addition%20to%20its%20role%20in%20research%20integrity%2C%20improving%20the%20reproducibility%20of%20scientific%20studies%20can%20accelerate%20evaluation%20and%20reuse.%20This%20potential%20and%20wide%20support%20for%20the%20FAIR%20principles%20have%20motivated%20interest%20in%20metadata%20standards%20supporting%20reproducibility.%20Metadata%20provide%20context%20and%20provenance%20to%20raw%20data%20and%20methods%20and%20are%20essential%20to%20both%20discovery%20and%20validation.%20Despite%20this%20shared%20connection%20with%20scientific%20data%2C%20few%20studies%20have%20explicitly%20described%20how%20metadata%20enable%20reproducible%20computational%20research.%20This%20review%20employs%20a%20functional%20content%20analysis%20to%20identify%20metadata%20standards%20that%20support%20reproducibility%20across%20an%20analytic%20stack%20consisting%20of%20input%20data%2C%20tools%2C%20notebooks%2C%20pipelines%2C%20and%20publications.%20Our%20review%20provides%20background%20context%2C%20explores%20gaps%2C%20and%20discovers%20component%20trends%20of%20embeddedness%20and%20methodology%20weight%20from%20which%20we%20derive%20recommendations%20for%20future%20work.%22%2C%22date%22%3A%222021-09-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.patter.2021.100322%22%2C%22ISSN%22%3A%222666-3899%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-09-27T13%3A58%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22L9I6BY45%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222021-05%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELi%20J%2C%20Duran%20MA%2C%20Dhanota%20N%2C%20Chatila%20WK%2C%20Bettigole%20SE%2C%20Kwon%20J%2C%20Sriram%20RK%2C%20Humphries%20MP%2C%20Salto-Tellez%20M%2C%20James%20JA%2C%20Hanna%20MG%2C%20Melms%20JC%2C%20Vallabhaneni%20S%2C%20Litchfield%20K%2C%20Usaite%20I%2C%20Biswas%20D%2C%20Bareja%20R%2C%20Li%20HW%2C%20Martin%20ML%2C%20Dorsaint%20P%2C%20Cavallo%20JA%2C%20Li%20P%2C%20Pauli%20C%2C%20Gottesdiener%20L%2C%20DiPardo%20BJ%2C%20Hollmann%20TJ%2C%20Merghoub%20T%2C%20Wen%20HY%2C%20Reis-Filho%20JS%2C%20Riaz%20N%2C%20Su%20SSM%2C%20Kalbasi%20A%2C%20Vasan%20N%2C%20Powell%20SN%2C%20Wolchok%20JD%2C%20Elemento%20O%2C%20Swanton%20C%2C%20Shoushtari%20AN%2C%20Parkes%20EE%2C%20Izar%20B%2C%20Bakhoum%20SF.%20Metastasis%20and%20immune%20evasion%20from%20extracellular%20cGAMP%20hydrolysis.%20Cancer%20Discov.%202021%20May%3B11%285%29%3A1212%26%23x2013%3B1227.%20PMCID%3A%20PMC8102348%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metastasis%20and%20immune%20evasion%20from%20extracellular%20cGAMP%20hydrolysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercedes%20A.%22%2C%22lastName%22%3A%22Duran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ninjit%22%2C%22lastName%22%3A%22Dhanota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walid%20K.%22%2C%22lastName%22%3A%22Chatila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20E.%22%2C%22lastName%22%3A%22Bettigole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Kwon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roshan%20K.%22%2C%22lastName%22%3A%22Sriram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P.%22%2C%22lastName%22%3A%22Humphries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%22%2C%22lastName%22%3A%22Salto-Tellez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20A.%22%2C%22lastName%22%3A%22James%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Hanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreeram%22%2C%22lastName%22%3A%22Vallabhaneni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Litchfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ieva%22%2C%22lastName%22%3A%22Usaite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhruva%22%2C%22lastName%22%3A%22Biswas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%22%2C%22lastName%22%3A%22Bareja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%20Wei%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Laura%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Princesca%22%2C%22lastName%22%3A%22Dorsaint%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie-Ann%22%2C%22lastName%22%3A%22Cavallo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Pauli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Gottesdiener%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20J.%22%2C%22lastName%22%3A%22DiPardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Travis%20J.%22%2C%22lastName%22%3A%22Hollmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taha%22%2C%22lastName%22%3A%22Merghoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20S.%22%2C%22lastName%22%3A%22Reis-Filho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadeem%22%2C%22lastName%22%3A%22Riaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shin-San%20Michael%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anusha%22%2C%22lastName%22%3A%22Kalbasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Vasan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20N.%22%2C%22lastName%22%3A%22Powell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jedd%20D.%22%2C%22lastName%22%3A%22Wolchok%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Elemento%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Swanton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20N.%22%2C%22lastName%22%3A%22Shoushtari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eileen%20E.%22%2C%22lastName%22%3A%22Parkes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20F.%22%2C%22lastName%22%3A%22Bakhoum%22%7D%5D%2C%22abstractNote%22%3A%22Cytosolic%20DNA%20is%20characteristic%20of%20chromosomally%20unstable%20metastatic%20cancer%20cells%2C%20resulting%20in%20constitutive%20activation%20of%20the%20cGAS-STING%20innate%20immune%20pathway.%20How%20tumors%20co-opt%20inflammatory%20signaling%20while%20evading%20immune%20surveillance%20remains%20unknown.%20Here%2C%20we%20show%20that%20the%20ectonucleotidase%20ENPP1%20promotes%20metastasis%20by%20selectively%20degrading%20extracellular%20cGAMP%2C%20an%20immune-stimulatory%20metabolite%20whose%20breakdown%20products%20include%20the%20immune%20suppressor%20adenosine.%20ENPP1%20loss%20suppresses%20metastasis%2C%20restores%20tumor%20immune%20infiltration%2C%20and%20potentiates%20response%20to%20immune%20checkpoint%20blockade%20in%20a%20manner%20dependent%20on%20tumor%20cGAS%20and%20host%20STING.%20Conversely%2C%20overexpression%20of%20wild-type%20ENPP1%2C%20but%20not%20an%20enzymatically%20weakened%20mutant%2C%20promotes%20migration%20and%20metastasis%2C%20in%20part%20through%20the%20generation%20of%20extracellular%20adenosine%2C%20and%20renders%20otherwise%20sensitive%20tumors%20completely%20resistant%20to%20immunotherapy.%20In%20human%20cancers%2C%20ENPP1%20expression%20correlates%20with%20reduced%20immune%20cell%20infiltration%2C%20increased%20metastasis%2C%20and%20resistance%20to%20anti-PD-1%5C%2FPD-L1%20treatment.%20Thus%2C%20cGAMP%20hydrolysis%20by%20ENPP1%20enables%20chromosomally%20unstable%20tumors%20to%20transmute%20cGAS%20activation%20into%20an%20immune-suppressive%20pathway.%20SIGNIFICANCE%3A%20Chromosomal%20instability%20promotes%20metastasis%20by%20generating%20chronic%20tumor%20inflammation.%20ENPP1%20facilitates%20metastasis%20and%20enables%20tumor%20cells%20to%20tolerate%20inflammation%20by%20hydrolyzing%20the%20immunotransmitter%20cGAMP%2C%20preventing%20its%20transfer%20from%20cancer%20cells%20to%20immune%20cells.This%20article%20is%20highlighted%20in%20the%20In%20This%20Issue%20feature%2C%20p.%20995.%22%2C%22date%22%3A%222021-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-20-0387%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22ZVK65ANP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELiu%20D%2C%20Lin%20JR%2C%20Robitschek%20EJ%2C%20Kasumova%20GG%2C%20Heyde%20A%2C%20Shi%20A%2C%20Kraya%20A%2C%20Zhang%20G%2C%20Moll%20T%2C%20Frederick%20DT%2C%20Chen%20YA%2C%20Wang%20S%2C%20Schapiro%20D%2C%20Ho%20LL%2C%20Bi%20K%2C%20Sahu%20A%2C%20Mei%20S%2C%20Miao%20B%2C%20Sharova%20T%2C%20Alvarez-Breckenridge%20C%2C%20Stocking%20JH%2C%20Kim%20T%2C%20Fadden%20R%2C%20Lawrence%20D%2C%20Hoang%20MP%2C%20Cahill%20DP%2C%20Malehmir%20M%2C%20Nowak%20MA%2C%20Brastianos%20PK%2C%20Lian%20CG%2C%20Ruppin%20E%2C%20Izar%20B%2C%20Herlyn%20M%2C%20Van%20Allen%20EM%2C%20Nathanson%20K%2C%20Flaherty%20KT%2C%20Sullivan%20RJ%2C%20Kellis%20M%2C%20Sorger%20PK%2C%20Boland%20GM.%20Evolution%20of%20delayed%20resistance%20to%20immunotherapy%20in%20a%20melanoma%20responder.%20Nat%20Med.%202021%20Jun%3B27%286%29%3A985%26%23x2013%3B992.%20PMCID%3A%20PMC8474080%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evolution%20of%20delayed%20resistance%20to%20immunotherapy%20in%20a%20melanoma%20responder%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20J.%22%2C%22lastName%22%3A%22Robitschek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gyulnara%20G.%22%2C%22lastName%22%3A%22Kasumova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Heyde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvin%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Kraya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tabea%22%2C%22lastName%22%3A%22Moll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennie%20T.%22%2C%22lastName%22%3A%22Frederick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li-Lun%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avinash%22%2C%22lastName%22%3A%22Sahu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benchun%22%2C%22lastName%22%3A%22Miao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatyana%22%2C%22lastName%22%3A%22Sharova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Alvarez-Breckenridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jackson%20H.%22%2C%22lastName%22%3A%22Stocking%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tommy%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riley%22%2C%22lastName%22%3A%22Fadden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%22%2C%22lastName%22%3A%22Lawrence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mai%20P.%22%2C%22lastName%22%3A%22Hoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohsen%22%2C%22lastName%22%3A%22Malehmir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20A.%22%2C%22lastName%22%3A%22Nowak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eytan%22%2C%22lastName%22%3A%22Ruppin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meenhard%22%2C%22lastName%22%3A%22Herlyn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Nathanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manolis%22%2C%22lastName%22%3A%22Kellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M.%22%2C%22lastName%22%3A%22Boland%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20initial%20responses1-3%2C%20most%20melanoma%20patients%20develop%20resistance4%20to%20immune%20checkpoint%20blockade%20%28ICB%29.%20To%20understand%20the%20evolution%20of%20resistance%2C%20we%20studied%2037%20tumor%20samples%20over%209%20years%20from%20a%20patient%20with%20metastatic%20melanoma%20with%20complete%20clinical%20response%20to%20ICB%20followed%20by%20delayed%20recurrence%20and%20death.%20Phylogenetic%20analysis%20revealed%20co-evolution%20of%20seven%20lineages%20with%20multiple%20convergent%2C%20but%20independent%20resistance-associated%20alterations.%20All%20recurrent%20tumors%20emerged%20from%20a%20lineage%20characterized%20by%20loss%20of%20chromosome%2015q%2C%20with%20post-treatment%20clones%20acquiring%20additional%20genomic%20driver%20events.%20Deconvolution%20of%20bulk%20RNA%20sequencing%20and%20highly%20multiplexed%20immunofluorescence%20%28t-CyCIF%29%20revealed%20differences%20in%20immune%20composition%20among%20different%20lineages.%20Imaging%20revealed%20a%20vasculogenic%20mimicry%20phenotype%20in%20NGFRhi%20tumor%20cells%20with%20high%20PD-L1%20expression%20in%20close%20proximity%20to%20immune%20cells.%20Rapid%20autopsy%20demonstrated%20two%20distinct%20NGFR%20spatial%20patterns%20with%20high%20polarity%20and%20proximity%20to%20immune%20cells%20in%20subcutaneous%20tumors%20versus%20a%20diffuse%20spatial%20pattern%20in%20lung%20tumors%2C%20suggesting%20different%20roles%20of%20this%20neural-crest-like%20program%20in%20different%20tumor%20microenvironments.%20Broadly%2C%20this%20study%20establishes%20a%20high-resolution%20map%20of%20the%20evolutionary%20dynamics%20of%20resistance%20to%20ICB%2C%20characterizes%20a%20de-differentiated%20neural-crest%20tumor%20population%20in%20melanoma%20immunotherapy%20resistance%20and%20describes%20site-specific%20differences%20in%20tumor-immune%20interactions%20via%20longitudinal%20analysis%20of%20a%20patient%20with%20melanoma%20with%20an%20unusual%20clinical%20course.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-021-01331-8%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A30%3A18Z%22%7D%7D%2C%7B%22key%22%3A%228VFUK7AF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lukyanenko%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELukyanenko%20S%2C%20Jang%20WD%2C%20Wei%20D%2C%20Struyven%20R%2C%20Kim%20Y%2C%20Leahy%20B%2C%20Yang%20H%2C%20Rush%20A%2C%20Ben-Yosef%20D%2C%20Needleman%20D%2C%20Pfister%20H.%20Developmental%20stage%20classification%20of%20embryos%20using%20two-stream%20neural%20network%20with%20linear-chain%20conditional%20random%20field.%20Med%20Image%20Comput%20Comput%20Assist%20Interv.%202021%20Sep%3B12908%3A363%26%23x2013%3B372.%20PMCID%3A%20PMC8526069%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Developmental%20stage%20classification%20of%20embryos%20using%20two-stream%20neural%20network%20with%20linear-chain%20conditional%20random%20field%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislav%22%2C%22lastName%22%3A%22Lukyanenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Dong%22%2C%22lastName%22%3A%22Jang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donglai%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robbert%22%2C%22lastName%22%3A%22Struyven%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoon%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Leahy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Rush%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalit%22%2C%22lastName%22%3A%22Ben-Yosef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Needleman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22The%20developmental%20process%20of%20embryos%20follows%20a%20monotonic%20order.%20An%20embryo%20can%20progressively%20cleave%20from%20one%20cell%20to%20multiple%20cells%20and%20finally%20transform%20to%20morula%20and%20blastocyst.%20For%20time-lapse%20videos%20of%20embryos%2C%20most%20existing%20developmental%20stage%20classification%20methods%20conduct%20per-frame%20predictions%20using%20an%20image%20frame%20at%20each%20time%20step.%20However%2C%20classification%20using%20only%20images%20suffers%20from%20overlapping%20between%20cells%20and%20imbalance%20between%20stages.%20Temporal%20information%20can%20be%20valuable%20in%20addressing%20this%20problem%20by%20capturing%20movements%20between%20neighboring%20frames.%20In%20this%20work%2C%20we%20propose%20a%20two-stream%20model%20for%20developmental%20stage%20classification.%20Unlike%20previous%20methods%2C%20our%20two-stream%20model%20accepts%20both%20temporal%20and%20image%20information.%20We%20develop%20a%20linear-chain%20conditional%20random%20field%20%28CRF%29%20on%20top%20of%20neural%20network%20features%20extracted%20from%20the%20temporal%20and%20image%20streams%20to%20make%20use%20of%20both%20modalities.%20The%20linear-chain%20CRF%20formulation%20enables%20tractable%20training%20of%20global%20sequential%20models%20over%20multiple%20frames%20while%20also%20making%20it%20possible%20to%20inject%20monotonic%20development%20order%20constraints%20into%20the%20learning%20process%20explicitly.%20We%20demonstrate%20our%20algorithm%20on%20two%20time-lapse%20embryo%20video%20datasets%3A%20i%29%20mouse%20and%20ii%29%20human%20embryo%20datasets.%20Our%20method%20achieves%2098.1%25%20and%2080.6%25%20for%20mouse%20and%20human%20embryo%20stage%20classification%2C%20respectively.%20Our%20approach%20will%20enable%20more%20pro-found%20clinical%20and%20biological%20studies%20and%20suggests%20a%20new%20direction%20for%20developmental%20stage%20classification%20by%20utilizing%20temporal%20information.%22%2C%22date%22%3A%222021%20Sep%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-3-030-87237-3_35%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22BYIPCTQW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Maliga%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMaliga%20Z%2C%20Nirmal%20AJ%2C%20Ericson%20NG%2C%20Boswell%20SA%2C%20U%26%23x2019%3BRen%20L%2C%20Podyminogin%20R%2C%20Chow%20J%2C%20Chen%20YA%2C%20Chen%20AA%2C%20Weinstock%20DM%2C%20Lian%20CG%2C%20Murphy%20GF%2C%20Kaldjian%20EP%2C%20Santagata%20S%2C%20Sorger%20PK.%20Micro-region%20transcriptomics%20of%20fixed%20human%20tissue%20using%20Pick-Seq.%20bioRxiv%3B%202021.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Micro-region%20transcriptomics%20of%20fixed%20human%20tissue%20using%20Pick-Seq%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nolan%20G.%22%2C%22lastName%22%3A%22Ericson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lance%22%2C%22lastName%22%3A%22U%5Cu2019Ren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Podyminogin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Chow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyce%20A.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Weinstock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20P.%22%2C%22lastName%22%3A%22Kaldjian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20Spatial%20transcriptomics%20and%20multiplexed%20imaging%20are%20complementary%20methods%20for%20studying%20tissue%20biology%20and%20disease.%20Recently%20developed%20spatial%20transcriptomic%20methods%20use%20fresh-frozen%20specimens%20but%20most%20diagnostic%20specimens%2C%20clinical%20trials%2C%20and%20tissue%20archives%20rely%20on%20formaldehyde-fixed%20tissue.%20Here%20we%20describe%20the%20Pick-Seq%20method%20for%20deep%20spatial%20transcriptional%20profiling%20of%20fixed%20tissue.%20Pick-Seq%20is%20a%20form%20of%20micro-region%20sequencing%20in%20which%20small%20regions%20of%20tissue%2C%20containing%205-20%20cells%2C%20are%20mechanically%20isolated%20on%20a%20microscope%20and%20then%20sequenced.%20We%20demonstrate%20the%20use%20of%20Pick-Seq%20with%20several%20different%20fixed%20and%20frozen%20human%20specimens.%20Application%20of%20Pick-Seq%20to%20a%20human%20melanoma%20with%20complex%20histology%20reveals%20significant%20differences%20in%20transcriptional%20programs%20associated%20with%20tumor%20invasion%2C%20proliferation%2C%20and%20immuno-editing.%20Parallel%20imaging%20confirms%20changes%20in%20immuno-phenotypes%20and%20cancer%20cell%20states.%20This%20work%20demonstrates%20the%20ability%20of%20Pick-Seq%20to%20generate%20deep%20spatial%20transcriptomic%20data%20from%20fixed%20and%20archival%20tissue%20with%20multiplexed%20imaging%20in%20parallel.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222021-03-19%22%2C%22DOI%22%3A%2210.1101%5C%2F2021.03.18.431004%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-08-13T14%3A16%3A43Z%22%7D%7D%2C%7B%22key%22%3A%228NMSD4IH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mancuso%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMancuso%20CP%2C%20Lu%20ZX%2C%20Qian%20J%2C%20Boswell%20SA%2C%20Springer%20M.%20A%20semi-quantitative%20isothermal%20diagnostic%20assay%20utilizing%20competitive%20amplification.%20Anal%20Chem.%202021%20Jul%2013%3B93%2827%29%3A9541%26%23x2013%3B9548.%20PMCID%3A%20PMC9837715%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20semi-quantitative%20isothermal%20diagnostic%20assay%20utilizing%20competitive%20amplification%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20P.%22%2C%22lastName%22%3A%22Mancuso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhi-Xiang%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Springer%22%7D%5D%2C%22abstractNote%22%3A%22Quantitative%20diagnostics%20that%20are%20rapid%2C%20inexpensive%2C%20sensitive%2C%20robust%2C%20and%20field-deployable%20are%20needed%20to%20contain%20the%20spread%20of%20infectious%20diseases%20and%20inform%20treatment%20strategies.%20While%20current%20gold-standard%20techniques%20are%20highly%20sensitive%20and%20quantitative%2C%20they%20are%20slow%20and%20require%20expensive%20equipment.%20Conversely%2C%20current%20rapid%20field-deployable%20assays%20available%20provide%20essentially%20binary%20information%20about%20the%20presence%20of%20the%20target%20analyte%2C%20not%20a%20quantitative%20measure%20of%20concentration.%20Here%2C%20we%20report%20the%20development%20of%20a%20molecular%20diagnostic%20test%20%5Bquantitative%20recombinase%20polymerase%20amplification%20%28qRPA%29%5D%20that%20utilizes%20competitive%20amplification%20during%20a%20recombinase%20polymerase%20amplification%20%28RPA%29%20assay%20to%20provide%20semi-quantitative%20information%20on%20a%20target%20nucleic%20acid.%20We%20demonstrate%20that%20qRPA%20can%20quantify%20DNA%2C%20RNA%2C%20and%20viral%20titers%20in%20HIV%20and%20COVID-19%20patient%20samples%20and%20that%20it%20is%20more%20robust%20to%20environmental%20perturbations%20than%20traditional%20RPA.%20These%20features%20make%20qRPA%20potentially%20useful%20for%20at-home%20testing%20to%20monitor%20the%20progress%20of%20viral%20infections%20or%20other%20diseases.%22%2C%22date%22%3A%222021-07-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.analchem.1c01576%22%2C%22ISSN%22%3A%221520-6882%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A49%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22RPBQZBS2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22May%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMay%20EA%2C%20Kalocsay%20M%2C%20D%26%23x2019%3BAuriac%20IG%2C%20Schuster%20PS%2C%20Gygi%20SP%2C%20Nachury%20MV%2C%20Mick%20DU.%20Time-resolved%20proteomics%20profiling%20of%20the%20ciliary%20Hedgehog%20response.%20J%20Cell%20Biol.%202021%20May%203%3B220%285%29.%20PMCID%3A%20PMC8054476%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Time-resolved%20proteomics%20profiling%20of%20the%20ciliary%20Hedgehog%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%20A.%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22In%5Cu00e8s%20Galtier%22%2C%22lastName%22%3A%22D%27Auriac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20S.%22%2C%22lastName%22%3A%22Schuster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxence%20V.%22%2C%22lastName%22%3A%22Nachury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20U.%22%2C%22lastName%22%3A%22Mick%22%7D%5D%2C%22abstractNote%22%3A%22The%20primary%20cilium%20is%20a%20signaling%20compartment%20that%20interprets%20Hedgehog%20signals%20through%20changes%20of%20its%20protein%2C%20lipid%2C%20and%20second%20messenger%20compositions.%20Here%2C%20we%20combine%20proximity%20labeling%20of%20cilia%20with%20quantitative%20mass%20spectrometry%20to%20unbiasedly%20profile%20the%20time-dependent%20alterations%20of%20the%20ciliary%20proteome%20in%20response%20to%20Hedgehog.%20This%20approach%20correctly%20identifies%20the%20three%20factors%20known%20to%20undergo%20Hedgehog-regulated%20ciliary%20redistribution%20and%20reveals%20two%20such%20additional%20proteins.%20First%2C%20we%20find%20that%20a%20regulatory%20subunit%20of%20the%20cAMP-dependent%20protein%20kinase%20%28PKA%29%20rapidly%20exits%20cilia%20together%20with%20the%20G%20protein-coupled%20receptor%20GPR161%20in%20response%20to%20Hedgehog%2C%20and%20we%20propose%20that%20the%20GPR161%5C%2FPKA%20module%20senses%20and%20amplifies%20cAMP%20signals%20to%20modulate%20ciliary%20PKA%20activity.%20Second%2C%20we%20identify%20the%20phosphatase%20Paladin%20as%20a%20cell%20type-specific%20regulator%20of%20Hedgehog%20signaling%20that%20enters%20primary%20cilia%20upon%20pathway%20activation.%20The%20broad%20applicability%20of%20quantitative%20ciliary%20proteome%20profiling%20promises%20a%20rapid%20characterization%20of%20ciliopathies%20and%20their%20underlying%20signaling%20malfunctions.%22%2C%22date%22%3A%222021-05-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1083%5C%2Fjcb.202007207%22%2C%22ISSN%22%3A%221540-8140%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-03-17T17%3A44%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22BFC43M6H%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22McAvoy%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-07%22%2C%22numChildren%22%3A33%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMcAvoy%20M%2C%20Bui%20ATN%2C%20Hansen%20C%2C%20Plana%20D%2C%20Said%20JT%2C%20Yu%20Z%2C%20Yang%20H%2C%20Freake%20J%2C%20Van%20C%2C%20Krikorian%20D%2C%20Cramer%20A%2C%20Smith%20L%2C%20Jiang%20L%2C%20Lee%20KJ%2C%20Li%20SJ%2C%20Beller%20B%2C%20Huggins%20K%2C%20Short%20MP%2C%20Yu%20SH%2C%20Mostaghimi%20A%2C%20Sorger%20PK%2C%20LeBoeuf%20NR.%203D%20Printed%20frames%20to%20enable%20reuse%20and%20improve%20the%20fit%20of%20N95%20and%20KN95%20respirators.%20BMC%20Biomed%20Eng.%202021%20Jun%207%3B3%281%29%3A10.%20PMCID%3A%20PMC8182357%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%223D%20Printed%20frames%20to%20enable%20reuse%20and%20improve%20the%20fit%20of%20N95%20and%20KN95%20respirators%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malia%22%2C%22lastName%22%3A%22McAvoy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ai-Tram%20N.%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20T.%22%2C%22lastName%22%3A%22Said%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zizi%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Freake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Krikorian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leanne%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liwei%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20J.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20J.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brandon%22%2C%22lastName%22%3A%22Beller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberley%22%2C%22lastName%22%3A%22Huggins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Short%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arash%22%2C%22lastName%22%3A%22Mostaghimi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%20response%20to%20supply%20shortages%20caused%20by%20the%20COVID-19%20pandemic%2C%20N95%20filtering%20facepiece%20respirators%20%28FFRs%20or%20%5C%22masks%5C%22%29%2C%20which%20are%20typically%20single-use%20devices%20in%20healthcare%20settings%2C%20are%20routinely%20being%20used%20for%20prolonged%20periods%20and%20in%20some%20cases%20decontaminated%20under%20%5C%22reuse%5C%22%20and%20%5C%22extended%20use%5C%22%20policies.%20However%2C%20the%20reusability%20of%20N95%20masks%20is%20limited%20by%20degradation%20of%20fit.%20Possible%20substitutes%2C%20such%20as%20KN95%20masks%20meeting%20Chinese%20standards%2C%20frequently%20fail%20fit%20testing%20even%20when%20new.%20The%20purpose%20of%20this%20study%20was%20to%20develop%20an%20inexpensive%20frame%20for%20damaged%20and%20poorly%20fitting%20masks%20using%20readily%20available%20materials%20and%203D%20printing.%5CnRESULTS%3A%20An%20iterative%20design%20process%20yielded%20a%20mask%20frame%20consisting%20of%20two%203D%20printed%20side%20pieces%2C%20malleable%20wire%20links%20that%20users%20press%20against%20their%20face%2C%20and%20cut%20lengths%20of%20elastic%20material%20that%20go%20around%20the%20head%20to%20hold%20the%20frame%20and%20mask%20in%20place.%20Volunteers%20%28n%5Cu2009%3D%5Cu200945%3B%20average%20BMI%5Cu2009%3D%5Cu200925.4%29%2C%20underwent%20qualitative%20fit%20testing%20with%20and%20without%20mask%20frames%20wearing%20one%20or%20more%20of%20four%20different%20brands%20of%20FFRs%20conforming%20to%20US%20N95%20or%20Chinese%20KN95%20standards.%20Masks%20passed%20qualitative%20fit%20testing%20in%20the%20absence%20of%20a%20frame%20at%20rates%20varying%20from%2048%20to%2094%5Cu2009%25%20%28depending%20on%20mask%20model%29.%20For%20individuals%20who%20underwent%20testing%20using%20respirators%20with%20broken%20or%20defective%20straps%2C%2080-100%5Cu2009%25%20%28average%2085%5Cu2009%25%29%20passed%20fit%20testing%20with%20mask%20frames.%20Among%20individuals%20who%20failed%20fit%20testing%20with%20a%20KN95%2C%20~%5Cu200950%5Cu2009%25%20passed%20testing%20by%20using%20a%20frame.%5CnCONCLUSIONS%3A%20Our%20study%20suggests%20that%20mask%20frames%20can%20prolong%20the%20lifespan%20of%20N95%20and%20KN95%20masks%20by%20serving%20as%20a%20substitute%20for%20broken%20or%20defective%20bands%20without%20adversely%20affecting%20fit.%20Use%20of%20frames%20made%20it%20possible%20for%20~%5Cu200973%5Cu2009%25%20of%20the%20test%20population%20to%20achieve%20a%20good%20fit%20based%20on%20qualitative%20and%20quantitative%20testing%20criteria%2C%20approaching%20the%2085-90%5Cu2009%25%20success%20rate%20observed%20for%20intact%20N95%20masks.%20Frames%20therefore%20represent%20a%20simple%20and%20inexpensive%20way%20of%20expanding%20access%20to%20PPE%20and%20extending%20their%20useful%20life.%20For%20clinicians%20and%20institutions%20interested%20in%20mask%20frames%2C%20designs%20and%20specifications%20are%20provided%20without%20restriction%20for%20use%20or%20modification.%20To%20ensure%20adequate%20performance%20in%20clinical%20settings%2C%20fit%20testing%20with%20user-specific%20masks%20and%20PanFab%20frames%20is%20required.%22%2C%22date%22%3A%222021-06-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs42490-021-00055-7%22%2C%22ISSN%22%3A%222524-4426%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A02%3A59Z%22%7D%7D%2C%7B%22key%22%3A%225UD56TZW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Mehta%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMehta%20AK%2C%20Cheney%20EM%2C%20Hartl%20CA%2C%20Pantelidou%20C%2C%20Oliwa%20M%2C%20Castrillon%20JA%2C%20Lin%20JR%2C%20Hurst%20KE%2C%20de%20Oliveira%20Taveira%20M%2C%20Johnson%20NT%2C%20Oldham%20WM%2C%20Kalocsay%20M%2C%20Berberich%20MJ%2C%20Boswell%20SA%2C%20Kothari%20A%2C%20Johnson%20S%2C%20Dillon%20DA%2C%20Lipschitz%20M%2C%20Rodig%20S%2C%20Santagata%20S%2C%20Garber%20JE%2C%20Tung%20N%2C%20Y%26%23xE9%3Blamos%20J%2C%20Thaxton%20JE%2C%20Mittendorf%20EA%2C%20Sorger%20PK%2C%20Shapiro%20GI%2C%20Guerriero%20JL.%20Targeting%20immunosuppressive%20macrophages%20overcomes%20PARP%20inhibitor%20resistance%20in%20BRCA1-associated%20triple-negative%20breast%20cancer.%20Nat%20Cancer.%202021%20Jan%3B2%281%29%3A66%26%23x2013%3B82.%20PMCID%3A%20PMC7963404%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20immunosuppressive%20macrophages%20overcomes%20PARP%20inhibitor%20resistance%20in%20BRCA1-associated%20triple-negative%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%20K.%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20M.%22%2C%22lastName%22%3A%22Cheney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20A.%22%2C%22lastName%22%3A%22Hartl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantia%22%2C%22lastName%22%3A%22Pantelidou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madisson%22%2C%22lastName%22%3A%22Oliwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20A.%22%2C%22lastName%22%3A%22Castrillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katie%20E.%22%2C%22lastName%22%3A%22Hurst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateus%22%2C%22lastName%22%3A%22de%20Oliveira%20Taveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20T.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20M.%22%2C%22lastName%22%3A%22Oldham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aditi%22%2C%22lastName%22%3A%22Kothari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikel%22%2C%22lastName%22%3A%22Lipschitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judy%20E.%22%2C%22lastName%22%3A%22Garber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Tung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Y%5Cu00e9lamos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20E.%22%2C%22lastName%22%3A%22Thaxton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20I.%22%2C%22lastName%22%3A%22Shapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20objective%20responses%20to%20PARP%20inhibition%20and%20improvements%20in%20progression-free%20survival%20compared%20to%20standard%20chemotherapy%20in%20patients%20with%20BRCA-associated%20triple-negative%20breast%20cancer%20%28TNBC%29%2C%20benefits%20are%20transitory.%20Using%20high%20dimensional%20single-cell%20profiling%20of%20human%20TNBC%2C%20here%20we%20demonstrate%20that%20macrophages%20are%20the%20predominant%20infiltrating%20immune%20cell%20type%20in%20BRCA-associated%20TNBC.%20Through%20multi-omics%20profiling%20we%20show%20that%20PARP%20inhibitors%20enhance%20both%20anti-%20and%20pro-tumor%20features%20of%20macrophages%20through%20glucose%20and%20lipid%20metabolic%20reprogramming%20driven%20by%20the%20sterol%20regulatory%20element-binding%20protein%201%20%28SREBP-1%29%20pathway.%20Combined%20PARP%20inhibitor%20therapy%20with%20CSF-1R%20blocking%20antibodies%20significantly%20enhanced%20innate%20and%20adaptive%20anti-tumor%20immunity%20and%20extends%20survival%20in%20BRCA-deficient%20tumors%20in%20vivo%20and%20is%20mediated%20by%20CD8%2B%20T-cells.%20Collectively%2C%20our%20results%20uncover%20macrophage-mediated%20immune%20suppression%20as%20a%20liability%20of%20PARP%20inhibitor%20treatment%20and%20demonstrate%20combined%20PARP%20inhibition%20and%20macrophage%20targeting%20therapy%20induces%20a%20durable%20reprogramming%20of%20the%20tumor%20microenvironment%2C%20thus%20constituting%20a%20promising%20therapeutic%20strategy%20for%20TNBC.%22%2C%22date%22%3A%222021-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs43018-020-00148-7%22%2C%22ISSN%22%3A%222662-1347%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A01%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22C8I7RHAW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Melms%20et%20al.%22%2C%22parsedDate%22%3A%222021-07%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMelms%20JC%2C%20Biermann%20J%2C%20Huang%20H%2C%20Wang%20Y%2C%20Nair%20A%2C%20Tagore%20S%2C%20Katsyv%20I%2C%20Rendeiro%20AF%2C%20Amin%20AD%2C%20Schapiro%20D%2C%20Frangieh%20CJ%2C%20Luoma%20AM%2C%20Filliol%20A%2C%20Fang%20Y%2C%20Ravichandran%20H%2C%20Clausi%20MG%2C%20Alba%20GA%2C%20Rogava%20M%2C%20Chen%20SW%2C%20Ho%20P%2C%20Montoro%20DT%2C%20Kornberg%20AE%2C%20Han%20AS%2C%20Bakhoum%20MF%2C%20Anandasabapathy%20N%2C%20Su%26%23xE1%3Brez-Fari%26%23xF1%3Bas%20M%2C%20Bakhoum%20SF%2C%20Bram%20Y%2C%20Borczuk%20A%2C%20Guo%20XV%2C%20Lefkowitch%20JH%2C%20Marboe%20C%2C%20Lagana%20SM%2C%20Del%20Portillo%20A%2C%20Tsai%20EJ%2C%20Zorn%20E%2C%20Markowitz%20GS%2C%20Schwabe%20RF%2C%20Schwartz%20RE%2C%20Elemento%20O%2C%20Saqi%20A%2C%20Hibshoosh%20H%2C%20Que%20J%2C%20Izar%20B.%20A%20molecular%20single-cell%20lung%20atlas%20of%20lethal%20COVID-19.%20Nature.%202021%20Jul%3B595%287865%29%3A114%26%23x2013%3B119.%20PMCID%3A%20PMC8814825%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20molecular%20single-cell%20lung%20atlas%20of%20lethal%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jana%22%2C%22lastName%22%3A%22Biermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huachao%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yiping%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somnath%22%2C%22lastName%22%3A%22Tagore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%22%2C%22lastName%22%3A%22Katsyv%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%20F.%22%2C%22lastName%22%3A%22Rendeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amit%20Dipak%22%2C%22lastName%22%3A%22Amin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20J.%22%2C%22lastName%22%3A%22Frangieh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrienne%20M.%22%2C%22lastName%22%3A%22Luoma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aveline%22%2C%22lastName%22%3A%22Filliol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yinshan%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiranmayi%22%2C%22lastName%22%3A%22Ravichandran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariano%20G.%22%2C%22lastName%22%3A%22Clausi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20A.%22%2C%22lastName%22%3A%22Alba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meri%22%2C%22lastName%22%3A%22Rogava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20W.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20T.%22%2C%22lastName%22%3A%22Montoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20E.%22%2C%22lastName%22%3A%22Kornberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnold%20S.%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathieu%20F.%22%2C%22lastName%22%3A%22Bakhoum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niroshana%22%2C%22lastName%22%3A%22Anandasabapathy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayte%22%2C%22lastName%22%3A%22Su%5Cu00e1rez-Fari%5Cu00f1as%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20F.%22%2C%22lastName%22%3A%22Bakhoum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yaron%22%2C%22lastName%22%3A%22Bram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Borczuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinzheng%20V.%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%20H.%22%2C%22lastName%22%3A%22Lefkowitch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Marboe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20M.%22%2C%22lastName%22%3A%22Lagana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armando%22%2C%22lastName%22%3A%22Del%20Portillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20J.%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Zorn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glen%20S.%22%2C%22lastName%22%3A%22Markowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20F.%22%2C%22lastName%22%3A%22Schwabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Schwartz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Elemento%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjali%22%2C%22lastName%22%3A%22Saqi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanina%22%2C%22lastName%22%3A%22Hibshoosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianwen%22%2C%22lastName%22%3A%22Que%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%5D%2C%22abstractNote%22%3A%22Respiratory%20failure%20is%20the%20leading%20cause%20of%20death%20in%20patients%20with%20severe%20SARS-CoV-2%20infection1%2C2%2C%20but%20the%20host%20response%20at%20the%20lung%20tissue%20level%20is%20poorly%20understood.%20Here%20we%20performed%20single-nucleus%20RNA%20sequencing%20of%20about%20116%2C000%20nuclei%20from%20the%20lungs%20of%20nineteen%20individuals%20who%20died%20of%20COVID-19%20and%20underwent%20rapid%20autopsy%20and%20seven%20control%20individuals.%20Integrated%20analyses%20identified%20substantial%20alterations%20in%20cellular%20composition%2C%20transcriptional%20cell%20states%2C%20and%20cell-to-cell%20interactions%2C%20thereby%20providing%20insight%20into%20the%20biology%20of%20lethal%20COVID-19.%20The%20lungs%20from%20individuals%20with%20COVID-19%20were%20highly%20inflamed%2C%20with%20dense%20infiltration%20of%20aberrantly%20activated%20monocyte-derived%20macrophages%20and%20alveolar%20macrophages%2C%20but%20had%20impaired%20T%20cell%20responses.%20Monocyte%5C%2Fmacrophage-derived%20interleukin-1%5Cu03b2%20and%20epithelial%20cell-derived%20interleukin-6%20were%20unique%20features%20of%20SARS-CoV-2%20infection%20compared%20to%20other%20viral%20and%20bacterial%20causes%20of%20pneumonia.%20Alveolar%20type%202%20cells%20adopted%20an%20inflammation-associated%20transient%20progenitor%20cell%20state%20and%20failed%20to%20undergo%20full%20transition%20into%20alveolar%20type%201%20cells%2C%20resulting%20in%20impaired%20lung%20regeneration.%20Furthermore%2C%20we%20identified%20expansion%20of%20recently%20described%20CTHRC1%2B%20pathological%20fibroblasts3%20contributing%20to%20rapidly%20ensuing%20pulmonary%20fibrosis%20in%20COVID-19.%20Inference%20of%20protein%20activity%20and%20ligand-receptor%20interactions%20identified%20putative%20drug%20targets%20to%20disrupt%20deleterious%20circuits.%20This%20atlas%20enables%20the%20dissection%20of%20lethal%20COVID-19%2C%20may%20inform%20our%20understanding%20of%20long-term%20complications%20of%20COVID-19%20survivors%2C%20and%20provides%20an%20important%20resource%20for%20therapeutic%20development.%22%2C%22date%22%3A%222021-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-021-03569-1%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-02-25T07%3A30%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22SAQN8FJP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ostaszewski%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOstaszewski%20M%2C%20Niarakis%20A%2C%20Mazein%20A%2C%20Kuperstein%20I%2C%20Phair%20R%2C%20Orta-Resendiz%20A%2C%20Singh%20V%2C%20Aghamiri%20SS%2C%20Acencio%20ML%2C%20Glaab%20E%2C%20Ruepp%20A%2C%20Fobo%20G%2C%20Montrone%20C%2C%20Brauner%20B%2C%20Frishman%20G%2C%20Monraz%20G%26%23xF3%3Bmez%20LC%2C%20Somers%20J%2C%20Hoch%20M%2C%20Kumar%20Gupta%20S%2C%20Scheel%20J%2C%20Borlinghaus%20H%2C%20Czauderna%20T%2C%20Schreiber%20F%2C%20Montagud%20A%2C%20Ponce%20de%20Leon%20M%2C%20Funahashi%20A%2C%20Hiki%20Y%2C%20Hiroi%20N%2C%20Yamada%20TG%2C%20Dr%26%23xE4%3Bger%20A%2C%20Renz%20A%2C%20Naveez%20M%2C%20Bocskei%20Z%2C%20Messina%20F%2C%20B%26%23xF6%3Brnigen%20D%2C%20Fergusson%20L%2C%20Conti%20M%2C%20Rameil%20M%2C%20Nakonecnij%20V%2C%20Vanhoefer%20J%2C%20Schmiester%20L%2C%20Wang%20M%2C%20Ackerman%20EE%2C%20Shoemaker%20JE%2C%20Zucker%20J%2C%20Oxford%20K%2C%20Teuton%20J%2C%20Kocakaya%20E%2C%20Summak%20GY%2C%20Hanspers%20K%2C%20Kutmon%20M%2C%20Coort%20S%2C%20Eijssen%20L%2C%20Ehrhart%20F%2C%20Rex%20DAB%2C%20Slenter%20D%2C%20Martens%20M%2C%20Pham%20N%2C%20Haw%20R%2C%20Jassal%20B%2C%20Matthews%20L%2C%20Orlic-Milacic%20M%2C%20Senff%20Ribeiro%20A%2C%20Rothfels%20K%2C%20Shamovsky%20V%2C%20Stephan%20R%2C%20Sevilla%20C%2C%20Varusai%20T%2C%20Ravel%20JM%2C%20Fraser%20R%2C%20Ortseifen%20V%2C%20Marchesi%20S%2C%20Gawron%20P%2C%20Smula%20E%2C%20Heirendt%20L%2C%20Satagopam%20V%2C%20Wu%20G%2C%20Riutta%20A%2C%20Golebiewski%20M%2C%20Owen%20S%2C%20Goble%20C%2C%20Hu%20X%2C%20Overall%20RW%2C%20Maier%20D%2C%20Bauch%20A%2C%20Gyori%20BM%2C%20Bachman%20JA%2C%20Vega%20C%2C%20Grou%26%23xE8%3Bs%20V%2C%20Vazquez%20M%2C%20Porras%20P%2C%20Licata%20L%2C%20Iannuccelli%20M%2C%20Sacco%20F%2C%20Nesterova%20A%2C%20Yuryev%20A%2C%20de%20Waard%20A%2C%20Turei%20D%2C%20Luna%20A%2C%20Babur%20O%2C%20Soliman%20S%2C%20Valdeolivas%20A%2C%20Esteban-Medina%20M%2C%20Pe%26%23xF1%3Ba-Chilet%20M%2C%20Rian%20K%2C%20Helikar%20T%2C%20Puniya%20BL%2C%20Modos%20D%2C%20Treveil%20A%2C%20Olbei%20M%2C%20De%20Meulder%20B%2C%20Ballereau%20S%2C%20Dugourd%20A%2C%20Naldi%20A%2C%20No%26%23xEB%3Bl%20V%2C%20Calzone%20L%2C%20Sander%20C%2C%20Demir%20E%2C%20Korcsmaros%20T%2C%20Freeman%20TC%2C%20Aug%26%23xE9%3B%20F%2C%20Beckmann%20JS%2C%20Hasenauer%20J%2C%20Wolkenhauer%20O%2C%20Wilighagen%20EL%2C%20Pico%20AR%2C%20Evelo%20CT%2C%20Gillespie%20ME%2C%20Stein%20LD%2C%20Hermjakob%20H%2C%20D%26%23x2019%3BEustachio%20P%2C%20Saez-Rodriguez%20J%2C%20Dopazo%20J%2C%20Valencia%20A%2C%20Kitano%20H%2C%20Barillot%20E%2C%20Auffray%20C%2C%20Balling%20R%2C%20Schneider%20R%2C%20COVID-19%20Disease%20Map%20Community.%20COVID19%20Disease%20Map%2C%20a%20computational%20knowledge%20repository%20of%20virus-host%20interaction%20mechanisms.%20Mol%20Syst%20Biol.%202021%20Oct%3B17%2810%29%3Ae10387.%20PMCID%3A%20PMC8524328%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID19%20Disease%20Map%2C%20a%20computational%20knowledge%20repository%20of%20virus-host%20interaction%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marek%22%2C%22lastName%22%3A%22Ostaszewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Niarakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Mazein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inna%22%2C%22lastName%22%3A%22Kuperstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Phair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelio%22%2C%22lastName%22%3A%22Orta-Resendiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidisha%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20Sadat%22%2C%22lastName%22%3A%22Aghamiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcio%20Luis%22%2C%22lastName%22%3A%22Acencio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enrico%22%2C%22lastName%22%3A%22Glaab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Ruepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gisela%22%2C%22lastName%22%3A%22Fobo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinna%22%2C%22lastName%22%3A%22Montrone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Brauner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Goar%22%2C%22lastName%22%3A%22Frishman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luis%20Crist%5Cu00f3bal%22%2C%22lastName%22%3A%22Monraz%20G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Somers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matti%22%2C%22lastName%22%3A%22Hoch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shailendra%22%2C%22lastName%22%3A%22Kumar%20Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Scheel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%22%2C%22lastName%22%3A%22Borlinghaus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tobias%22%2C%22lastName%22%3A%22Czauderna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Falk%22%2C%22lastName%22%3A%22Schreiber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnau%22%2C%22lastName%22%3A%22Montagud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Ponce%20de%20Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Funahashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yusuke%22%2C%22lastName%22%3A%22Hiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noriko%22%2C%22lastName%22%3A%22Hiroi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takahiro%20G.%22%2C%22lastName%22%3A%22Yamada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Dr%5Cu00e4ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alina%22%2C%22lastName%22%3A%22Renz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Naveez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zsolt%22%2C%22lastName%22%3A%22Bocskei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Messina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22B%5Cu00f6rnigen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%22%2C%22lastName%22%3A%22Fergusson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Conti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marius%22%2C%22lastName%22%3A%22Rameil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Nakonecnij%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakob%22%2C%22lastName%22%3A%22Vanhoefer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonard%22%2C%22lastName%22%3A%22Schmiester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muying%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20E.%22%2C%22lastName%22%3A%22Ackerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20E.%22%2C%22lastName%22%3A%22Shoemaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Zucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristie%22%2C%22lastName%22%3A%22Oxford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Teuton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ebru%22%2C%22lastName%22%3A%22Kocakaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00f6k%5Cu00e7e%20Ya%5Cu011fmur%22%2C%22lastName%22%3A%22Summak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristina%22%2C%22lastName%22%3A%22Hanspers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Kutmon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Coort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%22%2C%22lastName%22%3A%22Eijssen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Ehrhart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devasahayam%20Arokia%20Balaya%22%2C%22lastName%22%3A%22Rex%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Slenter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marvin%22%2C%22lastName%22%3A%22Martens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhung%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Haw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bijay%22%2C%22lastName%22%3A%22Jassal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Matthews%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marija%22%2C%22lastName%22%3A%22Orlic-Milacic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Senff%20Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Rothfels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Shamovsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralf%22%2C%22lastName%22%3A%22Stephan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristoffer%22%2C%22lastName%22%3A%22Sevilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thawfeek%22%2C%22lastName%22%3A%22Varusai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Marie%22%2C%22lastName%22%3A%22Ravel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupsha%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vera%22%2C%22lastName%22%3A%22Ortseifen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvia%22%2C%22lastName%22%3A%22Marchesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piotr%22%2C%22lastName%22%3A%22Gawron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Smula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Heirendt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venkata%22%2C%22lastName%22%3A%22Satagopam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guanming%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anders%22%2C%22lastName%22%3A%22Riutta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Golebiewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%22%2C%22lastName%22%3A%22Goble%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoming%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupert%20W.%22%2C%22lastName%22%3A%22Overall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dieter%22%2C%22lastName%22%3A%22Maier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Bauch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentin%22%2C%22lastName%22%3A%22Grou%5Cu00e8s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Vazquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%22%2C%22lastName%22%3A%22Porras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luana%22%2C%22lastName%22%3A%22Licata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Iannuccelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Sacco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasia%22%2C%22lastName%22%3A%22Nesterova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anton%22%2C%22lastName%22%3A%22Yuryev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22de%20Waard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denes%22%2C%22lastName%22%3A%22Turei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Augustin%22%2C%22lastName%22%3A%22Luna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ozgun%22%2C%22lastName%22%3A%22Babur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Soliman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberto%22%2C%22lastName%22%3A%22Valdeolivas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Esteban-Medina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Pe%5Cu00f1a-Chilet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kinza%22%2C%22lastName%22%3A%22Rian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%5Cu00e1%5Cu0161%22%2C%22lastName%22%3A%22Helikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhanwar%20Lal%22%2C%22lastName%22%3A%22Puniya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dezso%22%2C%22lastName%22%3A%22Modos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agatha%22%2C%22lastName%22%3A%22Treveil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marton%22%2C%22lastName%22%3A%22Olbei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22De%20Meulder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22Ballereau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lien%22%2C%22lastName%22%3A%22Dugourd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lien%22%2C%22lastName%22%3A%22Naldi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22No%5Cu00ebl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Calzone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Sander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emek%22%2C%22lastName%22%3A%22Demir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamas%22%2C%22lastName%22%3A%22Korcsmaros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%20C.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Aug%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%20S.%22%2C%22lastName%22%3A%22Beckmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Hasenauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olaf%22%2C%22lastName%22%3A%22Wolkenhauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Egon%20L.%22%2C%22lastName%22%3A%22Wilighagen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20R.%22%2C%22lastName%22%3A%22Pico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20T.%22%2C%22lastName%22%3A%22Evelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20E.%22%2C%22lastName%22%3A%22Gillespie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lincoln%20D.%22%2C%22lastName%22%3A%22Stein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henning%22%2C%22lastName%22%3A%22Hermjakob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22D%27Eustachio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julio%22%2C%22lastName%22%3A%22Saez-Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joaquin%22%2C%22lastName%22%3A%22Dopazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfonso%22%2C%22lastName%22%3A%22Valencia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Kitano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Barillot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Auffray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rudi%22%2C%22lastName%22%3A%22Balling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinhard%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22COVID-19%20Disease%20Map%20Community%22%7D%5D%2C%22abstractNote%22%3A%22We%20need%20to%20effectively%20combine%20the%20knowledge%20from%20surging%20literature%20with%20complex%20datasets%20to%20propose%20mechanistic%20models%20of%20SARS-CoV-2%20infection%2C%20improving%20data%20interpretation%20and%20predicting%20key%20targets%20of%20intervention.%20Here%2C%20we%20describe%20a%20large-scale%20community%20effort%20to%20build%20an%20open%20access%2C%20interoperable%20and%20computable%20repository%20of%20COVID-19%20molecular%20mechanisms.%20The%20COVID-19%20Disease%20Map%20%28C19DMap%29%20is%20a%20graphical%2C%20interactive%20representation%20of%20disease-relevant%20molecular%20mechanisms%20linking%20many%20knowledge%20sources.%20Notably%2C%20it%20is%20a%20computational%20resource%20for%20graph-based%20analyses%20and%20disease%20modelling.%20To%20this%20end%2C%20we%20established%20a%20framework%20of%20tools%2C%20platforms%20and%20guidelines%20necessary%20for%20a%20multifaceted%20community%20of%20biocurators%2C%20domain%20experts%2C%20bioinformaticians%20and%20computational%20biologists.%20The%20diagrams%20of%20the%20C19DMap%2C%20curated%20from%20the%20literature%2C%20are%20integrated%20with%20relevant%20interaction%20and%20text%20mining%20databases.%20We%20demonstrate%20the%20application%20of%20network%20analysis%20and%20modelling%20approaches%20by%20concrete%20examples%20to%20highlight%20new%20testable%20hypotheses.%20This%20framework%20helps%20to%20find%20signatures%20of%20SARS-CoV-2%20predisposition%2C%20treatment%20response%20or%20prioritisation%20of%20drug%20candidates.%20Such%20an%20approach%20may%20help%20deal%20with%20new%20waves%20of%20COVID-19%20or%20similar%20pandemics%20in%20the%20long-term%20perspective.%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.202110387%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A08%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22KR7S6HPT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Owen%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOwen%20SV%2C%20Wenner%20N%2C%20Dulberger%20CL%2C%20Rodwell%20EV%2C%20Bowers-Barnard%20A%2C%20Quinones-Olvera%20N%2C%20Rigden%20DJ%2C%20Rubin%20EJ%2C%20Garner%20EC%2C%20Baym%20M%2C%20Hinton%20JCD.%20Prophages%20encode%20phage-defense%20systems%20with%20cognate%20self-immunity.%20Cell%20Host%20Microbe.%202021%20Nov%2010%3B29%2811%29%3A1620-1633.e8.%20PMCID%3A%20PMC8585504%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prophages%20encode%20phage-defense%20systems%20with%20cognate%20self-immunity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Wenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L.%22%2C%22lastName%22%3A%22Dulberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ella%20V.%22%2C%22lastName%22%3A%22Rodwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Bowers-Barnard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Quinones-Olvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Rigden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Rubin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20C.%22%2C%22lastName%22%3A%22Garner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%20C.%20D.%22%2C%22lastName%22%3A%22Hinton%22%7D%5D%2C%22abstractNote%22%3A%22Temperate%20phages%20are%20pervasive%20in%20bacterial%20genomes%2C%20existing%20as%20vertically%20inherited%20islands%20termed%20prophages.%20Prophages%20are%20vulnerable%20to%20predation%20of%20their%20host%20bacterium%20by%20exogenous%20phages.%20Here%2C%20we%20identify%20BstA%2C%20a%20family%20of%20prophage-encoded%20phage-defense%20proteins%20in%20diverse%20Gram-negative%20bacteria.%20BstA%20localizes%20to%20sites%20of%20exogenous%20phage%20DNA%20replication%20and%20mediates%20abortive%20infection%2C%20suppressing%20the%20competing%20phage%20epidemic.%20During%20lytic%20replication%2C%20the%20BstA-encoding%20prophage%20is%20not%20itself%20inhibited%20by%20BstA%20due%20to%20self-immunity%20conferred%20by%20the%20anti-BstA%20%28aba%29%20element%2C%20a%20short%20stretch%20of%20DNA%20within%20the%20bstA%20locus.%20Inhibition%20of%20phage%20replication%20by%20distinct%20BstA%20proteins%20from%20Salmonella%2C%20Klebsiella%2C%20and%20Escherichia%20prophages%20is%20generally%20interchangeable%2C%20but%20each%20possesses%20a%20cognate%20aba%20element.%20The%20specificity%20of%20the%20aba%20element%20ensures%20that%20immunity%20is%20exclusive%20to%20the%20replicating%20prophage%2C%20preventing%20exploitation%20by%20variant%20BstA-encoding%20phages.%20The%20BstA%20protein%20allows%20prophages%20to%20defend%20host%20cells%20against%20exogenous%20phage%20attack%20without%20sacrificing%20the%20ability%20to%20replicate%20lytically.%22%2C%22date%22%3A%222021-11-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chom.2021.09.002%22%2C%22ISSN%22%3A%221934-6069%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A19%3A40Z%22%7D%7D%2C%7B%22key%22%3A%223JHFVZD7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pati%5Cu00f1o-Galindo%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-06%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPati%26%23xF1%3Bo-Galindo%20J%26%23xC1%3B%2C%20Filip%20I%2C%20Chowdhury%20R%2C%20Maranas%20CD%2C%20Sorger%20PK%2C%20AlQuraishi%20M%2C%20Rabadan%20R.%20Recombination%20and%20lineage-specific%20mutations%20linked%20to%20the%20emergence%20of%20SARS-CoV-2.%20Genome%20Med.%202021%20Aug%206%3B13%281%29%3A124.%20PMCID%3A%20PMC8343217%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recombination%20and%20lineage-specific%20mutations%20linked%20to%20the%20emergence%20of%20SARS-CoV-2%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20%5Cu00c1ngel%22%2C%22lastName%22%3A%22Pati%5Cu00f1o-Galindo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioan%22%2C%22lastName%22%3A%22Filip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ratul%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Costas%20D.%22%2C%22lastName%22%3A%22Maranas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raul%22%2C%22lastName%22%3A%22Rabadan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20emergence%20of%20SARS-CoV-2%20underscores%20the%20need%20to%20better%20understand%20the%20evolutionary%20processes%20that%20drive%20the%20emergence%20and%20adaptation%20of%20zoonotic%20viruses%20in%20humans.%20In%20the%20betacoronavirus%20genus%2C%20which%20also%20includes%20SARS-CoV%20and%20MERS-CoV%2C%20recombination%20frequently%20encompasses%20the%20receptor%20binding%20domain%20%28RBD%29%20of%20the%20Spike%20protein%2C%20which%20is%20responsible%20for%20viral%20binding%20to%20host%20cell%20receptors.%20In%20this%20work%2C%20we%20reconstruct%20the%20evolutionary%20events%20that%20have%20accompanied%20the%20emergence%20of%20SARS-CoV-2%2C%20with%20a%20special%20emphasis%20on%20the%20RBD%20and%20its%20adaptation%20for%20binding%20to%20its%20receptor%2C%20human%20ACE2.%5CnMETHODS%3A%20By%20means%20of%20phylogenetic%20and%20recombination%20analyses%2C%20we%20found%20evidence%20of%20a%20recombination%20event%20in%20the%20RBD%20involving%20ancestral%20linages%20to%20both%20SARS-CoV%20and%20SARS-CoV-2.%20We%20then%20assessed%20the%20effect%20of%20this%20recombination%20at%20protein%20level%20by%20reconstructing%20the%20RBD%20of%20the%20closest%20ancestors%20to%20SARS-CoV-2%2C%20SARS-CoV%2C%20and%20other%20Sarbecoviruses%2C%20including%20the%20most%20recent%20common%20ancestor%20of%20the%20recombining%20clade.%20The%20resulting%20information%20was%20used%20to%20measure%20and%20compare%2C%20in%20silico%2C%20their%20ACE2-binding%20affinities%20using%20the%20physics-based%20trRosetta%20algorithm.%5CnRESULTS%3A%20We%20show%20that%2C%20through%20an%20ancestral%20recombination%20event%2C%20SARS-CoV%20and%20SARS-CoV-2%20share%20an%20RBD%20sequence%20that%20includes%20two%20insertions%20%28positions%20432-436%20and%20460-472%29%2C%20as%20well%20as%20the%20variants%20427N%20and%20436Y.%20Both%20427N%20and%20436Y%20belong%20to%20a%20helix%20that%20interacts%20directly%20with%20the%20human%20ACE2%20%28hACE2%29%20receptor.%20Reconstruction%20of%20ancestral%20states%2C%20combined%20with%20protein-binding%20affinity%20analyses%2C%20suggests%20that%20the%20recombination%20event%20involving%20ancestral%20strains%20of%20SARS-CoV%20and%20SARS-CoV-2%20led%20to%20an%20increased%20affinity%20for%20hACE2%20binding%20and%20that%20alleles%20427N%20and%20436Y%20significantly%20enhanced%20affinity%20as%20well.%5CnCONCLUSIONS%3A%20We%20report%20an%20ancestral%20recombination%20event%20affecting%20the%20RBD%20of%20both%20SARS-CoV%20and%20SARS-CoV-2%20that%20was%20associated%20with%20an%20increased%20binding%20affinity%20to%20hACE2.%20Structural%20modeling%20indicates%20that%20ancestors%20of%20SARS-CoV-2%20may%20have%20acquired%20the%20ability%20to%20infect%20humans%20decades%20ago.%20The%20binding%20affinity%20with%20the%20human%20receptor%20would%20have%20been%20subsequently%20boosted%20in%20SARS-CoV%20and%20SARS-CoV-2%20through%20further%20mutations%20in%20RBD.%22%2C%22date%22%3A%222021-08-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13073-021-00943-6%22%2C%22ISSN%22%3A%221756-994X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-02-25T07%3A31%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22CALHAEQB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pence%20and%20Evans%22%2C%22parsedDate%22%3A%222021-10-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPence%20IJ%2C%20Evans%20CL.%20Translational%20biophotonics%20with%20Raman%20imaging%3A%20clinical%20applications%20and%20beyond.%20Analyst.%202021%20Oct%2025%3B146%2821%29%3A6379%26%23x2013%3B6393.%20PMCID%3A%20PMC8543123%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Translational%20biophotonics%20with%20Raman%20imaging%3A%20clinical%20applications%20and%20beyond%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20J.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Conor%20L.%22%2C%22lastName%22%3A%22Evans%22%7D%5D%2C%22abstractNote%22%3A%22Clinical%20medicine%20continues%20to%20seek%20novel%20rapid%20non-invasive%20tools%20capable%20of%20providing%20greater%20insight%20into%20disease%20progression%20and%20management.%20Raman%20scattering%20based%20technologies%20constitute%20a%20set%20of%20tools%20under%20continuing%20development%20to%20address%20outstanding%20challenges%20spanning%20diagnostic%20medicine%2C%20surgical%20guidance%2C%20therapeutic%20monitoring%2C%20and%20histopathology.%20Here%20we%20review%20the%20mechanisms%20and%20clinical%20applications%20of%20Raman%20scattering%2C%20specifically%20focusing%20on%20high-speed%20imaging%20methods%20that%20can%20provide%20spatial%20context%20for%20translational%20biomedical%20applications.%22%2C%22date%22%3A%222021-10-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1039%5C%2Fd1an00954k%22%2C%22ISSN%22%3A%221364-5528%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22SGREPJ6G%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pettit%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPettit%20ME%2C%20Boswell%20SA%2C%20Qian%20J%2C%20Novak%20R%2C%20Springer%20M.%20Accessioning%20and%20automation%20compatible%20anterior%20nares%20swab%20design.%20J%20Virol%20Methods.%202021%20May%2010%3B114153.%20PMCID%3A%20PMC8108477%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accessioning%20and%20automation%20compatible%20anterior%20nares%20swab%20design%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20E.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Novak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Springer%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20has%20resulted%20in%20an%20unparalleled%20need%20for%20viral%20testing%20capacity%20across%20the%20world%20and%20is%20a%20critical%20requirement%20for%20successful%20re-opening%20of%20economies.%20The%20logistical%20barriers%20to%20near-universal%20testing%20are%20considerable.%20We%20have%20designed%20an%20injection%20molded%20polypropylene%20anterior%20nares%20swab%2C%20the%20Rhinostic%2C%20with%20a%20screw%20cap%20integrated%20into%20the%20swab%20handle%20that%20is%20compatible%20with%20fully%20automated%20sample%20accessioning%20and%20processing.%20The%20ability%20to%20collect%20and%20release%20both%20human%20and%20viral%20material%20is%20comparable%20to%20that%20of%20several%20commonly%20used%20swabs%20on%20the%20market.%20SARS-CoV-2%20is%20stable%20on%20dry%20Rhinostic%20swabs%20for%20at%20least%203%20days%2C%20even%20at%2042%5Cu2009%5Cu00b0C%2C%20and%20elution%20can%20be%20achieved%20with%20small%20volumes.%20To%20test%20the%20performance%20of%20the%20Rhinostic%20in%20patients%2C%20119%20samples%20were%20collected%20with%20Rhinostic%20and%20the%20positive%20and%20negative%20determinations%20were%20100%25%20concordant%20with%20samples%20collected%20using%20Clinical%20Laboratory%20Improvement%20Amendments%20%28CLIA%29%20use%20approved%20nasal%20swabs%20at%20a%20clinical%20lab.%20The%20Rhinostic%20swab%20and%20barcoded%20tube%20set%20can%20be%20produced%2C%20sterilized%2C%20and%20packaged%20cost%20effectively%20and%20is%20designed%20to%20be%20adopted%20by%20clinical%20laboratories%20using%20automation%20to%20increase%20throughput%20and%20dramatically%20reduce%20the%20cost%20of%20a%20standard%20SARS-CoV-2%20detection%20pipeline.%22%2C%22date%22%3A%222021-05-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jviromet.2021.114153%22%2C%22ISSN%22%3A%221879-0984%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-03-17T17%3A42%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22KLJWJBG8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Plana%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-29%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPlana%20D%2C%20Tian%20E%2C%20Cramer%20AK%2C%20Yang%20H%2C%20Carmack%20MM%2C%20Sinha%20MS%2C%20Bourgeois%20FT%2C%20Yu%20SH%2C%20Masse%20P%2C%20Boyer%20J%2C%20Kim%20M%2C%20Mo%20J%2C%20LeBoeuf%20NR%2C%20Li%20J%2C%20Sorger%20PK.%20Assessing%20the%20filtration%20efficiency%20and%20regulatory%20status%20of%20N95s%20and%20nontraditional%20filtering%20face-piece%20respirators%20available%20during%20the%20COVID-19%20pandemic.%20BMC%20Infect%20Dis.%202021%20Jul%2029%3B21%281%29%3A712.%20PMCID%3A%20PMC8319695%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Assessing%20the%20filtration%20efficiency%20and%20regulatory%20status%20of%20N95s%20and%20nontraditional%20filtering%20face-piece%20respirators%20available%20during%20the%20COVID-19%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enze%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%20K.%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20M.%22%2C%22lastName%22%3A%22Carmack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%20T.%22%2C%22lastName%22%3A%22Bourgeois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Masse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%22%2C%22lastName%22%3A%22Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minjune%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhan%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20COVID-19%20pandemic%20has%20severely%20disrupted%20supply%20chains%20for%20many%20types%20of%20Personal%20Protective%20Equipment%20%28PPE%29%2C%20particularly%20surgical%20N95%20filtering%20facepiece%20respirators%20%28FFRs%3B%20%5C%22masks%5C%22%29.%20As%20a%20consequence%2C%20an%20Emergency%20Use%20Authorization%20%28EUA%29%20from%20the%20FDA%20has%20allowed%20use%20of%20industrial%20N95%20respirators%20and%20importation%20of%20N95-type%20masks%20manufactured%20to%20international%20standards%3B%20these%20include%20KN95%20masks%20from%20China%20and%20FFP2%20masks%20from%20the%20European%20Union.%5CnMETHODS%3A%20We%20conducted%20a%20survey%20of%20masks%20in%20the%20inventory%20of%20major%20academic%20medical%20centers%20in%20Boston%2C%20MA%20to%20determine%20provenance%20and%20manufacturer%20or%20supplier.%20We%20then%20assembled%20a%20testing%20apparatus%20at%20a%20university%20laboratory%20and%20performed%20a%20modified%20test%20of%20filtration%20performance%20using%20KCl%20and%20ambient%20particulate%20matter%20on%20masks%20from%20hospital%20inventories%3B%20an%20accompanying%20website%20shows%20how%20to%20build%20and%20use%20the%20testing%20apparatus.%5CnRESULTS%3A%20Over%20100%20different%20makes%20and%20models%20of%20traditional%20and%20nontraditional%20filtering%20facepiece%20respirators%20%28N95-type%20masks%29%20were%20in%20the%20inventory%20of%20surveyed%20U.S.%20teaching%20hospitals%20as%20opposed%20to%202-5%20models%20under%20normal%20circumstances.%20A%20substantial%20number%20of%20unfamiliar%20masks%20are%20from%20unknown%20manufacturers.%20Many%20are%20not%20correctly%20labelled%20and%20do%20not%20perform%20to%20accepted%20standards%20and%20a%20subset%20are%20obviously%20dangerous%3B%20many%20of%20these%20masks%20are%20likely%20to%20be%20counterfeit.%20Due%20to%20the%20absence%20of%20publicly%20available%20information%20on%20mask%20suppliers%20and%20inconsistent%20labeling%20of%20KN95%20masks%2C%20it%20is%20difficult%20to%20distinguish%20between%20legitimate%20and%20counterfeit%20products.%5CnCONCLUSIONS%3A%20Many%20FFRs%20available%20for%20procurement%20during%20the%20COVID-19%20pandemic%20do%20not%20provide%20levels%20of%20fit%20and%20filtration%20similar%20to%20those%20of%20N95%20masks%20and%20are%20not%20acceptable%20for%20use%20in%20healthcare%20settings.%20Based%20on%20these%20results%2C%20and%20in%20consultation%20with%20occupational%20health%20officers%2C%20we%20make%20six%20recommendations%20to%20assist%20end%20users%20in%20acquiring%20legitimate%20products.%20Institutions%20should%20always%20assess%20masks%20from%20non-traditional%20supply%20chains%20by%20checking%20their%20markings%20and%20manufacturer%20information%20against%20data%20provided%20by%20NIOSH%20and%20the%20latest%20FDA%20EUA%20Appendix%20A.%20In%20the%20absence%20of%20verifiable%20information%20on%20the%20legitimacy%20of%20mask%20source%2C%20institutions%20should%20consider%20measuring%20mask%20fit%20and%20filtration%20directly.%20We%20also%20make%20suggestions%20for%20regulatory%20agencies%20regarding%20labeling%20and%20public%20disclosure%20aimed%20at%20increasing%20pandemic%20resilience.%22%2C%22date%22%3A%222021-07-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-021-06008-8%22%2C%22ISSN%22%3A%221471-2334%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A02%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22526UCGMP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pomeranz%20Krummel%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-15%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPomeranz%20Krummel%20DA%2C%20Nasti%20TH%2C%20Kaluzova%20M%2C%20Kallay%20L%2C%20Bhattacharya%20D%2C%20Melms%20JC%2C%20Izar%20B%2C%20Xu%20M%2C%20Burnham%20A%2C%20Ahmed%20T%2C%20Li%20G%2C%20Lawson%20D%2C%20Kowalski%20J%2C%20Cao%20Y%2C%20Switchenko%20JM%2C%20Ionascu%20D%2C%20Cook%20JM%2C%20Medvedovic%20M%2C%20Jenkins%20A%2C%20Khan%20MK%2C%20Sengupta%20S.%20Melanoma%20cell%20intrinsic%20GABAA%20receptor%20enhancement%20potentiates%20radiation%20and%20immune%20checkpoint%20inhibitor%20response%20by%20promoting%20direct%20and%20T%20cell-mediated%20antitumor%20activity.%20Int%20J%20Radiat%20Oncol%20Biol%20Phys.%202021%20Mar%2015%3B109%284%29%3A1040%26%23x2013%3B1053.%20PMCID%3A%20PMC8329598%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Melanoma%20cell%20intrinsic%20GABAA%20receptor%20enhancement%20potentiates%20radiation%20and%20immune%20checkpoint%20inhibitor%20response%20by%20promoting%20direct%20and%20T%20cell-mediated%20antitumor%20activity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Pomeranz%20Krummel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tahseen%20H.%22%2C%22lastName%22%3A%22Nasti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milota%22%2C%22lastName%22%3A%22Kaluzova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Kallay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debanjan%22%2C%22lastName%22%3A%22Bhattacharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxwell%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Burnham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taukir%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guanguan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Lawson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Kowalski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yichun%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20M.%22%2C%22lastName%22%3A%22Switchenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Ionascu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Cook%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Medvedovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%20K.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soma%22%2C%22lastName%22%3A%22Sengupta%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Most%20patients%20with%20metastatic%20melanoma%20show%20variable%20responses%20to%20radiation%20therapy%20and%20do%20not%20benefit%20from%20immune%20checkpoint%20inhibitors.%20Improved%20strategies%20for%20combination%20therapy%20that%20leverage%20potential%20benefits%20from%20radiation%20therapy%20and%20immune%20checkpoint%20inhibitors%20are%20critical.%5CnMETHODS%20AND%20MATERIALS%3A%20We%20analyzed%20metastatic%20melanoma%20tumors%20in%20the%20TCGA%20cohort%20for%20expression%20of%20genes%20coding%20for%20subunits%20of%20type%20A%20%5Cu03b3-aminobutyric%20acid%20%28GABA%29%20receptor%20%28GABAAR%29%2C%20a%20chloride%20ion%20channel%20and%20major%20inhibitory%20neurotransmitter%20receptor.%20Electrophysiology%20was%20used%20to%20determine%20whether%20melanoma%20cells%20possess%20intrinsic%20GABAAR%20activity.%20Melanoma%20cell%20viability%20studies%20were%20conducted%20to%20test%20whether%20enhancing%20GABAAR%20mediated%20chloride%20transport%20using%20benzodiazepine-impaired%20viability.%20A%20syngeneic%20melanoma%20mouse%20model%20was%20used%20to%20assay%20the%20effect%20of%20benzodiazepine%20on%20tumor%20volume%20and%20its%20ability%20to%20potentiate%20radiation%20therapy%20or%20immunotherapy.%20Treated%20tumors%20were%20analyzed%20for%20changes%20in%20gene%20expression%20by%20RNA%20sequencing%20and%20presence%20of%20tumor-infiltrating%20lymphocytes%20by%20flow%20cytometry.%5CnRESULTS%3A%20Genes%20coding%20for%20subunits%20of%20GABAARs%20express%20functional%20GABAARs%20in%20melanoma%20cells.%20By%20enhancing%20GABAAR-mediated%20anion%20transport%2C%20benzodiazepines%20depolarize%20melanoma%20cells%20and%20impair%20their%20viability.%20In%5Cu00a0vivo%2C%20benzodiazepine%20alone%20reduces%20tumor%20growth%20and%20potentiates%20radiation%20therapy%20and%20%5Cu03b1-PD-L1%20antitumor%20activity.%20The%20combination%20of%20benzodiazepine%2C%20radiation%20therapy%2C%20and%20%5Cu03b1-PD-L1%20results%20in%20near%20complete%20regression%20of%20treated%20tumors%20and%20a%20potent%20abscopal%20effect%2C%20mediated%20by%20increased%20infiltration%20of%20polyfunctional%20CD8%2B%20T%20cells.%20Treated%20tumors%20show%20expression%20of%20cytokine-cytokine%20receptor%20interactions%20and%20overrepresentation%20of%20p53%20signaling.%5CnCONCLUSIONS%3A%20This%20study%20identifies%20an%20antitumor%20strategy%20combining%20radiation%20and%5C%2For%20an%20immune%20checkpoint%20inhibitor%20with%20modulation%20of%20GABAARs%20in%20melanoma%20using%20benzodiazepine.%22%2C%22date%22%3A%222021-03-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijrobp.2020.10.025%22%2C%22ISSN%22%3A%221879-355X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22GTQ7LBK7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rodriguez%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-15%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERodriguez%20S%2C%20Hug%20C%2C%20Todorov%20P%2C%20Moret%20N%2C%20Boswell%20SA%2C%20Evans%20K%2C%20Zhou%20G%2C%20Johnson%20NT%2C%20Hyman%20BT%2C%20Sorger%20PK%2C%20Albers%20MW%2C%20Sokolov%20A.%20Machine%20learning%20identifies%20candidates%20for%20drug%20repurposing%20in%20Alzheimer%26%23x2019%3Bs%20disease.%20Nat%20Commun.%202021%20Feb%2015%3B12%281%29%3A1033.%20PMCID%3A%20PMC7884393%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Machine%20learning%20identifies%20candidates%20for%20drug%20repurposing%20in%20Alzheimer%27s%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petar%22%2C%22lastName%22%3A%22Todorov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nienke%22%2C%22lastName%22%3A%22Moret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20T.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bradley%20T.%22%2C%22lastName%22%3A%22Hyman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%5D%2C%22abstractNote%22%3A%22Clinical%20trials%20of%20novel%20therapeutics%20for%20Alzheimer%27s%20Disease%20%28AD%29%20have%20consumed%20a%20large%20amount%20of%20time%20and%20resources%20with%20largely%20negative%20results.%20Repurposing%20drugs%20already%20approved%20by%20the%20Food%20and%20Drug%20Administration%20%28FDA%29%20for%20another%20indication%20is%20a%20more%20rapid%20and%20less%20expensive%20option.%20We%20present%20DRIAD%20%28Drug%20Repurposing%20In%20AD%29%2C%20a%20machine%20learning%20framework%20that%20quantifies%20potential%20associations%20between%20the%20pathology%20of%20AD%20severity%20%28the%20Braak%20stage%29%20and%20molecular%20mechanisms%20as%20encoded%20in%20lists%20of%20gene%20names.%20DRIAD%20is%20applied%20to%20lists%20of%20genes%20arising%20from%20perturbations%20in%20differentiated%20human%20neural%20cell%20cultures%20by%2080%20FDA-approved%20and%20clinically%20tested%20drugs%2C%20producing%20a%20ranked%20list%20of%20possible%20repurposing%20candidates.%20Top-scoring%20drugs%20are%20inspected%20for%20common%20trends%20among%20their%20targets.%20We%20propose%20that%20the%20DRIAD%20method%20can%20be%20used%20to%20nominate%20drugs%20that%2C%20after%20additional%20validation%20and%20identification%20of%20relevant%20pharmacodynamic%20biomarker%28s%29%2C%20could%20be%20readily%20evaluated%20in%20a%20clinical%20trial.%22%2C%22date%22%3A%222021-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-021-21330-0%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A15%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22T9TV5GB6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rodriguez%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERodriguez%20S%2C%20Sahin%20A%2C%20Schrank%20BR%2C%20Al-Lawati%20H%2C%20Costantino%20I%2C%20Benz%20E%2C%20Fard%20D%2C%20Albers%20AD%2C%20Cao%20L%2C%20Gomez%20AC%2C%20Evans%20K%2C%20Ratti%20E%2C%20Cudkowicz%20M%2C%20Frosch%20MP%2C%20Talkowski%20M%2C%20Sorger%20PK%2C%20Hyman%20BT%2C%20Albers%20MW.%20Genome-encoded%20cytoplasmic%20double-stranded%20RNAs%2C%20found%20in%20C9ORF72%20ALS-FTD%20brain%2C%20propagate%20neuronal%20loss.%20Sci%20Transl%20Med.%202021%20Jul%207%3B13%28601%29%3Aeaaz4699.%20PMCID%3A%20PMC8779652%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genome-encoded%20cytoplasmic%20double-stranded%20RNAs%2C%20found%20in%20C9ORF72%20ALS-FTD%20brain%2C%20propagate%20neuronal%20loss%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asli%22%2C%22lastName%22%3A%22Sahin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20R.%22%2C%22lastName%22%3A%22Schrank%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hawra%22%2C%22lastName%22%3A%22Al-Lawati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Costantino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Benz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darian%22%2C%22lastName%22%3A%22Fard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alefiya%20D.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luxiang%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20C.%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Ratti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merit%22%2C%22lastName%22%3A%22Cudkowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P.%22%2C%22lastName%22%3A%22Frosch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Talkowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bradley%20T.%22%2C%22lastName%22%3A%22Hyman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22Triggers%20of%20innate%20immune%20signaling%20in%20the%20CNS%20of%20patients%20with%20amyotrophic%20lateral%20sclerosis%20and%20frontotemporal%20degeneration%20%28ALS%5C%2FFTD%29%20remain%20elusive.%20We%20report%20the%20presence%20of%20cytoplasmic%20double-stranded%20RNA%20%28cdsRNA%29%2C%20an%20established%20trigger%20of%20innate%20immunity%2C%20in%20ALS-FTD%20brains%20carrying%20C9ORF72%20intronic%20hexanucleotide%20expansions%20that%20included%20genomically%20encoded%20expansions%20of%20the%20G4C2%20repeat%20sequences.%20The%20presence%20of%20cdsRNA%20in%20human%20brains%20was%20coincident%20with%20cytoplasmic%20TAR%20DNA%20binding%20protein%2043%20%28TDP-43%29%20inclusions%2C%20a%20pathologic%20hallmark%20of%20ALS%5C%2FFTD.%20Introducing%20cdsRNA%20into%20cultured%20human%20neural%20cells%20induced%20type%20I%20interferon%20%28IFN-I%29%20signaling%20and%20death%20that%20was%20rescued%20by%20FDA-approved%20JAK%20inhibitors.%20In%20mice%2C%20genomically%20encoded%20dsRNAs%20expressed%20exclusively%20in%20a%20neuronal%20class%20induced%20IFN-I%20and%20death%20in%20connected%20neurons%20non-cell-autonomously.%20Our%20findings%20establish%20that%20genomically%20encoded%20cdsRNAs%20trigger%20sterile%2C%20viral-mimetic%20IFN-I%20induction%20and%20propagated%20death%20within%20neural%20circuits%20and%20may%20drive%20neuroinflammation%20and%20neurodegeneration%20in%20patients%20with%20ALS%5C%2FFTD.%22%2C%22date%22%3A%222021-07-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.aaz4699%22%2C%22ISSN%22%3A%221946-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A27%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22PKMFZGDP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schmiester%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-26%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchmiester%20L%2C%20Sch%26%23xE4%3Blte%20Y%2C%20Bergmann%20FT%2C%20Camba%20T%2C%20Dudkin%20E%2C%20Egert%20J%2C%20Fr%26%23xF6%3Bhlich%20F%2C%20Fuhrmann%20L%2C%20Hauber%20AL%2C%20Kemmer%20S%2C%20Lakrisenko%20P%2C%20Loos%20C%2C%20Merkt%20S%2C%20M%26%23xFC%3Bller%20W%2C%20Pathirana%20D%2C%20Raim%26%23xFA%3Bndez%20E%2C%20Refisch%20L%2C%20Rosenblatt%20M%2C%20Stapor%20PL%2C%20St%26%23xE4%3Bdter%20P%2C%20Wang%20D%2C%20Wieland%20FG%2C%20Banga%20JR%2C%20Timmer%20J%2C%20Villaverde%20AF%2C%20Sahle%20S%2C%20Kreutz%20C%2C%20Hasenauer%20J%2C%20Weindl%20D.%20PEtab-Interoperable%20specification%20of%20parameter%20estimation%20problems%20in%20systems%20biology.%20PLoS%20Comput%20Biol.%202021%20Jan%2026%3B17%281%29%3Ae1008646.%20PMCID%3A%20PMC7864467%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PEtab-Interoperable%20specification%20of%20parameter%20estimation%20problems%20in%20systems%20biology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonard%22%2C%22lastName%22%3A%22Schmiester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yannik%22%2C%22lastName%22%3A%22Sch%5Cu00e4lte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%20T.%22%2C%22lastName%22%3A%22Bergmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tacio%22%2C%22lastName%22%3A%22Camba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Dudkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janine%22%2C%22lastName%22%3A%22Egert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%22%2C%22lastName%22%3A%22Fuhrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20L.%22%2C%22lastName%22%3A%22Hauber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svenja%22%2C%22lastName%22%3A%22Kemmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polina%22%2C%22lastName%22%3A%22Lakrisenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolin%22%2C%22lastName%22%3A%22Loos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Merkt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wolfgang%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dilan%22%2C%22lastName%22%3A%22Pathirana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elba%22%2C%22lastName%22%3A%22Raim%5Cu00fandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Refisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcus%22%2C%22lastName%22%3A%22Rosenblatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20L.%22%2C%22lastName%22%3A%22Stapor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22St%5Cu00e4dter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dantong%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franz-Georg%22%2C%22lastName%22%3A%22Wieland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julio%20R.%22%2C%22lastName%22%3A%22Banga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%22%2C%22lastName%22%3A%22Timmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%20F.%22%2C%22lastName%22%3A%22Villaverde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sven%22%2C%22lastName%22%3A%22Sahle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Kreutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Hasenauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Weindl%22%7D%5D%2C%22abstractNote%22%3A%22Reproducibility%20and%20reusability%20of%20the%20results%20of%20data-based%20modeling%20studies%20are%20essential.%20Yet%2C%20there%20has%20been-so%20far-no%20broadly%20supported%20format%20for%20the%20specification%20of%20parameter%20estimation%20problems%20in%20systems%20biology.%20Here%2C%20we%20introduce%20PEtab%2C%20a%20format%20which%20facilitates%20the%20specification%20of%20parameter%20estimation%20problems%20using%20Systems%20Biology%20Markup%20Language%20%28SBML%29%20models%20and%20a%20set%20of%20tab-separated%20value%20files%20describing%20the%20observation%20model%20and%20experimental%20data%20as%20well%20as%20parameters%20to%20be%20estimated.%20We%20already%20implemented%20PEtab%20support%20into%20eight%20well-established%20model%20simulation%20and%20parameter%20estimation%20toolboxes%20with%20hundreds%20of%20users%20in%20total.%20We%20provide%20a%20Python%20library%20for%20validation%20and%20modification%20of%20a%20PEtab%20problem%20and%20currently%2020%20example%20parameter%20estimation%20problems%20based%20on%20recent%20studies.%22%2C%22date%22%3A%222021-01-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1008646%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22WGLBETUU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Schmucker%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-28%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESchmucker%20R%2C%20Farina%20G%2C%20Faeder%20J%2C%20Fr%26%23xF6%3Bhlich%20F%2C%20Saglam%20AS%2C%20Sandholm%20T.%20Combination%20treatment%20optimization%20using%20a%20pan-cancer%20pathway%20model.%20PLoS%20Comput%20Biol.%202021%20Dec%2028%3B17%2812%29%3Ae1009689.%20PMCID%3A%20PMC8747684%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Combination%20treatment%20optimization%20using%20a%20pan-cancer%20pathway%20model%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Schmucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriele%22%2C%22lastName%22%3A%22Farina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Faeder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20Sinan%22%2C%22lastName%22%3A%22Saglam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuomas%22%2C%22lastName%22%3A%22Sandholm%22%7D%5D%2C%22abstractNote%22%3A%22The%20design%20of%20efficient%20combination%20therapies%20is%20a%20difficult%20key%20challenge%20in%20the%20treatment%20of%20complex%20diseases%20such%20as%20cancers.%20The%20large%20heterogeneity%20of%20cancers%20and%20the%20large%20number%20of%20available%20drugs%20renders%20exhaustive%20in%20vivo%20or%20even%20in%20vitro%20investigation%20of%20possible%20treatments%20impractical.%20In%20recent%20years%2C%20sophisticated%20mechanistic%2C%20ordinary%20differential%20equation-based%20pathways%20models%20that%20can%20predict%20treatment%20responses%20at%20a%20molecular%20level%20have%20been%20developed.%20However%2C%20surprisingly%20little%20effort%20has%20been%20put%20into%20leveraging%20these%20models%20to%20find%20novel%20therapies.%20In%20this%20paper%20we%20use%20for%20the%20first%20time%2C%20to%20our%20knowledge%2C%20a%20large-scale%20state-of-the-art%20pan-cancer%20signaling%20pathway%20model%20to%20identify%20candidates%20for%20novel%20combination%20therapies%20to%20treat%20individual%20cancer%20cell%20lines%20from%20various%20tissues%20%28e.g.%2C%20minimizing%20proliferation%20while%20keeping%20dosage%20low%20to%20avoid%20adverse%20side%20effects%29%20and%20populations%20of%20heterogeneous%20cancer%20cell%20lines%20%28e.g.%2C%20minimizing%20the%20maximum%20or%20average%20proliferation%20across%20the%20cell%20lines%20while%20keeping%20dosage%20low%29.%20We%20also%20show%20how%20our%20method%20can%20be%20used%20to%20optimize%20the%20drug%20combinations%20used%20in%20sequential%20treatment%20plans-that%20is%2C%20optimized%20sequences%20of%20potentially%20different%20drug%20combinations-providing%20additional%20benefits.%20In%20order%20to%20solve%20the%20treatment%20optimization%20problems%2C%20we%20combine%20the%20Covariance%20Matrix%20Adaptation%20Evolution%20Strategy%20%28CMA-ES%29%20algorithm%20with%20a%20significantly%20more%20scalable%20sampling%20scheme%20for%20truncated%20Gaussian%20distributions%2C%20based%20on%20a%20Hamiltonian%20Monte-Carlo%20method.%20These%20optimization%20techniques%20are%20independent%20of%20the%20signaling%20pathway%20model%2C%20and%20can%20thus%20be%20adapted%20to%20find%20treatment%20candidates%20for%20other%20complex%20diseases%20than%20cancers%20as%20well%2C%20as%20long%20as%20a%20suitable%20predictive%20model%20is%20available.%22%2C%22date%22%3A%222021-12-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1009689%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22V9TABT3Z%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shimada%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-08%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShimada%20K%2C%20Bachman%20JA%2C%20Muhlich%20JL%2C%20Mitchison%20TJ.%20shinyDepMap%2C%20a%20tool%20to%20identify%20targetable%20cancer%20genes%20and%20their%20functional%20connections%20from%20Cancer%20Dependency%20Map%20data.%20Elife.%202021%20Feb%208%3B10%3Ae57116.%20PMCID%3A%20PMC7924953%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22shinyDepMap%2C%20a%20tool%20to%20identify%20targetable%20cancer%20genes%20and%20their%20functional%20connections%20from%20Cancer%20Dependency%20Map%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Shimada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Individual%20cancers%20rely%20on%20distinct%20essential%20genes%20for%20their%20survival.%20The%20Cancer%20Dependency%20Map%20%28DepMap%29%20is%20an%20ongoing%20project%20to%20uncover%20these%20gene%20dependencies%20in%20hundreds%20of%20cancer%20cell%20lines.%20To%20make%20this%20drug%20discovery%20resource%20more%20accessible%20to%20the%20scientific%20community%2C%20we%20built%20an%20easy-to-use%20browser%2C%20shinyDepMap%20%28https%3A%5C%2F%5C%2Flabsyspharm.shinyapps.io%5C%2Fdepmap%29.%20shinyDepMap%20combines%20CRISPR%20and%20shRNA%20data%20to%20determine%2C%20for%20each%20gene%2C%20the%20growth%20reduction%20caused%20by%20knockout%5C%2Fknockdown%20and%20the%20selectivity%20of%20this%20effect%20across%20cell%20lines.%20The%20tool%20also%20clusters%20genes%20with%20similar%20dependencies%2C%20revealing%20functional%20relationships.%20shinyDepMap%20can%20be%20used%20to%20%281%29%20predict%20the%20efficacy%20and%20selectivity%20of%20drugs%20targeting%20particular%20genes%3B%20%282%29%20identify%20maximally%20sensitive%20cell%20lines%20for%20testing%20a%20drug%3B%20%283%29%20target%20hop%2C%20that%20is%2C%20navigate%20from%20an%20undruggable%20protein%20with%20the%20desired%20selectivity%20profile%2C%20such%20as%20an%20activated%20oncogene%2C%20to%20more%20druggable%20targets%20with%20a%20similar%20profile%3B%20and%20%284%29%20identify%20novel%20pathways%20driving%20cancer%20cell%20growth%20and%20survival.%22%2C%22date%22%3A%222021-02-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.57116%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22KZ54ZRQ7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sritharan%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESritharan%20D%2C%20Wang%20S%2C%20Hormoz%20S.%20Computing%20the%20Riemannian%20curvature%20of%20image%20patch%20and%20single-cell%20RNA%20sequencing%20data%20manifolds%20using%20extrinsic%20differential%20geometry.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202021%20Jul%2020%3B118%2829%29%3Ae2100473118.%20PMCID%3A%20PMC8307776%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Computing%20the%20Riemannian%20curvature%20of%20image%20patch%20and%20single-cell%20RNA%20sequencing%20data%20manifolds%20using%20extrinsic%20differential%20geometry%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Duluxan%22%2C%22lastName%22%3A%22Sritharan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sahand%22%2C%22lastName%22%3A%22Hormoz%22%7D%5D%2C%22abstractNote%22%3A%22Most%20high-dimensional%20datasets%20are%20thought%20to%20be%20inherently%20low-dimensional-that%20is%2C%20data%20points%20are%20constrained%20to%20lie%20on%20a%20low-dimensional%20manifold%20embedded%20in%20a%20high-dimensional%20ambient%20space.%20Here%2C%20we%20study%20the%20viability%20of%20two%20approaches%20from%20differential%20geometry%20to%20estimate%20the%20Riemannian%20curvature%20of%20these%20low-dimensional%20manifolds.%20The%20intrinsic%20approach%20relates%20curvature%20to%20the%20Laplace-Beltrami%20operator%20using%20the%20heat-trace%20expansion%20and%20is%20agnostic%20to%20how%20a%20manifold%20is%20embedded%20in%20a%20high-dimensional%20space.%20The%20extrinsic%20approach%20relates%20the%20ambient%20coordinates%20of%20a%20manifold%27s%20embedding%20to%20its%20curvature%20using%20the%20Second%20Fundamental%20Form%20and%20the%20Gauss-Codazzi%20equation.%20We%20found%20that%20the%20intrinsic%20approach%20fails%20to%20accurately%20estimate%20the%20curvature%20of%20even%20a%20two-dimensional%20constant-curvature%20manifold%2C%20whereas%20the%20extrinsic%20approach%20was%20able%20to%20handle%20more%20complex%20toy%20models%2C%20even%20when%20confounded%20by%20practical%20constraints%20like%20small%20sample%20sizes%20and%20measurement%20noise.%20To%20test%20the%20applicability%20of%20the%20extrinsic%20approach%20to%20real-world%20data%2C%20we%20computed%20the%20curvature%20of%20a%20well-studied%20manifold%20of%20image%20patches%20and%20recapitulated%20its%20topological%20classification%20as%20a%20Klein%20bottle.%20Lastly%2C%20we%20applied%20the%20extrinsic%20approach%20to%20study%20single-cell%20transcriptomic%20sequencing%20%28scRNAseq%29%20datasets%20of%20blood%2C%20gastrulation%2C%20and%20brain%20cells%20to%20quantify%20the%20Riemannian%20curvature%20of%20scRNAseq%20manifolds.%22%2C%22date%22%3A%222021-07-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1073%5C%2Fpnas.2100473118%22%2C%22ISSN%22%3A%221091-6490%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22QU83ZFTS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tsabar%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETsabar%20M%2C%20Lovitch%20SB%2C%20Jambhekar%20A%2C%20Lahav%20G.%20Connecting%20timescales%20in%20biology%3A%20can%20early%20dynamical%20measurements%20predict%20long-term%20outcomes%3F%20Trends%20Cancer.%202021%20Apr%3B7%284%29%3A301%26%23x2013%3B308.%20PMCID%3A%20PMC8796003%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Connecting%20timescales%20in%20biology%3A%20can%20early%20dynamical%20measurements%20predict%20long-term%20outcomes%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Tsabar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Lovitch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22Prediction%20of%20long-term%20outcomes%20from%20short-term%20measurements%20remains%20a%20fundamental%20challenge.%20Quantitative%20assessment%20of%20signaling%20dynamics%2C%20and%20the%20resulting%20transcriptomic%20and%20proteomic%20responses%2C%20has%20yielded%20fundamental%20insights%20into%20cellular%20outcomes.%20However%2C%20the%20utility%20of%20these%20measurements%20is%20limited%20by%20their%20short%20timescale%20%28hours%20to%20days%29%2C%20while%20the%20consequences%20of%20these%20events%20frequently%20unfold%20over%20longer%20timescales.%20Here%2C%20we%20discuss%20the%20predictive%20power%20of%20static%20and%20dynamic%20measurements%2C%20drawing%20examples%20from%20fields%20that%20have%20harnessed%20the%20predictive%20capabilities%20of%20such%20measurements.%20We%20then%20explore%20potential%20approaches%20to%20close%20this%20timescale%20gap%20using%20complementary%20measurements%20and%20computational%20approaches%2C%20focusing%20on%20the%20example%20of%20dynamic%20measurements%20of%20signaling%20factors%20and%20their%20impacts%20on%20cellular%20outcomes.%22%2C%22date%22%3A%222021-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.trecan.2020.12.008%22%2C%22ISSN%22%3A%222405-8025%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A48%3A07Z%22%7D%7D%5D%7D
1.
Abtahi S, Gliksman NR, Heneghan JF, Nilsen SP, Muhlich JL, Copeland J, Rozbicki E, Allan C, Dudeja PK, Turner JR. A simple method for creating a high-content microscope for imaging multiplexed tissue microarrays. Curr Protoc. 2021 Apr;1(4):e68. PMCID: PMC8103673
1.
AlQuraishi M, Sorger PK. Differentiable biology: using deep learning for biophysics-based and data-driven modeling of molecular mechanisms. Nat Methods. 2021 Oct;18(10):1169–1180. PMCID: PMC8793939
1.
Antonini MJ, Plana D, Srinivasan S, Atta L, Achanta A, Yang H, Cramer AK, Freake J, Sinha MS, Yu SH, LeBoeuf NR, Linville-Engler B, Sorger PK. A crisis-responsive framework for medical device development applied to the COVID-19 pandemic. Front Digit Health. 2021 Mar;3:617106. PMCID: PMC8064560
1.
Bouatta N, Sorger P, AlQuraishi M. Protein structure prediction by AlphaFold2: are attention and symmetries all you need? Acta Crystallogr D Struct Biol. 2021 Aug 1;77(Pt 8):982–991. PMCID: PMC8329862
1.
Břinda K, Baym M, Kucherov G. Simplitigs as an efficient and scalable representation of de Bruijn graphs. Genome Biol. 2021 Apr 6;22(1):96. PMCID: PMC8025321
1.
Burger ML, Cruz AM, Crossland GE, Gaglia G, Ritch CC, Blatt SE, Bhutkar A, Canner D, Kienka T, Tavana SZ, Barandiaran AL, Garmilla A, Schenkel JM, Hillman M, de Los Rios Kobara I, Li A, Jaeger AM, Hwang WL, Westcott PMK, Manos MP, Holovatska MM, Hodi FS, Regev A, Santagata S, Jacks T. Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors. Cell. 2021 Sep 16;184(19):4996-5014.e26. PMCID: PMC8522630
1.
Cramer AK, Plana D, Yang H, Carmack MM, Tian E, Sinha MS, Krikorian D, Turner D, Mo J, Li J, Gupta R, Manning H, Bourgeois FT, Yu SH, Sorger PK, LeBoeuf NR. Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE. Sci Rep. 2021 Jan 21;11(1):2051. PMCID: PMC7819989
1.
Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, LaFleur MW, Ringel AE, Yao CH, Kurmi K, Juneja VR, Trombley JD, Haigis MC, Sharpe AH. Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells. Cancer Immunol Res. 2021 Feb;9(2):184–199. PMCID: PMC7864883
1.
Duraiswamy J, Turrini R, Minasyan A, Barras D, Crespo I, Grimm AJ, Casado J, Genolet R, Benedetti F, Wicky A, Ioannidou K, Castro W, Neal C, Moriot A, Renaud-Tissot S, Anstett V, Fahr N, Tanyi JL, Eiva MA, Jacobson CA, Montone KT, Westergaard MCW, Svane IM, Kandalaft LE, Delorenzi M, Sorger PK, Färkkilä A, Michielin O, Zoete V, Carmona SJ, Foukas PG, Powell DJ, Rusakiewicz S, Doucey MA, Dangaj Laniti D, Coukos G. Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. Cancer Cell. 2021 Dec 13;39(12):1623-1642.e20. PMCID: PMC8861565
1.
Färkkilä A, Rodríguez A, Oikkonen J, Gulhan DC, Nguyen H, Domínguez J, Ramos S, Mills CE, Pérez-Villatoro F, Lazaro JB, Zhou J, Clairmont CS, Moreau LA, Park PJ, Sorger PK, Hautaniemi S, Frias S, D’Andrea AD. Heterogeneity and clonal evolution of acquired PARP inhibitor resistance in TP53- and BRCA1-deficient cells. Cancer Res. 2021 May 15;81(10):2774–2787. PMCID: PMC8323804
1.
Fröhlich F, Weindl D, Schälte Y, Pathirana D, Paszkowski Ł, Lines GT, Stapor P, Hasenauer J. AMICI: high-performance sensitivity analysis for large ordinary differential equation models. Bioinformatics. 2021 Apr 2;btab227. PMCID: PMC8545331
1.
Gevertz JL, Greene JM, Sanchez-Tapia CH, Sontag ED. A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing. J Theor Biol. 2021 Feb 7;510:110539. PMCID: PMC7840295
1.
Goldberg J, Pastorello RG, Vallius T, Davis J, Cui YX, Agudo J, Waks AG, Keenan T, McAllister SS, Tolaney SM, Mittendorf EA, Guerriero JL. The immunology of hormone receptor positive breast cancer. Front Immunol. 2021;12:674192. PMCID: PMC8202289
1.
Gyori BM, Bachman JA. From knowledge to models: automated modeling in systems and synthetic biology. Current Opinion in Systems Biology [Internet]. 2021 [cited 2023 Oct 30];28:100362. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2452310021000561
1.
Hemming ML, Coy S, Lin JR, Andersen JL, Przybyl J, Mazzola E, Abdelhamid Ahmed AH, van de Rijn M, Sorger PK, Armstrong SA, Demetri GD, Santagata S. HAND1 and BARX1 act as transcriptional and anatomic determinants of malignancy in gastrointestinal stromal tumor. Clin Cancer Res. 2021 Mar 15;27(6):1706–1719. PMCID: PMC7956056
1.
Ietswaart R, Gyori BM, Bachman JA, Sorger PK, Churchman LS. GeneWalk identifies relevant gene functions for a biological context using network representation learning. Genome Biol. 2021 Feb 2;22(1):55. PMCID: PMC7852222
1.
Inde Z, Croker BA, Yapp C, Joshi GN, Spetz J, Fraser C, Qin X, Xu L, Deskin B, Ghelfi E, Webb G, Carlin AF, Zhu YP, Leibel SL, Garretson AF, Clark AE, Duran JM, Pretorius V, Crotty-Alexander LE, Li C, Lee JC, Sodhi C, Hackam DJ, Sun X, Hata AN, Kobzik L, Miller J, Park JA, Brownfield D, Jia H, Sarosiek KA. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity. Sci Adv. 2021 Aug 18;7(34):eabf8609. PMCID: PMC8373124
1.
Jayakar S, Shim J, Jo S, Bean BP, Singeç I, Woolf CJ. Developing nociceptor-selective treatments for acute and chronic pain. Sci Transl Med. 2021 Nov 10;13(619):eabj9837. PMCID: PMC9964063
1.
Jerby-Arnon L, Neftel C, Shore ME, Weisman HR, Mathewson ND, McBride MJ, Haas B, Izar B, Volorio A, Boulay G, Cironi L, Richman AR, Broye LC, Gurski JM, Luo CC, Mylvaganam R, Nguyen L, Mei S, Melms JC, Georgescu C, Cohen O, Buendia-Buendia JE, Segerstolpe A, Sud M, Cuoco MS, Labes D, Gritsch S, Zollinger DR, Ortogero N, Beechem JM, Petur Nielsen G, Chebib I, Nguyen-Ngoc T, Montemurro M, Cote GM, Choy E, Letovanec I, Cherix S, Wagle N, Sorger PK, Haynes AB, Mullen JT, Stamenkovic I, Rivera MN, Kadoch C, Wucherpfennig KW, Rozenblatt-Rosen O, Suvà ML, Riggi N, Regev A. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. Nat Med. 2021 Feb;27(2):289–300. PMCID: PMC8817899
1.
Jiang B, Gao Y, Che J, Lu W, Kaltheuner IH, Dries R, Kalocsay M, Berberich MJ, Jiang J, You I, Kwiatkowski N, Riching KM, Daniels DL, Sorger PK, Geyer M, Zhang T, Gray NS. Discovery and resistance mechanism of a selective CDK12 degrader. Nat Chem Biol. 2021 Jun;17(6):675–683. PMCID: PMC8590456
1.
Kassamali B, Yu Z, Davis C, Carmack M, Bui ATN, Said JT, Plana D, Yang H, Sorger P, LeBoeuf NR, LaChance AH. Conversion of existing UVB phototherapy units to UVC germicidal chambers for N95 decontamination: lessons learned. Photobiomodul Photomed Laser Surg. 2021 Feb;39(2):83–85. PMCID: PMC8106246
1.
Keenan TE, Li T, Vallius T, Guerriero JL, Tayob N, Kochupurakkal B, Davis J, Pastorello R, Tahara RK, Anderson L, Conway J, He MX, Shannon E, Godin RE, Sorger PK, D’Andrea A, Overmoyer B, Winer EP, Mittendorf EA, Van Allen EM, Shapiro GI, Tolaney SM. Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer. Clin Cancer Res. 2021 Feb 15;27(4):983–991. PMCID: PMC7887044
1.
Koikawa K, Kibe S, Suizu F, Sekino N, Kim N, Manz TD, Pinch BJ, Akshinthala D, Verma A, Gaglia G, Nezu Y, Ke S, Qiu C, Ohuchida K, Oda Y, Lee TH, Wegiel B, Clohessy JG, London N, Santagata S, Wulf GM, Hidalgo M, Muthuswamy SK, Nakamura M, Gray NS, Zhou XZ, Lu KP. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Cell. 2021 Sep 2;184(18):4753-4771.e27. PMCID: PMC8557351
1.
Kothakonda A, Atta L, Plana D, Ward F, Davis C, Cramer A, Moran R, Freake J, Tian E, Mazor O, Gorelik P, Van C, Hansen C, Yang H, Li Y, Sinha MS, Li J, Yu SH, LeBoeuf NR, Sorger PK. De novo powered air-purifying respirator design and fabrication for pandemic response. Front Bioeng Biotechnol. 2021 Sep 6;9:690905. PMCID: PMC8450396
1.
Larkins-Ford J, Greenstein T, Van N, Degefu YN, Olson MC, Sokolov A, Aldridge BB. Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis. Cell Syst. 2021 Nov 17;12(11):1046-1063.e7. PMCID: PMC8617591
1.
Lee J, Vernet A, Gruber NG, Kready KM, Burrill DR, Way JC, Silver PA. Rational engineering of an erythropoietin fusion protein to treat hypoxia. Protein Eng Des Sel. 2021 Feb 15;34:gzab025. PMID: 34725710
1.
Leipzig J, Nüst D, Hoyt CT, Ram K, Greenberg J. The role of metadata in reproducible computational research. Patterns (N Y). 2021 Sep 10;2(9):100322. PMCID: PMC8441584
1.
Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J, Sriram RK, Humphries MP, Salto-Tellez M, James JA, Hanna MG, Melms JC, Vallabhaneni S, Litchfield K, Usaite I, Biswas D, Bareja R, Li HW, Martin ML, Dorsaint P, Cavallo JA, Li P, Pauli C, Gottesdiener L, DiPardo BJ, Hollmann TJ, Merghoub T, Wen HY, Reis-Filho JS, Riaz N, Su SSM, Kalbasi A, Vasan N, Powell SN, Wolchok JD, Elemento O, Swanton C, Shoushtari AN, Parkes EE, Izar B, Bakhoum SF. Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov. 2021 May;11(5):1212–1227. PMCID: PMC8102348
1.
Liu D, Lin JR, Robitschek EJ, Kasumova GG, Heyde A, Shi A, Kraya A, Zhang G, Moll T, Frederick DT, Chen YA, Wang S, Schapiro D, Ho LL, Bi K, Sahu A, Mei S, Miao B, Sharova T, Alvarez-Breckenridge C, Stocking JH, Kim T, Fadden R, Lawrence D, Hoang MP, Cahill DP, Malehmir M, Nowak MA, Brastianos PK, Lian CG, Ruppin E, Izar B, Herlyn M, Van Allen EM, Nathanson K, Flaherty KT, Sullivan RJ, Kellis M, Sorger PK, Boland GM. Evolution of delayed resistance to immunotherapy in a melanoma responder. Nat Med. 2021 Jun;27(6):985–992. PMCID: PMC8474080
1.
Lukyanenko S, Jang WD, Wei D, Struyven R, Kim Y, Leahy B, Yang H, Rush A, Ben-Yosef D, Needleman D, Pfister H. Developmental stage classification of embryos using two-stream neural network with linear-chain conditional random field. Med Image Comput Comput Assist Interv. 2021 Sep;12908:363–372. PMCID: PMC8526069
1.
Maliga Z, Nirmal AJ, Ericson NG, Boswell SA, U’Ren L, Podyminogin R, Chow J, Chen YA, Chen AA, Weinstock DM, Lian CG, Murphy GF, Kaldjian EP, Santagata S, Sorger PK. Micro-region transcriptomics of fixed human tissue using Pick-Seq. bioRxiv; 2021.
1.
Mancuso CP, Lu ZX, Qian J, Boswell SA, Springer M. A semi-quantitative isothermal diagnostic assay utilizing competitive amplification. Anal Chem. 2021 Jul 13;93(27):9541–9548. PMCID: PMC9837715
1.
May EA, Kalocsay M, D’Auriac IG, Schuster PS, Gygi SP, Nachury MV, Mick DU. Time-resolved proteomics profiling of the ciliary Hedgehog response. J Cell Biol. 2021 May 3;220(5). PMCID: PMC8054476
1.
McAvoy M, Bui ATN, Hansen C, Plana D, Said JT, Yu Z, Yang H, Freake J, Van C, Krikorian D, Cramer A, Smith L, Jiang L, Lee KJ, Li SJ, Beller B, Huggins K, Short MP, Yu SH, Mostaghimi A, Sorger PK, LeBoeuf NR. 3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators. BMC Biomed Eng. 2021 Jun 7;3(1):10. PMCID: PMC8182357
1.
Mehta AK, Cheney EM, Hartl CA, Pantelidou C, Oliwa M, Castrillon JA, Lin JR, Hurst KE, de Oliveira Taveira M, Johnson NT, Oldham WM, Kalocsay M, Berberich MJ, Boswell SA, Kothari A, Johnson S, Dillon DA, Lipschitz M, Rodig S, Santagata S, Garber JE, Tung N, Yélamos J, Thaxton JE, Mittendorf EA, Sorger PK, Shapiro GI, Guerriero JL. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer. 2021 Jan;2(1):66–82. PMCID: PMC7963404
1.
Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, Katsyv I, Rendeiro AF, Amin AD, Schapiro D, Frangieh CJ, Luoma AM, Filliol A, Fang Y, Ravichandran H, Clausi MG, Alba GA, Rogava M, Chen SW, Ho P, Montoro DT, Kornberg AE, Han AS, Bakhoum MF, Anandasabapathy N, Suárez-Fariñas M, Bakhoum SF, Bram Y, Borczuk A, Guo XV, Lefkowitch JH, Marboe C, Lagana SM, Del Portillo A, Tsai EJ, Zorn E, Markowitz GS, Schwabe RF, Schwartz RE, Elemento O, Saqi A, Hibshoosh H, Que J, Izar B. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021 Jul;595(7865):114–119. PMCID: PMC8814825
1.
Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A, Singh V, Aghamiri SS, Acencio ML, Glaab E, Ruepp A, Fobo G, Montrone C, Brauner B, Frishman G, Monraz Gómez LC, Somers J, Hoch M, Kumar Gupta S, Scheel J, Borlinghaus H, Czauderna T, Schreiber F, Montagud A, Ponce de Leon M, Funahashi A, Hiki Y, Hiroi N, Yamada TG, Dräger A, Renz A, Naveez M, Bocskei Z, Messina F, Börnigen D, Fergusson L, Conti M, Rameil M, Nakonecnij V, Vanhoefer J, Schmiester L, Wang M, Ackerman EE, Shoemaker JE, Zucker J, Oxford K, Teuton J, Kocakaya E, Summak GY, Hanspers K, Kutmon M, Coort S, Eijssen L, Ehrhart F, Rex DAB, Slenter D, Martens M, Pham N, Haw R, Jassal B, Matthews L, Orlic-Milacic M, Senff Ribeiro A, Rothfels K, Shamovsky V, Stephan R, Sevilla C, Varusai T, Ravel JM, Fraser R, Ortseifen V, Marchesi S, Gawron P, Smula E, Heirendt L, Satagopam V, Wu G, Riutta A, Golebiewski M, Owen S, Goble C, Hu X, Overall RW, Maier D, Bauch A, Gyori BM, Bachman JA, Vega C, Grouès V, Vazquez M, Porras P, Licata L, Iannuccelli M, Sacco F, Nesterova A, Yuryev A, de Waard A, Turei D, Luna A, Babur O, Soliman S, Valdeolivas A, Esteban-Medina M, Peña-Chilet M, Rian K, Helikar T, Puniya BL, Modos D, Treveil A, Olbei M, De Meulder B, Ballereau S, Dugourd A, Naldi A, Noël V, Calzone L, Sander C, Demir E, Korcsmaros T, Freeman TC, Augé F, Beckmann JS, Hasenauer J, Wolkenhauer O, Wilighagen EL, Pico AR, Evelo CT, Gillespie ME, Stein LD, Hermjakob H, D’Eustachio P, Saez-Rodriguez J, Dopazo J, Valencia A, Kitano H, Barillot E, Auffray C, Balling R, Schneider R, COVID-19 Disease Map Community. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms. Mol Syst Biol. 2021 Oct;17(10):e10387. PMCID: PMC8524328
1.
Owen SV, Wenner N, Dulberger CL, Rodwell EV, Bowers-Barnard A, Quinones-Olvera N, Rigden DJ, Rubin EJ, Garner EC, Baym M, Hinton JCD. Prophages encode phage-defense systems with cognate self-immunity. Cell Host Microbe. 2021 Nov 10;29(11):1620-1633.e8. PMCID: PMC8585504
1.
Patiño-Galindo JÁ, Filip I, Chowdhury R, Maranas CD, Sorger PK, AlQuraishi M, Rabadan R. Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2. Genome Med. 2021 Aug 6;13(1):124. PMCID: PMC8343217
1.
Pence IJ, Evans CL. Translational biophotonics with Raman imaging: clinical applications and beyond. Analyst. 2021 Oct 25;146(21):6379–6393. PMCID: PMC8543123
1.
Pettit ME, Boswell SA, Qian J, Novak R, Springer M. Accessioning and automation compatible anterior nares swab design. J Virol Methods. 2021 May 10;114153. PMCID: PMC8108477
1.
Plana D, Tian E, Cramer AK, Yang H, Carmack MM, Sinha MS, Bourgeois FT, Yu SH, Masse P, Boyer J, Kim M, Mo J, LeBoeuf NR, Li J, Sorger PK. Assessing the filtration efficiency and regulatory status of N95s and nontraditional filtering face-piece respirators available during the COVID-19 pandemic. BMC Infect Dis. 2021 Jul 29;21(1):712. PMCID: PMC8319695
1.
Pomeranz Krummel DA, Nasti TH, Kaluzova M, Kallay L, Bhattacharya D, Melms JC, Izar B, Xu M, Burnham A, Ahmed T, Li G, Lawson D, Kowalski J, Cao Y, Switchenko JM, Ionascu D, Cook JM, Medvedovic M, Jenkins A, Khan MK, Sengupta S. Melanoma cell intrinsic GABAA receptor enhancement potentiates radiation and immune checkpoint inhibitor response by promoting direct and T cell-mediated antitumor activity. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):1040–1053. PMCID: PMC8329598
1.
Rodriguez S, Hug C, Todorov P, Moret N, Boswell SA, Evans K, Zhou G, Johnson NT, Hyman BT, Sorger PK, Albers MW, Sokolov A. Machine learning identifies candidates for drug repurposing in Alzheimer’s disease. Nat Commun. 2021 Feb 15;12(1):1033. PMCID: PMC7884393
1.
Rodriguez S, Sahin A, Schrank BR, Al-Lawati H, Costantino I, Benz E, Fard D, Albers AD, Cao L, Gomez AC, Evans K, Ratti E, Cudkowicz M, Frosch MP, Talkowski M, Sorger PK, Hyman BT, Albers MW. Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss. Sci Transl Med. 2021 Jul 7;13(601):eaaz4699. PMCID: PMC8779652
1.
Schmiester L, Schälte Y, Bergmann FT, Camba T, Dudkin E, Egert J, Fröhlich F, Fuhrmann L, Hauber AL, Kemmer S, Lakrisenko P, Loos C, Merkt S, Müller W, Pathirana D, Raimúndez E, Refisch L, Rosenblatt M, Stapor PL, Städter P, Wang D, Wieland FG, Banga JR, Timmer J, Villaverde AF, Sahle S, Kreutz C, Hasenauer J, Weindl D. PEtab-Interoperable specification of parameter estimation problems in systems biology. PLoS Comput Biol. 2021 Jan 26;17(1):e1008646. PMCID: PMC7864467
1.
Schmucker R, Farina G, Faeder J, Fröhlich F, Saglam AS, Sandholm T. Combination treatment optimization using a pan-cancer pathway model. PLoS Comput Biol. 2021 Dec 28;17(12):e1009689. PMCID: PMC8747684
1.
Shimada K, Bachman JA, Muhlich JL, Mitchison TJ. shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data. Elife. 2021 Feb 8;10:e57116. PMCID: PMC7924953
1.
Sritharan D, Wang S, Hormoz S. Computing the Riemannian curvature of image patch and single-cell RNA sequencing data manifolds using extrinsic differential geometry. Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2100473118. PMCID: PMC8307776
1.
Tsabar M, Lovitch SB, Jambhekar A, Lahav G. Connecting timescales in biology: can early dynamical measurements predict long-term outcomes? Trends Cancer. 2021 Apr;7(4):301–308. PMCID: PMC8796003
2576724
IXMHRBF6
LSP Paper
2020
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MBAI39DU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aid%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-25%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAid%20M%2C%20Busman-Sahay%20K%2C%20Vidal%20SJ%2C%20Maliga%20Z%2C%20Bondoc%20S%2C%20Starke%20C%2C%20Terry%20M%2C%20Jacobson%20CA%2C%20Wrijil%20L%2C%20Ducat%20S%2C%20Brook%20OR%2C%20Miller%20AD%2C%20Porto%20M%2C%20Pellegrini%20KL%2C%20Pino%20M%2C%20Hoang%20TN%2C%20Chandrashekar%20A%2C%20Patel%20S%2C%20Stephenson%20K%2C%20Bosinger%20SE%2C%20Andersen%20H%2C%20Lewis%20MG%2C%20Hecht%20JL%2C%20Sorger%20PK%2C%20Martinot%20AJ%2C%20Estes%20JD%2C%20Barouch%20DH.%20Vascular%20disease%20and%20thrombosis%20in%20SARS-CoV-2-infected%20rhesus%20macaques.%20Cell.%202020%20Nov%2025%3B183%285%29%3A1354-1366.e13.%20PMCID%3A%20PMC7546181%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vascular%20disease%20and%20thrombosis%20in%20SARS-CoV-2-infected%20rhesus%20macaques%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malika%22%2C%22lastName%22%3A%22Aid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22Busman-Sahay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20J.%22%2C%22lastName%22%3A%22Vidal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Bondoc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carly%22%2C%22lastName%22%3A%22Starke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Terry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Wrijil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Ducat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%20R.%22%2C%22lastName%22%3A%22Brook%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maciel%22%2C%22lastName%22%3A%22Porto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20L.%22%2C%22lastName%22%3A%22Pellegrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Pino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20N.%22%2C%22lastName%22%3A%22Hoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abishek%22%2C%22lastName%22%3A%22Chandrashekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shivani%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Stephenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20E.%22%2C%22lastName%22%3A%22Bosinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanne%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20G.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20L.%22%2C%22lastName%22%3A%22Hecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20J.%22%2C%22lastName%22%3A%22Martinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20D.%22%2C%22lastName%22%3A%22Estes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%20H.%22%2C%22lastName%22%3A%22Barouch%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20has%20led%20to%20extensive%20morbidity%20and%20mortality%20throughout%20the%20world.%20Clinical%20features%20that%20drive%20SARS-CoV-2%20pathogenesis%20in%20humans%20include%20inflammation%20and%20thrombosis%2C%20but%20the%20mechanistic%20details%20underlying%20these%20processes%20remain%20to%20be%20determined.%20In%20this%20study%2C%20we%20demonstrate%20endothelial%20disruption%20and%20vascular%20thrombosis%20in%20histopathologic%20sections%20of%20lungs%20from%20both%20humans%20and%20rhesus%20macaques%20infected%20with%20SARS-CoV-2.%20To%20define%20key%20molecular%20pathways%20associated%20with%20SARS-CoV-2%20pathogenesis%20in%20macaques%2C%20we%20performed%20transcriptomic%20analyses%20of%20bronchoalveolar%20lavage%20and%20peripheral%20blood%20and%20proteomic%20analyses%20of%20serum.%20We%20observed%20macrophage%20infiltrates%20in%20lung%20and%20upregulation%20of%20macrophage%2C%20complement%2C%20platelet%20activation%2C%20thrombosis%2C%20and%20proinflammatory%20markers%2C%20including%20C-reactive%20protein%2C%20MX1%2C%20IL-6%2C%20IL-1%2C%20IL-8%2C%20TNF%5Cu03b1%2C%20and%20NF-%5Cu03baB.%20These%20results%20suggest%20a%20model%20in%20which%20critical%20interactions%20between%20inflammatory%20and%20thrombosis%20pathways%20lead%20to%20SARS-CoV-2-induced%20vascular%20disease.%20Our%20findings%20suggest%20potential%20therapeutic%20targets%20for%20COVID-19.%22%2C%22date%22%3A%222020-11-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2020.10.005%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-02-25T07%3A28%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22ZMZHDFRC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Berginski%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-20%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBerginski%20ME%2C%20Moret%20N%2C%20Liu%20C%2C%20Goldfarb%20D%2C%20Sorger%20PK%2C%20Gomez%20SM.%20The%20Dark%20Kinase%20Knowledgebase%3A%20an%20online%20compendium%20of%20knowledge%20and%20experimental%20results%20of%20understudied%20kinases.%20Nucleic%20Acids%20Res.%202020%20Oct%2020%3B49%28D1%29%3AD529%26%23x2013%3BD535.%20PMCID%3A%20PMC7778917%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Dark%20Kinase%20Knowledgebase%3A%20an%20online%20compendium%20of%20knowledge%20and%20experimental%20results%20of%20understudied%20kinases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20E.%22%2C%22lastName%22%3A%22Berginski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nienke%22%2C%22lastName%22%3A%22Moret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changchang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Goldfarb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20M.%22%2C%22lastName%22%3A%22Gomez%22%7D%5D%2C%22abstractNote%22%3A%22Kinases%20form%20the%20backbone%20of%20numerous%20cell%20signaling%20pathways%2C%20with%20their%20dysfunction%20similarly%20implicated%20in%20multiple%20pathologies.%20Further%20facilitated%20by%20their%20druggability%2C%20kinases%20are%20a%20major%20focus%20of%20therapeutic%20development%20efforts%20in%20diseases%20such%20as%20cancer%2C%20infectious%20disease%20and%20autoimmune%20disorders.%20While%20their%20importance%20is%20clear%2C%20the%20role%20or%20biological%20function%20of%20nearly%20one-third%20of%20kinases%20is%20largely%20unknown.%20Here%2C%20we%20describe%20a%20data%20resource%2C%20the%20Dark%20Kinase%20Knowledgebase%20%28DKK%3B%20https%3A%5C%2F%5C%2Fdarkkinome.org%29%2C%20that%20is%20specifically%20focused%20on%20providing%20data%20and%20reagents%20for%20these%20understudied%20kinases%20to%20the%20broader%20research%20community.%20Supported%20through%20NIH%27s%20Illuminating%20the%20Druggable%20Genome%20%28IDG%29%20Program%2C%20the%20DKK%20is%20focused%20on%20data%20and%20knowledge%20generation%20for%20162%20poorly%20studied%20or%20%27dark%27%20kinases.%20Types%20of%20data%20provided%20through%20the%20DKK%20include%20parallel%20reaction%20monitoring%20%28PRM%29%20peptides%20for%20quantitative%20proteomics%2C%20protein%20interactions%2C%20NanoBRET%20reagents%2C%20and%20kinase-specific%20compounds.%20Higher-level%20data%20is%20similarly%20being%20generated%20and%20consolidated%20such%20as%20tissue%20gene%20expression%20profiles%20and%2C%20longer-term%2C%20functional%20relationships%20derived%20through%20perturbation%20studies.%20Associated%20web%20tools%20that%20help%20investigators%20interrogate%20both%20internal%20and%20external%20data%20are%20also%20provided%20through%20the%20site.%20As%20an%20evolving%20resource%2C%20the%20DKK%20seeks%20to%20continually%20support%20and%20enhance%20knowledge%20on%20these%20potentially%20high-impact%20druggable%20targets.%22%2C%22date%22%3A%22Oct%2020%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fnar%5C%2Fgkaa853%22%2C%22ISSN%22%3A%221362-4962%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-02-14T17%3A32%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22P7LYERJF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bhola%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-16%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBhola%20PD%2C%20Ahmed%20E%2C%20Guerriero%20JL%2C%20Sicinska%20E%2C%20Su%20E%2C%20Lavrova%20E%2C%20Ni%20J%2C%20Chipashvili%20O%2C%20Hagan%20T%2C%20Pioso%20MS%2C%20McQueeney%20K%2C%20Ng%20K%2C%20Aguirre%20AJ%2C%20Cleary%20JM%2C%20Cocozziello%20D%2C%20Sotayo%20A%2C%20Ryan%20J%2C%20Zhao%20JJ%2C%20Letai%20A.%20High-throughput%20dynamic%20BH3%20profiling%20may%20quickly%20and%20accurately%20predict%20effective%20therapies%20in%20solid%20tumors.%20Sci%20Signal.%202020%20Jun%2016%3B13%28636%29.%20PMCID%3A%20PMC8023011%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High-throughput%20dynamic%20BH3%20profiling%20may%20quickly%20and%20accurately%20predict%20effective%20therapies%20in%20solid%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20D.%22%2C%22lastName%22%3A%22Bhola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eman%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizaveta%22%2C%22lastName%22%3A%22Lavrova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Ni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otari%22%2C%22lastName%22%3A%22Chipashvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Hagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%20S.%22%2C%22lastName%22%3A%22Pioso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelley%22%2C%22lastName%22%3A%22McQueeney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimmie%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20J.%22%2C%22lastName%22%3A%22Aguirre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Cleary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Cocozziello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alaba%22%2C%22lastName%22%3A%22Sotayo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20decades%20of%20effort%2C%20the%20sensitivity%20of%20patient%20tumors%20to%20individual%20drugs%20is%20often%20not%20predictable%20on%20the%20basis%20of%20molecular%20markers%20alone.%20Therefore%2C%20unbiased%2C%20high-throughput%20approaches%20to%20match%20patient%20tumors%20to%20effective%20drugs%2C%20without%20requiring%20a%20priori%20molecular%20hypotheses%2C%20are%20critically%20needed.%20Here%2C%20we%20improved%20upon%20a%20method%20that%20we%20previously%20reported%20and%20developed%20called%20high-throughput%20dynamic%20BH3%20profiling%20%28HT-DBP%29.%20HT-DBP%20is%20a%20microscopy-based%2C%20single-cell%20resolution%20assay%20that%20enables%20chemical%20screens%20of%20hundreds%20to%20thousands%20of%20candidate%20drugs%20on%20freshly%20isolated%20tumor%20cells.%20The%20method%20identifies%20chemical%20inducers%20of%20mitochondrial%20apoptotic%20signaling%2C%20a%20mechanism%20of%20cell%20death.%20HT-DBP%20requires%20only%2024%20hours%20of%20ex%20vivo%20culture%2C%20which%20enables%20a%20more%20immediate%20study%20of%20fresh%20primary%20tumor%20cells%20and%20minimizes%20adaptive%20changes%20that%20occur%20with%20prolonged%20ex%20vivo%20culture.%20Effective%20compounds%20identified%20by%20HT-DBP%20induced%20tumor%20regression%20in%20genetically%20engineered%20and%20patient-derived%20xenograft%20%28PDX%29%20models%20of%20breast%20cancer.%20We%20additionally%20found%20that%20chemical%20vulnerabilities%20changed%20as%20cancer%20cells%20expanded%20ex%20vivo.%20Furthermore%2C%20using%20PDX%20models%20of%20colon%20cancer%20and%20resected%20tumors%20from%20colon%20cancer%20patients%2C%20our%20data%20demonstrated%20that%20HT-DBP%20could%20be%20used%20to%20generate%20personalized%20pharmacotypes.%20Thus%2C%20HT-DBP%20appears%20to%20be%20an%20ex%20vivo%20functional%20method%20with%20sufficient%20scale%20to%20simultaneously%20function%20as%20a%20companion%20diagnostic%2C%20therapeutic%20personalization%2C%20and%20discovery%20tool.%22%2C%22date%22%3A%222020-06-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscisignal.aay1451%22%2C%22ISSN%22%3A%221937-9145%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T15%3A00%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22K5SKBPL2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22B%5Cu0159inda%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EB%26%23x159%3Binda%20K%2C%20Callendrello%20A%2C%20Ma%20KC%2C%20MacFadden%20DR%2C%20Charalampous%20T%2C%20Lee%20RS%2C%20Cowley%20L%2C%20Wadsworth%20CB%2C%20Grad%20YH%2C%20Kucherov%20G%2C%20O%26%23x2019%3BGrady%20J%2C%20Baym%20M%2C%20Hanage%20WP.%20Rapid%20inference%20of%20antibiotic%20resistance%20and%20susceptibility%20by%20genomic%20neighbour%20typing.%20Nat%20Microbiol.%202020%20Mar%3B5%283%29%3A455%26%23x2013%3B464.%20PMCID%3A%20PMC7044115%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rapid%20inference%20of%20antibiotic%20resistance%20and%20susceptibility%20by%20genomic%20neighbour%20typing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karel%22%2C%22lastName%22%3A%22B%5Cu0159inda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alanna%22%2C%22lastName%22%3A%22Callendrello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20C.%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%20R.%22%2C%22lastName%22%3A%22MacFadden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Themoula%22%2C%22lastName%22%3A%22Charalampous%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20S.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Cowley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crista%20B.%22%2C%22lastName%22%3A%22Wadsworth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yonatan%20H.%22%2C%22lastName%22%3A%22Grad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Kucherov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22O%27Grady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20P.%22%2C%22lastName%22%3A%22Hanage%22%7D%5D%2C%22abstractNote%22%3A%22Surveillance%20of%20drug-resistant%20bacteria%20is%20essential%20for%20healthcare%20providers%20to%20deliver%20effective%20empirical%20antibiotic%20therapy.%20However%2C%20traditional%20molecular%20epidemiology%20does%20not%20typically%20occur%20on%20a%20timescale%20that%20could%20affect%20patient%20treatment%20and%20outcomes.%20Here%2C%20we%20present%20a%20method%20called%20%27genomic%20neighbour%20typing%27%20for%20inferring%20the%20phenotype%20of%20a%20bacterial%20sample%20by%20identifying%20its%20closest%20relatives%20in%20a%20database%20of%20genomes%20with%20metadata.%20We%20show%20that%20this%20technique%20can%20infer%20antibiotic%20susceptibility%20and%20resistance%20for%20both%20Streptococcus%20pneumoniae%20and%20Neisseria%20gonorrhoeae.%20We%20implemented%20this%20with%20rapid%20k-mer%20matching%2C%20which%2C%20when%20used%20on%20Oxford%20Nanopore%20MinION%20data%2C%20can%20run%20in%20real%20time.%20This%20resulted%20in%20the%20determination%20of%20resistance%20within%2010%5Cu2009min%20%2891%25%20sensitivity%20and%20100%25%20specificity%20for%20S.%20pneumoniae%20and%2081%25%20sensitivity%20and%20100%25%20specificity%20for%20N.%20gonorrhoeae%20from%20isolates%20with%20a%20representative%20database%29%20of%20starting%20sequencing%2C%20and%20within%204%5Cu2009h%20of%20sample%20collection%20%2875%25%20sensitivity%20and%20100%25%20specificity%20for%20S.%20pneumoniae%29%20for%20clinical%20metagenomic%20sputum%20samples.%20This%20flexible%20approach%20has%20wide%20application%20for%20pathogen%20surveillance%20and%20may%20be%20used%20to%20greatly%20accelerate%20appropriate%20empirical%20antibiotic%20treatment.%22%2C%22date%22%3A%222020-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41564-019-0656-6%22%2C%22ISSN%22%3A%222058-5276%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A14%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22VMYDWV36%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Chopra%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-22%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChopra%20SS%2C%20Jenney%20A%2C%20Palmer%20A%2C%20Niepel%20M%2C%20Chung%20M%2C%20Mills%20C%2C%20Sivakumaren%20SC%2C%20Liu%20Q%2C%20Chen%20JY%2C%20Yapp%20C%2C%20Asara%20JM%2C%20Gray%20NS%2C%20Sorger%20PK.%20Torin2%20exploits%20replication%20and%20checkpoint%20vulnerabilities%20to%20cause%20death%20of%20PI3K-activated%20triple-negative%20breast%20cancer%20cells.%20Cell%20Syst.%202020%20Jan%2022%3B10%281%29%3A66-81.e11.%20PMCID%3A%20PMC7000271%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Torin2%20exploits%20replication%20and%20checkpoint%20vulnerabilities%20to%20cause%20death%20of%20PI3K-activated%20triple-negative%20breast%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sameer%20S.%22%2C%22lastName%22%3A%22Chopra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Jenney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sindhu%20Carmen%22%2C%22lastName%22%3A%22Sivakumaren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qingsong%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Asara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Frequent%20mutation%20of%20PI3K%5C%2FAKT%5C%2FmTOR%20signaling%20pathway%20genes%20in%20human%20cancers%20has%20stimulated%20large%20investments%20in%20targeted%20drugs%20but%20clinical%20successes%20are%20rare.%20As%20a%20result%2C%20many%20cancers%20with%20high%20PI3K%20pathway%20activity%2C%20such%20as%20triple-negative%20breast%20cancer%20%28TNBC%29%2C%20are%20treated%20primarily%20with%20chemotherapy.%20By%20systematically%20analyzing%20responses%20of%20TNBC%20cells%20to%20a%20diverse%20collection%20of%20PI3K%20pathway%20inhibitors%2C%20we%20find%20that%20one%20drug%2C%20Torin2%2C%20is%20unusually%20effective%20because%20it%20inhibits%20both%20mTOR%20and%20other%20PI3K-like%20kinases%20%28PIKKs%29.%20In%20contrast%20to%20mTOR-selective%20inhibitors%2C%20Torin2%20exploits%20dependencies%20on%20several%20kinases%20for%20S-phase%20progression%20and%20cell-cycle%20checkpoints%2C%20thereby%20causing%20accumulation%20of%20single-stranded%20DNA%20and%20death%20by%20replication%20catastrophe%20or%20mitotic%20failure.%20Thus%2C%20Torin2%20and%20its%20chemical%20analogs%20represent%20a%20mechanistically%20distinct%20class%20of%20PI3K%20pathway%20inhibitors%20that%20are%20uniquely%20cytotoxic%20to%20TNBC%20cells.%20This%20insight%20could%20be%20translated%20therapeutically%20by%20further%20developing%20Torin2%20analogs%20or%20combinations%20of%20existing%20mTOR%20and%20PIKK%20inhibitors.%22%2C%22date%22%3A%22Jan%2022%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2019.11.001%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A07%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22F237924E%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coy%20et%20al.%22%2C%22parsedDate%22%3A%222020-04%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoy%20S%2C%20Rashid%20R%2C%20Stemmer-Rachamimov%20A%2C%20Santagata%20S.%20An%20update%20on%20the%20CNS%20manifestations%20of%20neurofibromatosis%20type%202.%20Acta%20Neuropathol.%202020%20Apr%3B139%284%29%3A643%26%23x2013%3B665.%20PMCID%3A%20PMC7038792%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20update%20on%20the%20CNS%20manifestations%20of%20neurofibromatosis%20type%202%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anat%22%2C%22lastName%22%3A%22Stemmer-Rachamimov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Neurofibromatosis%20type%20II%20%28NF2%29%20is%20a%20tumor%20predisposition%20syndrome%20characterized%20by%20the%20development%20of%20distinctive%20nervous%20system%20lesions.%20NF2%20results%20from%20loss-of-function%20alterations%20in%20the%20NF2%20gene%20on%20chromosome%2022%2C%20with%20resultant%20dysfunction%20of%20its%20protein%20product%20merlin.%20NF2%20is%20most%20commonly%20associated%20with%20the%20development%20of%20bilateral%20vestibular%20schwannomas%3B%20however%2C%20patients%20also%20have%20a%20predisposition%20to%20development%20of%20other%20tumors%20including%20meningiomas%2C%20ependymomas%2C%20and%20peripheral%2C%20spinal%2C%20and%20cranial%20nerve%20schwannomas.%20Patients%20may%20also%20develop%20other%20characteristic%20manifestations%20such%20as%20ocular%20lesions%2C%20neuropathies%2C%20meningioangiomatosis%2C%20and%20glial%20hamartia.%20NF2%20has%20a%20highly%20variable%20clinical%20course%2C%20with%20some%20patients%20exhibiting%20a%20severe%20phenotype%20and%20development%20of%20multiple%20tumors%20at%20an%20early%20age%2C%20while%20others%20may%20be%20nearly%20asymptomatic%20throughout%20their%20lifetime.%20Despite%20the%20high%20morbidity%20associated%20with%20NF2%20in%20severe%20cases%2C%20management%20of%20NF2-associated%20lesions%20primarily%20consists%20of%20surgical%20resection%20and%20treatment%20of%20symptoms%2C%20and%20there%20are%20currently%20no%20FDA-approved%20systemic%20therapies%20that%20address%20the%20underlying%20biology%20of%20the%20syndrome.%20Refinements%20to%20the%20diagnostic%20criteria%20of%20NF2%20have%20been%20proposed%20over%20time%20due%20to%20increasing%20understanding%20of%20clinical%20and%20molecular%20data.%20Large-population%20studies%20have%20demonstrated%20that%20some%20features%20such%20as%20the%20development%20of%20gliomas%20and%20neurofibromas%2C%20currently%20included%20as%20diagnostic%20criteria%2C%20may%20require%20further%20clarification%20and%20modification.%20Meanwhile%2C%20burgeoning%20insights%20into%20the%20molecular%20biology%20of%20NF2%20have%20shed%20light%20on%20the%20etiology%20and%20highly%20variable%20severity%20of%20the%20disease%20and%20suggested%20numerous%20putative%20molecular%20targets%20for%20therapeutic%20intervention.%20Here%2C%20we%20review%20the%20clinicopathologic%20features%20of%20NF2%2C%20current%20understanding%20of%20the%20molecular%20biology%20of%20NF2%2C%20particularly%20with%20regard%20to%20central%20nervous%20system%20lesions%2C%20ongoing%20therapeutic%20studies%2C%20and%20avenues%20for%20further%20research.%22%2C%22date%22%3A%222020-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00401-019-02029-5%22%2C%22ISSN%22%3A%221432-0533%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22LCACAWVT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cunningham%20et%20al.%22%2C%22parsedDate%22%3A%222020-02%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECunningham%20JM%2C%20Koytiger%20G%2C%20Sorger%20PK%2C%20AlQuraishi%20M.%20Biophysical%20prediction%20of%20protein-peptide%20interactions%20and%20signaling%20networks%20using%20machine%20learning.%20Nat%20Methods.%202020%20Feb%3B17%282%29%3A175%26%23x2013%3B183.%20PMCID%3A%20PMC7004877%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biophysical%20prediction%20of%20protein-peptide%20interactions%20and%20signaling%20networks%20using%20machine%20learning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Cunningham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grigoriy%22%2C%22lastName%22%3A%22Koytiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22In%20mammalian%20cells%2C%20much%20of%20signal%20transduction%20is%20mediated%20by%20weak%20protein-protein%20interactions%20between%20globular%20peptide-binding%20domains%20%28PBDs%29%20and%20unstructured%20peptidic%20motifs%20in%20partner%20proteins.%20The%20number%20and%20diversity%20of%20these%20PBDs%20%28over%201%2C800%20are%20known%29%2C%20their%20low%20binding%20affinities%20and%20the%20sensitivity%20of%20binding%20properties%20to%20minor%20sequence%20variation%20represent%20a%20substantial%20challenge%20to%20experimental%20and%20computational%20analysis%20of%20PBD%20specificity%20and%20the%20networks%20PBDs%20create.%20Here%2C%20we%20introduce%20a%20bespoke%20machine-learning%20approach%2C%20hierarchical%20statistical%20mechanical%20modeling%20%28HSM%29%2C%20capable%20of%20accurately%20predicting%20the%20affinities%20of%20PBD-peptide%20interactions%20across%20multiple%20protein%20families.%20By%20synthesizing%20biophysical%20priors%20within%20a%20modern%20machine-learning%20framework%2C%20HSM%20outperforms%20existing%20computational%20methods%20and%20high-throughput%20experimental%20assays.%20HSM%20models%20are%20interpretable%20in%20familiar%20biophysical%20terms%20at%20three%20spatial%20scales%3A%20the%20energetics%20of%20protein-peptide%20binding%2C%20the%20multidentate%20organization%20of%20protein-protein%20interactions%20and%20the%20global%20architecture%20of%20signaling%20networks.%22%2C%22date%22%3A%22Feb%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-019-0687-1%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22YX28PBMJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Drijvers%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-10%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDrijvers%20JM%2C%20Sharpe%20AH%2C%20Haigis%20MC.%20The%20effects%20of%20age%20and%20systemic%20metabolism%20on%20anti-tumor%20T%20cell%20responses.%20Elife.%202020%20Nov%2010%3B9%3Ae62420.%20PMCID%3A%20PMC7655106%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effects%20of%20age%20and%20systemic%20metabolism%20on%20anti-tumor%20T%20cell%20responses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jefte%20M.%22%2C%22lastName%22%3A%22Drijvers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Average%20age%20and%20obesity%20prevalence%20are%20increasing%20globally.%20Both%20aging%20and%20obesity%20are%20characterized%20by%20profound%20systemic%20metabolic%20and%20immunologic%20changes%20and%20are%20cancer%20risk%20factors.%20The%20mechanisms%20linking%20age%20and%20body%20weight%20to%20cancer%20are%20incompletely%20understood%2C%20but%20recent%20studies%20have%20provided%20evidence%20that%20the%20anti-tumor%20immune%20response%20is%20reduced%20in%20both%20conditions%2C%20while%20responsiveness%20to%20immune%20checkpoint%20blockade%2C%20a%20form%20of%20cancer%20immunotherapy%2C%20is%20paradoxically%20intact.%20Dietary%20restriction%2C%20which%20promotes%20health%20and%20lifespan%2C%20may%20enhance%20cancer%20immunity.%20These%20findings%20illustrate%20that%20the%20systemic%20context%20can%20impact%20anti-tumor%20immunity%20and%20immunotherapy%20responsiveness.%20Here%2C%20we%20review%20the%20current%20knowledge%20of%20how%20age%20and%20systemic%20metabolic%20state%20affect%20the%20anti-tumor%20immune%20response%2C%20with%20an%20emphasis%20on%20CD8%2B%20T%20cells%2C%20which%20are%20key%20players%20in%20anti-tumor%20immunity.%20A%20better%20understanding%20of%20the%20underlying%20mechanisms%20may%20lead%20to%20novel%20therapies%20enhancing%20anti-tumor%20immunity%20in%20the%20context%20of%20aging%20or%20metabolic%20dysfunction.%22%2C%22date%22%3A%222020-11-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.62420%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A01%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22SQMWEIG3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Drouin%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDrouin%20A%2C%20Wallbillich%20N%2C%20Theberge%20M%2C%20Liu%20S%2C%20Katz%20J%2C%20Bellovoda%20K%2C%20Se%20Yun%20Cheon%20S%2C%20Gootkind%20F%2C%20Bierman%20E%2C%20Zavras%20J%2C%20Berberich%20MJ%2C%20Kalocsay%20M%2C%20Guastaldi%20F%2C%20Salvadori%20N%2C%20Troulis%20M%2C%20Fusco%20DN.%20Impact%20of%20Zika%20virus%20on%20the%20human%20type%20I%20interferon%20osteoimmune%20response.%20Cytokine.%202020%20Oct%2029%3B137%3A155342.%20PMID%3A%2033130337%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20Zika%20virus%20on%20the%20human%20type%20I%20interferon%20osteoimmune%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Drouin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Wallbillich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Theberge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Katz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamela%22%2C%22lastName%22%3A%22Bellovoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scarlett%22%2C%22lastName%22%3A%22Se%20Yun%20Cheon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%22%2C%22lastName%22%3A%22Gootkind%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Bierman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Zavras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Guastaldi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Salvadori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Troulis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dahlene%20N.%22%2C%22lastName%22%3A%22Fusco%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20developing%20field%20of%20osteoimmunology%20supports%20importance%20of%20an%20interferon%20%28IFN%29%20response%20pathway%20in%20osteoblasts.%20Clarifying%20osteoblast-IFN%20interactions%20is%20important%20because%20IFN%20is%20used%20as%20salvage%20anti-tumor%20therapy%20but%20systemic%20toxicity%20is%20high%20with%20variable%20clinical%20results.%20In%20addition%2C%20osteoblast%20response%20to%20systemic%20bursts%20and%20disruptions%20of%20IFN%20pathways%20induced%20by%20viral%20infection%20may%20influence%20bone%20remodeling.%20ZIKA%20virus%20%28ZIKV%29%20infection%20impacts%20bone%20development%20in%20humans%20and%20IFN%20response%20in%20vitro.%20Consistently%2C%20initial%20evidence%20of%20permissivity%20to%20ZIKV%20has%20been%20reported%20in%20human%20osteoblasts.%5CnHYPOTHESIS%3A%20Osteoblast-like%20Saos-2%20cells%20are%20permissive%20to%20ZIKV%20and%20responsive%20to%20IFN.%5CnMETHODS%3A%20Multiple%20approaches%20were%20used%20to%20assess%20whether%20Saos-2%20cells%20are%20permissive%20to%20ZIKV%20infection%20and%20exhibit%20IFN-mediated%20ZIKV%20suppression.%20Proteomic%20methods%20were%20used%20to%20evaluate%20impact%20of%20ZIKV%20and%20IFN%20on%20Saos-2%20cells.%5CnRESULTS%3A%20Evidence%20is%20presented%20confirming%20Saos-2%20cells%20are%20permissive%20to%20ZIKV%20and%20support%20IFN-mediated%20suppression%20of%20ZIKV.%20ZIKV%20and%20IFN%20differentially%20impact%20the%20Saos-2%20proteome%2C%20exemplified%20by%20HELZ2%20protein%20which%20is%20upregulated%20by%20IFN%20but%20non%20responsive%20to%20ZIKV.%20Both%20ZIKV%20and%20IFN%20suppress%20proteins%20associated%20with%20microcephaly%5C%2Fpseudo-TORCH%20syndrome%20%28BI1%2C%20KI20A%20and%20UBP18%29%2C%20and%20ZIKV%20induces%20potential%20entry%20factor%20PLVAP.%5CnCONCLUSIONS%3A%20Transient%20ZIKV%20infection%20influences%20osteoimmune%20state%2C%20and%20IFN%20and%20ZIKV%20activate%20distinct%20proteomes%20in%20Saos-2%20cells%2C%20which%20could%20inform%20therapeutic%2C%20engineered%2C%20disruptions.%22%2C%22date%22%3A%22Oct%2029%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cyto.2020.155342%22%2C%22ISSN%22%3A%221096-0023%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-01-10T18%3A21%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22Z4X56QKB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Du%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDu%20G%2C%20Rao%20S%2C%20Gurbani%20D%2C%20Henning%20NJ%2C%20Jiang%20J%2C%20Che%20J%2C%20Yang%20A%2C%20Ficarro%20SB%2C%20Marto%20JA%2C%20Aguirre%20AJ%2C%20Sorger%20PK%2C%20Westover%20KD%2C%20Zhang%20T%2C%20Gray%20NS.%20Structure-based%20design%20of%20a%20potent%20and%20selective%20covalent%20inhibitor%20for%20SRC%20kinase%20that%20targets%20a%20P-loop%20cysteine.%20J%20Med%20Chem.%202020%20Feb%2027%3B63%284%29%3A1624%26%23x2013%3B1641.%20PMCID%3A%20PMC7493195%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structure-based%20design%20of%20a%20potent%20and%20selective%20covalent%20inhibitor%20for%20SRC%20kinase%20that%20targets%20a%20P-loop%20cysteine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suman%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%22%2C%22lastName%22%3A%22Gurbani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathaniel%20J.%22%2C%22lastName%22%3A%22Henning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianwei%22%2C%22lastName%22%3A%22Che%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annan%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Ficarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarrod%20A.%22%2C%22lastName%22%3A%22Marto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20J.%22%2C%22lastName%22%3A%22Aguirre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22SRC%20is%20a%20major%20regulator%20of%20many%20signaling%20pathways%20and%20contributes%20to%20cancer%20development.%20However%2C%20development%20of%20a%20selective%20SRC%20inhibitor%20has%20been%20challenging%2C%20and%20FDA-approved%20SRC%20inhibitors%2C%20dasatinib%20and%20bosutinib%2C%20are%20multitargeted%20kinase%20inhibitors.%20Here%2C%20we%20describe%20our%20efforts%20to%20develop%20a%20selective%20SRC%20covalent%20inhibitor%20by%20targeting%20cysteine%20277%20on%20the%20P-loop%20of%20SRC.%20Using%20a%20promiscuous%20covalent%20kinase%20inhibitor%20%28CKI%29%20SM1-71%20as%20a%20starting%20point%2C%20we%20developed%20covalent%20inhibitor%2015a%2C%20which%20discriminates%20SRC%20from%20other%20covalent%20targets%20of%20SM1-71%20including%20TAK1%20and%20FGFR1.%20As%20an%20irreversible%20covalent%20inhibitor%2C%20compound%2015a%20exhibited%20sustained%20inhibition%20of%20SRC%20signaling%20both%20in%20vitro%20and%20in%20vivo.%20Moreover%2C%2015a%20exhibited%20potent%20antiproliferative%20effects%20in%20nonsmall%20cell%20lung%20cancer%20cell%20lines%20harboring%20SRC%20activation%2C%20thus%20providing%20evidence%20that%20this%20approach%20may%20be%20promising%20for%20further%20drug%20development%20efforts.%22%2C%22date%22%3A%222020-02-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.jmedchem.9b01502%22%2C%22ISSN%22%3A%221520-4804%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A38%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22LDW7HI62%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22F%5Cu00e4rkkil%5Cu00e4%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-19%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EF%26%23xE4%3Brkkil%26%23xE4%3B%20A%2C%20Gulhan%20DC%2C%20Casado%20J%2C%20Jacobson%20CA%2C%20Nguyen%20H%2C%20Kochupurakkal%20B%2C%20Maliga%20Z%2C%20Yapp%20C%2C%20Chen%20YA%2C%20Schapiro%20D%2C%20Zhou%20Y%2C%20Graham%20JR%2C%20Dezube%20BJ%2C%20Munster%20P%2C%20Santagata%20S%2C%20Garcia%20E%2C%20Rodig%20S%2C%20Lako%20A%2C%20Chowdhury%20D%2C%20Shapiro%20GI%2C%20Matulonis%20UA%2C%20Park%20PJ%2C%20Hautaniemi%20S%2C%20Sorger%20PK%2C%20Swisher%20EM%2C%20D%26%23x2019%3BAndrea%20AD%2C%20Konstantinopoulos%20PA.%20Immunogenomic%20profiling%20determines%20responses%20to%20combined%20PARP%20and%20PD-1%20inhibition%20in%20ovarian%20cancer.%20Nat%20Commun.%202020%20Mar%2019%3B11%281%29%3A1459.%20PMCID%3A%20PMC7081234%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immunogenomic%20profiling%20determines%20responses%20to%20combined%20PARP%20and%20PD-1%20inhibition%20in%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doga%20C.%22%2C%22lastName%22%3A%22Gulhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Casado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huy%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bose%22%2C%22lastName%22%3A%22Kochupurakkal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yinghui%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20R.%22%2C%22lastName%22%3A%22Graham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20J.%22%2C%22lastName%22%3A%22Dezube%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Munster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Lako%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipanjan%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20I.%22%2C%22lastName%22%3A%22Shapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ursula%20A.%22%2C%22lastName%22%3A%22Matulonis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20J.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sampsa%22%2C%22lastName%22%3A%22Hautaniemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20M.%22%2C%22lastName%22%3A%22Swisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20D.%22%2C%22lastName%22%3A%22D%27Andrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Panagiotis%20A.%22%2C%22lastName%22%3A%22Konstantinopoulos%22%7D%5D%2C%22abstractNote%22%3A%22Combined%20PARP%20and%20immune%20checkpoint%20inhibition%20has%20yielded%20encouraging%20results%20in%20ovarian%20cancer%2C%20but%20predictive%20biomarkers%20are%20lacking.%20We%20performed%20immunogenomic%20profiling%20and%20highly%20multiplexed%20single-cell%20imaging%20on%20tumor%20samples%20from%20patients%20enrolled%20in%20a%20Phase%20I%5C%2FII%20trial%20of%20niraparib%20and%20pembrolizumab%20in%20ovarian%20cancer%5Cu00a0%28NCT02657889%29.%20We%20identify%20two%20determinants%20of%20response%3B%20mutational%20signature%203%20reflecting%20defective%20homologous%20recombination%20DNA%20repair%2C%20and%20positive%20immune%20score%20as%20a%20surrogate%20of%20interferon-primed%20exhausted%20CD8%5Cu2009%2B%5Cu2009T-cells%20in%20the%20tumor%20microenvironment.%20Presence%20of%20one%20or%20both%20features%20associates%20with%20an%20improved%20outcome%20while%20concurrent%20absence%20yields%20no%20responses.%20Single-cell%20spatial%20analysis%20reveals%20prominent%20interactions%20of%20exhausted%20CD8%5Cu2009%2B%5Cu2009T-cells%20and%20PD-L1%5Cu2009%2B%5Cu2009macrophages%20and%20PD-L1%5Cu2009%2B%5Cu2009tumor%20cells%20as%20mechanistic%20determinants%20of%20response.%20Furthermore%2C%20spatial%20analysis%20of%20two%20extreme%20responders%20shows%20differential%20clustering%20of%20exhausted%20CD8%5Cu2009%2B%5Cu2009T-cells%20with%20PD-L1%5Cu2009%2B%5Cu2009macrophages%20in%20the%20first%2C%20and%20exhausted%20CD8%5Cu2009%2B%5Cu2009T-cells%20with%20cancer%20cells%20harboring%20genomic%20PD-L1%20and%20PD-L2%20amplification%20in%20the%20second.%22%2C%22date%22%3A%22Mar%2019%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-020-15315-8%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A13%3A19Z%22%7D%7D%2C%7B%22key%22%3A%229ISDQ2FV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gaglia%20et%20al.%22%2C%22parsedDate%22%3A%222020-02%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGaglia%20G%2C%20Rashid%20R%2C%20Yapp%20C%2C%20Joshi%20GN%2C%20Li%20CG%2C%20Lindquist%20SL%2C%20Sarosiek%20KA%2C%20Whitesell%20L%2C%20Sorger%20PK%2C%20Santagata%20S.%20HSF1%20phase%20transition%20mediates%20stress%20adaptation%20and%20cell%20fate%20decisions.%20Nat%20Cell%20Biol.%202020%20Feb%3B22%282%29%3A151%26%23x2013%3B158.%20PMCID%3A%20PMC7135912%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HSF1%20phase%20transition%20mediates%20stress%20adaptation%20and%20cell%20fate%20decisions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaurav%20N.%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%20G.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20L.%22%2C%22lastName%22%3A%22Lindquist%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Whitesell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Under%20proteotoxic%20stress%2C%20some%20cells%20survive%20whereas%20others%20die.%20The%20mechanisms%20governing%20this%20heterogeneity%20in%20cell%20fate%20remain%20unknown.%20Here%20we%20report%20that%20condensation%20and%20phase%20transition%20of%20heat-shock%20factor%201%20%28HSF1%29%2C%20a%20transcriptional%20regulator%20of%20chaperones1%2C2%2C%20is%20integral%20to%20cell-fate%20decisions%20underlying%20survival%20or%20death.%20During%20stress%2C%20HSF1%20drives%20chaperone%20expression%20but%20also%20accumulates%20separately%20in%20nuclear%20stress%20bodies%20called%20foci3-6.%20Foci%20formation%20has%20been%20regarded%20as%20a%20marker%20of%20cells%20actively%20upregulating%20chaperones3%2C6-10.%20Using%20multiplexed%20tissue%20imaging%2C%20we%20observed%20HSF1%20foci%20in%20human%20tumours.%20Paradoxically%2C%20their%20presence%20inversely%20correlated%20with%20chaperone%20expression.%20By%20live-cell%20microscopy%20and%20single-cell%20analysis%2C%20we%20found%20that%20foci%20dissolution%20rather%20than%20formation%20promoted%20HSF1%20activity%20and%20cell%20survival.%20During%20prolonged%20stress%2C%20the%20biophysical%20properties%20of%20HSF1%20foci%20changed%3B%20small%2C%20fluid%20condensates%20enlarged%20into%20indissoluble%20gel-like%20arrangements%20with%20immobilized%20HSF1.%20Chaperone%20gene%20induction%20was%20reduced%20in%20such%20cells%2C%20which%20were%20prone%20to%20apoptosis.%20Quantitative%20analysis%20suggests%20that%20survival%20under%20stress%20results%20from%20competition%20between%20concurrent%20but%20opposing%20mechanisms.%20Foci%20may%20serve%20as%20sensors%20that%20tune%20cytoprotective%20responses%2C%20balancing%20rapid%20transient%20responses%20and%20irreversible%20outcomes.%22%2C%22date%22%3A%222020-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41556-019-0458-3%22%2C%22ISSN%22%3A%221476-4679%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22QHNCA5VK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gerosa%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-18%22%2C%22numChildren%22%3A13%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGerosa%20L%2C%20Chidley%20C%2C%20Fr%26%23xF6%3Bhlich%20F%2C%20Sanchez%20G%2C%20Lim%20SK%2C%20Muhlich%20J%2C%20Chen%20JY%2C%20Vallabhaneni%20S%2C%20Baker%20GJ%2C%20Schapiro%20D%2C%20Atanasova%20MI%2C%20Chylek%20LA%2C%20Shi%20T%2C%20Yi%20L%2C%20Nicora%20CD%2C%20Claas%20A%2C%20Ng%20TSC%2C%20Kohler%20RH%2C%20Lauffenburger%20DA%2C%20Weissleder%20R%2C%20Miller%20MA%2C%20Qian%20WJ%2C%20Wiley%20HS%2C%20Sorger%20PK.%20Receptor-driven%20ERK%20pulses%20reconfigure%20MAPK%20signaling%20and%20enable%20persistence%20of%20drug-adapted%20BRAF-mutant%20melanoma%20cells.%20Cell%20Syst.%202020%20Nov%2018%3B11%285%29%3A478-494.e9.%20PMCID%3A%20PMC8009031%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Receptor-driven%20ERK%20pulses%20reconfigure%20MAPK%20signaling%20and%20enable%20persistence%20of%20drug-adapted%20BRAF-mutant%20melanoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Gerosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang%20Kyun%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreeram%22%2C%22lastName%22%3A%22Vallabhaneni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariya%20I.%22%2C%22lastName%22%3A%22Atanasova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lily%20A.%22%2C%22lastName%22%3A%22Chylek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tujin%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lian%22%2C%22lastName%22%3A%22Yi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20D.%22%2C%22lastName%22%3A%22Nicora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22Claas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20S.%20C.%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rainer%20H.%22%2C%22lastName%22%3A%22Kohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20A.%22%2C%22lastName%22%3A%22Lauffenburger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%22%2C%22lastName%22%3A%22Weissleder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miles%20A.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Jun%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20Steven%22%2C%22lastName%22%3A%22Wiley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Targeted%20inhibition%20of%20oncogenic%20pathways%20can%20be%20highly%20effective%20in%20halting%20the%20rapid%20growth%20of%20tumors%20but%20often%20leads%20to%20the%20emergence%20of%20slowly%20dividing%20persister%20cells%2C%20which%20constitute%20a%20reservoir%20for%20the%20selection%20of%20drug-resistant%20clones.%20In%20BRAFV600E%20melanomas%2C%20RAF%20and%20MEK%20inhibitors%20efficiently%20block%20oncogenic%20signaling%2C%20but%20persister%20cells%20emerge.%20Here%2C%20we%20show%20that%20persister%20cells%20escape%20drug-induced%20cell-cycle%20arrest%20via%20brief%2C%20sporadic%20ERK%20pulses%20generated%20by%20transmembrane%20receptors%20and%20growth%20factors%20operating%20in%20an%20autocrine%5C%2Fparacrine%20manner.%20Quantitative%20proteomics%20and%20computational%20modeling%20show%20that%20ERK%20pulsing%20is%20enabled%20by%20rewiring%20of%20mitogen-activated%20protein%20kinase%20%28MAPK%29%20signaling%3A%20from%20an%20oncogenic%20BRAFV600E%20monomer-driven%20configuration%20that%20is%20drug%20sensitive%20to%20a%20receptor-driven%20configuration%20that%20involves%20Ras-GTP%20and%20RAF%20dimers%20and%20is%20highly%20resistant%20to%20RAF%20and%20MEK%20inhibitors.%20Altogether%2C%20this%20work%20shows%20that%20pulsatile%20MAPK%20activation%20by%20factors%20in%20the%20microenvironment%20generates%20a%20persistent%20population%20of%20melanoma%20cells%20that%20rewires%20MAPK%20signaling%20to%20sustain%20non-genetic%20drug%20resistance.%22%2C%22date%22%3A%222020-11-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2020.10.002%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A20%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22CL4FQJKH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hafner%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHafner%20A%2C%20Reyes%20J%2C%20Stewart-Ornstein%20J%2C%20Tsabar%20M%2C%20Jambhekar%20A%2C%20Lahav%20G.%20Quantifying%20the%20central%20dogma%20in%20the%20p53%20pathway%20in%20live%20single%20cells.%20Cell%20Syst.%202020%20Jun%2024%3B10%286%29%3A495-505.e4.%20PMCID%3A%20PMC7413213%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Quantifying%20the%20central%20dogma%20in%20the%20p53%20pathway%20in%20live%20single%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonina%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Stewart-Ornstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Tsabar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22Transcription%20factors%20%28TFs%29%20integrate%20signals%20to%20regulate%20target%20gene%20expression%2C%20but%20we%20generally%20lack%20a%20quantitative%20understanding%20of%20how%20changes%20in%20TF%20levels%20regulate%20mRNA%20and%20protein%20production.%20Here%2C%20we%20established%20a%20system%20to%20simultaneously%20monitor%20the%20levels%20of%20p53%2C%20a%20TF%20that%20shows%20oscillations%20following%20DNA%20damage%2C%20and%20the%20transcription%20and%20protein%20levels%20of%20its%20target%20p21%20in%20individual%20cells.%20p21%20transcription%20tracked%20p53%20dynamics%2C%20while%20p21%20protein%20steadily%20accumulated.%20p21%20transcriptional%20activation%20showed%20bursts%20of%20mRNA%20production%2C%20with%20p53%20levels%20regulating%20the%20probability%20but%20not%20magnitude%20of%20activation.%20Variations%20in%20p53%20levels%20between%20cells%20contributed%20to%20heterogeneous%20p21%20transcription%20while%20independent%20p21%20alleles%20exhibited%20highly%20correlated%20behaviors.%20Pharmacologically%20elevating%20p53%20increased%20the%20probability%20of%20p21%20transcription%20with%20minor%20effects%20on%20its%20magnitude%2C%20leading%20to%20a%20strong%20increase%20in%20p21%20protein%20levels.%20Our%20results%20reveal%20quantitative%20mechanisms%20by%20which%20TF%20dynamics%20can%20regulate%20protein%20levels%20of%20its%20targets.%20A%20record%20of%20this%20paper%27s%20transparent%20peer%20review%20process%20is%20included%20in%20the%20Supplemental%20Information.%22%2C%22date%22%3A%222020-06-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2020.05.001%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A39%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22GTPWJZBT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hemming%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-14%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHemming%20ML%2C%20Nathenson%20MJ%2C%20Lin%20JR%2C%20Mei%20S%2C%20Du%20Z%2C%20Malik%20K%2C%20Marino-Enriquez%20A%2C%20Jagannathan%20JP%2C%20Sorger%20PK%2C%20Bertagnolli%20M%2C%20Sicinska%20E%2C%20Demetri%20GD%2C%20Santagata%20S.%20Response%20and%20mechanisms%20of%20resistance%20to%20larotrectinib%20and%20selitrectinib%20in%20metastatic%20undifferentiated%20sarcoma%20harboring%20oncogenic%20fusion%20of%20NTRK1.%20JCO%20Precis%20Oncol.%202020%20Feb%2014%3B4%3A79%26%23x2013%3B90.%20PMCID%3A%20PMC7055910%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Response%20and%20mechanisms%20of%20resistance%20to%20larotrectinib%20and%20selitrectinib%20in%20metastatic%20undifferentiated%20sarcoma%20harboring%20oncogenic%20fusion%20of%20NTRK1%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Hemming%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Nathenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karan%22%2C%22lastName%22%3A%22Malik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Marino-Enriquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jyothi%20P.%22%2C%22lastName%22%3A%22Jagannathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Bertagnolli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20D.%22%2C%22lastName%22%3A%22Demetri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Feb%2014%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2Fpo.19.00287%22%2C%22ISSN%22%3A%222473-4284%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T20%3A34%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22ZPTZRKLP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hoffer%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-15%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoffer%20J%2C%20Rashid%20R%2C%20Muhlich%20JL%2C%20Chen%20YA%2C%20Russell%20DPW%2C%20Ruokonen%20J%2C%20Krueger%20R%2C%20Pfister%20H%2C%20Santagata%20S%2C%20Sorger%20PK.%20Minerva%3A%20a%20light-weight%2C%20narrative%20image%20browser%20for%20multiplexed%20tissue%20images.%20J%20Open%20Source%20Softw.%202020%20Oct%2015%3B5%2854%29%3A2579.%20PMCID%3A%20PMC7989801%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Minerva%3A%20a%20light-weight%2C%20narrative%20image%20browser%20for%20multiplexed%20tissue%20images%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20Peter%20William%22%2C%22lastName%22%3A%22Russell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juha%22%2C%22lastName%22%3A%22Ruokonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Advances%20in%20highly%20multiplexed%20tissue%20imaging%20are%20transforming%20our%20understanding%20of%20human%20biology%20by%20enabling%20detection%20and%20localization%20of%2010-100%20proteins%20at%20subcellular%20resolution%20%28Bodenmiller%2C%202016%29.%20Efforts%20are%20now%20underway%20to%20create%20public%20atlases%20of%20multiplexed%20images%20of%20normal%20and%20diseased%20tissues%20%28Rozenblatt-Rosen%20et%20al.%2C%202020%29.%20Both%20research%20and%20clinical%20applications%20of%20tissue%20imaging%20benefit%20from%20recording%20data%20from%20complete%20specimens%20so%20that%20data%20on%20cell%20state%20and%20composition%20can%20be%20studied%20in%20the%20context%20of%20overall%20tissue%20architecture.%20As%20a%20practical%20matter%2C%20specimen%20size%20is%20limited%20by%20the%20dimensions%20of%20microscopy%20slides%20%282.5%20%5Cu00d7%207.5%20cm%20or%20~2-8%20cm2%20of%20tissue%20depending%20on%20shape%29.%20With%20current%20microscopy%20technology%2C%20specimens%20of%20this%20size%20can%20be%20imaged%20at%20sub-micron%20resolution%20across%20~60%20spectral%20channels%20and%20~106%20cells%2C%20resulting%20in%20image%20files%20of%20terabyte%20size.%20However%2C%20the%20rich%20detail%20and%20multiscale%20properties%20of%20these%20images%20pose%20a%20substantial%20computational%20challenge%20%28Rashid%20et%20al.%2C%202020%29.%20See%20Rashid%20et%20al.%20%282020%29%20for%20an%20comparison%20of%20existing%20visualization%20tools%20targeting%20these%20multiplexed%20tissue%20images.%22%2C%22date%22%3A%222020-10-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21105%5C%2Fjoss.02579%22%2C%22ISSN%22%3A%222475-9066%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A34%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22K9NNSUVP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Izar%20et%20al.%22%2C%22parsedDate%22%3A%222020-08%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIzar%20B%2C%20Tirosh%20I%2C%20Stover%20EH%2C%20Wakiro%20I%2C%20Cuoco%20MS%2C%20Alter%20I%2C%20Rodman%20C%2C%20Leeson%20R%2C%20Su%20MJ%2C%20Shah%20P%2C%20Iwanicki%20M%2C%20Walker%20SR%2C%20Kanodia%20A%2C%20Melms%20JC%2C%20Mei%20S%2C%20Lin%20JR%2C%20Porter%20CBM%2C%20Slyper%20M%2C%20Waldman%20J%2C%20Jerby-Arnon%20L%2C%20Ashenberg%20O%2C%20Brinker%20TJ%2C%20Mills%20C%2C%20Rogava%20M%2C%20Vigneau%20S%2C%20Sorger%20PK%2C%20Garraway%20LA%2C%20Konstantinopoulos%20PA%2C%20Liu%20JF%2C%20Matulonis%20U%2C%20Johnson%20BE%2C%20Rozenblatt-Rosen%20O%2C%20Rotem%20A%2C%20Regev%20A.%20A%20single-cell%20landscape%20of%20high-grade%20serous%20ovarian%20cancer.%20Nat%20Med.%202020%20Aug%3B26%288%29%3A1271%26%23x2013%3B1279.%20PMCID%3A%20PMC7723336%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20single-cell%20landscape%20of%20high-grade%20serous%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itay%22%2C%22lastName%22%3A%22Tirosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20H.%22%2C%22lastName%22%3A%22Stover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Wakiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Cuoco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idan%22%2C%22lastName%22%3A%22Alter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Rodman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Leeson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Ju%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parin%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcin%22%2C%22lastName%22%3A%22Iwanicki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20R.%22%2C%22lastName%22%3A%22Walker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhay%22%2C%22lastName%22%3A%22Kanodia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20B.%20M.%22%2C%22lastName%22%3A%22Porter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michal%22%2C%22lastName%22%3A%22Slyper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Waldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Livnat%22%2C%22lastName%22%3A%22Jerby-Arnon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orr%22%2C%22lastName%22%3A%22Ashenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Titus%20J.%22%2C%22lastName%22%3A%22Brinker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meri%22%2C%22lastName%22%3A%22Rogava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Vigneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Panagiotis%20A.%22%2C%22lastName%22%3A%22Konstantinopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joyce%20F.%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ursula%22%2C%22lastName%22%3A%22Matulonis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%5D%2C%22abstractNote%22%3A%22Malignant%20abdominal%20fluid%20%28ascites%29%20frequently%20develops%20in%20women%20with%20advanced%20high-grade%20serous%20ovarian%20cancer%20%28HGSOC%29%20and%20is%20associated%20with%20drug%20resistance%20and%20a%20poor%20prognosis1.%20To%20comprehensively%20characterize%20the%20HGSOC%20ascites%20ecosystem%2C%20we%20used%20single-cell%20RNA%20sequencing%20to%20profile%20~11%2C000%20cells%20from%2022%20ascites%20specimens%20from%2011%20patients%20with%20HGSOC.%20We%20found%20significant%20inter-patient%20variability%20in%20the%20composition%20and%20functional%20programs%20of%20ascites%20cells%2C%20including%20immunomodulatory%20fibroblast%20sub-populations%20and%20dichotomous%20macrophage%20populations.%20We%20found%20that%20the%20previously%20described%20immunoreactive%20and%20mesenchymal%20subtypes%20of%20HGSOC%2C%20which%20have%20prognostic%20implications%2C%20reflect%20the%20abundance%20of%20immune%20infiltrates%20and%20fibroblasts%20rather%20than%20distinct%20subsets%20of%20malignant%20cells2.%20Malignant%20cell%20variability%20was%20partly%20explained%20by%20heterogeneous%20copy%20number%20alteration%20patterns%20or%20expression%20of%20a%20stemness%20program.%20Malignant%20cells%20shared%20expression%20of%20inflammatory%20programs%20that%20were%20largely%20recapitulated%20in%20single-cell%20RNA%20sequencing%20of%20~35%2C000%20cells%20from%20additionally%20collected%20samples%2C%20including%20three%20ascites%2C%20two%20primary%20HGSOC%20tumors%20and%20three%20patient%20ascites-derived%20xenograft%20models.%20Inhibition%20of%20the%20JAK%5C%2FSTAT%20pathway%2C%20which%20was%20expressed%20in%20both%20malignant%20cells%20and%20cancer-associated%20fibroblasts%2C%20had%20potent%20anti-tumor%20activity%20in%20primary%20short-term%20cultures%20and%20patient-derived%20xenograft%20models.%20Our%20work%20contributes%20to%20resolving%20the%20HSGOC%20landscape3-5%20and%20provides%20a%20resource%20for%20the%20development%20of%20novel%20therapeutic%20approaches.%22%2C%22date%22%3A%222020-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-020-0926-0%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A13%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22IG5QF8CD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kalocsay%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-15%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKalocsay%20M%2C%20Maliga%20Z%2C%20Nirmal%20AJ%2C%20Eisert%20RJ%2C%20Bradshaw%20GA%2C%20Solomon%20IH%2C%20Chen%20YA%2C%20Pelletier%20RJ%2C%20Jacobson%20CA%2C%20Mintseris%20J%2C%20Padera%20RF%2C%20Martinot%20AJ%2C%20Barouch%20DH%2C%20Santagata%20S%2C%20Sorger%20PK.%20Multiplexed%20proteomics%20and%20imaging%20of%20resolving%20and%20lethal%20SARS-CoV-2%20infection%20in%20the%20lung%20%5BInternet%5D.%20bioRxiv%3B%202020%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.10.14.339952%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.10.14.339952%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Multiplexed%20proteomics%20and%20imaging%20of%20resolving%20and%20lethal%20SARS-CoV-2%20infection%20in%20the%20lung%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20H%22%2C%22lastName%22%3A%22Solomon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%20J.%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julian%22%2C%22lastName%22%3A%22Mintseris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20F.%22%2C%22lastName%22%3A%22Padera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20J.%22%2C%22lastName%22%3A%22Martinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%20H.%22%2C%22lastName%22%3A%22Barouch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20Normal%20tissue%20physiology%20and%20repair%20depends%20on%20communication%20with%20the%20immune%20system.%20Understanding%20this%20communication%20at%20the%20molecular%20level%20in%20intact%20tissue%20requires%20new%20methods.%20The%20consequences%20of%20SARS-CoV-2%20infection%2C%20which%20can%20result%20in%20acute%20respiratory%20distress%2C%20thrombosis%20and%20death%2C%20has%20been%20studied%20primarily%20in%20accessible%20liquid%20specimens%20such%20as%20blood%2C%20sputum%20and%20bronchoalveolar%20lavage%2C%20all%20of%20which%20are%20peripheral%20to%20the%20primary%20site%20of%20infection%20in%20the%20lung.%20Here%2C%20we%20describe%20the%20combined%20use%20of%20multiplexed%20deep%20proteomics%20with%20multiplexed%20imaging%20to%20profile%20infection%20and%20its%20sequelae%20directly%20in%20fixed%20lung%20tissue%20specimens%20obtained%20from%20necropsy%20of%20infected%20animals%20and%20autopsy%20of%20human%20decedents.%20We%20characterize%20multiple%20steps%20in%20disease%20response%20from%20cytokine%20accumulation%20and%20protein%20phosphorylation%20to%20activation%20of%20receptors%2C%20changes%20in%20signaling%20pathways%2C%20and%20crosslinking%20of%20fibrin%20to%20form%20clots.%20Our%20data%20reveal%20significant%20differences%20between%20naturally%20resolving%20SARS-CoV-2%20infection%20in%20rhesus%20macaques%20and%20lethal%20COVID-19%20in%20humans.%20The%20approach%20we%20describe%20is%20broadly%20applicable%20to%20other%20tissues%20and%20diseases.%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Summary%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Proteomics%20of%20infected%20tissue%20reveals%20differences%20in%20inflammatory%20and%20thrombotic%20responses%20between%20resolving%20and%20lethal%20COVID-19.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222020-10-15%22%2C%22DOI%22%3A%2210.1101%5C%2F2020.10.14.339952%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.10.14.339952%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T19%3A25%3A55Z%22%7D%7D%2C%7B%22key%22%3A%223VF5AFS7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Krueger%20et%20al.%22%2C%22parsedDate%22%3A%222020-01%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKrueger%20R%2C%20Beyer%20J%2C%20Jang%20WD%2C%20Kim%20NW%2C%20Sokolov%20A%2C%20Sorger%20PK%2C%20Pfister%20H.%20Facetto%3A%20combining%20unsupervised%20and%20supervised%20learning%20for%20hierarchical%20phenotype%20analysis%20in%20multi-channel%20image%20data.%20IEEE%20Trans%20Vis%20Comput%20Graph.%202020%20Jan%3B26%281%29%3A227%26%23x2013%3B237.%20PMCID%3A%20PMC7045445%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Facetto%3A%20combining%20unsupervised%20and%20supervised%20learning%20for%20hierarchical%20phenotype%20analysis%20in%20multi-channel%20image%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Beyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Dong%22%2C%22lastName%22%3A%22Jang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nam%20Wook%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22Facetto%20is%20a%20scalable%20visual%20analytics%20application%20that%20is%20used%20to%20discover%20single-cell%20phenotypes%20in%20high-dimensional%20multi-channel%20microscopy%20images%20of%20human%20tumors%20and%20tissues.%20Such%20images%20represent%20the%20cutting%20edge%20of%20digital%20histology%20and%20promise%20to%20revolutionize%20how%20diseases%20such%20as%20cancer%20are%20studied%2C%20diagnosed%2C%20and%20treated.%20Highly%20multiplexed%20tissue%20images%20are%20complex%2C%20comprising%20109%20or%20more%20pixels%2C%2060-plus%20channels%2C%20and%20millions%20of%20individual%20cells.%20This%20makes%20manual%20analysis%20challenging%20and%20error-prone.%20Existing%20automated%20approaches%20are%20also%20inadequate%2C%20in%20large%20part%2C%20because%20they%20are%20unable%20to%20effectively%20exploit%20the%20deep%20knowledge%20of%20human%20tissue%20biology%20available%20to%20anatomic%20pathologists.%20To%20overcome%20these%20challenges%2C%20Facetto%20enables%20a%20semi-automated%20analysis%20of%20cell%20types%20and%20states.%20It%20integrates%20unsupervised%20and%20supervised%20learning%20into%20the%20image%20and%20feature%20exploration%20process%20and%20offers%20tools%20for%20analytical%20provenance.%20Experts%20can%20cluster%20the%20data%20to%20discover%20new%20types%20of%20cancer%20and%20immune%20cells%20and%20use%20clustering%20results%20to%20train%20a%20convolutional%20neural%20network%20that%20classifies%20new%20cells%20accordingly.%20Likewise%2C%20the%20output%20of%20classifiers%20can%20be%20clustered%20to%20discover%20aggregate%20patterns%20and%20phenotype%20subsets.%20We%20also%20introduce%20a%20new%20hierarchical%20approach%20to%20keep%20track%20of%20analysis%20steps%20and%20data%20subsets%20created%20by%20users%3B%20this%20assists%20in%20the%20identification%20of%20cell%20types.%20Users%20can%20build%20phenotype%20trees%20and%20interact%20with%20the%20resulting%20hierarchical%20structures%20of%20both%20high-dimensional%20feature%20and%20image%20spaces.%20We%20report%20on%20use-cases%20in%20which%20domain%20scientists%20explore%20various%20large-scale%20fluorescence%20imaging%20datasets.%20We%20demonstrate%20how%20Facetto%20assists%20users%20in%20steering%20the%20clustering%20and%20classification%20process%2C%20inspecting%20analysis%20results%2C%20and%20gaining%20new%20scientific%20insights%20into%20cancer%20biology.%22%2C%22date%22%3A%22Jan%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1109%5C%2FTVCG.2019.2934547%22%2C%22ISSN%22%3A%221941-0506%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22MCNIMSGS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leahy%20et%20al.%22%2C%22parsedDate%22%3A%222020-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELeahy%20BD%2C%20Jang%20WD%2C%20Yang%20HY%2C%20Struyven%20R%2C%20Wei%20D%2C%20Sun%20Z%2C%20Lee%20KR%2C%20Royston%20C%2C%20Cam%20L%2C%20Kalma%20Y%2C%20Azem%20F%2C%20Ben-Yosef%20D%2C%20Pfister%20H%2C%20Needleman%20D.%20Automated%20measurements%20of%20key%20morphological%20features%20of%20human%20embryos%20for%20IVF.%20Med%20Image%20Comput%20Comput%20Assist%20Interv.%202020%20Oct%3B12265%3A25%26%23x2013%3B35.%20PMCID%3A%20PMC7732604%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Automated%20measurements%20of%20key%20morphological%20features%20of%20human%20embryos%20for%20IVF%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20D.%22%2C%22lastName%22%3A%22Leahy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.-D.%22%2C%22lastName%22%3A%22Jang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20Y.%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Struyven%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20R.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Royston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Cam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Kalma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Azem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Ben-Yosef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Needleman%22%7D%5D%2C%22abstractNote%22%3A%22A%20major%20challenge%20in%20clinical%20In-Vitro%20Fertilization%20%28IVF%29%20is%20selecting%20the%20highest%20quality%20embryo%20to%20transfer%20to%20the%20patient%20in%20the%20hopes%20of%20achieving%20a%20pregnancy.%20Time-lapse%20microscopy%20provides%20clinicians%20with%20a%20wealth%20of%20information%20for%20selecting%20embryos.%20However%2C%20the%20resulting%20movies%20of%20embryos%20are%20currently%20analyzed%20manually%2C%20which%20is%20time%20consuming%20and%20subjective.%20Here%2C%20we%20automate%20feature%20extraction%20of%20time-lapse%20microscopy%20of%20human%20embryos%20with%20a%20machine-learning%20pipeline%20of%20five%20convolutional%20neural%20networks%20%28CNNs%29.%20Our%20pipeline%20consists%20of%20%281%29%20semantic%20segmentation%20of%20the%20regions%20of%20the%20embryo%2C%20%282%29%20regression%20predictions%20of%20fragment%20severity%2C%20%283%29%20classification%20of%20the%20developmental%20stage%2C%20and%20object%20instance%20segmentation%20of%20%284%29%20cells%20and%20%285%29%20pronuclei.%20Our%20approach%20greatly%20speeds%20up%20the%20measurement%20of%20quantitative%2C%20biologically%20relevant%20features%20that%20may%20aid%20in%20embryo%20selection.%22%2C%22date%22%3A%222020-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-3-030-59722-1_3%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A24Z%22%7D%7D%2C%7B%22key%22%3A%226TUSYU4R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-16%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELi%20Z%2C%20Pinch%20BJ%2C%20Olson%20CM%2C%20Donovan%20KA%2C%20Nowak%20RP%2C%20Mills%20CE%2C%20Scott%20DA%2C%20Doctor%20ZM%2C%20Eleuteri%20NA%2C%20Chung%20M%2C%20Sorger%20PK%2C%20Fischer%20ES%2C%20Gray%20NS.%20Development%20and%20characterization%20of%20a%20Wee1%20kinase%20degrader.%20Cell%20Chem%20Biol.%202020%20Jan%2016%3B27%281%29%3A57-65.e9.%20PMCID%3A%20PMC6980656%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20and%20characterization%20of%20a%20Wee1%20kinase%20degrader%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhengnian%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benika%20J.%22%2C%22lastName%22%3A%22Pinch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Calla%20M.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Donovan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rados%5Cu0142aw%20P.%22%2C%22lastName%22%3A%22Nowak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Scott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zainab%20M.%22%2C%22lastName%22%3A%22Doctor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20A.%22%2C%22lastName%22%3A%22Eleuteri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20S.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22The%20G1%5C%2FS%20cell%20cycle%20checkpoint%20is%20frequently%20dysregulated%20in%20cancer%2C%20leaving%20cancer%20cells%20reliant%20on%20a%20functional%20G2%5C%2FM%20checkpoint%20to%20prevent%20excessive%20DNA%20damage.%20Wee1%20regulates%20the%20G2%5C%2FM%20checkpoint%20by%20phosphorylating%20CDK1%20at%20Tyr15%20to%20prevent%20mitotic%20entry.%20Previous%20drug%20development%20efforts%20targeting%20Wee1%20resulted%20in%20the%20clinical-grade%20inhibitor%2C%20AZD1775.%20However%2C%20AZD1775%20is%20burdened%20by%20dose-limiting%20adverse%20events%2C%20and%20has%20off-target%20PLK1%20activity.%20In%20an%20attempt%20to%20overcome%20these%20limitations%2C%20we%20developed%20Wee1%20degraders%20by%20conjugating%20AZD1775%20to%20the%20cereblon%20%28CRBN%29-binding%20ligand%2C%20pomalidomide.%20The%20resulting%20lead%20compound%2C%20ZNL-02-096%2C%20degrades%20Wee1%20while%20sparing%20PLK1%2C%20induces%20G2%5C%2FM%20accumulation%20at%2010-fold%20lower%20doses%20than%20AZD1775%2C%20and%20synergizes%20with%20Olaparib%20in%20ovarian%20cancer%20cells.%20We%20demonstrate%20that%20ZNL-02-096%20has%20CRBN-dependent%20pharmacology%20that%20is%20distinct%20from%20AZD1775%2C%20which%20justifies%20further%20evaluation%20of%20selective%20Wee1%20degraders.%22%2C%22date%22%3A%222020-01-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.10.013%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A37%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22P2VQALM9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222020-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20Z%2C%20Wei%20D%2C%20Jang%20WD%2C%20Zhou%20S%2C%20Chen%20X%2C%20Wang%20X%2C%20Schalek%20R%2C%20Berger%20D%2C%20Matejek%20B%2C%20Kamentsky%20L%2C%20Peleg%20A%2C%20Haehn%20D%2C%20Jones%20T%2C%20Parag%20T%2C%20Lichtman%20J%2C%20Pfister%20H.%20Two%20stream%20active%20query%20suggestion%20for%20active%20learning%20in%20connectomics.%20Comput%20Vis%20ECCV.%202020%20Aug%3B12363%3A103%26%23x2013%3B120.%20PMCID%3A%20PMC7746018%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Two%20stream%20active%20query%20suggestion%20for%20active%20learning%20in%20connectomics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zudi%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donglai%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Dong%22%2C%22lastName%22%3A%22Jang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siyan%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xupeng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xueying%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Schalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Berger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Matejek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Kamentsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adi%22%2C%22lastName%22%3A%22Peleg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Haehn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thouis%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toufiq%22%2C%22lastName%22%3A%22Parag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeff%22%2C%22lastName%22%3A%22Lichtman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22For%20large-scale%20vision%20tasks%20in%20biomedical%20images%2C%20the%20labeled%20data%20is%20often%20limited%20to%20train%20effective%20deep%20models.%20Active%20learning%20is%20a%20common%20solution%2C%20where%20a%20query%20suggestion%20method%20selects%20representative%20unlabeled%20samples%20for%20annotation%2C%20and%20the%20new%20labels%20are%20used%20to%20improve%20the%20base%20model.%20However%2C%20most%20query%20suggestion%20models%20optimize%20their%20learnable%20parameters%20only%20on%20the%20limited%20labeled%20data%20and%20consequently%20become%20less%20effective%20for%20the%20more%20challenging%20unlabeled%20data.%20To%20tackle%20this%2C%20we%20propose%20a%20two-stream%20active%20query%20suggestion%20approach.%20In%20addition%20to%20the%20supervised%20feature%20extractor%2C%20we%20introduce%20an%20unsupervised%20one%20optimized%20on%20all%20raw%20images%20to%20capture%20diverse%20image%20features%2C%20which%20can%20later%20be%20improved%20by%20fine-tuning%20on%20new%20labels.%20As%20a%20use%20case%2C%20we%20build%20an%20end-to-end%20active%20learning%20framework%20with%20our%20query%20suggestion%20method%20for%203D%20synapse%20detection%20and%20mitochondria%20segmentation%20in%20connectomics.%20With%20the%20framework%2C%20we%20curate%2C%20to%20our%20best%20knowledge%2C%20the%20largest%20connectomics%20dataset%20with%20dense%20synapses%20and%20mitochondria%20annotation.%20On%20this%20new%20dataset%2C%20our%20method%20outperforms%20previous%20state-of-the-art%20methods%20by%203.1%25%20for%20synapse%20and%203.8%25%20for%20mitochondria%20in%20terms%20of%20region-of-interest%20proposal%20accuracy.%20We%20also%20apply%20our%20method%20to%20image%20classification%2C%20where%20it%20outperforms%20previous%20approaches%20on%20CIFAR-10%20under%20the%20same%20limited%20annotation%20budget.%20The%20project%20page%20is%20https%3A%5C%2F%5C%2Fzudi-lin.github.io%5C%2Fprojects%5C%2F%23two_stream_active.%22%2C%22date%22%3A%222020-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-3-030-58523-5_7%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22E93AW42L%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-15%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELiu%20Y%2C%20Ferguson%20FM%2C%20Li%20L%2C%20Kuljanin%20M%2C%20Mills%20CE%2C%20Subramanian%20K%2C%20Harshbarger%20W%2C%20Gondi%20S%2C%20Wang%20J%2C%20Sorger%20PK%2C%20Mancias%20JD%2C%20Gray%20NS%2C%20Westover%20KD.%20Chemical%20biology%20toolkit%20for%20DCLK1%20reveals%20connection%20to%20RNA%20processing.%20Cell%20Chem%20Biol.%202020%20Oct%2015%3B27%2810%29%3A1229-1240.e4.%20PMCID%3A%20PMC8053042%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemical%20biology%20toolkit%20for%20DCLK1%20reveals%20connection%20to%20RNA%20processing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fleur%20M.%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lianbo%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miljan%22%2C%22lastName%22%3A%22Kuljanin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wayne%22%2C%22lastName%22%3A%22Harshbarger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudershan%22%2C%22lastName%22%3A%22Gondi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20D.%22%2C%22lastName%22%3A%22Mancias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%5D%2C%22abstractNote%22%3A%22Doublecortin-like%20kinase%201%20%28DCLK1%29%20is%20critical%20for%20neurogenesis%2C%20but%20overexpression%20is%20also%20observed%20in%20multiple%20cancers%20and%20is%20associated%20with%20poor%20prognosis.%20Nevertheless%2C%20the%20function%20of%20DCLK1%20in%20cancer%2C%20especially%20the%20context-dependent%20functions%2C%20are%20poorly%20understood.%20We%20present%20a%20%5C%22toolkit%5C%22%20that%20includes%20the%20DCLK1%20inhibitor%20DCLK1-IN-1%2C%20a%20complementary%20DCLK1-IN-1-resistant%20mutation%20G532A%2C%20and%20kinase%20dead%20mutants%20D511N%20and%20D533N%2C%20which%20can%20be%20used%20to%20investigate%20signaling%20pathways%20regulated%20by%20DCLK1.%20Using%20a%20cancer%20cell%20line%20engineered%20to%20be%20DCLK1%20dependent%20for%20growth%20and%20cell%20migration%2C%20we%20show%20that%20this%20toolkit%20can%20be%20used%20to%20discover%20associations%20between%20DCLK1%20kinase%20activity%20and%20biological%20processes.%20In%20particular%2C%20we%20show%20an%20association%20between%20DCLK1%20and%20RNA%20processing%2C%20including%20the%20identification%20of%20CDK11%20as%20a%20potential%20substrate%20of%20DCLK1%20using%20phosphoproteomics.%22%2C%22date%22%3A%222020-10-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2020.07.011%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-07-10T18%3A38%3A03Z%22%7D%7D%2C%7B%22key%22%3A%223SHJIAY2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lyashenko%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-21%22%2C%22numChildren%22%3A12%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELyashenko%20E%2C%20Niepel%20M%2C%20Dixit%20PD%2C%20Lim%20SK%2C%20Sorger%20PK%2C%20Vitkup%20D.%20Receptor-based%20mechanism%20of%20relative%20sensing%20and%20cell%20memory%20in%20mammalian%20signaling%20networks.%20Elife.%202020%20Jan%2021%3B9%3Ae50342.%20PMCID%3A%20PMC7046471%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Receptor-based%20mechanism%20of%20relative%20sensing%20and%20cell%20memory%20in%20mammalian%20signaling%20networks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugenia%22%2C%22lastName%22%3A%22Lyashenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Purushottam%20D.%22%2C%22lastName%22%3A%22Dixit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang%20Kyun%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Vitkup%22%7D%5D%2C%22abstractNote%22%3A%22Detecting%20relative%20rather%20than%20absolute%20changes%20in%20extracellular%20signals%20enables%20cells%20to%20make%20decisions%20in%20constantly%20fluctuating%20environments.%20It%20is%20currently%20not%20well%20understood%20how%20mammalian%20signaling%20networks%20store%20the%20memories%20of%20past%20stimuli%20and%20subsequently%20use%20them%20to%20compute%20relative%20signals%2C%20that%20is%20perform%20fold%20change%20detection.%20Using%20the%20growth%20factor-activated%20PI3K-Akt%20signaling%20pathway%2C%20we%20develop%20here%20computational%20and%20analytical%20models%2C%20and%20experimentally%20validate%20a%20novel%20non-transcriptional%20mechanism%20of%20relative%20sensing%20in%20mammalian%20cells.%20This%20mechanism%20relies%20on%20a%20new%20form%20of%20cellular%20memory%2C%20where%20cells%20effectively%20encode%20past%20stimulation%20levels%20in%20the%20abundance%20of%20cognate%20receptors%20on%20the%20cell%20surface.%20The%20surface%20receptor%20abundance%20is%20regulated%20by%20background%20signal-dependent%20receptor%20endocytosis%20and%20down-regulation.%20We%20show%20the%20robustness%20and%20specificity%20of%20relative%20sensing%20for%20two%20physiologically%20important%20ligands%2C%20epidermal%20growth%20factor%20%28EGF%29%20and%20hepatocyte%20growth%20factor%20%28HGF%29%2C%20and%20across%20wide%20ranges%20of%20background%20stimuli.%20Our%20results%20suggest%20that%20similar%20mechanisms%20of%20cell%20memory%20and%20fold%20change%20detection%20may%20be%20important%20in%20diverse%20signaling%20cascades%20and%20multiple%20biological%20contexts.%22%2C%22date%22%3A%222020-01-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.50342%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A54%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22QUG2MHYR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Magid%20et%20al.%22%2C%22parsedDate%22%3A%222020-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMagid%20SA%2C%20Jang%20WD%2C%20Schapiro%20D%2C%20Wei%20D%2C%20Tompkin%20J%2C%20Sorger%20PK%2C%20Pfister%20H.%20Channel%20embedding%20for%20informative%20protein%20identification%20from%20highly%20multiplexed%20images.%20Med%20Image%20Comput%20Comput%20Assist%20Interv.%202020%20Oct%3B12265%3A3%26%23x2013%3B13.%20PMCID%3A%20PMC7713713%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Channel%20embedding%20for%20informative%20protein%20identification%20from%20highly%20multiplexed%20images%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salma%20Abdel%22%2C%22lastName%22%3A%22Magid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Dong%22%2C%22lastName%22%3A%22Jang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donglai%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Tompkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22Interest%20is%20growing%20rapidly%20in%20using%20deep%20learning%20to%20classify%20biomedical%20images%2C%20and%20interpreting%20these%20deep-learned%20models%20is%20necessary%20for%20life-critical%20decisions%20and%20scientific%20discovery.%20Effective%20interpretation%20techniques%20accelerate%20biomarker%20discovery%20and%20provide%20new%20insights%20into%20the%20etiology%2C%20diagnosis%2C%20and%20treatment%20of%20disease.%20Most%20interpretation%20techniques%20aim%20to%20discover%20spatially-salient%20regions%20within%20images%2C%20but%20few%20techniques%20consider%20imagery%20with%20multiple%20channels%20of%20information.%20For%20instance%2C%20highly%20multiplexed%20tumor%20and%20tissue%20images%20have%2030-100%20channels%20and%20require%20interpretation%20methods%20that%20work%20across%20many%20channels%20to%20provide%20deep%20molecular%20insights.%20We%20propose%20a%20novel%20channel%20embedding%20method%20that%20extracts%20features%20from%20each%20channel.%20We%20then%20use%20these%20features%20to%20train%20a%20classifier%20for%20prediction.%20Using%20this%20channel%20embedding%2C%20we%20apply%20an%20interpretation%20method%20to%20rank%20the%20most%20discriminative%20channels.%20To%20validate%20our%20approach%2C%20we%20conduct%20an%20ablation%20study%20on%20a%20synthetic%20dataset.%20Moreover%2C%20we%20demonstrate%20that%20our%20method%20aligns%20with%20biological%20findings%20on%20highly%20multiplexed%20images%20of%20breast%20cancer%20cells%20while%20outperforming%20baseline%20pipelines.%20Code%20is%20available%20at%20https%3A%5C%2F%5C%2Fsabdelmagid.github.io%5C%2Fmiccai2020-project%5C%2F.%22%2C%22date%22%3A%222020-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-3-030-59722-1_1%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A41%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22BFRGPPAZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mallela%20et%20al.%22%2C%22parsedDate%22%3A%222020-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMallela%20A%2C%20Nariya%20MK%2C%20Deeds%20EJ.%20Crosstalk%20and%20ultrasensitivity%20in%20protein%20degradation%20pathways.%20PLoS%20Comput%20Biol.%202020%20Dec%3B16%2812%29%3Ae1008492.%20PMCID%3A%20PMC7793289%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Crosstalk%20and%20ultrasensitivity%20in%20protein%20degradation%20pathways%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Mallela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Deeds%22%7D%5D%2C%22abstractNote%22%3A%22Protein%20turnover%20is%20vital%20to%20cellular%20homeostasis.%20Many%20proteins%20are%20degraded%20efficiently%20only%20after%20they%20have%20been%20post-translationally%20%5C%22tagged%5C%22%20with%20a%20polyubiquitin%20chain.%20Ubiquitylation%20is%20a%20form%20of%20Post-Translational%20Modification%20%28PTM%29%3A%20addition%20of%20a%20ubiquitin%20to%20the%20chain%20is%20catalyzed%20by%20E3%20ligases%2C%20and%20removal%20of%20ubiquitin%20is%20catalyzed%20by%20a%20De-UBiquitylating%20enzyme%20%28DUB%29.%20Nearly%20four%20decades%20ago%2C%20Goldbeter%20and%20Koshland%20discovered%20that%20reversible%20PTM%20cycles%20function%20like%20on-off%20switches%20when%20the%20substrates%20are%20at%20saturating%20concentrations.%20Although%20this%20finding%20has%20had%20profound%20implications%20for%20the%20understanding%20of%20switch-like%20behavior%20in%20biochemical%20networks%2C%20the%20general%20behavior%20of%20PTM%20cycles%20subject%20to%20synthesis%20and%20degradation%20has%20not%20been%20studied.%20Using%20a%20mathematical%20modeling%20approach%2C%20we%20found%20that%20simply%20introducing%20protein%20turnover%20to%20a%20standard%20modification%20cycle%20has%20profound%20effects%2C%20including%20significantly%20reducing%20the%20switch-like%20nature%20of%20the%20response.%20Our%20findings%20suggest%20that%20many%20classic%20results%20on%20PTM%20cycles%20may%20not%20hold%20in%20vivo%20where%20protein%20turnover%20is%20ubiquitous.%20We%20also%20found%20that%20proteins%20sharing%20an%20E3%20ligase%20can%20have%20closely%20related%20changes%20in%20their%20expression%20levels.%20These%20results%20imply%20that%20it%20may%20be%20difficult%20to%20interpret%20experimental%20results%20obtained%20from%20either%20overexpressing%20or%20knocking%20down%20protein%20levels%2C%20since%20changes%20in%20protein%20expression%20can%20be%20coupled%20via%20E3%20ligase%20crosstalk.%20Understanding%20crosstalk%20and%20competition%20for%20E3%20ligases%20will%20be%20key%20in%20ultimately%20developing%20a%20global%20picture%20of%20protein%20homeostasis.%22%2C%22date%22%3A%222020-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1008492%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-03-03T17%3A39%3A22Z%22%7D%7D%2C%7B%22key%22%3A%224X5IUZ8J%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Melms%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-15%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMelms%20JC%2C%20Vallabhaneni%20S%2C%20Mills%20CE%2C%20Yapp%20C%2C%20Chen%20JY%2C%20Morelli%20E%2C%20Waszyk%20P%2C%20Kumar%20S%2C%20Deming%20D%2C%20Moret%20N%2C%20Rodriguez%20S%2C%20Subramanian%20K%2C%20Rogava%20M%2C%20Cartwright%20ANR%2C%20Luoma%20A%2C%20Mei%20S%2C%20Brinker%20TJ%2C%20Miller%20DM%2C%20Spektor%20A%2C%20Schadendorf%20D%2C%20Riggi%20N%2C%20Wucherpfennig%20KW%2C%20Sorger%20PK%2C%20Izar%20B.%20Inhibition%20of%20haspin%20kinase%20promotes%20cell-intrinsic%20and%20extrinsic%20antitumor%20activity.%20Cancer%20Res.%202020%20Feb%2015%3B80%284%29%3A798%26%23x2013%3B810.%20PMCID%3A%20PMC7029677%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inhibition%20of%20haspin%20kinase%20promotes%20cell-intrinsic%20and%20extrinsic%20antitumor%20activity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sreeram%22%2C%22lastName%22%3A%22Vallabhaneni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugenio%22%2C%22lastName%22%3A%22Morelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Waszyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushil%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derrick%22%2C%22lastName%22%3A%22Deming%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nienke%22%2C%22lastName%22%3A%22Moret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meri%22%2C%22lastName%22%3A%22Rogava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20N.%20R.%22%2C%22lastName%22%3A%22Cartwright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrienne%22%2C%22lastName%22%3A%22Luoma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Titus%20J.%22%2C%22lastName%22%3A%22Brinker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Spektor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Schadendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolo%22%2C%22lastName%22%3A%22Riggi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%20W.%22%2C%22lastName%22%3A%22Wucherpfennig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%5D%2C%22abstractNote%22%3A%22Patients%20with%20melanoma%20resistant%20to%20RAF%5C%2FMEK%20inhibitors%20%28RMi%29%20are%20frequently%20resistant%20to%20other%20therapies%2C%20such%20as%20immune%20checkpoint%20inhibitors%20%28ICI%29%2C%20and%20individuals%20succumb%20to%20their%20disease.%20New%20drugs%20that%20control%20tumor%20growth%20and%20favorably%20modulate%20the%20immune%20environment%20are%20therefore%20needed.%20We%20report%20that%20the%20small-molecule%20CX-6258%20has%20potent%20activity%20against%20both%20RMi-sensitive%20%28RMS%29%20and%20-resistant%20%28RMR%29%20melanoma%20cell%20lines.%20Haspin%20kinase%20%28HASPIN%29%20was%20identified%20as%20a%20target%20of%20CX-6258.%20HASPIN%20inhibition%20resulted%20in%20reduced%20proliferation%2C%20frequent%20formation%20of%20micronuclei%2C%20recruitment%20of%20cGAS%2C%20and%20activation%20of%20the%20cyclic%20GMP-AMP%20synthase%20%28cGAS%29-stimulator%20of%20interferon%20genes%20%28STING%29%20pathway.%20In%20murine%20models%2C%20CX-6258%20induced%20a%20potent%20cGAS-dependent%20type-I%20IFN%20response%20in%20tumor%20cells%2C%20increased%20IFN%5Cu03b3-producing%20CD8%2B%20T%20cells%2C%20and%20reduced%20Treg%20frequency%20in%20vivo.%20HASPIN%20was%20more%20strongly%20expressed%20in%20malignant%20compared%20with%20healthy%20tissue%20and%20its%20inhibition%20by%20CX-6258%20had%20minimal%20toxicity%20in%20ex%20vivo-expanded%20human%20tumor-infiltrating%20lymphocytes%20%28TIL%29%2C%20proliferating%20TILs%2C%20and%20in%20vitro%20differentiated%20neurons%2C%20suggesting%20a%20potential%20therapeutic%20index%20for%20anticancer%20therapy.%20Furthermore%2C%20the%20activity%20of%20CX-6258%20was%20validated%20in%20several%20Ewing%20sarcoma%20and%20multiple%20myeloma%20cell%20lines.%20Thus%2C%20HASPIN%20inhibition%20may%20overcome%20drug%20resistance%20in%20melanoma%2C%20modulate%20the%20immune%20environment%2C%20and%20target%20a%20vulnerability%20in%20different%20cancer%20lineages.%20SIGNIFICANCE%3A%20HASPIN%20inhibition%20by%20CX-6258%20is%20a%20novel%20and%20potent%20strategy%20for%20RAF%5C%2FMEK%20inhibitor-resistant%20melanoma%20and%20potentially%20other%20tumor%20types.%20HASPIN%20inhibition%20has%20direct%20antitumor%20activity%20and%20induces%20a%20favorable%20immune%20microenvironment.%22%2C%22date%22%3A%22Feb%2015%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-19-2330%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-01T14%3A24%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22LQ8C8UP9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moret%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-02%22%2C%22numChildren%22%3A11%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMoret%20N%2C%20Liu%20C%2C%20Gyori%20BM%2C%20Bachman%20JA%2C%20Steppi%20A%2C%20Hug%20C%2C%20Taujale%20R%2C%20Huang%20LC%2C%20Berginski%20ME%2C%20Gomez%20SM%2C%20Kannan%20N%2C%20Sorger%20PK.%20A%20resource%20for%20exploring%20the%20understudied%20human%20kinome%20for%20research%20and%20therapeutic%20opportunities%20%5BInternet%5D.%20bioRxiv%3B%202020%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.04.02.022277%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.04.02.022277%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22A%20resource%20for%20exploring%20the%20understudied%20human%20kinome%20for%20research%20and%20therapeutic%20opportunities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nienke%22%2C%22lastName%22%3A%22Moret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changchang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Steppi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahil%22%2C%22lastName%22%3A%22Taujale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang-Chin%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20E.%22%2C%22lastName%22%3A%22Berginski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20M.%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natarajan%22%2C%22lastName%22%3A%22Kannan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20The%20functions%20of%20protein%20kinases%20have%20been%20widely%20studied%20and%20over%2060%20kinase%20inhibitors%20are%20FDA-approved%20drugs.%20Membership%20in%20the%20human%20kinome%20is%20nonetheless%20subject%20to%20multiple%20overlapping%20and%20inconsistent%20definitions%20and%20is%20unevenly%20studied%2C%20complicating%20functional%20genomics%20and%20chemical%20genetics.%20We%20describe%20objective%20criteria%20for%20refining%20the%20definition%20of%20the%20human%20kinome%20to%20comprise%20an%20extended%20set%20of%20710%20kinase%20domains%20and%20a%20more%20narrowly%20curated%20set%20of%20557%20protein%20kinase%20like%20%28PKL%29%20domains.%20An%20online%20tool%20%28%5Cn%20%20%20%20%20%20%20%20%20%20%20%20www.kinome.org%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%29%5Cn%20%20%20%20%20%20%20%20%20%20%20%20makes%20it%20possible%20to%20sort%20these%20sets%20on%20multiple%20structural%20and%20functional%20criteria.%20Focusing%20on%20the%20least%20studied%20one-third%20of%20the%20kinome%20we%20find%20that%20many%20proteins%20are%20differentially%20expressed%2C%20essential%20in%20multiple%20cell%20lines%2C%20and%20mutated%20in%20the%20Cancer%20Genome%20Atlas.%20We%20show%20that%20some%20understudied%20kinases%20are%20high%20affinity%20off-targets%20of%20clinical-grade%20compounds%20and%20approved%20drugs%20and%20we%20describe%20an%20optimized%20small%20molecule%20library%20making%20use%20of%20this%20information%20for%20selective%20kinome%20perturbation.%20We%20conclude%20that%20the%20understudied%20kinome%20contains%20physiologically%20important%20proteins%2C%20including%20possible%20targets%20for%20future%20drug%20discovery%20campaigns.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222020-04-02%22%2C%22DOI%22%3A%2210.1101%5C%2F2020.04.02.022277%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.04.02.022277%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-11-01T14%3A17%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22YEKRDR32%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Mostaghimi%20et%20al.%22%2C%22parsedDate%22%3A%222020-12-18%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMostaghimi%20A%2C%20Antonini%20MJ%2C%20Plana%20D%2C%20Anderson%20PD%2C%20Beller%20B%2C%20Boyer%20EW%2C%20Fannin%20A%2C%20Freake%20J%2C%20Oakley%20R%2C%20Sinha%20MS%2C%20Smith%20L%2C%20Van%20C%2C%20Yang%20H%2C%20Sorger%20PK%2C%20LeBoeuf%20NR%2C%20Yu%20SH.%20Regulatory%20and%20safety%20considerations%20in%20deploying%20a%20locally%20fabricated%2C%20reusable%20face%20shield%20in%20a%20hospital%20responding%20to%20the%20COVID-19%20pandemic.%20Med%20%28N%20Y%29.%202020%20Dec%2018%3B1%281%29%3A139-151.e4.%20PMCID%3A%20PMC7304404%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Regulatory%20and%20safety%20considerations%20in%20deploying%20a%20locally%20fabricated%2C%20reusable%20face%20shield%20in%20a%20hospital%20responding%20to%20the%20COVID-19%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arash%22%2C%22lastName%22%3A%22Mostaghimi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc-Joseph%22%2C%22lastName%22%3A%22Antonini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%20D.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brandon%22%2C%22lastName%22%3A%22Beller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20W.%22%2C%22lastName%22%3A%22Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amber%22%2C%22lastName%22%3A%22Fannin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Freake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Oakley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leanne%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Due%20to%20supply%20chain%20disruption%2C%20the%20COVID-19%20pandemic%20has%20caused%20severe%20shortages%20in%20personal%20protective%20equipment%20for%20health%20care%20professionals.%20Local%20fabrication%20based%20on%203D%20printing%20is%20one%20way%20to%20address%20this%20challenge%2C%20particularly%20in%20the%20case%20of%20products%20such%20as%20protective%20face%20shields.%20No%20clear%20path%20exists%2C%20however%2C%20for%20introducing%20a%20locally%20fabricated%20product%20into%20a%20clinical%20setting.%5CnMethods%3A%20We%20describe%20a%20research%20protocol%20under%20Institutional%20Review%20Board%20supervision%20that%20allowed%20clinicians%20to%20participate%20in%20an%20iterative%20design%20process%20followed%20by%20real-world%20testing%20in%20an%20emergency%20department.%20All%20designs%2C%20materials%20used%2C%20testing%20protocols%2C%20and%20survey%20results%20are%20reported%20in%20full%20to%20facilitate%20similar%20efforts%20in%20other%20clinical%20settings.%5CnFindings%3A%20Clinical%20testing%20allowed%20the%20incident%20command%20team%20at%20a%20major%20academic%20medical%20center%20to%20introduce%20the%20locally%20fabricated%20face%20shield%20into%20general%20use%20in%20a%20rapid%20but%20well-controlled%20manner.%20Unlike%20standard%20hospital%20face%20shields%2C%20the%20locally%20fabricated%20design%20was%20intended%20to%20be%20reusable.%20We%20discuss%20the%20design%20and%20testing%20process%20and%20provide%20an%20overview%20of%20regulatory%20considerations%20associated%20with%20fabrication%20and%20testing%20of%20personal%20protective%20equipment%2C%20such%20as%20face%20shields.%5CnConclusions%3A%20Our%20work%20serves%20as%20a%20case%20study%20for%20robust%2C%20local%20responses%20to%20pandemic-related%20disruption%20of%20medical%20supply%20chains%20with%20implications%20for%20health%20care%20professionals%2C%20hospital%20administrators%2C%20regulatory%20agencies%2C%20and%20concerned%20citizens%20in%20the%20COVID-19%20and%20future%20health%20care%20emergencies.%5CnFunding%3A%20%3A%20This%20work%20was%20supported%20by%20the%20Harvard%20MIT%20Center%20for%20Regulatory%20Sciences%2C%20NIH%5C%2FNCI%20grants%20U54-CA225088%20and%20T32-GM007753%2C%20and%20the%20Harvard%20Ludwig%20Center.%20M.-J.A.%20is%20a%20Friends%20of%20McGovern%20Graduate%20Fellow.%22%2C%22date%22%3A%222020-12-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medj.2020.06.003%22%2C%22ISSN%22%3A%222666-6340%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A04%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22XM9LMNT2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nam%20et%20al.%22%2C%22parsedDate%22%3A%222020-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENam%20KM%2C%20Gyori%20BM%2C%20Amethyst%20SV%2C%20Bates%20DJ%2C%20Gunawardena%20J.%20Robustness%20and%20parameter%20geography%20in%20post-translational%20modification%20systems.%20PLoS%20Comput%20Biol.%202020%20May%3B16%285%29%3Ae1007573.%20PMCID%3A%20PMC7224580%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Robustness%20and%20parameter%20geography%20in%20post-translational%20modification%20systems%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kee-Myoung%22%2C%22lastName%22%3A%22Nam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silviana%20V.%22%2C%22lastName%22%3A%22Amethyst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Bates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Gunawardena%22%7D%5D%2C%22abstractNote%22%3A%22Biological%20systems%20are%20acknowledged%20to%20be%20robust%20to%20perturbations%20but%20a%20rigorous%20understanding%20of%20this%20has%20been%20elusive.%20In%20a%20mathematical%20model%2C%20perturbations%20often%20exert%20their%20effect%20through%20parameters%2C%20so%20sizes%20and%20shapes%20of%20parametric%20regions%20offer%20an%20integrated%20global%20estimate%20of%20robustness.%20Here%2C%20we%20explore%20this%20%5C%22parameter%20geography%5C%22%20for%20bistability%20in%20post-translational%20modification%20%28PTM%29%20systems.%20We%20use%20the%20previously%20developed%20%5C%22linear%20framework%5C%22%20for%20timescale%20separation%20to%20describe%20the%20steady-states%20of%20a%20two-site%20PTM%20system%20as%20the%20solutions%20of%20two%20polynomial%20equations%20in%20two%20variables%2C%20with%20eight%20non-dimensional%20parameters.%20Importantly%2C%20this%20approach%20allows%20us%20to%20accommodate%20enzyme%20mechanisms%20of%20arbitrary%20complexity%20beyond%20the%20conventional%20Michaelis-Menten%20scheme%2C%20which%20unrealistically%20forbids%20product%20rebinding.%20We%20further%20use%20the%20numerical%20algebraic%20geometry%20tools%20Bertini%2C%20Paramotopy%2C%20and%20alphaCertified%20to%20statistically%20assess%20the%20solutions%20to%20these%20equations%20at%20%5Cu223c109%20parameter%20points%20in%20total.%20Subject%20to%20sampling%20limitations%2C%20we%20find%20no%20bistability%20when%20substrate%20amount%20is%20below%20a%20threshold%20relative%20to%20enzyme%20amounts.%20As%20substrate%20increases%2C%20the%20bistable%20region%20acquires%208-dimensional%20volume%20which%20increases%20in%20an%20apparently%20monotonic%20and%20sigmoidal%20manner%20towards%20saturation.%20The%20region%20remains%20connected%20but%20not%20convex%2C%20albeit%20with%20a%20high%20visibility%20ratio.%20Surprisingly%2C%20the%20saturating%20bistable%20region%20occupies%20a%20much%20smaller%20proportion%20of%20the%20sampling%20domain%20under%20mechanistic%20assumptions%20more%20realistic%20than%20the%20Michaelis-Menten%20scheme.%20We%20find%20that%20bistability%20is%20compromised%20by%20product%20rebinding%20and%20that%20unrealistic%20assumptions%20on%20enzyme%20mechanisms%20have%20obscured%20its%20parametric%20rarity.%20The%20apparent%20monotonic%20increase%20in%20volume%20of%20the%20bistable%20region%20remains%20perplexing%20because%20the%20region%20itself%20does%20not%20grow%20monotonically%3A%20parameter%20points%20can%20move%20back%20and%20forth%20between%20monostability%20and%20bistability.%20We%20suggest%20mathematical%20conjectures%20and%20questions%20arising%20from%20these%20findings.%20Advances%20in%20theory%20and%20software%20now%20permit%20insights%20into%20parameter%20geography%20to%20be%20uncovered%20by%20high-dimensional%2C%20data-centric%20analysis.%22%2C%22date%22%3A%222020-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1007573%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T18%3A42%3A03Z%22%7D%7D%2C%7B%22key%22%3A%224TT66W8K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-18%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Plana%20D%2C%20Sorger%20PK.%20Comparing%20the%20efficacy%20of%20cancer%20therapies%20between%20subgroups%20in%20basket%20trials.%20Cell%20Syst.%202020%20Nov%2018%3B11%285%29%3A449-460.e2.%20PMCID%3A%20PMC8022348%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparing%20the%20efficacy%20of%20cancer%20therapies%20between%20subgroups%20in%20basket%20trials%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20need%20to%20test%20anticancer%20drugs%20in%20multiple%20indications%20has%20been%20addressed%20by%20basket%20trials%2C%20which%20are%20Phase%20I%20or%20II%20clinical%20trials%20involving%20multiple%20tumor%20subtypes%20and%20a%20single%20master%20protocol.%20Basket%20trials%20typically%20involve%20few%20patients%20per%20type%2C%20making%20it%20challenging%20to%20rigorously%20compare%20responses%20across%20types.%20We%20describe%20the%20use%20of%20permutation%20testing%20to%20test%20for%20differences%20among%20subgroups%20using%20empirical%20null%20distributions%20and%20the%20Benjamini-Hochberg%20procedure%20to%20control%20for%20false%20discovery.%20We%20apply%20the%20approach%20retrospectively%20to%20tumor-volume%20changes%20and%20progression-free%20survival%20in%20published%20basket%20trials%20for%20neratinib%2C%20larotrectinib%2C%20pembrolizumab%2C%20and%20imatinib%20and%20uncover%20examples%20of%20therapeutic%20benefit%20missed%20by%20conventional%20binomial%20testing.%20For%20example%2C%20we%20identify%20an%20overlooked%20opportunity%20for%20use%20of%20neratinib%20in%20lung%20cancers%20carrying%20ERBB2%20Exon%2020%20mutations.%20Permutation%20testing%20can%20be%20used%20to%20design%20basket%20trials%20but%20is%20more%20conservatively%20introduced%20alongside%20established%20approaches%20to%20enrollment%20such%20as%20Simon%27s%20two-stage%20design.%22%2C%22date%22%3A%222020-11-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2020.09.003%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A03%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22SJSTLJTT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-01%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Plana%20D%2C%20Gao%20H%2C%20Korn%20JM%2C%20Yang%20G%2C%20Green%20J%2C%20Zhang%20X%2C%20Velazquez%20R%2C%20McLaughlin%20ME%2C%20Ruddy%20DA%2C%20Kowal%20C%2C%20Muszynski%20J%2C%20Bullock%20C%2C%20Rivera%20S%2C%20Rakiec%20DP%2C%20Elliott%20G%2C%20Fordjour%20P%2C%20Meyer%20R%2C%20Loo%20A%2C%20Kurth%20E%2C%20Engelman%20JA%2C%20Bitter%20H%2C%20Sellers%20WR%2C%20Williams%20JA%2C%20Sorger%20PK.%20A%20proof%20of%20concept%20for%20biomarker-guided%20targeted%20therapy%20against%20ovarian%20cancer%20based%20on%20patient-derived%20tumor%20xenografts.%20Cancer%20Res.%202020%20Oct%201%3B80%2819%29%3A4278%26%23x2013%3B4287.%20PMCID%3A%20PMC7541581%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20proof%20of%20concept%20for%20biomarker-guided%20targeted%20therapy%20against%20ovarian%20cancer%20based%20on%20patient-derived%20tumor%20xenografts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hui%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Korn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guizhi%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Green%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiamei%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Velazquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20E.%22%2C%22lastName%22%3A%22McLaughlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Ruddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colleen%22%2C%22lastName%22%3A%22Kowal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Muszynski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Bullock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacy%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Rakiec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22GiNell%22%2C%22lastName%22%3A%22Elliott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Fordjour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Loo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Kurth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Engelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%22%2C%22lastName%22%3A%22Bitter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20R.%22%2C%22lastName%22%3A%22Sellers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliet%20A.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Advanced%20ovarian%20cancers%20are%20a%20leading%20cause%20of%20cancer-related%20death%20in%20women%20and%20are%20currently%20treated%20with%20surgery%20and%20chemotherapy.%20This%20standard%20of%20care%20is%20often%20temporarily%20successful%20but%20exhibits%20a%20high%20rate%20of%20relapse%2C%20after%20which%2C%20treatment%20options%20are%20few.%20Here%20we%20investigate%20whether%20biomarker-guided%20use%20of%20multiple%20targeted%20therapies%2C%20including%20small%20molecules%20and%20antibody-drug%20conjugates%2C%20is%20a%20viable%20alternative.%20A%20panel%20of%20patient-derived%20ovarian%20cancer%20xenografts%20%28PDX%29%2C%20similar%20in%20genetics%20and%20chemotherapy%20responsiveness%20to%20human%20tumors%2C%20was%20exposed%20to%2021%20monotherapies%20and%20combination%20therapies.%20Three%20monotherapies%20and%20one%20combination%20were%20found%20to%20be%20active%20in%20different%20subsets%20of%20PDX.%20Analysis%20of%20gene%20expression%20data%20identified%20biomarkers%20associated%20with%20responsiveness%20to%20each%20of%20the%20three%20targeted%20therapies%2C%20none%20of%20which%20directly%20inhibits%20an%20oncogenic%20driver.%20While%20no%20single%20treatment%20had%20as%20high%20a%20response%20rate%20as%20chemotherapy%2C%20nearly%2090%25%20of%20PDXs%20were%20eligible%20for%20and%20responded%20to%20at%20least%20one%20biomarker-guided%20treatment%2C%20including%20tumors%20resistant%20to%20standard%20chemotherapy.%20The%20distribution%20of%20biomarker%20positivity%20in%20The%20Cancer%20Genome%20Atlas%20data%20suggests%20the%20potential%20for%20a%20similar%20precision%20approach%20in%20human%20patients.%20SIGNIFICANCE%3A%20This%20study%20exploits%20a%20panel%20of%20patient-derived%20xenografts%20to%20demonstrate%20that%20most%20ovarian%20tumors%20can%20be%20matched%20to%20effective%20biomarker-guided%20treatments.%22%2C%22date%22%3A%22Oct%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-19-3850%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A04%3A27Z%22%7D%7D%2C%7B%22key%22%3A%2262WMADUZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pena%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPena%20AM%2C%20Chen%20X%2C%20Pence%20IJ%2C%20Bornschl%26%23xF6%3Bgl%20T%2C%20Jeong%20S%2C%20Gr%26%23xE9%3Bgoire%20S%2C%20Luengo%20GS%2C%20Hallegot%20P%2C%20Obeidy%20P%2C%20Feizpour%20A%2C%20Chan%20KF%2C%20Evans%20CL.%20Imaging%20and%20quantifying%20drug%20delivery%20in%20skin%20-%20Part%202%3A%20Fluorescence%20andvibrational%20spectroscopic%20imaging%20methods.%20Adv%20Drug%20Deliv%20Rev.%202020%20Jan%201%3B153%3A147%26%23x2013%3B168.%20PMCID%3A%20PMC7483684%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Imaging%20and%20quantifying%20drug%20delivery%20in%20skin%20-%20Part%202%3A%20Fluorescence%20andvibrational%20spectroscopic%20imaging%20methods%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana-Maria%22%2C%22lastName%22%3A%22Pena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xueqin%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20J.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Bornschl%5Cu00f6gl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sinyoung%22%2C%22lastName%22%3A%22Jeong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Gr%5Cu00e9goire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20S.%22%2C%22lastName%22%3A%22Luengo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Hallegot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peyman%22%2C%22lastName%22%3A%22Obeidy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amin%22%2C%22lastName%22%3A%22Feizpour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kin%20F.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Conor%20L.%22%2C%22lastName%22%3A%22Evans%22%7D%5D%2C%22abstractNote%22%3A%22Understanding%20the%20delivery%20and%20diffusion%20of%20topically-applied%20drugs%20on%20human%20skin%20is%20of%20paramount%20importance%20in%20both%20pharmaceutical%20and%20cosmetics%20research.%20This%20information%20is%20critical%20in%20early%20stages%20of%20drug%20development%20and%20allows%20the%20identification%20of%20the%20most%20promising%20ingredients%20delivered%20at%20optimal%20concentrations%20to%20their%20target%20skin%20compartments.%20Different%20skin%20imaging%20methods%2C%20invasive%20and%20non-invasive%2C%20are%20available%20to%20characterize%20and%20quantify%20the%20spatiotemporal%20distribution%20of%20a%20drug%20within%20ex%20vivo%20and%20in%20vivo%20human%20skin.%20The%20first%20part%20of%20this%20review%20detailed%20invasive%20imaging%20methods%20%28autoradiography%2C%20MALDI%20and%20SIMS%29.%20This%20second%20part%20reviews%20non-invasive%20imaging%20methods%20that%20can%20be%20applied%20in%20vivo%3A%20i%29%20fluorescence%20%28conventional%2C%20confocal%2C%20and%20multiphoton%29%20and%20second%20harmonic%20generation%20microscopies%20and%20ii%29%20vibrational%20spectroscopic%20imaging%20methods%20%28infrared%2C%20confocal%20Raman%2C%20and%20coherent%20Raman%20scattering%20microscopies%29.%20Finally%2C%20a%20flow%20chart%20for%20the%20selection%20of%20imaging%20methods%20is%20presented%20to%20guide%20human%20skin%20ex%20vivo%20and%20in%20vivo%20drug%20delivery%20studies.%22%2C%22date%22%3A%22Jan%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.addr.2020.03.003%22%2C%22ISSN%22%3A%221872-8294%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A02%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22A7CMQFB7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Plana%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-27%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPlana%20D%2C%20Tian%20E%2C%20Cramer%20AK%2C%20Yang%20H%2C%20Carmack%20MM%2C%20Sinha%20MS%2C%20Bourgeois%20FT%2C%20Yu%20SH%2C%20Masse%20P%2C%20Boyer%20J%2C%20Kim%20M%2C%20Mo%20J%2C%20LeBoeuf%20NR%2C%20Li%20J%2C%20Sorger%20PK.%20Assessing%20the%20quality%20of%20nontraditional%20N95%20filtering%20face-piece%20respirators%20available%20during%20the%20COVID-19%20pandemic%20%5BInternet%5D.%20medRxiv%3B%202020%20%5Bcited%202024%20Aug%2012%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.07.25.20161968%27%3Ehttp%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.07.25.20161968%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Assessing%20the%20quality%20of%20nontraditional%20N95%20filtering%20face-piece%20respirators%20available%20during%20the%20COVID-19%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enze%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avilash%20K.%22%2C%22lastName%22%3A%22Cramer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20M.%22%2C%22lastName%22%3A%22Carmack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%20T.%22%2C%22lastName%22%3A%22Bourgeois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Masse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%22%2C%22lastName%22%3A%22Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minjune%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhan%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Background%5Cn%20%20%20%20%20%20%20%20%20%20%20%20During%20the%20current%20COVID-19%20pandemic%2C%20supply%20chains%20for%20Personal%20Protective%20Equipment%20%28PPE%29%20have%20been%20severely%20disrupted%20and%20many%20products%2C%20particularly%20surgical%20N95%20filtering%20facepiece%20respirators%20%28FFRs%3B%20%5Cu201cmasks%5Cu201d%29%20are%20in%20short%20supply.%20As%20a%20consequence%2C%20an%20Emergency%20Use%20Authorization%20%28EUA%29%20from%20the%20FDA%20has%20allowed%20importation%20of%20N95-type%20masks%20manufactured%20to%20international%20standards%3B%20these%20include%20KN95%20masks%20from%20China%20and%20FFP2%20masks%20from%20the%20European%20Union.%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Methods%5Cn%20%20%20%20%20%20%20%20%20%20%20%20We%20conducted%20a%20survey%20of%20mask%20in%20the%20inventory%20of%20major%20academic%20medical%20centers%20in%20Boston%2C%20MA%20to%20determine%20provenance%20and%20manufacturer.%20We%20then%20assembled%20a%20simple%20apparatus%20for%20performing%20a%20necessary%20%28but%20not%20sufficient%29%20test%20of%20filtration%20performance%20and%20tested%20masks%20from%20the%20inventory%3B%20an%20accompanying%20website%20shows%20how%20to%20build%20and%20use%20the%20testing%20apparatus.%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Results%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Our%20survey%20showed%20that%2C%20seven%20months%20after%20the%20start%20of%20the%20COVID-19%20pandemic%2C%20over%20100%20different%20makes%20and%20models%20of%20N95-type%20masks%20are%20in%20the%20inventory%20of%20local%20hospitals%20as%20opposed%20to%202-5%20models%20under%20normal%20circumstances.%20A%20substantial%20number%20of%20unfamiliar%20masks%20are%20from%20unknown%20manufacturers.%20Many%20did%20not%20perform%20to%20accepted%20standards%20and%20are%20likely%20to%20be%20counterfeit.%20Due%20to%20the%20absence%20of%20publicly%20available%20information%20on%20mask%20suppliers%20in%20the%20FDA%20EUA%20and%20confusing%20or%20inconsistent%20labeling%20of%20KN95%20masks%2C%20it%20is%20difficult%20to%20distinguish%20legitimate%20and%20counterfeit%20products.%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Many%20of%20the%20FFR%20masks%20available%20for%20procurement%20during%20the%20COVID-19%20pandemic%20do%20not%20provide%20levels%20of%20fit%20and%20filtration%20similar%20to%20those%20of%20N95%20masks%20and%20are%20not%20acceptable%20for%20use%20in%20healthcare%20settings.%20Based%20on%20these%20results%2C%20and%20in%20consultation%20with%20occupational%20health%20officers%2C%20we%20make%20six%20recommendations%20for%20end%20users%20to%20assist%20in%20acquiring%20legitimate%20products.%20In%20particular%2C%20institutions%20should%20always%20assess%20masks%20from%20non-traditional%20supply%20chains%20by%20checking%20their%20markings%20and%20manufacturer%20information%20against%20data%20provided%20by%20NIOSH%20and%20the%20latest%20FDA%20EUA%20Appendix%20A.%20In%20the%20absence%20of%20verifiable%20information%20on%20the%20legitimacy%20of%20mask%20source%2C%20institutions%20should%20consider%20measuring%20mask%20fit%20and%20filtration%20directly.%20We%20also%20make%20suggestions%20for%20U.S%20and%20Chinese%20regulatory%20agencies%20with%20regard%20to%20labeling%20and%20public%20disclosure%20aimed%20at%20increase%20pandemic%20resilience.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222020-07-27%22%2C%22DOI%22%3A%2210.1101%5C%2F2020.07.25.20161968%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.07.25.20161968%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%2C%22WWA6ACMR%22%5D%2C%22dateModified%22%3A%222024-08-13T13%3A44%3A41Z%22%7D%7D%2C%7B%22key%22%3A%2272SM6ENR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pomeranz%20Krummel%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-01%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPomeranz%20Krummel%20DA%2C%20Nasti%20TH%2C%20Izar%20B%2C%20Press%20RH%2C%20Xu%20M%2C%20Lowder%20L%2C%20Kallay%20L%2C%20Rupji%20M%2C%20Rosen%20H%2C%20Su%20J%2C%20Curran%20W%2C%20Olson%20J%2C%20Weinberg%20B%2C%20Schniederjan%20M%2C%20Neill%20S%2C%20Lawson%20D%2C%20Kowalski%20J%2C%20Khan%20MK%2C%20Sengupta%20S.%20Impact%20of%20sequencing%20radiation%20therapy%20and%20immune%20checkpoint%20inhibitors%20in%20the%20treatment%20of%20melanoma%20brain%20metastases.%20Int%20J%20Radiat%20Oncol%20Biol%20Phys.%202020%20Sep%201%3B108%281%29%3A157%26%23x2013%3B163.%20PMCID%3A%20PMC7839060%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20sequencing%20radiation%20therapy%20and%20immune%20checkpoint%20inhibitors%20in%20the%20treatment%20of%20melanoma%20brain%20metastases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Pomeranz%20Krummel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tahseen%20H.%22%2C%22lastName%22%3A%22Nasti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20H.%22%2C%22lastName%22%3A%22Press%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxwell%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsey%22%2C%22lastName%22%3A%22Lowder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Kallay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manali%22%2C%22lastName%22%3A%22Rupji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Havi%22%2C%22lastName%22%3A%22Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%22%2C%22lastName%22%3A%22Curran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brent%22%2C%22lastName%22%3A%22Weinberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Schniederjan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stewart%22%2C%22lastName%22%3A%22Neill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Lawson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Kowalski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%20K.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soma%22%2C%22lastName%22%3A%22Sengupta%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Melanoma%20brain%20metastases%20%28MBM%29%20occur%20in%20%5Cu223c50%25%20of%20melanoma%20patients.%20Although%20both%20radiation%20therapy%20%28RT%29%20and%20immune%20checkpoint%20inhibitor%20%28ICI%29%20are%20used%20alone%20or%20in%20combination%20for%20MBM%20treatment%2C%20the%20role%20of%20this%20combination%20and%20how%20these%20treatments%20could%20best%20be%20sequenced%20remains%20unclear.%5CnMETHODS%20AND%20MATERIALS%3A%20We%20conducted%20a%20retrospective%20analysis%20of%20patients%20with%20resected%20MBM%20who%20underwent%20treatment%20with%20RT%2C%20ICI%2C%20or%20a%20combination%20of%20RT%20and%20ICI.%20Among%20the%20latter%2C%20we%20specifically%20investigated%20the%20differential%20gene%20expression%20via%20RNA-sequencing%20between%20patients%20who%20received%20RT%20first%20then%20ICI%20%28RT%20%5Cu2192%20ICI%29%20versus%20ICI%20first%20then%20RT%20%28ICI%20%5Cu2192%20RT%29.%20We%20used%20a%20glycoprotein-transduced%20syngeneic%20melanoma%20mouse%20model%20for%20validation%20experiments.%5CnRESULTS%3A%20We%20found%20that%20for%20patients%20with%20resected%20MBM%2C%20a%20combination%20of%20RT%20and%20ICI%20confers%20superior%20survival%20compared%20with%20RT%20alone.%20Specifically%2C%20we%20found%20that%20RT%20%5Cu2192%20ICI%20was%20superior%20compared%20with%20ICI%20%5Cu2192%20RT.%20Transcriptome%20analysis%20of%20resected%20MBM%20revealed%20that%20the%20RT%20%5Cu2192%20ICI%20cohort%20demonstrated%20deregulation%20of%20genes%20involved%20in%20apoptotic%20signaling%20and%20key%20modulators%20of%20inflammation%20that%20are%20most%20implicated%20in%20nuclear%20factor%20kappa-light-chain-enhancer%20of%20activated%20B%20cells%20signaling.%20In%20a%20preclinical%20model%2C%20we%20showed%20that%20RT%20followed%20by%20anti-programmed%20death-ligand%201%20therapy%20was%20superior%20to%20the%20reverse%20sequence%20of%20therapy%2C%20supporting%20the%20observations%20we%20made%20in%20patients%20with%20MBM.%5CnCONCLUSIONS%3A%20Our%20study%20provides%20initial%20insights%20into%20the%20optimal%20sequence%20of%20RT%20and%20ICI%20in%20the%20treatment%20of%20MBM%20after%20surgical%20resection.%20Prospective%20studies%20examining%20the%20best%20sequence%20of%20RT%20and%20ICI%20are%20necessary%2C%20and%20our%20study%20contributes%20to%20the%20rationale%20to%20pursue%20these.%22%2C%22date%22%3A%222020-09-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijrobp.2020.01.043%22%2C%22ISSN%22%3A%221879-355X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A22Z%22%7D%7D%2C%7B%22key%22%3A%2293J5ZNH6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Qian%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EQian%20J%2C%20Lu%20ZX%2C%20Mancuso%20CP%2C%20Jhuang%20HY%2C%20Del%20Carmen%20Barajas-Ornelas%20R%2C%20Boswell%20SA%2C%20Ram%26%23xED%3Brez-Guadiana%20FH%2C%20Jones%20V%2C%20Sonti%20A%2C%20Sedlack%20K%2C%20Artzi%20L%2C%20Jung%20G%2C%20Arammash%20M%2C%20Pettit%20ME%2C%20Melfi%20M%2C%20Lyon%20L%2C%20Owen%20SV%2C%20Baym%20M%2C%20Khalil%20AS%2C%20Silver%20PA%2C%20Rudner%20DZ%2C%20Springer%20M.%20Barcoded%20microbial%20system%20for%20high-resolution%20object%20provenance.%20Science.%202020%20Jun%205%3B368%286495%29%3A1135%26%23x2013%3B1140.%20PMID%3A%2032499444%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Barcoded%20microbial%20system%20for%20high-resolution%20object%20provenance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhi-Xiang%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20P.%22%2C%22lastName%22%3A%22Mancuso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Han-Ying%22%2C%22lastName%22%3A%22Jhuang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roc%5Cu00edo%22%2C%22lastName%22%3A%22Del%20Carmen%20Barajas-Ornelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20H.%22%2C%22lastName%22%3A%22Ram%5Cu00edrez-Guadiana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victoria%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akhila%22%2C%22lastName%22%3A%22Sonti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kole%22%2C%22lastName%22%3A%22Sedlack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lior%22%2C%22lastName%22%3A%22Artzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giyoung%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Arammash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20E.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Melfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorena%22%2C%22lastName%22%3A%22Lyon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%20S.%22%2C%22lastName%22%3A%22Khalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Silver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20Z.%22%2C%22lastName%22%3A%22Rudner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Springer%22%7D%5D%2C%22abstractNote%22%3A%22Determining%20where%20an%20object%20has%20been%20is%20a%20fundamental%20challenge%20for%20human%20health%2C%20commerce%2C%20and%20food%20safety.%20Location-specific%20microbes%20in%20principle%20offer%20a%20cheap%20and%20sensitive%20way%20to%20determine%20object%20provenance.%20We%20created%20a%20synthetic%2C%20scalable%20microbial%20spore%20system%20that%20identifies%20object%20provenance%20in%20under%201%20hour%20at%20meter-scale%20resolution%20and%20near%20single-spore%20sensitivity%20and%20can%20be%20safely%20introduced%20into%20and%20recovered%20from%20the%20environment.%20This%20system%20solves%20the%20key%20challenges%20in%20object%20provenance%3A%20persistence%20in%20the%20environment%2C%20scalability%2C%20rapid%20and%20facile%20decoding%2C%20and%20biocontainment.%20Our%20system%20is%20compatible%20with%20SHERLOCK%2C%20a%20Cas13a%20RNA-guided%20nucleic%20acid%20detection%20assay%2C%20facilitating%20its%20implementation%20in%20a%20wide%20range%20of%20applications.%22%2C%22date%22%3A%2206-05-2020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.aba5584%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A55%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22CQPY8WDN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qu%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EQu%20J%2C%20Steppi%20A%2C%20Zhong%20D%2C%20Hao%20J%2C%20Wang%20J%2C%20Lung%20PY%2C%20Zhao%20T%2C%20He%20Z%2C%20Zhang%20J.%20Triage%20of%20documents%20containing%20protein%20interactions%20affected%20by%20mutations%20using%20an%20NLP%20based%20machine%20learning%20approach.%20BMC%20Genomics.%202020%20Nov%2010%3B21%281%29%3A773.%20PMCID%3A%20PMC7654050%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Triage%20of%20documents%20containing%20protein%20interactions%20affected%20by%20mutations%20using%20an%20NLP%20based%20machine%20learning%20approach%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinchan%22%2C%22lastName%22%3A%22Qu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Steppi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dongrui%22%2C%22lastName%22%3A%22Zhong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Hao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jian%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei-Yau%22%2C%22lastName%22%3A%22Lung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tingting%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinfeng%22%2C%22lastName%22%3A%22Zhang%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Information%20on%20protein-protein%20interactions%20affected%20by%20mutations%20is%20very%20useful%20for%20understanding%20the%20biological%20effect%20of%20mutations%20and%20for%20developing%20treatments%20targeting%20the%20interactions.%20In%20this%20study%2C%20we%20developed%20a%20natural%20language%20processing%20%28NLP%29%20based%20machine%20learning%20approach%20for%20extracting%20such%20information%20from%20literature.%20Our%20aim%20is%20to%20identify%20journal%20abstracts%20or%20paragraphs%20in%20full-text%20articles%20that%20contain%20at%20least%20one%20occurrence%20of%20a%20protein-protein%20interaction%20%28PPI%29%20affected%20by%20a%20mutation.%5CnRESULTS%3A%20Our%20system%20makes%20use%20of%20latest%20NLP%20methods%20with%20a%20large%20number%20of%20engineered%20features%20including%20some%20based%20on%20pre-trained%20word%20embedding.%20Our%20final%20model%20achieved%20satisfactory%20performance%20in%20the%20Document%20Triage%20Task%20of%20the%20BioCreative%20VI%20Precision%20Medicine%20Track%20with%20highest%20recall%20and%20comparable%20F1-score.%5CnCONCLUSIONS%3A%20The%20performance%20of%20our%20method%20indicates%20that%20it%20is%20ideally%20suited%20for%20being%20combined%20with%20manual%20annotations.%20Our%20machine%20learning%20framework%20and%20engineered%20features%20will%20also%20be%20very%20helpful%20for%20other%20researchers%20to%20further%20improve%20this%20and%20other%20related%20biological%20text%20mining%20tasks%20using%20either%20traditional%20machine%20learning%20or%20deep%20learning%20based%20methods.%22%2C%22date%22%3A%222020-11-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12864-020-07185-7%22%2C%22ISSN%22%3A%221471-2164%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-05-17T13%3A24%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22Y9TV3QEN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Revach%20et%20al.%22%2C%22parsedDate%22%3A%222020-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERevach%20OY%2C%20Liu%20S%2C%20Jenkins%20RW.%20Targeting%20TANK-binding%20kinase%201%20%28TBK1%29%20in%20cancer.%20Expert%20Opin%20Ther%20Targets.%202020%20Nov%3B24%2811%29%3A1065%26%23x2013%3B1078.%20PMCID%3A%20PMC7644630%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20TANK-binding%20kinase%201%20%28TBK1%29%20in%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Or-Yam%22%2C%22lastName%22%3A%22Revach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuming%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20W.%22%2C%22lastName%22%3A%22Jenkins%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20TANK-binding%20kinase%201%20%28TBK1%29%20is%20a%20Ser%5C%2FThr%20kinase%20with%20a%20central%20role%20in%20coordinating%20the%20cellular%20response%20to%20invading%20pathogens%20and%20regulating%20key%20inflammatory%20signaling%20cascades.%20While%20intact%20TBK1%20signaling%20is%20required%20for%20successful%20anti-viral%20signaling%2C%20dysregulated%20TBK1%20signaling%20has%20been%20linked%20to%20a%20variety%20of%20pathophysiologic%20conditions%2C%20including%20cancer.%20Several%20lines%20of%20evidence%20support%20a%20role%20for%20TBK1%20in%20cancer%20pathogenesis%2C%20but%20the%20specific%20roles%20and%20regulation%20of%20TBK1%20remain%20incompletely%20understood.%20A%20key%20challenge%20is%20the%20diversity%20of%20cellular%20processes%20that%20are%20regulated%20by%20TBK1%2C%20including%20inflammation%2C%20cell%20cycle%2C%20autophagy%2C%20energy%20homeostasis%2C%20and%20cell%20death.%20Nevertheless%2C%20evidence%20from%20pre-clinical%20cancer%20models%20suggests%20that%20targeting%20TBK1%20may%20be%20an%20effective%20strategy%20for%20anti-cancer%20therapy%20in%20specific%20settings.%5CnAREAS%20COVERED%3A%20This%20review%20provides%20an%20overview%20of%20the%20roles%20and%20regulation%20of%20TBK1%20with%20a%20focus%20on%20cancer%20pathogenesis%20and%20drug%20targeting%20of%20TBK1%20as%20an%20anti-cancer%20strategy.%20Relevant%20literature%20was%20derived%20from%20a%20PubMed%20search%20encompassing%20studies%20from%201999%20to%202020.%5CnEXPERT%20OPINION%3A%20TBK1%20is%20emerging%20as%20a%20potential%20target%20for%20anti-cancer%20therapy.%20Inhibition%20of%20TBK1%20alone%20may%20be%20insufficient%20to%20restrain%20the%20growth%20of%20most%20cancers%3B%20hence%2C%20combination%20strategies%20will%20likely%20be%20necessary.%20Improved%20understanding%20of%20tumor-intrinsic%20and%20tumor-extrinsic%20TBK1%20signaling%20will%20inform%20novel%20therapeutic%20strategies.%22%2C%22date%22%3A%222020-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F14728222.2020.1826929%22%2C%22ISSN%22%3A%221744-7631%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A48%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22YZETZ256%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ringel%20et%20al.%22%2C%22parsedDate%22%3A%222020-12-23%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERingel%20AE%2C%20Drijvers%20JM%2C%20Baker%20GJ%2C%20Catozzi%20A%2C%20Garc%26%23xED%3Ba-Ca%26%23xF1%3Baveras%20JC%2C%20Gassaway%20BM%2C%20Miller%20BC%2C%20Juneja%20VR%2C%20Nguyen%20TH%2C%20Joshi%20S%2C%20Yao%20CH%2C%20Yoon%20H%2C%20Sage%20PT%2C%20LaFleur%20MW%2C%20Trombley%20JD%2C%20Jacobson%20CA%2C%20Maliga%20Z%2C%20Gygi%20SP%2C%20Sorger%20PK%2C%20Rabinowitz%20JD%2C%20Sharpe%20AH%2C%20Haigis%20MC.%20Obesity%20shapes%20metabolism%20in%20the%20tumor%20microenvironment%20to%20suppress%20anti-tumor%20immunity.%20Cell.%202020%20Dec%2023%3B183%287%29%3A1848-1866.e26.%20PMCID%3A%20PMC8064125%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Obesity%20shapes%20metabolism%20in%20the%20tumor%20microenvironment%20to%20suppress%20anti-tumor%20immunity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20E.%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jefte%20M.%22%2C%22lastName%22%3A%22Drijvers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessia%22%2C%22lastName%22%3A%22Catozzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20C.%22%2C%22lastName%22%3A%22Garc%5Cu00eda-Ca%5Cu00f1averas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brandon%20M.%22%2C%22lastName%22%3A%22Gassaway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20C.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikram%20R.%22%2C%22lastName%22%3A%22Juneja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thao%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shakchhi%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cong-Hui%22%2C%22lastName%22%3A%22Yao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haejin%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20T.%22%2C%22lastName%22%3A%22Sage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20W.%22%2C%22lastName%22%3A%22LaFleur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20D.%22%2C%22lastName%22%3A%22Trombley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Rabinowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H.%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Obesity%20is%20a%20major%20cancer%20risk%20factor%2C%20but%20how%20differences%20in%20systemic%20metabolism%20change%20the%20tumor%20microenvironment%20%28TME%29%20and%20impact%20anti-tumor%20immunity%20is%20not%20understood.%20Here%2C%20we%20demonstrate%20that%20high-fat%20diet%20%28HFD%29-induced%20obesity%20impairs%20CD8%2B%20T%5Cu00a0cell%20function%20in%20the%20murine%20TME%2C%20accelerating%20tumor%20growth.%20We%20generate%20a%20single-cell%20resolution%20atlas%20of%20cellular%20metabolism%20in%20the%20TME%2C%20detailing%20how%20it%20changes%20with%20diet-induced%20obesity.%20We%20find%20that%20tumor%20and%20CD8%2B%20T%5Cu00a0cells%20display%20distinct%20metabolic%20adaptations%20to%20obesity.%20Tumor%20cells%20increase%20fat%20uptake%20with%20HFD%2C%20whereas%20tumor-infiltrating%20CD8%2B%20T%5Cu00a0cells%20do%20not.%20These%20differential%20adaptations%20lead%20to%20altered%20fatty%20acid%20partitioning%20in%20HFD%20tumors%2C%20impairing%20CD8%2B%20T%5Cu00a0cell%20infiltration%20and%20function.%20Blocking%20metabolic%20reprogramming%20by%20tumor%20cells%20in%20obese%20mice%20improves%20anti-tumor%20immunity.%20Analysis%20of%20human%20cancers%20reveals%20similar%20transcriptional%20changes%20in%20CD8%2B%20T%5Cu00a0cell%20markers%2C%20suggesting%20interventions%20that%20exploit%20metabolism%20to%20improve%20cancer%20immunotherapy.%22%2C%22date%22%3A%222020-12-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2020.11.009%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A01%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22ADFP5WBN%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rodriguez%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERodriguez%20S%2C%20Cao%20L%2C%20Rickenbacher%20GT%2C%20Benz%20EG%2C%20Magdamo%20C%2C%20Gomez%20LR%2C%20Holbrook%20EH%2C%20Albers%20AD%2C%20Gallagher%20R%2C%20Westover%20MB%2C%20Evans%20KE%2C%20Tatar%20DJ%2C%20Mukerji%20S%2C%20Zafonte%20R%2C%20Boyer%20EW%2C%20Yu%20CR%2C%20Albers%20MW.%20Innate%20immune%20signaling%20in%20the%20olfactory%20epithelium%20reduces%20odorant%20receptor%20levels%3A%20modeling%20transient%20smell%20loss%20in%20COVID-19%20patients%20%5BInternet%5D.%20medRxiv%3B%202020%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.06.14.20131128%27%3Ehttp%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.06.14.20131128%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Innate%20immune%20signaling%20in%20the%20olfactory%20epithelium%20reduces%20odorant%20receptor%20levels%3A%20modeling%20transient%20smell%20loss%20in%20COVID-19%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luxiang%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20T.%22%2C%22lastName%22%3A%22Rickenbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20G.%22%2C%22lastName%22%3A%22Benz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Magdamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%20Ramirez%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20H.%22%2C%22lastName%22%3A%22Holbrook%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alefiya%20D.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rose%22%2C%22lastName%22%3A%22Gallagher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Brandon%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%20E.%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Tatar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shibani%22%2C%22lastName%22%3A%22Mukerji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ross%22%2C%22lastName%22%3A%22Zafonte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20W%22%2C%22lastName%22%3A%22Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20Ron%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20Post-infectious%20anosmias%20typically%20follow%20death%20of%20olfactory%20sensory%20neurons%20%28OSNs%29%20with%20a%20months-long%20recovery%20phase%20associated%20with%20parosmias.%20While%20profound%20anosmia%20is%20the%20leading%20symptom%20associated%20with%20COVID-19%20infection%2C%20many%20patients%20regain%20olfactory%20function%20within%20days%20to%20weeks%20without%20distortions.%20Here%2C%20we%20demonstrate%20that%20sterile%20induction%20of%20anti-viral%20type%20I%20interferon%20signaling%20in%20the%20mouse%20olfactory%20epithelium%20is%20associated%20with%20diminished%20odor%20discrimination%20and%20reduced%20odor-evoked%20local%20field%20potentials.%20RNA%20levels%20of%20all%20class%20I%2C%20class%20II%2C%20and%20TAAR%20odorant%20receptors%20are%20markedly%20reduced%20in%20OSNs%20in%20a%20non-cell%20autonomous%20manner.%20We%20find%20that%20people%20infected%20with%20COVID-19%20rate%20odors%20with%20lower%20intensities%20and%20have%20odor%20discrimination%20deficits%20relative%20to%20people%20that%20tested%20negative%20for%20COVID-19.%20Taken%20together%2C%20we%20propose%20that%20inflammatory-mediated%20loss%20of%20odorant%20receptor%20expression%20with%20preserved%20circuit%20integrity%20accounts%20for%20the%20profound%20anosmia%20and%20rapid%20recovery%20of%20olfactory%20function%20without%20parosmias%20caused%20by%20COVID-19.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222020-06-16%22%2C%22DOI%22%3A%2210.1101%5C%2F2020.06.14.20131128%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fmedrxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2020.06.14.20131128%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A16%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22D2BM36DF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rozenblatt-Rosen%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-16%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERozenblatt-Rosen%20O%2C%20Regev%20A%2C%20Oberdoerffer%20P%2C%20Nawy%20T%2C%20Hupalowska%20A%2C%20Rood%20JE%2C%20Ashenberg%20O%2C%20Cerami%20E%2C%20Coffey%20RJ%2C%20Demir%20E%2C%20Ding%20L%2C%20Esplin%20ED%2C%20Ford%20JM%2C%20Goecks%20J%2C%20Ghosh%20S%2C%20Gray%20JW%2C%20Guinney%20J%2C%20Hanlon%20SE%2C%20Hughes%20SK%2C%20Hwang%20ES%2C%20Iacobuzio-Donahue%20CA%2C%20Jan%26%23xE9%3B-Valbuena%20J%2C%20Johnson%20BE%2C%20Lau%20KS%2C%20Lively%20T%2C%20Mazzilli%20SA%2C%20Pe%26%23x2019%3Ber%20D%2C%20Santagata%20S%2C%20Shalek%20AK%2C%20Schapiro%20D%2C%20Snyder%20MP%2C%20Sorger%20PK%2C%20Spira%20AE%2C%20Srivastava%20S%2C%20Tan%20K%2C%20West%20RB%2C%20Williams%20EH%2C%20Human%20Tumor%20Atlas%20Network.%20The%20Human%20Tumor%20Atlas%20Network%3A%20charting%20tumor%20transitions%20across%20space%20and%20time%20at%20single-cell%20resolution.%20Cell.%202020%20Apr%2016%3B181%282%29%3A236%26%23x2013%3B249.%20PMCID%3A%20PMC7376497%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Human%20Tumor%20Atlas%20Network%3A%20charting%20tumor%20transitions%20across%20space%20and%20time%20at%20single-cell%20resolution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Oberdoerffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tal%22%2C%22lastName%22%3A%22Nawy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Hupalowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20E.%22%2C%22lastName%22%3A%22Rood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orr%22%2C%22lastName%22%3A%22Ashenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Cerami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Coffey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emek%22%2C%22lastName%22%3A%22Demir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Ding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Esplin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Goecks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharmistha%22%2C%22lastName%22%3A%22Ghosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Guinney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20E.%22%2C%22lastName%22%3A%22Hanlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%20K.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Shelley%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20A.%22%2C%22lastName%22%3A%22Iacobuzio-Donahue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judit%22%2C%22lastName%22%3A%22Jan%5Cu00e9-Valbuena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%20S.%22%2C%22lastName%22%3A%22Lau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracy%22%2C%22lastName%22%3A%22Lively%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Mazzilli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Pe%27er%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20K.%22%2C%22lastName%22%3A%22Shalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Snyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avrum%20E.%22%2C%22lastName%22%3A%22Spira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudhir%22%2C%22lastName%22%3A%22Srivastava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20B.%22%2C%22lastName%22%3A%22West%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20H.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Human%20Tumor%20Atlas%20Network%22%7D%5D%2C%22abstractNote%22%3A%22Crucial%20transitions%20in%20cancer-including%20tumor%20initiation%2C%20local%20expansion%2C%20metastasis%2C%20and%20therapeutic%20resistance-involve%20complex%20interactions%20between%20cells%20within%20the%20dynamic%20tumor%20ecosystem.%20Transformative%20single-cell%20genomics%20technologies%20and%20spatial%20multiplex%20in%20situ%20methods%20now%20provide%20an%20opportunity%20to%20interrogate%20this%20complexity%20at%20unprecedented%20resolution.%20The%20Human%20Tumor%20Atlas%20Network%20%28HTAN%29%2C%20part%20of%20the%20National%20Cancer%20Institute%20%28NCI%29%20Cancer%20Moonshot%20Initiative%2C%20will%20establish%20a%20clinical%2C%20experimental%2C%20computational%2C%20and%20organizational%20framework%20to%20generate%20informative%20and%20accessible%20three-dimensional%20atlases%20of%20cancer%20transitions%20for%20a%20diverse%20set%20of%20tumor%20types.%20This%20effort%20complements%20both%20ongoing%20efforts%20to%20map%20healthy%20organs%20and%20previous%20large-scale%20cancer%20genomics%20approaches%20focused%20on%20bulk%20sequencing%20at%20a%20single%20point%20in%20time.%20Generating%20single-cell%2C%20multiparametric%2C%20longitudinal%20atlases%20and%20integrating%20them%20with%20clinical%20outcomes%20should%20help%20identify%20novel%20predictive%20biomarkers%20and%20features%20as%20well%20as%20therapeutically%20relevant%20cell%20types%2C%20cell%20states%2C%20and%20cellular%20interactions%20across%20transitions.%20The%20resulting%20tumor%20atlases%20should%20have%20a%20profound%20impact%20on%20our%20understanding%20of%20cancer%20biology%20and%20have%20the%20potential%20to%20improve%20cancer%20detection%2C%20prevention%2C%20and%20therapeutic%20discovery%20for%20better%20precision-medicine%20treatments%20of%20cancer%20patients%20and%20those%20at%20risk%20for%20cancer.%22%2C%22date%22%3A%22Apr%2016%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2020.03.053%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A39%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22RKVM5UTP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Russell-Goldman%20and%20Murphy%22%2C%22parsedDate%22%3A%222020-07%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERussell-Goldman%20E%2C%20Murphy%20GF.%20The%20pathobiology%20of%20skin%20aging%3A%20new%20insights%20into%20an%20old%20dilemma.%20Am%20J%20Pathol.%202020%20Jul%3B190%287%29%3A1356%26%23x2013%3B1369.%20PMCID%3A%20PMC7481755%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20pathobiology%20of%20skin%20aging%3A%20new%20insights%20into%20an%20old%20dilemma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%22%2C%22lastName%22%3A%22Russell-Goldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%5D%2C%22abstractNote%22%3A%22Long%20considered%20both%20physiologic%20and%20inevitable%2C%20skin%20aging%20is%20a%20degenerative%20phenomenon%20whereby%20both%20intrinsic%20and%20environmental%20factors%20conspire%20to%20produce%20an%20authentic%20disease.%20The%20consequences%20of%20this%20disorder%20are%20many%20and%20varied%2C%20ranging%20from%20atrophy%20and%20fragility%20to%20defective%20repair%20to%20deficient%20immunity%20and%20vulnerability%20to%20certain%20infections.%20The%20pathobiologic%20basis%20for%20skin%20aging%20remains%20poorly%20understood.%20At%20a%20cellular%20level%2C%20stem%20cell%20dysfunction%20and%20attrition%20appear%20to%20be%20key%20events%2C%20and%20both%20genetic%20and%20epigenetic%20factors%20are%20involved%20in%20a%20complex%20interplay%20that%20over%20time%20results%20in%20deterioration%20of%20our%20main%20protective%20interface%20with%20the%20external%20environment.%20Past%20and%20current%20understanding%20of%20the%20cellular%20and%20molecular%20intricacies%20of%20skin%20aging%20provide%20a%20foundation%20for%20future%20approaches%20designed%20to%20thwart%20the%20aging%20phenotype.%20Herein%2C%20the%20authors%20provide%20a%20review%20of%20current%20insights%20into%20skin%20aging%2C%20including%20the%20mechanisms%20of%20skin%20aging%2C%20the%20role%20of%20stem%20cells%20in%20skin%20aging%20and%20the%20implications%20of%20skin%20aging%20for%20the%20microbiome%20and%20for%20the%20development%20of%20cancer.%20Conquest%20of%20the%20oft%20overlooked%20disease%20of%20skin%20aging%20should%20have%20broad%20implications%20that%20transcend%20the%20integument%20and%20inform%20novel%20approaches%20to%20retarding%20aging%20and%20age-related%20dysfunction%20in%20those%20internal%20organs%20that%20youthful%20skin%20was%20designed%20to%20envelop%20and%20safeguard.%22%2C%22date%22%3A%222020-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajpath.2020.03.007%22%2C%22ISSN%22%3A%221525-2191%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A39%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22UL6KPJFR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Santoriello%20et%20al.%22%2C%22parsedDate%22%3A%222020-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESantoriello%20C%2C%20Sporrij%20A%2C%20Yang%20S%2C%20Flynn%20RA%2C%20Henriques%20T%2C%20Dorjsuren%20B%2C%20Custo%20Greig%20E%2C%20McCall%20W%2C%20Stanhope%20ME%2C%20Fazio%20M%2C%20Superdock%20M%2C%20Lichtig%20A%2C%20Adatto%20I%2C%20Abraham%20BJ%2C%20Kalocsay%20M%2C%20Jurynec%20M%2C%20Zhou%20Y%2C%20Adelman%20K%2C%20Calo%20E%2C%20Zon%20LI.%20RNA%20helicase%20DDX21%20mediates%20nucleotide%20stress%20responses%20in%20neural%20crest%20and%20melanoma%20cells.%20Nat%20Cell%20Biol.%202020%20Apr%3B22%284%29%3A372%26%23x2013%3B379.%20PMCID%3A%20PMC7185069%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22RNA%20helicase%20DDX21%20mediates%20nucleotide%20stress%20responses%20in%20neural%20crest%20and%20melanoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Santoriello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Sporrij%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Song%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20A.%22%2C%22lastName%22%3A%22Flynn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Telmo%22%2C%22lastName%22%3A%22Henriques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bilguujin%22%2C%22lastName%22%3A%22Dorjsuren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugenia%22%2C%22lastName%22%3A%22Custo%20Greig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wyatt%22%2C%22lastName%22%3A%22McCall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%20E.%22%2C%22lastName%22%3A%22Stanhope%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurizio%22%2C%22lastName%22%3A%22Fazio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Superdock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asher%22%2C%22lastName%22%3A%22Lichtig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Adatto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20J.%22%2C%22lastName%22%3A%22Abraham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Jurynec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Adelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%22%2C%22lastName%22%3A%22Calo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonard%20I.%22%2C%22lastName%22%3A%22Zon%22%7D%5D%2C%22abstractNote%22%3A%22The%20availability%20of%20nucleotides%20has%20a%20direct%20impact%20on%20transcription.%20The%20inhibition%20of%20dihydroorotate%20dehydrogenase%20%28DHODH%29%20with%20leflunomide%20impacts%20nucleotide%20pools%20by%20reducing%20pyrimidine%20levels.%20Leflunomide%20abrogates%20the%20effective%20transcription%20elongation%20of%20genes%20required%20for%20neural%20crest%20development%20and%20melanoma%20growth%20in%20vivo1.%20To%20define%20the%20mechanism%20of%20action%2C%20we%20undertook%20an%20in%20vivo%20chemical%20suppressor%20screen%20for%20restoration%20of%20neural%20crest%20after%20leflunomide%20treatment.%20Surprisingly%2C%20we%20found%20that%20alterations%20in%20progesterone%20and%20progesterone%20receptor%20%28Pgr%29%20signalling%20strongly%20suppressed%20leflunomide-mediated%20neural%20crest%20effects%20in%20zebrafish.%20In%20addition%2C%20progesterone%20bypasses%20the%20transcriptional%20elongation%20block%20resulting%20from%20Paf%20complex%20deficiency%2C%20rescuing%20neural%20crest%20defects%20in%20ctr9%20morphant%20and%20paf1%28alnz24%29%20mutant%20embryos.%20Using%20proteomics%2C%20we%20found%20that%20Pgr%20binds%20the%20RNA%20helicase%20protein%20Ddx21.%20ddx21-deficient%20zebrafish%20show%20resistance%20to%20leflunomide-induced%20stress.%20At%20a%20molecular%20level%2C%20nucleotide%20depletion%20reduced%20the%20chromatin%20occupancy%20of%20DDX21%20in%20human%20A375%20melanoma%20cells.%20Nucleotide%20supplementation%20reversed%20the%20gene%20expression%20signature%20and%20DDX21%20occupancy%20changes%20prompted%20by%20leflunomide.%20Together%2C%20our%20results%20show%20that%20DDX21%20acts%20as%20a%20sensor%20and%20mediator%20of%20transcription%20during%20nucleotide%20stress.%22%2C%22date%22%3A%222020-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41556-020-0493-0%22%2C%22ISSN%22%3A%221476-4679%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-03-03T17%3A33%3A00Z%22%7D%7D%2C%7B%22key%22%3A%222LFRTHNS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shamsaei%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-02%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShamsaei%20B%2C%20Chojnacki%20S%2C%20Pilarczyk%20M%2C%20Najafabadi%20M%2C%20Niu%20W%2C%20Chen%20C%2C%20Ross%20K%2C%20Matlock%20A%2C%20Muhlich%20J%2C%20Chutipongtanate%20S%2C%20Zheng%20J%2C%20Turner%20J%2C%20Vidovi%26%23x107%3B%20D%2C%20Jaffe%20J%2C%20MacCoss%20M%2C%20Wu%20C%2C%20Pillai%20A%2C%20Ma%26%23x2019%3Bayan%20A%2C%20Sch%26%23xFC%3Brer%20S%2C%20Kouril%20M%2C%20Medvedovic%20M%2C%20Meller%20J.%20piNET%3A%20a%20versatile%20web%20platform%20for%20downstream%20analysis%20and%20visualization%20of%20proteomics%20data.%20Nucleic%20Acids%20Res.%202020%20Jul%202%3B48%28W1%29%3AW85%26%23x2013%3BW93.%20PMCID%3A%20PMC7319557%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22piNET%3A%20a%20versatile%20web%20platform%20for%20downstream%20analysis%20and%20visualization%20of%20proteomics%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Behrouz%22%2C%22lastName%22%3A%22Shamsaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Szymon%22%2C%22lastName%22%3A%22Chojnacki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcin%22%2C%22lastName%22%3A%22Pilarczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Najafabadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Niu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chuming%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Matlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somchai%22%2C%22lastName%22%3A%22Chutipongtanate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Du%5Cu0161ica%22%2C%22lastName%22%3A%22Vidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jake%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22MacCoss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Pillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avi%22%2C%22lastName%22%3A%22Ma%27ayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Sch%5Cu00fcrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michal%22%2C%22lastName%22%3A%22Kouril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Medvedovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarek%22%2C%22lastName%22%3A%22Meller%22%7D%5D%2C%22abstractNote%22%3A%22Rapid%20progress%20in%20proteomics%20and%20large-scale%20profiling%20of%20biological%20systems%20at%20the%20protein%20level%20necessitates%20the%20continued%20development%20of%20efficient%20computational%20tools%20for%20the%20analysis%20and%20interpretation%20of%20proteomics%20data.%20Here%2C%20we%20present%20the%20piNET%20server%20that%20facilitates%20integrated%20annotation%2C%20analysis%20and%20visualization%20of%20quantitative%20proteomics%20data%2C%20with%20emphasis%20on%20PTM%20networks%20and%20integration%20with%20the%20LINCS%20library%20of%20chemical%20and%20genetic%20perturbation%20signatures%20in%20order%20to%20provide%20further%20mechanistic%20and%20functional%20insights.%20The%20primary%20input%20for%20the%20server%20consists%20of%20a%20set%20of%20peptides%20or%20proteins%2C%20optionally%20with%20PTM%20sites%2C%20and%20their%20corresponding%20abundance%20values.%20Several%20interconnected%20workflows%20can%20be%20used%20to%20generate%3A%20%28i%29%20interactive%20graphs%20and%20tables%20providing%20comprehensive%20annotation%20and%20mapping%20between%20peptides%20and%20proteins%20with%20PTM%20sites%3B%20%28ii%29%20high%20resolution%20and%20interactive%20visualization%20for%20enzyme-substrate%20networks%2C%20including%20kinases%20and%20their%20phospho-peptide%20targets%3B%20%28iii%29%20mapping%20and%20visualization%20of%20LINCS%20signature%20connectivity%20for%20chemical%20inhibitors%20or%20genetic%20knockdown%20of%20enzymes%20upstream%20of%20their%20target%20PTM%20sites.%20piNET%20has%20been%20built%20using%20a%20modular%20Spring-Boot%20JAVA%20platform%20as%20a%20fast%2C%20versatile%20and%20easy%20to%20use%20tool.%20The%20Apache%20Lucene%20indexing%20is%20used%20for%20fast%20mapping%20of%20peptides%20into%20UniProt%20entries%20for%20the%20human%2C%20mouse%20and%20other%20commonly%20used%20model%20organism%20proteomes.%20PTM-centric%20network%20analyses%20combine%20PhosphoSitePlus%2C%20iPTMnet%20and%20SIGNOR%20databases%20of%20validated%20enzyme-substrate%20relationships%2C%20for%20kinase%20networks%20augmented%20by%20DeepPhos%20predictions%20and%20sequence-based%20mapping%20of%20PhosphoSitePlus%20consensus%20motifs.%20Concordant%20LINCS%20signatures%20are%20mapped%20using%20iLINCS.%20For%20each%20workflow%2C%20a%20RESTful%20API%20counterpart%20can%20be%20used%20to%20generate%20the%20results%20programmatically%20in%20the%20json%20format.%20The%20server%20is%20available%20at%20http%3A%5C%2F%5C%2Fpinet-server.org%2C%20and%20it%20is%20free%20and%20open%20to%20all%20users%20without%20login%20requirement.%22%2C%22date%22%3A%222020-07-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fnar%5C%2Fgkaa436%22%2C%22ISSN%22%3A%221362-4962%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T18%3A41%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22NYNXRM97%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Slyper%20et%20al.%22%2C%22parsedDate%22%3A%222020-05%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESlyper%20M%2C%20Porter%20CBM%2C%20Ashenberg%20O%2C%20Waldman%20J%2C%20Drokhlyansky%20E%2C%20Wakiro%20I%2C%20Smillie%20C%2C%20Smith-Rosario%20G%2C%20Wu%20J%2C%20Dionne%20D%2C%20Vigneau%20S%2C%20Jan%26%23xE9%3B-Valbuena%20J%2C%20Tickle%20TL%2C%20Napolitano%20S%2C%20Su%20MJ%2C%20Patel%20AG%2C%20Karlstrom%20A%2C%20Gritsch%20S%2C%20Nomura%20M%2C%20Waghray%20A%2C%20Gohil%20SH%2C%20Tsankov%20AM%2C%20Jerby-Arnon%20L%2C%20Cohen%20O%2C%20Klughammer%20J%2C%20Rosen%20Y%2C%20Gould%20J%2C%20Nguyen%20L%2C%20Hofree%20M%2C%20Tramontozzi%20PJ%2C%20Li%20B%2C%20Wu%20CJ%2C%20Izar%20B%2C%20Haq%20R%2C%20Hodi%20FS%2C%20Yoon%20CH%2C%20Hata%20AN%2C%20Baker%20SJ%2C%20Suv%26%23xE0%3B%20ML%2C%20Bueno%20R%2C%20Stover%20EH%2C%20Clay%20MR%2C%20Dyer%20MA%2C%20Collins%20NB%2C%20Matulonis%20UA%2C%20Wagle%20N%2C%20Johnson%20BE%2C%20Rotem%20A%2C%20Rozenblatt-Rosen%20O%2C%20Regev%20A.%20A%20single-cell%20and%20single-nucleus%20RNA-Seq%20toolbox%20for%20fresh%20and%20frozen%20human%20tumors.%20Nat%20Med.%202020%20May%3B26%285%29%3A792%26%23x2013%3B802.%20PMCID%3A%20PMC7220853%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20single-cell%20and%20single-nucleus%20RNA-Seq%20toolbox%20for%20fresh%20and%20frozen%20human%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michal%22%2C%22lastName%22%3A%22Slyper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20B.%20M.%22%2C%22lastName%22%3A%22Porter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orr%22%2C%22lastName%22%3A%22Ashenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Waldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%22%2C%22lastName%22%3A%22Drokhlyansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22Wakiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Smillie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Smith-Rosario%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingyi%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%22%2C%22lastName%22%3A%22Dionne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Vigneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judit%22%2C%22lastName%22%3A%22Jan%5Cu00e9-Valbuena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20L.%22%2C%22lastName%22%3A%22Tickle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Napolitano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Ju%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anand%20G.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asa%22%2C%22lastName%22%3A%22Karlstrom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Gritsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masashi%22%2C%22lastName%22%3A%22Nomura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avinash%22%2C%22lastName%22%3A%22Waghray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satyen%20H.%22%2C%22lastName%22%3A%22Gohil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20M.%22%2C%22lastName%22%3A%22Tsankov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Livnat%22%2C%22lastName%22%3A%22Jerby-Arnon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofir%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Klughammer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanay%22%2C%22lastName%22%3A%22Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Gould%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lan%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matan%22%2C%22lastName%22%3A%22Hofree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20J.%22%2C%22lastName%22%3A%22Tramontozzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20J.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rizwan%22%2C%22lastName%22%3A%22Haq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Stephen%22%2C%22lastName%22%3A%22Hodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20H.%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20N.%22%2C%22lastName%22%3A%22Hata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20L.%22%2C%22lastName%22%3A%22Suv%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Bueno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20H.%22%2C%22lastName%22%3A%22Stover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22Clay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Dyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20B.%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ursula%20A.%22%2C%22lastName%22%3A%22Matulonis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikhil%22%2C%22lastName%22%3A%22Wagle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%5D%2C%22abstractNote%22%3A%22Single-cell%20genomics%20is%20essential%20to%20chart%20tumor%20ecosystems.%20Although%20single-cell%20RNA-Seq%20%28scRNA-Seq%29%20profiles%20RNA%20from%20cells%20dissociated%20from%20fresh%20tumors%2C%20single-nucleus%20RNA-Seq%20%28snRNA-Seq%29%20is%20needed%20to%20profile%20frozen%20or%20hard-to-dissociate%20tumors.%20Each%20requires%20customization%20to%20different%20tissue%20and%20tumor%20types%2C%20posing%20a%20barrier%20to%20adoption.%20Here%2C%20we%20have%20developed%20a%20systematic%20toolbox%20for%20profiling%20fresh%20and%20frozen%20clinical%20tumor%20samples%20using%20scRNA-Seq%20and%20snRNA-Seq%2C%20respectively.%20We%20analyzed%20216%2C490%20cells%20and%20nuclei%20from%2040%20samples%20across%2023%20specimens%20spanning%20eight%20tumor%20types%20of%20varying%20tissue%20and%20sample%20characteristics.%20We%20evaluated%20protocols%20by%20cell%20and%20nucleus%20quality%2C%20recovery%20rate%20and%20cellular%20composition.%20scRNA-Seq%20and%20snRNA-Seq%20from%20matched%20samples%20recovered%20the%20same%20cell%20types%2C%20but%20at%20different%20proportions.%20Our%20work%20provides%20guidance%20for%20studies%20in%20a%20broad%20range%20of%20tumors%2C%20including%20criteria%20for%20testing%20and%20selecting%20methods%20from%20the%20toolbox%20for%20other%20tumors%2C%20thus%20paving%20the%20way%20for%20charting%20tumor%20atlases.%22%2C%22date%22%3A%22May%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-020-0844-1%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A58%3A18Z%22%7D%7D%2C%7B%22key%22%3A%228PJJVM3U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Steppi%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-16%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESteppi%20A%2C%20Gyori%20BM%2C%20Bachman%20JA.%20Adeft%3A%20Acromine-based%20Disambiguation%20of%20Entities%20from%20Text%20with%20applications%20to%20the%20biomedical%20literature.%20J%20Open%20Source%20Softw.%202020%20Jan%2016%3B5%2845%29%3A1708.%20PMCID%3A%20PMC7182313%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adeft%3A%20Acromine-based%20Disambiguation%20of%20Entities%20from%20Text%20with%20applications%20to%20the%20biomedical%20literature%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Steppi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-01-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21105%5C%2Fjoss.01708%22%2C%22ISSN%22%3A%222475-9066%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A03%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22WJM94GIF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Teng%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETeng%20M%2C%20Jiang%20J%2C%20He%20Z%2C%20Kwiatkowski%20NP%2C%20Donovan%20KA%2C%20Mills%20CE%2C%20Victor%20C%2C%20Hatcher%20JM%2C%20Fischer%20ES%2C%20Sorger%20PK%2C%20Zhang%20T%2C%20Gray%20NS.%20Development%20of%20CDK2%20and%20CDK5%20dual%20degrader%20TMX-2172.%20Angew%20Chem%20Int%20Ed%20Engl.%202020%20Aug%2010%3B59%2833%29%3A13865%26%23x2013%3B13870.%20PMCID%3A%20PMC7703486%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20of%20CDK2%20and%20CDK5%20dual%20degrader%20TMX-2172%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingxing%22%2C%22lastName%22%3A%22Teng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhixiang%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20P.%22%2C%22lastName%22%3A%22Kwiatkowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Donovan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Victor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Hatcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20S.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%202%20%28CDK2%29%20is%20a%20potential%20therapeutic%20target%20for%20the%20treatment%20of%20cancer.%20Development%20of%20CDK2%20inhibitors%20has%20been%20extremely%20challenging%20as%20its%20ATP-binding%20site%20shares%20high%20similarity%20with%20CDK1%2C%20a%20related%20kinase%20whose%20inhibition%20causes%20toxic%20effects.%20Here%2C%20we%20report%20the%20development%20of%20TMX-2172%2C%20a%20heterobifunctional%20CDK2%20degrader%20with%20degradation%20selectivity%20for%20CDK2%20and%20CDK5%20over%20not%20only%20CDK1%2C%20but%20transcriptional%20CDKs%20%28CDK7%20and%20CDK9%29%20and%20cell%20cycle%20CDKs%20%28CDK4%20and%20CDK6%29%20as%20well.%20In%20addition%2C%20we%20demonstrate%20that%20antiproliferative%20activity%20in%20ovarian%20cancer%20cells%20%28OVCAR8%29%20depends%20on%20CDK2%20degradation%20and%20correlates%20with%20high%20expression%20of%20cyclin%20E1%20%28CCNE1%29%2C%20which%20functions%20as%20a%20regulatory%20subunit%20of%20CDK2.%20Collectively%2C%20our%20work%20provides%20evidence%20that%20TMX-2172%20represents%20a%20lead%20for%20further%20development%20and%20that%20CDK2%20degradation%20is%20a%20potentially%20valuable%20therapeutic%20strategy%20in%20ovarian%20and%20other%20cancers%20that%20overexpress%20CCNE1.%22%2C%22date%22%3A%222020-08-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fanie.202004087%22%2C%22ISSN%22%3A%221521-3773%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A40%3A32Z%22%7D%7D%2C%7B%22key%22%3A%223ASZEYSM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tran%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETran%20AP%2C%20Ali%20Al-Radhawi%20M%2C%20Kareva%20I%2C%20Wu%20J%2C%20Waxman%20DJ%2C%20Sontag%20ED.%20Delicate%20balances%20in%20cancer%20chemotherapy%3A%20modeling%20immune%20recruitment%20and%20emergence%20of%20systemic%20drug%20resistance.%20Front%20Immunol.%202020%3B11%3A1376.%20PMCID%3A%20PMC7338613%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delicate%20balances%20in%20cancer%20chemotherapy%3A%20modeling%20immune%20recruitment%20and%20emergence%20of%20systemic%20drug%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anh%20Phong%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Ali%20Al-Radhawi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kareva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junjie%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Waxman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20D.%22%2C%22lastName%22%3A%22Sontag%22%7D%5D%2C%22abstractNote%22%3A%22Metronomic%20chemotherapy%20can%20drastically%20enhance%20immunogenic%20tumor%20cell%20death.%20However%2C%20the%20mechanisms%20responsible%20are%20still%20incompletely%20understood.%20Here%2C%20we%20develop%20a%20mathematical%20model%20to%20elucidate%20the%20underlying%20complex%20interactions%20between%20tumor%20growth%2C%20immune%20system%20activation%2C%20and%20therapy-mediated%20immunogenic%20cell%20death.%20Our%20model%20is%20conceptually%20simple%2C%20yet%20it%20provides%20a%20surprisingly%20excellent%20fit%20to%20empirical%20data%20obtained%20from%20a%20GL261%20SCID%20mouse%20glioma%20model%20treated%20with%20cyclophosphamide%20on%20a%20metronomic%20schedule.%20The%20model%20includes%20terms%20representing%20immune%20recruitment%20as%20well%20as%20the%20emergence%20of%20drug%20resistance%20during%20prolonged%20metronomic%20treatments.%20Strikingly%2C%20a%20single%20fixed%20set%20of%20parameters%2C%20adjusted%20neither%20for%20individuals%20nor%20for%20drug%20schedule%2C%20recapitulates%20experimental%20data%20across%20various%20drug%20regimens%20remarkably%20well%2C%20including%20treatments%20administered%20at%20intervals%20ranging%20from%206%20to%2012%20days.%20Additionally%2C%20the%20model%20predicts%20peak%20immune%20activation%20times%2C%20rediscovering%20experimental%20data%20that%20had%20not%20been%20used%20in%20parameter%20fitting%20or%20in%20model%20construction.%20Notably%2C%20the%20validated%20model%20suggests%20that%20immunostimulatory%20and%20immunosuppressive%20intermediates%20are%20responsible%20for%20the%20observed%20phenomena%20of%20resistance%20and%20immune%20cell%20recruitment%2C%20and%20thus%20for%20variation%20of%20responses%20with%20respect%20to%20different%20schedules%20of%20drug%20administration.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.01376%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A36%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22BE7YHQBS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tsabar%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETsabar%20M%2C%20Mock%20CS%2C%20Venkatachalam%20V%2C%20Reyes%20J%2C%20Karhohs%20KW%2C%20Oliver%20TG%2C%20Regev%20A%2C%20Jambhekar%20A%2C%20Lahav%20G.%20A%20switch%20in%20p53%20dynamics%20marks%20cells%20that%20escape%20from%20DSB-induced%20cell%20cycle%20arrest.%20Cell%20Rep.%202020%20Aug%204%3B32%285%29%3A107995.%20PMCID%3A%20PMC7521664%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20switch%20in%20p53%20dynamics%20marks%20cells%20that%20escape%20from%20DSB-induced%20cell%20cycle%20arrest%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Tsabar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20S.%22%2C%22lastName%22%3A%22Mock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veena%22%2C%22lastName%22%3A%22Venkatachalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%20W.%22%2C%22lastName%22%3A%22Karhohs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trudy%20G.%22%2C%22lastName%22%3A%22Oliver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22Cellular%20responses%20to%20stimuli%20can%20evolve%20over%20time%2C%20resulting%20in%20distinct%20early%20and%20late%20phases%20in%20response%20to%20a%20single%20signal.%20DNA%20damage%20induces%20a%20complex%20response%20that%20is%20largely%20orchestrated%20by%20the%20transcription%20factor%20p53%2C%20whose%20dynamics%20influence%20whether%20a%20damaged%20cell%20will%20arrest%20and%20repair%20the%20damage%20or%20will%20initiate%20cell%20death.%20How%20p53%20responses%20and%20cellular%20outcomes%20evolve%20in%20the%20presence%20of%20continuous%20DNA%20damage%20remains%20unknown.%20Here%2C%20we%20have%20found%20that%20a%20subset%20of%20cells%20switches%20from%20oscillating%20to%20sustained%20p53%20dynamics%20several%20days%20after%20undergoing%20damage.%20The%20switch%20results%20from%20cell%20cycle%20progression%20in%20the%20presence%20of%20damaged%20DNA%2C%20which%20activates%20the%20caspase-2-PIDDosome%2C%20a%20complex%20that%20stabilizes%20p53%20by%20inactivating%20its%20negative%20regulator%20MDM2.%20This%20work%20defines%20a%20molecular%20pathway%20that%20is%20activated%20if%20the%20canonical%20checkpoints%20fail%20to%20halt%20mitosis%20in%20the%20presence%20of%20damaged%20DNA.%22%2C%22date%22%3A%22Aug%2004%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2020.107995%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A40%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22UYBT42DY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tyan%20et%20al.%22%2C%22parsedDate%22%3A%222020-09%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETyan%20K%2C%20Levin%20A%2C%20Avalos-Pacheco%20A%2C%20Plana%20D%2C%20Rand%20EA%2C%20Yang%20H%2C%20Maliszewski%20LE%2C%20Chylek%20LA%2C%20Atta%20L%2C%20Tye%20MA%2C%20Carmack%20MM%2C%20Oglesby%20NS%2C%20Burgin%20S%2C%20Yu%20SH%2C%20LeBoeuf%20NR%2C%20Kemp%20JM.%20Considerations%20for%20the%20selection%20and%20use%20of%20disinfectants%20against%20SARS-CoV-2%20in%20a%20health%20care%20setting.%20Open%20Forum%20Infect%20Dis.%202020%20Sep%3B7%289%29%3Aofaa396.%20PMCID%3A%20PMC7499694%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Considerations%20for%20the%20selection%20and%20use%20of%20disinfectants%20against%20SARS-CoV-2%20in%20a%20health%20care%20setting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Tyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriane%22%2C%22lastName%22%3A%22Levin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Avalos-Pacheco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%20A.%22%2C%22lastName%22%3A%22Rand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22Maliszewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lily%20A.%22%2C%22lastName%22%3A%22Chylek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyla%22%2C%22lastName%22%3A%22Atta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Tye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20M.%22%2C%22lastName%22%3A%22Carmack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20Synclaire%22%2C%22lastName%22%3A%22Oglesby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Burgin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20R.%22%2C%22lastName%22%3A%22LeBoeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20M.%22%2C%22lastName%22%3A%22Kemp%22%7D%5D%2C%22abstractNote%22%3A%22Proper%20disinfection%20using%20adequate%20disinfecting%20agents%20will%20be%20necessary%20for%20infection%20control%20strategies%20against%20coronavirus%20disease%202019%20%28COVID-19%29.%20However%2C%20limited%20guidance%20exists%20on%20effective%20surface%20disinfectants%20or%20best%20practices%20for%20their%20use%20against%20severe%20acute%20respiratory%20coronavirus%202.%20We%20outlined%20a%20process%20of%20fully%20characterizing%20over%20350%20products%20on%20the%20Environmental%20Protection%20Agency%20List%20N%2C%20including%20pH%2C%20method%20of%20delivery%2C%20indication%20for%20equipment%20sterilization%2C%20and%20purchase%20availability.%20We%20then%20developed%20a%20streamlined%20set%20of%20guidelines%20to%20help%20rapidly%20evaluate%20and%20select%20suitable%20disinfectants%20from%20List%20N%2C%20including%20practicality%2C%20efficacy%2C%20safety%2C%20and%20cost%5C%2Favailability.%20This%20resource%20guides%20the%20evaluation%20of%20ideal%20disinfectants%20amidst%20practical%20considerations%20posed%20by%20the%20COVID-19%20pandemic.%22%2C%22date%22%3A%22Sep%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofaa396%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A03%3A44Z%22%7D%7D%5D%7D
1.
Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH. Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell. 2020 Nov 25;183(5):1354-1366.e13. PMCID: PMC7546181
1.
Berginski ME, Moret N, Liu C, Goldfarb D, Sorger PK, Gomez SM. The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases. Nucleic Acids Res. 2020 Oct 20;49(D1):D529–D535. PMCID: PMC7778917
1.
Bhola PD, Ahmed E, Guerriero JL, Sicinska E, Su E, Lavrova E, Ni J, Chipashvili O, Hagan T, Pioso MS, McQueeney K, Ng K, Aguirre AJ, Cleary JM, Cocozziello D, Sotayo A, Ryan J, Zhao JJ, Letai A. High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors. Sci Signal. 2020 Jun 16;13(636). PMCID: PMC8023011
1.
Břinda K, Callendrello A, Ma KC, MacFadden DR, Charalampous T, Lee RS, Cowley L, Wadsworth CB, Grad YH, Kucherov G, O’Grady J, Baym M, Hanage WP. Rapid inference of antibiotic resistance and susceptibility by genomic neighbour typing. Nat Microbiol. 2020 Mar;5(3):455–464. PMCID: PMC7044115
1.
Chopra SS, Jenney A, Palmer A, Niepel M, Chung M, Mills C, Sivakumaren SC, Liu Q, Chen JY, Yapp C, Asara JM, Gray NS, Sorger PK. Torin2 exploits replication and checkpoint vulnerabilities to cause death of PI3K-activated triple-negative breast cancer cells. Cell Syst. 2020 Jan 22;10(1):66-81.e11. PMCID: PMC7000271
1.
Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol. 2020 Apr;139(4):643–665. PMCID: PMC7038792
1.
Cunningham JM, Koytiger G, Sorger PK, AlQuraishi M. Biophysical prediction of protein-peptide interactions and signaling networks using machine learning. Nat Methods. 2020 Feb;17(2):175–183. PMCID: PMC7004877
1.
Drijvers JM, Sharpe AH, Haigis MC. The effects of age and systemic metabolism on anti-tumor T cell responses. Elife. 2020 Nov 10;9:e62420. PMCID: PMC7655106
1.
Drouin A, Wallbillich N, Theberge M, Liu S, Katz J, Bellovoda K, Se Yun Cheon S, Gootkind F, Bierman E, Zavras J, Berberich MJ, Kalocsay M, Guastaldi F, Salvadori N, Troulis M, Fusco DN. Impact of Zika virus on the human type I interferon osteoimmune response. Cytokine. 2020 Oct 29;137:155342. PMID: 33130337
1.
Du G, Rao S, Gurbani D, Henning NJ, Jiang J, Che J, Yang A, Ficarro SB, Marto JA, Aguirre AJ, Sorger PK, Westover KD, Zhang T, Gray NS. Structure-based design of a potent and selective covalent inhibitor for SRC kinase that targets a P-loop cysteine. J Med Chem. 2020 Feb 27;63(4):1624–1641. PMCID: PMC7493195
1.
Färkkilä A, Gulhan DC, Casado J, Jacobson CA, Nguyen H, Kochupurakkal B, Maliga Z, Yapp C, Chen YA, Schapiro D, Zhou Y, Graham JR, Dezube BJ, Munster P, Santagata S, Garcia E, Rodig S, Lako A, Chowdhury D, Shapiro GI, Matulonis UA, Park PJ, Hautaniemi S, Sorger PK, Swisher EM, D’Andrea AD, Konstantinopoulos PA. Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer. Nat Commun. 2020 Mar 19;11(1):1459. PMCID: PMC7081234
1.
Gaglia G, Rashid R, Yapp C, Joshi GN, Li CG, Lindquist SL, Sarosiek KA, Whitesell L, Sorger PK, Santagata S. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020 Feb;22(2):151–158. PMCID: PMC7135912
1.
Gerosa L, Chidley C, Fröhlich F, Sanchez G, Lim SK, Muhlich J, Chen JY, Vallabhaneni S, Baker GJ, Schapiro D, Atanasova MI, Chylek LA, Shi T, Yi L, Nicora CD, Claas A, Ng TSC, Kohler RH, Lauffenburger DA, Weissleder R, Miller MA, Qian WJ, Wiley HS, Sorger PK. Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells. Cell Syst. 2020 Nov 18;11(5):478-494.e9. PMCID: PMC8009031
1.
Hafner A, Reyes J, Stewart-Ornstein J, Tsabar M, Jambhekar A, Lahav G. Quantifying the central dogma in the p53 pathway in live single cells. Cell Syst. 2020 Jun 24;10(6):495-505.e4. PMCID: PMC7413213
1.
Hemming ML, Nathenson MJ, Lin JR, Mei S, Du Z, Malik K, Marino-Enriquez A, Jagannathan JP, Sorger PK, Bertagnolli M, Sicinska E, Demetri GD, Santagata S. Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1. JCO Precis Oncol. 2020 Feb 14;4:79–90. PMCID: PMC7055910
1.
Hoffer J, Rashid R, Muhlich JL, Chen YA, Russell DPW, Ruokonen J, Krueger R, Pfister H, Santagata S, Sorger PK. Minerva: a light-weight, narrative image browser for multiplexed tissue images. J Open Source Softw. 2020 Oct 15;5(54):2579. PMCID: PMC7989801
1.
Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P, Iwanicki M, Walker SR, Kanodia A, Melms JC, Mei S, Lin JR, Porter CBM, Slyper M, Waldman J, Jerby-Arnon L, Ashenberg O, Brinker TJ, Mills C, Rogava M, Vigneau S, Sorger PK, Garraway LA, Konstantinopoulos PA, Liu JF, Matulonis U, Johnson BE, Rozenblatt-Rosen O, Rotem A, Regev A. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020 Aug;26(8):1271–1279. PMCID: PMC7723336
1.
Kalocsay M, Maliga Z, Nirmal AJ, Eisert RJ, Bradshaw GA, Solomon IH, Chen YA, Pelletier RJ, Jacobson CA, Mintseris J, Padera RF, Martinot AJ, Barouch DH, Santagata S, Sorger PK. Multiplexed proteomics and imaging of resolving and lethal SARS-CoV-2 infection in the lung [Internet]. bioRxiv; 2020 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/2020.10.14.339952
1.
Krueger R, Beyer J, Jang WD, Kim NW, Sokolov A, Sorger PK, Pfister H. Facetto: combining unsupervised and supervised learning for hierarchical phenotype analysis in multi-channel image data. IEEE Trans Vis Comput Graph. 2020 Jan;26(1):227–237. PMCID: PMC7045445
1.
Leahy BD, Jang WD, Yang HY, Struyven R, Wei D, Sun Z, Lee KR, Royston C, Cam L, Kalma Y, Azem F, Ben-Yosef D, Pfister H, Needleman D. Automated measurements of key morphological features of human embryos for IVF. Med Image Comput Comput Assist Interv. 2020 Oct;12265:25–35. PMCID: PMC7732604
1.
Li Z, Pinch BJ, Olson CM, Donovan KA, Nowak RP, Mills CE, Scott DA, Doctor ZM, Eleuteri NA, Chung M, Sorger PK, Fischer ES, Gray NS. Development and characterization of a Wee1 kinase degrader. Cell Chem Biol. 2020 Jan 16;27(1):57-65.e9. PMCID: PMC6980656
1.
Lin Z, Wei D, Jang WD, Zhou S, Chen X, Wang X, Schalek R, Berger D, Matejek B, Kamentsky L, Peleg A, Haehn D, Jones T, Parag T, Lichtman J, Pfister H. Two stream active query suggestion for active learning in connectomics. Comput Vis ECCV. 2020 Aug;12363:103–120. PMCID: PMC7746018
1.
Liu Y, Ferguson FM, Li L, Kuljanin M, Mills CE, Subramanian K, Harshbarger W, Gondi S, Wang J, Sorger PK, Mancias JD, Gray NS, Westover KD. Chemical biology toolkit for DCLK1 reveals connection to RNA processing. Cell Chem Biol. 2020 Oct 15;27(10):1229-1240.e4. PMCID: PMC8053042
1.
Lyashenko E, Niepel M, Dixit PD, Lim SK, Sorger PK, Vitkup D. Receptor-based mechanism of relative sensing and cell memory in mammalian signaling networks. Elife. 2020 Jan 21;9:e50342. PMCID: PMC7046471
1.
Magid SA, Jang WD, Schapiro D, Wei D, Tompkin J, Sorger PK, Pfister H. Channel embedding for informative protein identification from highly multiplexed images. Med Image Comput Comput Assist Interv. 2020 Oct;12265:3–13. PMCID: PMC7713713
1.
Mallela A, Nariya MK, Deeds EJ. Crosstalk and ultrasensitivity in protein degradation pathways. PLoS Comput Biol. 2020 Dec;16(12):e1008492. PMCID: PMC7793289
1.
Melms JC, Vallabhaneni S, Mills CE, Yapp C, Chen JY, Morelli E, Waszyk P, Kumar S, Deming D, Moret N, Rodriguez S, Subramanian K, Rogava M, Cartwright ANR, Luoma A, Mei S, Brinker TJ, Miller DM, Spektor A, Schadendorf D, Riggi N, Wucherpfennig KW, Sorger PK, Izar B. Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity. Cancer Res. 2020 Feb 15;80(4):798–810. PMCID: PMC7029677
1.
Moret N, Liu C, Gyori BM, Bachman JA, Steppi A, Hug C, Taujale R, Huang LC, Berginski ME, Gomez SM, Kannan N, Sorger PK. A resource for exploring the understudied human kinome for research and therapeutic opportunities [Internet]. bioRxiv; 2020 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/2020.04.02.022277
1.
Mostaghimi A, Antonini MJ, Plana D, Anderson PD, Beller B, Boyer EW, Fannin A, Freake J, Oakley R, Sinha MS, Smith L, Van C, Yang H, Sorger PK, LeBoeuf NR, Yu SH. Regulatory and safety considerations in deploying a locally fabricated, reusable face shield in a hospital responding to the COVID-19 pandemic. Med (N Y). 2020 Dec 18;1(1):139-151.e4. PMCID: PMC7304404
1.
Nam KM, Gyori BM, Amethyst SV, Bates DJ, Gunawardena J. Robustness and parameter geography in post-translational modification systems. PLoS Comput Biol. 2020 May;16(5):e1007573. PMCID: PMC7224580
1.
Palmer AC, Plana D, Sorger PK. Comparing the efficacy of cancer therapies between subgroups in basket trials. Cell Syst. 2020 Nov 18;11(5):449-460.e2. PMCID: PMC8022348
1.
Palmer AC, Plana D, Gao H, Korn JM, Yang G, Green J, Zhang X, Velazquez R, McLaughlin ME, Ruddy DA, Kowal C, Muszynski J, Bullock C, Rivera S, Rakiec DP, Elliott G, Fordjour P, Meyer R, Loo A, Kurth E, Engelman JA, Bitter H, Sellers WR, Williams JA, Sorger PK. A proof of concept for biomarker-guided targeted therapy against ovarian cancer based on patient-derived tumor xenografts. Cancer Res. 2020 Oct 1;80(19):4278–4287. PMCID: PMC7541581
1.
Pena AM, Chen X, Pence IJ, Bornschlögl T, Jeong S, Grégoire S, Luengo GS, Hallegot P, Obeidy P, Feizpour A, Chan KF, Evans CL. Imaging and quantifying drug delivery in skin - Part 2: Fluorescence andvibrational spectroscopic imaging methods. Adv Drug Deliv Rev. 2020 Jan 1;153:147–168. PMCID: PMC7483684
1.
Plana D, Tian E, Cramer AK, Yang H, Carmack MM, Sinha MS, Bourgeois FT, Yu SH, Masse P, Boyer J, Kim M, Mo J, LeBoeuf NR, Li J, Sorger PK. Assessing the quality of nontraditional N95 filtering face-piece respirators available during the COVID-19 pandemic [Internet]. medRxiv; 2020 [cited 2024 Aug 12]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.07.25.20161968
1.
Pomeranz Krummel DA, Nasti TH, Izar B, Press RH, Xu M, Lowder L, Kallay L, Rupji M, Rosen H, Su J, Curran W, Olson J, Weinberg B, Schniederjan M, Neill S, Lawson D, Kowalski J, Khan MK, Sengupta S. Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):157–163. PMCID: PMC7839060
1.
Qian J, Lu ZX, Mancuso CP, Jhuang HY, Del Carmen Barajas-Ornelas R, Boswell SA, Ramírez-Guadiana FH, Jones V, Sonti A, Sedlack K, Artzi L, Jung G, Arammash M, Pettit ME, Melfi M, Lyon L, Owen SV, Baym M, Khalil AS, Silver PA, Rudner DZ, Springer M. Barcoded microbial system for high-resolution object provenance. Science. 2020 Jun 5;368(6495):1135–1140. PMID: 32499444
1.
Qu J, Steppi A, Zhong D, Hao J, Wang J, Lung PY, Zhao T, He Z, Zhang J. Triage of documents containing protein interactions affected by mutations using an NLP based machine learning approach. BMC Genomics. 2020 Nov 10;21(1):773. PMCID: PMC7654050
1.
Revach OY, Liu S, Jenkins RW. Targeting TANK-binding kinase 1 (TBK1) in cancer. Expert Opin Ther Targets. 2020 Nov;24(11):1065–1078. PMCID: PMC7644630
1.
Ringel AE, Drijvers JM, Baker GJ, Catozzi A, García-Cañaveras JC, Gassaway BM, Miller BC, Juneja VR, Nguyen TH, Joshi S, Yao CH, Yoon H, Sage PT, LaFleur MW, Trombley JD, Jacobson CA, Maliga Z, Gygi SP, Sorger PK, Rabinowitz JD, Sharpe AH, Haigis MC. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020 Dec 23;183(7):1848-1866.e26. PMCID: PMC8064125
1.
Rodriguez S, Cao L, Rickenbacher GT, Benz EG, Magdamo C, Gomez LR, Holbrook EH, Albers AD, Gallagher R, Westover MB, Evans KE, Tatar DJ, Mukerji S, Zafonte R, Boyer EW, Yu CR, Albers MW. Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients [Internet]. medRxiv; 2020 [cited 2023 Oct 31]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.06.14.20131128
1.
Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E, Ding L, Esplin ED, Ford JM, Goecks J, Ghosh S, Gray JW, Guinney J, Hanlon SE, Hughes SK, Hwang ES, Iacobuzio-Donahue CA, Jané-Valbuena J, Johnson BE, Lau KS, Lively T, Mazzilli SA, Pe’er D, Santagata S, Shalek AK, Schapiro D, Snyder MP, Sorger PK, Spira AE, Srivastava S, Tan K, West RB, Williams EH, Human Tumor Atlas Network. The Human Tumor Atlas Network: charting tumor transitions across space and time at single-cell resolution. Cell. 2020 Apr 16;181(2):236–249. PMCID: PMC7376497
1.
Russell-Goldman E, Murphy GF. The pathobiology of skin aging: new insights into an old dilemma. Am J Pathol. 2020 Jul;190(7):1356–1369. PMCID: PMC7481755
1.
Santoriello C, Sporrij A, Yang S, Flynn RA, Henriques T, Dorjsuren B, Custo Greig E, McCall W, Stanhope ME, Fazio M, Superdock M, Lichtig A, Adatto I, Abraham BJ, Kalocsay M, Jurynec M, Zhou Y, Adelman K, Calo E, Zon LI. RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells. Nat Cell Biol. 2020 Apr;22(4):372–379. PMCID: PMC7185069
1.
Shamsaei B, Chojnacki S, Pilarczyk M, Najafabadi M, Niu W, Chen C, Ross K, Matlock A, Muhlich J, Chutipongtanate S, Zheng J, Turner J, Vidović D, Jaffe J, MacCoss M, Wu C, Pillai A, Ma’ayan A, Schürer S, Kouril M, Medvedovic M, Meller J. piNET: a versatile web platform for downstream analysis and visualization of proteomics data. Nucleic Acids Res. 2020 Jul 2;48(W1):W85–W93. PMCID: PMC7319557
1.
Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, Patel AG, Karlstrom A, Gritsch S, Nomura M, Waghray A, Gohil SH, Tsankov AM, Jerby-Arnon L, Cohen O, Klughammer J, Rosen Y, Gould J, Nguyen L, Hofree M, Tramontozzi PJ, Li B, Wu CJ, Izar B, Haq R, Hodi FS, Yoon CH, Hata AN, Baker SJ, Suvà ML, Bueno R, Stover EH, Clay MR, Dyer MA, Collins NB, Matulonis UA, Wagle N, Johnson BE, Rotem A, Rozenblatt-Rosen O, Regev A. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020 May;26(5):792–802. PMCID: PMC7220853
1.
Steppi A, Gyori BM, Bachman JA. Adeft: Acromine-based Disambiguation of Entities from Text with applications to the biomedical literature. J Open Source Softw. 2020 Jan 16;5(45):1708. PMCID: PMC7182313
1.
Teng M, Jiang J, He Z, Kwiatkowski NP, Donovan KA, Mills CE, Victor C, Hatcher JM, Fischer ES, Sorger PK, Zhang T, Gray NS. Development of CDK2 and CDK5 dual degrader TMX-2172. Angew Chem Int Ed Engl. 2020 Aug 10;59(33):13865–13870. PMCID: PMC7703486
1.
Tran AP, Ali Al-Radhawi M, Kareva I, Wu J, Waxman DJ, Sontag ED. Delicate balances in cancer chemotherapy: modeling immune recruitment and emergence of systemic drug resistance. Front Immunol. 2020;11:1376. PMCID: PMC7338613
1.
Tsabar M, Mock CS, Venkatachalam V, Reyes J, Karhohs KW, Oliver TG, Regev A, Jambhekar A, Lahav G. A switch in p53 dynamics marks cells that escape from DSB-induced cell cycle arrest. Cell Rep. 2020 Aug 4;32(5):107995. PMCID: PMC7521664
1.
Tyan K, Levin A, Avalos-Pacheco A, Plana D, Rand EA, Yang H, Maliszewski LE, Chylek LA, Atta L, Tye MA, Carmack MM, Oglesby NS, Burgin S, Yu SH, LeBoeuf NR, Kemp JM. Considerations for the selection and use of disinfectants against SARS-CoV-2 in a health care setting. Open Forum Infect Dis. 2020 Sep;7(9):ofaa396. PMCID: PMC7499694
2576724
IXMHRBF6
LSP Paper
2019
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22S3MGWHKA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alley%20et%20al.%22%2C%22parsedDate%22%3A%222019-12%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlley%20EC%2C%20Khimulya%20G%2C%20Biswas%20S%2C%20AlQuraishi%20M%2C%20Church%20GM.%20Unified%20rational%20protein%20engineering%20with%20sequence-based%20deep%20representation%20learning.%20Nat%20Methods.%202019%20Dec%3B16%2812%29%3A1315%26%23x2013%3B1322.%20PMCID%3A%20PMC7067682%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Unified%20rational%20protein%20engineering%20with%20sequence-based%20deep%20representation%20learning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20C.%22%2C%22lastName%22%3A%22Alley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grigory%22%2C%22lastName%22%3A%22Khimulya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Surojit%22%2C%22lastName%22%3A%22Biswas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20M.%22%2C%22lastName%22%3A%22Church%22%7D%5D%2C%22abstractNote%22%3A%22Rational%20protein%20engineering%20requires%20a%20holistic%20understanding%20of%20protein%20function.%20Here%2C%20we%20apply%20deep%20learning%20to%20unlabeled%20amino-acid%20sequences%20to%20distill%20the%20fundamental%20features%20of%20a%20protein%20into%20a%20statistical%20representation%20that%20is%20semantically%20rich%20and%20structurally%2C%20evolutionarily%20and%20biophysically%20grounded.%20We%20show%20that%20the%20simplest%20models%20built%20on%20top%20of%20this%20unified%20representation%20%28UniRep%29%20are%20broadly%20applicable%20and%20generalize%20to%20unseen%20regions%20of%20sequence%20space.%20Our%20data-driven%20approach%20predicts%20the%20stability%20of%20natural%20and%20de%20novo%20designed%20proteins%2C%20and%20the%20quantitative%20function%20of%20molecularly%20diverse%20mutants%2C%20competitively%20with%20the%20state-of-the-art%20methods.%20UniRep%20further%20enables%20two%20orders%20of%20magnitude%20efficiency%20improvement%20in%20a%20protein%20engineering%20task.%20UniRep%20is%20a%20versatile%20summary%20of%20fundamental%20protein%20features%20that%20can%20be%20applied%20across%20protein%20engineering%20informatics.%22%2C%22date%22%3A%222019-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-019-0598-1%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A03%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22LUB9TM7Y%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AlQuraishi%22%2C%22parsedDate%22%3A%222019-06-11%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M.%20ProteinNet%3A%20a%20standardized%20data%20set%20for%20machine%20learning%20of%20protein%20structure.%20BMC%20Bioinformatics.%202019%20Jun%2011%3B20%281%29%3A311.%20PMCID%3A%20PMC6560865%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ProteinNet%3A%20a%20standardized%20data%20set%20for%20machine%20learning%20of%20protein%20structure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Rapid%20progress%20in%20deep%20learning%20has%20spurred%20its%20application%20to%20bioinformatics%20problems%20including%20protein%20structure%20prediction%20and%20design.%20In%20classic%20machine%20learning%20problems%20like%20computer%20vision%2C%20progress%20has%20been%20driven%20by%20standardized%20data%20sets%20that%20facilitate%20fair%20assessment%20of%20new%20methods%20and%20lower%20the%20barrier%20to%20entry%20for%20non-domain%20experts.%20While%20data%20sets%20of%20protein%20sequence%20and%20structure%20exist%2C%20they%20lack%20certain%20components%20critical%20for%20machine%20learning%2C%20including%20high-quality%20multiple%20sequence%20alignments%20and%20insulated%20training%5C%2Fvalidation%20splits%20that%20account%20for%20deep%20but%20only%20weakly%20detectable%20homology%20across%20protein%20space.%5CnRESULTS%3A%20We%20created%20the%20ProteinNet%20series%20of%20data%20sets%20to%20provide%20a%20standardized%20mechanism%20for%20training%20and%20assessing%20data-driven%20models%20of%20protein%20sequence-structure%20relationships.%20ProteinNet%20integrates%20sequence%2C%20structure%2C%20and%20evolutionary%20information%20in%20programmatically%20accessible%20file%20formats%20tailored%20for%20machine%20learning%20frameworks.%20Multiple%20sequence%20alignments%20of%20all%20structurally%20characterized%20proteins%20were%20created%20using%20substantial%20high-performance%20computing%20resources.%20Standardized%20data%20splits%20were%20also%20generated%20to%20emulate%20the%20difficulty%20of%20past%20CASP%20%28Critical%20Assessment%20of%20protein%20Structure%20Prediction%29%20experiments%20by%20resetting%20protein%20sequence%20and%20structure%20space%20to%20the%20historical%20states%20that%20preceded%20six%20prior%20CASPs.%20Utilizing%20sensitive%20evolution-based%20distance%20metrics%20to%20segregate%20distantly%20related%20proteins%2C%20we%20have%20additionally%20created%20validation%20sets%20distinct%20from%20the%20official%20CASP%20sets%20that%20faithfully%20mimic%20their%20difficulty.%5CnCONCLUSION%3A%20ProteinNet%20represents%20a%20comprehensive%20and%20accessible%20resource%20for%20training%20and%20assessing%20machine-learned%20models%20of%20protein%20structure.%22%2C%22date%22%3A%22Jun%2011%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12859-019-2932-0%22%2C%22ISSN%22%3A%221471-2105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A56%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22PLEA3Y6U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AlQuraishi%22%2C%22parsedDate%22%3A%222019-11-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M.%20AlphaFold%20at%20CASP13.%20Bioinformatics.%202019%20Nov%201%3B35%2822%29%3A4862%26%23x2013%3B4865.%20PMCID%3A%20PMC6907002%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22AlphaFold%20at%20CASP13%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22SUMMARY%3A%20Computational%20prediction%20of%20protein%20structure%20from%20sequence%20is%20broadly%20viewed%20as%20a%20foundational%20problem%20of%20biochemistry%20and%20one%20of%20the%20most%20difficult%20challenges%20in%20bioinformatics.%20Once%20every%20two%20years%20the%20Critical%20Assessment%20of%20protein%20Structure%20Prediction%20%28CASP%29%20experiments%20are%20held%20to%20assess%20the%20state%20of%20the%20art%20in%20the%20field%20in%20a%20blind%20fashion%2C%20by%20presenting%20predictor%20groups%20with%20protein%20sequences%20whose%20structures%20have%20been%20solved%20but%20have%20not%20yet%20been%20made%20publicly%20available.%20The%20first%20CASP%20was%20organized%20in%201994%2C%20and%20the%20latest%2C%20CASP13%2C%20took%20place%20last%20December%2C%20when%20for%20the%20first%20time%20the%20industrial%20laboratory%20DeepMind%20entered%20the%20competition.%20DeepMind%27s%20entry%2C%20AlphaFold%2C%20placed%20first%20in%20the%20Free%20Modeling%20%28FM%29%20category%2C%20which%20assesses%20methods%20on%20their%20ability%20to%20predict%20novel%20protein%20folds%20%28the%20Zhang%20group%20placed%20first%20in%20the%20Template-Based%20Modeling%20%28TBM%29%20category%2C%20which%20assess%20methods%20on%20predicting%20proteins%20whose%20folds%20are%20related%20to%20ones%20already%20in%20the%20Protein%20Data%20Bank.%29%20DeepMind%27s%20success%20generated%20significant%20public%20interest.%20Their%20approach%20builds%20on%20two%20ideas%20developed%20in%20the%20academic%20community%20during%20the%20preceding%20decade%3A%20%28i%29%20the%20use%20of%20co-evolutionary%20analysis%20to%20map%20residue%20co-variation%20in%20protein%20sequence%20to%20physical%20contact%20in%20protein%20structure%2C%20and%20%28ii%29%20the%20application%20of%20deep%20neural%20networks%20to%20robustly%20identify%20patterns%20in%20protein%20sequence%20and%20co-evolutionary%20couplings%20and%20convert%20them%20into%20contact%20maps.%20In%20this%20Letter%2C%20we%20contextualize%20the%20significance%20of%20DeepMind%27s%20entry%20within%20the%20broader%20history%20of%20CASP%2C%20relate%20AlphaFold%27s%20methodological%20advances%20to%20prior%20work%2C%20and%20speculate%20on%20the%20future%20of%20this%20important%20problem.%22%2C%22date%22%3A%22Nov%2001%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtz422%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A03%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22AS49JI4N%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AlQuraishi%22%2C%22parsedDate%22%3A%222019-03-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M.%20Parallelized%20natural%20extension%20reference%20frame%3A%20parallelized%20conversion%20from%20internal%20to%20Cartesian%20coordinates.%20J%20Comput%20Chem.%202019%20Mar%2015%3B40%287%29%3A885%26%23x2013%3B892.%20PMID%3A%2030614534%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Parallelized%20natural%20extension%20reference%20frame%3A%20parallelized%20conversion%20from%20internal%20to%20Cartesian%20coordinates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22The%20conversion%20of%20polymer%20parameterization%20from%20internal%20coordinates%20%28bond%20lengths%2C%20angles%2C%20and%20torsions%29%20to%20Cartesian%20coordinates%20is%20a%20fundamental%20task%20in%20molecular%20modeling%2C%20often%20performed%20using%20the%20natural%20extension%20reference%20frame%20%28NeRF%29%20algorithm.%20NeRF%20can%20be%20parallelized%20to%20process%20multiple%20polymers%20simultaneously%2C%20but%20is%20not%20parallelizable%20along%20the%20length%20of%20a%20single%20polymer.%20A%20mathematically%20equivalent%20algorithm%2C%20pNeRF%2C%20has%20been%20derived%20that%20is%20parallelizable%20along%20a%20polymer%27s%20length.%20Empirical%20analysis%20demonstrates%20an%20order-of-magnitude%20speed%20up%20using%20modern%20GPUs%20and%20CPUs.%20In%20machine%20learning-based%20workflows%2C%20in%20which%20partial%20derivatives%20are%20backpropagated%20through%20NeRF%20equations%20and%20neural%20network%20primitives%2C%20switching%20to%20pNeRF%20can%20reduce%20the%20fractional%20computational%20cost%20of%20coordinate%20conversion%20from%20over%20two-thirds%20to%20around%2010%25.%20An%20optimized%20TensorFlow-based%20implementation%20of%20pNeRF%20is%20available%20on%20GitHub%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Faqlaboratory%5C%2Fpnerf%20%5Cu00a9%202018%20Wiley%20Periodicals%2C%20Inc.%22%2C%22date%22%3A%222019-03-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjcc.25772%22%2C%22ISSN%22%3A%221096-987X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A30%3A30Z%22%7D%7D%2C%7B%22key%22%3A%225JHIYFYH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22AlQuraishi%22%2C%22parsedDate%22%3A%222019-04-24%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M.%20End-to-end%20differentiable%20learning%20of%20protein%20structure.%20Cell%20Syst.%202019%20Apr%2024%3B8%284%29%3A292-301.e3.%20PMCID%3A%20PMC6513320%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22End-to-end%20differentiable%20learning%20of%20protein%20structure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%5D%2C%22abstractNote%22%3A%22Predicting%20protein%20structure%20from%20sequence%20is%20a%20central%20challenge%20of%20biochemistry.%20Co-evolution%20methods%20show%20promise%2C%20but%20an%20explicit%20sequence-to-structure%20map%20remains%20elusive.%20Advances%20in%20deep%20learning%20that%20replace%20complex%2C%20human-designed%20pipelines%20with%20differentiable%20models%20optimized%20end%20to%20end%20suggest%20the%20potential%20benefits%20of%20similarly%20reformulating%20structure%20prediction.%20Here%2C%20we%20introduce%20an%20end-to-end%20differentiable%20model%20for%20protein%20structure%20learning.%20The%20model%20couples%20local%20and%20global%20protein%20structure%20via%20geometric%20units%20that%20optimize%20global%20geometry%20without%20violating%20local%20covalent%20chemistry.%20We%20test%20our%20model%20using%20two%20challenging%20tasks%3A%20predicting%20novel%20folds%20without%20co-evolutionary%20data%20and%20predicting%20known%20folds%20without%20structural%20templates.%20In%20the%20first%20task%2C%20the%20model%20achieves%20state-of-the-art%20accuracy%2C%20and%20in%20the%20second%2C%20it%20comes%20within%201-2%5Cu00a0%5Cu00c5%3B%20competing%20methods%20using%20co-evolution%20and%20experimental%20templates%20have%20been%20refined%20over%20many%20years%2C%20and%20it%20is%20likely%20that%20the%20differentiable%20approach%20has%20substantial%20room%20for%20further%20improvement%2C%20with%20applications%20ranging%20from%20drug%20discovery%20to%20protein%20design.%22%2C%22date%22%3A%22Apr%2024%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2019.03.006%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A47%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22L9T2KKLI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bachman%20et%20al.%22%2C%22parsedDate%22%3A%222019-10-29%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBachman%20JA%2C%20Sorger%20PK%2C%20Gyori%20BM.%20Assembling%20a%20corpus%20of%20phosphoproteomic%20annotations%20using%20ProtMapper%20to%20normalize%20site%20information%20from%20databases%20and%20text%20mining%20%5BInternet%5D.%20bioRxiv%3B%202019%20%5Bcited%202023%20Oct%2031%5D.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F822668%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F822668%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Assembling%20a%20corpus%20of%20phosphoproteomic%20annotations%20using%20ProtMapper%20to%20normalize%20site%20information%20from%20databases%20and%20text%20mining%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20Protein%20phosphorylation%20regulates%20numerous%20cellular%20processes%20and%20is%20highly%20studied%20in%20biology.However%2C%20the%20analysis%20of%20phosphoproteomic%20datasets%20remains%20challenging%20due%20to%20limited%20information%20on%20upstream%20regulators%20of%20phosphosites%2C%20which%20is%20fragmented%20across%20multiple%20curated%20databases%20and%20unstructured%20literature.%20When%20aggregating%20information%20on%20phosphosites%20from%20six%20databases%20and%20three%20text%20mining%20systems%2C%20we%20found%20that%20a%20substantial%20proportion%20of%20phosphosites%20were%20mentioned%20at%20residue%20positions%20not%20matching%20the%20reference%20sequence.%20These%20errors%20were%20often%20attributable%20to%20the%20use%20of%20residue%20numbers%20from%20non-canonical%20protein%20isoforms%2C%20mouse%20or%20rat%20proteins%2C%20or%20post-translationally%20processed%20proteins.%20Non-canonical%20site%20numbering%20is%20also%20prevalent%20in%20mass%20spectrometry%20datasets%20from%20large-scale%20efforts%20such%20as%20the%20Clinical%20Proteomic%20Tumor%20Analysis%20Consortium%20%28CPTAC%29.%20To%20address%20these%20issues%2C%20we%20developed%20ProtMapper%2C%20an%20open-source%20Python%20tool%20that%20automatically%20normalizes%20site%20positions%20to%20human%20protein%20reference%20sequences.%20We%20used%20ProtMapper%20coupled%20with%20the%20INDRA%20knowledge%20assembly%20system%20to%20create%20a%20corpus%20of%2037%2C028%20regulatory%20annotations%20for%2016%2C332%20sites%20%5Cu2013%20to%20our%20knowledge%2C%20the%20most%20comprehensive%20corpus%20of%20literature-derived%20information%20about%20phosphosite%20regulation%20currently%20available.%20This%20work%20highlights%20how%20automated%20phosphosite%20normalization%20coupled%20to%20text%20mining%20and%20knowledge%20assembly%20allows%20researchers%20to%20leverage%20phosphosite%20information%20that%20exists%20within%20the%20scientific%20literature.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222019-10-29%22%2C%22DOI%22%3A%2210.1101%5C%2F822668%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F822668%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A09%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22BNKZS5HT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bandopadhayay%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-03%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBandopadhayay%20P%2C%20Piccioni%20F%2C%20O%26%23x2019%3BRourke%20R%2C%20Ho%20P%2C%20Gonzalez%20EM%2C%20Buchan%20G%2C%20Qian%20K%2C%20Gionet%20G%2C%20Girard%20E%2C%20Coxon%20M%2C%20Rees%20MG%2C%20Brenan%20L%2C%20Dubois%20F%2C%20Shapira%20O%2C%20Greenwald%20NF%2C%20Pages%20M%2C%20Balboni%20Iniguez%20A%2C%20Paolella%20BR%2C%20Meng%20A%2C%20Sinai%20C%2C%20Roti%20G%2C%20Dharia%20NV%2C%20Creech%20A%2C%20Tanenbaum%20B%2C%20Khadka%20P%2C%20Tracy%20A%2C%20Tiv%20HL%2C%20Hong%20AL%2C%20Coy%20S%2C%20Rashid%20R%2C%20Lin%20JR%2C%20Cowley%20GS%2C%20Lam%20FC%2C%20Goodale%20A%2C%20Lee%20Y%2C%20Schoolcraft%20K%2C%20Vazquez%20F%2C%20Hahn%20WC%2C%20Tsherniak%20A%2C%20Bradner%20JE%2C%20Yaffe%20MB%2C%20Milde%20T%2C%20Pfister%20SM%2C%20Qi%20J%2C%20Schenone%20M%2C%20Carr%20SA%2C%20Ligon%20KL%2C%20Kieran%20MW%2C%20Santagata%20S%2C%20Olson%20JM%2C%20Gokhale%20PC%2C%20Jaffe%20JD%2C%20Root%20DE%2C%20Stegmaier%20K%2C%20Johannessen%20CM%2C%20Beroukhim%20R.%20Neuronal%20differentiation%20and%20cell-cycle%20programs%20mediate%20response%20to%20BET-bromodomain%20inhibition%20in%20MYC-driven%20medulloblastoma.%20Nat%20Commun.%202019%20Jun%203%3B10%281%29%3A2400.%20PMCID%3A%20PMC6546744%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Neuronal%20differentiation%20and%20cell-cycle%20programs%20mediate%20response%20to%20BET-bromodomain%20inhibition%20in%20MYC-driven%20medulloblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pratiti%22%2C%22lastName%22%3A%22Bandopadhayay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Piccioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22O%27Rourke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20M.%22%2C%22lastName%22%3A%22Gonzalez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%22%2C%22lastName%22%3A%22Buchan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenin%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabrielle%22%2C%22lastName%22%3A%22Gionet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Girard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margo%22%2C%22lastName%22%3A%22Coxon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Rees%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Brenan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofer%22%2C%22lastName%22%3A%22Shapira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%20F.%22%2C%22lastName%22%3A%22Greenwald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Pages%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Balboni%20Iniguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenton%20R.%22%2C%22lastName%22%3A%22Paolella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Meng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Sinai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Roti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neekesh%20V.%22%2C%22lastName%22%3A%22Dharia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Creech%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Tanenbaum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prasidda%22%2C%22lastName%22%3A%22Khadka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Tracy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%20L.%22%2C%22lastName%22%3A%22Tiv%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20L.%22%2C%22lastName%22%3A%22Hong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20S.%22%2C%22lastName%22%3A%22Cowley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%20C.%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Goodale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yenarae%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22Schoolcraft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisca%22%2C%22lastName%22%3A%22Vazquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviad%22%2C%22lastName%22%3A%22Tsherniak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Bradner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20B.%22%2C%22lastName%22%3A%22Yaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Till%22%2C%22lastName%22%3A%22Milde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%20M.%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Qi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Schenone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20A.%22%2C%22lastName%22%3A%22Carr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Kieran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prafulla%20C.%22%2C%22lastName%22%3A%22Gokhale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20D.%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Root%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Stegmaier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cory%20M.%22%2C%22lastName%22%3A%22Johannessen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%5D%2C%22abstractNote%22%3A%22BET-bromodomain%20inhibition%20%28BETi%29%20has%20shown%20pre-clinical%20promise%20for%20MYC-amplified%20medulloblastoma.%20However%2C%20the%20mechanisms%20for%20its%20action%2C%20and%20ultimately%20for%20resistance%2C%20have%20not%20been%20fully%20defined.%20Here%2C%20using%20a%20combination%20of%20expression%20profiling%2C%20genome-scale%20CRISPR%5C%2FCas9-mediated%20loss%20of%20function%20and%20ORF%5C%2FcDNA%20driven%20rescue%20screens%2C%20and%20cell-based%20models%20of%20spontaneous%20resistance%2C%20we%20identify%20bHLH%5C%2Fhomeobox%20transcription%20factors%20and%20cell-cycle%20regulators%20as%20key%20genes%20mediating%20BETi%27s%20response%20and%20resistance.%20Cells%20that%20acquire%20drug%20tolerance%20exhibit%20a%20more%20neuronally%20differentiated%20cell-state%20and%20expression%20of%20lineage-specific%20bHLH%5C%2Fhomeobox%20transcription%20factors.%20However%2C%20they%20do%20not%20terminally%20differentiate%2C%20maintain%20expression%20of%20CCND2%2C%20and%20continue%20to%20cycle%20through%20S-phase.%20Moreover%2C%20CDK4%5C%2FCDK6%20inhibition%20delays%20acquisition%20of%20resistance.%20Therefore%2C%20our%20data%20provide%20insights%20about%20the%20mechanisms%20underlying%20BETi%20effects%20and%20the%20appearance%20of%20resistance%20and%20support%20the%20therapeutic%20use%20of%20combined%20cell-cycle%20inhibitors%20with%20BETi%20in%20MYC-amplified%20medulloblastoma.%22%2C%22date%22%3A%22Jun%2003%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-019-10307-9%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22PR7E9ELM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Du%20et%20al.%22%2C%22parsedDate%22%3A%222019-10%22%2C%22numChildren%22%3A11%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDu%20Z%2C%20Lin%20JR%2C%20Rashid%20R%2C%20Maliga%20Z%2C%20Wang%20S%2C%20Aster%20JC%2C%20Izar%20B%2C%20Sorger%20PK%2C%20Santagata%20S.%20Qualifying%20antibodies%20for%20image-based%20immune%20profiling%20and%20multiplexed%20tissue%20imaging.%20Nat%20Protoc.%202019%20Oct%3B14%2810%29%3A2900%26%23x2013%3B2930.%20PMCID%3A%20PMC6959005%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Qualifying%20antibodies%20for%20image-based%20immune%20profiling%20and%20multiplexed%20tissue%20imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%20C.%22%2C%22lastName%22%3A%22Aster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Multiplexed%20tissue%20imaging%20enables%20precise%2C%20spatially%20resolved%20enumeration%20and%20characterization%20of%20cell%20types%20and%20states%20in%20human%20resection%20specimens.%20A%20growing%20number%20of%20methods%20applicable%20to%20formalin-fixed%2C%20paraffin-embedded%20%28FFPE%29%20tissue%20sections%20have%20been%20described%2C%20the%20majority%20of%20which%20rely%20on%20antibodies%20for%20antigen%20detection%20and%20mapping.%20This%20protocol%20provides%20step-by-step%20procedures%20for%20confirming%20the%20selectivity%20and%20specificity%20of%20antibodies%20used%20in%20fluorescence-based%20tissue%20imaging%20and%20for%20the%20construction%20and%20validation%20of%20antibody%20panels.%20Although%20the%20protocol%20is%20implemented%20using%20tissue-based%20cyclic%20immunofluorescence%20%28t-CyCIF%29%20as%20an%20imaging%20platform%2C%20these%20antibody-testing%20methods%20are%20broadly%20applicable.%20We%20demonstrate%20assembly%20of%20a%2016-antibody%20panel%20for%20enumerating%20and%20localizing%20T%20cells%20and%20B%20cells%2C%20macrophages%2C%20and%20cells%20expressing%20immune%20checkpoint%20regulators.%20The%20protocol%20is%20accessible%20to%20individuals%20with%20experience%20in%20microscopy%20and%20immunofluorescence%3B%20some%20experience%20in%20computation%20is%20required%20for%20data%20analysis.%20A%20typical%2030-antibody%20dataset%20for%2020%20FFPE%20slides%20can%20be%20generated%20within%202%20weeks.%22%2C%22date%22%3A%222019-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41596-019-0206-y%22%2C%22ISSN%22%3A%221750-2799%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A17Z%22%7D%7D%2C%7B%22key%22%3A%225Y7CEN5C%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ferguson%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-20%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFerguson%20FM%2C%20Doctor%20ZM%2C%20Ficarro%20SB%2C%20Browne%20CM%2C%20Marto%20JA%2C%20Johnson%20JL%2C%20Yaron%20TM%2C%20Cantley%20LC%2C%20Kim%20ND%2C%20Sim%20T%2C%20Berberich%20MJ%2C%20Kalocsay%20M%2C%20Sorger%20PK%2C%20Gray%20NS.%20Discovery%20of%20covalent%20CDK14%20inhibitors%20with%20pan-TAIRE%20family%20specificity.%20Cell%20Chem%20Biol.%202019%20Jun%2020%3B26%286%29%3A804-817.e12.%20PMCID%3A%20PMC6588450%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20covalent%20CDK14%20inhibitors%20with%20pan-TAIRE%20family%20specificity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fleur%20M.%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zainab%20M.%22%2C%22lastName%22%3A%22Doctor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Ficarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20M.%22%2C%22lastName%22%3A%22Browne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarrod%20A.%22%2C%22lastName%22%3A%22Marto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jared%20L.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomer%20M.%22%2C%22lastName%22%3A%22Yaron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%20C.%22%2C%22lastName%22%3A%22Cantley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nam%20Doo%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taebo%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%2014%20%28CDK14%29%20and%20other%20TAIRE%20family%20kinases%20%28CDKs%2015-18%29%20are%20proteins%20that%20lack%20functional%20annotation%20but%20are%20frequent%20off-targets%20of%20clinical%20kinase%20inhibitors.%20In%20this%20study%20we%20develop%20and%20characterize%20FMF-04-159-2%2C%20a%20tool%20compound%20that%20specifically%20targets%20CDK14%20covalently%20and%20possesses%20a%20TAIRE%20kinase-biased%20selectivity%20profile.%20This%20tool%20compound%20and%20its%20reversible%20analog%20were%20used%20to%20characterize%20the%20cellular%20consequences%20of%20covalent%20CDK14%20inhibition%2C%20including%20an%20unbiased%20investigation%20using%20phospho-proteomics.%20To%20reduce%20confounding%20off-target%20activity%2C%20washout%20conditions%20were%20used%20to%20deconvolute%20CDK14-specific%20effects.%20This%20investigation%20suggested%20that%20CDK14%20plays%20a%20supporting%20role%20in%20cell-cycle%20regulation%2C%20particularly%20mitotic%20progression%2C%20and%20identified%20putative%20CDK14%20substrates.%20Together%2C%20these%20results%20represent%20an%20important%20step%20forward%20in%20understanding%20the%20cellular%20consequences%20of%20inhibiting%20CDK14%20kinase%20activity.%22%2C%22date%22%3A%222019-06-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.02.015%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A33%3A28Z%22%7D%7D%2C%7B%22key%22%3A%2232ZSBL92%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hafner%20et%20al.%22%2C%22parsedDate%22%3A%222019-08-15%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHafner%20M%2C%20Mills%20CE%2C%20Subramanian%20K%2C%20Chen%20C%2C%20Chung%20M%2C%20Boswell%20SA%2C%20Everley%20RA%2C%20Liu%20C%2C%20Walmsley%20CS%2C%20Juric%20D%2C%20Sorger%20PK.%20Multiomics%20profiling%20establishes%20the%20polypharmacology%20of%20FDA-approved%20CDK4%5C%2F6%20inhibitors%20and%20the%20potential%20for%20differential%20clinical%20activity.%20Cell%20Chem%20Biol.%202019%20Aug%2015%3B26%288%29%3A1067-1080.e8.%20PMCID%3A%20PMC6936329%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiomics%20profiling%20establishes%20the%20polypharmacology%20of%20FDA-approved%20CDK4%5C%2F6%20inhibitors%20and%20the%20potential%20for%20differential%20clinical%20activity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changchang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%20S.%22%2C%22lastName%22%3A%22Walmsley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dejan%22%2C%22lastName%22%3A%22Juric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20target%20profiles%20of%20many%20drugs%20are%20established%20early%20in%20their%20development%20and%20are%20not%20systematically%20revisited%20at%20the%20time%20of%20FDA%20approval.%20Thus%2C%20it%20is%20often%20unclear%20whether%20therapeutics%20with%20the%20same%20nominal%20targets%20but%20different%20chemical%20structures%20are%20functionally%20equivalent.%20In%20this%20paper%20we%20use%20five%20different%20phenotypic%20and%20biochemical%20assays%20to%20compare%20approved%20inhibitors%20of%20cyclin-dependent%20kinases%204%5C%2F6-collectively%20regarded%20as%20breakthroughs%20in%20the%20treatment%20of%20hormone%20receptor-positive%20breast%20cancer.%20We%20find%20that%20transcriptional%2C%20proteomic%2C%20and%20phenotypic%20changes%20induced%20by%20palbociclib%2C%20ribociclib%2C%20and%20abemaciclib%20differ%20significantly%3B%20abemaciclib%20in%20particular%20has%20advantageous%20activities%20partially%20overlapping%20those%20of%20alvocidib%2C%20an%20older%20polyselective%20CDK%20inhibitor.%20In%20cells%20and%20mice%2C%20abemaciclib%20inhibits%20kinases%20other%20than%20CDK4%5C%2F6%20including%20CDK2%5C%2Fcyclin%20A%5C%2FE-implicated%20in%20resistance%20to%20CDK4%5C%2F6%20inhibition-and%20CDK1%5C%2Fcyclin%20B.%20The%20multifaceted%20experimental%20and%20computational%20approaches%20described%20here%20therefore%20uncover%20underappreciated%20differences%20in%20CDK4%5C%2F6%20inhibitor%20activities%20with%20potential%20importance%20in%20treating%20human%20patients.%22%2C%22date%22%3A%222019-08-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.05.005%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A54%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22DBGCM7G5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoyt%20et%20al.%22%2C%22parsedDate%22%3A%222019-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoyt%20CT%2C%20Domingo-Fern%26%23xE1%3Bndez%20D%2C%20Aldisi%20R%2C%20Xu%20L%2C%20Kolpeja%20K%2C%20Spalek%20S%2C%20Wollert%20E%2C%20Bachman%20J%2C%20Gyori%20BM%2C%20Greene%20P%2C%20Hofmann-Apitius%20M.%20Re-curation%20and%20rational%20enrichment%20of%20knowledge%20graphs%20in%20Biological%20Expression%20Language.%20Database%20%28Oxford%29.%202019%20Jan%201%3B2019%3Abaz068.%20PMCID%3A%20PMC6587072%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Re-curation%20and%20rational%20enrichment%20of%20knowledge%20graphs%20in%20Biological%20Expression%20Language%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Domingo-Fern%5Cu00e1ndez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rana%22%2C%22lastName%22%3A%22Aldisi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lingling%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Kolpeja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Spalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Wollert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Greene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Hofmann-Apitius%22%7D%5D%2C%22abstractNote%22%3A%22The%20rapid%20accumulation%20of%20new%20biomedical%20literature%20not%20only%20causes%20curated%20knowledge%20graphs%20%28KGs%29%20to%20become%20outdated%20and%20incomplete%2C%20but%20also%20makes%20manual%20curation%20an%20impractical%20and%20unsustainable%20solution.%20Automated%20or%20semi-automated%20workflows%20are%20necessary%20to%20assist%20in%20prioritizing%20and%20curating%20the%20literature%20to%20update%20and%20enrich%20KGs.%20We%20have%20developed%20two%20workflows%3A%20one%20for%20re-curating%20a%20given%20KG%20to%20assure%20its%20syntactic%20and%20semantic%20quality%20and%20another%20for%20rationally%20enriching%20it%20by%20manually%20revising%20automatically%20extracted%20relations%20for%20nodes%20with%20low%20information%20density.%20We%20applied%20these%20workflows%20to%20the%20KGs%20encoded%20in%20Biological%20Expression%20Language%20from%20the%20NeuroMMSig%20database%20using%20content%20that%20was%20pre-extracted%20from%20MEDLINE%20abstracts%20and%20PubMed%20Central%20full-text%20articles%20using%20text%20mining%20output%20integrated%20by%20INDRA.%20We%20have%20made%20this%20workflow%20freely%20available%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fbel-enrichment%5C%2Fbel-enrichment.%22%2C%22date%22%3A%222019-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fdatabase%5C%2Fbaz068%22%2C%22ISSN%22%3A%221758-0463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T18%3A41%3A57Z%22%7D%7D%2C%7B%22key%22%3A%226NF9XU8T%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Juratli%20et%20al.%22%2C%22parsedDate%22%3A%222019-09-01%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJuratli%20TA%2C%20Jones%20PS%2C%20Wang%20N%2C%20Subramanian%20M%2C%20Aylwin%20SJB%2C%20Odia%20Y%2C%20Rostami%20E%2C%20Gudjonsson%20O%2C%20Shaw%20BL%2C%20Cahill%20DP%2C%20Galanis%20E%2C%20Barker%20FG%2C%20Santagata%20S%2C%20Brastianos%20PK.%20Targeted%20treatment%20of%20papillary%20craniopharyngiomas%20harboring%20BRAF%20V600E%20mutations.%20Cancer.%202019%20Sep%201%3B125%2817%29%3A2910%26%23x2013%3B2914.%20PMCID%3A%20PMC7032527%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeted%20treatment%20of%20papillary%20craniopharyngiomas%20harboring%20BRAF%20V600E%20mutations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tareq%20A.%22%2C%22lastName%22%3A%22Juratli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20S.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megha%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20J.%20B.%22%2C%22lastName%22%3A%22Aylwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazmin%22%2C%22lastName%22%3A%22Odia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elham%22%2C%22lastName%22%3A%22Rostami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olafur%22%2C%22lastName%22%3A%22Gudjonsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20L.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%20G.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019-09-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcncr.32197%22%2C%22ISSN%22%3A%221097-0142%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A11Z%22%7D%7D%2C%7B%22key%22%3A%2252RRECQR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Kalocsay%22%2C%22parsedDate%22%3A%222019-05-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKalocsay%20M.%20APEX%20peroxidase-catalyzed%20proximity%20labeling%20and%20multiplexed%20quantitative%20proteomics.%20Methods%20Mol%20Biol.%202019%20May%204%3B2008%3A41%26%23x2013%3B55.%20PMID%3A%2031124087%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22APEX%20peroxidase-catalyzed%20proximity%20labeling%20and%20multiplexed%20quantitative%20proteomics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%5D%2C%22abstractNote%22%3A%22Peroxidase-catalyzed%20proximity%20labeling%20is%20a%20powerful%20technique%20for%20defining%20the%20molecular%20environment%20of%20proteins%20in%20vivo.%20Expressing%20a%20protein%20of%20interest%20fused%20to%20a%20modified%20plant%20peroxidase%20%28APEX2%29%20allows%20labeling%20of%20nearby%20polypeptides.%20Addition%20of%20hydrogen%20peroxide%20%28H2O2%29%20and%20biotin-tyramide%20%28biotin-phenol%29%20generates%20short-lived%20radicals%20around%20the%20peroxidase.%20Labeling%20is%20thus%20restricted%20to%20proteins%20in%20close%20proximity%2C%20providing%20a%20snapshot%20of%20the%20local%20environment%20around%20the%20APEX2%20fusion%20protein.%20Combined%20with%20an%20initial%20perturbation%2C%20progressive%20changes%20in%20interaction%20partners%20can%20be%20tracked%2C%20e.g.%2C%20after%20drug%20treatment.%20Multiplexed%20quantitative%20mass%20spectrometry%20permits%20the%20parallel%20analysis%20of%20several%20experimental%20replicates%20or%20of%20up%20to%2011%20time%20points.%20Here%20we%20describe%20the%20denaturing%20purification%20of%20biotin-labeled%20proteins%20with%20magnetic%20streptavidin%20beads%2C%20and%20subsequent%20sample%20preparation%20for%20multiplexed%20quantitative%20mass%20spectrometry.%20Proximity-labeled%20proteins%20are%20enriched%20under%20strong%20denaturing%20conditions.%20Tryptic%20on-bead%20digest%20of%20purified%20proteins%20is%20combined%20with%20tandem%20mass%20tag%20peptide%20labeling%20%28TMT%29%2C%20alkaline%20reversed-phase%20peptide%20fractionation%2C%20and%20SPS%20MS3%20mass%20spectrometry.%20This%20analysis%20pipeline%20enables%20studies%20of%20complex%20protein%20environment%20changes%20in%20perturbed%20biological%20systems%2C%20as%20well%20as%20comparative%20studies%20of%20functional%20protein%20proximity%20in%20different%20cell%20lines.%20Through%20multiplexing%2C%20hundreds%20of%20proteins%20can%20be%20quantified%20in%20each%20experimental%20condition%20in%20parallel.%22%2C%22date%22%3A%22May%2004%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-1-4939-9537-0_4%22%2C%22ISSN%22%3A%221940-6029%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A32%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22B8PHWASI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Katzir%20et%20al.%22%2C%22parsedDate%22%3A%222019-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKatzir%20I%2C%20Cokol%20M%2C%20Aldridge%20BB%2C%20Alon%20U.%20Prediction%20of%20ultra-high-order%20antibiotic%20combinations%20based%20on%20pairwise%20interactions.%20PLoS%20Comput%20Biol.%202019%20Jan%3B15%281%29%3Ae1006774.%20PMCID%3A%20PMC6370231%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prediction%20of%20ultra-high-order%20antibiotic%20combinations%20based%20on%20pairwise%20interactions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itay%22%2C%22lastName%22%3A%22Katzir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uri%22%2C%22lastName%22%3A%22Alon%22%7D%5D%2C%22abstractNote%22%3A%22Drug%20combinations%20are%20a%20promising%20approach%20to%20achieve%20high%20efficacy%20at%20low%20doses%20and%20to%20overcome%20resistance.%20Drug%20combinations%20are%20especially%20useful%20when%20drugs%20cannot%20achieve%20effectiveness%20at%20tolerable%20doses%2C%20as%20occurs%20in%20cancer%20and%20tuberculosis%20%28TB%29.%20However%2C%20discovery%20of%20effective%20drug%20combinations%20faces%20the%20challenge%20of%20combinatorial%20explosion%2C%20in%20which%20the%20number%20of%20possible%20combinations%20increases%20exponentially%20with%20the%20number%20of%20drugs%20and%20doses.%20A%20recent%20advance%2C%20called%20the%20dose%20model%2C%20uses%20a%20mathematical%20formula%20to%20overcome%20combinatorial%20explosion%20by%20reducing%20the%20problem%20to%20a%20feasible%20quadratic%20one%3A%20using%20data%20on%20drug%20pairs%20at%20a%20few%20doses%2C%20the%20dose%20model%20accurately%20predicts%20the%20effect%20of%20combinations%20of%20three%20and%20four%20drugs%20at%20all%20doses.%20The%20dose%20model%20has%20not%20yet%20been%20tested%20on%20higher-order%20combinations%20beyond%20four%20drugs.%20To%20address%20this%2C%20we%20measured%20the%20effect%20of%20combinations%20of%20up%20to%20ten%20antibiotics%20on%20E.%20coli%20growth%2C%20and%20of%20up%20to%20five%20tuberculosis%20%28TB%29%20drugs%20on%20the%20growth%20of%20M.%20tuberculosis.%20We%20find%20that%20the%20dose%20model%20accurately%20predicts%20the%20effect%20of%20these%20higher-order%20combinations%2C%20including%20cases%20of%20strong%20synergy%20and%20antagonism.%20This%20study%20supports%20the%20view%20that%20the%20interactions%20between%20drug%20pairs%20carries%20key%20information%20that%20largely%20determines%20higher-order%20interactions.%20Therefore%2C%20systematic%20study%20of%20pairwise%20drug%20interactions%20is%20a%20compelling%20strategy%20to%20prioritize%20drug%20regimens%20in%20high-dimensional%20spaces.%22%2C%22date%22%3A%222019-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1006774%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A54%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22TI33L5DY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Koch%20et%20al.%22%2C%22parsedDate%22%3A%222019-02-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKoch%20R%2C%20Christie%20AL%2C%20Crombie%20JL%2C%20Palmer%20AC%2C%20Plana%20D%2C%20Shigemori%20K%2C%20Morrow%20SN%2C%20Van%20Scoyk%20A%2C%20Wu%20W%2C%20Brem%20EA%2C%20Secrist%20JP%2C%20Drew%20L%2C%20Schuller%20AG%2C%20Cidado%20J%2C%20Letai%20A%2C%20Weinstock%20DM.%20Biomarker-driven%20strategy%20for%20MCL1%20inhibition%20in%20T-cell%20lymphomas.%20Blood.%202019%20Feb%207%3B133%286%29%3A566%26%23x2013%3B575.%20PMCID%3A%20PMC6367646%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biomarker-driven%20strategy%20for%20MCL1%20inhibition%20in%20T-cell%20lymphomas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20L.%22%2C%22lastName%22%3A%22Christie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Crombie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Plana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kay%22%2C%22lastName%22%3A%22Shigemori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20N.%22%2C%22lastName%22%3A%22Morrow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandria%22%2C%22lastName%22%3A%22Van%20Scoyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenchao%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Brem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Paul%22%2C%22lastName%22%3A%22Secrist%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Drew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alwin%20G.%22%2C%22lastName%22%3A%22Schuller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Cidado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Weinstock%22%7D%5D%2C%22abstractNote%22%3A%22There%20is%20a%20pressing%20need%20for%20more%20effective%20therapies%20to%20treat%20patients%20with%20T-cell%20lymphomas%20%28TCLs%29%2C%20including%20first-line%20approaches%20that%20increase%20the%20response%20rate%20to%20cyclophosphamide%2C%20adriamycin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20chemotherapy.%20We%20characterized%20the%20mitochondrial%20apoptosis%20pathway%20in%20cell%20lines%20and%20patient-derived%20xenograft%20%28PDX%29%20models%20of%20TCL%20and%20assessed%20the%20in%20vitro%20efficacy%20of%20BH3%20mimetics%2C%20including%20the%20BCL2%20inhibitor%20venetoclax%2C%20the%20BCL2%5C%2FBCL-xL%20inhibitor%20navitoclax%2C%20and%20the%20novel%20MCL1%20inhibitor%20AZD5991.%20The%20abundance%20of%20antiapoptotic%20BCL2%20family%20members%20based%20on%20immunoblotting%20or%20RNA%20transcript%20levels%20correlated%20poorly%20with%20the%20activity%20of%20BH3%20mimetics.%20In%20contrast%2C%20the%20functional%20approach%20BH3%20profiling%20reliably%20predicted%20sensitivity%20to%20BH3%20mimetics%20in%20vitro%20and%20in%20vivo.%20We%20used%20BH3%20profiling%20to%20select%20TCL%20PDX%20that%20were%20dependent%20on%20MCL1.%20Mice%20xenografted%20with%20these%20PDX%20and%20treated%20with%20AZD5991%20had%20markedly%20improved%20survival.%20The%20combination%20of%20AZD5991%20and%20CHOP%20achieved%20synergy%20based%20on%20survival%20improvement%20beyond%20a%20mathematical%20%5C%22sum%20of%20benefits%5C%22%20model.%20Thus%2C%20MCL1%20inhibition%20is%20a%20promising%20strategy%20as%20both%20a%20single%20agent%20and%20in%20combination%20with%20chemotherapy%20for%20patients%20with%20TCL%20and%20functional%20dependence%20on%20MCL1.%22%2C%22date%22%3A%22Feb%2007%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1182%5C%2Fblood-2018-07-865527%22%2C%22ISSN%22%3A%221528-0020%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A56%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22QEF3PLDE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELee%20S%2C%20Jo%20S%2C%20Talbot%20S%2C%20Zhang%20HXB%2C%20Kotoda%20M%2C%20Andrews%20NA%2C%20Puopolo%20M%2C%20Liu%20PW%2C%20Jacquemont%20T%2C%20Pascal%20M%2C%20Heckman%20LM%2C%20Jain%20A%2C%20Lee%20J%2C%20Woolf%20CJ%2C%20Bean%20BP.%20Novel%20charged%20sodium%20and%20calcium%20channel%20inhibitor%20active%20against%20neurogenic%20inflammation.%20Elife.%202019%20Nov%2025%3B8.%20PMCID%3A%20PMC6877086%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Novel%20charged%20sodium%20and%20calcium%20channel%20inhibitor%20active%20against%20neurogenic%20inflammation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seungkyu%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sooyeon%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Talbot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Han-Xiong%20Bear%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masakazu%22%2C%22lastName%22%3A%22Kotoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nick%20A.%22%2C%22lastName%22%3A%22Andrews%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelino%22%2C%22lastName%22%3A%22Puopolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pin%20W.%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Jacquemont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maud%22%2C%22lastName%22%3A%22Pascal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurel%20M.%22%2C%22lastName%22%3A%22Heckman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aakanksha%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinbo%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20P.%22%2C%22lastName%22%3A%22Bean%22%7D%5D%2C%22abstractNote%22%3A%22Voltage-dependent%20sodium%20and%20calcium%20channels%20in%20pain-initiating%20nociceptor%20neurons%20are%20attractive%20targets%20for%20new%20analgesics.%20We%20made%20a%20permanently%20charged%20cationic%20derivative%20of%20an%20N-type%20calcium%20channel-inhibitor.%20Unlike%20cationic%20derivatives%20of%20local%20anesthetic%20sodium%20channel%20blockers%20like%20QX-314%2C%20this%20cationic%20compound%20inhibited%20N-type%20calcium%20channels%20more%20effectively%20with%20extracellular%20than%20intracellular%20application.%20Surprisingly%2C%20the%20compound%20is%20also%20a%20highly%20effective%20sodium%20channel%20inhibitor%20when%20applied%20extracellularly%2C%20producing%20more%20potent%20inhibition%20than%20lidocaine%20or%20bupivacaine.%20The%20charged%20inhibitor%20produced%20potent%20and%20long-lasting%20analgesia%20in%20mouse%20models%20of%20incisional%20wound%20and%20inflammatory%20pain%2C%20inhibited%20release%20of%20the%20neuropeptide%20calcitonin%20gene-related%20peptide%20%28CGRP%29%20from%20dorsal%20root%20ganglion%20neurons%2C%20and%20reduced%20inflammation%20in%20a%20mouse%20model%20of%20allergic%20asthma%2C%20which%20has%20a%20strong%20neurogenic%20component.%20The%20results%20show%20that%20some%20cationic%20molecules%20applied%20extracellularly%20can%20powerfully%20inhibit%20both%20sodium%20channels%20and%20calcium%20channels%2C%20thereby%20blocking%20both%20nociceptor%20excitability%20and%20pro-inflammatory%20peptide%20release.%22%2C%22date%22%3A%222019-11-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.48118%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A57%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22KNZ3HZWW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELiu%20B%2C%20Gyori%20BM%2C%20Thiagarajan%20PS.%20Statistical%20model%20checking-based%20analysis%20of%20biological%20networks.%20In%3A%20Li%26%23xF2%3B%20P%2C%20Zuliani%20P%2C%20editors.%20Automated%20Reasoning%20for%20Systems%20Biology%20and%20Medicine%20%5BInternet%5D.%20Cham%3A%20Springer%20International%20Publishing%3B%202019%20%5Bcited%202023%20Dec%202%5D.%20p.%2063%26%23x2013%3B92.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-030-17297-8_3%27%3Ehttp%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-030-17297-8_3%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Statistical%20model%20checking-based%20analysis%20of%20biological%20networks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Pietro%22%2C%22lastName%22%3A%22Li%5Cu00f2%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Zuliani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bing%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20S.%22%2C%22lastName%22%3A%22Thiagarajan%22%7D%5D%2C%22abstractNote%22%3A%22We%20introduce%20a%20framework%20for%20analyzing%20ordinary%20differential%20equation%20%28ODE%29%20models%20of%20biological%20networks%20using%20statistical%20model%20checking%20%28SMC%29.%20A%20key%20aspect%20of%20our%20work%20is%20the%20modeling%20of%20single-cell%20variability%20by%20assigning%20a%20probability%20distribution%20to%20intervals%20of%20initial%20concentration%20values%20and%20kinetic%20rate%20constants.%20We%20propagate%20this%20distribution%20through%20the%20system%20dynamics%20to%20obtain%20a%20distribution%20over%20the%20set%20of%20trajectories%20of%20the%20ODEs.%20This%20in%20turn%20opens%20the%20door%20for%20performing%20statistical%20analysis%20of%20the%20ODE%20system%5Cu2019s%20behavior.%20To%20illustrate%20this%2C%20we%20first%20encode%20quantitative%20data%20and%20qualitative%20trends%20as%20bounded%20linear%20time%20temporal%20logic%20%28BLTL%29%20formulas.%20Based%20on%20this%2C%20we%20construct%20a%20parameter%20estimation%20method%20using%20an%20SMC-driven%20evaluation%20procedure%20applied%20to%20the%20stochastic%20version%20of%20the%20behavior%20of%20the%20ODE%20system.%20We%20then%20describe%20how%20this%20SMC%20framework%20can%20be%20generalized%20to%20hybrid%20automata%20by%20exploiting%20the%20given%20distribution%20over%20the%20initial%20states%20and%20the%5Cu2014much%20more%20sophisticated%5Cu2014system%20dynamics%20to%20associate%20a%20Markov%20chain%20with%20the%20hybrid%20automaton.%20We%20then%20establish%20a%20strong%20relationship%20between%20the%20behaviors%20of%20the%20hybrid%20automaton%20and%20its%20associated%20Markov%20chain.%20Consequently%2C%20we%20sample%20trajectories%20from%20the%20hybrid%20automaton%20in%20a%20way%20that%20mimics%20the%20sampling%20of%20the%20trajectories%20of%20the%20Markov%20chain.%20This%20enables%20us%20to%20verify%20approximately%20that%20the%20Markov%20chain%20meets%20a%20BLTL%20specification%20with%20high%20probability.%20We%20have%20applied%20these%20methods%20to%20ODE-based%20models%20of%20Toll-like%20receptor%20signaling%20and%20the%20crosstalk%20between%20autophagy%20and%20apoptosis%2C%20as%20well%20as%20to%20systems%20exhibiting%20hybrid%20dynamics%20including%20the%20circadian%20clock%20pathway%20and%20cardiac%20cell%20physiology.%20We%20present%20an%20overview%20of%20these%20applications%20and%20summarize%20the%20main%20empirical%20results.%20These%20case%20studies%20demonstrate%20that%20our%20methods%20can%20be%20applied%20in%20a%20variety%20of%20practical%20settings.%22%2C%22bookTitle%22%3A%22Automated%20Reasoning%20for%20Systems%20Biology%20and%20Medicine%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%22978-3-030-17296-1%20978-3-030-17297-8%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-030-17297-8_3%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T04%3A09%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22YZQFIDR2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moret%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-16%22%2C%22numChildren%22%3A12%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMoret%20N%2C%20Clark%20NA%2C%20Hafner%20M%2C%20Wang%20Y%2C%20Lounkine%20E%2C%20Medvedovic%20M%2C%20Wang%20J%2C%20Gray%20N%2C%20Jenkins%20J%2C%20Sorger%20PK.%20Cheminformatics%20tools%20for%20analyzing%20and%20designing%20optimized%20small-molecule%20collections%20and%20libraries.%20Cell%20Chem%20Biol.%202019%20May%2016%3B26%285%29%3A765-777.e3.%20PMCID%3A%20PMC6526536%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cheminformatics%20tools%20for%20analyzing%20and%20designing%20optimized%20small-molecule%20collections%20and%20libraries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nienke%22%2C%22lastName%22%3A%22Moret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20A.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugen%22%2C%22lastName%22%3A%22Lounkine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Medvedovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Libraries%20of%20well-annotated%20small%20molecules%20have%20many%20uses%20in%20chemical%20genetics%2C%20drug%20discovery%2C%20and%20therapeutic%20repurposing.%20Multiple%20libraries%20are%20available%2C%20but%20few%20data-driven%20approaches%20exist%20to%20compare%20them%20and%20design%20new%20libraries.%20We%20describe%20an%20approach%20to%20scoring%20and%20creating%20libraries%20based%20on%20binding%20selectivity%2C%20target%20coverage%2C%20and%20induced%20cellular%20phenotypes%20as%20well%20as%20chemical%20structure%2C%20stage%20of%20clinical%20development%2C%20and%20user%20preference.%20The%20approach%2C%20available%20via%20the%20online%20tool%20http%3A%5C%2F%5C%2Fwww.smallmoleculesuite.org%2C%20assembles%20sets%20of%20compounds%20with%20the%20lowest%20possible%20off-target%20overlap.%20Analysis%20of%20six%20kinase%20inhibitor%20libraries%20using%20our%20approach%20reveals%20dramatic%20differences%20among%20them%20and%20led%20us%20to%20design%20a%20new%20LSP-OptimalKinase%20library%20that%20outperforms%20existing%20collections%20in%20target%20coverage%20and%20compact%20size.%20We%20also%20describe%20a%20mechanism%20of%20action%20library%20that%20optimally%20covers%201%2C852%20targets%20in%20the%20liganded%20genome.%20Our%20tools%20facilitate%20creation%2C%20analysis%2C%20and%20updates%20of%20both%20private%20and%20public%20compound%20collections.%22%2C%22date%22%3A%222019-05-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.02.018%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A33%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22Q9S6MCAY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Niepel%20et%20al.%22%2C%22parsedDate%22%3A%222019-07-24%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENiepel%20M%2C%20Hafner%20M%2C%20Mills%20CE%2C%20Subramanian%20K%2C%20Williams%20EH%2C%20Chung%20M%2C%20Gaudio%20B%2C%20Barrette%20AM%2C%20Stern%20AD%2C%20Hu%20B%2C%20Korkola%20JE%2C%20LINCS%20Consortium%2C%20Gray%20JW%2C%20Birtwistle%20MR%2C%20Heiser%20LM%2C%20Sorger%20PK.%20A%20multi-center%20study%20on%20the%20reproducibility%20of%20drug-response%20assays%20in%20mammalian%20cell%20lines.%20Cell%20Syst.%202019%20Jul%2024%3B9%281%29%3A35-48.e5.%20PMCID%3A%20PMC6700527%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20multi-center%20study%20on%20the%20reproducibility%20of%20drug-response%20assays%20in%20mammalian%20cell%20lines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20H.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Marie%22%2C%22lastName%22%3A%22Barrette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20D.%22%2C%22lastName%22%3A%22Stern%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Korkola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22LINCS%20Consortium%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Birtwistle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Heiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Evidence%20that%20some%20high-impact%20biomedical%20results%20cannot%20be%20repeated%20has%20stimulated%20interest%20in%20practices%20that%20generate%20findable%2C%20accessible%2C%20interoperable%2C%20and%20reusable%20%28FAIR%29%20data.%20Multiple%20papers%20have%20identified%20specific%20examples%20of%20irreproducibility%2C%20but%20practical%20ways%20to%20make%20data%20more%20reproducible%20have%20not%20been%20widely%20studied.%20Here%2C%20five%20research%20centers%20in%20the%20NIH%20LINCS%20Program%20Consortium%20investigate%20the%20reproducibility%20of%20a%20prototypical%20perturbational%20assay%3A%20quantifying%20the%20responsiveness%20of%20cultured%20cells%20to%20anti-cancer%20drugs.%20Such%20assays%20are%20important%20for%20drug%20development%2C%20studying%20cellular%20networks%2C%20and%20patient%20stratification.%20While%20many%20experimental%20and%20computational%20factors%20impact%20intra-%20and%20inter-center%20reproducibility%2C%20the%20factors%20most%20difficult%20to%20identify%20and%20control%20are%20those%20with%20a%20strong%20dependency%20on%20biological%20context.%20These%20factors%20often%20vary%20in%20magnitude%20with%20the%20drug%20being%20analyzed%20and%20with%20growth%20conditions.%20We%20provide%20ways%20to%20identify%20such%20context-sensitive%20factors%2C%20thereby%20improving%20both%20the%20theory%20and%20practice%20of%20reproducible%20cell-based%20assays.%22%2C%22date%22%3A%222019-07-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2019.06.005%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A55%3A17Z%22%7D%7D%2C%7B%22key%22%3A%229GDIQ9IV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Olson%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-20%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOlson%20CM%2C%20Liang%20Y%2C%20Leggett%20A%2C%20Park%20WD%2C%20Li%20L%2C%20Mills%20CE%2C%20Elsarrag%20SZ%2C%20Ficarro%20SB%2C%20Zhang%20T%2C%20D%26%23xFC%3Bster%20R%2C%20Geyer%20M%2C%20Sim%20T%2C%20Marto%20JA%2C%20Sorger%20PK%2C%20Westover%20KD%2C%20Lin%20CY%2C%20Kwiatkowski%20N%2C%20Gray%20NS.%20Development%20of%20a%20selective%20CDK7%20covalent%20inhibitor%20reveals%20predominant%20cell-cycle%20phenotype.%20Cell%20Chem%20Biol.%202019%20Jun%2020%3B26%286%29%3A792-803.e10.%20PMCID%3A%20PMC6588464%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20of%20a%20selective%20CDK7%20covalent%20inhibitor%20reveals%20predominant%20cell-cycle%20phenotype%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Calla%20M.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanke%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Leggett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Woojun%20D.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lianbo%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selma%20Z.%22%2C%22lastName%22%3A%22Elsarrag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Ficarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22D%5Cu00fcster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Geyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taebo%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarrod%20A.%22%2C%22lastName%22%3A%22Marto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Y.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Kwiatkowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%207%20%28CDK7%29%20regulates%20both%20cell%20cycle%20and%20transcription%2C%20but%20its%20precise%20role%20remains%20elusive.%20We%20previously%20described%20THZ1%2C%20a%20CDK7%20inhibitor%2C%20which%20dramatically%20inhibits%20superenhancer-associated%20gene%20expression.%20However%2C%20potent%20CDK12%5C%2F13%20off-target%20activity%20obscured%20CDK7s%20contribution%20to%20this%20phenotype.%20Here%2C%20we%20describe%20the%20discovery%20of%20a%5Cu00a0highly%20selective%20covalent%20CDK7%20inhibitor.%20YKL-5-124%20causes%20arrest%20at%20the%20G1%5C%2FS%20transition%20and%20inhibition%5Cu00a0of%20E2F-driven%20gene%20expression%3B%20these%20effects%20are%20rescued%20by%20a%20CDK7%20mutant%20unable%20to%20covalently%20engage%20YKL-5-124%2C%20demonstrating%20on-target%20specificity.%20Unlike%20THZ1%2C%20treatment%20with%20YKL-5-124%20resulted%20in%20no%20change%20to%20RNA%20polymerase%20II%20C-terminal%20domain%20phosphorylation%3B%20however%2C%20inhibition%20could%20be%20reconstituted%20by%20combining%20YKL-5-124%20and%20THZ531%2C%20a%20selective%20CDK12%5C%2F13%20inhibitor%2C%20revealing%20potential%20redundancies%20in%20CDK%20control%20of%20gene%20transcription.%20These%20findings%20highlight%20the%20importance%20of%20CDK7%5C%2F12%5C%2F13%20polypharmacology%20for%20anti-cancer%20activity%20of%20THZ1%20and%20posit%20that%20selective%20inhibition%20of%20CDK7%20may%20be%5Cu00a0useful%20for%20treatment%20of%20cancers%20marked%20by%20E2F%20misregulation.%22%2C%22date%22%3A%222019-06-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.02.012%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T15%3A33%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22SITF9MVY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-19%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Chidley%20C%2C%20Sorger%20PK.%20A%20curative%20combination%20cancer%20therapy%20achieves%20high%20fractional%20cell%20killing%20through%20low%20cross-resistance%20and%20drug%20additivity.%20Elife.%202019%20Nov%2019%3B8%3Ae50036.%20PMCID%3A%20PMC6897534%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20curative%20combination%20cancer%20therapy%20achieves%20high%20fractional%20cell%20killing%20through%20low%20cross-resistance%20and%20drug%20additivity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Curative%20cancer%20therapies%20are%20uncommon%20and%20nearly%20always%20involve%20multi-drug%20combinations%20developed%20by%20experimentation%20in%20humans%3B%20unfortunately%2C%20the%20mechanistic%20basis%20for%20the%20success%20of%20such%20combinations%20has%20rarely%20been%20investigated%20in%20detail%2C%20obscuring%20lessons%20learned.%20Here%2C%20we%20use%20isobologram%20analysis%20to%20score%20pharmacological%20interaction%2C%20and%20clone%20tracing%20and%20CRISPR%20screening%20to%20measure%20cross-resistance%20among%20the%20five%20drugs%20comprising%20R-CHOP%2C%20a%20combination%20therapy%20that%20frequently%20cures%20Diffuse%20Large%20B-Cell%20Lymphomas.%20We%20find%20that%20drugs%20in%20R-CHOP%20exhibit%20very%20low%20cross-resistance%20but%20not%20synergistic%20interaction%3A%20together%20they%20achieve%20a%20greater%20fractional%20kill%20according%20to%20the%20null%20hypothesis%20for%20both%20the%20Loewe%20dose-additivity%20model%20and%20the%20Bliss%20effect-independence%20model.%20These%20data%20provide%20direct%20evidence%20for%20the%2050%20year%20old%20hypothesis%20that%20a%20curative%20cancer%20therapy%20can%20be%20constructed%20on%20the%20basis%20of%20independently%20effective%20drugs%20having%20non-overlapping%20mechanisms%20of%20resistance%2C%20without%20synergistic%20interaction%2C%20which%20has%20immediate%20significance%20for%20the%20design%20of%20new%20drug%20combinations.%22%2C%22date%22%3A%222019-11-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.50036%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A11%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22QABPPXQL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pavkovic%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-14%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPavkovic%20M%2C%20Pantano%20L%2C%20Gerlach%20CV%2C%20Brutus%20S%2C%20Boswell%20SA%2C%20Everley%20RA%2C%20Shah%20JV%2C%20Sui%20SH%2C%20Vaidya%20VS.%20Multi%20omics%20analysis%20of%20fibrotic%20kidneys%20in%20two%20mouse%20models.%20Sci%20Data.%202019%20Jun%2014%3B6%281%29%3A92.%20PMCID%3A%20PMC6570759%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multi%20omics%20analysis%20of%20fibrotic%20kidneys%20in%20two%20mouse%20models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorena%22%2C%22lastName%22%3A%22Pantano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cory%20V.%22%2C%22lastName%22%3A%22Gerlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergine%22%2C%22lastName%22%3A%22Brutus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jagesh%20V.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannan%20H.%22%2C%22lastName%22%3A%22Sui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Kidney%20fibrosis%20represents%20an%20urgent%20unmet%20clinical%20need%20due%20to%20the%20lack%20of%20effective%20therapies%20and%20an%20inadequate%20understanding%20of%20the%20molecular%20pathogenesis.%20We%20have%20generated%20a%20comprehensive%20and%20combined%20multi-omics%20dataset%20%28proteomics%2C%20mRNA%20and%20small%20RNA%20transcriptomics%29%20of%20fibrotic%20kidneys%20that%20is%20searchable%20through%20a%20user-friendly%20web%20application%3A%20http%3A%5C%2F%5C%2Fhbcreports.med.harvard.edu%5C%2Ffmm%5C%2F%20.%20Two%20commonly%20used%20mouse%20models%20were%20utilized%3A%20a%20reversible%20chemical-induced%20injury%20model%20%28folic%20acid%20%28FA%29%20induced%20nephropathy%29%20and%20an%20irreversible%20surgically-induced%20fibrosis%20model%20%28unilateral%20ureteral%20obstruction%20%28UUO%29%29.%20mRNA%20and%20small%20RNA%20sequencing%2C%20as%20well%20as%2010-plex%20tandem%20mass%20tag%20%28TMT%29%20proteomics%20were%20performed%20with%20kidney%20samples%20from%20different%20time%20points%20over%20the%20course%20of%20fibrosis%20development.%20The%20bioinformatics%20workflow%20used%20to%20process%2C%20technically%20validate%2C%20and%20combine%20the%20single%20omics%20data%20will%20be%20described.%20In%20summary%2C%20we%20present%20temporal%20multi-omics%20data%20from%20fibrotic%20mouse%20kidneys%20that%20are%20accessible%20through%20an%20interrogation%20tool%20%28Mouse%20Kidney%20Fibromics%20browser%29%20to%20provide%20a%20searchable%20transcriptome%20and%20proteome%20for%20kidney%20fibrosis%20researchers.%22%2C%22date%22%3A%222019-06-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-019-0095-5%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T18%3A41%3A42Z%22%7D%7D%2C%7B%22key%22%3A%2233WMT43X%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ramm%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERamm%20S%2C%20Todorov%20P%2C%20Chandrasekaran%20V%2C%20Dohlman%20A%2C%20Monteiro%20MB%2C%20Pavkovic%20M%2C%20Muhlich%20J%2C%20Shankaran%20H%2C%20Chen%20WW%2C%20Mettetal%20JT%2C%20Vaidya%20VS.%20A%20systems%20toxicology%20approach%20for%20the%20prediction%20of%20kidney%20toxicity%20and%20its%20mechanisms%20in%20vitro.%20Toxicol%20Sci.%202019%20May%201%3B169%281%29%3A54%26%23x2013%3B69.%20PMCID%3A%20PMC6484891%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20systems%20toxicology%20approach%20for%20the%20prediction%20of%20kidney%20toxicity%20and%20its%20mechanisms%20in%20vitro%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Ramm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petar%22%2C%22lastName%22%3A%22Todorov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidya%22%2C%22lastName%22%3A%22Chandrasekaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anders%22%2C%22lastName%22%3A%22Dohlman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20B.%22%2C%22lastName%22%3A%22Monteiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harish%22%2C%22lastName%22%3A%22Shankaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20W.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%20T.%22%2C%22lastName%22%3A%22Mettetal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22The%20failure%20to%20predict%20kidney%20toxicity%20of%20new%20chemical%20entities%20early%20in%20the%20development%20process%20before%20they%20reach%20humans%20remains%20a%20critical%20issue.%20Here%2C%20we%20used%20primary%20human%20kidney%20cells%20and%20applied%20a%20systems%20biology%20approach%20that%20combines%20multidimensional%20datasets%20and%20machine%20learning%20to%20identify%20biomarkers%20that%20not%20only%20predict%20nephrotoxic%20compounds%20but%20also%20provide%20hints%20toward%20their%20mechanism%20of%20toxicity.%20Gene%20expression%20and%20high-content%20imaging-derived%20phenotypical%20data%20from%2046%20diverse%20kidney%20toxicants%20were%20analyzed%20using%20Random%20Forest%20machine%20learning.%20Imaging%20features%20capturing%20changes%20in%20cell%20morphology%20and%20nucleus%20texture%20along%20with%20mRNA%20levels%20of%20HMOX1%20and%20SQSTM1%20were%20identified%20as%20the%20most%20powerful%20predictors%20of%20toxicity.%20These%20biomarkers%20were%20validated%20by%20their%20ability%20to%20accurately%20predict%20kidney%20toxicity%20of%20four%20out%20of%20six%20candidate%20therapeutics%20that%20exhibited%20toxicity%20only%20in%20late%20stage%20preclinical%5C%2Fclinical%20studies.%20Network%20analysis%20of%20similarities%20in%20toxic%20phenotypes%20was%20performed%20based%20on%20live-cell%20high-content%20image%20analysis%20at%20seven%20time%20points.%20Using%20compounds%20with%20known%20mechanism%20as%20reference%2C%20we%20could%20infer%20potential%20mechanisms%20of%20toxicity%20of%20candidate%20therapeutics.%20In%20summary%2C%20we%20report%20an%20approach%20to%20generate%20a%20multidimensional%20biomarker%20panel%20for%20mechanistic%20de-risking%20and%20prediction%20of%20kidney%20toxicity%20in%20in%20vitro%20for%20new%20therapeutic%20candidates%20and%20chemical%20entities.%22%2C%22date%22%3A%222019-05-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ftoxsci%5C%2Fkfz021%22%2C%22ISSN%22%3A%221096-0929%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T04%3A11%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22BXUXLTNQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rao%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-20%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERao%20S%2C%20Gurbani%20D%2C%20Du%20G%2C%20Everley%20RA%2C%20Browne%20CM%2C%20Chaikuad%20A%2C%20Tan%20L%2C%20Schr%26%23xF6%3Bder%20M%2C%20Gondi%20S%2C%20Ficarro%20SB%2C%20Sim%20T%2C%20Kim%20ND%2C%20Berberich%20MJ%2C%20Knapp%20S%2C%20Marto%20JA%2C%20Westover%20KD%2C%20Sorger%20PK%2C%20Gray%20NS.%20Leveraging%20compound%20promiscuity%20to%20identify%20targetable%20cysteines%20within%20the%20kinome.%20Cell%20Chem%20Biol.%202019%20Jun%2020%3B26%286%29%3A818-829.e9.%20PMCID%3A%20PMC6634314%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Leveraging%20compound%20promiscuity%20to%20identify%20targetable%20cysteines%20within%20the%20kinome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suman%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%22%2C%22lastName%22%3A%22Gurbani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20M.%22%2C%22lastName%22%3A%22Browne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Apirat%22%2C%22lastName%22%3A%22Chaikuad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Schr%5Cu00f6der%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudershan%22%2C%22lastName%22%3A%22Gondi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Ficarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taebo%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nam%20Doo%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Knapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarrod%20A.%22%2C%22lastName%22%3A%22Marto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Covalent%20kinase%20inhibitors%2C%20which%20typically%20target%20cysteine%20residues%2C%20represent%20an%20important%20class%20of%20clinically%20relevant%20compounds.%20Approximately%20215%20kinases%20are%20known%20to%20have%20potentially%20targetable%20cysteines%20distributed%20across%2018%20spatially%20distinct%20locations%20proximal%20to%20the%20ATP-binding%20pocket.%20However%2C%20only%2040%20kinases%20have%20been%20covalently%20targeted%2C%20with%20certain%20cysteine%20sites%20being%20the%20primary%20focus.%20To%20address%20this%20disparity%2C%20we%20have%5Cu00a0developed%20a%20strategy%20that%20combines%20the%20use%5Cu00a0of%20a%20multi-targeted%20acrylamide-modified%20inhibitor%2C%20SM1-71%2C%20with%20a%20suite%20of%20complementary%20chemoproteomic%20and%20cellular%20approaches%20to%20identify%5Cu00a0additional%20targetable%20cysteines.%20Using%20this%20single%5Cu00a0multi-targeted%20compound%2C%20we%20successfully%20identified%2023%20kinases%20that%20are%20amenable%20to%20covalent%5Cu00a0inhibition%20including%20MKNK2%2C%20MAP2K1%5C%2F2%5C%2F3%5C%2F4%5C%2F6%5C%2F7%2C%20GAK%2C%20AAK1%2C%20BMP2K%2C%20MAP3K7%2C%20MAPKAPK5%2C%20GSK3A%5C%2FB%2C%20MAPK1%5C%2F3%2C%20SRC%2C%20YES1%2C%20FGFR1%2C%20ZAK%20%28MLTK%29%2C%20MAP3K1%2C%20LIMK1%2C%20and%20RSK2.%20The%20identification%20of%20nine%20of%20these%20kinases%20previously%20not%20targeted%20by%20a%20covalent%20inhibitor%20increases%20the%20number%20of%20targetable%20kinases%20and%20highlights%20opportunities%20for%20covalent%20kinase%20inhibitor%20development.%22%2C%22date%22%3A%22Jun%2020%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2019.02.021%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A56%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22NDJ4AUT9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rao%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-24%22%2C%22numChildren%22%3A11%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERao%20S%2C%20Du%20G%2C%20Hafner%20M%2C%20Subramanian%20K%2C%20Sorger%20PK%2C%20Gray%20NS.%20A%20multitargeted%20probe-based%20strategy%20to%20identify%20signaling%20vulnerabilities%20in%20cancers.%20J%20Biol%20Chem.%202019%20May%2024%3B294%2821%29%3A8664%26%23x2013%3B8673.%20PMCID%3A%20PMC6544847%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20multitargeted%20probe-based%20strategy%20to%20identify%20signaling%20vulnerabilities%20in%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suman%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Most%20cancer%20cells%20are%20dependent%20on%20a%20network%20of%20deregulated%20signaling%20pathways%20for%20survival%20and%20are%20insensitive%2C%20or%20rapidly%20evolve%20resistance%2C%20to%20selective%20inhibitors%20aimed%20at%20a%20single%20target.%20For%20these%20reasons%2C%20drugs%20that%20target%20more%20than%20one%20protein%20%28polypharmacology%29%20can%20be%20clinically%20advantageous.%20The%20discovery%20of%20useful%20polypharmacology%20remains%20serendipitous%20and%20is%20challenging%20to%20characterize%20and%20validate.%20In%20this%20study%2C%20we%20developed%20a%20non-genetic%20strategy%20for%20the%20identification%20of%20pathways%20that%20drive%20cancer%20cell%20proliferation%20and%20represent%20exploitable%20signaling%20vulnerabilities.%20Our%20approach%20is%20based%20on%20using%20a%20multitargeted%20kinase%20inhibitor%2C%20SM1-71%2C%20as%20a%20tool%20compound%20to%20identify%20combinations%20of%20targets%20whose%20simultaneous%20inhibition%20elicits%20a%20potent%20cytotoxic%20effect.%20As%20a%20proof%20of%20concept%2C%20we%20applied%20this%20approach%20to%20a%20KRAS-dependent%20non-small%20cell%20lung%20cancer%20%28NSCLC%29%20cell%20line%2C%20H23-KRASG12C%20Using%20a%20combination%20of%20phenotypic%20screens%2C%20signaling%20analyses%2C%20and%20kinase%20inhibitors%2C%20we%20found%20that%20dual%20inhibition%20of%20MEK1%5C%2F2%20and%20insulin-like%20growth%20factor%201%20receptor%20%28IGF1R%29%5C%2Finsulin%20receptor%20%28INSR%29%20is%20critical%20for%20blocking%20proliferation%20in%20cells.%20Our%20work%20supports%20the%20value%20of%20multitargeted%20tool%20compounds%20with%20well-validated%20polypharmacology%20and%20target%20space%20as%20tools%20to%20discover%20kinase%20dependences%20in%20cancer.%20We%20propose%20that%20the%20strategy%20described%20here%20is%20complementary%20to%20existing%20genetics-based%20approaches%2C%20generalizable%20to%20other%20systems%2C%20and%20enabling%20for%20future%20mechanistic%20and%20translational%20studies%20of%20polypharmacology%20in%20the%20context%20of%20signaling%20vulnerabilities%20in%20cancers.%22%2C%22date%22%3A%22May%2024%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1074%5C%2Fjbc.RA118.006805%22%2C%22ISSN%22%3A%221083-351X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A56%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22N46RZS2V%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rashid%20et%20al.%22%2C%22parsedDate%22%3A%222019-12-17%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERashid%20R%2C%20Gaglia%20G%2C%20Chen%20YA%2C%20Lin%20JR%2C%20Du%20Z%2C%20Maliga%20Z%2C%20Schapiro%20D%2C%20Yapp%20C%2C%20Muhlich%20J%2C%20Sokolov%20A%2C%20Sorger%20P%2C%20Santagata%20S.%20Highly%20multiplexed%20immunofluorescence%20images%20and%20single-cell%20data%20of%20immune%20markers%20in%20tonsil%20and%20lung%20cancer.%20Sci%20Data.%202019%20Dec%2017%3B6%281%29%3A323.%20PMCID%3A%20PMC6917801%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Highly%20multiplexed%20immunofluorescence%20images%20and%20single-cell%20data%20of%20immune%20markers%20in%20tonsil%20and%20lung%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgio%22%2C%22lastName%22%3A%22Gaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20data%20descriptor%2C%20we%20document%20a%20dataset%20of%20multiplexed%20immunofluorescence%20images%20and%20derived%20single-cell%20measurements%20of%20immune%20lineage%20and%20other%20markers%20in%20formaldehyde-fixed%20and%20paraffin-embedded%20%28FFPE%29%20human%20tonsil%20and%20lung%20cancer%20tissue.%20We%20used%20tissue%20cyclic%20immunofluorescence%20%28t-CyCIF%29%20to%20generate%20fluorescence%20images%20which%20we%20artifact%20corrected%20using%20the%20BaSiC%20tool%2C%20stitched%20and%20registered%20using%20the%20ASHLAR%20algorithm%2C%20and%20segmented%20using%20ilastik%20software%20and%20MATLAB.%20We%20extracted%20single-cell%20features%20from%20these%20images%20using%20HistoCAT%20software.%20The%20resulting%20dataset%20can%20be%20visualized%20using%20image%20browsers%20and%20analyzed%20using%20high-dimensional%2C%20single-cell%20methods.%20This%20dataset%20is%20a%20valuable%20resource%20for%20biological%20discovery%20of%20the%20immune%20system%20in%20normal%20and%20diseased%20states%20as%20well%20as%20for%20the%20development%20of%20multiplexed%20image%20analysis%20and%20viewing%20tools.%22%2C%22date%22%3A%22Dec%2017%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-019-0332-y%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22BUUJP9QL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rogava%20and%20Izar%22%2C%22parsedDate%22%3A%222019-11%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERogava%20M%2C%20Izar%20B.%20CXCR3%3A%20Here%20to%20stay%20to%20enhance%20cancer%20immunotherapy%3F%20EBioMedicine.%202019%20Nov%3B49%3A11%26%23x2013%3B12.%20PMCID%3A%20PMC6945198%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CXCR3%3A%20Here%20to%20stay%20to%20enhance%20cancer%20immunotherapy%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meri%22%2C%22lastName%22%3A%22Rogava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ebiom.2019.09.044%22%2C%22ISSN%22%3A%222352-3964%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A57%3A36Z%22%7D%7D%2C%7B%22key%22%3A%222UELVJ4C%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Smith%20and%20Aldridge%22%2C%22parsedDate%22%3A%222019-06-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESmith%20TC%2C%20Aldridge%20BB.%20Targeting%20drugs%20for%20tuberculosis.%20Science.%202019%20Jun%2028%3B364%286447%29%3A1234%26%23x2013%3B1235.%20PMID%3A%2031249047%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20drugs%20for%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trever%20C.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019-06-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.aay0211%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A52%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22BBD2WHFE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sokolov%20et%20al.%22%2C%22parsedDate%22%3A%222019-04-25%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESokolov%20A%2C%20Ashenden%20S%2C%20Sahin%20N%2C%20Lewis%20R%2C%20Erdem%20N%2C%20Ozaltan%20E%2C%20Bender%20A%2C%20Roth%20FP%2C%20Cokol%20M.%20Characterizing%20ABC-transporter%20substrate-likeness%20using%20a%20clean-slate%20genetic%20background.%20Front%20Pharmacol.%202019%20Apr%2025%3B10%3A448.%20PMCID%3A%20PMC6494965%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterizing%20ABC-transporter%20substrate-likeness%20using%20a%20clean-slate%20genetic%20background%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Ashenden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nil%22%2C%22lastName%22%3A%22Sahin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurdan%22%2C%22lastName%22%3A%22Erdem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elif%22%2C%22lastName%22%3A%22Ozaltan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Bender%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20P.%22%2C%22lastName%22%3A%22Roth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%5D%2C%22abstractNote%22%3A%22Mutations%20in%20ATP%20Binding%20Cassette%20%28ABC%29-transporter%20genes%20can%20have%20major%20effects%20on%20the%20bioavailability%20and%20toxicity%20of%20the%20drugs%20that%20are%20ABC-transporter%20substrates.%20Consequently%2C%20methods%20to%20predict%20if%20a%20drug%20is%20an%20ABC-transporter%20substrate%20are%20useful%20for%20drug%20development.%20Such%20methods%20traditionally%20relied%20on%20literature%20curated%20collections%20of%20ABC-transporter%20dependent%20membrane%20transfer%20assays.%20Here%2C%20we%20used%20a%20single%20large-scale%20dataset%20of%20376%20drugs%20with%20relative%20efficacy%20on%20an%20engineered%20yeast%20strain%20with%20all%20ABC-transporter%20genes%20deleted%20%28ABC-16%29%2C%20to%20explore%20the%20relationship%20between%20a%20drug%27s%20chemical%20structure%20and%20ABC-transporter%20substrate-likeness.%20We%20represented%20a%20drug%27s%20chemical%20structure%20by%20an%20array%20of%20substructure%20keys%20and%20explored%20several%20machine%20learning%20methods%20to%20predict%20the%20drug%27s%20efficacy%20in%20an%20ABC-16%20yeast%20strain.%20Gradient-Boosted%20Random%20Forest%20models%20outperformed%20all%20other%20methods%20with%20an%20AUC%20of%200.723.%20We%20prospectively%20validated%20the%20model%20using%20new%20experimental%20data%20and%20found%20significant%20agreement%20with%20predictions.%20Our%20analysis%20expands%20the%20previously%20reported%20chemical%20substructures%20associated%20with%20ABC-transporter%20substrates%20and%20provides%20an%20alternative%20means%20to%20investigate%20ABC-transporter%20substrate-likeness.%22%2C%22date%22%3A%22April%2025%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffphar.2019.00448%22%2C%22ISSN%22%3A%221663-9812%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A03%3A06Z%22%7D%7D%2C%7B%22key%22%3A%2222TAIA67%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Song%20et%20al.%22%2C%22parsedDate%22%3A%222019-02-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESong%20Y%2C%20Subramanian%20K%2C%20Berberich%20MJ%2C%20Rodriguez%20S%2C%20Latorre%20IJ%2C%20Luria%20CM%2C%20Everley%20R%2C%20Albers%20MW%2C%20Mitchison%20TJ%2C%20Sorger%20PK.%20A%20dynamic%20view%20of%20the%20proteomic%20landscape%20during%20differentiation%20of%20ReNcell%20VM%20cells%2C%20an%20immortalized%20human%20neural%20progenitor%20line.%20Sci%20Data.%202019%20Feb%2019%3B6%3A190016.%20PMCID%3A%20PMC6380223%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20dynamic%20view%20of%20the%20proteomic%20landscape%20during%20differentiation%20of%20ReNcell%20VM%20cells%2C%20an%20immortalized%20human%20neural%20progenitor%20line%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuyu%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%20J.%22%2C%22lastName%22%3A%22Latorre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20M.%22%2C%22lastName%22%3A%22Luria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Mitchison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20immortalized%20human%20ReNcell%20VM%20cell%20line%20represents%20a%20reproducible%20and%20easy-to-propagate%20cell%20culture%20system%20for%20studying%20the%20differentiation%20of%20neural%20progenitors.%20To%20better%20characterize%20the%20starting%20line%20and%20its%20subsequent%20differentiation%2C%20we%20assessed%20protein%20and%20phospho-protein%20levels%20and%20cell%20morphology%20over%20a%2015-day%20period%20during%20which%20ReNcell%20progenitors%20differentiated%20into%20neurons%2C%20astrocytes%20and%20oligodendrocytes.%20Five%20of%20the%20resulting%20datasets%20measured%20protein%20levels%20or%20states%20of%20phosphorylation%20based%20on%20tandem-mass-tag%20%28TMT%29%20mass%20spectrometry%20and%20four%20datasets%20characterized%20cellular%20phenotypes%20using%20high-content%20microscopy.%20Proteomic%20analysis%20revealed%20reproducible%20changes%20in%20pathways%20responsible%20for%20cytoskeletal%20rearrangement%2C%20cell%20phase%20transitions%2C%20neuronal%20migration%2C%20glial%20differentiation%2C%20neurotrophic%20signalling%20and%20extracellular%20matrix%20regulation.%20Proteomic%20and%20imaging%20data%20revealed%20accelerated%20differentiation%20in%20cells%20treated%20with%20the%20poly-selective%20CDK%20and%20GSK3%20inhibitor%20kenpaullone%20or%20the%20HMG-CoA%20reductase%20inhibitor%20mevastatin%2C%20both%20of%20which%20have%20previously%20been%20reported%20to%20promote%20neural%20differentiation.%20These%20data%20provide%20in-depth%20information%20on%20the%20ReNcell%20progenitor%20state%20and%20on%20neural%20differentiation%20in%20the%20presence%20and%20absence%20of%20drugs%2C%20setting%20the%20stage%20for%20functional%20studies.%22%2C%22date%22%3A%22Feb%2019%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fsdata.2019.16%22%2C%22ISSN%22%3A%222052-4463%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T13%3A16%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22256KJWZZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Todorov%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETodorov%20PV%2C%20Gyori%20BM%2C%20Bachman%20JA%2C%20Sorger%20PK.%20INDRA-IPM%3A%20interactive%20pathway%20modeling%20using%20natural%20language%20with%20automated%20assembly.%20Bioinformatics.%202019%20Nov%201%3B35%2821%29%3A4501%26%23x2013%3B4503.%20PMCID%3A%20PMC6821420%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22INDRA-IPM%3A%20interactive%20pathway%20modeling%20using%20natural%20language%20with%20automated%20assembly%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petar%20V.%22%2C%22lastName%22%3A%22Todorov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22SUMMARY%3A%20INDRA-IPM%20%28Interactive%20Pathway%20Map%29%20is%20a%20web-based%20pathway%20map%20modeling%20tool%20that%20combines%20natural%20language%20processing%20with%20automated%20model%20assembly%20and%20visualization.%20INDRA-IPM%20contextualizes%20models%20with%20expression%20data%20and%20exports%20them%20to%20standard%20formats.%5CnAVAILABILITY%20AND%20IMPLEMENTATION%3A%20INDRA-IPM%20is%20available%20at%3A%20http%3A%5C%2F%5C%2Fpathwaymap.indra.bio.%20Source%20code%20is%20available%20at%20http%3A%5C%2F%5C%2Fgithub.com%5C%2Fsorgerlab%5C%2Findra_pathway_map.%20The%20underlying%20web%20service%20API%20is%20available%20at%20http%3A%5C%2F%5C%2Fapi.indra.bio%3A8000.%5CnSUPPLEMENTARY%20INFORMATION%3A%20Supplementary%20data%20are%20available%20at%20Bioinformatics%20online.%22%2C%22date%22%3A%222019-11-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fbioinformatics%5C%2Fbtz289%22%2C%22ISSN%22%3A%221367-4811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A08%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22MNERQ2RX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWang%20H%2C%20Sheehan%20RP%2C%20Palmer%20AC%2C%20Everley%20RA%2C%20Boswell%20SA%2C%20Ron-Harel%20N%2C%20Ringel%20AE%2C%20Holton%20KM%2C%20Jacobson%20CA%2C%20Erickson%20AR%2C%20Maliszewski%20L%2C%20Haigis%20MC%2C%20Sorger%20PK.%20Adaptation%20of%20human%20iPSC-derived%20cardiomyocytes%20to%20tyrosine%20kinase%20inhibitors%20reduces%20acute%20cardiotoxicity%20via%20metabolic%20reprogramming.%20Cell%20Syst.%202019%20May%2022%3B8%285%29%3A412-426.e7.%20PMCID%3A%20PMC6657491%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adaptation%20of%20human%20iPSC-derived%20cardiomyocytes%20to%20tyrosine%20kinase%20inhibitors%20reduces%20acute%20cardiotoxicity%20via%20metabolic%20reprogramming%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20P.%22%2C%22lastName%22%3A%22Sheehan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noga%22%2C%22lastName%22%3A%22Ron-Harel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20E.%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristina%20M.%22%2C%22lastName%22%3A%22Holton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20R.%22%2C%22lastName%22%3A%22Erickson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Maliszewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Tyrosine%20kinase%20inhibitors%20%28TKIs%29%20are%20widely%20used%20to%20treat%20solid%20tumors%20but%20can%20be%20cardiotoxic.%20The%20molecular%20basis%20for%20this%20toxicity%20and%20its%20relationship%20to%20therapeutic%20mechanisms%20remain%20unclear%3B%20we%20therefore%20undertook%20a%20systems-level%20analysis%20of%20human%20cardiomyocytes%20%28CMs%29%20exposed%20to%20four%20TKIs.%20CMs%20differentiated%20from%20human%20induced%20pluripotent%20stem%20cells%20%28hiPSCs%29%20were%20exposed%20to%20sunitinib%2C%20sorafenib%2C%20lapatinib%2C%20or%20erlotinib%2C%20and%20responses%20were%20assessed%20by%20functional%20assays%2C%20microscopy%2C%20RNA%20sequencing%2C%20and%20mass%20spectrometry%20%28GEO%3A%20GSE114686%3B%20PRIDE%3A%20PXD012043%29.%20TKIs%20have%20diverse%20effects%20on%20hiPSC-CMs%20distinct%20from%20inhibition%20of%20tyrosine-kinase-mediated%20signal%20transduction%3B%20cardiac%20metabolism%20is%20particularly%20sensitive.%20Following%20sorafenib%20treatment%2C%20oxidative%20phosphorylation%20is%20downregulated%2C%20resulting%20in%20a%20profound%20defect%20in%20mitochondrial%20energetics.%20Cells%20adapt%20by%20upregulating%20aerobic%20glycolysis.%20Adaptation%20makes%20cells%20less%20acutely%20sensitive%20to%20sorafenib%20but%20may%20have%20long-term%20negative%20consequences.%20Thus%2C%20CMs%20exhibit%20adaptive%20responses%20to%20anti-cancer%20drugs%20conceptually%20similar%20to%20those%20previously%20shown%20in%20tumors%20to%20mediate%20drug%20resistance.%22%2C%22date%22%3A%22May%2022%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2019.03.009%22%2C%22ISSN%22%3A%222405-4720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A56%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22JFR7QWSK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222019-12%22%2C%22numChildren%22%3A11%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWang%20S%2C%20Lin%20JR%2C%20Sontag%20ED%2C%20Sorger%20PK.%20Inferring%20reaction%20network%20structure%20from%20single-cell%2C%20multiplex%20data%2C%20using%20toric%20systems%20theory.%20PLoS%20Comput%20Biol.%202019%20Dec%3B15%2812%29%3Ae1007311.%20PMCID%3A%20PMC6919632%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inferring%20reaction%20network%20structure%20from%20single-cell%2C%20multiplex%20data%2C%20using%20toric%20systems%20theory%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20D.%22%2C%22lastName%22%3A%22Sontag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20goal%20of%20many%20single-cell%20studies%20on%20eukaryotic%20cells%20is%20to%20gain%20insight%20into%20the%20biochemical%20reactions%20that%20control%20cell%20fate%20and%20state.%20In%20this%20paper%20we%20introduce%20the%20concept%20of%20Effective%20Stoichiometric%20Spaces%20%28ESS%29%20to%20guide%20the%20reconstruction%20of%20biochemical%20networks%20from%20multiplexed%2C%20fixed%20time-point%2C%20single-cell%20data.%20In%20contrast%20to%20methods%20based%20solely%20on%20statistical%20models%20of%20data%2C%20the%20ESS%20method%20leverages%20the%20power%20of%20the%20geometric%20theory%20of%20toric%20varieties%20to%20begin%20unraveling%20the%20structure%20of%20chemical%20reaction%20networks%20%28CRN%29.%20This%20application%20of%20toric%20theory%20enables%20a%20data-driven%20mapping%20of%20covariance%20relationships%20in%20single-cell%20measurements%20into%20stoichiometric%20information%2C%20one%20in%20which%20each%20cell%20subpopulation%20has%20its%20associated%20ESS%20interpreted%20in%20terms%20of%20CRN%20theory.%20In%20the%20development%20of%20ESS%20we%20reframe%20certain%20aspects%20of%20the%20theory%20of%20CRN%20to%20better%20match%20data%20analysis.%20As%20an%20application%20of%20our%20approach%20we%20process%20cytomery-%20and%20image-based%20single-cell%20datasets%20and%20identify%20differences%20in%20cells%20treated%20with%20kinase%20inhibitors.%20Our%20approach%20is%20directly%20applicable%20to%20data%20acquired%20using%20readily%20accessible%20experimental%20methods%20such%20as%20Fluorescence%20Activated%20Cell%20Sorting%20%28FACS%29%20and%20multiplex%20immunofluorescence.%22%2C%22date%22%3A%22Dec%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1007311%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T17%3A03%3A04Z%22%7D%7D%5D%7D
1.
Alley EC, Khimulya G, Biswas S, AlQuraishi M, Church GM. Unified rational protein engineering with sequence-based deep representation learning. Nat Methods. 2019 Dec;16(12):1315–1322. PMCID: PMC7067682
1.
AlQuraishi M. ProteinNet: a standardized data set for machine learning of protein structure. BMC Bioinformatics. 2019 Jun 11;20(1):311. PMCID: PMC6560865
1.
AlQuraishi M. AlphaFold at CASP13. Bioinformatics. 2019 Nov 1;35(22):4862–4865. PMCID: PMC6907002
1.
AlQuraishi M. Parallelized natural extension reference frame: parallelized conversion from internal to Cartesian coordinates. J Comput Chem. 2019 Mar 15;40(7):885–892. PMID: 30614534
1.
AlQuraishi M. End-to-end differentiable learning of protein structure. Cell Syst. 2019 Apr 24;8(4):292-301.e3. PMCID: PMC6513320
1.
Bachman JA, Sorger PK, Gyori BM. Assembling a corpus of phosphoproteomic annotations using ProtMapper to normalize site information from databases and text mining [Internet]. bioRxiv; 2019 [cited 2023 Oct 31]. Available from: http://biorxiv.org/lookup/doi/10.1101/822668
1.
Bandopadhayay P, Piccioni F, O’Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, Pages M, Balboni Iniguez A, Paolella BR, Meng A, Sinai C, Roti G, Dharia NV, Creech A, Tanenbaum B, Khadka P, Tracy A, Tiv HL, Hong AL, Coy S, Rashid R, Lin JR, Cowley GS, Lam FC, Goodale A, Lee Y, Schoolcraft K, Vazquez F, Hahn WC, Tsherniak A, Bradner JE, Yaffe MB, Milde T, Pfister SM, Qi J, Schenone M, Carr SA, Ligon KL, Kieran MW, Santagata S, Olson JM, Gokhale PC, Jaffe JD, Root DE, Stegmaier K, Johannessen CM, Beroukhim R. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun. 2019 Jun 3;10(1):2400. PMCID: PMC6546744
1.
Du Z, Lin JR, Rashid R, Maliga Z, Wang S, Aster JC, Izar B, Sorger PK, Santagata S. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nat Protoc. 2019 Oct;14(10):2900–2930. PMCID: PMC6959005
1.
Ferguson FM, Doctor ZM, Ficarro SB, Browne CM, Marto JA, Johnson JL, Yaron TM, Cantley LC, Kim ND, Sim T, Berberich MJ, Kalocsay M, Sorger PK, Gray NS. Discovery of covalent CDK14 inhibitors with pan-TAIRE family specificity. Cell Chem Biol. 2019 Jun 20;26(6):804-817.e12. PMCID: PMC6588450
1.
Hafner M, Mills CE, Subramanian K, Chen C, Chung M, Boswell SA, Everley RA, Liu C, Walmsley CS, Juric D, Sorger PK. Multiomics profiling establishes the polypharmacology of FDA-approved CDK4/6 inhibitors and the potential for differential clinical activity. Cell Chem Biol. 2019 Aug 15;26(8):1067-1080.e8. PMCID: PMC6936329
1.
Hoyt CT, Domingo-Fernández D, Aldisi R, Xu L, Kolpeja K, Spalek S, Wollert E, Bachman J, Gyori BM, Greene P, Hofmann-Apitius M. Re-curation and rational enrichment of knowledge graphs in Biological Expression Language. Database (Oxford). 2019 Jan 1;2019:baz068. PMCID: PMC6587072
1.
Juratli TA, Jones PS, Wang N, Subramanian M, Aylwin SJB, Odia Y, Rostami E, Gudjonsson O, Shaw BL, Cahill DP, Galanis E, Barker FG, Santagata S, Brastianos PK. Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer. 2019 Sep 1;125(17):2910–2914. PMCID: PMC7032527
1.
Kalocsay M. APEX peroxidase-catalyzed proximity labeling and multiplexed quantitative proteomics. Methods Mol Biol. 2019 May 4;2008:41–55. PMID: 31124087
1.
Katzir I, Cokol M, Aldridge BB, Alon U. Prediction of ultra-high-order antibiotic combinations based on pairwise interactions. PLoS Comput Biol. 2019 Jan;15(1):e1006774. PMCID: PMC6370231
1.
Koch R, Christie AL, Crombie JL, Palmer AC, Plana D, Shigemori K, Morrow SN, Van Scoyk A, Wu W, Brem EA, Secrist JP, Drew L, Schuller AG, Cidado J, Letai A, Weinstock DM. Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas. Blood. 2019 Feb 7;133(6):566–575. PMCID: PMC6367646
1.
Lee S, Jo S, Talbot S, Zhang HXB, Kotoda M, Andrews NA, Puopolo M, Liu PW, Jacquemont T, Pascal M, Heckman LM, Jain A, Lee J, Woolf CJ, Bean BP. Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation. Elife. 2019 Nov 25;8. PMCID: PMC6877086
1.
Liu B, Gyori BM, Thiagarajan PS. Statistical model checking-based analysis of biological networks. In: Liò P, Zuliani P, editors. Automated Reasoning for Systems Biology and Medicine [Internet]. Cham: Springer International Publishing; 2019 [cited 2023 Dec 2]. p. 63–92. Available from: http://link.springer.com/10.1007/978-3-030-17297-8_3
1.
Moret N, Clark NA, Hafner M, Wang Y, Lounkine E, Medvedovic M, Wang J, Gray N, Jenkins J, Sorger PK. Cheminformatics tools for analyzing and designing optimized small-molecule collections and libraries. Cell Chem Biol. 2019 May 16;26(5):765-777.e3. PMCID: PMC6526536
1.
Niepel M, Hafner M, Mills CE, Subramanian K, Williams EH, Chung M, Gaudio B, Barrette AM, Stern AD, Hu B, Korkola JE, LINCS Consortium, Gray JW, Birtwistle MR, Heiser LM, Sorger PK. A multi-center study on the reproducibility of drug-response assays in mammalian cell lines. Cell Syst. 2019 Jul 24;9(1):35-48.e5. PMCID: PMC6700527
1.
Olson CM, Liang Y, Leggett A, Park WD, Li L, Mills CE, Elsarrag SZ, Ficarro SB, Zhang T, Düster R, Geyer M, Sim T, Marto JA, Sorger PK, Westover KD, Lin CY, Kwiatkowski N, Gray NS. Development of a selective CDK7 covalent inhibitor reveals predominant cell-cycle phenotype. Cell Chem Biol. 2019 Jun 20;26(6):792-803.e10. PMCID: PMC6588464
1.
Palmer AC, Chidley C, Sorger PK. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. Elife. 2019 Nov 19;8:e50036. PMCID: PMC6897534
1.
Pavkovic M, Pantano L, Gerlach CV, Brutus S, Boswell SA, Everley RA, Shah JV, Sui SH, Vaidya VS. Multi omics analysis of fibrotic kidneys in two mouse models. Sci Data. 2019 Jun 14;6(1):92. PMCID: PMC6570759
1.
Ramm S, Todorov P, Chandrasekaran V, Dohlman A, Monteiro MB, Pavkovic M, Muhlich J, Shankaran H, Chen WW, Mettetal JT, Vaidya VS. A systems toxicology approach for the prediction of kidney toxicity and its mechanisms in vitro. Toxicol Sci. 2019 May 1;169(1):54–69. PMCID: PMC6484891
1.
Rao S, Gurbani D, Du G, Everley RA, Browne CM, Chaikuad A, Tan L, Schröder M, Gondi S, Ficarro SB, Sim T, Kim ND, Berberich MJ, Knapp S, Marto JA, Westover KD, Sorger PK, Gray NS. Leveraging compound promiscuity to identify targetable cysteines within the kinome. Cell Chem Biol. 2019 Jun 20;26(6):818-829.e9. PMCID: PMC6634314
1.
Rao S, Du G, Hafner M, Subramanian K, Sorger PK, Gray NS. A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers. J Biol Chem. 2019 May 24;294(21):8664–8673. PMCID: PMC6544847
1.
Rashid R, Gaglia G, Chen YA, Lin JR, Du Z, Maliga Z, Schapiro D, Yapp C, Muhlich J, Sokolov A, Sorger P, Santagata S. Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer. Sci Data. 2019 Dec 17;6(1):323. PMCID: PMC6917801
1.
Rogava M, Izar B. CXCR3: Here to stay to enhance cancer immunotherapy? EBioMedicine. 2019 Nov;49:11–12. PMCID: PMC6945198
1.
Smith TC, Aldridge BB. Targeting drugs for tuberculosis. Science. 2019 Jun 28;364(6447):1234–1235. PMID: 31249047
1.
Sokolov A, Ashenden S, Sahin N, Lewis R, Erdem N, Ozaltan E, Bender A, Roth FP, Cokol M. Characterizing ABC-transporter substrate-likeness using a clean-slate genetic background. Front Pharmacol. 2019 Apr 25;10:448. PMCID: PMC6494965
1.
Song Y, Subramanian K, Berberich MJ, Rodriguez S, Latorre IJ, Luria CM, Everley R, Albers MW, Mitchison TJ, Sorger PK. A dynamic view of the proteomic landscape during differentiation of ReNcell VM cells, an immortalized human neural progenitor line. Sci Data. 2019 Feb 19;6:190016. PMCID: PMC6380223
1.
Todorov PV, Gyori BM, Bachman JA, Sorger PK. INDRA-IPM: interactive pathway modeling using natural language with automated assembly. Bioinformatics. 2019 Nov 1;35(21):4501–4503. PMCID: PMC6821420
1.
Wang H, Sheehan RP, Palmer AC, Everley RA, Boswell SA, Ron-Harel N, Ringel AE, Holton KM, Jacobson CA, Erickson AR, Maliszewski L, Haigis MC, Sorger PK. Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming. Cell Syst. 2019 May 22;8(5):412-426.e7. PMCID: PMC6657491
1.
Wang S, Lin JR, Sontag ED, Sorger PK. Inferring reaction network structure from single-cell, multiplex data, using toric systems theory. PLoS Comput Biol. 2019 Dec;15(12):e1007311. PMCID: PMC6919632
2576724
IXMHRBF6
LSP Paper
2018
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2272D2U973%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Bachman%20et%20al.%22%2C%22parsedDate%22%3A%222018-06-28%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBachman%20JA%2C%20Gyori%20BM%2C%20Sorger%20PK.%20FamPlex%3A%20a%20resource%20for%20entity%20recognition%20and%20relationship%20resolution%20of%20human%20protein%20families%20and%20complexes%20in%20biomedical%20text%20mining.%20BMC%20Bioinformatics.%202018%20Jun%2028%3B19%281%29%3A248.%20PMCID%3A%20PMC6022344%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22FamPlex%3A%20a%20resource%20for%20entity%20recognition%20and%20relationship%20resolution%20of%20human%20protein%20families%20and%20complexes%20in%20biomedical%20text%20mining%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20For%20automated%20reading%20of%20scientific%20publications%20to%20extract%20useful%20information%20about%20molecular%20mechanisms%20it%20is%20critical%20that%20genes%2C%20proteins%20and%20other%20entities%20be%20correctly%20associated%20with%20uniform%20identifiers%2C%20a%20process%20known%20as%20named%20entity%20linking%20or%20%5C%22grounding.%5C%22%20Correct%20grounding%20is%20essential%20for%20resolving%20relationships%20among%20mined%20information%2C%20curated%20interaction%20databases%2C%20and%20biological%20datasets.%20The%20accuracy%20of%20this%20process%20is%20largely%20dependent%20on%20the%20availability%20of%20machine-readable%20resources%20associating%20synonyms%20and%20abbreviations%20commonly%20found%20in%20biomedical%20literature%20with%20uniform%20identifiers.%5CnRESULTS%3A%20In%20a%20task%20involving%20automated%20reading%20of%20%5Cu223c215%2C000%20articles%20using%20the%20REACH%20event%20extraction%20software%20we%20found%20that%20grounding%20was%20disproportionately%20inaccurate%20for%20multi-protein%20families%20%28e.g.%2C%20%5C%22AKT%5C%22%29%20and%20complexes%20with%20multiple%20subunits%20%28e.g.%5C%22NF-%20%5Cu03baB%5C%22%29.%20To%20address%20this%20problem%20we%20constructed%20FamPlex%2C%20a%20manually%20curated%20resource%20defining%20protein%20families%20and%20complexes%20as%20they%20are%20commonly%20encountered%20in%20biomedical%20text.%20In%20FamPlex%20the%20gene-level%20constituents%20of%20families%20and%20complexes%20are%20defined%20in%20a%20flexible%20format%20allowing%20for%20multi-level%2C%20hierarchical%20membership.%20To%20create%20FamPlex%2C%20text%20strings%20corresponding%20to%20entities%20were%20identified%20empirically%20from%20literature%20and%20linked%20manually%20to%20uniform%20identifiers%3B%20these%20identifiers%20were%20also%20mapped%20to%20equivalent%20entries%20in%20multiple%20related%20databases.%20FamPlex%20also%20includes%20curated%20prefix%20and%20suffix%20patterns%20that%20improve%20named%20entity%20recognition%20and%20event%20extraction.%20Evaluation%20of%20REACH%20extractions%20on%20a%20test%20corpus%20of%20%5Cu223c54%2C000%20articles%20showed%20that%20FamPlex%20significantly%20increased%20grounding%20accuracy%20for%20families%20and%20complexes%20%28from%2015%20to%2071%25%29.%20The%20hierarchical%20organization%20of%20entities%20in%20FamPlex%20also%20made%20it%20possible%20to%20integrate%20otherwise%20unconnected%20mechanistic%20information%20across%20families%2C%20subfamilies%2C%20and%20individual%20proteins.%20Applications%20of%20FamPlex%20to%20the%20TRIPS%5C%2FDRUM%20reading%20system%20and%20the%20Biocreative%20VI%20Bioentity%20Normalization%20Task%20dataset%20demonstrated%20the%20utility%20of%20FamPlex%20in%20other%20settings.%5CnCONCLUSION%3A%20FamPlex%20is%20an%20effective%20resource%20for%20improving%20named%20entity%20recognition%2C%20grounding%2C%20and%20relationship%20resolution%20in%20automated%20reading%20of%20biomedical%20text.%20The%20content%20in%20FamPlex%20is%20available%20in%20both%20tabular%20and%20Open%20Biomedical%20Ontology%20formats%20at%20https%3A%5C%2F%5C%2Fgithub.com%5C%2Fsorgerlab%5C%2Ffamplex%20under%20the%20Creative%20Commons%20CC0%20license%20and%20has%20been%20integrated%20into%20the%20TRIPS%5C%2FDRUM%20and%20REACH%20reading%20systems.%22%2C%22date%22%3A%222018-06-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12859-018-2211-5%22%2C%22ISSN%22%3A%221471-2105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A09%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22UUQLVW4F%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cokol%20et%20al.%22%2C%22parsedDate%22%3A%222018-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECokol%20M%2C%20Li%20C%2C%20Chandrasekaran%20S.%20Chemogenomic%20model%20identifies%20synergistic%20drug%20combinations%20robust%20to%20the%20pathogen%20microenvironment.%20PLoS%20Comput%20Biol.%202018%20Dec%3B14%2812%29%3Ae1006677.%20PMCID%3A%20PMC6329523%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemogenomic%20model%20identifies%20synergistic%20drug%20combinations%20robust%20to%20the%20pathogen%20microenvironment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sriram%22%2C%22lastName%22%3A%22Chandrasekaran%22%7D%5D%2C%22abstractNote%22%3A%22Antibiotics%20need%20to%20be%20effective%20in%20diverse%20environments%20in%20vivo.%20However%2C%20the%20pathogen%20microenvironment%20can%20have%20a%20significant%20impact%20on%20antibiotic%20potency.%20Further%2C%20antibiotics%20are%20increasingly%20used%20in%20combinations%20to%20combat%20resistance%2C%20yet%2C%20the%20effect%20of%20microenvironments%20on%20drug-combination%20efficacy%20is%20unknown.%20To%20exhaustively%20explore%20the%20impact%20of%20diverse%20microenvironments%20on%20drug-combinations%2C%20here%20we%20develop%20a%20computational%20framework-Metabolism%20And%20GENomics-based%20Tailoring%20of%20Antibiotic%20regimens%20%28MAGENTA%29.%20MAGENTA%20uses%20chemogenomic%20profiles%20of%20individual%20drugs%20and%20metabolic%20perturbations%20to%20predict%20synergistic%20or%20antagonistic%20drug-interactions%20in%20different%20microenvironments.%20We%20uncovered%20antibiotic%20combinations%20with%20robust%20synergy%20across%20nine%20distinct%20environments%20against%20both%20E.%20coli%20and%20A.%20baumannii%20by%20searching%20through%202556%20drug-combinations%20of%2072%20drugs.%20MAGENTA%20also%20accurately%20predicted%20the%20change%20in%20efficacy%20of%20bacteriostatic%20and%20bactericidal%20drug-combinations%20during%20growth%20in%20glycerol%20media%2C%20which%20we%20confirmed%20experimentally%20in%20both%20microbes.%20Our%20approach%20identified%20genes%20in%20glycolysis%20and%20glyoxylate%20pathway%20as%20top%20predictors%20of%20synergy%20and%20antagonism%20respectively.%20Our%20systems%20approach%20enables%20tailoring%20of%20antibiotic%20therapies%20based%20on%20the%20pathogen%20microenvironment.%22%2C%22date%22%3A%222018-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1006677%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A03%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22X9ISYIHK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cokol-Cakmak%20et%20al.%22%2C%22parsedDate%22%3A%222018-06-21%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECokol-Cakmak%20M%2C%20Bakan%20F%2C%20Cetiner%20S%2C%20Cokol%20M.%20Diagonal%20method%20to%20measure%20synergy%20among%20any%20number%20of%20drugs.%20J%20Vis%20Exp.%202018%20Jun%2021%3B%28136%29%3A57713.%20PMCID%3A%20PMC6101960%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diagonal%20method%20to%20measure%20synergy%20among%20any%20number%20of%20drugs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melike%22%2C%22lastName%22%3A%22Cokol-Cakmak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feray%22%2C%22lastName%22%3A%22Bakan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selim%22%2C%22lastName%22%3A%22Cetiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%5D%2C%22abstractNote%22%3A%22A%20synergistic%20drug%20combination%20has%20a%20higher%20efficacy%20compared%20to%20the%20effects%20of%20individual%20drugs.%20Checkerboard%20assays%2C%20where%20drugs%20are%20combined%20in%20many%20doses%2C%20allow%20sensitive%20measurement%20of%20drug%20interactions.%20However%2C%20these%20assays%20are%20costly%20and%20do%20not%20scale%20well%20for%20measuring%20interaction%20among%20many%20drugs.%20Several%20recent%20studies%20have%20reported%20drug%20interaction%20measurements%20using%20a%20diagonal%20sampling%20of%20the%20traditional%20checkerboard%20assay.%20This%20alternative%20methodology%20greatly%20decreases%20the%20cost%20of%20drug%20interaction%20experiments%20and%20allows%20interaction%20measurement%20for%20combinations%20with%20many%20drugs.%20Here%2C%20we%20describe%20a%20protocol%20to%20measure%20the%20three%20pairwise%20interactions%20and%20one%20three-way%20interaction%20among%20three%20antibiotics%20in%20duplicate%2C%20in%20five%20days%2C%20using%20only%20three%2096-well%20microplates%20and%20standard%20laboratory%20equipment.%20We%20present%20representative%20results%20showing%20that%20the%20three-antibiotic%20combination%20of%20Levofloxacin%20%2B%20Nalidixic%20Acid%20%2B%20Penicillin%20G%20is%20synergistic.%20Our%20protocol%20scales%20up%20to%20measure%20interactions%20among%20many%20drugs%20and%20in%20other%20biological%20contexts%2C%20allowing%20for%20efficient%20screens%20for%20multi-drug%20synergies%20against%20pathogens%20and%20tumors.%22%2C%22date%22%3A%222018-06-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3791%5C%2F57713%22%2C%22ISSN%22%3A%221940-087X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A20%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22VW38Y323%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coy%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-05%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoy%20S%2C%20Rashid%20R%2C%20Lin%20JR%2C%20Du%20Z%2C%20Donson%20AM%2C%20Hankinson%20TC%2C%20Foreman%20NK%2C%20Manley%20PE%2C%20Kieran%20MW%2C%20Reardon%20DA%2C%20Sorger%20PK%2C%20Santagata%20S.%20Multiplexed%20immunofluorescence%20reveals%20potential%20PD-1%5C%2FPD-L1%20pathway%20vulnerabilities%20in%20craniopharyngioma.%20Neuro%20Oncol.%202018%20Jul%205%3B20%288%29%3A1101%26%23x2013%3B1112.%20PMCID%3A%20PMC6280314%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiplexed%20immunofluorescence%20reveals%20potential%20PD-1%5C%2FPD-L1%20pathway%20vulnerabilities%20in%20craniopharyngioma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20M.%22%2C%22lastName%22%3A%22Donson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20C.%22%2C%22lastName%22%3A%22Hankinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20K.%22%2C%22lastName%22%3A%22Foreman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20E.%22%2C%22lastName%22%3A%22Manley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Kieran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Craniopharyngiomas%20are%20neoplasms%20of%20the%20sellar%5C%2Fparasellar%20region%20that%20are%20classified%20into%20adamantinomatous%20craniopharyngioma%20%28ACP%29%20and%20papillary%20craniopharyngioma%20%28PCP%29%20subtypes.%20Surgical%20resection%20of%20craniopharyngiomas%20is%20challenging%2C%20and%20recurrence%20is%20common%2C%20frequently%20leading%20to%20profound%20morbidity.%20BRAF%20V600E%20mutations%20render%20PCP%20susceptible%20to%20BRAF%5C%2FMEK%20inhibitors%2C%20but%20effective%20targeted%20therapies%20are%20needed%20for%20ACP.%20We%20explored%20the%20feasibility%20of%20targeting%20the%20programmed%20cell%20death%20protein%201%5C%2Fprogrammed%20death-ligand%201%20%28PD-1%5C%2FPD-L1%29%20immune%20checkpoint%20pathway%20in%20ACP%20and%20PCP.%5CnMETHODS%3A%20We%20mapped%20and%20quantified%20PD-L1%20and%20PD-1%20expression%20in%20ACP%20and%20PCP%20resections%20using%20immunohistochemistry%2C%20immunofluorescence%2C%20and%20RNA%20in%20situ%20hybridization.%20We%20used%20tissue-based%20cyclic%20immunofluorescence%20to%20map%20the%20spatial%20distribution%20of%20immune%20cells%20and%20characterize%20cell%20cycle%20and%20signaling%20pathways%20in%20ACP%20tumor%20cells%20which%20intrinsically%20express%20PD-1.%5CnRESULTS%3A%20All%20ACP%20%2815%20%5Cu00b1%2014%25%20of%20cells%2C%20n%20%3D%2023%2C%20average%20%5Cu00b1%20SD%29%20and%20PCP%20%2835%20%5Cu00b1%2022%25%20of%20cells%2C%20n%20%3D%2018%29%20resections%20expressed%20PD-L1.%20In%20ACP%2C%20PD-L1%20was%20predominantly%20expressed%20by%20tumor%20cells%20comprising%20the%20cyst%20lining.%20In%20PCP%2C%20PD-L1%20was%20highly%20expressed%20by%20tumor%20cells%20surrounding%20the%20stromal%20fibrovascular%20cores.%20ACP%20also%20exhibited%20tumor%20cell-intrinsic%20PD-1%20expression%20in%20whorled%20epithelial%20cells%20with%20nuclear-localized%20beta-catenin.%20These%20cells%20exhibited%20evidence%20of%20elevated%20mammalian%20target%20of%20rapamycin%20%28mTOR%29%20and%20mitogen-activated%20protein%20kinase%20%28MAPK%29%20signaling.%20Profiling%20of%20immune%20populations%20in%20ACP%20and%20PCP%20showed%20a%20modest%20density%20of%20CD8%2B%20T%20cells.%5CnCONCLUSIONS%3A%20ACP%20exhibit%20PD-L1%20expression%20in%20the%20tumor%20cyst%20lining%20and%20intrinsic%20PD-1%20expression%20in%20cells%20proposed%20to%20comprise%20an%20oncogenic%20stem-like%20population.%20In%20PCP%2C%20proliferative%20tumor%20cells%20express%20PD-L1%20in%20a%20continuous%20band%20at%20the%20stromal-epithelial%20interface.%20Targeting%20PD-L1%20and%5C%2For%20PD-1%20in%20both%20subtypes%20of%20craniopharyngioma%20might%20therefore%20be%20an%20effective%20therapeutic%20strategy.%22%2C%22date%22%3A%222018-07-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoy035%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A10%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22WTHGCF9R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Souza%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3Ede%20Souza%20CF%2C%20Sabedot%20TS%2C%20Malta%20TM%2C%20Stetson%20L%2C%20Morozova%20O%2C%20Sokolov%20A%2C%20Laird%20PW%2C%20Wiznerowicz%20M%2C%20Iavarone%20A%2C%20Snyder%20J%2C%20deCarvalho%20A%2C%20Sanborn%20Z%2C%20McDonald%20KL%2C%20Friedman%20WA%2C%20Tirapelli%20D%2C%20Poisson%20L%2C%20Mikkelsen%20T%2C%20Carlotti%20CG%2C%20Kalkanis%20S%2C%20Zenklusen%20J%2C%20Salama%20SR%2C%20Barnholtz-Sloan%20JS%2C%20Noushmehr%20H.%20A%20distinct%20DNA%20methylation%20shift%20in%20a%20subset%20of%20glioma%20CpG%20island%20methylator%20phenotypes%20during%20tumor%20recurrence.%20Cell%20Rep.%202018%20Apr%2010%3B23%282%29%3A637%26%23x2013%3B651.%20PMCID%3A%20PMC8859991%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20distinct%20DNA%20methylation%20shift%20in%20a%20subset%20of%20glioma%20CpG%20island%20methylator%20phenotypes%20during%20tumor%20recurrence%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camila%20Ferreira%22%2C%22lastName%22%3A%22de%20Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thais%20S.%22%2C%22lastName%22%3A%22Sabedot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tathiane%20M.%22%2C%22lastName%22%3A%22Malta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Stetson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olena%22%2C%22lastName%22%3A%22Morozova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20W.%22%2C%22lastName%22%3A%22Laird%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maciej%22%2C%22lastName%22%3A%22Wiznerowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Iavarone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Snyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22deCarvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Sanborn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kerrie%20L.%22%2C%22lastName%22%3A%22McDonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20A.%22%2C%22lastName%22%3A%22Friedman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Tirapelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laila%22%2C%22lastName%22%3A%22Poisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%22%2C%22lastName%22%3A%22Mikkelsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20G.%22%2C%22lastName%22%3A%22Carlotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Kalkanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Zenklusen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sofie%20R.%22%2C%22lastName%22%3A%22Salama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%20S.%22%2C%22lastName%22%3A%22Barnholtz-Sloan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Houtan%22%2C%22lastName%22%3A%22Noushmehr%22%7D%5D%2C%22abstractNote%22%3A%22Glioma%20diagnosis%20is%20based%20on%20histomorphology%20and%20grading%3B%20however%2C%20such%20classification%20does%20not%20have%20predictive%20clinical%20outcome%20after%20glioblastomas%20have%20developed.%20To%20date%2C%20no%20bona%20fide%20biomarkers%20that%20significantly%20translate%20into%20a%20survival%20benefit%20to%20glioblastoma%20patients%20have%20been%20identified.%20We%20previously%20reported%20that%20the%20IDH%20mutant%20G-CIMP-high%20subtype%20would%20be%20a%20predecessor%20to%20the%20G-CIMP-low%20subtype.%20Here%2C%20we%20performed%20a%20comprehensive%20DNA%20methylation%20longitudinal%20analysis%20of%20diffuse%20gliomas%20from%2077%20patients%20%28200%20tumors%29%20to%20enlighten%20the%5Cu00a0epigenome-based%20malignant%20transformation%20of%20initially%20lower-grade%20gliomas.%20Intra-subtype%20heterogeneity%20among%20G-CIMP-high%20primary%20tumors%20allowed%20us%20to%20identify%20predictive%20biomarkers%20for%20assessing%20the%20risk%20of%20malignant%20recurrence%20at%20early%20stages%20of%20disease.%20G-CIMP-low%20recurrence%20appeared%20in%209.5%25%20of%20all%20gliomas%2C%20and%20these%20resembled%20IDH-wild-type%20primary%20glioblastoma.%20G-CIMP-low%20recurrence%20can%20be%20characterized%20by%20distinct%20epigenetic%20changes%20at%20candidate%20functional%20tissue%20enhancers%20with%20AP-1%5C%2FSOX%20binding%20elements%2C%20mesenchymal%20stem%20cell-like%20epigenomic%20phenotype%2C%20and%20genomic%20instability.%20Molecular%20abnormalities%20of%20longitudinal%20G-CIMP%20offer%20possibilities%20to%20defy%20glioblastoma%20progression.%22%2C%22date%22%3A%222018-04-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2018.03.107%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A17%3A42Z%22%7D%7D%2C%7B%22key%22%3A%223XUM2LCZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dunn%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-27%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDunn%20IF%2C%20Du%20Z%2C%20Touat%20M%2C%20Sisti%20MB%2C%20Wen%20PY%2C%20Umeton%20R%2C%20Dubuc%20AM%2C%20Ducar%20M%2C%20Canoll%20PD%2C%20Severson%20E%2C%20Elvin%20JA%2C%20Ramkissoon%20SH%2C%20Lin%20JR%2C%20Cabrera%20L%2C%20Acevedo%20B%2C%20Sorger%20PK%2C%20Ligon%20KL%2C%20Santagata%20S%2C%20Reardon%20DA.%20Mismatch%20repair%20deficiency%20in%20high-grade%20meningioma%3A%20a%20rare%20but%20recurrent%20event%20associated%20with%20dramatic%20immune%20activation%20and%20clinical%20response%20to%20PD-1%20blockade.%20JCO%20Precis%20Oncol.%202018%20Nov%2027%3B2018.%20PMCID%3A%20PMC6383717%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mismatch%20repair%20deficiency%20in%20high-grade%20meningioma%3A%20a%20rare%20but%20recurrent%20event%20associated%20with%20dramatic%20immune%20activation%20and%20clinical%20response%20to%20PD-1%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20F.%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20B.%22%2C%22lastName%22%3A%22Sisti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renato%22%2C%22lastName%22%3A%22Umeton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20M.%22%2C%22lastName%22%3A%22Dubuc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Ducar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20D.%22%2C%22lastName%22%3A%22Canoll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Severson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%20A.%22%2C%22lastName%22%3A%22Elvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shakti%20H.%22%2C%22lastName%22%3A%22Ramkissoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lais%22%2C%22lastName%22%3A%22Cabrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Acevedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%2027%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FPO.18.00190%22%2C%22ISSN%22%3A%222473-4284%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T16%3A59%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22Q3LR2UWT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gonzalez%20Herrera%20et%20al.%22%2C%22parsedDate%22%3A%222018-02-20%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGonzalez%20Herrera%20KN%2C%20Zaganjor%20E%2C%20Ishikawa%20Y%2C%20Spinelli%20JB%2C%20Yoon%20H%2C%20Lin%20JR%2C%20Satterstrom%20FK%2C%20Ringel%20A%2C%20Mulei%20S%2C%20Souza%20A%2C%20Gorham%20JM%2C%20Benson%20CC%2C%20Seidman%20JG%2C%20Sorger%20PK%2C%20Clish%20CB%2C%20Haigis%20MC.%20Small-molecule%20screen%20identifies%20de%20novo%20nucleotide%20synthesis%20as%20a%20vulnerability%20of%20cells%20lacking%20SIRT3.%20Cell%20Rep.%202018%20Feb%2020%3B22%288%29%3A1945%26%23x2013%3B1955.%20PMCID%3A%20PMC5902027%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Small-molecule%20screen%20identifies%20de%20novo%20nucleotide%20synthesis%20as%20a%20vulnerability%20of%20cells%20lacking%20SIRT3%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karina%20N.%22%2C%22lastName%22%3A%22Gonzalez%20Herrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elma%22%2C%22lastName%22%3A%22Zaganjor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshinori%22%2C%22lastName%22%3A%22Ishikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20B.%22%2C%22lastName%22%3A%22Spinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haejin%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Kyle%22%2C%22lastName%22%3A%22Satterstrom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stacy%22%2C%22lastName%22%3A%22Mulei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Gorham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20C.%22%2C%22lastName%22%3A%22Benson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20G.%22%2C%22lastName%22%3A%22Seidman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clary%20B.%22%2C%22lastName%22%3A%22Clish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Sirtuin%203%20%28SIRT3%29%20is%20a%20NAD%2B-dependent%20deacetylase%20downregulated%20in%20aging%20and%20age-associated%20diseases%20such%20as%20cancer%20and%20neurodegeneration%20and%20in%20high-fat%20diet%20%28HFD%29-induced%20metabolic%20disorders.%20Here%2C%20we%20performed%20a%20small-molecule%20screen%20and%20identified%20an%20unexpected%20metabolic%20vulnerability%20associated%20with%20SIRT3%20loss.%20Azaserine%2C%20a%20glutamine%20analog%2C%20was%20the%20top%20compound%20that%20inhibited%20growth%20and%20proliferation%20of%20cells%20lacking%20SIRT3.%20Using%20stable%5Cu00a0isotope%20tracing%20of%20glutamine%2C%20we%20observed%20its%20increased%20incorporation%20into%20de%20novo%20nucleotide%20synthesis%20in%20SIRT3%20knockout%20%28KO%29%20cells.%20Furthermore%2C%20we%5Cu00a0found%20that%20SIRT3%20KO%20cells%20upregulated%20the%20diversion%20of%20glutamine%20into%20de%20novo%20nucleotide%20synthesis%20through%20hyperactive%20mTORC1%20signaling.%20Overexpression%20of%20SIRT3%20suppressed%20mTORC1%20and%20growth%20in%5Cu00a0vivo%20in%20a%20xenograft%20tumor%20model%20of%20breast%20cancer.%20Thus%2C%20we%20have%20uncovered%20a%20metabolic%20vulnerability%20of%20cells%20with%20SIRT3%20loss%20by%20using%20an%20unbiased%20small-molecule%20screen.%22%2C%22date%22%3A%222018-02-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2018.01.076%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A15%3A02Z%22%7D%7D%2C%7B%22key%22%3A%228GXQS29T%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Iglesias%20et%20al.%22%2C%22parsedDate%22%3A%222018-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIglesias%20N%2C%20Currie%20MA%2C%20Jih%20G%2C%20Paulo%20JA%2C%20Siuti%20N%2C%20Kalocsay%20M%2C%20Gygi%20SP%2C%20Moazed%20D.%20Automethylation-induced%20conformational%20switch%20in%20Clr4%20%28Suv39h%29%20maintains%20epigenetic%20stability.%20Nature.%202018%20Aug%3B560%287719%29%3A504%26%23x2013%3B508.%20PMCID%3A%20PMC6287498%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Automethylation-induced%20conformational%20switch%20in%20Clr4%20%28Suv39h%29%20maintains%20epigenetic%20stability%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nahid%22%2C%22lastName%22%3A%22Iglesias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Currie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gloria%22%2C%22lastName%22%3A%22Jih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joao%20A.%22%2C%22lastName%22%3A%22Paulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nertila%22%2C%22lastName%22%3A%22Siuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danesh%22%2C%22lastName%22%3A%22Moazed%22%7D%5D%2C%22abstractNote%22%3A%22Histone%20H3%20lysine%209%20methylation%20%28H3K9me%29%20mediates%20heterochromatic%20gene%20silencing%20and%20is%20important%20for%20genome%20stability%20and%20the%20regulation%20of%20gene%20expression1-4.%20The%20establishment%20and%20epigenetic%20maintenance%20of%20heterochromatin%20involve%20the%20recruitment%20of%20H3K9%20methyltransferases%20to%20specific%20sites%20on%20DNA%2C%20followed%20by%20the%20recognition%20of%20pre-existing%20H3K9me%20by%20the%20methyltransferase%20and%20methylation%20of%20proximal%20histone%20H35-11.%20This%20positive%20feedback%20loop%20must%20be%20tightly%20regulated%20to%20prevent%20deleterious%20epigenetic%20gene%20silencing.%20Extrinsic%20anti-silencing%20mechanisms%20involving%20histone%20demethylation%20or%20boundary%20elements%20help%20to%20limit%20the%20spread%20of%20inappropriate%20H3K9me12-15.%20However%2C%20how%20H3K9%20methyltransferase%20activity%20is%20locally%20restricted%20or%20prevented%20from%20initiating%20random%20H3K9me-which%20would%20lead%20to%20aberrant%20gene%20silencing%20and%20epigenetic%20instability-is%20not%20fully%20understood.%20Here%20we%20reveal%20an%20autoinhibited%20conformation%20in%20the%20conserved%20H3K9%20methyltransferase%20Clr4%20%28also%20known%20as%20Suv39h%29%20of%20the%20fission%20yeast%20Schizosaccharomyces%20pombe%20that%20has%20a%20critical%20role%20in%20preventing%20aberrant%20heterochromatin%20formation.%20Biochemical%20and%20X-ray%20crystallographic%20data%20show%20that%20an%20internal%20loop%20in%20Clr4%20inhibits%20the%20catalytic%20activity%20of%20this%20enzyme%20by%20blocking%20the%20histone%20H3K9%20substrate-binding%20pocket%2C%20and%20that%20automethylation%20of%20specific%20lysines%20in%20this%20loop%20promotes%20a%20conformational%20switch%20that%20enhances%20the%20H3K9me%20activity%20of%20Clr4.%20Mutations%20that%20are%20predicted%20to%20disrupt%20this%20regulation%20lead%20to%20aberrant%20H3K9me%2C%20loss%20of%20heterochromatin%20domains%20and%20inhibition%20of%20growth%2C%20demonstrating%20the%20importance%20of%20the%20intrinsic%20inhibition%20and%20auto-activation%20of%20Clr4%20in%20regulating%20the%20deposition%20of%20H3K9me%20and%20in%20preventing%20epigenetic%20instability.%20Conservation%20of%20the%20Clr4%20autoregulatory%20loop%20in%20other%20H3K9%20methyltransferases%20and%20the%20automethylation%20of%20a%20corresponding%20lysine%20in%20the%20human%20SUV39H2%20homologue16%20suggest%20that%20the%20mechanism%20described%20here%20is%20broadly%20conserved.%22%2C%22date%22%3A%222018-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-018-0398-2%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A18%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22SV2HAGDH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jerby-Arnon%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJerby-Arnon%20L%2C%20Shah%20P%2C%20Cuoco%20MS%2C%20Rodman%20C%2C%20Su%20MJ%2C%20Melms%20JC%2C%20Leeson%20R%2C%20Kanodia%20A%2C%20Mei%20S%2C%20Lin%20JR%2C%20Wang%20S%2C%20Rabasha%20B%2C%20Liu%20D%2C%20Zhang%20G%2C%20Margolais%20C%2C%20Ashenberg%20O%2C%20Ott%20PA%2C%20Buchbinder%20EI%2C%20Haq%20R%2C%20Hodi%20FS%2C%20Boland%20GM%2C%20Sullivan%20RJ%2C%20Frederick%20DT%2C%20Miao%20B%2C%20Moll%20T%2C%20Flaherty%20KT%2C%20Herlyn%20M%2C%20Jenkins%20RW%2C%20Thummalapalli%20R%2C%20Kowalczyk%20MS%2C%20Ca%26%23xF1%3Badas%20I%2C%20Schilling%20B%2C%20Cartwright%20ANR%2C%20Luoma%20AM%2C%20Malu%20S%2C%20Hwu%20P%2C%20Bernatchez%20C%2C%20Forget%20MA%2C%20Barbie%20DA%2C%20Shalek%20AK%2C%20Tirosh%20I%2C%20Sorger%20PK%2C%20Wucherpfennig%20K%2C%20Van%20Allen%20EM%2C%20Schadendorf%20D%2C%20Johnson%20BE%2C%20Rotem%20A%2C%20Rozenblatt-Rosen%20O%2C%20Garraway%20LA%2C%20Yoon%20CH%2C%20Izar%20B%2C%20Regev%20A.%20A%20cancer%20cell%20program%20promotes%20T%20cell%20exclusion%20and%20resistance%20to%20checkpoint%20blockade.%20Cell.%202018%20Nov%201%3B175%284%29%3A984-997.e24.%20PMCID%3A%20PMC6410377%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20cancer%20cell%20program%20promotes%20T%20cell%20exclusion%20and%20resistance%20to%20checkpoint%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Livnat%22%2C%22lastName%22%3A%22Jerby-Arnon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parin%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Cuoco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Rodman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Ju%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20C.%22%2C%22lastName%22%3A%22Melms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Leeson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhay%22%2C%22lastName%22%3A%22Kanodia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bokang%22%2C%22lastName%22%3A%22Rabasha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Margolais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orr%22%2C%22lastName%22%3A%22Ashenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20A.%22%2C%22lastName%22%3A%22Ott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20I.%22%2C%22lastName%22%3A%22Buchbinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rizwan%22%2C%22lastName%22%3A%22Haq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Stephen%22%2C%22lastName%22%3A%22Hodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M.%22%2C%22lastName%22%3A%22Boland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennie%20T.%22%2C%22lastName%22%3A%22Frederick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benchun%22%2C%22lastName%22%3A%22Miao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tabea%22%2C%22lastName%22%3A%22Moll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meenhard%22%2C%22lastName%22%3A%22Herlyn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20W.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohit%22%2C%22lastName%22%3A%22Thummalapalli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%20S.%22%2C%22lastName%22%3A%22Kowalczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Israel%22%2C%22lastName%22%3A%22Ca%5Cu00f1adas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bastian%22%2C%22lastName%22%3A%22Schilling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20N.%20R.%22%2C%22lastName%22%3A%22Cartwright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrienne%20M.%22%2C%22lastName%22%3A%22Luoma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shruti%22%2C%22lastName%22%3A%22Malu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Hwu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantale%22%2C%22lastName%22%3A%22Bernatchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Andr%5Cu00e9e%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20K.%22%2C%22lastName%22%3A%22Shalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itay%22%2C%22lastName%22%3A%22Tirosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wucherpfennig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Schadendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20H.%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%5D%2C%22abstractNote%22%3A%22Immune%20checkpoint%20inhibitors%20%28ICIs%29%20produce%20durable%20responses%20in%20some%20melanoma%20patients%2C%20but%20many%20patients%20derive%20no%20clinical%20benefit%2C%20and%20the%5Cu00a0molecular%20underpinnings%20of%20such%20resistance%20remain%5Cu00a0elusive.%20Here%2C%20we%20leveraged%20single-cell%20RNA%20sequencing%20%28scRNA-seq%29%20from%2033%20melanoma%20tumors%20and%20computational%20analyses%20to%20interrogate%20malignant%20cell%20states%20that%20promote%20immune%20evasion.%20We%20identified%20a%20resistance%20program%20expressed%20by%20malignant%20cells%20that%20is%20associated%20with%20T%5Cu00a0cell%20exclusion%20and%20immune%20evasion.%20The%20program%20is%20expressed%20prior%20to%20immunotherapy%2C%20characterizes%20cold%20niches%20in%20situ%2C%20and%20predicts%20clinical%20responses%20to%20anti-PD-1%20therapy%20in%20an%20independent%20cohort%20of%20112%20melanoma%20patients.%20CDK4%5C%2F6-inhibition%20represses%20this%20program%20in%20individual%20malignant%20cells%2C%20induces%20senescence%2C%20and%20reduces%20melanoma%20tumor%20outgrowth%20in%20mouse%20models%20in%5Cu00a0vivo%20when%20given%20in%20combination%20with%20immunotherapy.%20Our%20study%20provides%20a%20high-resolution%20landscape%20of%20ICI-resistant%20cell%20states%2C%20identifies%20clinically%20predictive%20signatures%2C%20and%20suggests%20new%20therapeutic%20strategies%20to%20overcome%20immunotherapy%20resistance.%22%2C%22date%22%3A%222018-11-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2018.09.006%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A08%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22MJE689J5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Keenan%20et%20al.%22%2C%22parsedDate%22%3A%222018-01-24%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKeenan%20AB%2C%20Jenkins%20SL%2C%20Jagodnik%20KM%2C%20Koplev%20S%2C%20He%20E%2C%20Torre%20D%2C%20Wang%20Z%2C%20Dohlman%20AB%2C%20Silverstein%20MC%2C%20Lachmann%20A%2C%20Kuleshov%20MV%2C%20Ma%26%23x2019%3Bayan%20A%2C%20Stathias%20V%2C%20Terryn%20R%2C%20Cooper%20D%2C%20Forlin%20M%2C%20Koleti%20A%2C%20Vidovic%20D%2C%20Chung%20C%2C%20Sch%26%23xFC%3Brer%20SC%2C%20Vasiliauskas%20J%2C%20Pilarczyk%20M%2C%20Shamsaei%20B%2C%20Fazel%20M%2C%20Ren%20Y%2C%20Niu%20W%2C%20Clark%20NA%2C%20White%20S%2C%20Mahi%20N%2C%20Zhang%20L%2C%20Kouril%20M%2C%20Reichard%20JF%2C%20Sivaganesan%20S%2C%20Medvedovic%20M%2C%20Meller%20J%2C%20Koch%20RJ%2C%20Birtwistle%20MR%2C%20Iyengar%20R%2C%20Sobie%20EA%2C%20Azeloglu%20EU%2C%20Kaye%20J%2C%20Osterloh%20J%2C%20Haston%20K%2C%20Kalra%20J%2C%20Finkbiener%20S%2C%20Li%20J%2C%20Milani%20P%2C%20Adam%20M%2C%20Escalante-Chong%20R%2C%20Sachs%20K%2C%20Lenail%20A%2C%20Ramamoorthy%20D%2C%20Fraenkel%20E%2C%20Daigle%20G%2C%20Hussain%20U%2C%20Coye%20A%2C%20Rothstein%20J%2C%20Sareen%20D%2C%20Ornelas%20L%2C%20Banuelos%20M%2C%20Mandefro%20B%2C%20Ho%20R%2C%20Svendsen%20CN%2C%20Lim%20RG%2C%20Stocksdale%20J%2C%20Casale%20MS%2C%20Thompson%20TG%2C%20Wu%20J%2C%20Thompson%20LM%2C%20Dardov%20V%2C%20Venkatraman%20V%2C%20Matlock%20A%2C%20Van%20Eyk%20JE%2C%20Jaffe%20JD%2C%20Papanastasiou%20M%2C%20Subramanian%20A%2C%20Golub%20TR%2C%20Erickson%20SD%2C%20Fallahi-Sichani%20M%2C%20Hafner%20M%2C%20Gray%20NS%2C%20Lin%20JR%2C%20Mills%20CE%2C%20Muhlich%20JL%2C%20Niepel%20M%2C%20Shamu%20CE%2C%20Williams%20EH%2C%20Wrobel%20D%2C%20Sorger%20PK%2C%20Heiser%20LM%2C%20Gray%20JW%2C%20Korkola%20JE%2C%20Mills%20GB%2C%20LaBarge%20M%2C%20Feiler%20HS%2C%20Dane%20MA%2C%20Bucher%20E%2C%20Nederlof%20M%2C%20Sudar%20D%2C%20Gross%20S%2C%20Kilburn%20DF%2C%20Smith%20R%2C%20Devlin%20K%2C%20Margolis%20R%2C%20Derr%20L%2C%20Lee%20A%2C%20Pillai%20A.%20The%20Library%20of%20Integrated%20Network-Based%20Cellular%20Signatures%20NIH%20program%3A%20system-level%20cataloging%20of%20human%20cells%20response%20to%20perturbations.%20Cell%20Syst.%202018%20Jan%2024%3B6%281%29%3A13%26%23x2013%3B24.%20PMCID%3A%20PMC5799026%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Library%20of%20Integrated%20Network-Based%20Cellular%20Signatures%20NIH%20program%3A%20system-level%20cataloging%20of%20human%20cells%20response%20to%20perturbations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Keenan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherry%20L.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20M.%22%2C%22lastName%22%3A%22Jagodnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Koplev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Torre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zichen%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anders%20B.%22%2C%22lastName%22%3A%22Dohlman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moshe%20C.%22%2C%22lastName%22%3A%22Silverstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Lachmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxim%20V.%22%2C%22lastName%22%3A%22Kuleshov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avi%22%2C%22lastName%22%3A%22Ma%27ayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vasileios%22%2C%22lastName%22%3A%22Stathias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Terryn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michele%22%2C%22lastName%22%3A%22Forlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amar%22%2C%22lastName%22%3A%22Koleti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dusica%22%2C%22lastName%22%3A%22Vidovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caty%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%20C.%22%2C%22lastName%22%3A%22Sch%5Cu00fcrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jouzas%22%2C%22lastName%22%3A%22Vasiliauskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcin%22%2C%22lastName%22%3A%22Pilarczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Behrouz%22%2C%22lastName%22%3A%22Shamsaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Fazel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Ren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Niu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20A.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shana%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naim%22%2C%22lastName%22%3A%22Mahi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lixia%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michal%22%2C%22lastName%22%3A%22Kouril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22Reichard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siva%22%2C%22lastName%22%3A%22Sivaganesan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Medvedovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaroslaw%22%2C%22lastName%22%3A%22Meller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rick%20J.%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Birtwistle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%22%2C%22lastName%22%3A%22Iyengar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20A.%22%2C%22lastName%22%3A%22Sobie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evren%20U.%22%2C%22lastName%22%3A%22Azeloglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Kaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeannette%22%2C%22lastName%22%3A%22Osterloh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Haston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaslin%22%2C%22lastName%22%3A%22Kalra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Finkbiener%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Milani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Adam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renan%22%2C%22lastName%22%3A%22Escalante-Chong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Sachs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Lenail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divya%22%2C%22lastName%22%3A%22Ramamoorthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%22%2C%22lastName%22%3A%22Fraenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gavin%22%2C%22lastName%22%3A%22Daigle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%22%2C%22lastName%22%3A%22Coye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Rothstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhruv%22%2C%22lastName%22%3A%22Sareen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loren%22%2C%22lastName%22%3A%22Ornelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Banuelos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berhan%22%2C%22lastName%22%3A%22Mandefro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ritchie%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clive%20N.%22%2C%22lastName%22%3A%22Svendsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20G.%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Stocksdale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malcolm%20S.%22%2C%22lastName%22%3A%22Casale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terri%20G.%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20M.%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victoria%22%2C%22lastName%22%3A%22Dardov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidya%22%2C%22lastName%22%3A%22Venkatraman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Matlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20E.%22%2C%22lastName%22%3A%22Van%20Eyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20D.%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malvina%22%2C%22lastName%22%3A%22Papanastasiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aravind%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20R.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20D.%22%2C%22lastName%22%3A%22Erickson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20E.%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20H.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Wrobel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Heiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%20W.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Korkola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20B.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22LaBarge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20S.%22%2C%22lastName%22%3A%22Feiler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Dane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmar%22%2C%22lastName%22%3A%22Bucher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Nederlof%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damir%22%2C%22lastName%22%3A%22Sudar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Gross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20F.%22%2C%22lastName%22%3A%22Kilburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaylyn%22%2C%22lastName%22%3A%22Devlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%22%2C%22lastName%22%3A%22Margolis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%22%2C%22lastName%22%3A%22Derr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Pillai%22%7D%5D%2C%22abstractNote%22%3A%22The%20Library%20of%20Integrated%20Network-Based%20Cellular%20Signatures%20%28LINCS%29%20is%20an%20NIH%20Common%20Fund%20program%20that%20catalogs%20how%20human%20cells%20globally%20respond%20to%20chemical%2C%20genetic%2C%20and%20disease%20perturbations.%20Resources%20generated%20by%20LINCS%20include%20experimental%20and%20computational%20methods%2C%20visualization%20tools%2C%20molecular%20and%20imaging%20data%2C%20and%20signatures.%20By%20assembling%20an%20integrated%20picture%20of%20the%20range%20of%20responses%20of%20human%20cells%20exposed%20to%20many%20perturbations%2C%20the%20LINCS%20program%20aims%20to%20better%20understand%20human%20disease%20and%20to%20advance%20the%20development%20of%20new%20therapies.%20Perturbations%20under%20study%20include%20drugs%2C%20genetic%20perturbations%2C%20tissue%20micro-environments%2C%20antibodies%2C%20and%20disease-causing%20mutations.%20Responses%20to%20perturbations%20are%20measured%20by%20transcript%20profiling%2C%20mass%20spectrometry%2C%20cell%20imaging%2C%20and%20biochemical%20methods%2C%20among%20other%20assays.%20The%20LINCS%20program%20focuses%20on%20cellular%20physiology%20shared%20among%20tissues%20and%20cell%20types%20relevant%20to%20an%20array%20of%20diseases%2C%20including%20cancer%2C%20heart%20disease%2C%20and%20neurodegenerative%20disorders.%20This%20Perspective%20describes%20LINCS%20technologies%2C%20datasets%2C%20tools%2C%20and%20approaches%20to%20data%20accessibility%20and%20reusability.%22%2C%22date%22%3A%222018-01-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2017.11.001%22%2C%22ISSN%22%3A%222405-4712%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A14%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22JMW8XZBS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-11%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR%2C%20Izar%20B%2C%20Wang%20S%2C%20Yapp%20C%2C%20Mei%20S%2C%20Shah%20PM%2C%20Santagata%20S%2C%20Sorger%20PK.%20Highly%20multiplexed%20immunofluorescence%20imaging%20of%20human%20tissues%20and%20tumors%20using%20t-CyCIF%20and%20conventional%20optical%20microscopes.%20Elife.%202018%20Jul%2011%3B7.%20PMCID%3A%20PMC6075866%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Highly%20multiplexed%20immunofluorescence%20imaging%20of%20human%20tissues%20and%20tumors%20using%20t-CyCIF%20and%20conventional%20optical%20microscopes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaolin%22%2C%22lastName%22%3A%22Mei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parin%20M.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22The%20architecture%20of%20normal%20and%20diseased%20tissues%20strongly%20influences%20the%20development%20and%20progression%20of%20disease%20as%20well%20as%20responsiveness%20and%20resistance%20to%20therapy.%20We%20describe%20a%20tissue-based%20cyclic%20immunofluorescence%20%28t-CyCIF%29%20method%20for%20highly%20multiplexed%20immuno-fluorescence%20imaging%20of%20formalin-fixed%2C%20paraffin-embedded%20%28FFPE%29%20specimens%20mounted%20on%20glass%20slides%2C%20the%20most%20widely%20used%20specimens%20for%20histopathological%20diagnosis%20of%20cancer%20and%20other%20diseases.%20t-CyCIF%20generates%20up%20to%2060-plex%20images%20using%20an%20iterative%20process%20%28a%20cycle%29%20in%20which%20conventional%20low-plex%20fluorescence%20images%20are%20repeatedly%20collected%20from%20the%20same%20sample%20and%20then%20assembled%20into%20a%20high-dimensional%20representation.%20t-CyCIF%20requires%20no%20specialized%20instruments%20or%20reagents%20and%20is%20compatible%20with%20super-resolution%20imaging%3B%20we%20demonstrate%20its%20application%20to%20quantifying%20signal%20transduction%20cascades%2C%20tumor%20antigens%20and%20immune%20markers%20in%20diverse%20tissues%20and%20tumors.%20The%20simplicity%20and%20adaptability%20of%20t-CyCIF%20makes%20it%20an%20effective%20method%20for%20pre-clinical%20and%20clinical%20research%20and%20a%20natural%20complement%20to%20single-cell%20genomics.%22%2C%22date%22%3A%22Jul%2011%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.31657%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A23%3A09Z%22%7D%7D%2C%7B%22key%22%3A%228QAYRT7Y%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shimada%20et%20al.%22%2C%22parsedDate%22%3A%222018-05-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShimada%20K%2C%20Reznik%20E%2C%20Stokes%20ME%2C%20Krishnamoorthy%20L%2C%20Bos%20PH%2C%20Song%20Y%2C%20Quartararo%20CE%2C%20Pagano%20NC%2C%20Carpizo%20DR%2C%20deCarvalho%20AC%2C%20Lo%20DC%2C%20Stockwell%20BR.%20Copper-binding%20small%20molecule%20induces%20oxidative%20stress%20and%20cell-cycle%20arrest%20in%20glioblastoma-patient-derived%20cells.%20Cell%20Chem%20Biol.%202018%20May%2017%3B25%285%29%3A585-594.e7.%20PMCID%3A%20PMC5959763%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Copper-binding%20small%20molecule%20induces%20oxidative%20stress%20and%20cell-cycle%20arrest%20in%20glioblastoma-patient-derived%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Shimada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduard%22%2C%22lastName%22%3A%22Reznik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20E.%22%2C%22lastName%22%3A%22Stokes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakshmi%22%2C%22lastName%22%3A%22Krishnamoorthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pieter%20H.%22%2C%22lastName%22%3A%22Bos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuyu%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20E.%22%2C%22lastName%22%3A%22Quartararo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nen%20C.%22%2C%22lastName%22%3A%22Pagano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20R.%22%2C%22lastName%22%3A%22Carpizo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20C.%22%2C%22lastName%22%3A%22deCarvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20C.%22%2C%22lastName%22%3A%22Lo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brent%20R.%22%2C%22lastName%22%3A%22Stockwell%22%7D%5D%2C%22abstractNote%22%3A%22Transition%20metals%20are%20essential%2C%20but%20deregulation%20of%20their%20metabolism%20causes%20toxicity.%20Here%2C%20we%20report%20that%20the%20compound%20NSC319726%20binds%20copper%20to%20induce%20oxidative%20stress%20and%20arrest%20glioblastoma-patient-derived%20cells%20at%20picomolar%20concentrations.%20Pharmacogenomic%20analysis%20suggested%20that%20NSC319726%20and%2065%20other%20structural%20analogs%20exhibit%20lethality%20through%20metal%20binding.%20Although%20NSC319726%20has%20been%20reported%20to%20function%20as%20a%20zinc%20ionophore%2C%20we%5Cu00a0report%20here%20that%20this%20compound%20binds%20to%20copper%5Cu00a0to%5Cu00a0arrest%20cell%20growth.%20We%20generated%20and%20validated%20pharmacogenomic%20predictions%3A%20copper%20toxicity%20was%20substantially%20inhibited%20by%20hypoxia%2C%20through%20an%20hypoxia-inducible-factor-1%5Cu03b1-dependent%20pathway%3B%20copper-bound%20NSC319726%20induced%20the%20generation%20of%20reactive%20oxygen%20species%20and%20depletion%20of%20deoxyribosyl%20purines%2C%20resulting%20in%20cell-cycle%20arrest.%20These%20results%20suggest%20that%20metal-induced%20DNA%20damage%20may%20be%20a%20consequence%20of%20exposure%20to%20some%20xenobiotics%2C%20therapeutic%20agents%2C%20as%20well%20as%20other%20causes%20of%20copper%20dysregulation%2C%20and%20reveal%20a%20potent%20mechanism%20for%20targeting%20glioblastomas.%22%2C%22date%22%3A%222018-05-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2018.02.010%22%2C%22ISSN%22%3A%222451-9448%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A19%3A45Z%22%7D%7D%2C%7B%22key%22%3A%226GCMXKGP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Spady%20et%20al.%22%2C%22parsedDate%22%3A%222018-09-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESpady%20ES%2C%20Wyche%20TP%2C%20Rollins%20NJ%2C%20Clardy%20J%2C%20Way%20JC%2C%20Silver%20PA.%20Mammalian%20cells%20engineered%20to%20produce%20new%20steroids.%20Chembiochem.%202018%20Sep%204%3B19%2817%29%3A1827%26%23x2013%3B1833.%20PMCID%3A%20PMC6156985%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mammalian%20cells%20engineered%20to%20produce%20new%20steroids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%20S.%22%2C%22lastName%22%3A%22Spady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20P.%22%2C%22lastName%22%3A%22Wyche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20J.%22%2C%22lastName%22%3A%22Rollins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%22%2C%22lastName%22%3A%22Clardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20C.%22%2C%22lastName%22%3A%22Way%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Silver%22%7D%5D%2C%22abstractNote%22%3A%22Steroids%20can%20be%20difficult%20to%20modify%20through%20traditional%20organic%20synthesis%20methods%2C%20but%20many%20enzymes%20regio-%20and%20stereoselectively%20process%20a%20wide%20variety%20of%20steroid%20substrates.%20We%20tested%20whether%20steroid-modifying%20enzymes%20could%20make%20novel%20steroids%20from%20non-native%20substrates.%20Numerous%20genes%20encoding%20steroid-modifying%20enzymes%2C%20including%20some%20bacterial%20enzymes%2C%20were%20expressed%20in%20mammalian%20cells%20by%20transient%20transfection%20and%20found%20to%20be%20active.%20We%20made%20three%20unusual%20steroids%20by%20stable%20expression%2C%20in%20HEK293%20cells%2C%20of%20the%207%5Cu03b1-hydroxylase%20CYP7B1%2C%20which%20was%20selected%20because%20of%20its%20high%20native%20product%20yield.%20These%20cells%20made%207%5Cu03b1%2C17%5Cu03b1-dihydroxypregnenolone%20and%207%5Cu03b2%2C17%5Cu03b1-dihydroxypregnenolone%20from%2017%5Cu03b1-hydroxypregnenolone%20and%20produced%2011%5Cu03b1%2C16%5Cu03b1-dihydroxyprogesterone%20from%2016%5Cu03b1-hydroxyprogesterone.%20The%20last%20two%20products%20were%20the%20result%20of%20CYP7B1-catalyzed%20hydroxylation%20at%20previously%20unobserved%20sites.%20A%20Rosetta%20docking%20model%20of%20CYP7B1%20suggested%20that%20these%20substrates%27%20D-ring%20hydroxy%20groups%20might%20prevent%20them%20from%20binding%20in%20the%20same%20way%20as%20the%20native%20substrates%2C%20bringing%20different%20carbon%20atoms%20close%20to%20the%20active%20ferryl%20oxygen%20atom.%20This%20new%20approach%20could%20potentially%20use%20other%20enzymes%20and%20substrates%20to%20produce%20many%20novel%20steroids%20for%20drug%20candidate%20testing.%22%2C%22date%22%3A%222018-09-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcbic.201800214%22%2C%22ISSN%22%3A%221439-7633%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-03T22%3A22%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22DVM2ZEWQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222018-09-21%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWang%20J%2C%20Erazo%20T%2C%20Ferguson%20FM%2C%20Buckley%20DL%2C%20Gomez%20N%2C%20Mu%26%23xF1%3Boz-Guardiola%20P%2C%20Di%26%23xE9%3Bguez-Mart%26%23xED%3Bnez%20N%2C%20Deng%20X%2C%20Hao%20M%2C%20Massefski%20W%2C%20Fedorov%20O%2C%20Offei-Addo%20NK%2C%20Park%20PM%2C%20Dai%20L%2C%20DiBona%20A%2C%20Becht%20K%2C%20Kim%20ND%2C%20McKeown%20MR%2C%20Roberts%20JM%2C%20Zhang%20J%2C%20Sim%20T%2C%20Alessi%20DR%2C%20Bradner%20JE%2C%20Lizcano%20JM%2C%20Blacklow%20SC%2C%20Qi%20J%2C%20Xu%20X%2C%20Gray%20NS.%20Structural%20and%20atropisomeric%20factors%20governing%20the%20selectivity%20of%20pyrimido-benzodiazipinones%20as%20inhibitors%20of%20kinases%20and%20bromodomains.%20ACS%20Chem%20Biol.%202018%20Sep%2021%3B13%289%29%3A2438%26%23x2013%3B2448.%20PMCID%3A%20PMC6333101%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20and%20atropisomeric%20factors%20governing%20the%20selectivity%20of%20pyrimido-benzodiazipinones%20as%20inhibitors%20of%20kinases%20and%20bromodomains%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinhua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatiana%22%2C%22lastName%22%3A%22Erazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fleur%20M.%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20L.%22%2C%22lastName%22%3A%22Buckley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nestor%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pau%22%2C%22lastName%22%3A%22Mu%5Cu00f1oz-Guardiola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nora%22%2C%22lastName%22%3A%22Di%5Cu00e9guez-Mart%5Cu00ednez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xianming%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingfeng%22%2C%22lastName%22%3A%22Hao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%22%2C%22lastName%22%3A%22Massefski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oleg%22%2C%22lastName%22%3A%22Fedorov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%20Kwaku%22%2C%22lastName%22%3A%22Offei-Addo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20M.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lingling%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22DiBona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Becht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nam%20Doo%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22McKeown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20M.%22%2C%22lastName%22%3A%22Roberts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinwei%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taebo%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dario%20R.%22%2C%22lastName%22%3A%22Alessi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20E.%22%2C%22lastName%22%3A%22Bradner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20M.%22%2C%22lastName%22%3A%22Lizcano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20C.%22%2C%22lastName%22%3A%22Blacklow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Qi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Bromodomains%20have%20been%20pursued%20intensively%20over%20the%20past%20several%20years%20as%20emerging%20targets%20for%20the%20development%20of%20anticancer%20and%20anti-inflammatory%20agents.%20It%20has%20recently%20been%20shown%20that%20some%20kinase%20inhibitors%20are%20able%20to%20potently%20inhibit%20the%20bromodomains%20of%20BRD4.%20The%20clinical%20activities%20of%20PLK%20inhibitor%20BI-2536%20and%20JAK2-FLT3%20inhibitor%20TG101348%20have%20been%20attributed%20to%20this%20unexpected%20polypharmacology%2C%20indicating%20that%20dual-kinase%5C%2Fbromodomain%20activity%20may%20be%20advantageous%20in%20a%20therapeutic%20context.%20However%2C%20for%20target%20validation%20and%20biological%20investigation%2C%20a%20more%20selective%20target%20profile%20is%20desired.%20Here%2C%20we%20report%20that%20benzo%5Be%5Dpyrimido-%5B5%2C4-%20b%5Ddiazepine-6%2811H%29-ones%2C%20versatile%20ATP-site%20directed%20kinase%20pharmacophores%20utilized%20in%20the%20development%20of%20inhibitors%20of%20multiple%20kinases%2C%20including%20several%20previously%20reported%20kinase%20chemical%20probes%2C%20are%20also%20capable%20of%20exhibiting%20potent%20BRD4-dependent%20pharmacology.%20Using%20a%20dual%20kinase-bromodomain%20inhibitor%20of%20the%20kinase%20domains%20of%20ERK5%20and%20LRRK2%2C%20and%20the%20bromodomain%20of%20BRD4%20as%20a%20case%20study%2C%20we%20define%20the%20structure-activity%20relationships%20required%20to%20achieve%20dual%20kinase%5C%2FBRD4%20activity%2C%20as%20well%20as%20how%20to%20direct%20selectivity%20toward%20inhibition%20of%20either%20ERK5%20or%20BRD4.%20This%20effort%20resulted%20in%20identification%20of%20one%20of%20the%20first%20reported%20kinase-selective%20chemical%20probes%20for%20ERK5%20%28JWG-071%29%2C%20a%20BET%20selective%20inhibitor%20with%201%20%5Cu03bcM%20BRD4%20IC50%20%28JWG-115%29%2C%20and%20additional%20inhibitors%20with%20rationally%20designed%20polypharmacology%20%28JWG-047%2C%20JWG-069%29.%20Co-crystallography%20of%20seven%20representative%20inhibitors%20with%20the%20first%20bromodomain%20of%20BRD4%20demonstrate%20that%20distinct%20atropisomeric%20conformers%20recognize%20the%20kinase%20ATP-site%20and%20the%20BRD4%20acetyl%20lysine%20binding%20site%2C%20conformational%20preferences%20supported%20by%20rigid%20docking%20studies.%22%2C%22date%22%3A%222018-09-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facschembio.7b00638%22%2C%22ISSN%22%3A%221554-8937%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-01-04T03%3A58%3A52Z%22%7D%7D%2C%7B%22key%22%3A%224XLX2WBH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weinstein%20et%20al.%22%2C%22parsedDate%22%3A%222018-08-27%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWeinstein%20ZB%2C%20Kuru%20N%2C%20Kiriakov%20S%2C%20Palmer%20AC%2C%20Khalil%20AS%2C%20Clemons%20PA%2C%20Zaman%20MH%2C%20Roth%20FP%2C%20Cokol%20M.%20Modeling%20the%20impact%20of%20drug%20interactions%20on%20therapeutic%20selectivity.%20Nat%20Commun.%202018%20Aug%2027%3B9%281%29%3A3452.%20PMCID%3A%20PMC6110842%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Modeling%20the%20impact%20of%20drug%20interactions%20on%20therapeutic%20selectivity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zohar%20B.%22%2C%22lastName%22%3A%22Weinstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurdan%22%2C%22lastName%22%3A%22Kuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Szilvia%22%2C%22lastName%22%3A%22Kiriakov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%20S.%22%2C%22lastName%22%3A%22Khalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20A.%22%2C%22lastName%22%3A%22Clemons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%20H.%22%2C%22lastName%22%3A%22Zaman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20P.%22%2C%22lastName%22%3A%22Roth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20therapies%20that%20produce%20synergistic%20growth%20inhibition%20are%20widely%20sought%20after%20for%20the%20pharmacotherapy%20of%20many%20pathological%20conditions.%20Therapeutic%20selectivity%2C%20however%2C%20depends%20on%20the%20difference%20between%20potency%20on%20disease-causing%20cells%20and%20potency%20on%20non-target%20cell%20types%20that%20cause%20toxic%20side%20effects.%20Here%2C%20we%20examine%20a%20model%20system%20of%20antimicrobial%20compound%20combinations%20applied%20to%20two%20highly%20diverged%20yeast%20species.%20We%20find%20that%20even%20though%20the%20drug%20interactions%20correlate%20between%20the%20two%20species%2C%20cell-type-specific%20differences%20in%20drug%20interactions%20are%20common%20and%20can%20dramatically%20alter%20the%20selectivity%20of%20compounds%20when%20applied%20in%20combination%20vs.%20single-drug%20activity-enhancing%2C%20diminishing%2C%20or%20inverting%20therapeutic%20windows.%20This%20study%20identifies%20drug%20combinations%20with%20enhanced%20cell-type-selectivity%20with%20a%20range%20of%20interaction%20types%2C%20which%20we%20experimentally%20validate%20using%20multiplexed%20drug-interaction%20assays%20for%20heterogeneous%20cell%20cultures.%20This%20analysis%20presents%20a%20model%20framework%20for%20evaluating%20drug%20combinations%20with%20increased%20efficacy%20and%20selectivity%20against%20pathogens%20or%20tumors.%22%2C%22date%22%3A%222018-08-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-018-05954-3%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A05%3A18Z%22%7D%7D%5D%7D
1.
Bachman JA, Gyori BM, Sorger PK. FamPlex: a resource for entity recognition and relationship resolution of human protein families and complexes in biomedical text mining. BMC Bioinformatics. 2018 Jun 28;19(1):248. PMCID: PMC6022344
1.
Cokol M, Li C, Chandrasekaran S. Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment. PLoS Comput Biol. 2018 Dec;14(12):e1006677. PMCID: PMC6329523
1.
Cokol-Cakmak M, Bakan F, Cetiner S, Cokol M. Diagonal method to measure synergy among any number of drugs. J Vis Exp. 2018 Jun 21;(136):57713. PMCID: PMC6101960
1.
Coy S, Rashid R, Lin JR, Du Z, Donson AM, Hankinson TC, Foreman NK, Manley PE, Kieran MW, Reardon DA, Sorger PK, Santagata S. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma. Neuro Oncol. 2018 Jul 5;20(8):1101–1112. PMCID: PMC6280314
1.
de Souza CF, Sabedot TS, Malta TM, Stetson L, Morozova O, Sokolov A, Laird PW, Wiznerowicz M, Iavarone A, Snyder J, deCarvalho A, Sanborn Z, McDonald KL, Friedman WA, Tirapelli D, Poisson L, Mikkelsen T, Carlotti CG, Kalkanis S, Zenklusen J, Salama SR, Barnholtz-Sloan JS, Noushmehr H. A distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence. Cell Rep. 2018 Apr 10;23(2):637–651. PMCID: PMC8859991
1.
Dunn IF, Du Z, Touat M, Sisti MB, Wen PY, Umeton R, Dubuc AM, Ducar M, Canoll PD, Severson E, Elvin JA, Ramkissoon SH, Lin JR, Cabrera L, Acevedo B, Sorger PK, Ligon KL, Santagata S, Reardon DA. Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. JCO Precis Oncol. 2018 Nov 27;2018. PMCID: PMC6383717
1.
Gonzalez Herrera KN, Zaganjor E, Ishikawa Y, Spinelli JB, Yoon H, Lin JR, Satterstrom FK, Ringel A, Mulei S, Souza A, Gorham JM, Benson CC, Seidman JG, Sorger PK, Clish CB, Haigis MC. Small-molecule screen identifies de novo nucleotide synthesis as a vulnerability of cells lacking SIRT3. Cell Rep. 2018 Feb 20;22(8):1945–1955. PMCID: PMC5902027
1.
Iglesias N, Currie MA, Jih G, Paulo JA, Siuti N, Kalocsay M, Gygi SP, Moazed D. Automethylation-induced conformational switch in Clr4 (Suv39h) maintains epigenetic stability. Nature. 2018 Aug;560(7719):504–508. PMCID: PMC6287498
1.
Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell. 2018 Nov 1;175(4):984-997.e24. PMCID: PMC6410377
1.
Keenan AB, Jenkins SL, Jagodnik KM, Koplev S, He E, Torre D, Wang Z, Dohlman AB, Silverstein MC, Lachmann A, Kuleshov MV, Ma’ayan A, Stathias V, Terryn R, Cooper D, Forlin M, Koleti A, Vidovic D, Chung C, Schürer SC, Vasiliauskas J, Pilarczyk M, Shamsaei B, Fazel M, Ren Y, Niu W, Clark NA, White S, Mahi N, Zhang L, Kouril M, Reichard JF, Sivaganesan S, Medvedovic M, Meller J, Koch RJ, Birtwistle MR, Iyengar R, Sobie EA, Azeloglu EU, Kaye J, Osterloh J, Haston K, Kalra J, Finkbiener S, Li J, Milani P, Adam M, Escalante-Chong R, Sachs K, Lenail A, Ramamoorthy D, Fraenkel E, Daigle G, Hussain U, Coye A, Rothstein J, Sareen D, Ornelas L, Banuelos M, Mandefro B, Ho R, Svendsen CN, Lim RG, Stocksdale J, Casale MS, Thompson TG, Wu J, Thompson LM, Dardov V, Venkatraman V, Matlock A, Van Eyk JE, Jaffe JD, Papanastasiou M, Subramanian A, Golub TR, Erickson SD, Fallahi-Sichani M, Hafner M, Gray NS, Lin JR, Mills CE, Muhlich JL, Niepel M, Shamu CE, Williams EH, Wrobel D, Sorger PK, Heiser LM, Gray JW, Korkola JE, Mills GB, LaBarge M, Feiler HS, Dane MA, Bucher E, Nederlof M, Sudar D, Gross S, Kilburn DF, Smith R, Devlin K, Margolis R, Derr L, Lee A, Pillai A. The Library of Integrated Network-Based Cellular Signatures NIH program: system-level cataloging of human cells response to perturbations. Cell Syst. 2018 Jan 24;6(1):13–24. PMCID: PMC5799026
1.
Lin JR, Izar B, Wang S, Yapp C, Mei S, Shah PM, Santagata S, Sorger PK. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. Elife. 2018 Jul 11;7. PMCID: PMC6075866
1.
Shimada K, Reznik E, Stokes ME, Krishnamoorthy L, Bos PH, Song Y, Quartararo CE, Pagano NC, Carpizo DR, deCarvalho AC, Lo DC, Stockwell BR. Copper-binding small molecule induces oxidative stress and cell-cycle arrest in glioblastoma-patient-derived cells. Cell Chem Biol. 2018 May 17;25(5):585-594.e7. PMCID: PMC5959763
1.
Spady ES, Wyche TP, Rollins NJ, Clardy J, Way JC, Silver PA. Mammalian cells engineered to produce new steroids. Chembiochem. 2018 Sep 4;19(17):1827–1833. PMCID: PMC6156985
1.
Wang J, Erazo T, Ferguson FM, Buckley DL, Gomez N, Muñoz-Guardiola P, Diéguez-Martínez N, Deng X, Hao M, Massefski W, Fedorov O, Offei-Addo NK, Park PM, Dai L, DiBona A, Becht K, Kim ND, McKeown MR, Roberts JM, Zhang J, Sim T, Alessi DR, Bradner JE, Lizcano JM, Blacklow SC, Qi J, Xu X, Gray NS. Structural and atropisomeric factors governing the selectivity of pyrimido-benzodiazipinones as inhibitors of kinases and bromodomains. ACS Chem Biol. 2018 Sep 21;13(9):2438–2448. PMCID: PMC6333101
1.
Weinstein ZB, Kuru N, Kiriakov S, Palmer AC, Khalil AS, Clemons PA, Zaman MH, Roth FP, Cokol M. Modeling the impact of drug interactions on therapeutic selectivity. Nat Commun. 2018 Aug 27;9(1):3452. PMCID: PMC6110842
2576724
IXMHRBF6
LSP Paper
2017
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%223VWCTDM3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cardenas-Gonzalez%20et%20al.%22%2C%22parsedDate%22%3A%222017-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECardenas-Gonzalez%20M%2C%20Srivastava%20A%2C%20Pavkovic%20M%2C%20Bijol%20V%2C%20Rennke%20HG%2C%20Stillman%20IE%2C%20Zhang%20X%2C%20Parikh%20S%2C%20Rovin%20BH%2C%20Afkarian%20M%2C%20de%20Boer%20IH%2C%20Himmelfarb%20J%2C%20Waikar%20SS%2C%20Vaidya%20VS.%20Identification%2C%20confirmation%2C%20and%20replication%20of%20novel%20urinary%20microRNA%20biomarkers%20in%20lupus%20nephritis%20and%20diabetic%20nephropathy.%20Clin%20Chem.%202017%20Sep%3B63%289%29%3A1515%26%23x2013%3B1526.%20PMCID%3A%20PMC5610914%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identification%2C%20confirmation%2C%20and%20replication%20of%20novel%20urinary%20microRNA%20biomarkers%20in%20lupus%20nephritis%20and%20diabetic%20nephropathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Cardenas-Gonzalez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anand%22%2C%22lastName%22%3A%22Srivastava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanesa%22%2C%22lastName%22%3A%22Bijol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helmut%20G.%22%2C%22lastName%22%3A%22Rennke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20E.%22%2C%22lastName%22%3A%22Stillman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaolan%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brad%20H.%22%2C%22lastName%22%3A%22Rovin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryam%22%2C%22lastName%22%3A%22Afkarian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20H.%22%2C%22lastName%22%3A%22de%20Boer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Himmelfarb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushrut%20S.%22%2C%22lastName%22%3A%22Waikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20prevalence%20of%20chronic%20kidney%20disease%20%28CKD%29%20is%20increasing%2C%20leading%20to%20significant%20morbidity%20and%20mortality.%20Kidney%20biopsy%20remains%20the%20gold%20standard%20for%20diagnosing%20the%20underlying%20etiology%20of%20CKD%2C%20but%20the%20procedure%20carries%20complication%20risks.%20The%20aim%20of%20this%20study%20was%20to%20identify%20novel%20noninvasive%20biomarkers%20correlating%20with%20kidney%20function%20and%20histopathology%20in%20biopsy-proven%20CKD%20patients.%5CnMETHODS%3A%20We%20profiled%202402%20urinary%20microRNAs%20%28miRNAs%29%20to%20identify%20and%20confirm%20differentially%20expressed%20miRNAs%20associated%20with%20kidney%20function%20and%20histopathology%20in%20patients%20with%20diabetic%20nephropathy%20%28n%20%3D%2058%29%20or%20lupus%20nephritis%20%28n%20%3D%2089%29%2C%20important%20etiologies%20of%20CKD%2C%20compared%20with%20healthy%20controls%20%28n%20%3D%2093%20and%20119%2C%20respectively%29.%20Top%20performing%20miRNAs%20were%20then%20measured%20in%202%20independent%20multi-institutional%20cohorts%20of%20patients%20with%20diabetes%20mellitus%20with%20%28n%20%3D%2074%29%20or%20without%20nephropathy%20%28n%20%3D%2071%29%20and%20systemic%20lupus%20erythematosus%20with%20%28n%20%3D%2086%29%20or%20without%20%28n%20%3D%2037%29%20nephritis.%5CnRESULTS%3A%20In%20patients%20with%20diabetic%20nephropathy%2C%20miR-2861%2C%20miR-1915-3p%2C%20and%20miR-4532%20were%20down-regulated%20%28%3E10-fold%2C%20P%20%3C%200.0001%29%20and%20were%20associated%20with%20estimated%20glomerular%20filtration%20rate%20%28P%20%3C%200.01%29%20and%20interstitial%20fibrosis%5C%2Ftubular%20atrophy%20%28P%20%3C%200.05%29.%20The%20c-statistics%20for%20miR-2861%2C%20miR-1915-3p%2C%20and%20miR-4532%20were%200.91%2C%200.86%2C%20and%200.85%2C%20respectively.%20In%20lupus%20nephritis%20patients%2C%20miR-3201%20and%20miR-1273e%20were%20down-regulated%20%28%3E3-fold%2C%20P%20%3C%200.0001%29%20and%20associated%20with%20endocapillary%20glomerular%20inflammation%20%28P%20%3C%200.01%29%2C%20with%20c-statistics%20of%200.97%20and%200.91%2C%20respectively.%5CnCONCLUSIONS%3A%20We%20have%20identified%20novel%20miRNAs%20that%20correlate%20with%20histopathological%20lesions%20and%20functional%20markers%20of%20kidney%20damage%20to%20facilitate%20sensitive%2C%20specific%2C%20and%20noninvasive%20detection%20of%20diabetic%20nephropathy%20and%20lupus%20nephritis.%22%2C%22date%22%3A%222017-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1373%5C%2Fclinchem.2017.274175%22%2C%22ISSN%22%3A%221530-8561%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T17%3A02%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22JYII69NI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Carlin%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECarlin%20DE%2C%20Paull%20EO%2C%20Graim%20K%2C%20Wong%20CK%2C%20Bivol%20A%2C%20Ryabinin%20P%2C%20Ellrott%20K%2C%20Sokolov%20A%2C%20Stuart%20JM.%20Prophetic%20granger%20causality%20to%20infer%20gene%20regulatory%20networks.%20PLoS%20One.%202017%3B12%2812%29%3Ae0170340.%20PMCID%3A%20PMC5718405%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prophetic%20granger%20causality%20to%20infer%20gene%20regulatory%20networks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20E.%22%2C%22lastName%22%3A%22Carlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20O.%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiley%22%2C%22lastName%22%3A%22Graim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20K.%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Bivol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ryabinin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%22%2C%22lastName%22%3A%22Ellrott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%5D%2C%22abstractNote%22%3A%22We%20introduce%20a%20novel%20method%20called%20Prophetic%20Granger%20Causality%20%28PGC%29%20for%20inferring%20gene%20regulatory%20networks%20%28GRNs%29%20from%20protein-level%20time%20series%20data.%20The%20method%20uses%20an%20L1-penalized%20regression%20adaptation%20of%20Granger%20Causality%20to%20model%20protein%20levels%20as%20a%20function%20of%20time%2C%20stimuli%2C%20and%20other%20perturbations.%20When%20combined%20with%20a%20data-independent%20network%20prior%2C%20the%20framework%20outperformed%20all%20other%20methods%20submitted%20to%20the%20HPN-DREAM%208%20breast%20cancer%20network%20inference%20challenge.%20Our%20investigations%20reveal%20that%20PGC%20provides%20complementary%20information%20to%20other%20approaches%2C%20raising%20the%20performance%20of%20ensemble%20learners%2C%20while%20on%20its%20own%20achieves%20moderate%20performance.%20Thus%2C%20PGC%20serves%20as%20a%20valuable%20new%20tool%20in%20the%20bioinformatics%20toolkit%20for%20analyzing%20temporal%20datasets.%20We%20investigate%20the%20general%20and%20cell-specific%20interactions%20predicted%20by%20our%20method%20and%20find%20several%20novel%20interactions%2C%20demonstrating%20the%20utility%20of%20the%20approach%20in%20charting%20new%20tumor%20wiring.%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0170340%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A30%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22WRUU6T93%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Cokol%20et%20al.%22%2C%22parsedDate%22%3A%222017-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECokol%20M%2C%20Kuru%20N%2C%20Bicak%20E%2C%20Larkins-Ford%20J%2C%20Aldridge%20BB.%20Efficient%20measurement%20and%20factorization%20of%20high-order%20drug%20interactions%20in%20Mycobacterium%20tuberculosis.%20Sci%20Adv.%202017%20Oct%3B3%2810%29%3Ae1701881.%20PMCID%3A%20PMC5636204%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficient%20measurement%20and%20factorization%20of%20high-order%20drug%20interactions%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurdan%22%2C%22lastName%22%3A%22Kuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ece%22%2C%22lastName%22%3A%22Bicak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonah%22%2C%22lastName%22%3A%22Larkins-Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22Combinations%20of%20three%20or%20more%20drugs%20are%20used%20to%20treat%20many%20diseases%2C%20including%20tuberculosis.%20Thus%2C%20it%20is%20important%20to%20understand%20how%20synergistic%20or%20antagonistic%20drug%20interactions%20affect%20the%20efficacy%20of%20combination%20therapies.%20However%2C%20our%20understanding%20of%20high-order%20drug%20interactions%20is%20limited%20because%20of%20the%20lack%20of%20both%20efficient%20measurement%20methods%20and%20theoretical%20framework%20for%20analysis%20and%20interpretation.%20We%20developed%20an%20efficient%20experimental%20sampling%20and%20scoring%20method%20%5Bdiagonal%20measurement%20of%20n-way%20drug%20interactions%20%28DiaMOND%29%5D%20to%20measure%20drug%20interactions%20for%20combinations%20of%20any%20number%20of%20drugs.%20DiaMOND%20provides%20an%20efficient%20alternative%20to%20checkerboard%20assays%2C%20which%20are%20commonly%20used%20to%20measure%20drug%20interactions.%20We%20established%20a%20geometric%20framework%20to%20factorize%20high-order%20drug%20interactions%20into%20lower-order%20components%2C%20thereby%20establishing%20a%20road%20map%20of%20how%20to%20use%20lower-order%20measurements%20to%20predict%20high-order%20interactions.%20Our%20framework%20is%20a%20generalized%20Loewe%20additivity%20model%20for%20high-order%20drug%20interactions.%20Using%20DiaMOND%2C%20we%20identified%20and%20analyzed%20synergistic%20and%20antagonistic%20antibiotic%20combinations%20against%20Mycobacteriumtuberculosis.%20Efficient%20measurement%20and%20factorization%20of%20high-order%20drug%20interactions%20by%20DiaMOND%20are%20broadly%20applicable%20to%20other%20cell%20types%20and%20disease%20models.%22%2C%22date%22%3A%222017-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.1701881%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A53%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22R2S29B3U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Fallahi-Sichani%20et%20al.%22%2C%22parsedDate%22%3A%222017-01-09%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFallahi-Sichani%20M%2C%20Becker%20V%2C%20Izar%20B%2C%20Baker%20GJ%2C%20Lin%20JR%2C%20Boswell%20SA%2C%20Shah%20P%2C%20Rotem%20A%2C%20Garraway%20LA%2C%20Sorger%20PK.%20Adaptive%20resistance%20of%20melanoma%20cells%20to%20RAF%20inhibition%20via%20reversible%20induction%20of%20a%20slowly%20dividing%20de-differentiated%20state.%20Mol%20Syst%20Biol.%202017%20Jan%209%3B13%281%29%3A905.%20PMCID%3A%20PMC5248573%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adaptive%20resistance%20of%20melanoma%20cells%20to%20RAF%20inhibition%20via%20reversible%20induction%20of%20a%20slowly%20dividing%20de-differentiated%20state%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Verena%22%2C%22lastName%22%3A%22Becker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parin%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Treatment%20of%20BRAF-mutant%20melanomas%20with%20MAP%20kinase%20pathway%20inhibitors%20is%20paradigmatic%20of%20the%20promise%20of%20precision%20cancer%20therapy%20but%20also%20highlights%20problems%20with%20drug%20resistance%20that%20limit%20patient%20benefit.%20We%20use%20live-cell%20imaging%2C%20single-cell%20analysis%2C%20and%20molecular%20profiling%20to%20show%20that%20exposure%20of%20tumor%20cells%20to%20RAF%5C%2FMEK%20inhibitors%20elicits%20a%20heterogeneous%20response%20in%20which%20some%20cells%20die%2C%20some%20arrest%2C%20and%20the%20remainder%20adapt%20to%20drug.%20Drug-adapted%20cells%20up-regulate%20markers%20of%20the%20neural%20crest%20%28e.g.%2C%20NGFR%29%2C%20a%20melanocyte%20precursor%2C%20and%20grow%20slowly.%20This%20phenotype%20is%20transiently%20stable%2C%20reverting%20to%20the%20drug-na%5Cu00efve%20state%20within%209%5Cu00a0days%20of%20drug%20withdrawal.%20Transcriptional%20profiling%20of%20cell%20lines%20and%20human%20tumors%20implicates%20a%20c-Jun%5C%2FECM%5C%2FFAK%5C%2FSrc%20cascade%20in%20de-differentiation%20in%20about%20one-third%20of%20cell%20lines%20studied%3B%20drug-induced%20changes%20in%20c-Jun%20and%20NGFR%20levels%20are%20also%20observed%20in%20xenograft%20and%20human%20tumors.%20Drugs%20targeting%20the%20c-Jun%5C%2FECM%5C%2FFAK%5C%2FSrc%20cascade%20as%20well%20as%20BET%20bromodomain%20inhibitors%20increase%20the%20maximum%20effect%20%28Emax%29%20of%20RAF%5C%2FMEK%20kinase%20inhibitors%20by%20promoting%20cell%20killing.%20Thus%2C%20analysis%20of%20reversible%20drug%20resistance%20at%20a%20single-cell%20level%20identifies%20signaling%20pathways%20and%20inhibitory%20drugs%20missed%20by%20assays%20that%20focus%20on%20cell%20populations.%22%2C%22date%22%3A%222017-01-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.20166796%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-31T19%3A22%3A30Z%22%7D%7D%2C%7B%22key%22%3A%223GA6B5VM%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fusco%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFusco%20DN%2C%20Pratt%20H%2C%20Kandilas%20S%2C%20Cheon%20SSY%2C%20Lin%20W%2C%20Cronkite%20DA%2C%20Basavappa%20M%2C%20Jeffrey%20KL%2C%20Anselmo%20A%2C%20Sadreyev%20R%2C%20Yapp%20C%2C%20Shi%20X%2C%20O%26%23x2019%3BSullivan%20JF%2C%20Gerszten%20RE%2C%20Tomaru%20T%2C%20Yoshino%20S%2C%20Satoh%20T%2C%20Chung%20RT.%20HELZ2%20is%20an%20IFN%20effector%20mediating%20suppression%20of%20dengue%20virus.%20Front%20Microbiol.%202017%3B8%3A240.%20PMCID%3A%20PMC5316548%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HELZ2%20is%20an%20IFN%20effector%20mediating%20suppression%20of%20dengue%20virus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dahlene%20N.%22%2C%22lastName%22%3A%22Fusco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henry%22%2C%22lastName%22%3A%22Pratt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Kandilas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scarlett%20Se%20Yun%22%2C%22lastName%22%3A%22Cheon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenyu%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20Alex%22%2C%22lastName%22%3A%22Cronkite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megha%22%2C%22lastName%22%3A%22Basavappa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%20L.%22%2C%22lastName%22%3A%22Jeffrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Anselmo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruslan%22%2C%22lastName%22%3A%22Sadreyev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20F.%22%2C%22lastName%22%3A%22O%27Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Gerszten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takuya%22%2C%22lastName%22%3A%22Tomaru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Yoshino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tetsurou%22%2C%22lastName%22%3A%22Satoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20T.%22%2C%22lastName%22%3A%22Chung%22%7D%5D%2C%22abstractNote%22%3A%22Flaviviral%20infections%20including%20dengue%20virus%20are%20an%20increasing%20clinical%20problem%20worldwide.%20Dengue%20infection%20triggers%20host%20production%20of%20the%20type%201%20IFN%2C%20IFN%20alpha%2C%20one%20of%20the%20strongest%20and%20broadest%20acting%20antivirals%20known.%20However%2C%20dengue%20virus%20subverts%20host%20IFN%20signaling%20at%20early%20steps%20of%20IFN%20signal%20transduction.%20This%20subversion%20allows%20unbridled%20viral%20replication%20which%20subsequently%20triggers%20ongoing%20production%20of%20IFN%20which%2C%20again%2C%20is%20subverted.%20Identification%20of%20downstream%20IFN%20antiviral%20effectors%20will%20provide%20targets%20which%20could%20be%20activated%20to%20restore%20broad%20acting%20antiviral%20activity%2C%20stopping%20the%20signal%20to%20produce%20endogenous%20IFN%20at%20toxic%20levels.%20To%20this%20end%2C%20we%20performed%20a%20targeted%20functional%20genomic%20screen%20for%20IFN%20antiviral%20effector%20genes%20%28IEGs%29%2C%20identifying%2056%20IEGs%20required%20for%20antiviral%20effects%20of%20IFN%20against%20fully%20infectious%20dengue%20virus.%20Dengue%20IEGs%20were%20enriched%20for%20genes%20encoding%20nuclear%20receptor%20interacting%20proteins%2C%20including%20HELZ2%2C%20MAP2K4%2C%20SLC27A2%2C%20HSP90AA1%2C%20and%20HSP90AB1.%20We%20focused%20on%20HELZ2%20%28Helicase%20With%20Zinc%20Finger%202%29%2C%20an%20IFN%20stimulated%20gene%20and%20IEG%20which%20encodes%20a%20promiscuous%20nuclear%20factor%20coactivator%20that%20exists%20in%20two%20isoforms.%20The%20two%20unique%20HELZ2%20isoforms%20are%20both%20IFN%20responsive%2C%20contain%20ISRE%20elements%2C%20and%20gene%20products%20increase%20in%20the%20nucleus%20upon%20IFN%20stimulation.%20Chromatin%20immunoprecipitation-sequencing%20revealed%20that%20the%20HELZ2%20complex%20interacts%20with%20triglyceride-regulator%20LMF1.%20Mass%20spectrometry%20revealed%20that%20HELZ2%20knockdown%20cells%20are%20depleted%20of%20triglyceride%20subsets.%20We%20thus%20sought%20to%20determine%20whether%20HELZ2%20interacts%20with%20a%20nuclear%20receptor%20known%20to%20regulate%20immune%20response%20and%20lipid%20metabolism%2C%20AHR%2C%20and%20identified%20HELZ2%3AAHR%20interactions%20via%20co-immunoprecipitation%2C%20found%20that%20AHR%20is%20a%20dengue%20IEG%2C%20and%20that%20an%20AHR%20ligand%2C%20FICZ%2C%20exhibits%20anti-dengue%20activity.%20Primary%20bone%20marrow%20derived%20macrophages%20from%20HELZ2%20knockout%20mice%2C%20compared%20to%20wild%20type%20controls%2C%20exhibit%20enhanced%20dengue%20infectivity.%20Overall%2C%20these%20findings%20reveal%20that%20IFN%20antiviral%20response%20is%20mediated%20by%20HELZ2%20transcriptional%20upregulation%2C%20enrichment%20of%20HELZ2%20protein%20levels%20in%20the%20nucleus%2C%20and%20activation%20of%20a%20transcriptional%20program%20that%20appears%20to%20modulate%20intracellular%20lipid%20state.%20IEGs%20identified%20in%20this%20study%20may%20serve%20as%20both%20%281%29%20potential%20targets%20for%20host%20directed%20antiviral%20design%2C%20downstream%20of%20the%20common%20flaviviral%20subversion%20point%2C%20as%20well%20as%20%282%29%20possible%20biomarkers%2C%20whose%20variation%2C%20natural%2C%20or%20iatrogenic%2C%20could%20affect%20host%20response%20to%20viral%20infections.%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmicb.2017.00240%22%2C%22ISSN%22%3A%221664-302X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A30%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22M77ZVWVU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gerlach%20and%20Vaidya%22%2C%22parsedDate%22%3A%222017-08%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGerlach%20CV%2C%20Vaidya%20VS.%20MicroRNAs%20in%20injury%20and%20repair.%20Arch%20Toxicol%20%5BInternet%5D.%202017%20Aug%3B91%288%29%3A2781%26%23x2013%3B2797.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs00204-017-1974-1%27%3Ehttp%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs00204-017-1974-1%3C%5C%2Fa%3E%20PMCID%3A%20PMC5843992%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MicroRNAs%20in%20injury%20and%20repair%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cory%20V.%22%2C%22lastName%22%3A%22Gerlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Organ%20damage%20and%20resulting%20pathologies%20often%20involve%20multiple%20deregulated%20pathways.%20MicroRNAs%20%28miRNAs%29%20are%20short%2C%20non-coding%20RNAs%20that%20regulate%20a%20multitude%20of%20genes%20at%20the%20post-transcriptional%20level.%20Since%20their%20discovery%20over%20two%20decades%20ago%2C%20miRNAs%20have%20been%20established%20as%20key%20players%20in%20the%20molecular%20mechanisms%20of%20mammalian%20biology%20including%20the%20maintenance%20of%20normal%20homeostasis%20and%20the%20regulation%20of%20disease%20pathogenesis.%20In%20recent%20years%2C%20there%20has%20been%20substantial%20progress%20in%20innovative%20techniques%20to%20measure%20miRNAs%20along%20with%20advances%20in%20targeted%20delivery%20of%20agents%20modulating%20their%20expression.%20This%20has%20expanded%20the%20scope%20of%20miRNAs%20from%20being%20important%20mediators%20of%20cell%20signaling%20to%20becoming%20viable%20quantitative%20biomarkers%20and%20therapeutic%20targets.%20Currently%2C%20miRNA%20therapeutics%20are%20in%20clinical%20trials%20for%20multiple%20disease%20areas%20and%20vast%20numbers%20of%20patents%20have%20been%20filed%20for%20miRNAs%20involved%20in%20various%20pathological%20states.%20In%20this%20review%2C%20we%20summarize%20miRNAs%20involved%20in%20organ%20injury%20and%20repair%2C%20specifically%20with%20regard%20to%20organs%20that%20are%20the%20most%20susceptible%20to%20injury%3A%20the%20liver%2C%20heart%20and%20kidney.%20In%20addition%2C%20we%20review%20the%20current%20state%20of%20knowledge%20on%20miRNA%20biology%2C%20miRNA%20biomarkers%20and%20nucleotide-based%20therapeutics%20designed%20to%20target%20miRNAs%20to%20prevent%20organ%20injury%20and%20promote%20repair.%22%2C%22date%22%3A%222017-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00204-017-1974-1%22%2C%22ISSN%22%3A%221432-0738%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs00204-017-1974-1%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-05-17T14%3A29%3A12Z%22%7D%7D%2C%7B%22key%22%3A%225S76LDKE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Goel%20et%20al.%22%2C%22parsedDate%22%3A%222017-08-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGoel%20S%2C%20DeCristo%20MJ%2C%20Watt%20AC%2C%20BrinJones%20H%2C%20Sceneay%20J%2C%20Li%20BB%2C%20Khan%20N%2C%20Ubellacker%20JM%2C%20Xie%20S%2C%20Metzger-Filho%20O%2C%20Hoog%20J%2C%20Ellis%20MJ%2C%20Ma%20CX%2C%20Ramm%20S%2C%20Krop%20IE%2C%20Winer%20EP%2C%20Roberts%20TM%2C%20Kim%20HJ%2C%20McAllister%20SS%2C%20Zhao%20JJ.%20CDK4%5C%2F6%20inhibition%20triggers%20anti-tumour%20immunity.%20Nature.%202017%20Aug%2024%3B548%287668%29%3A471%26%23x2013%3B475.%20PMCID%3A%20PMC5570667%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CDK4%5C%2F6%20inhibition%20triggers%20anti-tumour%20immunity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shom%22%2C%22lastName%22%3A%22Goel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%20J.%22%2C%22lastName%22%3A%22DeCristo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20C.%22%2C%22lastName%22%3A%22Watt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haley%22%2C%22lastName%22%3A%22BrinJones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaclyn%22%2C%22lastName%22%3A%22Sceneay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%20B.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naveed%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessalyn%20M.%22%2C%22lastName%22%3A%22Ubellacker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaozhen%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%22%2C%22lastName%22%3A%22Metzger-Filho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Hoog%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Ellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20X.%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Ramm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20E.%22%2C%22lastName%22%3A%22Krop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20P.%22%2C%22lastName%22%3A%22Winer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20M.%22%2C%22lastName%22%3A%22Roberts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hye-Jung%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20S.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinases%204%20and%206%20%28CDK4%5C%2F6%29%20are%20fundamental%20drivers%20of%20the%20cell%20cycle%20and%20are%20required%20for%20the%20initiation%20and%20progression%20of%20various%20malignancies.%20Pharmacological%20inhibitors%20of%20CDK4%5C%2F6%20have%20shown%20significant%20activity%20against%20several%20solid%20tumours.%20Their%20primary%20mechanism%20of%20action%20is%20thought%20to%20be%20the%20inhibition%20of%20phosphorylation%20of%20the%20retinoblastoma%20tumour%20suppressor%2C%20inducing%20G1%20cell%20cycle%20arrest%20in%20tumour%20cells.%20Here%20we%20use%20mouse%20models%20of%20breast%20carcinoma%20and%20other%20solid%20tumours%20to%20show%20that%20selective%20CDK4%5C%2F6%20inhibitors%20not%20only%20induce%20tumour%20cell%20cycle%20arrest%2C%20but%20also%20promote%20anti-tumour%20immunity.%20We%20confirm%20this%20phenomenon%20through%20transcriptomic%20analysis%20of%20serial%20biopsies%20from%20a%20clinical%20trial%20of%20CDK4%5C%2F6%20inhibitor%20treatment%20for%20breast%20cancer.%20The%20enhanced%20anti-tumour%20immune%20response%20has%20two%20underpinnings.%20First%2C%20CDK4%5C%2F6%20inhibitors%20activate%20tumour%20cell%20expression%20of%20endogenous%20retroviral%20elements%2C%20thus%20increasing%20intracellular%20levels%20of%20double-stranded%20RNA.%20This%20in%20turn%20stimulates%20production%20of%20type%20III%20interferons%20and%20hence%20enhances%20tumour%20antigen%20presentation.%20Second%2C%20CDK4%5C%2F6%20inhibitors%20markedly%20suppress%20the%20proliferation%20of%20regulatory%20T%20cells.%20Mechanistically%2C%20the%20effects%20of%20CDK4%5C%2F6%20inhibitors%20both%20on%20tumour%20cells%20and%20on%20regulatory%20T%20cells%20are%20associated%20with%20reduced%20activity%20of%20the%20E2F%20target%2C%20DNA%20methyltransferase%201.%20Ultimately%2C%20these%20events%20promote%20cytotoxic%20T-cell-mediated%20clearance%20of%20tumour%20cells%2C%20which%20is%20further%20enhanced%20by%20the%20addition%20of%20immune%20checkpoint%20blockade.%20Our%20findings%20indicate%20that%20CDK4%5C%2F6%20inhibitors%20increase%20tumour%20immunogenicity%20and%20provide%20a%20rationale%20for%20new%20combination%20regimens%20comprising%20CDK4%5C%2F6%20inhibitors%20and%20immunotherapies%20as%20anti-cancer%20treatment.%22%2C%22date%22%3A%222017-08-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnature23465%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T02%3A50%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22R93LSJEW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00f6nen%20et%20al.%22%2C%22parsedDate%22%3A%222017-11-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EG%26%23xF6%3Bnen%20M%2C%20Weir%20BA%2C%20Cowley%20GS%2C%20Vazquez%20F%2C%20Guan%20Y%2C%20Jaiswal%20A%2C%20Karasuyama%20M%2C%20Uzunangelov%20V%2C%20Wang%20T%2C%20Tsherniak%20A%2C%20Howell%20S%2C%20Marbach%20D%2C%20Hoff%20B%2C%20Norman%20TC%2C%20Airola%20A%2C%20Bivol%20A%2C%20Bunte%20K%2C%20Carlin%20D%2C%20Chopra%20S%2C%20Deran%20A%2C%20Ellrott%20K%2C%20Gopalacharyulu%20P%2C%20Graim%20K%2C%20Kaski%20S%2C%20Khan%20SA%2C%20Newton%20Y%2C%20Ng%20S%2C%20Pahikkala%20T%2C%20Paull%20E%2C%20Sokolov%20A%2C%20Tang%20H%2C%20Tang%20J%2C%20Wennerberg%20K%2C%20Xie%20Y%2C%20Zhan%20X%2C%20Zhu%20F%2C%20Broad-DREAM%20Community%2C%20Aittokallio%20T%2C%20Mamitsuka%20H%2C%20Stuart%20JM%2C%20Boehm%20JS%2C%20Root%20DE%2C%20Xiao%20G%2C%20Stolovitzky%20G%2C%20Hahn%20WC%2C%20Margolin%20AA.%20A%20community%20challenge%20for%20inferring%20genetic%20predictors%20of%20gene%20essentialities%20through%20analysis%20of%20a%20functional%20screen%20of%20cancer%20cell%20lines.%20Cell%20Syst.%202017%20Nov%2022%3B5%285%29%3A485-497.e3.%20PMCID%3A%20PMC5814247%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20community%20challenge%20for%20inferring%20genetic%20predictors%20of%20gene%20essentialities%20through%20analysis%20of%20a%20functional%20screen%20of%20cancer%20cell%20lines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehmet%22%2C%22lastName%22%3A%22G%5Cu00f6nen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%20A.%22%2C%22lastName%22%3A%22Weir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20S.%22%2C%22lastName%22%3A%22Cowley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisca%22%2C%22lastName%22%3A%22Vazquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuanfang%22%2C%22lastName%22%3A%22Guan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alok%22%2C%22lastName%22%3A%22Jaiswal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masayuki%22%2C%22lastName%22%3A%22Karasuyama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladislav%22%2C%22lastName%22%3A%22Uzunangelov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviad%22%2C%22lastName%22%3A%22Tsherniak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Howell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Marbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%22%2C%22lastName%22%3A%22Hoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thea%20C.%22%2C%22lastName%22%3A%22Norman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antti%22%2C%22lastName%22%3A%22Airola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Bivol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kerstin%22%2C%22lastName%22%3A%22Bunte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Carlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sahil%22%2C%22lastName%22%3A%22Chopra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alden%22%2C%22lastName%22%3A%22Deran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%22%2C%22lastName%22%3A%22Ellrott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peddinti%22%2C%22lastName%22%3A%22Gopalacharyulu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiley%22%2C%22lastName%22%3A%22Graim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Kaski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suleiman%20A.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yulia%22%2C%22lastName%22%3A%22Newton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sam%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tapio%22%2C%22lastName%22%3A%22Pahikkala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krister%22%2C%22lastName%22%3A%22Wennerberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaowei%22%2C%22lastName%22%3A%22Zhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fan%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Broad-DREAM%20Community%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tero%22%2C%22lastName%22%3A%22Aittokallio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Mamitsuka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20S.%22%2C%22lastName%22%3A%22Boehm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Root%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guanghua%22%2C%22lastName%22%3A%22Xiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Stolovitzky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20A.%22%2C%22lastName%22%3A%22Margolin%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20results%20of%20a%20DREAM%20challenge%20designed%20to%20predict%20relative%20genetic%20essentialities%20based%20on%20a%20novel%20dataset%20testing%2098%2C000%20shRNAs%20against%20149%20molecularly%20characterized%20cancer%20cell%20lines.%20We%20analyzed%20the%20results%20of%20over%203%2C000%20submissions%20over%20a%20period%20of%204%5Cu00a0months.%20We%20found%20that%20algorithms%20combining%20essentiality%20data%20across%20multiple%20genes%20demonstrated%20increased%20accuracy%3B%20gene%20expression%20was%20the%20most%20informative%20molecular%20data%20type%3B%20the%20identity%20of%20the%20gene%20being%20predicted%20was%20far%20more%20important%20than%20the%20modeling%20strategy%3B%20well-predicted%20genes%20and%20selected%20molecular%20features%20showed%20enrichment%20in%20functional%20categories%3B%20and%20frequently%20selected%20expression%20features%20correlated%20with%20survival%20in%20primary%20tumors.%20This%20study%20establishes%20benchmarks%20for%20gene%5Cu00a0essentiality%20prediction%2C%20presents%20a%20community%20resource%20for%20future%20comparison%20with%20this%20benchmark%2C%20and%20provides%20insights%20into%20factors%20influencing%20the%20ability%20to%20predict%20gene%20essentiality%20from%20functional%20genetic%20screens.%20This%20study%20also%20demonstrates%20the%20value%20of%20releasing%20pre-publication%20data%20publicly%20to%20engage%20the%20community%20in%20an%20open%20research%20collaboration.%22%2C%22date%22%3A%222017-11-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2017.09.004%22%2C%22ISSN%22%3A%222405-4712%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T17%3A07%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22R2QDQITR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gyori%20et%20al.%22%2C%22parsedDate%22%3A%222017-11-24%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGyori%20BM%2C%20Bachman%20JA%2C%20Subramanian%20K%2C%20Muhlich%20JL%2C%20Galescu%20L%2C%20Sorger%20PK.%20From%20word%20models%20to%20executable%20models%20of%20signaling%20networks%20using%20automated%20assembly.%20Mol%20Syst%20Biol.%202017%20Nov%2024%3B13%2811%29%3A954.%20PMCID%3A%20PMC5731347%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20word%20models%20to%20executable%20models%20of%20signaling%20networks%20using%20automated%20assembly%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Bachman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucian%22%2C%22lastName%22%3A%22Galescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Word%20models%20%28natural%20language%20descriptions%20of%20molecular%20mechanisms%29%20are%20a%20common%20currency%20in%20spoken%20and%20written%20communication%20in%20biomedicine%20but%20are%20of%20limited%20use%20in%20predicting%20the%20behavior%20of%20complex%20biological%20networks.%20We%20present%20an%20approach%20to%20building%20computational%20models%20directly%20from%20natural%20language%20using%20automated%20assembly.%20Molecular%20mechanisms%20described%20in%20simple%20English%20are%20read%20by%20natural%20language%20processing%20algorithms%2C%20converted%20into%20an%20intermediate%20representation%2C%20and%20assembled%20into%20executable%20or%20network%20models.%20We%20have%20implemented%20this%20approach%20in%20the%20Integrated%20Network%20and%20Dynamical%20Reasoning%20Assembler%20%28INDRA%29%2C%20which%20draws%20on%20existing%20natural%20language%20processing%20systems%20as%20well%20as%20pathway%20information%20in%20Pathway%20Commons%20and%20other%20online%20resources.%20We%20demonstrate%20the%20use%20of%20INDRA%20and%20natural%20language%20to%20model%20three%20biological%20processes%20of%20increasing%20scope%3A%20%28i%29%20p53%20dynamics%20in%20response%20to%20DNA%20damage%2C%20%28ii%29%20adaptive%20drug%20resistance%20in%20BRAF-V600E-mutant%20melanomas%2C%20and%20%28iii%29%20the%20RAS%20signaling%20pathway.%20The%20use%20of%20natural%20language%20makes%20the%20task%20of%20developing%20a%20model%20more%20efficient%20and%20it%20increases%20model%20transparency%2C%20thereby%20promoting%20collaboration%20with%20the%20broader%20biology%20community.%22%2C%22date%22%3A%222017-11-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.20177651%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A17%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22WLXYFQ6K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hafner%20et%20al.%22%2C%22parsedDate%22%3A%222017-06-19%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHafner%20M%2C%20Niepel%20M%2C%20Subramanian%20K%2C%20Sorger%20PK.%20Designing%20drug-response%20experiments%20and%20quantifying%20their%20results.%20Curr%20Protoc%20Chem%20Biol.%202017%20Jun%2019%3B9%282%29%3A96%26%23x2013%3B116.%20PMCID%3A%20PMC5729909%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Designing%20drug-response%20experiments%20and%20quantifying%20their%20results%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22We%20developed%20a%20Python%20package%20to%20help%20in%20performing%20drug-response%20experiments%20at%20medium%20and%20high%20throughput%20and%20evaluating%20sensitivity%20metrics%20from%20the%20resulting%20data.%20In%20this%20article%2C%20we%20describe%20the%20steps%20involved%20in%20%281%29%20generating%20files%20necessary%20for%20treating%20cells%20with%20the%20HP%20D300%20drug%20dispenser%2C%20by%20pin%20transfer%20or%20by%20manual%20pipetting%3B%20%282%29%20merging%20the%20data%20generated%20by%20high-throughput%20slide%20scanners%2C%20such%20as%20the%20Perkin%20Elmer%20Operetta%2C%20with%20treatment%20annotations%3B%20and%20%283%29%20analyzing%20the%20results%20to%20obtain%20data%20normalized%20to%20untreated%20controls%20and%20sensitivity%20metrics%20such%20as%20IC50%20or%20GR50%20.%20These%20modules%20are%20available%20on%20GitHub%20and%20provide%20an%20automated%20pipeline%20for%20the%20design%20and%20analysis%20of%20high-throughput%20drug%20response%20experiments%2C%20that%20helps%20to%20prevent%20errors%20that%20can%20arise%20from%20manually%20processing%20large%20data%20files.%20%5Cu00a9%202017%20by%20John%20Wiley%20%26%20Sons%2C%20Inc.%22%2C%22date%22%3A%222017-06-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcpch.19%22%2C%22ISSN%22%3A%222160-4762%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A59%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22P4CXHIEB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lin%22%2C%22parsedDate%22%3A%222017-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR.%20Multiplexed%20single-cell%20imaging%3A%20past%2C%20present%2C%20and%20future.%20Assay%20Drug%20Dev%20Technol.%202017%20Jan%3B15%281%29%3A8%26%23x2013%3B10.%20PMCID%3A%20PMC5248548%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiplexed%20single-cell%20imaging%3A%20past%2C%20present%2C%20and%20future%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%5D%2C%22abstractNote%22%3A%22Jia-Ren%20Lin%20from%20the%20Laboratory%20of%20Systems%20Pharmacology%20at%20Harvard%20Medical%20School%20was%20awarded%20best%20poster%20at%20the%20annual%20Society%20of%20Biomolecular%20Imaging%20and%20Informatics%20meeting%20held%20in%20Boston%2C%20September%202016.%20His%20work%20focuses%20on%20single-cell%20imaging%2C%20especially%20on%20developing%20new%20methods%20for%20simultaneously%20detecting%20many%20antigens%2C%20named%20cyclic%20immunofluorescence%20%28CycIF%29.%20This%20method%20could%20be%20applied%20in%20different%20stages%20of%20drug%20development%2C%20from%20discovery%20phase%2C%20preclinical%20research%20to%20clinical%20research.%20The%20current%20works%20and%20future%20directions%20of%20CycIF%20method%20are%20summarized%20in%20the%20following%20overview.%22%2C%22date%22%3A%222017-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fadt.2016.765%22%2C%22ISSN%22%3A%221557-8127%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A38%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22UTUFLJJB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Logsdon%20et%20al.%22%2C%22parsedDate%22%3A%222017-11-06%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELogsdon%20MM%2C%20Ho%20PY%2C%20Papavinasasundaram%20K%2C%20Richardson%20K%2C%20Cokol%20M%2C%20Sassetti%20CM%2C%20Amir%20A%2C%20Aldridge%20BB.%20A%20parallel%20adder%20coordinates%20mycobacterial%20cell-cycle%20progression%20and%20cell-size%20homeostasis%20in%20the%20context%20of%20asymmetric%20growth%20and%20organization.%20Curr%20Biol.%202017%20Nov%206%3B27%2821%29%3A3367-3374.e7.%20PMCID%3A%20PMC5687851%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20parallel%20adder%20coordinates%20mycobacterial%20cell-cycle%20progression%20and%20cell-size%20homeostasis%20in%20the%20context%20of%20asymmetric%20growth%20and%20organization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20M.%22%2C%22lastName%22%3A%22Logsdon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Po-Yi%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kadamba%22%2C%22lastName%22%3A%22Papavinasasundaram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirill%22%2C%22lastName%22%3A%22Richardson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20M.%22%2C%22lastName%22%3A%22Sassetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariel%22%2C%22lastName%22%3A%22Amir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22In%20model%20bacteria%2C%20such%20as%20E.%20coli%20and%20B.%20subtilis%2C%20regulation%20of%20cell-cycle%20progression%20and%20cellular%20organization%20achieves%20consistency%20in%20cell%20size%2C%20replication%20dynamics%2C%20and%20chromosome%20positioning%20%5B1-3%5D.%20Mycobacteria%20elongate%20and%20divide%20asymmetrically%2C%20giving%20rise%20to%20significant%20variation%20in%20cell%20size%20and%20elongation%20rate%20among%20closely%20related%20cells%20%5B4%2C%205%5D.%20Given%20the%20physical%20asymmetry%20of%20mycobacteria%2C%20the%20models%20that%20describe%20coordination%20of%20cellular%20organization%20and%20cell-cycle%20progression%20in%20model%20bacteria%20are%20not%20directly%20translatable%20%5B1%2C%202%2C%206-8%5D.%20Here%2C%20we%20used%20time-lapse%20microscopy%20and%20fluorescent%20reporters%20of%20DNA%20replication%20and%20chromosome%20positioning%20to%20examine%20the%20coordination%20of%20growth%2C%20division%2C%20and%20chromosome%20dynamics%20at%20a%20single-cell%20level%20in%20Mycobacterium%20smegmatis%20%28M.%5Cu00a0smegmatis%29%20and%20Mycobacterium%20bovis%20Bacillus%20Calmette-Gu%5Cu00e9rin%20%28BCG%29.%20By%20analyzing%20chromosome%20and%20replisome%20localization%2C%20we%20demonstrated%20that%20chromosome%20positioning%20is%20asymmetric%20and%20proportional%20to%20cell%20size.%20Furthermore%2C%20we%20found%20that%20cellular%20asymmetry%20is%20maintained%20throughout%20the%20cell%20cycle%20and%20is%20not%20established%20at%20division.%20Using%20measurements%20and%20stochastic%20modeling%20of%20mycobacterial%20cell%20size%20and%20cell-cycle%20timing%20in%20both%20slow%20and%20fast%20growth%20conditions%2C%20we%20found%20that%20well-studied%20models%20of%20cell-size%20control%20are%20insufficient%20to%20explain%20the%20mycobacterial%20cell%20cycle.%20Instead%2C%20we%20showed%20that%20mycobacterial%20cell-cycle%20progression%20is%20regulated%20by%20an%20unprecedented%20mechanism%20involving%20parallel%20adders%20%28i.e.%2C%20constant%20growth%20increments%29%20that%20start%20at%20replication%20initiation.%20Together%2C%20these%20adders%20enable%20mycobacterial%20populations%20to%20regulate%20cell%20size%2C%20growth%2C%20and%20heterogeneity%20in%20the%20face%20of%20varying%20environments.%22%2C%22date%22%3A%222017-11-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cub.2017.09.046%22%2C%22ISSN%22%3A%221879-0445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A52%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22VJG2ZJ9Q%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mason%20et%20al.%22%2C%22parsedDate%22%3A%222017-05-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMason%20DJ%2C%20Stott%20I%2C%20Ashenden%20S%2C%20Weinstein%20ZB%2C%20Karakoc%20I%2C%20Meral%20S%2C%20Kuru%20N%2C%20Bender%20A%2C%20Cokol%20M.%20Prediction%20of%20antibiotic%20interactions%20using%20descriptors%20derived%20from%20molecular%20structure.%20J%20Med%20Chem.%202017%20May%2011%3B60%289%29%3A3902%26%23x2013%3B3912.%20PMID%3A%2028383902%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prediction%20of%20antibiotic%20interactions%20using%20descriptors%20derived%20from%20molecular%20structure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Mason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Stott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Ashenden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zohar%20B.%22%2C%22lastName%22%3A%22Weinstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idil%22%2C%22lastName%22%3A%22Karakoc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selin%22%2C%22lastName%22%3A%22Meral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurdan%22%2C%22lastName%22%3A%22Kuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Bender%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20antibiotic%20therapies%20are%20clinically%20important%20in%20the%20fight%20against%20bacterial%20infections.%20However%2C%20the%20search%20space%20of%20drug%20combinations%20is%20large%2C%20making%20the%20identification%20of%20effective%20combinations%20a%20challenging%20task.%20Here%2C%20we%20present%20a%20computational%20framework%20that%20uses%20substructure%20profiles%20derived%20from%20the%20molecular%20structures%20of%20drugs%20and%20predicts%20antibiotic%20interactions.%20Using%20a%20previously%20published%20data%20set%20of%20153%20drug%20pairs%2C%20we%20showed%20that%20substructure%20profiles%20are%20useful%20in%20predicting%20synergy.%20We%20experimentally%20measured%20the%20interaction%20of%20123%20new%20drug%20pairs%2C%20as%20a%20prospective%20validation%20set%20for%20our%20approach%2C%20and%20identified%2037%20new%20synergistic%20pairs.%20Of%20the%2012%20pairs%20predicted%20to%20be%20synergistic%2C%2010%20were%20experimentally%20validated%2C%20corresponding%20to%20a%202.8-fold%20enrichment.%20Having%20thus%20validated%20our%20methodology%2C%20we%20produced%20a%20compendium%20of%20interaction%20predictions%20for%20all%20pairwise%20combinations%20among%20100%20antibiotics.%20Our%20methodology%20can%20make%20reliable%20antibiotic%20interaction%20predictions%20for%20any%20antibiotic%20pair%20within%20the%20applicability%20domain%20of%20the%20model%20since%20it%20solely%20requires%20chemical%20structures%20as%20an%20input.%22%2C%22date%22%3A%222017-05-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.jmedchem.7b00204%22%2C%22ISSN%22%3A%221520-4804%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A59%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22ZPSVDLZ6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Niepel%20et%20al.%22%2C%22parsedDate%22%3A%222017-10-30%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENiepel%20M%2C%20Hafner%20M%2C%20Duan%20Q%2C%20Wang%20Z%2C%20Paull%20EO%2C%20Chung%20M%2C%20Lu%20X%2C%20Stuart%20JM%2C%20Golub%20TR%2C%20Subramanian%20A%2C%20Ma%26%23x2019%3Bayan%20A%2C%20Sorger%20PK.%20Common%20and%20cell-type%20specific%20responses%20to%20anti-cancer%20drugs%20revealed%20by%20high%20throughput%20transcript%20profiling.%20Nat%20Commun.%202017%20Oct%2030%3B8%281%29%3A1186.%20PMCID%3A%20PMC5662764%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Common%20and%20cell-type%20specific%20responses%20to%20anti-cancer%20drugs%20revealed%20by%20high%20throughput%20transcript%20profiling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiaonan%22%2C%22lastName%22%3A%22Duan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zichen%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20O.%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaodong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20R.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aravind%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Avi%22%2C%22lastName%22%3A%22Ma%27ayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22More%20effective%20use%20of%20targeted%20anti-cancer%20drugs%20depends%20on%20elucidating%20the%20connection%20between%20the%20molecular%20states%20induced%20by%20drug%20treatment%20and%20the%20cellular%20phenotypes%20controlled%20by%20these%20states%2C%20such%20as%20cytostasis%20and%20death.%20This%20is%20particularly%20true%20when%20mutation%20of%20a%20single%20gene%20is%20inadequate%20as%20a%20predictor%20of%20drug%20response.%20The%20current%20paper%20describes%20a%20data%20set%20of%20~600%20drug%20cell%20line%20pairs%20collected%20as%20part%20of%20the%20NIH%20LINCS%20Program%20%28%20http%3A%5C%2F%5C%2Fwww.lincsproject.org%5C%2F%20%29%20in%20which%20molecular%20data%20%28reduced%20dimensionality%20transcript%20L1000%20profiles%29%20were%20recorded%20across%20dose%20and%20time%20in%20parallel%20with%20phenotypic%20data%20on%20cellular%20cytostasis%20and%20cytotoxicity.%20We%20report%20that%20transcriptional%20and%20phenotypic%20responses%20correlate%20with%20each%20other%20in%20general%2C%20but%20whereas%20inhibitors%20of%20chaperones%20and%20cell%20cycle%20kinases%20induce%20similar%20transcriptional%20changes%20across%20cell%20lines%2C%20changes%20induced%20by%20drugs%20that%20inhibit%20intra-cellular%20signaling%20kinases%20are%20cell-type%20specific.%20In%20some%20drug%5C%2Fcell%20line%20pairs%20significant%20changes%20in%20transcription%20are%20observed%20without%20a%20change%20in%20cell%20growth%20or%20survival%3B%20analysis%20of%20such%20pairs%20identifies%20drug%20equivalence%20classes%20and%2C%20in%20one%20case%2C%20synergistic%20drug%20interactions.%20In%20this%20case%2C%20synergy%20involves%20cell-type%20specific%20suppression%20of%20an%20adaptive%20drug%20response.%22%2C%22date%22%3A%222017-10-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-017-01383-w%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A05%3A21Z%22%7D%7D%2C%7B%22key%22%3A%225H6J4QFQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Niepel%20et%20al.%22%2C%22parsedDate%22%3A%222017-06-19%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENiepel%20M%2C%20Hafner%20M%2C%20Chung%20M%2C%20Sorger%20PK.%20Measuring%20cancer%20drug%20sensitivity%20and%20resistance%20in%20cultured%20cells.%20Curr%20Protoc%20Chem%20Biol.%202017%20Jun%2019%3B9%282%29%3A55%26%23x2013%3B74.%20PMCID%3A%20PMC5538315%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Measuring%20cancer%20drug%20sensitivity%20and%20resistance%20in%20cultured%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Measuring%20the%20potencies%20of%20small-molecule%20drugs%20in%20cell%20lines%20is%20a%20critical%20aspect%20of%20preclinical%20pharmacology.%20Such%20experiments%20are%20also%20prototypical%20of%20high-throughput%20experiments%20in%20multi-well%20plates.%20The%20procedure%20is%20simple%20in%20principle%2C%20but%20many%20unrecognized%20factors%20can%20affect%20the%20results%2C%20potentially%20making%20data%20unreliable.%20The%20procedures%20for%20measuring%20drug%20response%20described%20here%20were%20developed%20by%20the%20NIH%20LINCS%20program%20to%20improve%20reproducibility.%20Key%20features%20include%20maximizing%20uniform%20cell%20growth%20during%20the%20assay%20period%2C%20accounting%20for%20the%20effects%20of%20cell%20density%20on%20response%2C%20and%20correcting%20sensitivity%20measures%20for%20differences%20in%20proliferation%20rates.%20Two%20related%20protocols%20are%20described%3A%20one%20involves%20an%20endpoint%20measure%20well-suited%20to%20large-scale%20studies%20and%20the%20second%20is%20a%20time-dependent%20measurement%20that%20reveals%20changes%20in%20response%20over%20time.%20The%20methods%20can%20be%20adapted%20to%20other%20types%20of%20plate-based%20experiments.%20%5Cu00a9%202017%20by%20John%20Wiley%20%26%20Sons%2C%20Inc.%22%2C%22date%22%3A%222017-06-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcpch.21%22%2C%22ISSN%22%3A%222160-4762%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T17%3A00%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22587ARLKL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paek%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-06%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPaek%20J%2C%20Kalocsay%20M%2C%20Staus%20DP%2C%20Wingler%20L%2C%20Pascolutti%20R%2C%20Paulo%20JA%2C%20Gygi%20SP%2C%20Kruse%20AC.%20Multidimensional%20tracking%20of%20GPCR%20signaling%20via%20peroxidase-catalyzed%20proximity%20labeling.%20Cell.%202017%20Apr%206%3B169%282%29%3A338-349.e11.%20PMCID%3A%20PMC5514552%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multidimensional%20tracking%20of%20GPCR%20signaling%20via%20peroxidase-catalyzed%20proximity%20labeling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaeho%22%2C%22lastName%22%3A%22Paek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dean%20P.%22%2C%22lastName%22%3A%22Staus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Wingler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberta%22%2C%22lastName%22%3A%22Pascolutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joao%20A.%22%2C%22lastName%22%3A%22Paulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20C.%22%2C%22lastName%22%3A%22Kruse%22%7D%5D%2C%22abstractNote%22%3A%22G-protein-coupled%20receptors%20%28GPCRs%29%20play%20critical%20roles%20in%20regulating%20physiological%20processes%20ranging%20from%20neurotransmission%20to%20cardiovascular%20function.%20Current%20methods%20for%20tracking%20GPCR%20signaling%20suffer%20from%20low%20throughput%2C%20modification%20or%20overexpression%20of%20effector%20proteins%2C%20and%20low%20temporal%20resolution.%20Here%2C%20we%20show%20that%20peroxidase-catalyzed%20proximity%20labeling%20can%20be%20combined%20with%20isobaric%20tagging%20and%20mass%20spectrometry%20to%20enable%20quantitative%2C%20time-resolved%20measurement%20of%20GPCR%20agonist%20response%20in%20living%20cells.%20Using%20this%20technique%2C%20termed%20%5C%22GPCR-APEX%2C%5C%22%20we%20track%20activation%20and%20internalization%20of%20the%20angiotensin%20II%20type%201%20receptor%20and%20the%20%5Cu03b22%20adrenoceptor.%20These%20receptors%20co-localize%20with%20a%20variety%20of%5Cu00a0G%20proteins%20even%20before%20receptor%20activation%2C%20and%20activated%20receptors%20are%20largely%20sequestered%20from%20G%5Cu00a0proteins%20upon%20internalization.%20Additionally%2C%20the%20two%20receptors%20show%20differing%20internalization%20kinetics%2C%20and%20we%20identify%20the%20membrane%20protein%20LMBRD2%20as%5Cu00a0a%5Cu00a0potential%20regulator%20of%20%5Cu03b22%20adrenoceptor%20signaling%2C%20underscoring%20the%20value%20of%20a%20dynamic%20view%20of%20receptor%20function.%22%2C%22date%22%3A%222017-04-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2017.03.028%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A58%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22GKE6YY8S%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20and%20Sorger%22%2C%22parsedDate%22%3A%222017-12-14%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Sorger%20PK.%20Combination%20cancer%20therapy%20can%20confer%20benefit%20via%20patient-to-patient%20variability%20without%20drug%20additivity%20or%20synergy.%20Cell.%202017%20Dec%2014%3B171%287%29%3A1678-1691.e13.%20PMCID%3A%20PMC5741091%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Combination%20cancer%20therapy%20can%20confer%20benefit%20via%20patient-to-patient%20variability%20without%20drug%20additivity%20or%20synergy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20cancer%20therapies%20aim%20to%20improve%20the%20probability%20and%20magnitude%20of%20therapeutic%20responses%20and%20reduce%20the%20likelihood%20of%20acquired%20resistance%20in%20an%20individual%20patient.%20However%2C%20drugs%20are%20tested%20in%20clinical%20trials%20on%20genetically%20diverse%20patient%20populations.%20We%20show%20here%20that%20patient-to-patient%20variability%20and%20independent%20drug%20action%20are%20sufficient%20to%20explain%20the%20superiority%20of%20many%20FDA-approved%20drug%20combinations%20in%20the%20absence%20of%20drug%20synergy%20or%20additivity.%20This%20is%20also%20true%20for%20combinations%20tested%20in%20patient-derived%20tumor%20xenografts.%20In%20a%20combination%20exhibiting%20independent%20drug%20action%2C%20each%20patient%20benefits%20solely%20from%20the%20drug%20to%20which%20his%20or%20her%20tumor%20is%20most%20sensitive%2C%20with%20no%20added%20benefit%20from%20other%20drugs.%20Even%20when%20drug%20combinations%20exhibit%20additivity%20or%20synergy%20in%20pre-clinical%20models%2C%20patient-to-patient%20variability%20and%20low%20cross-resistance%20make%20independent%20action%20the%20dominant%20mechanism%20in%20clinical%20populations.%20This%20insight%20represents%20a%20different%20way%20to%20interpret%20trial%20data%20and%20a%20different%20way%20to%20design%20combination%20therapies.%22%2C%22date%22%3A%222017-12-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2017.11.009%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A11%3A11Z%22%7D%7D%2C%7B%22key%22%3A%2297CCWHJ7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Subramanian%20and%20Tyson%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESubramanian%20K%2C%20Tyson%20JJ.%20Spatiotemporal%20models%20of%20the%20asymmetric%20division%20cycle%20of%20Caulobacter%20crescentus.%20In%3A%20Tassan%20JP%2C%20Kubiak%20JZ%2C%20editors.%20Asymmetric%20Cell%20Division%20in%20Development%2C%20Differentiation%20and%20Cancer%20%5BInternet%5D.%20Cham%3A%20Springer%20International%20Publishing%3B%202017%20%5Bcited%202023%20Dec%202%5D.%20p.%2023%26%23x2013%3B48.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-319-53150-2_2%27%3Ehttp%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-319-53150-2_2%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Spatiotemporal%20models%20of%20the%20asymmetric%20division%20cycle%20of%20Caulobacter%20crescentus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Tassan%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Jacek%20Z.%22%2C%22lastName%22%3A%22Kubiak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Tyson%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Asymmetric%20Cell%20Division%20in%20Development%2C%20Differentiation%20and%20Cancer%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22978-3-319-53149-6%20978-3-319-53150-2%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-319-53150-2_2%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T16%3A33%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22J6I5V272%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tan%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-15%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETan%20L%2C%20Gurbani%20D%2C%20Weisberg%20EL%2C%20Jones%20DS%2C%20Rao%20S%2C%20Singer%20WD%2C%20Bernard%20FM%2C%20Mowafy%20S%2C%20Jenney%20A%2C%20Du%20G%2C%20Nonami%20A%2C%20Griffin%20JD%2C%20Lauffenburger%20DA%2C%20Westover%20KD%2C%20Sorger%20PK%2C%20Gray%20NS.%20Studies%20of%20TAK1-centered%20polypharmacology%20with%20novel%20covalent%20TAK1%20inhibitors.%20Bioorg%20Med%20Chem.%202017%20Feb%2015%3B25%284%29%3A1320%26%23x2013%3B1328.%20PMCID%3A%20PMC5484535%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Studies%20of%20TAK1-centered%20polypharmacology%20with%20novel%20covalent%20TAK1%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%22%2C%22lastName%22%3A%22Gurbani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%20L.%22%2C%22lastName%22%3A%22Weisberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20S.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suman%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20D.%22%2C%22lastName%22%3A%22Singer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faviola%20M.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samar%22%2C%22lastName%22%3A%22Mowafy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annie%22%2C%22lastName%22%3A%22Jenney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atsushi%22%2C%22lastName%22%3A%22Nonami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20D.%22%2C%22lastName%22%3A%22Griffin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20A.%22%2C%22lastName%22%3A%22Lauffenburger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Targeted%20polypharmacology%20provides%20an%20efficient%20method%20of%20treating%20diseases%20such%20as%20cancer%20with%20complex%2C%20multigenic%20causes%20provided%20that%20compounds%20with%20advantageous%20activity%20profiles%20can%20be%20discovered.%20Novel%20covalent%20TAK1%20inhibitors%20were%20validated%20in%20cellular%20contexts%20for%20their%20ability%20to%20inhibit%20the%20TAK1%20kinase%20and%20for%20their%20polypharmacology.%20Several%20inhibitors%20phenocopied%20reported%20TAK1%20inhibitor%205Z-7-oxozaenol%20with%20comparable%20efficacy%20and%20complementary%20kinase%20selectivity%20profiles.%20Compound%205%20exhibited%20the%20greatest%20potency%20in%20RAS-mutated%20and%20wild-type%20RAS%20cell%20lines%20from%20various%20cancer%20types.%20A%20biotinylated%20derivative%20of%205%2C%2027%2C%20was%20used%20to%20verify%20TAK1%20binding%20in%20cells.%20The%20newly%20described%20inhibitors%20constitute%20useful%20tools%20for%20further%20development%20of%20multi-targeting%20TAK1-centered%20inhibitors%20for%20cancer%20and%20other%20diseases.%22%2C%22date%22%3A%222017-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bmc.2016.11.034%22%2C%22ISSN%22%3A%221464-3391%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A49%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22RYNDD274%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tan%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETan%20L%2C%20Gurbani%20D%2C%20Weisberg%20EL%2C%20Hunter%20JC%2C%20Li%20L%2C%20Jones%20DS%2C%20Ficarro%20SB%2C%20Mowafy%20S%2C%20Tam%20CP%2C%20Rao%20S%2C%20Du%20G%2C%20Griffin%20JD%2C%20Sorger%20PK%2C%20Marto%20JA%2C%20Westover%20KD%2C%20Gray%20NS.%20Structure-guided%20development%20of%20covalent%20TAK1%20inhibitors.%20Bioorg%20Med%20Chem.%202017%20Feb%201%3B25%283%29%3A838%26%23x2013%3B846.%20PMCID%3A%20PMC5484537%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structure-guided%20development%20of%20covalent%20TAK1%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%22%2C%22lastName%22%3A%22Gurbani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%20L.%22%2C%22lastName%22%3A%22Weisberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20C.%22%2C%22lastName%22%3A%22Hunter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lianbo%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20S.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20B.%22%2C%22lastName%22%3A%22Ficarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samar%22%2C%22lastName%22%3A%22Mowafy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun-Pong%22%2C%22lastName%22%3A%22Tam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suman%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20D.%22%2C%22lastName%22%3A%22Griffin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarrod%20A.%22%2C%22lastName%22%3A%22Marto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20D.%22%2C%22lastName%22%3A%22Westover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22TAK1%20%28transforming%20growth%20factor-%5Cu03b2-activated%20kinase%201%29%20is%20an%20essential%20intracellular%20mediator%20of%20cytokine%20and%20growth%20factor%20signaling%20and%20a%20potential%20therapeutic%20target%20for%20the%20treatment%20of%20immune%20diseases%20and%20cancer.%20Herein%20we%20report%20development%20of%20a%20series%20of%202%2C4-disubstituted%20pyrimidine%20covalent%20TAK1%20inhibitors%20that%20target%20Cys174%2C%20a%20residue%20immediately%20adjacent%20to%20the%20%27DFG-motif%27%20of%20the%20kinase%20activation%20loop.%20Co-crystal%20structures%20of%20TAK1%20with%20candidate%20compounds%20enabled%20iterative%20rounds%20of%20structure-based%20design%20and%20biological%20testing%20to%20arrive%20at%20optimized%20compounds.%20Lead%20compounds%20such%20as%202%20and%2010%20showed%20greater%20than%2010-fold%20biochemical%20selectivity%20for%20TAK1%20over%20the%20closely%20related%20kinases%20MEK1%20and%20ERK1%20which%20possess%20an%20equivalently%20positioned%20cysteine%20residue.%20These%20compounds%20are%20smaller%2C%20more%20easily%20synthesized%2C%20and%20exhibit%20a%20different%20spectrum%20of%20kinase%20selectivity%20relative%20to%20previously%20reported%20macrocyclic%20natural%20product%20TAK1%20inhibitors%20such%20as%205Z-7-oxozeanol.%22%2C%22date%22%3A%222017-02-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bmc.2016.11.035%22%2C%22ISSN%22%3A%221464-3391%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A49%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22EATHGYER%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tanguturi%20et%20al.%22%2C%22parsedDate%22%3A%222017-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETanguturi%20SK%2C%20Trippa%20L%2C%20Ramkissoon%20SH%2C%20Pelton%20K%2C%20Knoff%20D%2C%20Sandak%20D%2C%20Lindeman%20NI%2C%20Ligon%20AH%2C%20Beroukhim%20R%2C%20Parmigiani%20G%2C%20Wen%20PY%2C%20Ligon%20KL%2C%20Alexander%20BM.%20Leveraging%20molecular%20datasets%20for%20biomarker-based%20clinical%20trial%20design%20in%20glioblastoma.%20Neuro%20Oncol.%202017%20Jul%201%3B19%287%29%3A908%26%23x2013%3B917.%20PMCID%3A%20PMC5570228%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Leveraging%20molecular%20datasets%20for%20biomarker-based%20clinical%20trial%20design%20in%20glioblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20K.%22%2C%22lastName%22%3A%22Tanguturi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Trippa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shakti%20H.%22%2C%22lastName%22%3A%22Ramkissoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristine%22%2C%22lastName%22%3A%22Pelton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Knoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Sandak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20I.%22%2C%22lastName%22%3A%22Lindeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azra%20H.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Parmigiani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Alexander%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Biomarkers%20can%20improve%20clinical%20trial%20efficiency%2C%20but%20designing%20and%20interpreting%20biomarker-driven%20trials%20require%20knowledge%20of%20relationships%20among%20biomarkers%2C%20clinical%20covariates%2C%20and%20endpoints.%20We%20investigated%20these%20relationships%20across%20genomic%20subgroups%20of%20glioblastoma%20%28GBM%29%20within%20our%20institution%20%28DF%5C%2FBWCC%29%2C%20validated%20results%20in%20The%20Cancer%20Genome%20Atlas%20%28TCGA%29%2C%20and%20demonstrated%20potential%20impacts%20on%20clinical%20trial%20design%20and%20interpretation.%5CnMETHODS%3A%20We%20identified%20genotyped%20patients%20at%20DF%5C%2FBWCC%2C%20and%20clinical%20associations%20across%204%20common%20GBM%20genomic%20biomarker%20groups%20were%20compared%20along%20with%20overall%20survival%20%28OS%29%2C%20progression-free%20survival%20%28PFS%29%2C%20and%20survival%20post-progression%20%28SPP%29.%20Significant%20associations%20were%20validated%20in%20TCGA.%20Biomarker-based%20clinical%20trials%20were%20simulated%20using%20various%20assumptions.%5CnRESULTS%3A%20Epidermal%20growth%20factor%20receptor%20%28EGFR%29%28%2B%29%20and%20p53%28-%29%20subgroups%20were%20more%20likely%20isocitrate%20dehydrogenase%20%28IDH%29%20wild-type.%20Phosphatidylinositol-3%20kinase%20%28PI3K%29%28%2B%29%20patients%20were%20older%2C%20and%20patients%20with%20O6-DNA%20methylguanine-methyltransferase%20%28MGMT%29-promoter%20methylation%20were%20more%20often%20female.%20OS%2C%20PFS%2C%20and%20SPP%20were%20all%20longer%20for%20IDH%20mutant%20and%20MGMT%20methylated%20patients%2C%20but%20there%20was%20no%20independent%20prognostic%20value%20for%20other%20genomic%20subgroups.%20PI3K%28%2B%29%20patients%20had%20shorter%20PFS%20among%20IDH%20wild-type%20tumors%2C%20however%2C%20and%20no%20DF%5C%2FBWCC%20long-term%20survivors%20were%20either%20EGFR%28%2B%29%20%280%25%20vs%207%25%2C%20P%20%3D%20.014%29%20or%20p53%28-%29%20%280%25%20vs%2010%25%2C%20P%20%3D%20.005%29.%20The%20degree%20of%20biomarker%20overlap%20impacted%20the%20efficiency%20of%20Bayesian-adaptive%20clinical%20trials%2C%20while%20PFS%20and%20OS%20distribution%20variation%20had%20less%20impact.%20Biomarker%20frequency%20was%20proportionally%20associated%20with%20sample%20size%20in%20all%20designs.%5CnCONCLUSIONS%3A%20We%20identified%20several%20associations%20between%20GBM%20genomic%20subgroups%20and%20clinical%20or%20molecular%20prognostic%20covariates%20and%20validated%20known%20prognostic%20factors%20in%20all%20survival%20periods.%20These%20results%20are%20important%20for%20biomarker-based%20trial%20design%20and%20interpretation%20of%20biomarker-only%20and%20nonrandomized%20trials.%22%2C%22date%22%3A%222017-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnow312%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T03%3A10%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22M63TEFUC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Vijay%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVijay%20S%2C%20Vinh%20DN%2C%20Hai%20HT%2C%20Ha%20VTN%2C%20Dung%20VTM%2C%20Dinh%20TD%2C%20Nhung%20HN%2C%20Tram%20TTB%2C%20Aldridge%20BB%2C%20Hanh%20NT%2C%20Thu%20DDA%2C%20Phu%20NH%2C%20Thwaites%20GE%2C%20Thuong%20NTT.%20Influence%20of%20stress%20and%20antibiotic%20resistance%20on%20cell-length%20distribution%20in%20Mycobacterium%20tuberculosis%20clinical%20isolates.%20Front%20Microbiol.%202017%3B8%3A2296.%20PMCID%3A%20PMC5702322%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Influence%20of%20stress%20and%20antibiotic%20resistance%20on%20cell-length%20distribution%20in%20Mycobacterium%20tuberculosis%20clinical%20isolates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinivasan%22%2C%22lastName%22%3A%22Vijay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dao%20N.%22%2C%22lastName%22%3A%22Vinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hoang%20T.%22%2C%22lastName%22%3A%22Hai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vu%20T.%20N.%22%2C%22lastName%22%3A%22Ha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vu%20T.%20M.%22%2C%22lastName%22%3A%22Dung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tran%20D.%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hoang%20N.%22%2C%22lastName%22%3A%22Nhung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trinh%20T.%20B.%22%2C%22lastName%22%3A%22Tram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20T.%22%2C%22lastName%22%3A%22Hanh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Do%20D.%20A.%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20H.%22%2C%22lastName%22%3A%22Phu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%20E.%22%2C%22lastName%22%3A%22Thwaites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20T.%20T.%22%2C%22lastName%22%3A%22Thuong%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterial%20cellular%20variations%20in%20growth%20and%20division%20increase%20heterogeneity%20in%20cell%20length%2C%20possibly%20contributing%20to%20cell-to-cell%20variation%20in%20host%20and%20antibiotic%20stress%20tolerance.%20This%20may%20be%20one%20of%20the%20factors%20influencingMycobacterium%20tuberculosispersistence%20to%20antibiotics.%20Tuberculosis%20%28TB%29%20is%20a%20major%20public%20health%20problem%20in%20developing%20countries%2C%20antibiotic%20persistence%2C%20and%20emergence%20of%20antibiotic%20resistance%20further%20complicates%20this%20problem.%20We%20wanted%20to%20investigate%20the%20factors%20influencing%20cell-length%20distribution%20in%20clinicalM.%20tuberculosisstrains.%20In%20parallel%20we%20examinedM.%20tuberculosiscell-length%20distribution%20in%20a%20large%20set%20of%20clinical%20strains%20%28n%3D%20158%29%20fromex%20vivosputum%20samples%2Cin%20vitromacrophage%20models%2C%20andin%20vitrocultures.%20Our%20aim%20was%20to%20understand%20the%20influence%20of%20clinically%20relevant%20factors%20such%20as%20host%20stresses%2CM.%20tuberculosislineages%2C%20antibiotic%20resistance%2C%20antibiotic%20concentrations%2C%20and%20disease%20severity%20on%20the%20cell%20size%20distribution%20in%20clinicalM.%20tuberculosisstrains.%20Increased%20cell%20size%20and%20cell-to-cell%20variation%20in%20cell%20length%20were%20associated%20with%20bacteria%20in%20sputum%20and%20infected%20macrophages%20rather%20than%20liquid%20culture.%20Multidrug-resistant%20%28MDR%29%20strains%20displayed%20increased%20cell%20length%20heterogeneity%20compared%20to%20sensitive%20strains%20in%20infected%20macrophages%20and%20also%20during%20growth%20under%20rifampicin%20%28RIF%29%20treatment.%20Importantly%2C%20increased%20cell%20length%20was%20also%20associated%20with%20pulmonary%20TB%20disease%20severity.%20Supporting%20these%20findings%2C%20individual%20host%20stresses%2C%20such%20as%20oxidative%20stress%20and%20iron%20deficiency%2C%20increased%20cell-length%20heterogeneity%20ofM.%20tuberculosisstrains.%20In%20addition%20we%20also%20observed%20synergism%20between%20host%20stress%20and%20RIF%20treatment%20in%20increasing%20cell%20length%20in%20MDR-TB%20strains.%20This%20study%20has%20identified%20some%20clinical%20factors%20contributing%20to%20cell-length%20heterogeneity%20in%20clinicalM.%20tuberculosisstrains.%20The%20role%20of%20these%20cellular%20adaptations%20to%20host%20and%20antibiotic%20tolerance%20needs%20further%20investigation.%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmicb.2017.02296%22%2C%22ISSN%22%3A%221664-302X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A15%3A56Z%22%7D%7D%2C%7B%22key%22%3A%223Z9D2NMQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Viswanathan%20et%20al.%22%2C%22parsedDate%22%3A%222017-07-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EViswanathan%20VS%2C%20Ryan%20MJ%2C%20Dhruv%20HD%2C%20Gill%20S%2C%20Eichhoff%20OM%2C%20Seashore-Ludlow%20B%2C%20Kaffenberger%20SD%2C%20Eaton%20JK%2C%20Shimada%20K%2C%20Aguirre%20AJ%2C%20Viswanathan%20SR%2C%20Chattopadhyay%20S%2C%20Tamayo%20P%2C%20Yang%20WS%2C%20Rees%20MG%2C%20Chen%20S%2C%20Boskovic%20ZV%2C%20Javaid%20S%2C%20Huang%20C%2C%20Wu%20X%2C%20Tseng%20YY%2C%20Roider%20EM%2C%20Gao%20D%2C%20Cleary%20JM%2C%20Wolpin%20BM%2C%20Mesirov%20JP%2C%20Haber%20DA%2C%20Engelman%20JA%2C%20Boehm%20JS%2C%20Kotz%20JD%2C%20Hon%20CS%2C%20Chen%20Y%2C%20Hahn%20WC%2C%20Levesque%20MP%2C%20Doench%20JG%2C%20Berens%20ME%2C%20Shamji%20AF%2C%20Clemons%20PA%2C%20Stockwell%20BR%2C%20Schreiber%20SL.%20Dependency%20of%20a%20therapy-resistant%20state%20of%20cancer%20cells%20on%20a%20lipid%20peroxidase%20pathway.%20Nature.%202017%20Jul%2027%3B547%287664%29%3A453%26%23x2013%3B457.%20PMCID%3A%20PMC5667900%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dependency%20of%20a%20therapy-resistant%20state%20of%20cancer%20cells%20on%20a%20lipid%20peroxidase%20pathway%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vasanthi%20S.%22%2C%22lastName%22%3A%22Viswanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harshil%20D.%22%2C%22lastName%22%3A%22Dhruv%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shubhroz%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ossia%20M.%22%2C%22lastName%22%3A%22Eichhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brinton%22%2C%22lastName%22%3A%22Seashore-Ludlow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20D.%22%2C%22lastName%22%3A%22Kaffenberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20K.%22%2C%22lastName%22%3A%22Eaton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Shimada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20J.%22%2C%22lastName%22%3A%22Aguirre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinivas%20R.%22%2C%22lastName%22%3A%22Viswanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shrikanta%22%2C%22lastName%22%3A%22Chattopadhyay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%22%2C%22lastName%22%3A%22Tamayo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wan%20Seok%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Rees%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sixun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarko%20V.%22%2C%22lastName%22%3A%22Boskovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Javaid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cherrie%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoyun%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuen-Yi%22%2C%22lastName%22%3A%22Tseng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%20M.%22%2C%22lastName%22%3A%22Roider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Cleary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Wolpin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%20P.%22%2C%22lastName%22%3A%22Mesirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Haber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Engelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20S.%22%2C%22lastName%22%3A%22Boehm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanne%20D.%22%2C%22lastName%22%3A%22Kotz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cindy%20S.%22%2C%22lastName%22%3A%22Hon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mitchell%20P.%22%2C%22lastName%22%3A%22Levesque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20G.%22%2C%22lastName%22%3A%22Doench%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20E.%22%2C%22lastName%22%3A%22Berens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alykhan%20F.%22%2C%22lastName%22%3A%22Shamji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20A.%22%2C%22lastName%22%3A%22Clemons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brent%20R.%22%2C%22lastName%22%3A%22Stockwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20L.%22%2C%22lastName%22%3A%22Schreiber%22%7D%5D%2C%22abstractNote%22%3A%22Plasticity%20of%20the%20cell%20state%20has%20been%20proposed%20to%20drive%20resistance%20to%20multiple%20classes%20of%20cancer%20therapies%2C%20thereby%20limiting%20their%20effectiveness.%20A%20high-mesenchymal%20cell%20state%20observed%20in%20human%20tumours%20and%20cancer%20cell%20lines%20has%20been%20associated%20with%20resistance%20to%20multiple%20treatment%20modalities%20across%20diverse%20cancer%20lineages%2C%20but%20the%20mechanistic%20underpinning%20for%20this%20state%20has%20remained%20incompletely%20understood.%20Here%20we%20molecularly%20characterize%20this%20therapy-resistant%20high-mesenchymal%20cell%20state%20in%20human%20cancer%20cell%20lines%20and%20organoids%20and%20show%20that%20it%20depends%20on%20a%20druggable%20lipid-peroxidase%20pathway%20that%20protects%20against%20ferroptosis%2C%20a%20non-apoptotic%20form%20of%20cell%20death%20induced%20by%20the%20build-up%20of%20toxic%20lipid%20peroxides.%20We%20show%20that%20this%20cell%20state%20is%20characterized%20by%20activity%20of%20enzymes%20that%20promote%20the%20synthesis%20of%20polyunsaturated%20lipids.%20These%20lipids%20are%20the%20substrates%20for%20lipid%20peroxidation%20by%20lipoxygenase%20enzymes.%20This%20lipid%20metabolism%20creates%20a%20dependency%20on%20pathways%20converging%20on%20the%20phospholipid%20glutathione%20peroxidase%20%28GPX4%29%2C%20a%20selenocysteine-containing%20enzyme%20that%20dissipates%20lipid%20peroxides%20and%20thereby%20prevents%20the%20iron-mediated%20reactions%20of%20peroxides%20that%20induce%20ferroptotic%20cell%20death.%20Dependency%20on%20GPX4%20was%20found%20to%20exist%20across%20diverse%20therapy-resistant%20states%20characterized%20by%20high%20expression%20of%20ZEB1%2C%20including%20epithelial-mesenchymal%20transition%20in%20epithelial-derived%20carcinomas%2C%20TGF%5Cu03b2-mediated%20therapy-resistance%20in%20melanoma%2C%20treatment-induced%20neuroendocrine%20transdifferentiation%20in%20prostate%20cancer%2C%20and%20sarcomas%2C%20which%20are%20fixed%20in%20a%20mesenchymal%20state%20owing%20to%20their%20cells%20of%20origin.%20We%20identify%20vulnerability%20to%20ferroptic%20cell%20death%20induced%20by%20inhibition%20of%20a%20lipid%20peroxidase%20pathway%20as%20a%20feature%20of%20therapy-resistant%20cancer%20cells%20across%20diverse%20mesenchymal%20cell-state%20contexts.%22%2C%22date%22%3A%222017-07-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnature23007%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A17%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22RG2KC8KZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222017-10-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWang%20Y%2C%20Woehrstein%20JB%2C%20Donoghue%20N%2C%20Dai%20M%2C%20Avenda%26%23xF1%3Bo%20MS%2C%20Schackmann%20RCJ%2C%20Zoeller%20JJ%2C%20Wang%20SSH%2C%20Tillberg%20PW%2C%20Park%20D%2C%20Lapan%20SW%2C%20Boyden%20ES%2C%20Brugge%20JS%2C%20Kaeser%20PS%2C%20Church%20GM%2C%20Agasti%20SS%2C%20Jungmann%20R%2C%20Yin%20P.%20Rapid%20sequential%20in%20situ%20multiplexing%20with%20DNA%20exchange%20imaging%20in%20neuronal%20cells%20and%20tissues.%20Nano%20Lett.%202017%20Oct%2011%3B17%2810%29%3A6131%26%23x2013%3B6139.%20PMCID%3A%20PMC5658129%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rapid%20sequential%20in%20situ%20multiplexing%20with%20DNA%20exchange%20imaging%20in%20neuronal%20cells%20and%20tissues%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20B.%22%2C%22lastName%22%3A%22Woehrstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%22%2C%22lastName%22%3A%22Donoghue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingjie%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maier%20S.%22%2C%22lastName%22%3A%22Avenda%5Cu00f1o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%20C.%20J.%22%2C%22lastName%22%3A%22Schackmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20J.%22%2C%22lastName%22%3A%22Zoeller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shan%20Shan%20H.%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20W.%22%2C%22lastName%22%3A%22Tillberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Demian%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%20W.%22%2C%22lastName%22%3A%22Lapan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20S.%22%2C%22lastName%22%3A%22Boyden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan%20S.%22%2C%22lastName%22%3A%22Brugge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%20S.%22%2C%22lastName%22%3A%22Kaeser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20M.%22%2C%22lastName%22%3A%22Church%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarit%20S.%22%2C%22lastName%22%3A%22Agasti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralf%22%2C%22lastName%22%3A%22Jungmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Yin%22%7D%5D%2C%22abstractNote%22%3A%22To%20decipher%20the%20molecular%20mechanisms%20of%20biological%20function%2C%20it%20is%20critical%20to%20map%20the%20molecular%20composition%20of%20individual%20cells%20or%20even%20more%20importantly%20tissue%20samples%20in%20the%20context%20of%20their%20biological%20environment%20in%20situ.%20Immunofluorescence%20%28IF%29%20provides%20specific%20labeling%20for%20molecular%20profiling.%20However%2C%20conventional%20IF%20methods%20have%20finite%20multiplexing%20capabilities%20due%20to%20spectral%20overlap%20of%20the%20fluorophores.%20Various%20sequential%20imaging%20methods%20have%20been%20developed%20to%20circumvent%20this%20spectral%20limit%20but%20are%20not%20widely%20adopted%20due%20to%20the%20common%20limitation%20of%20requiring%20multirounds%20of%20slow%20%28typically%20over%202%20h%20at%20room%20temperature%20to%20overnight%20at%204%20%5Cu00b0C%20in%20practice%29%20immunostaining.%20We%20present%20here%20a%20practical%20and%20robust%20method%2C%20which%20we%20call%20DNA%20Exchange%20Imaging%20%28DEI%29%2C%20for%20rapid%20in%20situ%20spectrally%20unlimited%20multiplexing.%20This%20technique%20overcomes%20speed%20restrictions%20by%20allowing%20for%20single-round%20immunostaining%20with%20DNA-barcoded%20antibodies%2C%20followed%20by%20rapid%20%28less%20than%2010%20min%29%20buffer%20exchange%20of%20fluorophore-bearing%20DNA%20imager%20strands.%20The%20programmability%20of%20DEI%20allows%20us%20to%20apply%20it%20to%20diverse%20microscopy%20platforms%20%28with%20Exchange%20Confocal%2C%20Exchange-SIM%2C%20Exchange-STED%2C%20and%20Exchange-PAINT%20demonstrated%20here%29%20at%20multiple%20desired%20resolution%20scales%20%28from%20%5Cu223c300%20nm%20down%20to%20sub-20%20nm%29.%20We%20optimized%20and%20validated%20the%20use%20of%20DEI%20in%20complex%20biological%20samples%2C%20including%20primary%20neuron%20cultures%20and%20tissue%20sections.%20These%20results%20collectively%20suggest%20DNA%20exchange%20as%20a%20versatile%2C%20practical%20platform%20for%20rapid%2C%20highly%20multiplexed%20in%20situ%20imaging%2C%20potentially%20enabling%20new%20applications%20ranging%20from%20basic%20science%2C%20to%20drug%20discovery%2C%20and%20to%20clinical%20pathology.%22%2C%22date%22%3A%222017-10-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.nanolett.7b02716%22%2C%22ISSN%22%3A%221530-6992%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-21T17%3A03%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22P2RGTRHA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yekkirala%20et%20al.%22%2C%22parsedDate%22%3A%222017-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYekkirala%20AS%2C%20Roberson%20DP%2C%20Bean%20BP%2C%20Woolf%20CJ.%20Breaking%20barriers%20to%20novel%20analgesic%20drug%20development.%20Nat%20Rev%20Drug%20Discov.%202017%20Nov%3B16%2811%29%3A810.%20PMCID%3A%20PMC6934078%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Breaking%20barriers%20to%20novel%20analgesic%20drug%20development%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%20S.%22%2C%22lastName%22%3A%22Yekkirala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20P.%22%2C%22lastName%22%3A%22Roberson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20P.%22%2C%22lastName%22%3A%22Bean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%5D%2C%22abstractNote%22%3A%22This%20corrects%20the%20article%20DOI%3A%2010.1038%5C%2Fnrd.2017.87.%22%2C%22date%22%3A%222017-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnrd.2017.202%22%2C%22ISSN%22%3A%221474-1784%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A56%3A45Z%22%7D%7D%2C%7B%22key%22%3A%229UUZN767%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Zhou%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhou%20J%2C%20Ramanathan%20R%2C%20Wong%20WF%2C%20Thiagarajan%20PS.%20Automated%20property%20synthesis%20of%20ODEs%20based%20bio-pathways%20models.%20In%3A%20Feret%20J%2C%20Koeppl%20H%2C%20editors.%20Computational%20Methods%20in%20Systems%20Biology.%20Cham%3A%20Springer%20International%20Publishing%3B%202017.%20p.%20265%26%23x2013%3B282.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Automated%20property%20synthesis%20of%20ODEs%20based%20bio-pathways%20models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Feret%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Heinz%22%2C%22lastName%22%3A%22Koeppl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ramanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weng-Fai%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20S.%22%2C%22lastName%22%3A%22Thiagarajan%22%7D%5D%2C%22abstractNote%22%3A%22Identifying%20non-trivial%20requirements%20for%20large%20complex%20dynamical%20systems%20is%20a%20challenging%20but%20fruitful%20task.%20Once%20identified%20such%20requirements%20can%20be%20used%20to%20validate%20updated%20versions%20of%20the%20system%20and%20verify%20functionally%20similar%20systems.%20Here%20we%20present%20a%20technique%20for%20discovering%20behavioural%20properties%20of%20bio-pathway%20models%20whose%20dynamics%20is%20modelled%20as%20a%20system%20of%20ordinary%20differential%20equations%20%28ODEs%29.%20These%20models%20are%20usually%20accompanied%20at%20best%20by%20high%20level%20functional%20requirements%20while%20undergoing%20many%20revisions%20as%20new%20experimental%20data%20becomes%20available.%20In%20this%20setting%20we%20first%20specify%20a%20set%20of%20property%20templates%20using%20bounded%20linear-time%20temporal%20logic%20%28BLTL%29.%20A%20template%20will%20have%20the%20skeletal%20structure%20of%20a%20BLTL%20formula%20but%20the%20time%20bounds%20associated%20with%20the%20temporal%20operator%20as%20well%20as%20the%20value%20bounds%20associated%20with%20the%20system%20variables%20encoded%20as%20atomic%20propositions%20will%20be%20unknown%20parameters.%20We%20classify%20a%20given%20model%5Cu2019s%20behavior%20as%20corresponding%20to%20one%20of%20these%20templates%20using%20a%20convolutional%20neural%20network.%20We%20then%20synthesize%20a%20concrete%20property%20from%20this%20template%20by%20estimating%20its%20parameters%20via%20a%20standard%20search%20procedure%20combined%20with%20statistical%20model%20checking%20%28SMC%29.%20We%20have%20synthesized%20and%20validated%20properties%20of%20a%20number%20of%20pathway%20models%20of%20varying%20complexity%20using%20our%20method.%22%2C%22bookTitle%22%3A%22Computational%20Methods%20in%20Systems%20Biology%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%22978-3-319-67470-4%20978-3-319-67471-1%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-08-13T14%3A16%3A24Z%22%7D%7D%5D%7D
1.
Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, Zhang X, Parikh S, Rovin BH, Afkarian M, de Boer IH, Himmelfarb J, Waikar SS, Vaidya VS. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clin Chem. 2017 Sep;63(9):1515–1526. PMCID: PMC5610914
1.
Carlin DE, Paull EO, Graim K, Wong CK, Bivol A, Ryabinin P, Ellrott K, Sokolov A, Stuart JM. Prophetic granger causality to infer gene regulatory networks. PLoS One. 2017;12(12):e0170340. PMCID: PMC5718405
1.
Cokol M, Kuru N, Bicak E, Larkins-Ford J, Aldridge BB. Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis. Sci Adv. 2017 Oct;3(10):e1701881. PMCID: PMC5636204
1.
Fallahi-Sichani M, Becker V, Izar B, Baker GJ, Lin JR, Boswell SA, Shah P, Rotem A, Garraway LA, Sorger PK. Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state. Mol Syst Biol. 2017 Jan 9;13(1):905. PMCID: PMC5248573
1.
Fusco DN, Pratt H, Kandilas S, Cheon SSY, Lin W, Cronkite DA, Basavappa M, Jeffrey KL, Anselmo A, Sadreyev R, Yapp C, Shi X, O’Sullivan JF, Gerszten RE, Tomaru T, Yoshino S, Satoh T, Chung RT. HELZ2 is an IFN effector mediating suppression of dengue virus. Front Microbiol. 2017;8:240. PMCID: PMC5316548
1.
Gerlach CV, Vaidya VS. MicroRNAs in injury and repair. Arch Toxicol [Internet]. 2017 Aug;91(8):2781–2797. Available from: http://link.springer.com/10.1007/s00204-017-1974-1 PMCID: PMC5843992
1.
Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma CX, Ramm S, Krop IE, Winer EP, Roberts TM, Kim HJ, McAllister SS, Zhao JJ. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017 Aug 24;548(7668):471–475. PMCID: PMC5570667
1.
Gönen M, Weir BA, Cowley GS, Vazquez F, Guan Y, Jaiswal A, Karasuyama M, Uzunangelov V, Wang T, Tsherniak A, Howell S, Marbach D, Hoff B, Norman TC, Airola A, Bivol A, Bunte K, Carlin D, Chopra S, Deran A, Ellrott K, Gopalacharyulu P, Graim K, Kaski S, Khan SA, Newton Y, Ng S, Pahikkala T, Paull E, Sokolov A, Tang H, Tang J, Wennerberg K, Xie Y, Zhan X, Zhu F, Broad-DREAM Community, Aittokallio T, Mamitsuka H, Stuart JM, Boehm JS, Root DE, Xiao G, Stolovitzky G, Hahn WC, Margolin AA. A community challenge for inferring genetic predictors of gene essentialities through analysis of a functional screen of cancer cell lines. Cell Syst. 2017 Nov 22;5(5):485-497.e3. PMCID: PMC5814247
1.
Gyori BM, Bachman JA, Subramanian K, Muhlich JL, Galescu L, Sorger PK. From word models to executable models of signaling networks using automated assembly. Mol Syst Biol. 2017 Nov 24;13(11):954. PMCID: PMC5731347
1.
Hafner M, Niepel M, Subramanian K, Sorger PK. Designing drug-response experiments and quantifying their results. Curr Protoc Chem Biol. 2017 Jun 19;9(2):96–116. PMCID: PMC5729909
1.
Lin JR. Multiplexed single-cell imaging: past, present, and future. Assay Drug Dev Technol. 2017 Jan;15(1):8–10. PMCID: PMC5248548
1.
Logsdon MM, Ho PY, Papavinasasundaram K, Richardson K, Cokol M, Sassetti CM, Amir A, Aldridge BB. A parallel adder coordinates mycobacterial cell-cycle progression and cell-size homeostasis in the context of asymmetric growth and organization. Curr Biol. 2017 Nov 6;27(21):3367-3374.e7. PMCID: PMC5687851
1.
Mason DJ, Stott I, Ashenden S, Weinstein ZB, Karakoc I, Meral S, Kuru N, Bender A, Cokol M. Prediction of antibiotic interactions using descriptors derived from molecular structure. J Med Chem. 2017 May 11;60(9):3902–3912. PMID: 28383902
1.
Niepel M, Hafner M, Duan Q, Wang Z, Paull EO, Chung M, Lu X, Stuart JM, Golub TR, Subramanian A, Ma’ayan A, Sorger PK. Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling. Nat Commun. 2017 Oct 30;8(1):1186. PMCID: PMC5662764
1.
Niepel M, Hafner M, Chung M, Sorger PK. Measuring cancer drug sensitivity and resistance in cultured cells. Curr Protoc Chem Biol. 2017 Jun 19;9(2):55–74. PMCID: PMC5538315
1.
Paek J, Kalocsay M, Staus DP, Wingler L, Pascolutti R, Paulo JA, Gygi SP, Kruse AC. Multidimensional tracking of GPCR signaling via peroxidase-catalyzed proximity labeling. Cell. 2017 Apr 6;169(2):338-349.e11. PMCID: PMC5514552
1.
Palmer AC, Sorger PK. Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy. Cell. 2017 Dec 14;171(7):1678-1691.e13. PMCID: PMC5741091
1.
Subramanian K, Tyson JJ. Spatiotemporal models of the asymmetric division cycle of Caulobacter crescentus. In: Tassan JP, Kubiak JZ, editors. Asymmetric Cell Division in Development, Differentiation and Cancer [Internet]. Cham: Springer International Publishing; 2017 [cited 2023 Dec 2]. p. 23–48. Available from: http://link.springer.com/10.1007/978-3-319-53150-2_2
1.
Tan L, Gurbani D, Weisberg EL, Jones DS, Rao S, Singer WD, Bernard FM, Mowafy S, Jenney A, Du G, Nonami A, Griffin JD, Lauffenburger DA, Westover KD, Sorger PK, Gray NS. Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. Bioorg Med Chem. 2017 Feb 15;25(4):1320–1328. PMCID: PMC5484535
1.
Tan L, Gurbani D, Weisberg EL, Hunter JC, Li L, Jones DS, Ficarro SB, Mowafy S, Tam CP, Rao S, Du G, Griffin JD, Sorger PK, Marto JA, Westover KD, Gray NS. Structure-guided development of covalent TAK1 inhibitors. Bioorg Med Chem. 2017 Feb 1;25(3):838–846. PMCID: PMC5484537
1.
Tanguturi SK, Trippa L, Ramkissoon SH, Pelton K, Knoff D, Sandak D, Lindeman NI, Ligon AH, Beroukhim R, Parmigiani G, Wen PY, Ligon KL, Alexander BM. Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma. Neuro Oncol. 2017 Jul 1;19(7):908–917. PMCID: PMC5570228
1.
Vijay S, Vinh DN, Hai HT, Ha VTN, Dung VTM, Dinh TD, Nhung HN, Tram TTB, Aldridge BB, Hanh NT, Thu DDA, Phu NH, Thwaites GE, Thuong NTT. Influence of stress and antibiotic resistance on cell-length distribution in Mycobacterium tuberculosis clinical isolates. Front Microbiol. 2017;8:2296. PMCID: PMC5702322
1.
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, Viswanathan SR, Chattopadhyay S, Tamayo P, Yang WS, Rees MG, Chen S, Boskovic ZV, Javaid S, Huang C, Wu X, Tseng YY, Roider EM, Gao D, Cleary JM, Wolpin BM, Mesirov JP, Haber DA, Engelman JA, Boehm JS, Kotz JD, Hon CS, Chen Y, Hahn WC, Levesque MP, Doench JG, Berens ME, Shamji AF, Clemons PA, Stockwell BR, Schreiber SL. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017 Jul 27;547(7664):453–457. PMCID: PMC5667900
1.
Wang Y, Woehrstein JB, Donoghue N, Dai M, Avendaño MS, Schackmann RCJ, Zoeller JJ, Wang SSH, Tillberg PW, Park D, Lapan SW, Boyden ES, Brugge JS, Kaeser PS, Church GM, Agasti SS, Jungmann R, Yin P. Rapid sequential in situ multiplexing with DNA exchange imaging in neuronal cells and tissues. Nano Lett. 2017 Oct 11;17(10):6131–6139. PMCID: PMC5658129
1.
Yekkirala AS, Roberson DP, Bean BP, Woolf CJ. Breaking barriers to novel analgesic drug development. Nat Rev Drug Discov. 2017 Nov;16(11):810. PMCID: PMC6934078
1.
Zhou J, Ramanathan R, Wong WF, Thiagarajan PS. Automated property synthesis of ODEs based bio-pathways models. In: Feret J, Koeppl H, editors. Computational Methods in Systems Biology. Cham: Springer International Publishing; 2017. p. 265–282.
2576724
IXMHRBF6
LSP Paper
2016
1
national-library-of-medicine-grant-proposals
50
creator
asc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228PHVS4MV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22AlQuraishi%20and%20Sorger%22%2C%22parsedDate%22%3A%222016-05-18%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M%2C%20Sorger%20PK.%20Reproducibility%20will%20only%20come%20with%20data%20liberation.%20Sci%20Transl%20Med.%202016%20May%2018%3B8%28339%29%3A339ed7.%20PMCID%3A%20PMC5084089%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reproducibility%20will%20only%20come%20with%20data%20liberation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016-05-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.aaf0968%22%2C%22ISSN%22%3A%221946-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A14%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22VHRJX5RX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22C%5Cu00e1rdenas-Gonz%5Cu00e1lez%20et%20al.%22%2C%22parsedDate%22%3A%222016-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EC%26%23xE1%3Brdenas-Gonz%26%23xE1%3Blez%20M%2C%20Jacobo%20Estrada%20T%2C%20Rodr%26%23xED%3Bguez-Mu%26%23xF1%3Boz%20R%2C%20Barrera-Chimal%20J%2C%20Bobadilla%20NA%2C%20Barbier%20OC%2C%20Del%20Razo%20LM.%20Sub-chronic%20exposure%20to%20fluoride%20impacts%20the%20response%20to%20a%20subsequent%20nephrotoxic%20treatment%20with%20gentamicin.%20J%20Appl%20Toxicol.%202016%20Feb%3B36%282%29%3A309%26%23x2013%3B319.%20PMID%3A%2026779593%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sub-chronic%20exposure%20to%20fluoride%20impacts%20the%20response%20to%20a%20subsequent%20nephrotoxic%20treatment%20with%20gentamicin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22C%5Cu00e1rdenas-Gonz%5Cu00e1lez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tania%22%2C%22lastName%22%3A%22Jacobo%20Estrada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%22%2C%22lastName%22%3A%22Rodr%5Cu00edguez-Mu%5Cu00f1oz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonatan%22%2C%22lastName%22%3A%22Barrera-Chimal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norma%20A.%22%2C%22lastName%22%3A%22Bobadilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%20C.%22%2C%22lastName%22%3A%22Barbier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luz%20M.%22%2C%22lastName%22%3A%22Del%20Razo%22%7D%5D%2C%22abstractNote%22%3A%22Fluoride%20is%20an%20important%20groundwater%20contaminant%2C%20and%20more%20than%20200%20million%20people%20are%20exposed%20to%20high%20fluoride%20levels%20in%20drinking%20water%2C%20the%20major%20source%20of%20fluoride%20exposure.%20Exposure%20above%202%5Cu2009ppm%20of%20fluoride%20is%20associated%20with%20renal%20impairment%20in%20humans.%20In%20rats%2C%20moderate%20levels%20of%20fluoride%20induce%20kidney%20injury%20at%20early%20stages%20in%20which%20the%20glomerular%20filtration%20rate%20%28GFR%29%20is%20not%20altered.%20In%20the%20present%20study%2C%20we%20investigated%20if%20sub-nephrotoxic%20stimulus%20induced%20by%20fluoride%20might%20impact%20the%20response%20to%20a%20subsequent%20nephrotoxic%20treatment%20with%20gentamicin.%20Male%20Wistar%20rats%20%28~21%5Cu2009days%29%20were%20exposed%20to%200%2C%2015%20or%2050%5Cu2009ppm%20of%20fluoride%20through%20drinking%20water%20during%2040%5Cu2009days.%20Afer%20that%2C%20rats%20were%20co-exposed%20to%20gentamicin%20%2840%5Cu2009mg%5Cu2009kg%28-1%29%5Cu2009day%28-1%29%2C%207%5Cu2009days%29.%20Gentamicin%20induced%20a%20marked%20decrease%20in%20the%20GFR%20and%20an%20increase%20in%20urinary%20levels%20as%20well%20as%20the%20protein%20and%20mRNA%20expression%20of%20biomarkers%20of%20early%20kidney%20injury%2C%20such%20as%20Kim-1.%20Interestingly%2C%20gentamicin%20nephrotoxicity%20was%20less%20pronounced%20in%20groups%20previously%20exposed%20to%20fluoride%20than%20in%20the%20group%20only%20treated%20with%20gentamicin.%20Fluoride%20induced%20Hsp72%2C%20a%20cytoprotective%20molecule%2C%20which%20might%20have%20improved%20the%20response%20against%20gentamicin.%20Moreover%2C%20fluoride%20decreased%20the%20expression%20of%20megalin%2C%20a%20molecule%20necessary%20for%20internalization%20of%20gentamicin%20into%20the%20proximal%20tubule%2C%20potentially%20reducing%20gentamicin%20accumulation.%20The%20present%20results%20suggest%20that%20fluoride%20reduced%20gentamicin-induced%20nephrotoxicity%20by%20inducing%20a%20compensatory%20response%20carried%20out%20by%20Hsp72%20and%20by%20decreasing%20gentamicin%20accumulation.%20These%20findings%20should%20not%20be%20interpreted%20to%20suggest%20that%20fluoride%20is%20a%20protective%20agent%20as%20megalin%20deficiency%20could%20lead%20to%20serious%20adverse%20effects%20on%20the%20kidney%20physiology.%22%2C%22date%22%3A%222016-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjat.3186%22%2C%22ISSN%22%3A%221099-1263%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T15%3A16%3A51Z%22%7D%7D%2C%7B%22key%22%3A%225KVZHELI%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Goel%20et%20al.%22%2C%22parsedDate%22%3A%222016-03-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGoel%20S%2C%20Wang%20Q%2C%20Watt%20AC%2C%20Tolaney%20SM%2C%20Dillon%20DA%2C%20Li%20W%2C%20Ramm%20S%2C%20Palmer%20AC%2C%20Yuzugullu%20H%2C%20Varadan%20V%2C%20Tuck%20D%2C%20Harris%20LN%2C%20Wong%20KK%2C%20Liu%20XS%2C%20Sicinski%20P%2C%20Winer%20EP%2C%20Krop%20IE%2C%20Zhao%20JJ.%20Overcoming%20therapeutic%20resistance%20in%20HER2-positive%20breast%20cancers%20with%20CDK4%5C%2F6%20inhibitors.%20Cancer%20Cell.%202016%20Mar%2014%3B29%283%29%3A255%26%23x2013%3B269.%20PMCID%3A%20PMC4794996%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Overcoming%20therapeutic%20resistance%20in%20HER2-positive%20breast%20cancers%20with%20CDK4%5C%2F6%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shom%22%2C%22lastName%22%3A%22Goel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20C.%22%2C%22lastName%22%3A%22Watt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Dillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Ramm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haluk%22%2C%22lastName%22%3A%22Yuzugullu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vinay%22%2C%22lastName%22%3A%22Varadan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Tuck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyndsay%20N.%22%2C%22lastName%22%3A%22Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwok-Kin%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%20Shirley%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piotr%22%2C%22lastName%22%3A%22Sicinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20P.%22%2C%22lastName%22%3A%22Winer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20E.%22%2C%22lastName%22%3A%22Krop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Using%20transgenic%20mouse%20models%2C%20cell%20line-based%20functional%20studies%2C%20and%20clinical%20specimens%2C%20we%20show%20that%20cyclin%20D1%5C%2FCDK4%20mediate%20resistance%20to%20targeted%20therapy%20for%20HER2-positive%20breast%20cancer.%20This%20is%20overcome%20using%20CDK4%5C%2F6%20inhibitors.%20Inhibition%20of%20CDK4%5C%2F6%20not%20only%20suppresses%20Rb%20phosphorylation%2C%20but%20also%20reduces%20TSC2%20phosphorylation%20and%20thus%20partially%20attenuates%20mTORC1%20activity.%20This%20relieves%20feedback%20inhibition%20of%20upstream%20EGFR%20family%20kinases%2C%20resensitizing%20tumors%20to%20EGFR%5C%2FHER2%20blockade.%20Consequently%2C%20dual%20inhibition%20of%20EGFR%5C%2FHER2%20and%20CDK4%5C%2F6%20invokes%20a%20more%20potent%20suppression%20of%20TSC2%20phosphorylation%20and%20hence%20mTORC1%5C%2FS6K%5C%2FS6RP%20activity.%20The%20suppression%20of%20both%20Rb%20and%20S6RP%20enhances%20G1%20arrest%20and%20a%20phenotype%20resembling%20cellular%20senescence.%20In%20vivo%2C%20CDK4%5C%2F6%20inhibitors%20sensitize%20patient-derived%20xenograft%20tumors%20to%20HER2-targeted%20therapies%20and%20delay%20tumor%20recurrence%20in%20a%20transgenic%20model%20of%20HER2-positive%20breast%20cancer.%22%2C%22date%22%3A%222016-03-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2016.02.006%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-17T01%3A15%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22MQMPZUTZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Hafner%20et%20al.%22%2C%22parsedDate%22%3A%222016-06%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHafner%20M%2C%20Niepel%20M%2C%20Chung%20M%2C%20Sorger%20PK.%20Growth%20rate%20inhibition%20metrics%20correct%20for%20confounders%20in%20measuring%20sensitivity%20to%20cancer%20drugs.%20Nat%20Methods.%202016%20Jun%3B13%286%29%3A521%26%23x2013%3B527.%20PMCID%3A%20PMC4887336%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Growth%20rate%20inhibition%20metrics%20correct%20for%20confounders%20in%20measuring%20sensitivity%20to%20cancer%20drugs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Drug%20sensitivity%20and%20resistance%20are%20conventionally%20quantified%20by%20IC50%20or%20Emax%20values%2C%20but%20these%20metrics%20are%20highly%20sensitive%20to%20the%20number%20of%20divisions%20taking%20place%20over%20the%20course%20of%20a%20response%20assay.%20The%20dependency%20of%20IC50%20and%20Emax%20on%20division%20rate%20creates%20artefactual%20correlations%20between%20genotype%20and%20drug%20sensitivity%2C%20while%20obscuring%20valuable%20biological%20insights%20and%20interfering%20with%20biomarker%20discovery.%20We%20derive%20alternative%20small%20molecule%20drug-response%20metrics%20that%20are%20insensitive%20to%20division%20number.%20These%20are%20based%20on%20estimation%20of%20the%20magnitude%20of%20drug-induced%20growth%20rate%20inhibition%20%28GR%29%20using%20endpoint%20or%20time-course%20assays.%20We%20show%20that%20GR50%20and%20GRmax%20are%20superior%20to%20conventional%20metrics%20for%20assessing%20the%20effects%20of%20small%20molecule%20drugs%20in%20dividing%20cells.%20Moreover%2C%20adopting%20GR%20metrics%20requires%20only%20modest%20changes%20in%20experimental%20protocols.%20We%20expect%20GR%20metrics%20to%20improve%20the%20study%20of%20cell%20signaling%20and%20growth%20using%20small%20molecules%20and%20biologics%20and%20to%20facilitate%20the%20discovery%20of%20drug-response%20biomarkers%20and%20the%20identification%20of%20drugs%20effective%20against%20specific%20patient-derived%20tumor%20cells.%22%2C%22date%22%3A%222016-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fnmeth.3853%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T20%3A16%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22LD6NX9VT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jadhav%20et%20al.%22%2C%22parsedDate%22%3A%222016-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJadhav%20S%2C%20Ajay%20AK%2C%20Trivedi%20P%2C%20Seematti%20J%2C%20Pellegrini%20K%2C%20Craciun%20F%2C%20Vaidya%20VS.%20RNA-binding%20protein%20Musashi%20homologue%201%20regulates%20kidney%20fibrosis%20by%20translational%20inhibition%20of%20p21%20and%20Numb%20mRNA.%20J%20Biol%20Chem.%202016%20Jul%201%3B291%2827%29%3A14085%26%23x2013%3B14094.%20PMCID%3A%20PMC4933168%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22RNA-binding%20protein%20Musashi%20homologue%201%20regulates%20kidney%20fibrosis%20by%20translational%20inhibition%20of%20p21%20and%20Numb%20mRNA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shreyas%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amrendra%20K.%22%2C%22lastName%22%3A%22Ajay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priyanka%22%2C%22lastName%22%3A%22Trivedi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenifer%22%2C%22lastName%22%3A%22Seematti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Pellegrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florin%22%2C%22lastName%22%3A%22Craciun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22RNA-binding%20proteins%20%28RBPs%29%20are%20recognized%20as%20key%20posttranscriptional%20regulators%20that%20not%20only%20modulate%20the%20spatiotemporal%20expression%20of%20genes%20during%20organism%20development%20but%20also%20regulate%20disease%20pathogenesis.%20Very%20limited%20information%20exists%20on%20the%20potential%20role%20of%20RBPs%20in%20modulating%20kidney%20fibrosis%2C%20which%20is%20a%20major%20hallmark%20of%20chronic%20kidney%20disease.%20Here%2C%20we%20report%20a%20novel%20mechanism%20in%20kidney%20fibrosis%20involving%20a%20RBP%2C%20Musashi%20homologue%201%20%28Msi1%29%2C%20which%20is%20expressed%20in%20tubular%20epithelial%20cells.%20Using%20two%20mechanistically%20distinct%20mouse%20models%20of%20kidney%20fibrosis%2C%20we%20show%20that%20Msi1%20protein%20levels%20are%20significantly%20down-regulated%20in%20the%20kidneys%20following%20fibrosis.%20We%20found%20that%20Msi1%20functions%20by%20negatively%20regulating%20the%20translation%20of%20its%20target%20mRNAs%2C%20p21%20and%20Numb%2C%20whose%20protein%20levels%20are%20markedly%20increased%20in%20kidney%20fibrosis.%20Also%2C%20Msi1%20overexpression%20and%20knockdown%20in%20kidney%20epithelial%20cells%20cause%20p21-%20and%20Numb-mediated%20cell%20cycle%20arrest.%20Furthermore%2C%20we%20observed%20that%20Numb%20looses%20its%20characteristic%20membrane%20localization%20in%20fibrotic%20kidneys%20and%20therefore%20is%20likely%20unable%20to%20inhibit%20Notch%20resulting%20in%20tubular%20cell%20death.%20Oleic%20acid%20is%20a%20known%20inhibitor%20of%20Msi1%20and%20injecting%20oleic%20acid%20followed%20by%20unilateral%20ureteral%20obstruction%20surgery%20in%20mice%20resulted%20in%20enhanced%20fibrosis%20compared%20with%20the%20control%20group%2C%20indicating%20that%20inhibiting%20Msi1%20activity%20renders%20the%20mice%20more%20susceptible%20to%20fibrosis.%20Given%20that%20deregulated%20fatty%20acid%20metabolism%20plays%20a%20key%20role%20in%20kidney%20fibrosis%2C%20these%20results%20demonstrate%20a%20novel%20connection%20between%20fatty%20acid%20and%20Msi1%2C%20an%20RNA-binding%20protein%2C%20in%20kidney%20fibrosis.%22%2C%22date%22%3A%222016-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1074%5C%2Fjbc.M115.713289%22%2C%22ISSN%22%3A%221083-351X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-20T03%3A11%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22J3UG8AZX%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222016-04-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELee%20JK%2C%20Phillips%20JW%2C%20Smith%20BA%2C%20Park%20JW%2C%20Stoyanova%20T%2C%20McCaffrey%20EF%2C%20Baertsch%20R%2C%20Sokolov%20A%2C%20Meyerowitz%20JG%2C%20Mathis%20C%2C%20Cheng%20D%2C%20Stuart%20JM%2C%20Shokat%20KM%2C%20Gustafson%20WC%2C%20Huang%20J%2C%20Witte%20ON.%20N-Myc%20drives%20neuroendocrine%20prostate%20cancer%20initiated%20from%20human%20prostate%20epithelial%20cells.%20Cancer%20Cell.%202016%20Apr%2011%3B29%284%29%3A536%26%23x2013%3B547.%20PMCID%3A%20PMC4829466%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22N-Myc%20drives%20neuroendocrine%20prostate%20cancer%20initiated%20from%20human%20prostate%20epithelial%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20K.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20A.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jung%20Wook%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanya%22%2C%22lastName%22%3A%22Stoyanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20F.%22%2C%22lastName%22%3A%22McCaffrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Baertsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20G.%22%2C%22lastName%22%3A%22Meyerowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colleen%22%2C%22lastName%22%3A%22Mathis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donghui%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevan%20M.%22%2C%22lastName%22%3A%22Shokat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Clay%22%2C%22lastName%22%3A%22Gustafson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiaoti%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20N.%22%2C%22lastName%22%3A%22Witte%22%7D%5D%2C%22abstractNote%22%3A%22MYCN%20amplification%20and%20overexpression%20are%20common%20in%20neuroendocrine%20prostate%20cancer%20%28NEPC%29.%20However%2C%20the%20impact%20of%20aberrant%20N-Myc%20expression%20in%20prostate%20tumorigenesis%20and%20the%20cellular%20origin%20of%20NEPC%20have%20not%20been%20established.%20We%20define%20N-Myc%20and%20activated%20AKT1%20as%20oncogenic%20components%20sufficient%20to%20transform%20human%20prostate%20epithelial%20cells%20to%20prostate%20adenocarcinoma%20and%20NEPC%20with%20phenotypic%20and%20molecular%20features%20of%20aggressive%2C%20late-stage%20human%20disease.%20We%20directly%20show%20that%20prostate%20adenocarcinoma%20and%20NEPC%20can%20arise%20from%20a%20common%20epithelial%20clone.%20Further%2C%20N-Myc%20is%20required%20for%20tumor%20maintenance%2C%20and%20destabilization%20of%20N-Myc%20through%20Aurora%20A%20kinase%20inhibition%20reduces%20tumor%20burden.%20Our%20findings%20establish%20N-Myc%20as%20a%20driver%20of%20NEPC%20and%20a%20target%20for%20therapeutic%20intervention.%22%2C%22date%22%3A%222016-04-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2016.03.001%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-20T03%3A03%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22W7QNX7Q2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-07%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR%2C%20Fallahi-Sichani%20M%2C%20Chen%20JY%2C%20Sorger%20PK.%20Cyclic%20immunofluorescence%20%28CycIF%29%2C%20a%20highly%20multiplexed%20method%20for%20single-cell%20imaging.%20Curr%20Protoc%20Chem%20Biol.%202016%20Dec%207%3B8%284%29%3A251%26%23x2013%3B264.%20PMCID%3A%20PMC5233430%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cyclic%20immunofluorescence%20%28CycIF%29%2C%20a%20highly%20multiplexed%20method%20for%20single-cell%20imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Cyclic%20Immunofluorescence%20%28CycIF%29%20is%20a%20public-domain%20method%20for%20performing%20highly%20multiplexed%20immunofluorescence%20imaging%20using%20a%20conventional%20epifluorescence%20microscope.%20It%20uses%20simple%20reagents%20and%20existing%20antibodies%20to%20construct%20images%20with%20up%20to%2030%20channels%20by%20sequential%204-%20to%206-channel%20imaging%20followed%20by%20fluorophore%20inactivation.%20Three%20variant%20methods%20are%20described%2C%20the%20most%20generally%20useful%20of%20which%20involves%20staining%20fixed%20cells%20with%20antibodies%20directly%20conjugated%20to%20Alexa%20Fluor%20dyes%20and%20imaging%20in%20four%20colors%2C%20inactivating%20fluorophores%20using%20a%20mild%20base%20in%20the%20presence%20of%20hydrogen%20peroxide%20and%20light%2C%20and%20then%20performing%20another%20round%20of%20staining%20and%20imaging.%20Cell%20morphology%20is%20preserved%20through%20multiple%20rounds%20of%20CycIF%2C%20and%20signal-to-noise%20ratios%20appear%20to%20increase.%20Unlike%20antibody-stripping%20methods%2C%20CycIF%20is%20gentle%20and%20optimized%20for%20monolayers%20of%20cultured%20cells.%20A%20second%20protocol%20involves%20indirect%20immunofluorescence%20and%20a%20third%20enables%20chemical%20inactivation%20of%20genetically%20encoded%20fluorescent%20proteins%2C%20allowing%20multiplex%20immunofluorescence%20to%20be%20combined%20with%20live-cell%20analysis%20of%20cells%20expressing%20fluorescent%20reporter%20proteins.%20%5Cu00a9%202016%20by%20John%20Wiley%20%26%20Sons%2C%20Inc.%22%2C%22date%22%3A%222016-12-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcpch.14%22%2C%22ISSN%22%3A%222160-4762%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-20T03%3A16%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22B5ZYL968%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pavkovic%20and%20Vaidya%22%2C%22parsedDate%22%3A%222016-07%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPavkovic%20M%2C%20Vaidya%20VS.%20MicroRNAs%20and%20drug-induced%20kidney%20injury.%20Pharmacol%20Ther.%202016%20Jul%3B163%3A48%26%23x2013%3B57.%20PMCID%3A%20PMC4887322%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MicroRNAs%20and%20drug-induced%20kidney%20injury%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Drug-induced%20kidney%20injury%20%28DIKI%29%20is%20a%20severe%20complication%20in%20hospitalized%20patients%20associated%20with%20higher%20probabilities%20of%20developing%20progressive%20chronic%20kidney%20disease%20or%20end-stage%20renal%20diseases.%20Furthermore%2C%20DIKI%20is%20a%20problem%20during%20preclinical%20and%20clinical%20phases%20of%20drug%20development%20leading%20to%20high%20rates%20of%20project%20terminations.%20Understanding%20the%20molecular%20perturbations%20caused%20by%20DIKI%20would%20pave%20the%20way%20for%20a%20new%20class%20of%20therapeutics%20to%20mitigate%20the%20damage.%20Yet%2C%20another%20approach%20to%20ameliorate%20DIKI%20is%20identifying%20sensitive%20and%20specific%20translational%20biomarkers%20that%20outperform%20the%20current%20diagnostic%20analytes%20like%20serum%20creatinine%20and%20facilitate%20early%20diagnosis.%20MicroRNAs%20%28miRNAs%29%2C%20a%20class%20of%20non-coding%20RNAs%2C%20are%20increasingly%20being%20recognized%20to%20have%20a%20two-pronged%20approach%20toward%20DIKI%20management%3A%201%29%20miRNAs%20have%20a%20regulatory%20role%20in%20gene%20expression%20and%20signaling%20pathways%20thereby%20making%20them%20novel%20interventional%20targets%20and%202%29%20miRNAs%20enable%20diagnosis%20and%20prognosis%20of%20DIKI%20because%20of%20their%20stable%20presence%20in%20biofluids.%20In%20this%20review%2C%20apart%20from%20summarizing%20the%20literature%20on%20miRNAs%20in%20DIKI%2C%20we%20report%20small%20RNA%20sequencing%20results%20showing%20miRNA%20expression%20profiles%20at%20baseline%20in%20normal%20kidney%20samples%20from%20mice%20and%20humans.%20Additionally%2C%20we%20also%20compared%20the%20miRNA%20expression%20in%20biopsies%20of%20normal%20human%20kidneys%20to%20patients%20with%20acute%20tubular%20necrosis%2C%20and%20found%2076%20miRNAs%20significantly%20downregulated%20and%2047%20miRNAs%20upregulated%20%28FDR%20adjusted%20p%3C0.05%2C%20%2B%5C%2F-2-fold%20change%29.%20In%20summary%2C%20we%20highlight%20the%20transformative%20potential%20of%20miRNAs%20in%20therapeutics%20and%20translational%20medicine%20with%20a%20focus%20on%20drug-induced%20kidney%20damage.%22%2C%22date%22%3A%222016-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.pharmthera.2016.03.016%22%2C%22ISSN%22%3A%221879-016X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A12%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22D7PVB99K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pavkovic%20et%20al.%22%2C%22parsedDate%22%3A%222016-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPavkovic%20M%2C%20Robinson-Cohen%20C%2C%20Chua%20AS%2C%20Nicoara%20O%2C%20C%26%23xE1%3Brdenas-Gonz%26%23xE1%3Blez%20M%2C%20Bijol%20V%2C%20Ramachandran%20K%2C%20Hampson%20L%2C%20Pirmohamed%20M%2C%20Antoine%20DJ%2C%20Frendl%20G%2C%20Himmelfarb%20J%2C%20Waikar%20SS%2C%20Vaidya%20VS.%20Detection%20of%20drug-induced%20acute%20kidney%20injury%20in%20humans%20using%20urinary%20KIM-1%2C%20miR-21%2C%20-200c%2C%20and%20-423.%20Toxicol%20Sci.%202016%20Jul%3B152%281%29%3A205%26%23x2013%3B213.%20PMCID%3A%20PMC5009468%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Detection%20of%20drug-induced%20acute%20kidney%20injury%20in%20humans%20using%20urinary%20KIM-1%2C%20miR-21%2C%20-200c%2C%20and%20-423%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassianne%22%2C%22lastName%22%3A%22Robinson-Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20S.%22%2C%22lastName%22%3A%22Chua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oana%22%2C%22lastName%22%3A%22Nicoara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22C%5Cu00e1rdenas-Gonz%5Cu00e1lez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanesa%22%2C%22lastName%22%3A%22Bijol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krithika%22%2C%22lastName%22%3A%22Ramachandran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%22%2C%22lastName%22%3A%22Hampson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Munir%22%2C%22lastName%22%3A%22Pirmohamed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20J.%22%2C%22lastName%22%3A%22Antoine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gyorgy%22%2C%22lastName%22%3A%22Frendl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Himmelfarb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushrut%20S.%22%2C%22lastName%22%3A%22Waikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Drug-induced%20acute%20kidney%20injury%20%28AKI%29%20is%20often%20encountered%20in%20hospitalized%20patients.%20Although%20serum%20creatinine%20%28SCr%29%20is%20still%20routinely%20used%20for%20assessing%20AKI%2C%20it%20is%20known%20to%20be%20insensitive%20and%20nonspecific.%20Therefore%2C%20our%20objective%20was%20to%20evaluate%20kidney%20injury%20molecule%201%20%28KIM-1%29%20in%20conjunction%20with%20microRNA%20%28miR%29-21%2C%20-200c%2C%20and%20-423%20as%20urinary%20biomarkers%20for%20drug-induced%20AKI%20in%20humans.%20In%20a%20cross-sectional%20cohort%20of%20patients%20%28n%5Cu2009%3D%5Cu2009135%29%20with%20acetaminophen%20%28APAP%29%20overdose%2C%20all%204%20biomarkers%20were%20significantly%20%28P%5Cu2009%3C%5Cu2009.004%29%20higher%20not%20only%20in%20APAP-overdosed%20%28OD%29%20patients%20with%20AKI%20%28based%20on%20SCr%20increase%29%20but%20also%20in%20APAP-OD%20patients%20without%20clinical%20diagnosis%20of%20AKI%20compared%20with%20healthy%20volunteers.%20In%20a%20longitudinal%20cohort%20of%20patients%20with%20malignant%20mesothelioma%20receiving%20intraoperative%20cisplatin%20%28Cp%29%20therapy%20%28n%5Cu2009%3D%5Cu2009108%29%20the%204%20biomarkers%20increased%20significantly%20%28P%5Cu2009%3C%5Cu2009.0014%29%20over%20time%20after%20Cp%20administration%2C%20but%20could%20not%20be%20used%20to%20distinguish%20patients%20with%20or%20without%20AKI.%20Evidence%20for%20human%20proximal%20tubular%20epithelial%20cells%20%28HPTECs%29%20being%20the%20source%20of%20miRNAs%20in%20urine%20was%20obtained%20first%2C%20by%20in%20situ%20hybridization%20based%20confirmation%20of%20increase%20in%20miR-21%20expression%20in%20the%20kidney%20sections%20of%20AKI%20patients%20and%20second%2C%20by%20increased%20levels%20of%20miR-21%2C%20-200c%2C%20and%20-423%20in%20the%20medium%20of%20cultured%20HPTECs%20treated%20with%20Cp%20and%204-aminophenol%20%28APAP%20degradation%20product%29.%20Target%20prediction%20analysis%20revealed%201102%20mRNA%20targets%20of%20miR-21%2C%20-200c%2C%20and%20-423%20that%20are%20associated%20with%20pathways%20perturbed%20in%20diverse%20pathological%20kidney%20conditions.%20In%20summary%2C%20we%20report%20noninvasive%20detection%20of%20AKI%20in%20humans%20by%20combining%20the%20sensitivity%20of%20KIM-1%20along%20with%20mechanistic%20potentials%20of%20miR-21%2C%20-200c%2C%20and%20-423.%22%2C%22date%22%3A%222016-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ftoxsci%5C%2Fkfw077%22%2C%22ISSN%22%3A%221096-0929%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-20T03%3A10%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22H9N9W9EL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pellegrini%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPellegrini%20KL%2C%20Gerlach%20CV%2C%20Craciun%20FL%2C%20Ramachandran%20K%2C%20Bijol%20V%2C%20Kissick%20HT%2C%20Vaidya%20VS.%20Application%20of%20small%20RNA%20sequencing%20to%20identify%20microRNAs%20in%20acute%20kidney%20injury%20and%20fibrosis.%20Toxicol%20Appl%20Pharmacol.%202016%20Dec%201%3B312%3A42%26%23x2013%3B52.%20PMCID%3A%20PMC4912473%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Application%20of%20small%20RNA%20sequencing%20to%20identify%20microRNAs%20in%20acute%20kidney%20injury%20and%20fibrosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20L.%22%2C%22lastName%22%3A%22Pellegrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cory%20V.%22%2C%22lastName%22%3A%22Gerlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florin%20L.%22%2C%22lastName%22%3A%22Craciun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krithika%22%2C%22lastName%22%3A%22Ramachandran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanesa%22%2C%22lastName%22%3A%22Bijol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haydn%20T.%22%2C%22lastName%22%3A%22Kissick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Establishing%20a%20microRNA%20%28miRNA%29%20expression%20profile%20in%20affected%20tissues%20provides%20an%20important%20foundation%20for%20the%20discovery%20of%20miRNAs%20involved%20in%20the%20development%20or%20progression%20of%20pathologic%20conditions.%20We%20conducted%20small%20RNA%20sequencing%20to%20generate%20a%20temporal%20profile%20of%20miRNA%20expression%20in%20the%20kidneys%20using%20a%20mouse%20model%20of%20folic%20acid-induced%20%28250mg%5C%2Fkgi.p.%29%20kidney%20injury%20and%20fibrosis.%20From%20the%20103%20miRNAs%20that%20were%20differentially%20expressed%20over%20the%20time%20course%20%28%3E2-fold%2C%20p%3C0.05%29%2C%20we%20chose%20to%20further%20investigate%20miR-18a-5p%2C%20which%20is%20expressed%20during%20the%20acute%20stage%20of%20the%20injury%3B%20miR-132-3p%2C%20which%20is%20upregulated%20during%20transition%20between%20acute%20and%20fibrotic%20injury%3B%20and%20miR-146b-5p%2C%20which%20is%20highly%20expressed%20at%20the%20peak%20of%20fibrosis.%20Using%20qRT-PCR%2C%20we%20confirmed%20the%20increased%20expression%20of%20these%20candidate%20miRNAs%20in%20the%20folic%20acid%20model%20as%20well%20as%20in%20other%20established%20mouse%20models%20of%20acute%20injury%20%28ischemia%5C%2Freperfusion%20injury%29%20and%20fibrosis%20%28unilateral%20ureteral%20obstruction%29.%20In%20situ%20hybridization%20confirmed%20high%20expression%20of%20miR-18a-5p%2C%20miR-132-3p%20and%20miR-146b-5p%20throughout%20the%20kidney%20cortex%20in%20mice%20and%20humans%20with%20severe%20kidney%20injury%20or%20fibrosis.%20When%20primary%20human%20proximal%20tubular%20epithelial%20cells%20were%20treated%20with%20model%20nephrotoxicants%20such%20as%20cadmium%20chloride%20%28CdCl2%29%2C%20arsenic%20trioxide%2C%20aristolochic%20acid%20%28AA%29%2C%20potassium%20dichromate%20%28K2Cr2O7%29%20and%20cisplatin%2C%20miRNA-132-3p%20was%20upregulated%204.3-fold%20after%20AA%20treatment%20and%201.5-fold%20after%20K2Cr2O7%20and%20CdCl2%20treatment.%20These%20results%20demonstrate%20the%20application%20of%20temporal%20small%20RNA%20sequencing%20to%20identify%20miR-18a%2C%20miR-132%20and%20miR-146b%20as%20differentially%20expressed%20miRNAs%20during%20distinct%20phases%20of%20kidney%20injury%20and%20fibrosis%20progression.%22%2C%22date%22%3A%222016-12-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.taap.2015.12.002%22%2C%22ISSN%22%3A%221096-0333%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A13%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22RL689ME5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ramm%20et%20al.%22%2C%22parsedDate%22%3A%222016-08-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERamm%20S%2C%20Adler%20M%2C%20Vaidya%20VS.%20A%20high-throughput%20screening%20assay%20to%20identify%20kidney%20toxic%20compounds.%20Curr%20Protoc%20Toxicol%20%5BInternet%5D.%202016%20Aug%201%3B69%3A9.10.1-9.10.26.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.wiley.com%5C%2F10.1002%5C%2Fcptx.12%27%3Ehttp%3A%5C%2F%5C%2Fdoi.wiley.com%5C%2F10.1002%5C%2Fcptx.12%3C%5C%2Fa%3E%20PMCID%3A%20PMC4981919%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20high-throughput%20screening%20assay%20to%20identify%20kidney%20toxic%20compounds%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Ramm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Adler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22Kidney%20toxicity%20due%20to%20drugs%20and%20chemicals%20poses%20a%20significant%20health%20burden%20for%20patients%20and%20a%20financial%20risk%20for%20pharmaceutical%20companies.%20However%2C%20currently%20no%20sensitive%20and%20high-throughput%20in%20vitro%20method%20exists%20for%20predictive%20nephrotoxicity%20assessment.%20Primary%20human%20proximal%20tubular%20epithelial%20cells%20%28HPTECs%29%20possess%20characteristics%20of%20differentiated%20epithelial%20cells%2C%20making%20them%20a%20desirable%20model%20to%20use%20in%20in%20vitro%20screening%20systems.%20Additionally%2C%20heme%20oxygenase%201%20%28HO-1%29%20protein%20expression%20is%20upregulated%20as%20a%20protective%20mechanism%20during%20kidney%20toxicant-induced%20oxidative%20stress%20or%20inflammation%20in%20HPTECs%20and%20can%20therefore%20be%20used%20as%20a%20biomarker%20for%20nephrotoxicity.%20In%20this%20article%2C%20we%20describe%20two%20different%20methods%20to%20screen%20for%20HO-1%20increase%3A%20A%20homogeneous%20time%20resolved%20fluorescence%20%28HTRF%29%20assay%20and%20an%20immunofluorescence%20assay.%20The%20latter%20provides%20lower%20throughput%20but%20higher%20sensitivity%20due%20to%20the%20combination%20of%20two%20readouts%2C%20HO-1%20intensity%20and%20cell%20number.%20The%20methods%20described%20in%20the%20protocol%20are%20amendable%20for%20other%20cell%20types%20as%20well.%20%5Cu00a9%202016%20by%20John%20Wiley%20%26%20Sons%2C%20Inc.%22%2C%22date%22%3A%222016-08-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcptx.12%22%2C%22ISSN%22%3A%221934-9262%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdoi.wiley.com%5C%2F10.1002%5C%2Fcptx.12%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-20T03%3A12%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22XHRFUFHB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Richardson%20et%20al.%22%2C%22parsedDate%22%3A%222016-07-19%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERichardson%20K%2C%20Bennion%20OT%2C%20Tan%20S%2C%20Hoang%20AN%2C%20Cokol%20M%2C%20Aldridge%20BB.%20Temporal%20and%20intrinsic%20factors%20of%20rifampicin%20tolerance%20in%20mycobacteria.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202016%20Jul%2019%3B113%2829%29%3A8302%26%23x2013%3B8307.%20PMCID%3A%20PMC4961206%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20and%20intrinsic%20factors%20of%20rifampicin%20tolerance%20in%20mycobacteria%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirill%22%2C%22lastName%22%3A%22Richardson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20T.%22%2C%22lastName%22%3A%22Bennion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shumin%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anh%20N.%22%2C%22lastName%22%3A%22Hoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murat%22%2C%22lastName%22%3A%22Cokol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacteria%20grow%20and%20divide%20asymmetrically%2C%20creating%20variability%20in%20growth%20pole%20age%2C%20growth%20properties%2C%20and%20antibiotic%20susceptibilities.%20Here%2C%20we%20investigate%20the%20importance%20of%20growth%20pole%20age%20and%20other%20growth%20properties%20in%20determining%20the%20spectrum%20of%20responses%20of%20Mycobacterium%20smegmatis%20to%20challenge%20with%20rifampicin.%20We%20used%20a%20combination%20of%20live-cell%20microscopy%20and%20modeling%20to%20prospectively%20identify%20subpopulations%20with%20altered%20rifampicin%20susceptibility.%20We%20found%20two%20subpopulations%20that%20had%20increased%20susceptibility.%20At%20the%20initiation%20of%20treatment%2C%20susceptible%20cells%20were%20either%20small%20and%20at%20early%20stages%20of%20the%20cell%20cycle%2C%20or%20large%20and%20in%20later%20stages%20of%20their%20cell%20cycle.%20In%20contrast%20to%20this%20temporal%20window%20of%20susceptibility%2C%20tolerance%20was%20associated%20with%20factors%20inherited%20at%20division%3A%20long%20birth%20length%20and%20mature%20growth%20poles.%20Thus%2C%20rifampicin%20response%20is%20complex%20and%20due%20to%20a%20combination%20of%20differences%20established%20from%20both%20asymmetric%20division%20and%20the%20timing%20of%20treatment%20relative%20to%20cell%20birth.%22%2C%22date%22%3A%222016-07-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1073%5C%2Fpnas.1600372113%22%2C%22ISSN%22%3A%221091-6490%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T21%3A53%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22R6WQR5CQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sokolov%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESokolov%20A%2C%20Paull%20EO%2C%20Stuart%20JM.%20One-class%20detection%20of%20cell%20states%20in%20tumor%20subtypes.%20Pac%20Symp%20Biocomput.%202016%3B21%3A405%26%23x2013%3B416.%20PMCID%3A%20PMC4856035%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22One-class%20detection%20of%20cell%20states%20in%20tumor%20subtypes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20O.%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%5D%2C%22abstractNote%22%3A%22The%20cellular%20composition%20of%20a%20tumor%20greatly%20influences%20the%20growth%2C%20spread%2C%20immune%20activity%2C%20drug%20response%2C%20and%20other%20aspects%20of%20the%20disease.%20Tumor%20cells%20are%20usually%20comprised%20of%20a%20heterogeneous%20mixture%20of%20subclones%2C%20each%20of%20which%20could%20contain%20their%20own%20distinct%20character.%20The%20presence%20of%20minor%20subclones%20poses%20a%20serious%20health%20risk%20for%20patients%20as%20any%20one%20of%20them%20could%20harbor%20a%20fitness%20advantage%20with%20respect%20to%20the%20current%20treatment%20regimen%2C%20fueling%20resistance.%20It%20is%20therefore%20vital%20to%20accurately%20assess%20the%20make-up%20of%20cell%20states%20within%20a%20tumor%20biopsy.%20Transcriptome-wide%20assays%20from%20RNA%20sequencing%20provide%20key%20data%20from%20which%20cell%20state%20signatures%20can%20be%20detected.%20However%2C%20the%20challenge%20is%20to%20find%20them%20within%20samples%20containing%20mixtures%20of%20cell%20types%20of%20unknown%20proportions.%20We%20propose%20a%20novel%20one-class%20method%20based%20on%20logistic%20regression%20and%20show%20that%20its%20performance%20is%20competitive%20to%20two%20established%20SVM-based%20methods%20for%20this%20detection%20task.%20We%20demonstrate%20that%20one-class%20models%20are%20able%20to%20identify%20specific%20cell%20types%20in%20heterogeneous%20cell%20populations%20better%20than%20their%20binary%20predictor%20counterparts.%20We%20derive%20one-class%20predictors%20for%20the%20major%20breast%20and%20bladder%20subtypes%20and%20reaffirm%20the%20connection%20between%20these%20two%20tissues.%20In%20addition%2C%20we%20use%20a%20one-class%20predictor%20to%20quantitatively%20associate%20an%20embryonic%20stem%20cell%20signature%20with%20an%20aggressive%20breast%20cancer%20subtype%20that%20reveals%20shared%20stemness%20pathways%20potentially%20important%20for%20treatment.%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222335-6936%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-17T01%3A13%3A41Z%22%7D%7D%2C%7B%22key%22%3A%229KYZW23J%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sokolov%20et%20al.%22%2C%22parsedDate%22%3A%222016-03%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESokolov%20A%2C%20Carlin%20DE%2C%20Paull%20EO%2C%20Baertsch%20R%2C%20Stuart%20JM.%20Pathway-based%20genomics%20prediction%20using%20generalized%20elastic%20net.%20PLoS%20Comput%20Biol.%202016%20Mar%3B12%283%29%3Ae1004790.%20PMCID%3A%20PMC4784899%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pathway-based%20genomics%20prediction%20using%20generalized%20elastic%20net%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20E.%22%2C%22lastName%22%3A%22Carlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20O.%22%2C%22lastName%22%3A%22Paull%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Baertsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Stuart%22%7D%5D%2C%22abstractNote%22%3A%22We%20present%20a%20novel%20regularization%20scheme%20called%20The%20Generalized%20Elastic%20Net%20%28GELnet%29%20that%20incorporates%20gene%20pathway%20information%20into%20feature%20selection.%20The%20proposed%20formulation%20is%20applicable%20to%20a%20wide%20variety%20of%20problems%20in%20which%20the%20interpretation%20of%20predictive%20features%20using%20known%20molecular%20interactions%20is%20desired.%20The%20method%20naturally%20steers%20solutions%20toward%20sets%20of%20mechanistically%20interlinked%20genes.%20Using%20experiments%20on%20synthetic%20data%2C%20we%20demonstrate%20that%20pathway-guided%20results%20maintain%2C%20and%20often%20improve%2C%20the%20accuracy%20of%20predictors%20even%20in%20cases%20where%20the%20full%20gene%20network%20is%20unknown.%20We%20apply%20the%20method%20to%20predict%20the%20drug%20response%20of%20breast%20cancer%20cell%20lines.%20GELnet%20is%20able%20to%20reveal%20genetic%20determinants%20of%20sensitivity%20and%20resistance%20for%20several%20compounds.%20In%20particular%2C%20for%20an%20EGFR%5C%2FHER2%20inhibitor%2C%20it%20finds%20a%20possible%20trans-differentiation%20resistance%20mechanism%20missed%20by%20the%20corresponding%20pathway%20agnostic%20approach.%22%2C%22date%22%3A%222016-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1004790%22%2C%22ISSN%22%3A%221553-7358%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-17T01%3A14%3A58Z%22%7D%7D%2C%7B%22key%22%3A%2258PF3X88%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tirosh%20et%20al.%22%2C%22parsedDate%22%3A%222016-04-08%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETirosh%20I%2C%20Izar%20B%2C%20Prakadan%20SM%2C%20Wadsworth%20MH%2C%20Treacy%20D%2C%20Trombetta%20JJ%2C%20Rotem%20A%2C%20Rodman%20C%2C%20Lian%20C%2C%20Murphy%20G%2C%20Fallahi-Sichani%20M%2C%20Dutton-Regester%20K%2C%20Lin%20JR%2C%20Cohen%20O%2C%20Shah%20P%2C%20Lu%20D%2C%20Genshaft%20AS%2C%20Hughes%20TK%2C%20Ziegler%20CGK%2C%20Kazer%20SW%2C%20Gaillard%20A%2C%20Kolb%20KE%2C%20Villani%20AC%2C%20Johannessen%20CM%2C%20Andreev%20AY%2C%20Van%20Allen%20EM%2C%20Bertagnolli%20M%2C%20Sorger%20PK%2C%20Sullivan%20RJ%2C%20Flaherty%20KT%2C%20Frederick%20DT%2C%20Jan%26%23xE9%3B-Valbuena%20J%2C%20Yoon%20CH%2C%20Rozenblatt-Rosen%20O%2C%20Shalek%20AK%2C%20Regev%20A%2C%20Garraway%20LA.%20Dissecting%20the%20multicellular%20ecosystem%20of%20metastatic%20melanoma%20by%20single-cell%20RNA-seq.%20Science.%202016%20Apr%208%3B352%286282%29%3A189%26%23x2013%3B196.%20PMCID%3A%20PMC4944528%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dissecting%20the%20multicellular%20ecosystem%20of%20metastatic%20melanoma%20by%20single-cell%20RNA-seq%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itay%22%2C%22lastName%22%3A%22Tirosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%20M.%22%2C%22lastName%22%3A%22Prakadan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20H.%22%2C%22lastName%22%3A%22Wadsworth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Treacy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Trombetta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Rodman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%22%2C%22lastName%22%3A%22Dutton-Regester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofir%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parin%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20S.%22%2C%22lastName%22%3A%22Genshaft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Travis%20K.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carly%20G.%20K.%22%2C%22lastName%22%3A%22Ziegler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20W.%22%2C%22lastName%22%3A%22Kazer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleth%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kellie%20E.%22%2C%22lastName%22%3A%22Kolb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra-Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Villani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cory%20M.%22%2C%22lastName%22%3A%22Johannessen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleksandr%20Y.%22%2C%22lastName%22%3A%22Andreev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Bertagnolli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennie%20T.%22%2C%22lastName%22%3A%22Frederick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judit%22%2C%22lastName%22%3A%22Jan%5Cu00e9-Valbuena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20H.%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orit%22%2C%22lastName%22%3A%22Rozenblatt-Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20K.%22%2C%22lastName%22%3A%22Shalek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aviv%22%2C%22lastName%22%3A%22Regev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%5D%2C%22abstractNote%22%3A%22To%20explore%20the%20distinct%20genotypic%20and%20phenotypic%20states%20of%20melanoma%20tumors%2C%20we%20applied%20single-cell%20RNA%20sequencing%20%28RNA-seq%29%20to%204645%20single%20cells%20isolated%20from%2019%20patients%2C%20profiling%20malignant%2C%20immune%2C%20stromal%2C%20and%20endothelial%20cells.%20Malignant%20cells%20within%20the%20same%20tumor%20displayed%20transcriptional%20heterogeneity%20associated%20with%20the%20cell%20cycle%2C%20spatial%20context%2C%20and%20a%20drug-resistance%20program.%20In%20particular%2C%20all%20tumors%20harbored%20malignant%20cells%20from%20two%20distinct%20transcriptional%20cell%20states%2C%20such%20that%20tumors%20characterized%20by%20high%20levels%20of%20the%20MITF%20transcription%20factor%20also%20contained%20cells%20with%20low%20MITF%20and%20elevated%20levels%20of%20the%20AXL%20kinase.%20Single-cell%20analyses%20suggested%20distinct%20tumor%20microenvironmental%20patterns%2C%20including%20cell-to-cell%20interactions.%20Analysis%20of%20tumor-infiltrating%20T%20cells%20revealed%20exhaustion%20programs%2C%20their%20connection%20to%20T%20cell%20activation%20and%20clonal%20expansion%2C%20and%20their%20variability%20across%20patients.%20Overall%2C%20we%20begin%20to%20unravel%20the%20cellular%20ecosystem%20of%20tumors%20and%20how%20single-cell%20genomics%20offers%20insights%20with%20implications%20for%20both%20targeted%20and%20immune%20therapies.%22%2C%22date%22%3A%222016-04-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.aad0501%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-31T00%3A17%3A22Z%22%7D%7D%5D%7D
1.
AlQuraishi M, Sorger PK. Reproducibility will only come with data liberation. Sci Transl Med. 2016 May 18;8(339):339ed7. PMCID: PMC5084089
1.
Cárdenas-González M, Jacobo Estrada T, Rodríguez-Muñoz R, Barrera-Chimal J, Bobadilla NA, Barbier OC, Del Razo LM. Sub-chronic exposure to fluoride impacts the response to a subsequent nephrotoxic treatment with gentamicin. J Appl Toxicol. 2016 Feb;36(2):309–319. PMID: 26779593
1.
Goel S, Wang Q, Watt AC, Tolaney SM, Dillon DA, Li W, Ramm S, Palmer AC, Yuzugullu H, Varadan V, Tuck D, Harris LN, Wong KK, Liu XS, Sicinski P, Winer EP, Krop IE, Zhao JJ. Overcoming therapeutic resistance in HER2-positive breast cancers with CDK4/6 inhibitors. Cancer Cell. 2016 Mar 14;29(3):255–269. PMCID: PMC4794996
1.
Hafner M, Niepel M, Chung M, Sorger PK. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods. 2016 Jun;13(6):521–527. PMCID: PMC4887336
1.
Jadhav S, Ajay AK, Trivedi P, Seematti J, Pellegrini K, Craciun F, Vaidya VS. RNA-binding protein Musashi homologue 1 regulates kidney fibrosis by translational inhibition of p21 and Numb mRNA. J Biol Chem. 2016 Jul 1;291(27):14085–14094. PMCID: PMC4933168
1.
Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, Cheng D, Stuart JM, Shokat KM, Gustafson WC, Huang J, Witte ON. N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Cancer Cell. 2016 Apr 11;29(4):536–547. PMCID: PMC4829466
1.
Lin JR, Fallahi-Sichani M, Chen JY, Sorger PK. Cyclic immunofluorescence (CycIF), a highly multiplexed method for single-cell imaging. Curr Protoc Chem Biol. 2016 Dec 7;8(4):251–264. PMCID: PMC5233430
1.
Pavkovic M, Vaidya VS. MicroRNAs and drug-induced kidney injury. Pharmacol Ther. 2016 Jul;163:48–57. PMCID: PMC4887322
1.
Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, Frendl G, Himmelfarb J, Waikar SS, Vaidya VS. Detection of drug-induced acute kidney injury in humans using urinary KIM-1, miR-21, -200c, and -423. Toxicol Sci. 2016 Jul;152(1):205–213. PMCID: PMC5009468
1.
Pellegrini KL, Gerlach CV, Craciun FL, Ramachandran K, Bijol V, Kissick HT, Vaidya VS. Application of small RNA sequencing to identify microRNAs in acute kidney injury and fibrosis. Toxicol Appl Pharmacol. 2016 Dec 1;312:42–52. PMCID: PMC4912473
1.
Ramm S, Adler M, Vaidya VS. A high-throughput screening assay to identify kidney toxic compounds. Curr Protoc Toxicol [Internet]. 2016 Aug 1;69:9.10.1-9.10.26. Available from: http://doi.wiley.com/10.1002/cptx.12 PMCID: PMC4981919
1.
Richardson K, Bennion OT, Tan S, Hoang AN, Cokol M, Aldridge BB. Temporal and intrinsic factors of rifampicin tolerance in mycobacteria. Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8302–8307. PMCID: PMC4961206
1.
Sokolov A, Paull EO, Stuart JM. One-class detection of cell states in tumor subtypes. Pac Symp Biocomput. 2016;21:405–416. PMCID: PMC4856035
1.
Sokolov A, Carlin DE, Paull EO, Baertsch R, Stuart JM. Pathway-based genomics prediction using generalized elastic net. PLoS Comput Biol. 2016 Mar;12(3):e1004790. PMCID: PMC4784899
1.
Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, Fallahi-Sichani M, Dutton-Regester K, Lin JR, Cohen O, Shah P, Lu D, Genshaft AS, Hughes TK, Ziegler CGK, Kazer SW, Gaillard A, Kolb KE, Villani AC, Johannessen CM, Andreev AY, Van Allen EM, Bertagnolli M, Sorger PK, Sullivan RJ, Flaherty KT, Frederick DT, Jané-Valbuena J, Yoon CH, Rozenblatt-Rosen O, Shalek AK, Regev A, Garraway LA. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016 Apr 8;352(6282):189–196. PMCID: PMC4944528
2015
2576724
IXMHRBF6
LSP Paper
2015
1
national-library-of-medicine-grant-proposals
50
creator
asc
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226GCZSEWF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AlQuraishi%20et%20al.%22%2C%22parsedDate%22%3A%222015-11-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M%2C%20Tang%20S%2C%20Xia%20X.%20An%20affinity-structure%20database%20of%20helix-turn-helix%3A%20DNA%20complexes%20with%20a%20universal%20coordinate%20system.%20BMC%20Bioinformatics%20%5BInternet%5D.%202015%20Nov%2019%3B16%281%29%3A390.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbmcbioinformatics.biomedcentral.com%5C%2Farticles%5C%2F10.1186%5C%2Fs12859-015-0819-2%27%3Ehttp%3A%5C%2F%5C%2Fbmcbioinformatics.biomedcentral.com%5C%2Farticles%5C%2F10.1186%5C%2Fs12859-015-0819-2%3C%5C%2Fa%3E%20PMCID%3A%20PMC4653904%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20affinity-structure%20database%20of%20helix-turn-helix%3A%20DNA%20complexes%20with%20a%20universal%20coordinate%20system%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengdong%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xide%22%2C%22lastName%22%3A%22Xia%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Molecular%20interactions%20between%20proteins%20and%20DNA%20molecules%20underlie%20many%20cellular%20processes%2C%20including%20transcriptional%20regulation%2C%20chromosome%20replication%2C%20and%20nucleosome%20positioning.%20Computational%20analyses%20of%20protein-DNA%20interactions%20rely%20on%20experimental%20data%20characterizing%20known%20protein-DNA%20interactions%20structurally%20and%20biochemically.%20While%20many%20databases%20exist%20that%20contain%20either%20structural%20or%20biochemical%20data%2C%20few%20integrate%20these%20two%20data%20sources%20in%20a%20unified%20fashion.%20Such%20integration%20is%20becoming%20increasingly%20critical%20with%20the%20rapid%20growth%20of%20structural%20and%20biochemical%20data%2C%20and%20the%20emergence%20of%20algorithms%20that%20rely%20on%20the%20synthesis%20of%20multiple%20data%20types%20to%20derive%20computational%20models%20of%20molecular%20interactions.%5CnDESCRIPTION%3A%20We%20have%20developed%20an%20integrated%20affinity-structure%20database%20in%20which%20the%20experimental%20and%20quantitative%20DNA%20binding%20affinities%20of%20helix-turn-helix%20proteins%20are%20mapped%20onto%20the%20crystal%20structures%20of%20the%20corresponding%20protein-DNA%20complexes.%20This%20database%20provides%20access%20to%3A%20%28i%29%20protein-DNA%20structures%2C%20%28ii%29%20quantitative%20summaries%20of%20protein-DNA%20binding%20affinities%20using%20position%20weight%20matrices%2C%20and%20%28iii%29%20raw%20experimental%20data%20of%20protein-DNA%20binding%20instances.%20Critically%2C%20this%20database%20establishes%20a%20correspondence%20between%20experimental%20structural%20data%20and%20quantitative%20binding%20affinity%20data%20at%20the%20single%20basepair%20level.%20Furthermore%2C%20we%20present%20a%20novel%20alignment%20algorithm%20that%20structurally%20aligns%20the%20protein-DNA%20complexes%20in%20the%20database%20and%20creates%20a%20unified%20residue-level%20coordinate%20system%20for%20comparing%20the%20physico-chemical%20environments%20at%20the%20interface%20between%20complexes.%20Using%20this%20unified%20coordinate%20system%2C%20we%20compute%20the%20statistics%20of%20atomic%20interactions%20at%20the%20protein-DNA%20interface%20of%20helix-turn-helix%20proteins.%20We%20provide%20an%20interactive%20website%20for%20visualization%2C%20querying%2C%20and%20analyzing%20this%20database%2C%20and%20a%20downloadable%20version%20to%20facilitate%20programmatic%20analysis.%5CnCONCLUSIONS%3A%20This%20database%20will%20facilitate%20the%20analysis%20of%20protein-DNA%20interactions%20and%20the%20development%20of%20programmatic%20computational%20methods%20that%20capitalize%20on%20integration%20of%20structural%20and%20biochemical%20datasets.%20The%20database%20can%20be%20accessed%20at%20http%3A%5C%2F%5C%2FProteinDNA.hms.harvard.edu.%22%2C%22date%22%3A%22Nov%2019%2C%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12859-015-0819-2%22%2C%22ISSN%22%3A%221471-2105%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbmcbioinformatics.biomedcentral.com%5C%2Farticles%5C%2F10.1186%5C%2Fs12859-015-0819-2%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222020-12-03T21%3A15%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22Z2G68AM8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Baym%20et%20al.%22%2C%22parsedDate%22%3A%222015-05-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBaym%20M%2C%20Kryazhimskiy%20S%2C%20Lieberman%20TD%2C%20Chung%20H%2C%20Desai%20MM%2C%20Kishony%20R.%20Inexpensive%20multiplexed%20library%20preparation%20for%20megabase-sized%20genomes.%20PLoS%20One.%202015%20May%2022%3B10%285%29%3Ae0128036.%20PMCID%3A%20PMC4441430%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inexpensive%20multiplexed%20library%20preparation%20for%20megabase-sized%20genomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%22%2C%22lastName%22%3A%22Kryazhimskiy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tami%20D.%22%2C%22lastName%22%3A%22Lieberman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hattie%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20M.%22%2C%22lastName%22%3A%22Desai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Kishony%22%7D%5D%2C%22abstractNote%22%3A%22Whole-genome%20sequencing%20has%20become%20an%20indispensible%20tool%20of%20modern%20biology.%20However%2C%20the%20cost%20of%20sample%20preparation%20relative%20to%20the%20cost%20of%20sequencing%20remains%20high%2C%20especially%20for%20small%20genomes%20where%20the%20former%20is%20dominant.%20Here%20we%20present%20a%20protocol%20for%20rapid%20and%20inexpensive%20preparation%20of%20hundreds%20of%20multiplexed%20genomic%20libraries%20for%20Illumina%20sequencing.%20By%20carrying%20out%20the%20Nextera%20tagmentation%20reaction%20in%20small%20volumes%2C%20replacing%20costly%20reagents%20with%20cheaper%20equivalents%2C%20and%20omitting%20unnecessary%20steps%2C%20we%20achieve%20a%20cost%20of%20library%20preparation%20of%20%248%20per%20sample%2C%20approximately%206%20times%20cheaper%20than%20the%20standard%20Nextera%20XT%20protocol.%20Furthermore%2C%20our%20procedure%20takes%20less%20than%205%20hours%20for%2096%20samples.%20Several%20hundred%20samples%20can%20then%20be%20pooled%20on%20the%20same%20HiSeq%20lane%20via%20custom%20barcodes.%20Our%20method%20will%20be%20useful%20for%20re-sequencing%20of%20microbial%20or%20viral%20genomes%2C%20including%20those%20from%20evolution%20experiments%2C%20genetic%20screens%2C%20and%20environmental%20samples%2C%20as%20well%20as%20for%20other%20sequencing%20applications%20including%20large%20amplicon%2C%20open%20chromosome%2C%20artificial%20chromosomes%2C%20and%20RNA%20sequencing.%22%2C%22date%22%3A%222015-05-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0128036%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-27T20%3A37%3A45Z%22%7D%7D%2C%7B%22key%22%3A%228YZAK2W7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Elia%20et%20al.%22%2C%22parsedDate%22%3A%222015-09-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EElia%20AEH%2C%20Boardman%20AP%2C%20Wang%20DC%2C%20Huttlin%20EL%2C%20Everley%20RA%2C%20Dephoure%20N%2C%20Zhou%20C%2C%20Koren%20I%2C%20Gygi%20SP%2C%20Elledge%20SJ.%20Quantitative%20proteomic%20atlas%20of%20ubiquitination%20and%20acetylation%20in%20the%20DNA%20damage%20response.%20Mol%20Cell.%202015%20Sep%203%3B59%285%29%3A867%26%23x2013%3B881.%20PMCID%3A%20PMC4560960%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Quantitative%20proteomic%20atlas%20of%20ubiquitination%20and%20acetylation%20in%20the%20DNA%20damage%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20E.%20H.%22%2C%22lastName%22%3A%22Elia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20P.%22%2C%22lastName%22%3A%22Boardman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20L.%22%2C%22lastName%22%3A%22Huttlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%22%2C%22lastName%22%3A%22Dephoure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chunshui%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itay%22%2C%22lastName%22%3A%22Koren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Elledge%22%7D%5D%2C%22abstractNote%22%3A%22Execution%20of%20the%20DNA%20damage%20response%20%28DDR%29%20relies%20upon%20a%20dynamic%20array%20of%20protein%20modifications.%20Using%20quantitative%20proteomics%2C%20we%20have%20globally%20profiled%20ubiquitination%2C%20acetylation%2C%20and%20phosphorylation%20in%20response%20to%20UV%20and%20ionizing%20radiation.%20To%20improve%20acetylation%20site%20profiling%2C%20we%20developed%20the%20strategy%20FACET-IP.%20Our%20datasets%20of%2033%2C500%20ubiquitination%20and%2016%2C740%20acetylation%20sites%20provide%20valuable%20insight%20into%20DDR%20remodeling%20of%20the%20proteome.%20We%20find%20that%20K6-%20and%20K33-linked%20polyubiquitination%20undergo%20bulk%20increases%20in%20response%20to%20DNA%20damage%2C%20raising%20the%20possibility%20that%20these%20linkages%20are%20largely%20dedicated%20to%20DDR%20function.%20We%20also%20show%20that%20Cullin-RING%20ligases%20mediate%2010%25%20of%20DNA%20damage-induced%20ubiquitination%20events%20and%20that%20EXO1%20is%20an%20SCF-Cyclin%20F%20substrate%20in%20the%20response%20to%20UV%20radiation.%20Our%20extensive%20datasets%20uncover%20additional%20regulated%20sites%20on%20known%20DDR%20players%20such%20as%20PCNA%20and%20identify%20previously%20unknown%20DDR%20targets%20such%20as%20CENPs%2C%20underscoring%20the%20broad%20impact%20of%20the%20DDR%20on%20cellular%20physiology.%22%2C%22date%22%3A%222015-09-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.molcel.2015.05.006%22%2C%22ISSN%22%3A%221097-4164%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-16T16%3A47%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22MUNTMDE8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fallahi-Sichani%20et%20al.%22%2C%22parsedDate%22%3A%222015-03-26%22%2C%22numChildren%22%3A9%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFallahi-Sichani%20M%2C%20Moerke%20NJ%2C%20Niepel%20M%2C%20Zhang%20T%2C%20Gray%20NS%2C%20Sorger%20PK.%20Systematic%20analysis%20of%20BRAF%28V600E%29%20melanomas%20reveals%20a%20role%20for%20JNK%5C%2Fc-Jun%20pathway%20in%20adaptive%20resistance%20to%20drug-induced%20apoptosis.%20Mol%20Syst%20Biol.%202015%20Mar%2026%3B11%283%29%3A797.%20PMCID%3A%20PMC4380931%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systematic%20analysis%20of%20BRAF%28V600E%29%20melanomas%20reveals%20a%20role%20for%20JNK%5C%2Fc-Jun%20pathway%20in%20adaptive%20resistance%20to%20drug-induced%20apoptosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20J.%22%2C%22lastName%22%3A%22Moerke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Niepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Drugs%20that%20inhibit%20RAF%5C%2FMEK%20signaling%2C%20such%20as%20vemurafenib%2C%20elicit%20profound%20but%20often%20temporary%20anti-tumor%20responses%20in%20patients%20with%20BRAF%28V%29%20%28600E%29%20melanoma.%20Adaptive%20responses%20to%20RAF%5C%2FMEK%20inhibition%20occur%20on%20a%20timescale%20of%20hours%20to%20days%2C%20involve%20homeostatic%20responses%20that%20reactivate%20MAP%20kinase%20signaling%20and%20compensatory%20mitogenic%20pathways%2C%20and%20attenuate%20the%20anti-tumor%20effects%20of%20RAF%5C%2FMEK%20inhibitors.%20We%20profile%20adaptive%20responses%20across%20a%20panel%20of%20melanoma%20cell%20lines%20using%20multiplex%20biochemical%20measurement%2C%20single-cell%20assays%2C%20and%20statistical%20modeling%20and%20show%20that%20adaptation%20involves%20at%20least%20six%20signaling%20cascades%20that%20act%20to%20reduce%20drug%20potency%20%28IC50%29%20and%20maximal%20effect%20%28i.e.%2C%20Emax%5Cu00a0%5Cu226a%5Cu00a01%29.%20Among%20these%20cascades%2C%20we%20identify%20a%20role%20for%20JNK%5C%2Fc-Jun%20signaling%20in%20vemurafenib%20adaptation%20and%20show%20that%20RAF%20and%20JNK%20inhibitors%20synergize%20in%20cell%20killing.%20This%20arises%20because%20JNK%20inhibition%20prevents%20a%20subset%20of%20cells%20in%20a%20cycling%20population%20from%20becoming%20quiescent%20upon%20vemurafenib%20treatment%2C%20thereby%20reducing%20drug%20Emax.%20Our%20findings%20demonstrate%20the%20breadth%20and%20diversity%20of%20adaptive%20responses%20to%20RAF%5C%2FMEK%20inhibition%20and%20a%20means%20to%20identify%20which%20steps%20in%20a%20signaling%20cascade%20are%20most%20predictive%20of%20phenotypic%20response.%22%2C%22date%22%3A%222015-03-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15252%5C%2Fmsb.20145877%22%2C%22ISSN%22%3A%221744-4292%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A49%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22DZWR3AEB%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Krukenberg%20et%20al.%22%2C%22parsedDate%22%3A%222015-04-23%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKrukenberg%20KA%2C%20Kim%20S%2C%20Tan%20ES%2C%20Maliga%20Z%2C%20Mitchison%20TJ.%20Extracellular%20poly%28ADP-ribose%29%20is%20a%20pro-inflammatory%20signal%20for%20macrophages.%20Chem%20Biol.%202015%20Apr%2023%3B22%284%29%3A446%26%23x2013%3B452.%20PMCID%3A%20PMC4409933%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracellular%20poly%28ADP-ribose%29%20is%20a%20pro-inflammatory%20signal%20for%20macrophages%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%20A.%22%2C%22lastName%22%3A%22Krukenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sujeong%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%20S.%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Poly%28ADP-ribose%29%20polymerase%201%20%28PARP1%29%20synthesizes%20poly%28ADP-ribose%29%20%28PAR%29%2C%20an%20essential%20post-translational%20modification%20whose%20function%20is%20important%20in%20many%20cellular%20processes%20including%20DNA%20damage%20signaling%2C%20cell%20death%2C%20and%20inflammation.%20All%20known%20PAR%20biology%20is%20intracellular%2C%20but%20we%20suspected%20it%20might%20also%20play%20a%20role%20in%20cell-to-cell%20communication%20during%20inflammation.%20We%20found%20that%20PAR%20activated%20cytokine%20release%20in%20human%20and%20mouse%20macrophages%2C%20a%20hallmark%20of%20innate%20immune%20activation%2C%20and%20determined%20structure-activity%20relationships.%20PAR%20was%20rapidly%20internalized%20by%20murine%20macrophages%2C%20while%20the%20monomer%2C%20ADP-ribose%2C%20was%20not.%20Inhibitors%20of%20Toll-like%20receptor%202%20%28TLR2%29%20and%20TLR4%20signaling%20blocked%20macrophage%20responses%20to%20PAR%2C%20and%20PAR%20induced%20TLR2%20and%20TLR4%20signaling%20in%20reporter%20cell%20lines%20suggesting%20it%20was%20recognized%20by%20these%20TLRs%2C%20much%20like%20bacterial%20pathogens.%20We%20propose%20that%20PAR%20acts%20as%20an%20extracellular%20damage%20associated%20molecular%20pattern%20that%20drives%20inflammatory%20signaling.%22%2C%22date%22%3A%222015-04-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chembiol.2015.03.007%22%2C%22ISSN%22%3A%221879-1301%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A12%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22ASETZFFG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222015-09-25%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELin%20JR%2C%20Fallahi-Sichani%20M%2C%20Sorger%20PK.%20Highly%20multiplexed%20imaging%20of%20single%20cells%20using%20a%20high-throughput%20cyclic%20immunofluorescence%20method.%20Nat%20Commun%20%5BInternet%5D.%202015%20Sep%2025%3B6%3A8390.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F26399630%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F26399630%3C%5C%2Fa%3E%20PMCID%3A%20PMC4587398%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Highly%20multiplexed%20imaging%20of%20single%20cells%20using%20a%20high-throughput%20cyclic%20immunofluorescence%20method%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Fallahi-Sichani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Single-cell%20analysis%20reveals%20aspects%20of%20cellular%20physiology%20not%20evident%20from%20population-based%20studies%2C%20particularly%20in%20the%20case%20of%20highly%20multiplexed%20methods%20such%20as%20mass%20cytometry%20%28CyTOF%29%20able%20to%20correlate%20the%20levels%20of%20multiple%20signalling%2C%20differentiation%20and%20cell%20fate%20markers.%20Immunofluorescence%20%28IF%29%20microscopy%20adds%20information%20on%20cell%20morphology%20and%20the%20microenvironment%20that%20are%20not%20obtained%20using%20flow-based%20techniques%2C%20but%20the%20multiplicity%20of%20conventional%20IF%20is%20limited.%20This%20has%20motivated%20development%20of%20imaging%20methods%20that%20require%20specialized%20instrumentation%2C%20exotic%20reagents%20or%20proprietary%20protocols%20that%20are%20difficult%20to%20reproduce%20in%20most%20laboratories.%20Here%20we%20report%20a%20public-domain%20method%20for%20achieving%20high%20multiplicity%20single-cell%20IF%20using%20cyclic%20immunofluorescence%20%28CycIF%29%2C%20a%20simple%20and%20versatile%20procedure%20in%20which%20four-colour%20staining%20alternates%20with%20chemical%20inactivation%20of%20fluorophores%20to%20progressively%20build%20a%20multichannel%20image.%20Because%20CycIF%20uses%20standard%20reagents%20and%20instrumentation%20and%20is%20no%20more%20expensive%20than%20conventional%20IF%2C%20it%20is%20suitable%20for%20high-throughput%20assays%20and%20screening%20applications.%22%2C%22date%22%3A%22September%2025%2C%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fncomms9390%22%2C%22ISSN%22%3A%222041-1723%20%28ELECTRONIC%29%202041-1723%20%28LINKING%29%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F26399630%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222022-02-14T17%3A32%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22PL92LU3L%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Muntel%20et%20al.%22%2C%22parsedDate%22%3A%222015-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMuntel%20J%2C%20Boswell%20SA%2C%20Tang%20S%2C%20Ahmed%20S%2C%20Wapinski%20I%2C%20Foley%20G%2C%20Steen%20H%2C%20Springer%20M.%20Abundance-based%20classifier%20for%20the%20prediction%20of%20mass%20spectrometric%20peptide%20detectability%20upon%20enrichment%20%28PPA%29.%20Mol%20Cell%20Proteomics.%202015%20Feb%3B14%282%29%3A430%26%23x2013%3B440.%20PMCID%3A%20PMC4350037%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Abundance-based%20classifier%20for%20the%20prediction%20of%20mass%20spectrometric%20peptide%20detectability%20upon%20enrichment%20%28PPA%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Muntel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaojun%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saima%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilan%22%2C%22lastName%22%3A%22Wapinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greg%22%2C%22lastName%22%3A%22Foley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanno%22%2C%22lastName%22%3A%22Steen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Springer%22%7D%5D%2C%22abstractNote%22%3A%22The%20function%20of%20a%20large%20percentage%20of%20proteins%20is%20modulated%20by%20post-translational%20modifications%20%28PTMs%29.%20Currently%2C%20mass%20spectrometry%20%28MS%29%20is%20the%20only%20proteome-wide%20technology%20that%20can%20identify%20PTMs.%20Unfortunately%2C%20the%20inability%20to%20detect%20a%20PTM%20by%20MS%20is%20not%20proof%20that%20the%20modification%20is%20not%20present.%20The%20detectability%20of%20peptides%20varies%20significantly%20making%20MS%20potentially%20blind%20to%20a%20large%20fraction%20of%20peptides.%20Learning%20from%20published%20algorithms%20that%20generally%20focus%20on%20predicting%20the%20most%20detectable%20peptides%20we%20developed%20a%20tool%20that%20incorporates%20protein%20abundance%20into%20the%20peptide%20prediction%20algorithm%20with%20the%20aim%20to%20determine%20the%20detectability%20of%20every%20peptide%20within%20a%20protein.%20We%20tested%20our%20tool%2C%20%5C%22Peptide%20Prediction%20with%20Abundance%5C%22%20%28PPA%29%2C%20on%20in-house%20acquired%20as%20well%20as%20published%20data%20sets%20from%20other%20groups%20acquired%20on%20different%20instrument%20platforms.%20Incorporation%20of%20protein%20abundance%20into%20the%20prediction%20allows%20us%20to%20assess%20not%20only%20the%20detectability%20of%20all%20peptides%20but%20also%20whether%20a%20peptide%20of%20interest%20is%20likely%20to%20become%20detectable%20upon%20enrichment.%20We%20validated%20the%20ability%20of%20our%20tool%20to%20predict%20changes%20in%20protein%20detectability%20with%20a%20dilution%20series%20of%2031%20purified%20proteins%20at%20several%20different%20concentrations.%20PPA%20predicted%20the%20concentration%20dependent%20peptide%20detectability%20in%2078%25%20of%20the%20cases%20correctly%2C%20demonstrating%20its%20utility%20for%20predicting%20the%20protein%20enrichment%20needed%20to%20observe%20a%20peptide%20of%20interest%20in%20targeted%20experiments.%20This%20is%20especially%20important%20in%20the%20analysis%20of%20PTMs.%20PPA%20is%20available%20as%20a%20web-based%20or%20executable%20package%20that%20can%20work%20with%20generally%20applicable%20defaults%20or%20retrained%20from%20a%20pilot%20MS%20data%20set.%22%2C%22date%22%3A%222015-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1074%5C%2Fmcp.M114.044321%22%2C%22ISSN%22%3A%221535-9484%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A13%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22L6TIJXRS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Palmer%20et%20al.%22%2C%22parsedDate%22%3A%222015-06-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Toprak%20E%2C%20Baym%20M%2C%20Kim%20S%2C%20Veres%20A%2C%20Bershtein%20S%2C%20Kishony%20R.%20Delayed%20commitment%20to%20evolutionary%20fate%20in%20antibiotic%20resistance%20fitness%20landscapes.%20Nat%20Commun.%202015%20Jun%2010%3B6%3A7385.%20PMCID%3A%20PMC4548896%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delayed%20commitment%20to%20evolutionary%20fate%20in%20antibiotic%20resistance%20fitness%20landscapes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erdal%22%2C%22lastName%22%3A%22Toprak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seungsoo%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Veres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shimon%22%2C%22lastName%22%3A%22Bershtein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Kishony%22%7D%5D%2C%22abstractNote%22%3A%22Predicting%20evolutionary%20paths%20to%20antibiotic%20resistance%20is%20key%20for%20understanding%20and%20controlling%20drug%20resistance.%20When%20considering%20a%20single%20final%20resistant%20genotype%2C%20epistatic%20contingencies%20among%20mutations%20restrict%20evolution%20to%20a%20small%20number%20of%20adaptive%20paths.%20Less%20attention%20has%20been%20given%20to%20multi-peak%20landscapes%2C%20and%20while%20specific%20peaks%20can%20be%20favoured%2C%20it%20is%20unknown%20whether%20and%20how%20early%20a%20commitment%20to%20final%20fate%20is%20made.%20Here%20we%20characterize%20a%20multi-peaked%20adaptive%20landscape%20for%20trimethoprim%20resistance%20by%20constructing%20all%20combinatorial%20alleles%20of%20seven%20resistance-conferring%20mutations%20in%20dihydrofolate%20reductase.%20We%20observe%20that%20epistatic%20interactions%20increase%20rather%20than%20decrease%20the%20accessibility%20of%20each%20peak%3B%20while%20they%20restrict%20the%20number%20of%20direct%20paths%2C%20they%20generate%20more%20indirect%20paths%2C%20where%20mutations%20are%20adaptively%20gained%20and%20later%20adaptively%20lost%20or%20changed.%20This%20enhanced%20accessibility%20allows%20evolution%20to%20proceed%20through%20many%20adaptive%20steps%20while%20delaying%20commitment%20to%20genotypic%20fate%2C%20hindering%20our%20ability%20to%20predict%20or%20control%20evolutionary%20outcomes.%22%2C%22date%22%3A%222015-06-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fncomms8385%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-25T22%3A15%3A32Z%22%7D%7D%2C%7B%22key%22%3A%2272QG4DSW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pavkovic%20et%20al.%22%2C%22parsedDate%22%3A%222015-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPavkovic%20M%2C%20Riefke%20B%2C%20Frisk%20AL%2C%20Gr%26%23xF6%3Bticke%20I%2C%20Ellinger-Ziegelbauer%20H.%20Glomerulonephritis-induced%20changes%20in%20kidney%20gene%20expression%20in%20rats.%20Genom%20Data%20%5BInternet%5D.%202015%20Dec%3B6%3A81%26%23x2013%3B82.%20Available%20from%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2213596015300131%27%3Ehttp%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2213596015300131%3C%5C%2Fa%3E%20PMCID%3A%20PMC4664719%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Glomerulonephritis-induced%20changes%20in%20kidney%20gene%20expression%20in%20rats%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bj%5Cu00f6rn%22%2C%22lastName%22%3A%22Riefke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna-Lena%22%2C%22lastName%22%3A%22Frisk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ina%22%2C%22lastName%22%3A%22Gr%5Cu00f6ticke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidrun%22%2C%22lastName%22%3A%22Ellinger-Ziegelbauer%22%7D%5D%2C%22abstractNote%22%3A%22We%20investigated%20a%20glomerulonephritis%20%28GN%29%20model%20in%20rats%20induced%20by%20nephrotoxic%20serum%20%28NTS%29%20which%20contains%20antibodies%20against%20the%20glomerular%20basement%20membrane%20%28GBM%29.%20The%20anti-GBM%20GN%20model%20in%20rats%20is%20widely%20used%20since%20its%20biochemical%20and%20histopathological%20characteristics%20are%20similar%20to%20crescentic%20nephritis%20and%20Goodpasture%27s%20disease%20in%20humans%20%28Pusey%2C%202003%5B2%5D%29.%20Male%20Wistar%20Kyoto%20%28WKY%29%20and%20Sprague-Dawley%20%28SD%29%20rats%20were%20dosed%20once%20with%201%2C%202.5%20and%205%5Cu00a0ml%5C%2Fkg%20nephrotoxic%20serum%20%28NTS%29%20or%201.5%20and%205%5Cu00a0ml%5C%2Fkg%20NTS%2C%20respectively.%20GN%20and%20tubular%20damage%20were%20observed%20histopathologically%20in%20all%20treated%20rats%20after%2014%5Cu00a0days.%20To%20obtain%20insight%20into%20molecular%20processes%20during%20GN%20pathogenesis%2C%20mRNA%20expression%20was%20investigated%20in%20WKY%20and%20SD%20kidneys%20using%20Affymetrix%27s%20GeneChip%20Rat%20genome%20230_2.0%20arrays%20%28GSE64265%29.%20The%20immunopathological%20processes%20during%20GN%20are%20still%20not%20fully%20understood%20and%20likely%20involve%20both%20innate%20and%20adaptive%20immunity.%20In%20the%20present%20study%2C%20several%20hundred%20mRNAs%20were%20found%20deregulated%2C%20which%20functionally%20were%20mostly%20associated%20with%20inflammation%20and%20regeneration.%20The%20%5Cu03b2-chain%20of%20the%20major%20histocompatibility%20complex%20class%20II%20RT1.B%20%28Rt1-Bb%29%20and%20complement%20component%206%20%28C6%29%20were%20identified%20as%20two%20mRNAs%20differentially%20expressed%20between%20WKY%20and%20SD%20rat%20strains%20which%20could%20be%20related%20to%20known%20different%20susceptibilities%20to%20NTS%20of%20different%20rat%20strains%3B%20both%20were%20increased%20in%20WKY%20and%20decreased%20in%20SD%20rats%20%28Pavkovic%20et%20al.%2C%202015%20%5B1%5D%29.%20Increased%20Rt1-Bb%20expression%20in%20WKY%20rats%20could%20indicate%20a%20stronger%20and%20more%20persistent%20cellular%20reaction%20of%20the%20adaptive%20immune%20system%20in%20this%20strain%2C%20in%20line%20with%20findings%20indicating%20adaptive%20immune%20reactions%20during%20GN.%20The%20complement%20cascade%20is%20also%20known%20to%20be%20essential%20for%20GN%20development%2C%20especially%20terminal%20cascade%20products%20like%20C6.%22%2C%22date%22%3A%222015-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.gdata.2015.08.021%22%2C%22ISSN%22%3A%222213-5960%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2213596015300131%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-05-11T14%3A20%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22ZJS7RFVD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pavkovic%20et%20al.%22%2C%22parsedDate%22%3A%222015-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPavkovic%20M%2C%20Riefke%20B%2C%20Frisk%20AL%2C%20Gr%26%23xF6%3Bticke%20I%2C%20Ellinger-Ziegelbauer%20H.%20Glomerulonephritis-Induced%20changes%20in%20urinary%20and%20kidney%20microRNA%20profiles%20in%20rats.%20Toxicol%20Sci.%202015%20Jun%3B145%282%29%3A348%26%23x2013%3B359.%20PMID%3A%2025758243%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Glomerulonephritis-Induced%20changes%20in%20urinary%20and%20kidney%20microRNA%20profiles%20in%20rats%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mira%22%2C%22lastName%22%3A%22Pavkovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bj%5Cu00f6rn%22%2C%22lastName%22%3A%22Riefke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna-Lena%22%2C%22lastName%22%3A%22Frisk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ina%22%2C%22lastName%22%3A%22Gr%5Cu00f6ticke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidrun%22%2C%22lastName%22%3A%22Ellinger-Ziegelbauer%22%7D%5D%2C%22abstractNote%22%3A%22MicroRNAs%20%28miRNAs%29%20regulate%20gene%20expression%20post-transcriptionally%20and%20thus%20are%20involved%20in%20various%20physiological%20and%20pathological%20states.%20Due%20to%20their%20stability%20in%20biofluids%20miRNAs%20have%20also%20been%20proposed%20as%20biomarkers%20%28BMs%29%20for%20tissue%20injury.%20We%20investigated%20the%20usefulness%20of%20urinary%20miRNAs%20for%20detection%20of%20site-specific%20renal%20damage%20in%20an%20antiglomerular%20basement%20membrane%20glomerulonephritis%20%28GN%29%20model%20in%20rats%20by%20comparing%20GN-induced%20urinary%20miRNAs%20profiles%20to%20traditional%20and%20newer%20protein%20BMs%2C%20and%20to%20proximal%20tubular%20injury-induced%20urinary%20miRNA%20profiles%20observed%20previously%20after%20cisplatin%20%28Cp%29%20treatment.%20Male%20Wistar%20Kyoto%20and%20Sprague%20Dawley%20rats%20were%20dosed%20once%20with%201%2C%202.5%2C%20and%205%5Cu2009ml%5C%2Fkg%20nephrotoxic%20serum%20%28NTS%29%20or%201.5%20and%205%5Cu2009ml%5C%2Fkg%20NTS%2C%20respectively.%20GN%20and%20tubular%20damage%20were%20observed%20histopathologically%20in%20all%20treated%20rats%20after%2014%20days.%20Although%20serum%20creatinine%20and%20BUN%20were%20not%20changed%2C%20several%20protein%20BMs%20and%2074%20urinary%20miRNAs%20were%20found%20to%20be%20increased%208%20and%2014%20days%20after%20NTS%20administration.%20Of%20these%2074%20miRNAs%2C%205%20were%20identified%20as%20increased%20after%20NTS%20but%20not%20after%20Cp%20treatment.%20Using%20in%20situ%20hybridization%20two%20of%20them%2C%20miR-10%5Cu2009b%20and%20-100%2C%20were%20found%20to%20be%20localized%20in%20distal%20segments%20of%20the%20nephron%2C%20potentially%20reflecting%20the%20tubular%20injury%20in%20those%20regions.%20Furthermore%2C%20evaluation%20of%20both%20miRNA%20and%20mRNA%20expression%20in%20the%20kidney%20revealed%20possible%20miRNA-mRNA%20interactions%20mostly%20associated%20with%20fibrotic%20and%20transforming%20growth%20factor%20%5Cu03b2%20signaling.%20In%20conclusion%2C%20our%20investigations%20support%20the%20potential%20of%20urinary%20miRNAs%20as%20specific%20BMs%20for%20kidney%20injury%2C%20and%20suggest%20a%20role%20of%20miRNAs%20in%20pathological%20processes%20during%20GN%20in%20the%20kidney.%22%2C%22date%22%3A%222015-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ftoxsci%5C%2Fkfv053%22%2C%22ISSN%22%3A%221096-0929%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-16T01%3A21%3A06Z%22%7D%7D%2C%7B%22key%22%3A%2272EZV4VK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xu%20et%20al.%22%2C%22parsedDate%22%3A%222015-07-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EXu%20X%2C%20Choi%20SH%2C%20Hu%20T%2C%20Tiyanont%20K%2C%20Habets%20R%2C%20Groot%20AJ%2C%20Vooijs%20M%2C%20Aster%20JC%2C%20Chopra%20R%2C%20Fryer%20C%2C%20Blacklow%20SC.%20Insights%20into%20autoregulation%20of%20Notch3%20from%20structural%20and%20functional%20studies%20of%20its%20negative%20regulatory%20region.%20Structure.%202015%20Jul%207%3B23%287%29%3A1227%26%23x2013%3B1235.%20PMCID%3A%20PMC4497832%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Insights%20into%20autoregulation%20of%20Notch3%20from%20structural%20and%20functional%20studies%20of%20its%20negative%20regulatory%20region%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sung%20Hee%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiancen%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kittichoat%22%2C%22lastName%22%3A%22Tiyanont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Habets%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arjan%20J.%22%2C%22lastName%22%3A%22Groot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Vooijs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%20C.%22%2C%22lastName%22%3A%22Aster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajiv%22%2C%22lastName%22%3A%22Chopra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christy%22%2C%22lastName%22%3A%22Fryer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20C.%22%2C%22lastName%22%3A%22Blacklow%22%7D%5D%2C%22abstractNote%22%3A%22Notch%20receptors%20are%20transmembrane%20proteins%20that%20undergo%20activating%20proteolysis%20in%20response%20to%20ligand%20stimulation.%20A%20negative%20regulatory%20region%20%28NRR%29%20maintains%20receptor%20quiescence%20by%20preventing%20protease%20cleavage%20prior%20to%20ligand%20binding.%20We%20report%20here%20the%20X-ray%20structure%20of%20the%20NRR%20of%20autoinhibited%20human%20Notch3%2C%20and%20compare%20it%20with%20the%20Notch1%20and%20Notch2%20NRRs.%20The%20overall%20architecture%20of%20the%20autoinhibited%20conformation%2C%20in%20which%20three%20LIN12-Notch%20repeat%20%28LNR%29%20modules%20wrap%20around%20a%20heterodimerization%20domain%2C%20is%20preserved%20in%20Notch3%2C%20but%20the%20autoinhibited%20conformation%20of%20the%20Notch3%20NRR%20is%20less%20stable.%20The%20Notch3%20NRR%20uses%20a%20highly%20conserved%20surface%20on%20the%20third%20LNR%20module%20to%20form%20a%20dimer%20in%20the%20crystal.%20Similar%20homotypic%20interfaces%20exist%20in%20Notch1%20and%20Notch2.%20Together%2C%20these%20studies%20reveal%20distinguishing%20structural%20features%20associated%20with%20increased%20basal%20activity%20of%20Notch3%2C%20demonstrate%20increased%20ligand-independent%20signaling%20for%20disease-associated%20mutations%20that%20map%20to%20the%20Notch3%20NRR%2C%20and%20identify%20a%20conserved%20dimerization%20interface%20present%20in%20multiple%20Notch%20receptors.%22%2C%22date%22%3A%222015-07-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.str.2015.05.001%22%2C%22ISSN%22%3A%221878-4186%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-12-16T16%3A46%3A20Z%22%7D%7D%5D%7D
1.
AlQuraishi M, Tang S, Xia X. An affinity-structure database of helix-turn-helix: DNA complexes with a universal coordinate system. BMC Bioinformatics [Internet]. 2015 Nov 19;16(1):390. Available from: http://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-015-0819-2 PMCID: PMC4653904
1.
Baym M, Kryazhimskiy S, Lieberman TD, Chung H, Desai MM, Kishony R. Inexpensive multiplexed library preparation for megabase-sized genomes. PLoS One. 2015 May 22;10(5):e0128036. PMCID: PMC4441430
1.
Elia AEH, Boardman AP, Wang DC, Huttlin EL, Everley RA, Dephoure N, Zhou C, Koren I, Gygi SP, Elledge SJ. Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response. Mol Cell. 2015 Sep 3;59(5):867–881. PMCID: PMC4560960
1.
Fallahi-Sichani M, Moerke NJ, Niepel M, Zhang T, Gray NS, Sorger PK. Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis. Mol Syst Biol. 2015 Mar 26;11(3):797. PMCID: PMC4380931
1.
Krukenberg KA, Kim S, Tan ES, Maliga Z, Mitchison TJ. Extracellular poly(ADP-ribose) is a pro-inflammatory signal for macrophages. Chem Biol. 2015 Apr 23;22(4):446–452. PMCID: PMC4409933
1.
Lin JR, Fallahi-Sichani M, Sorger PK. Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method. Nat Commun [Internet]. 2015 Sep 25;6:8390. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26399630 PMCID: PMC4587398
1.
Muntel J, Boswell SA, Tang S, Ahmed S, Wapinski I, Foley G, Steen H, Springer M. Abundance-based classifier for the prediction of mass spectrometric peptide detectability upon enrichment (PPA). Mol Cell Proteomics. 2015 Feb;14(2):430–440. PMCID: PMC4350037
1.
Palmer AC, Toprak E, Baym M, Kim S, Veres A, Bershtein S, Kishony R. Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes. Nat Commun. 2015 Jun 10;6:7385. PMCID: PMC4548896
1.
Pavkovic M, Riefke B, Frisk AL, Gröticke I, Ellinger-Ziegelbauer H. Glomerulonephritis-induced changes in kidney gene expression in rats. Genom Data [Internet]. 2015 Dec;6:81–82. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2213596015300131 PMCID: PMC4664719
1.
Pavkovic M, Riefke B, Frisk AL, Gröticke I, Ellinger-Ziegelbauer H. Glomerulonephritis-Induced changes in urinary and kidney microRNA profiles in rats. Toxicol Sci. 2015 Jun;145(2):348–359. PMID: 25758243
1.
Xu X, Choi SH, Hu T, Tiyanont K, Habets R, Groot AJ, Vooijs M, Aster JC, Chopra R, Fryer C, Blacklow SC. Insights into autoregulation of Notch3 from structural and functional studies of its negative regulatory region. Structure. 2015 Jul 7;23(7):1227–1235. PMCID: PMC4497832
2576724
IXMHRBF6
LSP Paper
2014
1
national-library-of-medicine-grant-proposals
50
creator
asc
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22V4Z4FVIL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AlQuraishi%20et%20al.%22%2C%22parsedDate%22%3A%222014-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlQuraishi%20M%2C%20Koytiger%20G%2C%20Jenney%20A%2C%20MacBeath%20G%2C%20Sorger%20PK.%20A%20multiscale%20statistical%20mechanical%20framework%20integrates%20biophysical%20and%20genomic%20data%20to%20assemble%20cancer%20networks.%20Nat%20Genet.%202014%20Dec%3B46%2812%29%3A1363%26%23x2013%3B1371.%20PMCID%3A%20PMC4244270%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20multiscale%20statistical%20mechanical%20framework%20integrates%20biophysical%20and%20genomic%20data%20to%20assemble%20cancer%20networks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22AlQuraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grigoriy%22%2C%22lastName%22%3A%22Koytiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Jenney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gavin%22%2C%22lastName%22%3A%22MacBeath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Functional%20interpretation%20of%20genomic%20variation%20is%20critical%20to%20understanding%20human%20disease%2C%20but%20it%20remains%20difficult%20to%20predict%20the%20effects%20of%20specific%20mutations%20on%20protein%20interaction%20networks%20and%20the%20phenotypes%20they%20regulate.%20We%20describe%20an%20analytical%20framework%20based%20on%20multiscale%20statistical%20mechanics%20that%20integrates%20genomic%20and%20biophysical%20data%20to%20model%20the%20human%20SH2-phosphoprotein%20network%20in%20normal%20and%20cancer%20cells.%20We%20apply%20our%20approach%20to%20data%20in%20The%20Cancer%20Genome%20Atlas%20%28TCGA%29%20and%20test%20model%20predictions%20experimentally.%20We%20find%20that%20mutations%20mapping%20to%20phosphoproteins%20often%20create%20new%20interactions%20but%20that%20mutations%20altering%20SH2%20domains%20result%20almost%20exclusively%20in%20loss%20of%20interactions.%20Some%20of%20these%20mutations%20eliminate%20all%20interactions%2C%20but%20many%20cause%20more%20selective%20loss%2C%20thereby%20rewiring%20specific%20edges%20in%20highly%20connected%20subnetworks.%20Moreover%2C%20idiosyncratic%20mutations%20appear%20to%20be%20as%20functionally%20consequential%20as%20recurrent%20mutations.%20By%20synthesizing%20genomic%2C%20structural%20and%20biochemical%20data%2C%20our%20framework%20represents%20a%20new%20approach%20to%20the%20interpretation%20of%20genetic%20variation.%22%2C%22date%22%3A%222014-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fng.3138%22%2C%22ISSN%22%3A%221546-1718%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-27T20%3A28%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22MN8YBQ2Z%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chung%20et%20al.%22%2C%22parsedDate%22%3A%222014-05-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChung%20JJ%2C%20Shim%20SH%2C%20Everley%20RA%2C%20Gygi%20SP%2C%20Zhuang%20X%2C%20Clapham%20DE.%20Structurally%20distinct%20Ca%282%2B%29%20signaling%20domains%20of%20sperm%20flagella%20orchestrate%20tyrosine%20phosphorylation%20and%20motility.%20Cell.%202014%20May%208%3B157%284%29%3A808%26%23x2013%3B822.%20PMCID%3A%20PMC4032590%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structurally%20distinct%20Ca%282%2B%29%20signaling%20domains%20of%20sperm%20flagella%20orchestrate%20tyrosine%20phosphorylation%20and%20motility%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Ju%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang-Hee%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaowei%22%2C%22lastName%22%3A%22Zhuang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Clapham%22%7D%5D%2C%22abstractNote%22%3A%22Spermatozoa%20must%20leave%20one%20organism%2C%20navigate%20long%20distances%2C%20and%20deliver%20their%20paternal%20DNA%20into%20a%20mature%20egg.%20For%20successful%20navigation%20and%20delivery%2C%20a%20sperm-specific%20calcium%20channel%20is%20activated%20in%20the%20mammalian%20flagellum.%20The%20genes%20encoding%20this%20channel%20%28CatSpers%29%20appear%20first%20in%20ancient%20uniflagellates%2C%20suggesting%20that%20sperm%20use%20adaptive%20strategies%20developed%20long%20ago%20for%20single-cell%20navigation.%20Here%2C%20using%20genetics%2C%20super-resolution%20fluorescence%20microscopy%2C%20and%20phosphoproteomics%2C%20we%20investigate%20the%20CatSper-dependent%20mechanisms%20underlying%20this%20flagellar%20switch.%20We%20find%20that%20the%20CatSper%20channel%20is%20required%20for%20four%20linear%20calcium%20domains%20that%20organize%20signaling%20proteins%20along%20the%20flagella.%20This%20unique%20structure%20focuses%20tyrosine%20phosphorylation%20in%20time%20and%20space%20as%20sperm%20acquire%20the%20capacity%20to%20fertilize.%20In%20heterogeneous%20sperm%20populations%2C%20we%20find%20unique%20molecular%20phenotypes%2C%20but%20only%20sperm%20with%20intact%20CatSper%20domains%20that%20organize%20time-dependent%20and%20spatially%20specific%20protein%20tyrosine%20phosphorylation%20successfully%20migrate.%20These%20findings%20illuminate%20flagellar%20adaptation%2C%20signal%20transduction%20cascade%20organization%2C%20and%20fertility.%22%2C%22date%22%3A%222014-05-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2014.02.056%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T15%3A55%3A50Z%22%7D%7D%2C%7B%22key%22%3A%229ZP2WU4P%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Palmer%20and%20Kishony%22%2C%22parsedDate%22%3A%222014-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPalmer%20AC%2C%20Kishony%20R.%20Opposing%20effects%20of%20target%20overexpression%20reveal%20drug%20mechanisms.%20Nat%20Commun.%202014%20Jul%201%3B5%3A4296.%20PMCID%3A%20PMC4408919%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Opposing%20effects%20of%20target%20overexpression%20reveal%20drug%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Kishony%22%7D%5D%2C%22abstractNote%22%3A%22Overexpression%20of%20a%20drug%27s%20molecular%20target%20often%20increases%20drug%20resistance%2C%20offering%20a%20pathway%20for%20adaptive%20evolution%20and%20a%20tool%20for%20target%20identification.%20It%20is%20unclear%20though%20why%20this%20phenomenon%20applies%20to%20some%20drugs%20but%20not%20others.%20Here%20we%20gradually%20overexpressed%20antibiotic%20targets%20in%20Escherichia%20coli%20and%20found%20that%20drug%20resistance%20can%20increase%2C%20remain%20unchanged%2C%20decrease%20or%20even%20change%20non-monotonically.%20Even%20a%20single%20target%20can%20produce%20opposing%20responses%20to%20its%20different%20inhibitors.%20We%20explain%20these%20contradicting%20effects%20with%20quantitative%20models%20of%20enzyme%20inhibition%20that%20account%20for%20fitness%20costs%20and%20the%20biochemical%20activity%20or%20inactivity%20of%20drug-enzyme%20complexes.%20Thus%2C%20target%20overexpression%20confers%20resistance%20or%20sensitivity%20as%20a%20predictable%20property%20of%20drug%20mechanism%2C%20explaining%20its%20variable%20presence%20in%20nature%20as%20a%20resistance%20mechanism.%20Though%20overexpression%20screens%20may%20fail%20at%20identifying%20unknown%20targets%2C%20overexpressing%20known%20or%20putative%20targets%20provides%20a%20systematic%20approach%20to%20distinguish%20between%20simple%20inhibition%20and%20complex%20mechanisms%20of%20drug%20action.%22%2C%22date%22%3A%222014-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fncomms5296%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222021-05-10T20%3A42%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22HI8LC4N2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pellegrini%20et%20al.%22%2C%22parsedDate%22%3A%222014-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPellegrini%20KL%2C%20Han%20T%2C%20Bijol%20V%2C%20Saikumar%20J%2C%20Craciun%20FL%2C%20Chen%20WW%2C%20Fuscoe%20JC%2C%20Vaidya%20VS.%20MicroRNA-155%20deficient%20mice%20experience%20heightened%20kidney%20toxicity%20when%20dosed%20with%20cisplatin.%20Toxicol%20Sci.%202014%20Oct%3B141%282%29%3A484%26%23x2013%3B492.%20PMCID%3A%20PMC4200048%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MicroRNA-155%20deficient%20mice%20experience%20heightened%20kidney%20toxicity%20when%20dosed%20with%20cisplatin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20L.%22%2C%22lastName%22%3A%22Pellegrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanesa%22%2C%22lastName%22%3A%22Bijol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janani%22%2C%22lastName%22%3A%22Saikumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florin%20L.%22%2C%22lastName%22%3A%22Craciun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20W.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%22%2C%22lastName%22%3A%22Fuscoe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20S.%22%2C%22lastName%22%3A%22Vaidya%22%7D%5D%2C%22abstractNote%22%3A%22The%20development%20of%20nephrotoxicity%20limits%20the%20maximum%20achievable%20dosage%20and%20treatment%20intervals%20for%20cisplatin%20chemotherapy.%20Therefore%2C%20identifying%20mechanisms%20that%20regulate%20this%20toxicity%20could%20offer%20novel%20methods%20to%20optimize%20cisplatin%20delivery.%20MicroRNAs%20are%20capable%20of%20regulating%20many%20different%20genes%2C%20and%20can%20influence%20diverse%20cellular%20processes%2C%20including%20cell%20death%20and%20apoptosis.%20We%20previously%20observed%20miR-155%20to%20be%20highly%20increased%20following%20ischemic%20or%20toxic%20injury%20to%20the%20kidneys%20and%2C%20therefore%2C%20sought%20to%20determine%20whether%20mice%20deficient%20in%20miR-155%20would%20respond%20differently%20to%20kidney%20injury.%20We%20treated%20C57BL%5C%2F6%20and%20miR-155%28-%5C%2F-%29%20mice%20with%2020%20mg%5C%2Fkg%20of%20cisplatin%20and%20found%20a%20significantly%20higher%20level%20of%20kidney%20injury%20in%20the%20miR-155%28-%5C%2F-%29%20mice.%20Genome-wide%20expression%20profiling%20and%20bioinformatic%20analysis%20indicated%20the%20activation%20of%20a%20number%20of%20canonical%20signaling%20pathways%20relating%20to%20apoptosis%20and%20oxidative%20stress%20over%20the%20course%20of%20the%20injury%2C%20and%20identified%20potential%20upstream%20regulators%20of%20these%20effects.%20One%20predicted%20upstream%20regulator%20was%20c-Fos%2C%20which%20has%20two%20confirmed%20miR-155%20binding%20sites%20in%20its%203%27%20UTR%20and%2C%20therefore%2C%20can%20be%20directly%20regulated%20by%20miR-155.%20We%20established%20that%20the%20miR-155%28-%5C%2F-%29%20mice%20had%20significantly%20higher%20levels%20of%20c-Fos%20mRNA%20and%20protein%20than%20the%20C57BL%5C%2F6%20mice%20at%2072%20h%20after%20cisplatin%20exposure.%20These%20data%20indicate%20a%20role%20for%20miR-155%20in%20the%20cisplatin%20response%20and%20suggest%20that%20targeting%20of%20c-Fos%20could%20be%20investigated%20to%20reduce%20cisplatin-induced%20nephrotoxicity.%22%2C%22date%22%3A%222014-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ftoxsci%5C%2Fkfu143%22%2C%22ISSN%22%3A%221096-0929%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A13%3A33Z%22%7D%7D%5D%7D
1.
AlQuraishi M, Koytiger G, Jenney A, MacBeath G, Sorger PK. A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks. Nat Genet. 2014 Dec;46(12):1363–1371. PMCID: PMC4244270
1.
Chung JJ, Shim SH, Everley RA, Gygi SP, Zhuang X, Clapham DE. Structurally distinct Ca(2+) signaling domains of sperm flagella orchestrate tyrosine phosphorylation and motility. Cell. 2014 May 8;157(4):808–822. PMCID: PMC4032590
1.
Palmer AC, Kishony R. Opposing effects of target overexpression reveal drug mechanisms. Nat Commun. 2014 Jul 1;5:4296. PMCID: PMC4408919
1.
Pellegrini KL, Han T, Bijol V, Saikumar J, Craciun FL, Chen WW, Fuscoe JC, Vaidya VS. MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin. Toxicol Sci. 2014 Oct;141(2):484–492. PMCID: PMC4200048
2576724
IXMHRBF6
LSP Paper
2013
1
national-library-of-medicine-grant-proposals
50
creator
asc
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22B6EMNAE2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Everley%20et%20al.%22%2C%22parsedDate%22%3A%222013-06-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EEverley%20RA%2C%20Kunz%20RC%2C%20McAllister%20FE%2C%20Gygi%20SP.%20Increasing%20throughput%20in%20targeted%20proteomics%20assays%3A%2054-plex%20quantitation%20in%20a%20single%20mass%20spectrometry%20run.%20Anal%20Chem.%202013%20Jun%204%3B85%2811%29%3A5340%26%23x2013%3B5346.%20PMID%3A%2023662842%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increasing%20throughput%20in%20targeted%20proteomics%20assays%3A%2054-plex%20quantitation%20in%20a%20single%20mass%20spectrometry%20run%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20C.%22%2C%22lastName%22%3A%22Kunz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%20E.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Gygi%22%7D%5D%2C%22abstractNote%22%3A%22Targeted%20proteomics%20assays%20such%20as%20those%20measuring%20end%20points%20in%20activity%20assays%20are%20sensitive%20and%20specific%20but%20often%20lack%20in%20throughput.%20In%20an%20effort%20to%20significantly%20increase%20throughput%2C%20a%20comparison%20was%20made%20between%20the%20traditional%20approach%20which%20utilizes%20an%20internal%20standard%20and%20the%20multiplexing%20approach%20which%20relies%20on%20isobaric%20tagging.%20A%20kinase%20activity%20assay%20was%20used%20for%20proof%20of%20concept%2C%20and%20experiments%20included%20three%20biological%20replicates%20for%20every%20condition.%20Results%20from%20the%20two%20approaches%20were%20highly%20similar%20with%20the%20multiplexing%20showing%20greater%20throughput.%20Two%20novel%206-plex%20isobaric%20tags%20were%20added%20for%20a%20total%20of%20three%206-plex%20experiments%20%2818-plex%29%20in%20a%20single%20run.%20Next%2C%20three%20mass%20variants%20of%20the%20target%20peptide%20were%20labeled%20with%20the%20three%20isobaric%20tags%20giving%20nine%206-plex%20reactions%20for%2054-plex%20quantitation%20in%20a%20single%20run.%20Since%20the%20multiplexing%20approach%20allows%20all%20samples%20to%20be%20combined%20prior%20to%20purification%20and%20acquisition%2C%20the%2054-plex%20approach%20resulted%20in%20a%20significant%20reduction%20in%20purification%20resources%20%28time%2C%20reagents%2C%20etc.%29%20and%20a%20~50-fold%20improvement%20in%20acquisition%20throughput.%20We%20demonstrate%20the%2054-plex%20assay%20in%20several%20ways%20including%20measuring%20inhibition%20of%20PKA%20activity%20in%20MCF7%20cell%20lysates%20for%20a%20panel%20of%20nine%20compounds.%22%2C%22date%22%3A%222013-06-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Fac400845e%22%2C%22ISSN%22%3A%221520-6882%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A12%3A33Z%22%7D%7D%5D%7D
1.
Everley RA, Kunz RC, McAllister FE, Gygi SP. Increasing throughput in targeted proteomics assays: 54-plex quantitation in a single mass spectrometry run. Anal Chem. 2013 Jun 4;85(11):5340–5346. PMID: 23662842
2576724
IXMHRBF6
LSP Paper
2011
1
national-library-of-medicine-grant-proposals
50
creator
asc
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TVQEU9PK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Orth%20et%20al.%22%2C%22parsedDate%22%3A%222011-07-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOrth%20JD%2C%20Kohler%20RH%2C%20Foijer%20F%2C%20Sorger%20PK%2C%20Weissleder%20R%2C%20Mitchison%20TJ.%20Analysis%20of%20mitosis%20and%20antimitotic%20drug%20responses%20in%20tumors%20by%20in%20vivo%20microscopy%20and%20single-cell%20pharmacodynamics.%20Cancer%20Res.%202011%20Jul%201%3B71%2813%29%3A4608%26%23x2013%3B4616.%20PMCID%3A%20PMC3129392%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Analysis%20of%20mitosis%20and%20antimitotic%20drug%20responses%20in%20tumors%20by%20in%20vivo%20microscopy%20and%20single-cell%20pharmacodynamics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20D.%22%2C%22lastName%22%3A%22Orth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rainer%20H.%22%2C%22lastName%22%3A%22Kohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Floris%22%2C%22lastName%22%3A%22Foijer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%22%2C%22lastName%22%3A%22Weissleder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Cancer%20relies%20upon%20frequent%20or%20abnormal%20cell%20division%2C%20but%20how%20the%20tumor%20microenvironment%20affects%20mitotic%20processes%20in%20vivo%20remains%20unclear%2C%20largely%20due%20to%20the%20technical%20challenges%20of%20optical%20access%2C%20spatial%20resolution%2C%20and%20motion.%20We%20developed%20high-resolution%20in%20vivo%20microscopy%20methods%20to%20visualize%20mitosis%20in%20a%20murine%20xenograft%20model%20of%20human%20cancer.%20Using%20these%20methods%2C%20we%20determined%20whether%20the%20single-cell%20response%20to%20the%20antimitotic%20drug%20paclitaxel%20%28Ptx%29%20was%20the%20same%20in%20tumors%20as%20in%20cell%20culture%2C%20observed%20the%20impact%20of%20Ptx%20on%20the%20tumor%20response%20as%20a%20whole%2C%20and%20evaluated%20the%20single-cell%20pharmacodynamics%20%28PD%29%20of%20Ptx%20%28by%20in%20vivo%20PD%20microscopy%29.%20Mitotic%20initiation%20was%20generally%20less%20frequent%20in%20tumors%20than%20in%20cell%20culture%2C%20but%20subsequently%20it%20proceeded%20normally.%20Ptx%20treatment%20caused%20spindle%20assembly%20defects%20and%20mitotic%20arrest%2C%20followed%20by%20slippage%20from%20mitotic%20arrest%2C%20multinucleation%2C%20and%20apoptosis.%20Compared%20with%20cell%20culture%2C%20the%20peak%20mitotic%20index%20in%20tumors%20exposed%20to%20Ptx%20was%20lower%20and%20the%20tumor%20cells%20survived%20longer%20after%20mitotic%20arrest%2C%20becoming%20multinucleated%20rather%20than%20dying%20directly%20from%20mitotic%20arrest.%20Thus%2C%20the%20tumor%20microenvironment%20was%20much%20less%20proapoptotic%20than%20cell%20culture.%20The%20morphologies%20associated%20with%20mitotic%20arrest%20were%20dose%20and%20time%20dependent%2C%20thereby%20providing%20a%20semiquantitative%2C%20single-cell%20measure%20of%20PD.%20Although%20many%20tumor%20cells%20did%20not%20progress%20through%20Ptx-induced%20mitotic%20arrest%2C%20tumor%20significantly%20regressed%20in%20the%20model.%20Our%20findings%20show%20that%20in%20vivo%20microscopy%20offers%20a%20useful%20tool%20to%20visualize%20mitosis%20during%20tumor%20progression%2C%20drug%20responses%2C%20and%20cell%20fate%20at%20the%20single-cell%20level.%22%2C%22date%22%3A%222011-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-11-0412%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222023-10-30T23%3A14%3A27Z%22%7D%7D%5D%7D
1.
Orth JD, Kohler RH, Foijer F, Sorger PK, Weissleder R, Mitchison TJ. Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res. 2011 Jul 1;71(13):4608–4616. PMCID: PMC3129392